Citrus Sinensis ID: 017712
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 367 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.629 | 0.228 | 0.502 | 1e-65 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.629 | 0.224 | 0.485 | 3e-61 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.626 | 0.224 | 0.470 | 2e-57 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.599 | 0.224 | 0.406 | 2e-42 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.588 | 0.180 | 0.411 | 3e-40 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.588 | 0.178 | 0.398 | 7e-40 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.588 | 0.178 | 0.393 | 3e-39 | |
| Q9ZPS9 | 1143 | Serine/threonine-protein | no | no | 0.645 | 0.207 | 0.379 | 2e-38 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.577 | 0.180 | 0.377 | 7e-38 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.615 | 0.221 | 0.379 | 9e-38 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 250 bits (638), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 119/237 (50%), Positives = 166/237 (70%), Gaps = 6/237 (2%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+ DL NATNGFSS+N++G+G+FG+VY L + +AVKV N+ R G KSF +EC++
Sbjct: 691 SYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECES 750
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
+I+HRN+V++ TA S +D+QG F+A++Y+FMPNGSL+ WL ++ + +
Sbjct: 751 LKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTL 810
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
++L+IAIDVA L YLH C PIAHC+LKPSNVLLDD++ HV DFG+AR L D++
Sbjct: 811 LERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEE 870
Query: 315 NRF-----ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366
+ F ++G+ GY PEY +G + S GDVYSFGILLLEMFTG RP++ +F G
Sbjct: 871 SFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGG 927
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (601), Expect = 3e-61, Method: Compositional matrix adjust.
Identities = 115/237 (48%), Positives = 166/237 (70%), Gaps = 6/237 (2%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+++L++AT+ FSS NLIG+GNFG+V+ G L + +AVKV NL++ G +KSF +EC+
Sbjct: 701 SYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECET 760
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
I+HRN+V++ T S +D +G F+A+VY+FMP GSL+ WL+ +D + +
Sbjct: 761 FKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTP 820
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
+KL+IAIDVA AL YLH C P+AHC++KPSN+LLDD++ HV DFG+A+ L D++
Sbjct: 821 AEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRE 880
Query: 315 ---NRFIC--IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366
N+F ++G+ GY PEY +G + S GDVYSFGILLLEMF+G +P+D F G
Sbjct: 881 SFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAG 937
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (569), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 111/236 (47%), Positives = 156/236 (66%), Gaps = 6/236 (2%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+ +LY T GFSS+NLIG+GNFG+V+ G L +A+KV NL + G +KSF +EC+A
Sbjct: 708 SYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEA 767
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
I+HRN+V++ T S D++G F+A+VY+FMPNG+L+ WL + + +
Sbjct: 768 LGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGL 827
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
+L+IAIDVA AL YLH C PIAHC++KPSN+LLD ++ HV DFG+A+ L D+
Sbjct: 828 FARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRD 887
Query: 315 NRFI-----CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365
I ++G+ GY PEY +G S GDVYSFGI+LLE+FTG RP++ +F
Sbjct: 888 TFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFV 943
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 173 bits (439), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 104/256 (40%), Positives = 146/256 (57%), Gaps = 36/256 (14%)
Query: 127 EGKQTINNP-----SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR 181
E KQ N+P S++ L AT GF++++LIG+G FG VY G L + T +AVKV +
Sbjct: 636 EEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLD--- 692
Query: 182 PGG----SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL 237
P S SFK EC+ +HRN++R+ T S F A+V MPNGSLE L
Sbjct: 693 PKTALEFSGSFKRECQILKRTRHRNLIRIITTCSK-----PGFNALVLPLMPNGSLERHL 747
Query: 238 RGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297
+ ++ N + + ++I DVA + YLH + HC+LKPSN+LLDDEM
Sbjct: 748 YPGEYSSK-----NLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTA 802
Query: 298 HVGDFGMARFLPAIDKQ------------NRFICIKGSTGYIPPEYDLGCEASTYGDVYS 345
V DFG++R + +++ + +C GS GYI PEY +G AST+GDVYS
Sbjct: 803 LVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLC--GSVGYIAPEYGMGKRASTHGDVYS 860
Query: 346 FGILLLEMFTGIRPSD 361
FG+LLLE+ +G RP+D
Sbjct: 861 FGVLLLEIVSGRRPTD 876
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 166 bits (420), Expect = 3e-40, Method: Compositional matrix adjust.
Identities = 93/226 (41%), Positives = 132/226 (58%), Gaps = 10/226 (4%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
+F DL ATNGF + +LIG+G FG VY L DG+ +A+K + G + F +E +
Sbjct: 872 TFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETI 931
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
IKHRN+V + + V + + +VY+FM GSLE+ L D + N+ +
Sbjct: 932 GKIKHRNLVPLL-GYCKVGDE----RLLVYEFMKYGSLEDVLH---DPKKAGVKLNWSTR 983
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+K IAI A L +LH +C P I H ++K SNVLLD+ + V DFGMAR + A+D
Sbjct: 984 RK--IAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHL 1041
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
+ G+ GY+PPEY ST GDVYS+G++LLE+ TG RP+D
Sbjct: 1042 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTD 1087
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 164 bits (416), Expect = 7e-40, Method: Compositional matrix adjust.
Identities = 90/226 (39%), Positives = 133/226 (58%), Gaps = 10/226 (4%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
+F DL ATNGF + +L+G+G FG VY L DG+ +A+K + G + F +E +
Sbjct: 877 TFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETI 936
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
IKHRN+V + + V + + +VY++M GSLE+ L + T + N+ +
Sbjct: 937 GKIKHRNLVPLL-GYCKVGEE----RLLVYEYMKYGSLEDVLHDRKKTG---IKLNWPAR 988
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+K IAI A L +LH +C P I H ++K SNVLLD+ + V DFGMAR + A+D
Sbjct: 989 RK--IAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHL 1046
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
+ G+ GY+PPEY ST GDVYS+G++LLE+ TG +P+D
Sbjct: 1047 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTD 1092
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 162 bits (411), Expect = 3e-39, Method: Compositional matrix adjust.
Identities = 89/226 (39%), Positives = 132/226 (58%), Gaps = 10/226 (4%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
+F DL ATNGF + +L+G+G FG VY L DG+ +A+K + G + F +E +
Sbjct: 877 TFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETI 936
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
IKHRN+V + + V + + +VY++M GSLE+ L + + N+ +
Sbjct: 937 GKIKHRNLVPLL-GYCKVGEE----RLLVYEYMKYGSLEDVLHDRKKIG---IKLNWPAR 988
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+K IAI A L +LH +C P I H ++K SNVLLD+ + V DFGMAR + A+D
Sbjct: 989 RK--IAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHL 1046
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
+ G+ GY+PPEY ST GDVYS+G++LLE+ TG +P+D
Sbjct: 1047 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTD 1092
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 160 bits (404), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 93/245 (37%), Positives = 138/245 (56%), Gaps = 8/245 (3%)
Query: 117 KKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKV 176
+K+ L V ++ + F L ATNGFS+A++IG G FG V+ TL DG+++A+K
Sbjct: 808 EKEPLSINVATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSVAIKK 867
Query: 177 FNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEW 236
+ G + F +E + IKHRN+V + + + + + +VY+FM GSLEE
Sbjct: 868 LIRLSCQGDREFMAEMETLGKIKHRNLVPLL-GYCKIGEE----RLLVYEFMQYGSLEEV 922
Query: 237 LRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296
L G R + + +KK IA A L +LH +C P I H ++K SNVLLD +M
Sbjct: 923 LHGPRTGEKRRI-LGWEERKK--IAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDME 979
Query: 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
V DFGMAR + A+D + G+ GY+PPEY + GDVYS G+++LE+ +G
Sbjct: 980 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEILSG 1039
Query: 357 IRPSD 361
RP+D
Sbjct: 1040 KRPTD 1044
|
Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 158 bits (399), Expect = 7e-38, Method: Compositional matrix adjust.
Identities = 86/228 (37%), Positives = 133/228 (58%), Gaps = 16/228 (7%)
Query: 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGSKSFKSECKAA 195
K+L AT+ F+SAN+IG+ + +VY G L DGT IAVKV NL K F +E K
Sbjct: 861 KELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTL 920
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
+KHRN+V++ G ++ + KA+V FM NG+LE+ + G + P+ +
Sbjct: 921 SQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIHG----SAAPIGS---LL 969
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+K+D+ + +A + YLH PI HC+LKP+N+LLD + + HV DFG AR L + +
Sbjct: 970 EKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGS 1029
Query: 316 RFI---CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360
+G+ GY+ PE+ + +T DV+SFGI+++E+ T RP+
Sbjct: 1030 TTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPT 1077
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 157 bits (398), Expect = 9e-38, Method: Compositional matrix adjust.
Identities = 90/237 (37%), Positives = 132/237 (55%), Gaps = 11/237 (4%)
Query: 125 VYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG 184
++ K + N S D+ +T+ F+ AN+IG G FG VY TL DGT +A+K +
Sbjct: 721 LFHNKDSNNELSLDDILKSTSSFNQANIIGCGGFGLVYKATLPDGTKVAIKRLSGDTGQM 780
Query: 185 SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN 244
+ F++E + +H N+V + +Y+ K ++Y +M NGSL+ WL K D
Sbjct: 781 DREFQAEVETLSRAQHPNLVHLLGY---CNYKND--KLLIYSYMDNGSLDYWLHEKVDG- 834
Query: 245 WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304
P + ++ K +L IA A L YLH C+P I H ++K SN+LL D + H+ DFG+
Sbjct: 835 --PPSLDW--KTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTFVAHLADFGL 890
Query: 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
AR + D + G+ GYIPPEY A+ GDVYSFG++LLE+ TG RP D
Sbjct: 891 ARLILPYDTHVTTDLV-GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGRRPMD 946
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 367 | ||||||
| 359486510 | 965 | PREDICTED: probable LRR receptor-like se | 0.618 | 0.235 | 0.621 | 8e-76 | |
| 449440271 | 1343 | PREDICTED: LOW QUALITY PROTEIN: putative | 0.885 | 0.241 | 0.420 | 6e-74 | |
| 255585471 | 963 | serine-threonine protein kinase, plant-t | 0.891 | 0.339 | 0.464 | 1e-73 | |
| 224081190 | 1011 | predicted protein [Populus trichocarpa] | 0.623 | 0.226 | 0.591 | 2e-73 | |
| 224097750 | 1023 | predicted protein [Populus trichocarpa] | 0.643 | 0.230 | 0.574 | 7e-73 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.643 | 0.230 | 0.578 | 8e-73 | |
| 255586722 | 936 | serine-threonine protein kinase, plant-t | 0.621 | 0.243 | 0.608 | 2e-72 | |
| 224135241 | 985 | predicted protein [Populus trichocarpa] | 0.673 | 0.250 | 0.551 | 5e-72 | |
| 449483700 | 1343 | PREDICTED: LOW QUALITY PROTEIN: putative | 0.885 | 0.241 | 0.412 | 4e-71 | |
| 224116466 | 1008 | predicted protein [Populus trichocarpa] | 0.618 | 0.225 | 0.579 | 6e-70 |
| >gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 290 bits (742), Expect = 8e-76, Method: Compositional matrix adjust.
Identities = 148/238 (62%), Positives = 176/238 (73%), Gaps = 11/238 (4%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKA 194
S++ L AT+GFSS+NLIG G+FGSVY G L DGT IAVKV NL+R G SKSF +EC+A
Sbjct: 627 SYQSLLRATDGFSSSNLIGVGSFGSVYKGILDHDGTAIAVKVLNLLRKGASKSFIAECEA 686
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDT---NWRPLNFN 251
NI+HRN+V+V TA SGVDYQG FKAVVY+FM NGSLE+WL T + P N
Sbjct: 687 LRNIRHRNLVKVLTACSGVDYQGNDFKAVVYEFMVNGSLEQWLHPTPTTAEASAPPRKLN 746
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
FL ++L+IAIDVACAL YLH CQ PI HC+LKPSNVLLD EM GHVGDFG+A+FLP
Sbjct: 747 FL--QRLNIAIDVACALDYLHHQCQTPIVHCDLKPSNVLLDTEMTGHVGDFGIAKFLPEA 804
Query: 312 -----DKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364
+ Q+ I I+G+ GY PEY +G E ST GDVYSFGILLLEMFTG RP++ +F
Sbjct: 805 ATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKRPTEDMF 862
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440271|ref|XP_004137908.1| PREDICTED: LOW QUALITY PROTEIN: putative receptor-like protein kinase At3g47110-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 284 bits (726), Expect = 6e-74, Method: Compositional matrix adjust.
Identities = 157/373 (42%), Positives = 218/373 (58%), Gaps = 48/373 (12%)
Query: 4 VSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILD-VVFFQEIE 62
+S GD++S+GILLLEM G RP DD F +++++H F + ALP A I+D + F+E
Sbjct: 890 ISIEGDIFSYGILLLEMIIGKRPTDDTFGNDMDIHLFTRRALPRDALSIIDPSILFEETC 949
Query: 63 EEETMYKKASSTCTQSSII----LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118
+EE K S I+ +ECL+SI R G+ CS P+ER ++ V + L+ IK
Sbjct: 950 QEENNDDKVKSGEDHKEIVPRWKVECLVSIMRIGLTCSLRAPSERTSMSVVVNELQAIKS 1009
Query: 119 KLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFN 178
LK T+ + +D+ G+ +AVKV N
Sbjct: 1010 SYLK-------GTLKVLALRDIS-------------------------LHGSMVAVKVLN 1037
Query: 179 LIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR 238
L + G SKS EC A NI+HRN++++ T+ S +D QG FKA+V+ FM NG+L+ WL
Sbjct: 1038 LQQQGASKSTVDECNALSNIRHRNLLKIITSCSSIDGQGDEFKALVFNFMSNGNLDSWLH 1097
Query: 239 GKDD-TNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297
+ TN R L+ + ++L+IAID+AC L YLH C+PPIAHC+LKPSN+LLDD+M+
Sbjct: 1098 STNQGTNQRRLS----LIQRLNIAIDIACGLDYLHNHCEPPIAHCDLKPSNILLDDDMVA 1153
Query: 298 HVGDFGMARFL--PAIDK----QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLL 351
HVGDFG+AR + + D+ Q + +KGS GYIPPEY G S GDV+S+GILLL
Sbjct: 1154 HVGDFGLARLMLEESNDQISFSQTMSLALKGSVGYIPPEYGSGSRISIEGDVFSYGILLL 1213
Query: 352 EMFTGIRPSDGIF 364
EM G RP D F
Sbjct: 1214 EMIIGKRPIDDTF 1226
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585471|ref|XP_002533428.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526716|gb|EEF28948.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 283 bits (723), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 165/355 (46%), Positives = 223/355 (62%), Gaps = 28/355 (7%)
Query: 36 NLHNFVKSALPE-RAEEILDVV--FFQEIEEEETMYKKASSTCTQSSIIL-----ECLIS 87
N + S+L RA +ILD+ + + ++K AS+T + + +L E +
Sbjct: 556 NFQGLIPSSLSSLRALQILDLSNNHLSGMVPSKGIFKNASATSVEGNNMLCGGIPEFQLP 615
Query: 88 ICRTGVACSAEL-PNERMKINDVESRLRLI---------KKKLLKTPVYEGKQTINNPSF 137
+C + L P + I+ + LI +KK+ +T ++ I S+
Sbjct: 616 VCNSARHKKNRLTPVLKTVISAISGMAFLILMLYLFWFRQKKVNETTADFSEKKIMELSY 675
Query: 138 KDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAI 196
++L+ AT+GFSSAN+IG G+FGSVY G L +GT IAVKVFNL+R GG KSF +EC+A
Sbjct: 676 QNLHKATDGFSSANIIGMGSFGSVYKGRLDREGTLIAVKVFNLMRRGGFKSFLAECEALR 735
Query: 197 NIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPL---NFNFL 253
NI+HRN+++V TA S +DY G FKA+VY+FM NGSLEEWL TN L NFL
Sbjct: 736 NIRHRNLLKVLTACSSLDYHGNDFKALVYEFMVNGSLEEWLHPPVATNEAELETRKLNFL 795
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
++L+IAIDVA AL YLH C+P I HC+LKPSN+LLD+E+ GHVGDFG+ARFL +
Sbjct: 796 --QRLNIAIDVASALYYLHHHCEPQIVHCDLKPSNILLDEELTGHVGDFGLARFLLDATQ 853
Query: 314 ----QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364
Q+ I ++G+ GY PPEY + E STYGDVYS+GILLLEMFTG RP D +F
Sbjct: 854 NHYTQSSSIGVRGTVGYAPPEYGMSSEVSTYGDVYSYGILLLEMFTGKRPMDDMF 908
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 281 bits (720), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 139/235 (59%), Positives = 172/235 (73%), Gaps = 6/235 (2%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKA 194
+++DL AT+GFSS+NL+GAG FGSVY GTL DG +AVKV NL+R G SKSF +EC A
Sbjct: 692 TYQDLLQATDGFSSSNLVGAGAFGSVYRGTLTSDGAVVAVKVLNLLRKGASKSFMAECAA 751
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
INI+HRN+V+V TA S D+QG FKA+VY+FM NGSLEEWL ++ P N +
Sbjct: 752 LINIRHRNLVKVITACSSNDFQGNDFKALVYEFMVNGSLEEWLHPVHISDVTPETRNLDL 811
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
++L+IAIDVA AL YLH CQ P+ HC+LKPSNVLL D+M VGDFG+ARFLP Q
Sbjct: 812 VQRLNIAIDVASALDYLHNHCQVPVVHCDLKPSNVLLGDDMTACVGDFGLARFLPEASNQ 871
Query: 315 -----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364
+ + +KG+ GY PEY +G E STYGDVYS+GILLLEMFTG RP+DG+F
Sbjct: 872 LPADESSSVGLKGTIGYAAPEYGMGSEVSTYGDVYSYGILLLEMFTGRRPTDGMF 926
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 280 bits (716), Expect = 7e-73, Method: Compositional matrix adjust.
Identities = 139/242 (57%), Positives = 173/242 (71%), Gaps = 6/242 (2%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKS 187
+ T +++DL AT GFS ANLIGAG+FGSVY G L DG +AVKVFNL+R G SKS
Sbjct: 687 ESTFQRVAYEDLLQATKGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKS 746
Query: 188 FKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP 247
F +EC A INI+HRN+V+V TA SG+D+QG FKA+VY+FM NGSLEEWL ++
Sbjct: 747 FMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPVQISDEAH 806
Query: 248 LNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
+ + + ++L+IAIDVA AL YLH CQ +AHC+LKPSNVLLD +M HVGDFG+AR
Sbjct: 807 VRRDLSLLQRLNIAIDVASALDYLHNHCQIAVAHCDLKPSNVLLDGDMTAHVGDFGLARL 866
Query: 308 LPAIDK-----QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
LP Q I +KG+ GY PEY LG E S YGDVYS+GILLLE+FTG RP++G
Sbjct: 867 LPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTNG 926
Query: 363 IF 364
+F
Sbjct: 927 LF 928
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 280 bits (716), Expect = 8e-73, Method: Compositional matrix adjust.
Identities = 140/242 (57%), Positives = 172/242 (71%), Gaps = 6/242 (2%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKS 187
+ T +++DL ATNGFS ANLIGAG+FGSVY G L DG +AVKVFNL+R G SKS
Sbjct: 689 ESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKS 748
Query: 188 FKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP 247
F +EC A INI+HRN+V+V TA SG+D+QG FKA+VY+FM NGSLEEWL ++
Sbjct: 749 FMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQISDEAH 808
Query: 248 LNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
+ + ++L+IAIDVA AL YLH CQ I HC+LKPSNVLLD ++ HVGDFG+AR
Sbjct: 809 RRRDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGLARL 868
Query: 308 LPAIDK-----QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
LP Q I +KG+ GY PEY LG E S YGDVYS+GILLLE+FTG RP+DG
Sbjct: 869 LPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTDG 928
Query: 363 IF 364
+F
Sbjct: 929 LF 930
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586722|ref|XP_002533985.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526036|gb|EEF28405.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 278 bits (712), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 140/230 (60%), Positives = 170/230 (73%), Gaps = 2/230 (0%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDG-TTIAVKVFNLIRPGGSKSFKSECKA 194
S+ LY AT+GFSSAN +GAG+FG+V+ G L G T+IAVKVFNL+R G KSF +EC+A
Sbjct: 619 SYHTLYKATDGFSSANTLGAGSFGTVFKGELGGGETSIAVKVFNLMRHGAFKSFIAECEA 678
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
NI+HRN+V+V TA S VDYQG FKA+VY+FM NGSLEEWL D+ P N N I
Sbjct: 679 LRNIRHRNLVKVLTACSSVDYQGNEFKALVYEFMVNGSLEEWLHPPDEAKAIPRN-NLNI 737
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
++L+IA+DVACAL YLH C+ PI HC+LKPSN+LLD+EM GHVGDFG+A+F Q
Sbjct: 738 LQRLNIAVDVACALDYLHNHCETPIIHCDLKPSNILLDNEMTGHVGDFGLAKFYRERSHQ 797
Query: 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364
+ I I+GS GY P EY G E ST GDVYS+GILLLE+FTG RP D F
Sbjct: 798 SSSIGIRGSLGYAPAEYGTGNEVSTSGDVYSYGILLLEIFTGKRPMDDWF 847
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224135241|ref|XP_002327600.1| predicted protein [Populus trichocarpa] gi|222836154|gb|EEE74575.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 277 bits (709), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 144/261 (55%), Positives = 180/261 (68%), Gaps = 14/261 (5%)
Query: 109 VESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLF- 167
++ LR K L + ++G ++KDL ATNGFSS NLIGAG+FGSVY G L
Sbjct: 633 LKKSLRKTKNDLAREIPFQGV------AYKDLRQATNGFSSENLIGAGSFGSVYKGLLAS 686
Query: 168 DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227
DG +AVKVFNL+R G SKSF EC A NI+HRN+V+V A++GVD QG FKA+VY+F
Sbjct: 687 DGVIVAVKVFNLLREGASKSFMRECAALTNIRHRNLVKVLCAYAGVDVQGKDFKALVYEF 746
Query: 228 MPNGSLEEWLRGKDDTNWR----PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283
M NGSLEEWL + T ++ P N N + ++L+IAIDVA AL YLH C+ PIAHC+
Sbjct: 747 MINGSLEEWLH-PNQTLYQEVHEPRNLNLI--QRLNIAIDVANALDYLHNHCKTPIAHCD 803
Query: 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDV 343
LKPSNVLLD +M HVGDFG+ +FL Q + +KG+ GY PEY +G E ST GDV
Sbjct: 804 LKPSNVLLDGDMTAHVGDFGLLKFLSEASCQTSSVGLKGTVGYAAPEYGIGSEVSTLGDV 863
Query: 344 YSFGILLLEMFTGIRPSDGIF 364
YS+GILLLEM TG RP+D +F
Sbjct: 864 YSYGILLLEMITGKRPTDSMF 884
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449483700|ref|XP_004156664.1| PREDICTED: LOW QUALITY PROTEIN: putative receptor-like protein kinase At3g47110-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 274 bits (701), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 154/373 (41%), Positives = 214/373 (57%), Gaps = 48/373 (12%)
Query: 4 VSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILD-VVFFQEIE 62
+S GD++S+GILLLEM G RP DD F +++++H F + ALP A I+D + F+E
Sbjct: 890 ISIEGDIFSYGILLLEMIIGKRPTDDTFGNDMDIHLFTRRALPRDALSIIDPSILFEETC 949
Query: 63 EEETMYKKASSTCTQSSII----LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118
+EE K S I+ +ECL+SI R G+ CS P+ER ++ V + L+ IK
Sbjct: 950 QEENNDDKVKSGEDHKEIVPRWKVECLVSIMRIGLTCSLRAPSERTSMSVVVNELQAIKS 1009
Query: 119 KLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFN 178
LK T+ + +D+ G+ +AVKV N
Sbjct: 1010 SYLK-------GTLKVLALRDIS-------------------------LHGSMVAVKVLN 1037
Query: 179 LIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR 238
L + G SKS EC A NI+HRN++++ T+ S +D QG FKA+V+ FM N L+ WL
Sbjct: 1038 LQQQGASKSTVDECNALSNIRHRNLLKIITSCSSIDGQGDEFKALVFNFMSNXKLDSWLH 1097
Query: 239 GKDD-TNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297
+ TN R L+ + ++L+IAID+AC L YLH C+ PI HC++KPSNVLLDD+M+
Sbjct: 1098 STNQGTNQRRLS----LIQRLNIAIDIACGLDYLHNHCETPIIHCDIKPSNVLLDDDMVA 1153
Query: 298 HVGDFGMARFL--PAIDK----QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLL 351
HVGDFG+AR + + D+ Q + +KGS GYIPPEY G S GDV+S+GILLL
Sbjct: 1154 HVGDFGLARLMLEESNDQISFSQTMSLALKGSVGYIPPEYGSGSRISIEGDVFSYGILLL 1213
Query: 352 EMFTGIRPSDGIF 364
EM G RP D F
Sbjct: 1214 EMIIGKRPIDDTF 1226
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116466|ref|XP_002331904.1| predicted protein [Populus trichocarpa] gi|222874576|gb|EEF11707.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 270 bits (691), Expect = 6e-70, Method: Compositional matrix adjust.
Identities = 138/238 (57%), Positives = 171/238 (71%), Gaps = 11/238 (4%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKA 194
++KDL ATNGFSS NL+GAG+FGSVY G L FDG T+AVKVFNL+R G SKSF EC A
Sbjct: 687 AYKDLLQATNGFSSGNLVGAGSFGSVYKGVLAFDGVTVAVKVFNLLREGASKSFMRECAA 746
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL---RGKDDTNWRPLNFN 251
+NI+HRN+V+V A +GVD QG FKA+VY+FM NGSLEEWL D +P N N
Sbjct: 747 LLNIRHRNLVKVLFACAGVDVQGNDFKALVYEFMINGSLEEWLHPIHTLDLEVHQPKNLN 806
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL--- 308
+ ++L+IAIDVA AL YLH C+ PI HC+LKPSNVLLD +M HVGDFG+ +FL
Sbjct: 807 LI--QRLNIAIDVANALDYLHNQCKMPIVHCDLKPSNVLLDGDMTAHVGDFGLLKFLSEA 864
Query: 309 --PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364
+ Q + +KG+ GY PEY +G E ST+GDV+S+GILLLEM TG RP+D +F
Sbjct: 865 SCQSSSSQTSSVGLKGTVGYAAPEYGIGSEVSTFGDVHSYGILLLEMITGKRPTDSMF 922
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 367 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.626 | 0.227 | 0.512 | 1.6e-59 | |
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.629 | 0.460 | 0.497 | 2.2e-59 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.626 | 0.227 | 0.487 | 2e-58 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.629 | 0.224 | 0.485 | 3.6e-58 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.629 | 0.228 | 0.476 | 5.1e-57 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.621 | 0.222 | 0.478 | 4.4e-53 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.613 | 0.219 | 0.476 | 4.4e-53 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.607 | 0.227 | 0.411 | 7.6e-38 | |
| TAIR|locus:2005498 | 1196 | BRI1 "BRASSINOSTEROID INSENSIT | 0.588 | 0.180 | 0.415 | 1.5e-37 | |
| TAIR|locus:2185118 | 657 | AT5G02070 [Arabidopsis thalian | 0.585 | 0.327 | 0.372 | 3.3e-37 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 1.6e-59, P = 1.6e-59
Identities = 122/238 (51%), Positives = 169/238 (71%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+ DL NATNGFSS+N++G+G+FG+VY L + +AVKV N+ R G KSF +EC++
Sbjct: 691 SYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECES 750
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD-DTNWRPLNFNFL 253
+I+HRN+V++ TA S +D+QG F+A++Y+FMPNGSL+ WL ++ + RP L
Sbjct: 751 LKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTL 810
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
+++ L+IAIDVA L YLH C PIAHC+LKPSNVLLDD++ HV DFG+AR L D+
Sbjct: 811 LER-LNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDE 869
Query: 314 QNRF-----ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366
++ F ++G+ GY PEY +G + S GDVYSFGILLLEMFTG RP++ +F G
Sbjct: 870 ESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGG 927
|
|
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 609 (219.4 bits), Expect = 2.2e-59, P = 2.2e-59
Identities = 118/237 (49%), Positives = 167/237 (70%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+++LYNAT+GFSS+NLIG+GNF V+ G L + +AVKV NL++ G +KSF +EC++
Sbjct: 198 SYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKSFIAECES 257
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
I+HRN+ ++ T S +D QG F+A+VY+FMP GSL+ WL+ +D + + +
Sbjct: 258 FKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNHSRSLTF 317
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
+K++IAIDVA AL YLH C P+AHC++KPSNVLLDD++ HV DFG+AR L D++
Sbjct: 318 AEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYNFDEK 377
Query: 315 ---NRFIC--IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366
N+F ++G+ GY PEY +G + S GDVYSFG+LLLEMFTG +P+D F G
Sbjct: 378 TFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNSFGG 434
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 607 (218.7 bits), Expect = 2.0e-58, P = 2.0e-58
Identities = 116/238 (48%), Positives = 171/238 (71%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+ DL NAT+GFSS+N++G+G+FG+V+ L + +AVKV N+ R G KSF +EC++
Sbjct: 690 SYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECES 749
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD-DTNWRPLNFNFL 253
+I+HRN+V++ TA + +D+QG F+A++Y+FMPNGSL++WL ++ + RP L
Sbjct: 750 LKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTL 809
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
+++ L+IAIDVA L YLH C PIAHC+LKPSN+LLDD++ HV DFG+AR L D+
Sbjct: 810 LER-LNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQ 868
Query: 314 QNRF-----ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366
++ F ++G+ GY PEY +G + S +GDVYSFG+L+LEMFTG RP++ +F G
Sbjct: 869 ESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGG 926
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 591 (213.1 bits), Expect = 3.6e-58, Sum P(2) = 3.6e-58
Identities = 115/237 (48%), Positives = 166/237 (70%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+++L++AT+ FSS NLIG+GNFG+V+ G L + +AVKV NL++ G +KSF +EC+
Sbjct: 701 SYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECET 760
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
I+HRN+V++ T S +D +G F+A+VY+FMP GSL+ WL+ +D + +
Sbjct: 761 FKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTP 820
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
+KL+IAIDVA AL YLH C P+AHC++KPSN+LLDD++ HV DFG+A+ L D++
Sbjct: 821 AEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRE 880
Query: 315 ---NRFIC--IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366
N+F ++G+ GY PEY +G + S GDVYSFGILLLEMF+G +P+D F G
Sbjct: 881 SFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAG 937
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 594 (214.2 bits), Expect = 5.1e-57, P = 5.1e-57
Identities = 113/237 (47%), Positives = 164/237 (69%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+ DL NATNGFSS+N++G+G+FG+V+ L + +AVKV N+ R G KSF +EC++
Sbjct: 692 SYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECES 751
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
+ +HRN+V++ TA + D+QG F+A++Y+++PNGS++ WL ++ R +
Sbjct: 752 LKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTL 811
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
++L+I IDVA L YLH C PIAHC+LKPSNVLL+D++ HV DFG+AR L DK+
Sbjct: 812 LERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKE 871
Query: 315 ---NRFIC--IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366
N+ ++G+ GY PEY +G + S +GDVYSFG+LLLEMFTG RP+D +F G
Sbjct: 872 SFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGG 928
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 4.4e-53, P = 4.4e-53
Identities = 113/236 (47%), Positives = 157/236 (66%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKA 194
S+ +LY T GFSS+NLIG+GNFG+V+ G L +A+KV NL + G +KSF +EC+A
Sbjct: 708 SYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEA 767
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD-DTNWRPLNFNFL 253
I+HRN+V++ T S D++G F+A+VY+FMPNG+L+ WL + + P L
Sbjct: 768 LGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGL 827
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
+ L+IAIDVA AL YLH C PIAHC++KPSN+LLD ++ HV DFG+A+ L D+
Sbjct: 828 FAR-LNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDR 886
Query: 314 QNRFIC-----IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364
I ++G+ GY PEY +G S GDVYSFGI+LLE+FTG RP++ +F
Sbjct: 887 DTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLF 942
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 4.4e-53, P = 4.4e-53
Identities = 112/235 (47%), Positives = 154/235 (65%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
S+ L AT+GF+ NL+G+G+FGSVY G L +AVKV L P KSF +EC+A
Sbjct: 697 SYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEAL 756
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK--DDTNWRPLNFNFL 253
N++HRN+V++ T S +D +G FKA+VY FMPNGSLE+W+ + D + R LN +
Sbjct: 757 RNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLH-- 814
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL----P 309
+++ I +DVACAL YLH P+ HC++K SNVLLD +M+ HVGDFG+AR L
Sbjct: 815 --RRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTS 872
Query: 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364
I + + G+ GY PEY +G AST+GD+YS+GIL+LE+ TG RP+D F
Sbjct: 873 LIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTF 927
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 416 (151.5 bits), Expect = 7.6e-38, P = 7.6e-38
Identities = 104/253 (41%), Positives = 146/253 (57%)
Query: 127 EGKQTINNP-----SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFN-LI 180
E KQ N+P S++ L AT GF++++LIG+G FG VY G L + T +AVKV +
Sbjct: 636 EEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKT 695
Query: 181 RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK 240
S SFK EC+ +HRN++R+ T S G F A+V MPNGSLE L
Sbjct: 696 ALEFSGSFKRECQILKRTRHRNLIRIITTCSK---PG--FNALVLPLMPNGSLERHLYPG 750
Query: 241 DDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300
+ + N + + + ++I DVA + YLH + HC+LKPSN+LLDDEM V
Sbjct: 751 E---YSSKNLDLI--QLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVT 805
Query: 301 DFGMARFLPAIDKQ------------NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGI 348
DFG++R + +++ + +C GS GYI PEY +G AST+GDVYSFG+
Sbjct: 806 DFGISRLVQGVEETVSTDDSVSFGSTDGLLC--GSVGYIAPEYGMGKRASTHGDVYSFGV 863
Query: 349 LLLEMFTGIRPSD 361
LLLE+ +G RP+D
Sbjct: 864 LLLEIVSGRRPTD 876
|
|
| TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 415 (151.1 bits), Expect = 1.5e-37, P = 1.5e-37
Identities = 94/226 (41%), Positives = 131/226 (57%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
+F DL ATNGF + +LIG+G FG VY L DG+ +A+K + G + F +E +
Sbjct: 872 TFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETI 931
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
IKHRN+V + G G + +VY+FM GSLE+ L D + N+ +
Sbjct: 932 GKIKHRNLVPLL----GYCKVGDE-RLLVYEFMKYGSLEDVLH---DPKKAGVKLNWSTR 983
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+K IAI A L +LH +C P I H ++K SNVLLD+ + V DFGMAR + A+D
Sbjct: 984 RK--IAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHL 1041
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
+ G+ GY+PPEY ST GDVYS+G++LLE+ TG RP+D
Sbjct: 1042 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTD 1087
|
|
| TAIR|locus:2185118 AT5G02070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 388 (141.6 bits), Expect = 3.3e-37, Sum P(2) = 3.3e-37
Identities = 85/228 (37%), Positives = 126/228 (55%)
Query: 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN 197
+++ ATN FS NLIG G FG V+ L DGT A+K L G+ +E +
Sbjct: 354 REITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNNTKGTDQILNEVRILCQ 413
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
+ HR++VR+ VD + ++Y+F+PNG+L E L G D W+PL + +++
Sbjct: 414 VNHRSLVRLLGCC--VDLE---LPLLIYEFIPNGTLFEHLHGSSDRTWKPLTW----RRR 464
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR- 316
L IA A L YLH QPPI H ++K SN+LLD+++ V DFG++R + + N
Sbjct: 465 LQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDLTETANNE 524
Query: 317 ---FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
F +G+ GY+ PEY + + DVYSFG++LLEM T + D
Sbjct: 525 SHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAID 572
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00029263001 | SubName- Full=Chromosome chr13 scaffold_48, whole genome shotgun sequence; (886 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 367 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-30 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-27 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-15 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-14 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-08 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-06 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-05 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-04 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.001 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.002 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.002 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.002 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 0.002 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.002 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.002 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.002 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 0.003 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.003 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.003 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.003 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.004 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSK-SFKSECKAAINIKHRNIVRVFTAF 210
+G G FG+VY G +A+K+ E + + H NIV+++ F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ +V ++ GSL++ L+ N L+ + +++ I + + L Y
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLK----ENEGKLSEDEILR----ILLQILEGLEY 107
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIP 328
LH I H +LKP N+LLD + G V DFG+++ L ++ I G+ Y+
Sbjct: 108 LH---SNGIIHRDLKPENILLDSD-NGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMA 161
Query: 329 PEYDLGCEASTY-GDVYSFGILLLEM 353
PE LG + D++S G++L E+
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 9e-30
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 153 IGAGNFGSVYNGTLFD-----GTTIAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG VY GTL T +AVK + F E + H NIVR
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR- 65
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
GV QG +V ++MP G L ++LR + +K L +A+ +A
Sbjct: 66 ---LLGVCTQGEPLY-IVTEYMPGGDLLDFLRKHGE--------KLTLKDLLQMALQIAK 113
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID----KQNRFICIKG 322
+ YL H +L N L+ + ++ + DFG++R + D + + IK
Sbjct: 114 GMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK- 169
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
++ PE + ++ DV+SFG+LL E+FT
Sbjct: 170 ---WMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 63/219 (28%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFT 208
+G G+FG VY G +A+KV + + E K +KH NIVR++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
F D +V ++ G L + L+ L+ + + AL
Sbjct: 65 VFEDEDKL-----YLVMEYCEGGDLFDLLK-----KRGRLSEDEARF----YLRQILSAL 110
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGY 326
YLH I H +LKP N+LLD++ GHV DFG+AR L +K F+ G+ Y
Sbjct: 111 EYLHSKG---IVHRDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFV---GTPEY 162
Query: 327 IPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ PE Y D++S G++L E+ TG P
Sbjct: 163 MAPEVLLGKGYGKAV------DIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 36/224 (16%)
Query: 153 IGAGNFGSVYNGTLFD-----GTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNI 203
+G G FG VY G L +AVK ++ S + F E + + H N+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
V+ GV + +V ++M G L +LR + L A+
Sbjct: 64 VK----LLGVCTEEEPLY-IVMEYMEGGDLLSYLRKNRP--------KLSLSDLLSFALQ 110
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA---IDKQNRFICI 320
+A + YL H +L N L+ + ++ + DFG++R L K+ + I
Sbjct: 111 IARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI 167
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ ++ PE + ++ DV+SFG+LL E+FT G +P G+
Sbjct: 168 R----WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 207
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 39/226 (17%)
Query: 153 IGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNI 203
+G G FG VY GTL +AVK ++ S + F E + + H NI
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
V+ GV + +V ++MP G L ++LR + L A+
Sbjct: 64 VK----LLGVCTEEEPLM-IVMEYMPGGDLLDYLRKNRPKE-------LSLSDLLSFALQ 111
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+A + YL H +L N L+ + ++ + DFG++R L D K
Sbjct: 112 IARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY------YKVK 162
Query: 324 TGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
G +P PE + ++ DV+SFG+LL E+FT G P G+
Sbjct: 163 GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM 208
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G+G+FG+VY G +AVK+ + ++ + E + + H NIVR+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI-- 64
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
+V ++ G L ++L PL+ + KK IA+ + L
Sbjct: 65 --DAFEDKDHL-YLVMEYCEGGDLFDYLSRG-----GPLSED-EAKK---IALQILRGLE 112
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
YLH + I H +LKP N+LLD+ + + DFG+A+ L G+ Y+ P
Sbjct: 113 YLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV--GTPWYMAP 167
Query: 330 EYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGI 363
E LG DV+S G++L E+ TG P G
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGE 202
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 151 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+G G FG VY G L T +AVK ++ S+ F E + + H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT---LKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+VR+ GV + +V ++M G L ++LR P +K L AI
Sbjct: 58 VVRLL----GVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
+A + YL H +L N L+ ++++ + DFG++R + D K
Sbjct: 113 QIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-----RKK 164
Query: 323 STGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ G +P PE ++ DV+SFG+LL E+FT G P G+
Sbjct: 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 151 NLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVF 207
L+G G+FGSVY D G +AVK L ++ + E + +++H NIVR +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 208 TAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
G + K + F+ GSL L+ + L +I+K +
Sbjct: 66 ----GSERD--EEKNTLNIFLEYVSGGSLSSLLK-----KFGKLP-EPVIRK---YTRQI 110
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
L YLH I H ++K +N+L+D + + + DFG A+ L I+ ++G+
Sbjct: 111 LEGLAYLH-SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
++ PE G E D++S G ++EM TG P
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 94.4 bits (233), Expect = 2e-21
Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKH-RNIVRVF 207
+G G+FG VY D +A+KV + + F E + ++ H NIV+++
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
F Q +V +++ GSLE+ L+ + L I + A
Sbjct: 65 DFF-----QDEGSLYLVMEYVDGGSLEDLLK------KIGRKGPLSESEALFILAQILSA 113
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLPAID----KQNRFICIKG 322
L YLH I H ++KP N+LLD D + + DFG+A+ LP G
Sbjct: 114 LEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
Query: 323 STGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGI 363
+ GY+ PE LG + D++S GI L E+ TG+ P +G
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 8e-21
Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 151 NLIGAGNFGSVYNGT---LFDGTT--IAVKVFNLIRPGGSKS-FKSECKAAINIKHRNIV 204
+G G+FG V L D T +AVK N +S F+ E + + H NIV
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 205 RVFTAFSGVDY-QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA-- 261
+ + GV G R ++ +++P+GSL ++L+ D L+ I
Sbjct: 70 K----YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR----LLLFSSQICKG 121
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
+D + RY+H D L N+L++ E + + DFG+A+ LP DK ++
Sbjct: 122 MDYLGSQRYIHRD---------LAARNILVESEDLVKISDFGLAKVLPE-DKDYYYV--- 168
Query: 322 GSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360
G P PE + S+ DV+SFG+ L E+FT PS
Sbjct: 169 KEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-19
Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 29/212 (13%)
Query: 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSK-SFKSECKAAINIKHRNIVRVFTAF 210
IG GNFG VY G L T +AVK P K F E + H NIV++
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI--- 58
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV Q +V + +P GSL +LR K + +KK L +++D A + Y
Sbjct: 59 -GVCVQKQPI-YIVMELVPGGSLLTFLRKKKN--------RLTVKKLLQMSLDAAAGMEY 108
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
L H +L N L+ + + + DFGM+R +++ + IP +
Sbjct: 109 LESKN---CIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIK 160
Query: 331 YDLGCEASTYG------DVYSFGILLLEMFTG 356
+ EA YG DV+S+GILL E F+
Sbjct: 161 WT-APEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 7e-19
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 42/222 (18%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVR 205
F IG G FG VY G +A+KV L + +E + KH NIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA---I 262
+ ++ + + +V +F GSL++ L+ + L + IA
Sbjct: 62 YYGSY---LKKDELW--IVMEFCSGGSLKDLLKST----NQTLT-------ESQIAYVCK 105
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICI 320
++ L YLH I H ++K +N+LL + G V DFG++ L +N +
Sbjct: 106 ELLKGLEYLH---SNGIIHRDIKAANILLTSD--GEVKLIDFGLSAQLSDTKARNTMV-- 158
Query: 321 KGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTG 356
G+ ++ PE YD D++S GI +E+ G
Sbjct: 159 -GTPYWMAPEVINGKPYDYKA------DIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 46/228 (20%)
Query: 153 IGAGNFGSVYNGTLF------DGTTIAVKVF-NLIRPGGSKSFKSECKAAINIKHRNIVR 205
+G G FG V+ G + D +AVK K F+ E + N +H NIV+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-------- 257
F GV +G +V+++M +G L ++LR + FL
Sbjct: 73 ----FYGVCTEGDPP-IMVFEYMEHGDLNKFLRSHGP------DAAFLKSPDSPMGELTL 121
Query: 258 ---LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
L IA+ +A + YL H H +L N L+ +++ +GDFGM+R +
Sbjct: 122 SQLLQIAVQIASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT 175
Query: 312 DKQNRFICIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
D + + G T ++PPE + + +T DV+SFG++L E+FT
Sbjct: 176 D----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSK-SFKSECKAAINIKHRNIVRVFTAF 210
IG G FG V G + G +AVK L + +F +E ++H N+V+
Sbjct: 13 TIGKGEFGDVMLGD-YRGQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQ----L 65
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV QG +V ++M GSL ++LR + R + + ++L A+DV + Y
Sbjct: 66 LGVVLQGNPL-YIVTEYMAKGSLVDYLR----SRGRAVI---TLAQQLGFALDVCEGMEY 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP-- 328
L + H +L NVL+ ++++ V DFG+A + +G +P
Sbjct: 118 LE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLA----------KEASQGQDSGKLPVK 164
Query: 329 ---PEYDLGCEASTYGDVYSFGILLLEMFT 355
PE + ST DV+SFGILL E+++
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 66/222 (29%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 151 NLIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVF 207
N IG G FG VY L G +AVK + K E K +KH N+V+ +
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 208 TAFSGVDYQGARFKAVVYKFMP---NGSLEEWLRGK--DDTNWRPLNFNFLIKKKLDIAI 262
GV+ + VY FM G+LEE L D + + L++
Sbjct: 66 ----GVEVHREK----VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE------- 110
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL--PAIDKQNRFICI 320
L YLH I H ++KP+N+ LD + +GDFG A L +
Sbjct: 111 ----GLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL 163
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE G + +G D++S G ++LEM TG RP
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 26/225 (11%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
F+ +G+G FG V+ G + +A+K+ + F+ E +A ++H++++ +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 207 FTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
F S + Y ++ + M GSL +LR + + +D+A V
Sbjct: 68 FAVCSVGEPVY-------IITELMEKGSLLAFLRSPEGQVLP-------VASLIDMACQV 113
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL--PAIDKQNRFICIKG 322
A + YL + H +L N+L+ ++++ V DFG+AR + ++ I K
Sbjct: 114 AEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK- 169
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTG 366
+ PE ST DV+SFGILL EMFT G P G+
Sbjct: 170 ---WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH 211
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-17
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 34/211 (16%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
IG+G FG V+ G + +A+K IR G + F E + + + H +V+++
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKT---IREGAMSEEDFIEEAQVMMKLSHPKLVQLY--- 65
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV + + +V++FM +G L ++LR + F + L + +DV + Y
Sbjct: 66 -GVCTERSPI-CLVFEFMEHGCLSDYLRAQRGK--------FSQETLLGMCLDVCEGMAY 115
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG----- 325
L + H +L N L+ + + V DFGM RF+ +D Q STG
Sbjct: 116 LESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV--LDDQ-----YTSSTGTKFPV 165
Query: 326 -YIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
+ PE + S+ DV+SFG+L+ E+F+
Sbjct: 166 KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 37/213 (17%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+GAG FG V+ GT T +AVK ++PG ++F E + ++H +V+++
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKT---LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 211 SGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
S + Y +V ++M GSL ++L K + L L+ D+A +A +
Sbjct: 71 SEEEPIY-------IVTEYMSKGSLLDFL--KSGEG-KKLRLPQLV----DMAAQIAEGM 116
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328
YL H +L N+L+ + ++ + DFG+AR + + + + +G+ P
Sbjct: 117 AYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLI----EDDEYTAREGAK--FP 167
Query: 329 PEYDLGCEASTYG------DVYSFGILLLEMFT 355
++ EA+ YG DV+SFGILL E+ T
Sbjct: 168 IKWT-APEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 28/211 (13%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V+ GT T +A+K ++PG ++F E + ++H +V+++
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
S +V ++M GSL ++L+G+ R + + +D+A +A + Y
Sbjct: 71 SEEPIY------IVTEYMSKGSLLDFLKGEMGKYLR-------LPQLVDMAAQIASGMAY 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST---GYI 327
+ + H +L+ +N+L+ + ++ V DFG+AR + + N + +G+ +
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKWT 170
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIR 358
PE L + DV+SFGILL E+ T R
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 34/212 (16%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+G+G FG V+ G +A+K +IR G F E K + + H N+V+++
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQLY--- 65
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLR---GKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
GV + +V ++M NG L +LR GK T W LD+ DV A
Sbjct: 66 -GVCTKQRPIF-IVTEYMANGCLLNYLRERKGKLGTEWL-----------LDMCSDVCEA 112
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
+ YL + H +L N L+ ++ + V DFG+AR++ +D Q + +G+ +
Sbjct: 113 MEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV--LDDQ--YTSSQGTKFPV 165
Query: 328 ---PPEYDLGCEASTYGDVYSFGILLLEMFTG 356
PPE S+ DV+SFG+L+ E+F+
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V+ GT T +AVK ++PG +SF E + ++H +V+++
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKT---LKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
S +V ++M GSL ++L+ D R L L+ D+A VA + Y
Sbjct: 71 S------EEPIYIVTEYMSKGSLLDFLK---DGEGRALKLPNLV----DMAAQVAAGMAY 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST---GYI 327
+ + H +L+ +N+L+ D ++ + DFG+AR + + N + +G+ +
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLI----EDNEYTARQGAKFPIKWT 170
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIR 358
PE L + DV+SFGILL E+ T R
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-15
Identities = 69/221 (31%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSK-SFKSECKAAINIKHRNIVRVFTAF 210
L+G GNFG V+ GTL D T +AVK P K F SE + H NIV++
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI--- 58
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV Q +V + +P G +LR K D K+ + A+D A + Y
Sbjct: 59 -GVCTQRQPI-YIVMELVPGGDFLSFLRKKKD--------ELKTKQLVKFALDAAAGMAY 108
Query: 271 LHC-DCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
L +C H +L N L+ + + + DFGM+R +++ I IP
Sbjct: 109 LESKNC----IHRDLAARNCLVGENNVLKISDFGMSR------QEDDGIYSSSGLKQIPI 158
Query: 330 EYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
++ EA YG DV+S+GILL E F+ G+ P G+
Sbjct: 159 KWT-APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 27/208 (12%)
Query: 153 IGAGNFGSVYNGTLFDGTT-IAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTA 209
+GAG FG V+ G L++ TT +AVK ++PG K F +E + ++H +++++
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKT---LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 210 FSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
+ + Y +V + M GSL E+L+G R L LI D+A VA
Sbjct: 70 CTLEEPIY-------IVTELMKYGSLLEYLQGGAG---RALKLPQLI----DMAAQVASG 115
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
+ YL + Q I H +L NVL+ + I V DFG+AR + + R K +
Sbjct: 116 MAYL--EAQNYI-HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR-EGAKFPIKWT 171
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFT 355
PE L S DV+SFGILL E+ T
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-15
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 153 IGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG V+ + D +AVK K F+ E + N++H +IV+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK- 71
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR--GKD-----DTNWRPLNFNFLIKKKLD 259
F GV G +V+++M +G L ++LR G D D R + + L
Sbjct: 72 ---FYGVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
IA +A + YL H +L N L+ ++ +GDFGM+R + + D +
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD----YYR 180
Query: 320 IKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
+ G T ++PPE + + +T DV+SFG++L E+FT G +P
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G+ G VY G A+K ++ K E K + + +V+ + AF
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
Y+ ++V ++M GSL + L+ + L IA + L Y
Sbjct: 69 ----YKEGEI-SIVLEYMDGGSLADLLKKV-----GKIPEPVLAY----IARQILKGLDY 114
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP-AIDKQNRFICIKGSTGYIPP 329
LH I H ++KPSN+L++ + + DFG+++ L +D+ N F+ G+ Y+ P
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV---GTVTYMSP 169
Query: 330 EYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
E G S D++S G+ LLE G P
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 64/225 (28%), Positives = 94/225 (41%), Gaps = 51/225 (22%)
Query: 153 IGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNI 203
+G G+FG V G L+ A+KV +I+ + +E I H I
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY-----AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK-KKLD--- 259
V++ AF Q +V ++ P G L F+ L K +
Sbjct: 56 VKLHYAF-----QTEEKLYLVLEYAPGGEL----------------FSHLSKEGRFSEER 94
Query: 260 ---IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQ 314
A ++ AL YLH I + +LKP N+LLD + GH+ DFG+A+ L + +
Sbjct: 95 ARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDAD--GHIKLTDFGLAKELSSEGSR 149
Query: 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
C G+ Y+ PE LG D +S G+LL EM TG P
Sbjct: 150 TNTFC--GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 67/221 (30%), Positives = 100/221 (45%), Gaps = 39/221 (17%)
Query: 152 LIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGS-----KSFKSECKAAINIKHRNIVR 205
L+G+G+FGSVY G L DG AVK +L G + K + E ++H NIV+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 206 VFTAFSGVDYQG-ARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
Y G R + +Y F+ P GSL + L+ K + P+ + ++ L
Sbjct: 67 ---------YLGTEREEDNLYIFLELVPGGSLAKLLK-KYGSFPEPVIRLY-TRQILL-- 113
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
L YLH H ++K +N+L+D + + DFGMA+ + F K
Sbjct: 114 -----GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---K 162
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
GS ++ PE YG D++S G +LEM TG P
Sbjct: 163 GSPYWMAPEVIAQQGG--YGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 37/228 (16%)
Query: 153 IGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG V+ D +AVK + F+ E + ++H++IVR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR----------GKDDTNWRPLNFNFLIKK 256
F GV +G R +V+++M +G L +LR G +D L +
Sbjct: 72 ---FYGVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM--- 124
Query: 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
L IA +A + YL H +L N L+ ++ +GDFGM+R + + D
Sbjct: 125 -LAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---- 176
Query: 317 FICIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
+ + G T ++PPE L + +T D++SFG++L E+FT G +P
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 5e-14
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 147 FSSANLIGAGNFGSVYNG-TLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNI 203
+ +LIG G FG VY G L G +A+K +L I+ KS E N+KH NI
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL---IKKKLDI 260
V+ + + + ++ ++ NGSL + ++ + P + + + + L
Sbjct: 62 VKYIGSI-----ETSDSLYIILEYAENGSLRQIIK-----KFGPFPESLVAVYVYQVLQ- 110
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
L YLH + + H ++K +N+L + G V DFG+A L + K +
Sbjct: 111 ------GLAYLH---EQGVIHRDIKAANILTTKD--GVVKLADFGVATKLNDVSKDDA-- 157
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ G+ ++ PE AST D++S G ++E+ TG P
Sbjct: 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212
IG G FG V G + G +AVK +++F +E ++H N+V++
Sbjct: 14 IGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 68
Query: 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLH 272
V+ +G + +V ++M GSL ++LR + + L + L+K ++DV A+ YL
Sbjct: 69 VEEKGGLY--IVTEYMAKGSLVDYLRSRGRS---VLGGDCLLK----FSLDVCEAMEYLE 119
Query: 273 CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYD 332
+ H +L NVL+ ++ + V DFG+ + + + + PE
Sbjct: 120 AN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEAL 171
Query: 333 LGCEASTYGDVYSFGILLLEMFT 355
+ ST DV+SFGILL E+++
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 46/237 (19%)
Query: 152 LIGAGNFGSVYNGTLF-DGTTIAVKVFN---LIRPGGSKSFKSECKAAIN--IKHRNIVR 205
+IG G+F +V A+K+ + LI+ K K E K + H I++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE-KEVLTRLNGHPGIIK 66
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
++ F D + F V ++ PNG L +++R + + + + A ++
Sbjct: 67 LYYTFQ--DEENLYF---VLEYAPNGELLQYIR-------KYGSLDEKCTRF--YAAEIL 112
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDK-QNRFICIK- 321
AL YLH I H +LKP N+LLD +M H+ DFG A+ L ++
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 322 ----------------GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ Y+ PE A D+++ G ++ +M TG P G
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212
IG G FG+V G + G +AVK N+ +++F E + H+N+VR+ G
Sbjct: 14 IGEGEFGAVLQGE-YTGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLL----G 66
Query: 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLH 272
V + +V + M G+L +LR + + + L ++DVA + YL
Sbjct: 67 VILHNGLY--IVMELMSKGNLVNFLRTRG-------RALVSVIQLLQFSLDVAEGMEYLE 117
Query: 273 CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP-AIDKQNRFICIKGSTGYIPPEY 331
+ H +L N+L+ ++ + V DFG+AR +D N + +K + PE
Sbjct: 118 ---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD--NSKLPVK----WTAPEA 168
Query: 332 DLGCEASTYGDVYSFGILLLEMFT 355
+ S+ DV+S+G+LL E+F+
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 152 LIGAGNFGSV----YNGTLFDGT--TIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVR 205
+G GNFGSV Y+ L D T +AVK + F+ E + +++H NIV+
Sbjct: 11 QLGKGNFGSVELCRYD-PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 206 VFTAFSGVDYQ-GARFKAVVYKFMPNGSLEEWL---RGKDDTNWRPLNFNFLIKKKLDIA 261
+ GV Y G R +V +++P GSL ++L R + D + L + I K
Sbjct: 70 ----YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR-KLLLYASQICK----G 120
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
++ + RY+H D L N+L++ E +GDFG+ + LP DK+ +
Sbjct: 121 MEYLGSKRYVHRD---------LATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREP 170
Query: 322 GSTG--YIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
G + + PE + S DV+SFG++L E+FT
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 54/211 (25%), Positives = 102/211 (48%), Gaps = 33/211 (15%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+GAG FG V+ G + T +AVK ++PG ++F E ++H +VR++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKT---LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 211 SGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
+ + Y ++ ++M GSL ++L+ + L+ K +D + +A +
Sbjct: 71 TKEEPIY-------IITEYMAKGSLLDFLKSDEGGK-------VLLPKLIDFSAQIAEGM 116
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI- 327
Y+ + H +L+ +NVL+ + ++ + DFG+AR + + N + +G+ I
Sbjct: 117 AYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVI----EDNEYTAREGAKFPIK 169
Query: 328 ---PPEYDLGCEASTYGDVYSFGILLLEMFT 355
P + G + DV+SFGILL E+ T
Sbjct: 170 WTAPEAINFGS-FTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 153 IGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG V+ + D +AVK K F E + N++H +IV+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK- 71
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR--GKDDTNWRPLN--FNFLIKKKLDIAI 262
F GV +G +V+++M +G L ++LR G D N + L IA
Sbjct: 72 ---FYGVCVEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
+A + YL H +L N L+ + ++ +GDFGM+R + + D + + G
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD----YYRVGG 180
Query: 323 ST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
T ++PPE + + +T DV+S G++L E+FT G +P
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 30/223 (13%)
Query: 152 LIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGSKSFKSECKAAINI---KHRNIVR 205
L+G+G FG+V+ G D I V + + G ++F+ + + H IVR
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ G Q +V + P GSL + +R D+ L+ L L+ + +A
Sbjct: 74 LLGICPGASLQ------LVTQLSPLGSLLDHVRQHRDS----LDPQRL----LNWCVQIA 119
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
+ YL + H NL N+LL + I + DFG+A L DK+ + K
Sbjct: 120 KGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFT-------GIRPSD 361
++ E L + DV+S+G+ + EM + G+RP +
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (166), Expect = 8e-13
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 42/227 (18%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN-------IKHRN 202
IG G+FG VY DG +K +L S + E + A+N + H N
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDL-----SNMSEKEREDALNEVKILKKLNHPN 60
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
I++ + +F + M G L + ++ + F ++ LD
Sbjct: 61 IIKYYESFEEKGK--------LCIVMEYADGGDLSQKIK-----KQKKEGKPFPEEQILD 107
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL-PAIDKQNRFI 318
+ + AL+YLH I H ++KP N+ L + +GDFG+++ L +D +
Sbjct: 108 WFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV 164
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
G+ Y+ PE C+ Y D++S G +L E+ T P +G
Sbjct: 165 ---GTPYYLSPEL---CQNKPYNYKSDIWSLGCVLYELCTLKHPFEG 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-13
Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V+ GT T +A+K ++PG ++F E + ++H +V ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKT---LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
S +V +FM GSL ++L+ D + + + +D+A +A + Y
Sbjct: 71 SEEPIY------IVTEFMGKGSLLDFLKEGDGKYLK-------LPQLVDMAAQIADGMAY 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST---GYI 327
+ + H +L+ +N+L+ D ++ + DFG+AR + + N + +G+ +
Sbjct: 118 IE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI----EDNEYTARQGAKFPIKWT 170
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIR 358
PE L + DV+SFGILL E+ T R
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 9e-13
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 30/214 (14%)
Query: 152 LIGAGNFGSVYNGT----LFDGTTIAVKVFNLIRPGG-SKSFKSECKAAINIKHRNIVRV 206
+G G+FG V G +AVK + F E ++ H N++R+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ GV +V + P GSL + LR + +FLI D A+ +A
Sbjct: 62 Y----GVVLTHPLM--MVTELAPLGSLLDRLR-------KDALGHFLISTLCDYAVQIAN 108
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID-----KQNRFICIK 321
+RYL H +L N+LL + +GDFG+ R LP + +++ +
Sbjct: 109 GMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF- 164
Query: 322 GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
+ PE S DV+ FG+ L EMFT
Sbjct: 165 ---AWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-13
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 151 NLIGAGNFGSVYNGTLFD-GTTIAVKVF--NLIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+ +G G +G VY G T+AVK + + + F E IKH N+V++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLL 68
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
GV + F ++ +FM G+L ++LR + + L +A ++ A
Sbjct: 69 ----GVCTREPPF-YIITEFMTYGNLLDYLRECNRQEVNAVVL-------LYMATQISSA 116
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
+ YL + H +L N L+ + + V DFG++R + D K +
Sbjct: 117 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWT 172
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
PE + S DV++FG+LL E+ T G+ P GI
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--SKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V G +A+K +I+ G F E K + + H +V+++
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ R +V ++M NG L +LR F + L++ DV + Y
Sbjct: 69 TK-----QRPIYIVTEYMSNGCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAY 115
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
L H +L N L+DD+ V DFG++R++ D+ + K + PPE
Sbjct: 116 LE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPE 171
Query: 331 YDLGCEASTYGDVYSFGILLLEMFT 355
L + S+ DV++FG+L+ E+++
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 35/220 (15%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+GAG FG V+ T T +AVK ++PG ++F +E ++H +V++
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ ++ +FM GSL ++L+ D+ + +PL K +D + +A + +
Sbjct: 71 TKEPIY------IITEFMAKGSLLDFLK-SDEGSKQPL------PKLIDFSAQIAEGMAF 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
+ Q H +L+ +N+L+ ++ + DFG+AR + + N + +G+ P +
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI----EDNEYTAREGAK--FPIK 168
Query: 331 YDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
+ EA +G DV+SFGILL+E+ T G P G+
Sbjct: 169 WT-APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 37/224 (16%)
Query: 153 IGAGNFGSVYNGTLF--DGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVF 207
+G GNFGSV G G + V V L + G K F E + H IVR+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
GV +G +V + P G L ++L+ + + + ++A VA
Sbjct: 63 ----GV-CKGEPL-MLVMELAPLGPLLKYLKKRREIP---------VSDLKELAHQVAMG 107
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG-- 325
+ YL H +L NVLL + + DFGM+R L A R +T
Sbjct: 108 MAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA-----TTAGR 159
Query: 326 -----YIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
Y P + G + S+ DV+S+G+ L E F+ G +P +
Sbjct: 160 WPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--SKSFKSECKAAINIKHRNIVRVFTAF 210
+G+G FG V+ G +A+K I G + F E K + + H +V+++
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLY--- 65
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV Q + +V +FM NG L +LR + + + L + DV + Y
Sbjct: 66 -GVCTQ-QKPLYIVTEFMENGCLLNYLRQRQGKLSKDM--------LLSMCQDVCEGMEY 115
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC-IKGSTGYIPP 329
L + H +L N L+ + V DFGM R++ +D + K + PP
Sbjct: 116 LE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKFPVKWSPP 170
Query: 330 EYDLGCEASTYGDVYSFGILLLEMFT 355
E + S+ DV+SFG+L+ E+FT
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 151 NLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+IG G FG V G L +A+K ++ G S F +E H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT---LKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 203 IVR---VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
I+R V T V ++ ++M NGSL+++LR D F + + +
Sbjct: 67 IIRLEGVVTKSRPV--------MIITEYMENGSLDKFLRENDG--------KFTVGQLVG 110
Query: 260 IAIDVACALRYL--HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ +A ++YL H +L N+L++ ++ V DFG++R L +
Sbjct: 111 MLRGIASGMKYLSEMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT--- 162
Query: 318 ICIKGSTGYIPPEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
KG G IP + EA Y DV+SFGI++ E+ + G RP
Sbjct: 163 YTTKG--GKIPIRWT-APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 20/228 (8%)
Query: 147 FSSANLIGAGNFGSVYNGTLF--DGTTIAVKVFNLIRPGGSKS----FKSECKAAINIKH 200
++G G FGSV G L DG+ + V V + + S F SE + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 201 RNIVRVF-TAFSGVDYQGARFKAVVYKFMPNGSLEEWL-RGKDDTNWRPLNFNFLIKKKL 258
N++++ F Q V+ FM +G L +L + ++ L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL----PEKLPLQTLL 116
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID--KQNR 316
+D+A + YL H +L N +L ++M V DFG+++ + + D +Q R
Sbjct: 117 KFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 317 FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
K +I E ++ DV++FG+ + E+ T G P G+
Sbjct: 174 I--AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 65/219 (29%), Positives = 95/219 (43%), Gaps = 34/219 (15%)
Query: 152 LIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
++G G +G VY L IA+K + E +KHRNIV+ +
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ----Y 70
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFN-----FLIKKKLDIAIDVA 265
G D + FK + + +P GSL LR K W PL N F K+ L+
Sbjct: 71 LGSDSENGFFK-IFMEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILE------ 119
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
L+YLH I H ++K NVL++ + + DFG ++ L I+ G+
Sbjct: 120 -GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE--TFTGTL 173
Query: 325 GYIPPEY-DLGCEASTYG---DVYSFGILLLEMFTGIRP 359
Y+ PE D G YG D++S G ++EM TG P
Sbjct: 174 QYMAPEVIDKGPRG--YGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 5e-12
Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 58/236 (24%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVR---- 205
IG G +G VY G +A+K + + G + E K ++H NIVR
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID-V 264
V + G Y +V+++M + L G L ++ +
Sbjct: 67 VTSKGKGSIY-------MVFEYMDHD-----LTG------------LLDSPEVKFTESQI 102
Query: 265 AC-------ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL---PAIDKQ 314
C L+YLH I H ++K SN+L++++ + + DFG+AR + D
Sbjct: 103 KCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159
Query: 315 NRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
NR I + Y PPE LG YG D++S G +L E+F G +P IF G
Sbjct: 160 NRVITL----WYRPPELLLGAT--RYGPEVDMWSVGCILAELFLG-KP---IFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 43/225 (19%)
Query: 152 LIGAGNFGSVYNGTL----FDGTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNI 203
+IGAG FG V+ G L +A+K ++PG ++ F SE H NI
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKT---LKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 204 VRVFTAFSGVDYQGARFK--AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
+R+ GV +FK ++ ++M NG+L+++LR D F + + +
Sbjct: 69 IRL----EGVV---TKFKPAMIITEYMENGALDKYLRDHDG--------EFSSYQLVGML 113
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
+A ++YL H +L N+L++ + V DFG++R L D + +
Sbjct: 114 RGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED-DPEGTYTT-- 167
Query: 322 GSTGYIPPEYDLGCEASTY------GDVYSFGILLLEMFT-GIRP 359
S G IP + EA Y DV+SFGI++ E+ + G RP
Sbjct: 168 -SGGKIPIRWT-APEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 9e-12
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 34/211 (16%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+GAG FG V+ G T +A+K ++ G ++F +E ++H +VR++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKS---LKQGSMSPEAFLAEANLMKQLQHPRLVRLY--- 67
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
V Q + ++ ++M NGSL ++L+ + L N LI D+A +A + +
Sbjct: 68 -AVVTQEPIY--IITEYMENGSLVDFLKTPEGIK---LTINKLI----DMAAQIAEGMAF 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
+ + H +L+ +N+L+ + + + DFG+AR + + N + +G+ P +
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLI----EDNEYTAREGAK--FPIK 168
Query: 331 YDLGCEASTYG------DVYSFGILLLEMFT 355
+ EA YG DV+SFGILL E+ T
Sbjct: 169 WT-APEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 65/218 (29%), Positives = 92/218 (42%), Gaps = 26/218 (11%)
Query: 151 NLIGAGNFGSVYNGTL----FDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIK--HR 201
+G G FG VY G D + V V L F E A I K H+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLME--ALIMSKFNHQ 69
Query: 202 NIVRVFTAFSGVDYQG-ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
NIVR GV ++ RF ++ + M G L+ +LR RP + +K L
Sbjct: 70 NIVR----LIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERP--SSLTMKDLLFC 121
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV---GDFGMARFLPAIDKQNRF 317
A DVA +YL + H ++ N LL + G V DFGMAR + +
Sbjct: 122 ARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 318 ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
++PPE L ++ DV+SFG+LL E+F+
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 9e-12
Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 153 IGAGNFGSVY----NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVR 205
I G +G V+ T G A+KV +IR +E + +V+
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK--KLDIAID 263
++ +F QG + +V +++P G L L N L + ++ IA +
Sbjct: 58 LYYSF-----QGKKNLYLVMEYLPGGDLASLLE----------NVGSLDEDVARIYIA-E 101
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARF--------LPAIDK 313
+ AL YLH I H +LKP N+L+D GH+ DFG+++ L +K
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEK 156
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+++ I G+ YI PE LG S D +S G +L E GI P
Sbjct: 157 EDKRIV--GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 151 NLIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
N+I G G+ Y G ++ +G VK N + S ++ ++H NIV++
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVN-SIPSSEIADMG---KLQHPNIVKLIGL 751
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
+ + ++++++ +L E LR +W +++ IAI +A ALR
Sbjct: 752 C-----RSEKGAYLIHEYIEGKNLSEVLRN---LSW---------ERRRKIAIGIAKALR 794
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG----STG 325
+LHC C P + NL P +++D + H + LP + +C S+
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPH-----LRLSLPGL------LCTDTKCFISSA 843
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364
Y+ PE + + D+Y FG++L+E+ TG P+D F
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882
|
Length = 968 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 60/220 (27%), Positives = 89/220 (40%), Gaps = 34/220 (15%)
Query: 153 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+G G+FG VY G T +A+K N S F +E +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK--DDTNWRPLNFNFLIKKKLDI 260
+VR GV G VV + M G L+ +LR + + N L L K + +
Sbjct: 71 VVR----LLGVVSTGQP-TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF-IQM 124
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
A ++A + YL H +L N ++ +++ +GDFGM R D
Sbjct: 125 AAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYYR 176
Query: 321 KGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
KG G +P PE +T DV+SFG++L EM T
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 41/227 (18%)
Query: 151 NLIGAGNFGSVYNGTLFD----GT---TIAVKVFNLIRPGGSKSFKSE--CKAAI--NIK 199
N +G+G FG VY GT D G+ +AVK +R G + K E +A + N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKT---LRKGATDQEKKEFLKEAHLMSNFN 57
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKL 258
H NIV++ + Q ++ + M G L +LR + + PL +K+ L
Sbjct: 58 HPNIVKLLGVCLLNEPQ-----YIIMELMEGGDLLSYLRDARVERFGPPL---LTLKELL 109
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL-----DDEMIGHVGDFGMARFLPAIDK 313
DI +DVA YL Q H +L N L+ D + + +GDFG+AR + D
Sbjct: 110 DICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166
Query: 314 QNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
K G +P PE L + +T DV+SFG+L+ E+ T
Sbjct: 167 YR-----KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 38/227 (16%)
Query: 147 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAIN-------I 198
F N IG G+FG V+ D A+K +L SK + E + AI+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-----SKMNRREREEAIDEARVLAKL 56
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
I+R + +F +D +V ++ NG L + L+ + RPL + + +
Sbjct: 57 DSSYIIRYYESF--LDKGKL---NIVMEYAENGDLHKLLKMQRG---RPLPEDQVWR--- 105
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
I + L +LH I H ++K N+ LD +GD G+A+ L F
Sbjct: 106 -FFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD---NTNFA 158
Query: 319 -CIKGSTGYIPPEYDLGCEASTY---GDVYSFGILLLEMFTGIRPSD 361
I G+ Y+ PE CE Y DV++ G++L E TG P D
Sbjct: 159 NTIVGTPYYLSPEL---CEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 152 LIGAGNFGSVY-NGTLFDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G FG V+ A+KV + IR + +E + + H I+R+F
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
RF ++ +++P G L +LR + F A ++ CA
Sbjct: 68 WT-----EHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF---------YASEIVCA 113
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTG 325
L YLH I + +LKP N+LLD E GH+ DFG A+ L ++R + G+
Sbjct: 114 LEYLH---SKEIVYRDLKPENILLDKE--GHIKLTDFGFAKKL-----RDRTWTLCGTPE 163
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE + D ++ GIL+ EM G P
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 47/237 (19%)
Query: 153 IGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRN 202
IG G FG V+ T +AVK +++ S F+ E H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADMQADFQREAALMAEFDHPN 69
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------------RP 247
IV++ GV G + +++++M G L E+LR + P
Sbjct: 70 IVKLL----GVCAVG-KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 248 LNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
L + + L IA VA + YL + H +L N L+ + M+ + DFG++R
Sbjct: 125 LPLSCTEQ--LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 308 LPAID----KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
+ + D +N I I+ ++PPE +T DV+++G++L E+F+ G++P
Sbjct: 180 IYSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 9e-11
Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 153 IGAGNFGSVYNGT---LFDGTTIAVKVFNLIRPGGSKSFKS---ECKAAINIKHRNIVRV 206
+G+G FG+VY G + I V + L K+ K E ++ H ++VR+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
Q ++ + MP G L +++R D + +L L+ + +A
Sbjct: 75 LGICLSSQVQ------LITQLMPLGCLLDYVRNHKDN----IGSQYL----LNWCVQIAK 120
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
+ YL + + H +L NVL+ + DFG+A+ L +K+ G
Sbjct: 121 GMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE-----YHAEGGK 172
Query: 327 IPPEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
+P ++ + E+ + DV+S+G+ + E+ T G +P +GI
Sbjct: 173 VPIKW-MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 32/212 (15%)
Query: 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKS-FKSECKAAINIKHRNIVRVFTAF 210
IG GNFG V++G L D T +AVK P K+ F E + H NIVR+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI--- 59
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKD-DTNWRPLNFNFLIKKKLDIAIDVACALR 269
GV Q K +Y M E ++G D T R +K+ + + + A +
Sbjct: 60 -GVCTQ----KQPIYIVM------ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGME 108
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
YL H +L N L+ ++ + + DFGM+R ++++ G IP
Sbjct: 109 YLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPV 160
Query: 330 EYDLGCEASTYG------DVYSFGILLLEMFT 355
++ EA YG DV+SFGILL E F+
Sbjct: 161 KWT-APEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 32/104 (30%), Positives = 46/104 (44%), Gaps = 6/104 (5%)
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
++ AL YLH I H ++KP N+LLD++ H+ DF +A + D
Sbjct: 105 WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-DTLTTSTS 160
Query: 320 IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
G+ GY+ PE S D +S G+ E G RP G
Sbjct: 161 --GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH 202
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 1e-10
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 44/220 (20%)
Query: 153 IGAGNFGSV----YNGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVR 205
+G G+FG V + G+ G A+K+ + +++ + +E + +I+H +V
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
++ +F Q +V +++P G L LR F A V
Sbjct: 66 LYGSF-----QDDSNLYLVMEYVPGGELFSHLRKSG---------RFPEPVARFYAAQVV 111
Query: 266 CALRYLH-CDCQPPIAHCNLKPSNVLLDDEMIGH--VGDFGMARFLPAIDKQNRFICIKG 322
AL YLH D I + +LKP N+LLD + G+ + DFG A+ + R + G
Sbjct: 112 LALEYLHSLD----IVYRDLKPENLLLDSD--GYIKITDFGFAKRVK-----GRTYTLCG 160
Query: 323 STGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ Y+ PE L YG D ++ GIL+ EM G P
Sbjct: 161 TPEYLAPEIILS---KGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 57/230 (24%), Positives = 107/230 (46%), Gaps = 39/230 (16%)
Query: 153 IGAGNFGSVYNGTLF------DGTTIAVKVF-NLIRPGGSKSFKSECKAAINIKHRNIVR 205
+G G FG VY G L T++A+K P + F+ E + +++H NIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL-----------RGKDDTNWRPLNFNFLI 254
+ GV + ++++++ +G L E+L D+T L+ +
Sbjct: 73 LL----GVCTKEQPT-CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF- 126
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID-- 312
L IAI +A + YL H +L N L+ + + + DFG++R + + D
Sbjct: 127 ---LHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 313 --KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
+ + ++ ++PPE L + +T D++SFG++L E+F+ G++P
Sbjct: 181 RVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 152 LIGAGNFGSVYNGTL----FDGTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNI 203
+IGAG FG V G L +A+K ++ G + + F SE H NI
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKT---LKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ + GV +R ++ +FM NG+L+ +LR D F + + + +
Sbjct: 68 IHL----EGV-VTKSRPVMIITEFMENGALDSFLRQNDG--------QFTVIQLVGMLRG 114
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+A ++YL + H +L N+L++ ++ V DFG++RFL + G
Sbjct: 115 IAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG- 170
Query: 324 TGYIP-----PEYDLGCEASTYGDVYSFGILLLE-MFTGIRP 359
G IP PE + ++ DV+S+GI++ E M G RP
Sbjct: 171 -GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 62/239 (25%), Positives = 96/239 (40%), Gaps = 58/239 (24%)
Query: 146 GFSSANLIGAGNFGSVYN-GTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN------- 197
F +G G++GSVY L D A+K +L GS S + E + A+N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDL----GSMS-QKEREDAVNEIRILAS 55
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG--------KDDTNWRPLN 249
+ H NI+ AF G + +V ++ P G L + + + WR
Sbjct: 56 VNHPNIISYKEAF----LDGNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--- 107
Query: 250 FNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
I I + L+ LH + I H +LK +N+LL + +GD G+++ L
Sbjct: 108 ----------IFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL- 153
Query: 310 AIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
K+N G+ Y+ PE Y D++S G LL EM T P +
Sbjct: 154 ---KKNMAKTQIGTPHYMAPEVWKGRPYSYKS------DIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 151 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS-FKSECKAAINIKHRNIVR 205
+IG G+FG VY+GTL D AVK N I F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVL- 59
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ G+ VV +M +G L ++R +T+ N +K + + VA
Sbjct: 60 ---SLLGICLPSEGSPLVVLPYMKHGDLRNFIR--SETH------NPTVKDLIGFGLQVA 108
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
+ YL H +L N +LD+ V DFG+AR DK+ + + TG
Sbjct: 109 KGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKE--YYSVHNHTG 161
Query: 326 YIPPEYDLGCEA------STYGDVYSFGILLLEMFT 355
P + E+ +T DV+SFG+LL E+ T
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 3e-10
Identities = 60/230 (26%), Positives = 91/230 (39%), Gaps = 49/230 (21%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVR---V 206
+G G +G VY G +A+K L G + E +KH NIV+ V
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ +V+++ + L+ D PL+ N LIK I +
Sbjct: 67 IHTERKL--------YLVFEYC-----DMDLKKYLDKRPGPLSPN-LIKS---IMYQLLR 109
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG- 325
L Y H I H +LKP N+L++ + + + DFG+AR I ++ T
Sbjct: 110 GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAF--------GIPLRTYTHE 158
Query: 326 -----YIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
Y PE LG Y D++S G + EM TG +P +F G
Sbjct: 159 VVTLWYRAPEILLGS--KHYSTAVDIWSVGCIFAEMITG-KP---LFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 153 IGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPGGSKSFK----SECKAAINI-KHRNI 203
+GAG FG V T + + V V +++P S + SE K ++ H NI
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAV-KMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 204 VRVFTA--FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDD---TNWRPLNFNFLIKKKL 258
V + A G V+ ++ G L +LR K + T L+F++ + K +
Sbjct: 102 VNLLGACTIGGPIL-------VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
C H +L NVLL I + DFG+AR I + ++
Sbjct: 155 AFLASKNCI-------------HRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYV 198
Query: 319 CIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+KG+ ++ PE C + DV+S+GILL E+F+ G P G+
Sbjct: 199 -VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 39/219 (17%)
Query: 153 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKSFKSECKAAI----NIKHRN 202
+G G+FG V +D G +AVK ++P + ++ K I N+ H N
Sbjct: 12 LGEGHFGKV-ELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 203 IVRVFTAFSGV-DYQGARFKAVVYKFMPNGSLEEWL-RGKDDTNWRPLNFNFLIKKKLDI 260
IV+ + G+ G ++ +F+P+GSL+E+L R K+ N +K++L
Sbjct: 68 IVK----YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN---------LKQQLKY 114
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
A+ + + YL H +L NVL++ E +GDFG+ + AI+ + +
Sbjct: 115 AVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK---AIETDKEYYTV 168
Query: 321 KGSTG----YIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
K + PE + + DV+SFG+ L E+ T
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 36/227 (15%)
Query: 152 LIGAGNFGSVYNGTLF-DGTTI----AVKVFN-LIRPGGSKSFKSECKAAINIKHRNIVR 205
++G+G FG+VY G +G T+ A+K+ N P + F E ++ H ++VR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ Q +V + MP+G L +++ D L N+ ++ +A
Sbjct: 74 LLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ--------IA 119
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
+ YL + + H +L NVL+ + DFG+AR L +K+ G
Sbjct: 120 KGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE-----YNADGG 171
Query: 326 YIPPEYDLGCEASTY------GDVYSFGILLLEMFT-GIRPSDGIFT 365
+P ++ + E Y DV+S+G+ + E+ T G +P DGI T
Sbjct: 172 KMPIKW-MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 152 LIGAGNFGSVYNGTLFD-GTTIAVKVFNLIR--PGGSKSFKS-ECKAAI--NIKHRNIVR 205
L+G G FG VY D G +AVK P K + EC+ + N++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ + ++ ++MP GS+++ L+ + L K I V
Sbjct: 69 YYGCL-----RDDETLSIFMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVE 118
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI-CIKGST 324
YLH + I H ++K +N+L D +GDFG ++ L I + + G+
Sbjct: 119 ----YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 325 GYIPPEYDLGCEASTYG---DVYSFGILLLEMFT 355
++ PE G YG DV+S G ++EM T
Sbjct: 172 YWMSPEVISG---EGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 53/247 (21%), Positives = 93/247 (37%), Gaps = 72/247 (29%)
Query: 151 NLIGAGNFGSV---YNGTLFDGTTIAVKVFNLIRPGGSKSFKS---------ECKAAINI 198
IG+G +G V + G +A+K + + F E K ++
Sbjct: 6 KPIGSGAYGVVCSAVDKRT--GRKVAIKKISNV-------FDDLIDAKRILREIKLLRHL 56
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAV--VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK 256
+H NI+ + F V V + M +T+ + +IK
Sbjct: 57 RHENIIGLLDIL--RPPSPEDFNDVYIVTELM-------------ETD-----LHKVIKS 96
Query: 257 KLDIAID--------VACALRYLH-CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
+ D + L+YLH + + H +LKPSN+L++ + DFG+AR
Sbjct: 97 PQPLTDDHIQYFLYQILRGLKYLHSAN----VIHRDLKPSNILVNSNCDLKICDFGLARG 152
Query: 308 LPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPS 360
+ + + F+ T Y+ PE L T D++S G + E+ T +P
Sbjct: 153 VDPDEDEKGFL-----TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KP- 205
Query: 361 DGIFTGK 367
+F G+
Sbjct: 206 --LFPGR 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 153 IGAGNFGSVYNGTLFDG-------TTIAVKVFNLIRPGGSK-SFKSECKAAINIKHRNIV 204
+G G+FG VY G + G T +A+K N + F +E ++V
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKLDIAID 263
R+ GV QG + V+ + M G L+ +LR + + P+ +KK + +A +
Sbjct: 73 RLL----GVVSQG-QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+A + YL+ + H +L N ++ ++ +GDFGM R + D KG
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGG 179
Query: 324 TGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
G +P PE +TY DV+SFG++L E+ T
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVF---NLIRPGGSKSFKSECKAAINIKHR--NIVRV 206
I G FGSVY G A+KV ++I + K+E +A + I+ + ++
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE-RAIMMIQGESPYVAKL 62
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR--GKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ +F DY +V +++ G ++ G +W K+ +V
Sbjct: 63 YYSFQSKDYL-----YLVMEYLNGGDCASLIKTLGGLPEDW--------AKQ---YIAEV 106
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKG 322
+ LH Q I H ++KP N+L+D GH+ DFG++R + +F+ G
Sbjct: 107 VLGVEDLH---QRGIIHRDIKPENLLIDQT--GHLKLTDFGLSR---NGLENKKFV---G 155
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ Y+ PE LG D +S G ++ E G P
Sbjct: 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 8e-10
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 153 IGAGNFGSV----YNGTLFDGTTIAVKVFNLIRPGGSK---SFKSECKAAINIKHRNIVR 205
+G G+FG V Y+ DGT V V L R G + +K E + H NIV+
Sbjct: 12 LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 206 VFTAFSGV-DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ G QG + ++ +++P GSL ++L P + + + L A +
Sbjct: 71 ----YKGCCSEQGGKGLQLIMEYVPLGSLRDYL---------PKH-KLNLAQLLLFAQQI 116
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
+ YLH Q I H +L NVLLD++ + +GDFG+A+ +P + R + G +
Sbjct: 117 CEGMAYLHS--QHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDS 172
Query: 325 G--YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360
+ E + S DV+SFG+ L E+ T
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 66/225 (29%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 153 IGAGNFGSVYNGTLF--DGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+GAGN G V L G +AVK L I K E IV + A
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWL-RGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
F G + Y M GSL++ L + R L IA+ V L
Sbjct: 68 FY---NNGDISICMEY--MDGGSLDKILKEVQGRIPERILGK---------IAVAVLKGL 113
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDKQNRFICIKGSTGY 326
YLH + I H ++KPSN+L++ G + DFG++ L F+ G++ Y
Sbjct: 114 TYLHEKHK--IIHRDVKPSNILVNSR--GQIKLCDFGVSGQLVN-SLAKTFV---GTSSY 165
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTG-------IRPSDGIF 364
+ PE G + S D++S G+ L+E+ TG P DGIF
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 45/229 (19%)
Query: 152 LIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN-----------IK 199
LIG+G+FGSVY G G +AVK + P S S K ++ ++ ++
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVK--QVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW----RPLNFNFLIK 255
H NIV+ + D+ + +++P GS+ L N+ L NF ++
Sbjct: 65 HENIVQYLGSSLDADHLN-----IFLEYVPGGSVAALL-----NNYGAFEETLVRNF-VR 113
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA----- 310
+ L L YLH I H ++K +N+L+D++ + DFG+++ L A
Sbjct: 114 QILK-------GLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST 163
Query: 311 IDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
R ++GS ++ PE + D++S G L++EM TG P
Sbjct: 164 KTNGAR-PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 67/237 (28%), Positives = 99/237 (41%), Gaps = 52/237 (21%)
Query: 152 LIGAGNFGSVYNGTLFD---GTTIAVKV-------FNLIRPGGSKSFKSECKAAINIKHR 201
LIG G G VY +D +A+K L++ K F E K A ++ H
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLK----KRFLREAKIAADLIHP 62
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMP---NGSLEEWLRG--KDDTNWRPLNFNFLIKK 256
IV V++ S D VY MP +L+ L+ + ++ + L +
Sbjct: 63 GIVPVYSICSDGD--------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARF------- 307
L I + + Y+H + H +LKP N+LL + G V D+G A F
Sbjct: 115 FLSIFHKICATIEYVH---SKGVLHRDLKPDNILLG--LFGEVVILDWGAAIFKKLEEED 169
Query: 308 LPAIDKQNRFIC---------IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
L ID R IC I G+ Y+ PE LG AS D+Y+ G++L +M T
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 47/137 (34%), Positives = 66/137 (48%), Gaps = 21/137 (15%)
Query: 235 EWLRGKDDTNWRPLNFNFLIKKKLDI------AIDVACALRYLHCDCQPPIAHCNLKPSN 288
E+L G D L F+ K D+ A ++ C L++LH I + +LK N
Sbjct: 76 EYLNGGD------LMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDN 126
Query: 289 VLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSF 346
+LLD + GH+ DFGM + D + C G+ YI PE LG + +T D +SF
Sbjct: 127 ILLDTD--GHIKIADFGMCKENMLGDAKTCTFC--GTPDYIAPEILLGQKYNTSVDWWSF 182
Query: 347 GILLLEMFTGIRPSDGI 363
G+LL EM G P G
Sbjct: 183 GVLLYEMLIGQSPFHGH 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 42/227 (18%)
Query: 152 LIGAGNFGSVY---NGTLFDGTTIAVKVFNL----------IRPGGSKSFKSECKAAINI 198
LIG G +G VY N T G +AVK L + K+ +SE + ++
Sbjct: 8 LIGKGTYGRVYLALNVT--TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR--GKDDTNWRPLNFNFLIKK 256
H NIV+ + +Y ++ +++P GS+ LR G+ + F ++
Sbjct: 66 DHLNIVQYLGFETTEEYL-----SIFLEYVPGGSIGSCLRTYGR----FEEQLVRFFTEQ 116
Query: 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
L+ L YLH I H +LK N+L+D + I + DFG+++ I ++
Sbjct: 117 VLE-------GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ 166
Query: 317 FICIKGSTGYIPPE----YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ ++GS ++ PE Y G A D++S G ++LEMF G RP
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G GN G+VY L +AVKV L I K SE + I+ + AF
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ R ++ +FM GSL+ + + + R IA+ V L Y
Sbjct: 69 ----FVENRI-SICTEFMDGGSLDVYRKIPEHVLGR-------------IAVAVVKGLTY 110
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFL-PAIDKQNRFICIKGSTGYI 327
L I H ++KPSN+L++ G V DFG++ L +I K G+ Y+
Sbjct: 111 L---WSLKILHRDVKPSNMLVNTR--GQVKLCDFGVSTQLVNSIAKT-----YVGTNAYM 160
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364
PE G + + DV+S GI +E+ G P I
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 21/136 (15%)
Query: 235 EWLRGKDDTNWRPLNFNFLIKKKLDI------AIDVACALRYLHCDCQPPIAHCNLKPSN 288
E+L G D L F+ + D A ++ C L++LH + I + +LK N
Sbjct: 76 EYLNGGD------LMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDN 126
Query: 289 VLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSF 346
VLLD + GH+ DFGM + + + C G+ YI PE G + + D +SF
Sbjct: 127 VLLDKD--GHIKIADFGMCKENMNGEGKASTFC--GTPDYIAPEILKGQKYNESVDWWSF 182
Query: 347 GILLLEMFTGIRPSDG 362
G+LL EM G P G
Sbjct: 183 GVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 146 GFSSANLIGAGNFGSVYNGTLFD---GTTIAVKVFNLIRPGGSKS----FKSECKAAINI 198
+ ++L+ G FG ++ G L D G V V + S+ E +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGL 65
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL---RGKDDTNWRPLNFNFLIK 255
H+NI+ + V + V+Y +M G+L+ +L R + N + L+ L+
Sbjct: 66 SHQNILPI----LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV- 120
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL-PAI--- 311
+AI +AC + YLH + + H ++ N ++D+E+ + D ++R L P
Sbjct: 121 ---HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 312 --DKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
D +NR + ++ E + E S+ DV+SFG+LL E+ T
Sbjct: 175 LGDNENRPV------KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTA 209
IG G G V+ G T+A+K L R G E KA +H +V++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
F G+ F +V ++MP L E LR ++ RPL +K + + + +
Sbjct: 68 FP----HGSGF-VLVMEYMP-SDLSEVLRDEE----RPLP-EAQVKSYMRMLLK---GVA 113
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR-FLPAIDKQNRFICIKGSTGYIP 328
Y+H I H +LKP+N+L+ + + + DFG+AR F + + Y
Sbjct: 114 YMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV--ATRWYRA 168
Query: 329 PEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
PE G Y D+++ G + E+ G P +F G+
Sbjct: 169 PELLYGAR--KYDPGVDLWAVGCIFAELLNG-SP---LFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 25/180 (13%)
Query: 187 SFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR 246
+ ++EC+ + H NI+ + F D +V ++ P G+L E+++ +
Sbjct: 45 AAQNECQVLKLLSHPNIIEYYENFL-EDKA----LMIVMEYAPGGTLAEYIQKR------ 93
Query: 247 PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVGDFGMA 305
N L + + AL ++H I H +LK N+LLD +M+ +GDFG++
Sbjct: 94 -CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGIS 149
Query: 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTY---GDVYSFGILLLEMFTGIRPSDG 362
+ L + K + G+ YI PE CE Y D+++ G +L E+ + R +
Sbjct: 150 KILSSKSKAYTVV---GTPCYISPEL---CEGKPYNQKSDIWALGCVLYELASLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 40/223 (17%)
Query: 152 LIGAGNFGSVYN--GTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----------- 198
+G+G FG VY +A+K N+ P K + K+ +I
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFM------PNGSLEEWLRGKDDTNWRPLNFNF 252
+H NIVR + F + R +Y M P G L+ K F
Sbjct: 67 RHPNIVRYYKTFL----ENDR----LYIVMDLIEGAPLGEHFNSLKEKKQ--------RF 110
Query: 253 LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID 312
++ +I + + ALRYLH + + I H +L P+N++L ++ + DFG+A+
Sbjct: 111 TEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQ 165
Query: 313 KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
+++ + G+ Y PE DV++FG +L +M T
Sbjct: 166 PESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 7e-09
Identities = 61/248 (24%), Positives = 98/248 (39%), Gaps = 59/248 (23%)
Query: 140 LYNATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKAAINI 198
L + T F +IG G +G VY G +A+K+ ++I + + E K NI
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-----EDEEEEIKEEYNI 55
Query: 199 -----KHRNIVRVFTAFSGVDYQGARFKAV----------VYKFMPNGSLEEWLRGKDDT 243
H NI + GA K V + GS+ + ++G
Sbjct: 56 LRKYSNHPNI---------ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK 106
Query: 244 NWRPLNFNFLIKKKLDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300
R K+ IA + L YLH + + H ++K N+LL V
Sbjct: 107 GKR--------LKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKN--AEVK 153
Query: 301 --DFGMARFLP-AIDKQNRFICIKGSTGYIPPEYDLGCEAS---TY---GDVYSFGILLL 351
DFG++ L + ++N FI G+ ++ PE + C+ +Y DV+S GI +
Sbjct: 154 LVDFGVSAQLDSTLGRRNTFI---GTPYWMAPEV-IACDEQPDASYDARSDVWSLGITAI 209
Query: 352 EMFTGIRP 359
E+ G P
Sbjct: 210 ELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 18/219 (8%)
Query: 152 LIGAGNFGSV-YNGTLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVFT 208
++G+G G+V + DG AVKV ++ + ++E +N +IV+
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 209 AFSGVDYQG---ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
F+ D + A+V + G L + ++ + TN R F + + I V
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN-RT----FREHEAGLLFIQVL 153
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI--DKQNRFICIKGS 323
A+ ++H + H ++K +N+LL + +GDFG ++ A D R C G+
Sbjct: 154 LAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC--GT 208
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
Y+ PE S D++S G+LL E+ T RP DG
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247
|
Length = 496 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 35/223 (15%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVR---V 206
IG G +G VY G +A+K L G K+ E K + H NI++ V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
F + +V++FM + L + ++ R L LIK +
Sbjct: 67 FRHKGDL--------YLVFEFM-DTDLYKLIKD----RQRGLP-ESLIKS---YLYQLLQ 109
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG- 325
L + H I H +LKP N+L++ E + + DFG+AR + R T
Sbjct: 110 GLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLAR---SFGSPVRPYTHYVVTRW 163
Query: 326 YIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGK 367
Y PE LG + + D++S G + E+ + RP +F GK
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSR-RP---LFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 43/134 (32%), Positives = 63/134 (47%), Gaps = 17/134 (12%)
Query: 235 EWLRGKDDTNWRPLNFNFLIKKKLDI------AIDVACALRYLHCDCQPPIAHCNLKPSN 288
E+L G D L F+ K + D+ A ++ C L++LH I + +LK N
Sbjct: 76 EFLNGGD------LMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDN 126
Query: 289 VLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGI 348
V+LD + + DFGM + + NR G+ YI PE G + + D +SFG+
Sbjct: 127 VMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGV 184
Query: 349 LLLEMFTGIRPSDG 362
LL EM G P G
Sbjct: 185 LLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 38/107 (35%), Positives = 58/107 (54%), Gaps = 13/107 (12%)
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDKQNRFICI 320
++A AL +LH I + +LKP N+LLD+E GH+ DFG+++ +ID + +
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSK--ESIDHEKKAYSF 158
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
G+ Y+ PE + D +SFG+L+ EM TG P F GK
Sbjct: 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQGK 201
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 32/219 (14%)
Query: 153 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G+FG VY G D T +AVK N S S + + + ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-----ESASLRERIEF---LNEASVMKG 65
Query: 207 FTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKLDIA 261
FT V G K VV + M +G L+ +LR + + P +++ + +A
Sbjct: 66 FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
++A + YL+ H +L N ++ + +GDFGM R + D K
Sbjct: 126 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----K 177
Query: 322 GSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
G G +P PE +T D++SFG++L E+ +
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 52/229 (22%), Positives = 103/229 (44%), Gaps = 31/229 (13%)
Query: 153 IGAGNFGSVYNGTLF-----DGTTIAVKVF-NLIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G FG +Y G L+ +A+K ++ P F+ E + H NIV +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWL--RGKDDTNWRPLNFNFLIKKKLD----- 259
+ + ++++++ G L E+L R + + +K LD
Sbjct: 73 LGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 260 -IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID----KQ 314
IAI +A + YL H +L N+L+ +++ + D G++R + + D +
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDG 362
+ I+ ++PPE + + S+ D++SFG++L E+F+ G++P G
Sbjct: 185 KSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 30/210 (14%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
IG G G VY T G +A+K L + + +E + KH NIV + ++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQN-KELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI---DVACAL 268
+ VV ++M GSL + + NF+ + IA +V L
Sbjct: 86 ---VGDELW--VVMEYMDGGSLTDIIT-----------QNFVRMNEPQIAYVCREVLQGL 129
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGY 326
YLH + H ++K N+LL G V DFG A L +K R + G+ +
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLS--KDGSVKLADFGFAAQLTK-EKSKR-NSVVGTPYW 182
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
+ PE + D++S GI+ +EM G
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 50/241 (20%)
Query: 152 LIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKSFK---SECKAAINI-KHR 201
+G G FG V +T+AVK+ L K SE + I KH+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP------LNFNFLIK 255
NI+ + + +G + VV ++ +G+L ++LR + RP + +
Sbjct: 77 NIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRAR-----RPPGEYASPDDPRPPE 126
Query: 256 KKL---DI---AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
+ L D+ A VA + +L H +L NVL+ ++ + + DFG+AR +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 310 AIDKQNRFICIKGSTGYIPPEYDLGCEA------STYGDVYSFGILLLEMFT-GIRPSDG 362
ID K + G +P ++ + EA + DV+SFG+LL E+FT G P G
Sbjct: 184 HIDYYR-----KTTNGRLPVKW-MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237
Query: 363 I 363
I
Sbjct: 238 I 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 43/226 (19%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGS------KSFKSECKAAINIKHRNIV 204
+G G F S Y + GT +AVK +R S ++ + E + + H +I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
R+ G + + F + ++M GS+ L + +I + +
Sbjct: 67 RML----GATCEDSHFN-LFVEWMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRGL 116
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH---VGDFGMARFLPAI-----DKQNR 316
+ YLH + Q I H ++K +N+L+D G + DFG A L A + Q +
Sbjct: 117 S----YLH-ENQ--IIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 317 FICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ G+ ++ PE G YG DV+S G +++EM T P
Sbjct: 168 LL---GTIAFMAPEVLRG---EQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 26/178 (14%)
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP--LNFNF---- 252
KH+NI+ + A + Q +V ++ G+L E+LR + RP ++++F
Sbjct: 76 KHKNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRAR-----RPPGMDYSFDTCK 125
Query: 253 ------LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306
K + A VA + YL H +L NVL+ ++ + + DFG+AR
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ ID + + ++ PE + DV+SFG+LL E+FT G P GI
Sbjct: 183 DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 25/216 (11%)
Query: 147 FSSANLIGAGNFGSVYNG-TLFDGTTIAVKV--FNLIRPGGSKSFKSECKAAINIKHRNI 203
F N IG G +G VY G +A+K + R G S E +N++H NI
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
V + G ++ F+ E+ L D P F + + +
Sbjct: 69 VELKEVV-----VGKHLDSI---FLVMEYCEQDLASLLDNMPTP----FSESQVKCLMLQ 116
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIK 321
+ L+YLH + I H +LK SN+LL D+ + DFG+AR LPA + +
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--- 170
Query: 322 GSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTG 356
+ Y PE LGC T D+++ G +L E+
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGS-KSFKSECKAAINIKHRNIVRVFTAF 210
IG G VY L + +A+K +L + S + E +A H N+V+ +T+F
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
V + +V ++ GSL + ++ + K +V L Y
Sbjct: 69 V-VGDE----LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK------EVLKGLEY 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL--PAIDKQNRFICIKGSTGYIP 328
LH + Q H ++K N+LL ++ + DFG++ L + G+ ++
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 329 PE-------YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
PE YD D++SFGI +E+ TG P
Sbjct: 175 PEVMEQVHGYDFK------ADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 65/253 (25%), Positives = 100/253 (39%), Gaps = 65/253 (25%)
Query: 128 GKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFNLIR 181
G S +L N IG+G G+VY G L+ A+KV I
Sbjct: 64 GSAPSAAKSLSEL-------ERVNRIGSGAGGTVYKVIHRPTGRLY-----ALKV---IY 108
Query: 182 PGGSKSFKSECKAAINI----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL 237
+ + + I I H N+V+ F + V+ +FM GSLE
Sbjct: 109 GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD----HNGEIQ-VLLEFMDGGSLE--- 160
Query: 238 RGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297
+ FL D+A + + YLH + I H ++KPSN+L++
Sbjct: 161 ------GTHIADEQFLA----DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNV 207
Query: 298 HVGDFGMARFLP-AIDKQNRFICIKGSTGYIPPE----------YDLGCEASTYGDVYSF 346
+ DFG++R L +D N + G+ Y+ PE YD G GD++S
Sbjct: 208 KIADFGVSRILAQTMDPCNSSV---GTIAYMSPERINTDLNHGAYD-GYA----GDIWSL 259
Query: 347 GILLLEMFTGIRP 359
G+ +LE + G P
Sbjct: 260 GVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 58/184 (31%), Positives = 83/184 (45%), Gaps = 38/184 (20%)
Query: 199 KHRNIVRVFTAFSGVDYQ-GARFKAVVYKFMPNGSLEEWLR-----GKDDT------NWR 246
KH+NI+ + GV Q G + V+ ++ G+L E+LR G D T
Sbjct: 76 KHKNIINLL----GVCTQEGPLY--VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129
Query: 247 PLNFNFLIKKKLDIAIDVACALRYLHCD-CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305
L+F L+ A VA + YL C H +L NVL+ ++ + + DFG+A
Sbjct: 130 QLSFKDLVS----CAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 306 RFLPAIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
R + ID K S G +P PE + DV+SFGIL+ E+FT G P
Sbjct: 182 RGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
Query: 360 SDGI 363
GI
Sbjct: 237 YPGI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 5e-08
Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 41/231 (17%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KH 200
F L+G G +G VY G + G A+KV ++ + + E K IN+ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----TGDEEEEIKQEINMLKKYSHH 62
Query: 201 RNIVRVFTAF-----SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
RNI + AF G+D Q +V +F GS+ + ++ + ++ +
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQ----LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQ 314
+ L L +LH Q + H ++K NVLL + + DFG+ A+ + ++
Sbjct: 119 EILR-------GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 168
Query: 315 NRFICIKGSTGYIPPEYDLGCEA---STY---GDVYSFGILLLEMFTGIRP 359
N FI G+ ++ PE + C+ +TY D++S GI +EM G P
Sbjct: 169 NTFI---GTPYWMAPEV-IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 152 LIGAGNFGSVYNGTL-FDG---TTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNI 203
+IGAG FG V +G L G +A+K ++ G + + F SE H NI
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKT---LKAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ + GV + + +V ++M NGSL+ +LR D F + + + +
Sbjct: 68 IHL----EGVVTKS-KPVMIVTEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRG 114
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+A ++YL H +L N+L++ ++ V DFG++R L D +G
Sbjct: 115 IASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEAAYTTRG- 168
Query: 324 TGYIP-----PEYDLGCEASTYGDVYSFGILLLE-MFTGIRP 359
G IP PE + ++ DV+S+GI++ E M G RP
Sbjct: 169 -GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 57/233 (24%), Positives = 85/233 (36%), Gaps = 45/233 (19%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTA 209
IG G+FG+V DG + K + + SE +KH NIVR +
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK------------ 257
+D R +Y M E+ G D LI+K
Sbjct: 68 I--ID----RSNQTLYIVM------EYCEGGDLAQ--------LIQKCKKERKYIEEEFI 107
Query: 258 LDIAIDVACALRYLH--CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP-AIDKQ 314
I + AL H D + H +LKP+N+ LD +GDFG+A+ L
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
++ G+ Y+ PE D++S G L+ E+ P FT +
Sbjct: 168 KTYV---GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP----FTAR 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 13/106 (12%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR--FLPAIDKQNR 316
A ++ L++LH + I + +LK NVLLD E GH+ DFGM + L +
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSE--GHIKIADFGMCKEGILGG-VTTST 155
Query: 317 FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
F C G+ YI PE D ++ G+LL EM G P +G
Sbjct: 156 F-C--GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 16/173 (9%)
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD----DTNWRPLNF---N 251
KH+NI+ + A + G + V+ ++ G+L E+LR + + + P
Sbjct: 82 KHKNIINLLGACT---QDGPLY--VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
K + A VA + YL H +L NVL+ ++ + + DFG+AR + I
Sbjct: 137 LSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193
Query: 312 DKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
D + + ++ PE + DV+SFG+LL E+FT G P G+
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 59/242 (24%), Positives = 95/242 (39%), Gaps = 69/242 (28%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHRNIVRV 206
+G G++GSVY G +A+KV + + E I+I IV+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKE----ISILKQCDSPYIVK- 62
Query: 207 FTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD--- 259
Y G+ FK +V ++ GS+ + ++ + K L
Sbjct: 63 --------YYGSYFKNTDLWIVMEYCGAGSVSDIMK--------------ITNKTLTEEE 100
Query: 260 IAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP-AIDKQN 315
IA L YLH H ++K N+LL++E + DFG++ L + K+N
Sbjct: 101 IAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157
Query: 316 RFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTG------IRPSDGI 363
I G+ ++ PE Y+ +A D++S GI +EM G I P I
Sbjct: 158 TVI---GTPFWMAPEVIQEIGYN--NKA----DIWSLGITAIEMAEGKPPYSDIHPMRAI 208
Query: 364 FT 365
F
Sbjct: 209 FM 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 63/246 (25%), Positives = 100/246 (40%), Gaps = 55/246 (22%)
Query: 153 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+G G FG V T F TT+AVK +++ S S SE + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVK---MLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR-------------------GKDDT 243
+++++ A S G ++ ++ GSL +LR D+
Sbjct: 65 VIKLYGACSQ---DGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 244 NWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303
+ R L LI A ++ ++YL + + H +L NVL+ + + DFG
Sbjct: 120 DERALTMGDLIS----FAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 304 MARFLPAIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GI 357
++R + D +K S G IP E +T DV+SFG+LL E+ T G
Sbjct: 173 LSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227
Query: 358 RPSDGI 363
P GI
Sbjct: 228 NPYPGI 233
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 54/230 (23%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 147 FSSANLIGAGNFGSVYNGTLF-DGTTI----AVKVF-NLIRPGGSKSFKSECKAAINIKH 200
F ++G+G FG+VY G +G + A+K P +K E ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
++ R+ Q ++ + MP G L +++R D N + L+
Sbjct: 69 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD--------NIGSQYLLNW 114
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+ +A + YL + + H +L NVL+ + DFG+A+ L A +K+
Sbjct: 115 CVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE-----Y 166
Query: 321 KGSTGYIPPEYDLGCEA---STY---GDVYSFGILLLEMFT-GIRPSDGI 363
G +P ++ + E+ Y DV+S+G+ + E+ T G +P DGI
Sbjct: 167 HAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 36/101 (35%), Positives = 46/101 (45%), Gaps = 10/101 (9%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A + C L +LH Q I + +LKP NVLLDD G+V D G+A L K
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDH--GNVRISDLGLAVELKGGKKIKGRA 155
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G+ GY+ PE G D ++ G L EM G P
Sbjct: 156 ---GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 36/107 (33%), Positives = 55/107 (51%), Gaps = 17/107 (15%)
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
AL+Y+H + H +LKPSN+LL+ + + DFG+AR L +++ + T Y
Sbjct: 119 ALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL---TDY 172
Query: 327 I------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTG 366
+ PE LG T G D++S G +L EM G +P +F G
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KP---LFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 40/108 (37%), Positives = 52/108 (48%), Gaps = 15/108 (13%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A ++A L +LH I + +LK NV+LD E GH+ DFGM + K R
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTF 161
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGI 363
C G+ YI PE YG D ++FG+LL EM G P DG
Sbjct: 162 C--GTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS-FKSECKAAINIKH---RNIVRV 206
LIG G +G+VY G + G +A+K+ NL P S + E ++ NI +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI--DV 264
+ G +G R ++ ++ GS+ ++ I +K I +V
Sbjct: 68 Y----GSYLKGPRL-WIIMEYAEGGSVRTLMKAGP------------IAEKYISVIIREV 110
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID-KQNRFICIKGS 323
AL+Y+H + H ++K +N+L+ + + DFG+A L K++ F+ G+
Sbjct: 111 LVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV---GT 164
Query: 324 TGYIPPEYDL-GCEASTYGDVYSFGILLLEMFTGIRP 359
++ PE G T D++S GI + EM TG P
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 152 LIGAGNFGSVYNGTLFD-GTTIAVKV--FNLIRPGGSKSFKS-ECKAAI--NIKHRNIVR 205
L+G G FG VY D G +A K F+ P SK + EC+ + N++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ + + + ++MP GS+++ L+ + L + K I
Sbjct: 69 YYGCLRD---RAEKTLTIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILE--- 117
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI-CIKGST 324
+ YLH + I H ++K +N+L D +GDFG ++ L I I + G+
Sbjct: 118 -GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
++ PE G DV+S G ++EM T P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 141 YNATNGFSSANLIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAI--N 197
+ + + +G G++ +VY G + +G +A+KV L G+ F + +A++
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKG 59
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
+KH NIV + + F+ V + L +++ K P N + +
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYV------HTDLCQYM-DKHPGGLHPENVKLFLFQL 112
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQN 315
L L Y+H Q I H +LKP N+L+ D + DFG+AR +P+ N
Sbjct: 113 LR-------GLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162
Query: 316 RFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363
+ + Y PP+ LG E ST D++ G + +EM G+ G+
Sbjct: 163 EVVTL----WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 41/231 (17%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KH 200
F ++G G +G VY G + G A+KV ++ ++ + E K IN+ H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----TEDEEEEIKLEINMLKKYSHH 72
Query: 201 RNIVRVFTAF-----SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
RNI + AF G D Q +V +F GS+ + ++ + ++ +
Sbjct: 73 RNIATYYGAFIKKSPPGHDDQ----LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQ 314
+ L L +LH + H ++K NVLL + + DFG+ A+ + ++
Sbjct: 129 EILR-------GLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178
Query: 315 NRFICIKGSTGYIPPEYDLGCEA---STY---GDVYSFGILLLEMFTGIRP 359
N FI G+ ++ PE + C+ +TY D++S GI +EM G P
Sbjct: 179 NTFI---GTPYWMAPEV-IACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARF-LPAIDKQNRFICIKG 322
CAL LH + + + +LKP N+LLD GH+ DFG+ + + DK N F C G
Sbjct: 104 CALENLH---KFNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTF-C--G 155
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ Y+ PE LG + D ++ G+LL EM TG+ P
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 151 NLIGAGNFGSVYNGTLF-DGTTI--AVKVFN-LIRPGGSKSFKSECKAAINI-KHRNIVR 205
++IG GNFG V + DG + A+K+ + F E + + H NI+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP-------LNFNFLIKKKL 258
+ A + +G + A+ Y P G+L ++LR P ++ L
Sbjct: 68 LLGA---CENRGYLYIAIEYA--PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
A DVA ++YL + H +L NVL+ + + + DFG++R +
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR--------GEEV 171
Query: 319 CIKGSTGYIPPEYDLGCEA------STYGDVYSFGILLLEMFT 355
+K + G +P + + E+ +T DV+SFG+LL E+ +
Sbjct: 172 YVKKTMGRLPVRW-MAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 42/228 (18%)
Query: 147 FSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNI 203
F IG G +G VY D G +A+K L + G + E K + HRNI
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 204 VR----VFTAFSGVDY---QGARFKAVVYKFMPN---GSLEEWLRGKDDTNWRPLNFNFL 253
V V +D+ +GA + +V+++M + G LE L ++ +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFY--LVFEYMDHDLMGLLESGL-----VHFSEDHIKSF 121
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
+K+ L+ L Y H + H ++K SN+LL+++ + DFG+AR + +
Sbjct: 122 MKQLLE-------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 314 Q---NRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFT 355
+ N+ I + Y PPE LG E YG DV+S G +L E+FT
Sbjct: 172 RPYTNKVITL----WYRPPELLLGEE--RYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 26/178 (14%)
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNF------ 252
KH+NI+ + A + Q +V ++ G+L E+LR + RP +
Sbjct: 79 KHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRAR-----RPPGMEYSYDIAR 128
Query: 253 ------LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306
K + VA + YL H +L NVL+ + + + DFG+AR
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ ID + + ++ PE + DV+SFG+L+ E+FT G P GI
Sbjct: 186 DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+ L +LH Q I + +LKP NVLLD++ + D G+A L D Q++ G+
Sbjct: 106 IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGT 160
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G++ PE G E D ++ G+ L EM P
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 13/108 (12%)
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDKQNRF 317
IA+ + AL YLH + + H ++KPSNVL++ G V DFG++ +L +D +
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRN--GQVKLCDFGISGYL--VDSVAKT 161
Query: 318 ICIKGSTGYIPPE-YDLGCEASTY---GDVYSFGILLLEMFTGIRPSD 361
I G Y+ PE + Y DV+S GI ++E+ TG P D
Sbjct: 162 IDA-GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 58/217 (26%), Positives = 85/217 (39%), Gaps = 36/217 (16%)
Query: 153 IGAGNFGSVYNGTL-FDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVFT 208
+G G FG V + T A+K ++ G + SE + H IV+++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 209 AFSGVDYQGARFKAVVY---KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
F Y +Y ++ G L LR + F+ + +A
Sbjct: 61 TFKDKKY--------IYMLMEYCLGGELWTILRDRG-------LFD-----EYTARFYIA 100
Query: 266 C---ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
C A YLH I + +LKP N+LLD + DFG A+ L + K F G
Sbjct: 101 CVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---G 154
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ Y+ PE L D +S GILL E+ TG P
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 61/226 (26%), Positives = 93/226 (41%), Gaps = 33/226 (14%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL------IRPGGSKSFKSECKAAINIKH 200
++ ++G G +G+VY G G IAVK L + + E ++KH
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
NIV + G ++ +F+P GS+ L + PL K I
Sbjct: 62 VNIV----QYLGTCLDDNTI-SIFMEFVPGGSISSILN-----RFGPLPEPVFCKYTKQI 111
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI----DKQNR 316
VA YLH +C + H ++K +NV+L I + DFG AR L + N
Sbjct: 112 LDGVA----YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM 164
Query: 317 FICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ G+ ++ PE S YG D++S G + EM TG P
Sbjct: 165 LKSMHGTPYWMAPEV---INESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 33/218 (15%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVK---VFNLIRPGGSKSFKSECKAAINIKHRN 202
F IG G F VY T L DG +A+K +F+L+ E + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL---- 258
+++ + +F + +V + G L ++ +F +K+L
Sbjct: 64 VIKYYASFIEDNELN-----IVLELADAGDLSRMIK------------HFKKQKRLIPEK 106
Query: 259 ---DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+ + AL ++H + H ++KP+NV + + +GD G+ RF + K
Sbjct: 107 TVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTT 161
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEM 353
+ G+ Y+ PE + D++S G LL EM
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 153 IGAGNFGS---VYNGTLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVF 207
IG G+FG V + DG +K N+ + P + + E N+KH NIV+
Sbjct: 8 IGEGSFGKAILVKSKE--DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 208 TAF--SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+F +G Y +V + G L + + + F + LD + +
Sbjct: 66 ESFEENGNLY-------IVMDYCEGGDLYKKINAQR-------GVLFPEDQILDWFVQIC 111
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
AL+++H I H ++K N+ L + +GDFG+AR L + + R CI G+
Sbjct: 112 LALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR-TCI-GTPY 166
Query: 326 YIPPEYDLGCEASTY---GDVYSFGILLLEMFT 355
Y+ PE CE Y D+++ G +L EM T
Sbjct: 167 YLSPEI---CENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 36/222 (16%)
Query: 152 LIGAGNFGSVYNGTLFD-GTTIAVKV--FNLIRPGGSKSFKS-ECKAAI--NIKHRNIVR 205
L+G G FG VY D G +AVK F+ P SK + EC+ + N+ H IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ D R ++ + MP GS+++ L+ ++ L N K I V+
Sbjct: 69 YYGCLR--DPM-ERTLSIFMEHMPGGSIKDQLK-----SYGALTENVTRKYTRQILEGVS 120
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS-- 323
YLH + I H ++K +N+L D +GDFG ++ L + IC+ G+
Sbjct: 121 ----YLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL-------QTICLSGTGM 166
Query: 324 ---TG---YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
TG ++ PE G D++S G ++EM T P
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 54/205 (26%), Positives = 81/205 (39%), Gaps = 27/205 (13%)
Query: 169 GTTIAVKVFNLIRPGGS---KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225
G +A+K+ P F+ E + H NIV + SG G F V+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD--SGEAPPGLLF--AVF 58
Query: 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285
+++P +L E L D L+ + LD +ACA I H +LK
Sbjct: 59 EYVPGRTLREVL--AADGALPAGETGRLMLQVLD---ALACAHN-------QGIVHRDLK 106
Query: 286 PSNVLL---DDEMIGHVGDFGMARFLP---AIDKQ--NRFICIKGSTGYIPPEYDLGCEA 337
P N+++ V DFG+ LP D R + G+ Y PE G
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166
Query: 338 STYGDVYSFGILLLEMFTGIRPSDG 362
+ D+Y++G++ LE TG R G
Sbjct: 167 TPNSDLYAWGLIFLECLTGQRVVQG 191
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 48/218 (22%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
IG+G +G VY + G +A+KV L + + E +H NIV F ++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC----A 267
D +V ++ GSL++ PL+ +L IA V
Sbjct: 71 RRDKL-----WIVMEYCGGGSLQDIY----QVTRGPLS-------ELQIAY-VCRETLKG 113
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPA-IDKQNRFICIKGST 324
L YLH + H ++K +N+LL ++ G V DFG++ L A I K+ FI G+
Sbjct: 114 LAYLH---ETGKIHRDIKGANILLTED--GDVKLADFGVSAQLTATIAKRKSFI---GTP 165
Query: 325 GYIPPE---------YDLGCEASTYGDVYSFGILLLEM 353
++ PE YD C D+++ GI +E+
Sbjct: 166 YWMAPEVAAVERKGGYDGKC------DIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 58/239 (24%), Positives = 105/239 (43%), Gaps = 42/239 (17%)
Query: 147 FSSANLIGAGNFGSVYNGTLF--DGT--TIAVKVF--NLIRPGGSKSFKSECKAAINIKH 200
F+ ++G G FGSV L DG+ +AVK+ ++ + F E H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 201 RNIVRVFTAFSGVDYQGARFKA------VVYKFMPNGSLEEWL---RGKDDTNWRPLNFN 251
N++++ GV + +R K V+ FM +G L +L R ++ F
Sbjct: 61 PNVIKLI----GVSLR-SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEP------FT 109
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
++ + ID+A + YL H +L N +L++ M V DFG+++ + +
Sbjct: 110 LPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG 166
Query: 312 DKQNRFICIKGSTGYIPPEYDLGCEA------STYGDVYSFGILLLEMFT-GIRPSDGI 363
D +G +P ++ L E+ +T+ DV++FG+ + E+ T G P G+
Sbjct: 167 DYYR-----QGCASKLPVKW-LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 19/221 (8%)
Query: 153 IGAGNFGSVYNGTLFDGTTI---AVKVFNLIRPGGSK--SFKSECKAAINIKHRNIVRVF 207
+G G FGSV G L +I AVK + S+ F SE H N++R+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 208 -TAFSGVDYQGARFKAVVYKFMPNGSLEEWL---RGKDDTNWRPLNFNFLIKKKLDIAID 263
V+ +G V+ FM +G L +L R D + P L+K D
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQM--LVK----FMTD 120
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+A + YL H +L N +L++ M V DFG+++ + D + K
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+I E +T DV+SFG+ + E+ T G P G+
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 63/258 (24%), Positives = 95/258 (36%), Gaps = 72/258 (27%)
Query: 145 NGFSSANLIGAGNFGSVYNGTLFDGTT---IAVKVFN---LIRPGGSKSFKSECKAAINI 198
+ F +IG G FG V+ + D T A+KV +I+ ++E +
Sbjct: 1 DDFEVIKVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA 58
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD--DTNWRPLNFNFLIKK 256
IV+++ +F Q +V ++MP G L L KD F I +
Sbjct: 59 DSPWIVKLYYSF-----QDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA----RFYIAE 109
Query: 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA--------R 306
L +A+D L ++H D +KP N+L+D + GH+ DFG+ R
Sbjct: 110 -LVLALDSVHKLGFIHRD---------IKPDNILIDAD--GHIKLADFGLCKKMNKAKDR 157
Query: 307 FLPAIDKQNRFICIK-------------------GSTGYIPPE------YDLGCEASTYG 341
D N G+ YI PE Y L C
Sbjct: 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC------ 211
Query: 342 DVYSFGILLLEMFTGIRP 359
D +S G++L EM G P
Sbjct: 212 DWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 45/228 (19%)
Query: 151 NLIGAGNFGSVY------NGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNI 203
++IG GNFG V +G D +K + + F E + + H NI
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI--------- 254
+ + A +++G + A+ ++ P+G+L ++LR P F I
Sbjct: 71 INLLGA---CEHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPA---FAIANSTASTLS 122
Query: 255 -KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
++ L A DVA + YL Q H +L N+L+ + + + DFG++R
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------- 172
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTY------GDVYSFGILLLEMFT 355
+ + +K + G +P + + E+ Y DV+S+G+LL E+ +
Sbjct: 173 -GQEVYVKKTMGRLPVRW-MAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 153 IGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPGGSKSFKSECKAAI--NIKHRNIVRV 206
+G G++G V +L DG +K NL + +E +A + +KH NIV
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-LDIAIDVA 265
++ G D +V F G L L+ + L + + ++ + +A
Sbjct: 65 RESWEGEDGL----LYIVMGFCEGGDLYHKLKEQKG--------KLLPENQVVEWFVQIA 112
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA-IDKQNRFICIKGST 324
AL+YLH + I H +LK NV L I VGD G+AR L D + I G+
Sbjct: 113 MALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI---GTP 166
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
Y+ PE + DV++ G + EM T
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 153 IGAGNFGSVY-------------NGTLFDGTTIAVKVFNLIRPGGSKS----FKSECKAA 195
+G G FG V+ FDG + V V ++R +K+ F E K
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAV-KMLRADVTKTARNDFLKEIKIM 71
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNF--- 252
+K+ NI+R+ GV ++ ++M NG L ++L ++ + N
Sbjct: 72 SRLKNPNIIRLL----GVCVSDDPL-CMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 253 LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID 312
I L +A+ +A ++YL H +L N L+ + + DFGM+R L + D
Sbjct: 127 SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 313 KQNRFICIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
+ I+G ++ E L + +T DV++FG+ L EMFT
Sbjct: 184 ----YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 52/226 (23%), Positives = 84/226 (37%), Gaps = 43/226 (19%)
Query: 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIA---VKVFNLIRPGGSKSFKSECKAAINIK 199
F IG G F VY L DG +A V++F ++ + E +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK--KK 257
H N+++ +F + N LE G + + +IK KK
Sbjct: 61 HPNVIKYLASF-------------IENNELNIVLELADAG---------DLSRMIKHFKK 98
Query: 258 LDIAID----------VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
I + AL ++H I H ++KP+NV + + +GD G+ RF
Sbjct: 99 QKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF 155
Query: 308 LPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEM 353
+ K + G+ Y+ PE + D++S G LL EM
Sbjct: 156 FSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 37/103 (35%), Positives = 52/103 (50%), Gaps = 14/103 (13%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
A ++ C L LH Q I + +LKP N+LLDD + D G+A +P + Q I
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQT----I 158
Query: 321 K---GSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRP 359
K G+ GY+ PE + E T+ D ++ G LL EM G P
Sbjct: 159 KGRVGTVGYMAPEV-VKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 10/105 (9%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL-PAIDKQNRFICIKGST 324
L+Y+H + H +LKPSN+L++++ +GDFGMAR L + + F+ +T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 325 -GYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
Y PE L E +T D++S G + EM G R +F GK
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQ---LFPGK 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 55/234 (23%), Positives = 94/234 (40%), Gaps = 50/234 (21%)
Query: 153 IGAGNFGSVY------------NGTLFDG-----TTIAVKVFNLIRPGGSKS----FKSE 191
+G G FG V+ + +AVKV +RP S + F E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV---LRPDASDNAREDFLKE 69
Query: 192 CKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR---GKDDT---NW 245
K + NI R+ + ++ ++M NG L ++L+ + N
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPL-----CMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 246 RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305
+ L+F+ L L +A +A +RYL H +L N L+ + DFGM+
Sbjct: 125 KSLSFSTL----LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 306 RFLPAIDKQNRFICIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
R L + D + ++G ++ E L + +T DV++FG+ L E+ T
Sbjct: 178 RNLYSSD----YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 74/241 (30%)
Query: 147 FSSANLIGAGNFGSVYNGTLFD---GTTIAVKVFNL-------------IRPGGSKSFKS 190
F+ IG G+FG VY D +A+KV +L I F S
Sbjct: 3 FTLLECIGKGSFGEVYKA--IDKRTNQVVAIKVIDLEEAEDEIEDIQQEI------QFLS 54
Query: 191 ECKAAINIKHRNIVRVFTAFSGVDYQGARFK-AVVYKFMPNGSLEEWLR-GKDDTNWRPL 248
+C++ I + + +F K ++ ++ GS + L+ GK D +
Sbjct: 55 QCRSP------YITKYYGSFLK------GSKLWIIMEYCGGGSCLDLLKPGKLDETY--- 99
Query: 249 NFNFLIKKKLDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305
IA +V L YLH + I H ++K +N+LL +E + DFG++
Sbjct: 100 -----------IAFILREVLLGLEYLHE--EGKI-HRDIKAANILLSEEGDVKLADFGVS 145
Query: 306 RFLPA-IDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIR 358
L + + K+N F+ G+ ++ PE YD D++S GI +E+ G
Sbjct: 146 GQLTSTMSKRNTFV---GTPFWMAPEVIKQSGYDEKA------DIWSLGITAIELAKGEP 196
Query: 359 P 359
P
Sbjct: 197 P 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR--FLPAIDKQNRFICIKGST 324
L Y+H + I H ++K +N+L+ + I + DFG+AR L K NR+ +
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 325 GYIPPEYDLGCEASTYG---DVYSFGILLLEMFT 355
Y PPE LG YG D++ G ++ EM+T
Sbjct: 188 WYRPPELLLGER--DYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 34/101 (33%), Positives = 47/101 (46%), Gaps = 9/101 (8%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A ++A AL YLH I + +LKP N+LLD + GHV DFG+ + K
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQ--GHVVLTDFGLCKEGIEHSKTTSTF 156
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
C G+ Y+ PE D + G +L EM G+ P
Sbjct: 157 C--GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 14/98 (14%)
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDKQNRFICIKGST 324
AL +LH + I + +LKP N+LLD GH+ DFG+++ +K C G+T
Sbjct: 108 ALEHLH---KYDIVYRDLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFC--GTT 160
Query: 325 GYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
Y+ PE L + Y D +S G+L+ EM G P
Sbjct: 161 EYLAPEVLL--DEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 39/130 (30%), Positives = 64/130 (49%), Gaps = 18/130 (13%)
Query: 240 KDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHC-DCQPPIAHCNLKPSNVLLDDEMIGH 298
+D + PL+ + L L + VA + +L +C H ++ NVLL D +
Sbjct: 201 EDTEDSWPLDLDDL----LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAK 252
Query: 299 VGDFGMARFLPAIDKQNRFICIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMF 354
+ DFG+AR I + ++ +KG+ ++ PE C + DV+S+GILL E+F
Sbjct: 253 ICDFGLAR---DIMNDSNYV-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 308
Query: 355 T-GIRPSDGI 363
+ G P GI
Sbjct: 309 SLGKSPYPGI 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 151 NLIGAGNFGSVYNGTLF-DGTTI--AVKVFN-LIRPGGSKSFKSECKAAINIKHR-NIVR 205
++IG GNFG V + DG + A+K + F E + + H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP-------LNFNFLIKKKL 258
+ A +++G + A+ Y P+G+L ++LR P ++ L
Sbjct: 61 LLGA---CEHRGYLYLAIEYA--PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
A DVA + YL Q H +L N+L+ + + + DFG++R + +
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEV 164
Query: 319 CIKGSTGYIPPEYDLGCEASTY------GDVYSFGILLLEMFT 355
+K + G +P + + E+ Y DV+S+G+LL E+ +
Sbjct: 165 YVKKTMGRLPVRW-MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 32/111 (28%), Positives = 50/111 (45%), Gaps = 6/111 (5%)
Query: 249 NFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308
N F ++ L A ++ C L LH + + +LKP N+LLDD + D G+A +
Sbjct: 96 NPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKI 152
Query: 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
P + + G+ GY+ PE + D + G L+ EM G P
Sbjct: 153 PEGESIRGRV---GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 63/242 (26%), Positives = 97/242 (40%), Gaps = 35/242 (14%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSV-YNGTLFDGTTIAVKV---FNLIRPGG 184
K TIN +DL + +IG G FG V A+K+ F +I+
Sbjct: 29 KDTINK--IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 86
Query: 185 SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN 244
S F E +V++F AF Q R+ +V ++MP G L + D
Sbjct: 87 SAFFWEERDIMAFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD--- 138
Query: 245 WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304
P + ++ +A+D ++ ++H D +KP N+LLD + DFG
Sbjct: 139 -VPEKWARFYTAEVVLALDAIHSMGFIHRD---------VKPDNMLLDKSGHLKLADFGT 188
Query: 305 ARFLPAIDKQNRFIC--IKGSTGYIPPEYDLGCEAST--YG---DVYSFGILLLEMFTGI 357
++K+ C G+ YI PE L + YG D +S G+ L EM G
Sbjct: 189 CM---KMNKEGMVRCDTAVGTPDYISPEV-LKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244
Query: 358 RP 359
P
Sbjct: 245 TP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 153 IGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
+G G FG VY + G A KV + + E + H IV++ AF
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF- 78
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYL 271
Y + ++ +F P G+++ + D P + ++ L+ AL+YL
Sbjct: 79 ---YWDGKL-WIMIEFCPGGAVDAIMLELDRGLTEP-QIQVICRQMLE-------ALQYL 126
Query: 272 HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQNRFICIKGSTGYIPPE 330
H I H +LK NVLL + + DFG+ A+ + + +++ FI G+ ++ PE
Sbjct: 127 H---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI---GTPYWMAPE 180
Query: 331 YDLGCEA---STY---GDVYSFGILLLEM 353
+ CE + Y D++S GI L+EM
Sbjct: 181 VVM-CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 53/228 (23%), Positives = 87/228 (38%), Gaps = 54/228 (23%)
Query: 153 IGAGNFGSVYNGTLFD-GTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVFT 208
+G G +G V+ D G +A+K L + + +E K +V++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 209 AFSGVDYQGARFKAVVY---KFMPNGSLEEWLRGKDDTNWRPLNFN---FLIKKKLDIAI 262
AF +Y +Y +++P G L N L+ + F +
Sbjct: 69 AFQDDEY--------LYLAMEYVPGGDFRTLL-----NNLGVLSEDHARFYM-------A 108
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICI 320
++ A+ LH + H +LKP N L+D GH+ DFG+++ + N +
Sbjct: 109 EMFEAVDALH---ELGYIHRDLKPENFLIDAS--GHIKLTDFGLSK--GIVTYANS---V 158
Query: 321 KGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
GS Y+ PE YD D +S G +L E G P G
Sbjct: 159 VGSPDYMAPEVLRGKGYDFTV------DYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 152 LIGAGNFGSVYNGTLF-DGTTIAVKV-FNLIR----PGGSKSFKSECKAAINIKHRNIVR 205
++G+G FG+VY G DG + + V ++R P +K E + + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR-GKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ Q +V + MP G L +++R KD + L L+ + +
Sbjct: 74 LLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL---------LNWCVQI 118
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
A + YL + + H +L NVL+ + DFG+AR L + + K
Sbjct: 119 AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
++ E L + DV+S+G+ + E+ T G +P DGI
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 142 NATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR 201
+ + N+IG G+FG VY D T+ V + +++ K+ E N+ H
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICID-TSEKVAIKKVLQDPQYKN--RELLIMKNLNHI 119
Query: 202 NIVRVFTAFSGVDYQGAR---FKAVVYKFMPNGSLEEWLRGKDDTNWR-PLNFNFLIKKK 257
NI+ + + ++ F VV +F+P ++ ++++ N PL FL+K
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPL---FLVKL- 174
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLPAIDKQNR 316
+ + AL Y+H I H +LKP N+L+D + + DFG A+ L A +
Sbjct: 175 --YSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229
Query: 317 FICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTG 356
+IC S Y PE LG +T+ D++S G ++ EM G
Sbjct: 230 YIC---SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 52/225 (23%), Positives = 81/225 (36%), Gaps = 58/225 (25%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN------------ 197
+G G + VY G +A+K I+ G + E K IN
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKK---IKLGE----RKEAKDGINFTALREIKLLQE 58
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
+KH NI+ + F +V++FM LE+ +IK K
Sbjct: 59 LKHPNIIGLLDVFGHKS-----NINLVFEFME-TDLEK-----------------VIKDK 95
Query: 258 LDI--AIDVAC-------ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308
+ D+ L YLH I H +LKP+N+L+ + + + DFG+AR
Sbjct: 96 SIVLTPADIKSYMLMTLRGLEYLH-SNW--ILHRDLKPNNLLIASDGVLKLADFGLARSF 152
Query: 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-DVYSFGILLLE 352
+ + Y PE G G D++S G + E
Sbjct: 153 G--SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 147 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIV 204
F + +GAGN G V+ + G +A K+ +L I+P + +++ + + H
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP----AIRNQIIRELQVLHECNS 62
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
F G Y ++ + M GSL++ L+ + L ++I V
Sbjct: 63 PYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPEQILG---------KVSIAV 112
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ-NRFICIKGS 323
L YL + I H ++KPSN+L++ + DFG++ L ID N F+ G+
Sbjct: 113 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV---GT 165
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE G S D++S G+ L+EM G P
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 33/101 (32%), Positives = 47/101 (46%), Gaps = 9/101 (8%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH--VGDFGMARFLPAIDKQNRFI 318
A +V AL +LH + + + +LK N+LLD E GH + DFGM +
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTF 156
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
C G+ YI PE E D ++ G+L+ EM G P
Sbjct: 157 C--GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 33/107 (30%), Positives = 50/107 (46%), Gaps = 9/107 (8%)
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
+ + + AL YL + H ++KPSN+LLD + DFG++ L +D + +
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRS 174
Query: 320 IKGSTGYIPPE-YDLGCEASTY---GDVYSFGILLLEMFTGIRPSDG 362
G Y+ PE D Y DV+S GI L+E+ TG P
Sbjct: 175 -AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 37/136 (27%), Positives = 49/136 (36%), Gaps = 38/136 (27%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A +V AL YLH I + +LKP N+LL + GH+ DF +++
Sbjct: 109 AAEVLLALEYLHLL---GIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 319 CIKGSTG---------------------------YIPPEYDLGCEASTYGDVYSFGILLL 351
KGS YI PE G + D ++ GILL
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223
Query: 352 EMFTGIRPSDGIFTGK 367
EM G P F G
Sbjct: 224 EMLYGTTP----FKGS 235
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 64/256 (25%), Positives = 109/256 (42%), Gaps = 57/256 (22%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS 187
++ +N K ++ ++S +G+G +GSV + G +A+K L RP S+
Sbjct: 3 REEVN----KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEI 56
Query: 188 FKS----ECKAAINIKHRNIVR---VFT-AFSGVDYQGARFKAVVYKFMPNGSLE-EWLR 238
F E +++H N++ VFT A SG ++Q Y MP + + +
Sbjct: 57 FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD------FYLVMPYMQTDLQKIM 110
Query: 239 GKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298
G + + +L+ + L C L+Y+H I H +LKP N+ ++++
Sbjct: 111 GHPLSEDK---VQYLVYQML-------CGLKYIH---SAGIIHRDLKPGNLAVNEDCELK 157
Query: 299 VGDFGMARFLPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYG-DVYSFGILLL 351
+ DFG+AR A TGY+ PE L D++S G ++
Sbjct: 158 ILDFGLARHADA-----------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 352 EMFTGIRPSDGIFTGK 367
EM TG +F GK
Sbjct: 207 EMLTG----KTLFKGK 218
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 37/107 (34%), Positives = 52/107 (48%), Gaps = 15/107 (14%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A +++ L +LH + I + +LK NV+LD E GH+ DFGM + R
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTF 161
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
C G+ YI PE YG D +++G+LL EM G P DG
Sbjct: 162 C--GTPDYIAPEI---IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 18/105 (17%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A ++ C L LH + I + +LKP N+LLDD GH+ D G+A +P +
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDY--GHIRISDLGLAVEIPEGET----- 157
Query: 319 CIK---GSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRP 359
I+ G+ GY+ PE + E T+ D + G L+ EM G P
Sbjct: 158 -IRGRVGTVGYMAPEV-VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 15/103 (14%)
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFIC 319
++ AL +LH + I + ++K N+LLD E GHV DFG+++ FL ++ C
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFC 167
Query: 320 IKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE G +G D +S GIL+ E+ TG P
Sbjct: 168 --GTIEYMAPEIIRG--KGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 52/228 (22%), Positives = 94/228 (41%), Gaps = 35/228 (15%)
Query: 147 FSSANL-----IGAGNFGSVY----NGTLFDG--TTIAVKVFNLIRPGGSKS-FKSECKA 194
F +NL +G G FG V+ G +G T + VK + +S F+ E
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR---GKDDTNWRPLNFN 251
+ H+N+VR+ G+ + ++ ++ G L+++LR KD+ P
Sbjct: 62 FRKLSHKNVVRLL----GLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPP---P 113
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
K+K+ + +A + +L H +L N L+ + V +++
Sbjct: 114 LSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK----- 165
Query: 312 DKQNRFICIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
D N + ++ PE + ST DV+SFG+L+ E+FT
Sbjct: 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 152 LIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKS----ECKAAI--NIKHRNIV 204
L+G G FG VY D G +AVK P ++ K EC+ + N++H IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPF-DPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ + D + + V ++MP GS+++ L+ + L N + I V
Sbjct: 68 QYYGCLR--DPEEKKLSIFV-EYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGV 119
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI-CIKGS 323
+ YLH + I H ++K +N+L D +GDFG ++ + I I + G+
Sbjct: 120 S----YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
++ PE G DV+S ++EM T P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 54/220 (24%), Positives = 85/220 (38%), Gaps = 35/220 (15%)
Query: 145 NGFSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI 198
+ +G G GSV G +F TI P K E + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP----NPDLQKQILRELEINKSC 56
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLE----EWLRGKDDTNWRPLNFNFLI 254
K IV+ + AF +D + + ++ GSL+ + + + L
Sbjct: 57 KSPYIVKYYGAF--LDESSSSIG-IAMEYCEGGSLDSIYKKVKKRGGRIGEKVL------ 107
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
IA V L YLH I H ++KPSN+LL + + DFG++ ++
Sbjct: 108 ---GKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSL 159
Query: 315 -NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEM 353
F G++ Y+ PE G S DV+S G+ LLE+
Sbjct: 160 AGTFT---GTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 51/225 (22%), Positives = 92/225 (40%), Gaps = 36/225 (16%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIR----PGGSKSFKSECKAAINIKHRNIVR-VF 207
IG G FG V G G + A V +R P F E + + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
+ Y +V +F P G L+ +LR + + L + +A +VA
Sbjct: 63 QCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR----MACEVASG 112
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA--RFLPAIDKQNRFI---CIKG 322
L +LH Q H +L N L ++ +GD+G+A ++ ++ +I C
Sbjct: 113 LLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY-----PEDYYITKDCHAV 164
Query: 323 STGYIPPEYD-------LGCEASTYGDVYSFGILLLEMFT-GIRP 359
++ PE L + + +++S G+ + E+FT +P
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 55/218 (25%), Positives = 85/218 (38%), Gaps = 27/218 (12%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGT--TIAVKVF---NLIRPGGSKSFKSECKAAINIKHR 201
F+ +G G+FG V T + +A+K F +I+ SE K I H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
V ++ +F Y +V +F+ G +LR N F A
Sbjct: 92 FCVNLYGSFKDESYL-----YLVLEFVIGGEFFTFLR---------RNKRFPNDVGCFYA 137
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
+ YL I + +LKP N+LLD + + DFG A+ +D + +C
Sbjct: 138 AQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV---VDTRTYTLC-- 189
Query: 322 GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G+ YI PE L D ++ GI + E+ G P
Sbjct: 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 153 IGAGNFGSVYN-GTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR----NIVRVF 207
+GAGN GSV + GT +A KV + G S + + + I H IV +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKV---VHIGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
AF + +FM GSL+ + P+ L K IA+ V
Sbjct: 70 GAF-----LNENNICMCMEFMDCGSLDRIYK-----KGGPIPVEILGK----IAVAVVEG 115
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDK-QNRFICIKGST 324
L YL+ + I H ++KPSN+L++ G + DFG++ L I+ + F+ G++
Sbjct: 116 LTYLYNVHR--IMHRDIKPSNILVNSR--GQIKLCDFGVSGEL--INSIADTFV---GTS 166
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE G + + DV+S GI ++E+ G P
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 61/233 (26%), Positives = 96/233 (41%), Gaps = 38/233 (16%)
Query: 147 FSSANL-----IGAGNFGSVYNGTLFD--GTTIAVKVFNLIRPGGS-KSFKSECKAAINI 198
F++ +L IG G FG+V N L GT +AVK K + +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTV-NKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM-- 57
Query: 199 KHRNIVRVFTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
+ + + V + GA F+ + + M + SL+++ + + + L
Sbjct: 58 RSSDCPYI------VKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG 110
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAID 312
K IA+ AL YL + + I H ++KPSN+LLD G++ DFG++ L
Sbjct: 111 K----IAVATVKALNYLKEELK--IIHRDVKPSNILLDRN--GNIKLCDFGISGQLVDSI 162
Query: 313 KQNRFICIKGSTGYIPPEYDLGCEASTY---GDVYSFGILLLEMFTGIRPSDG 362
+ R G Y+ PE Y DV+S GI L E+ TG P
Sbjct: 163 AKTRDA---GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 11/102 (10%)
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMAR-FLPAIDKQNRFIC 319
+++ AL YLH + I + +LK NVLLD E GH+ D+GM + L D + F
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFC- 157
Query: 320 IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
G+ YI PE G + D ++ G+L+ EM G P D
Sbjct: 158 --GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 37/220 (16%)
Query: 153 IGAGNFGSVYNGTL---FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR----NIVR 205
+G+GNFG V G +A+KV ++ KS + E I H+ IVR
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKV---LKNENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ A +V + G L ++L GK D + +++ V+
Sbjct: 60 MIGVCE------AEALMLVMEMASGGPLNKFLSGKKDE--------ITVSNVVELMHQVS 105
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
++YL H +L NVLL ++ + DFG+++ L A D + S G
Sbjct: 106 MGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----ARSAG 158
Query: 326 YIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
P PE + S+ DV+S+GI + E F+ G +P
Sbjct: 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 40/221 (18%)
Query: 152 LIGAGNFGSVYNGTL-FDGTTIAVKVFN---LIRPGGSKSFKSECKAAI-NIKHRNIVRV 206
+IG G+FG V DG+ AVKV +++ +E + N+KH +V +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+F Q A V ++ G L L+ + FL + A +VA
Sbjct: 62 HYSF-----QTAEKLYFVLDYVNGGELFFHLQRER---------CFLEPRARFYAAEVAS 107
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGST 324
A+ YLH I + +LKP N+LLD + GHV DFG+ + ++ + G+
Sbjct: 108 AIGYLH---SLNIIYRDLKPENILLDSQ--GHVVLTDFGLCK--EGVEPEETTSTFCGTP 160
Query: 325 GYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE YD D + G +L EM G+ P
Sbjct: 161 EYLAPEVLRKEPYDRTV------DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
F+ IG G+FG V+ G D T V +I ++ + + I + +
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
T + G +G + ++ +++ GS + LR P + F I L ++
Sbjct: 64 VTKYYGSYLKGTKL-WIIMEYLGGGSALDLLRAG------PFD-EFQIATMLK---EILK 112
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID-KQNRFICIKGSTG 325
L YLH + + H ++K +NVLL ++ + DFG+A L K+N F+ G+
Sbjct: 113 GLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV---GTPF 166
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360
++ PE + D++S GI +E+ G P+
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 53/236 (22%), Positives = 98/236 (41%), Gaps = 45/236 (19%)
Query: 153 IGAGNFGSVYNGTLFDGT------TIAVKVFNLIRPGG-SKSFKSECKAAINIKHRNIVR 205
+G FG VY G LF +A+K G + FK E ++H NIV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL----------RGKDD----TNWRPLNFN 251
+ + + ++++ + + L E+L DD + P +F
Sbjct: 73 LLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF- 126
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
+ I +A + +L + H +L NVL+ D++ + D G+ R + A
Sbjct: 127 ------VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 312 D----KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDG 362
D N + I+ ++ PE + + S D++S+G++L E+F+ G++P G
Sbjct: 178 DYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 147 FSSANLIGAGNFGSVYN-GTLFDGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIV 204
F + +GAGN G V G +A K+ +L I+P + +++ + + H
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP----AIRNQIIRELQVLHECNS 62
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
F G Y ++ + M GSL++ L+ + + L K ++I V
Sbjct: 63 PYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLK-----EAKRIPEEILGK----VSIAV 112
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ-NRFICIKGS 323
L YL Q I H ++KPSN+L++ + DFG++ L ID N F+ G+
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV---GT 165
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE G S D++S G+ L+E+ G P
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ-NRFI 318
I+I V L YL + I H ++KPSN+L++ + DFG++ L ID N F+
Sbjct: 104 ISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV 159
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G+ Y+ PE G + D++S G+ L+EM G P
Sbjct: 160 ---GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 153 IGAGNFGSVY-NGTLFDGTTIAVKVFNLIR-PGGSK-SFKSECKAAINIKHRNIVRVFTA 209
IG G+FG +Y D +K +L + P K + K E +KH NIV F +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
F G F +V ++ G L + + R F + L + ++ L+
Sbjct: 68 FQ---ENGRLF--IVMEYCDGGDLMKRIN-------RQRGVLFSEDQILSWFVQISLGLK 115
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDE-MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328
++H I H ++K N+ L M+ +GDFG+AR L + C+ G+ Y+
Sbjct: 116 HIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY-TCV-GTPYYLS 170
Query: 329 PEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
PE C+ Y D++S G +L E+ T P +G
Sbjct: 171 PEI---CQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 59/242 (24%), Positives = 92/242 (38%), Gaps = 54/242 (22%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKS--------ECKAAINIKHRNI 203
+G G FG VY + G +A+K + + K E K +KH N+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILM------HNEKDGFPITALREIKILKKLKHPNV 69
Query: 204 VRVFTAFSGVDY--QGARFKAVVYKFMP------NGSLEEWLRGKDDTNWRPLNFNFLIK 255
V + V+ + R + VY P +G LE +
Sbjct: 70 VPLIDMA--VERPDKSKRKRGSVYMVTPYMDHDLSGLLE-----NPSVKLTESQIKCYML 122
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+ L+ + YLH + I H ++K +N+L+D++ I + DFG+AR
Sbjct: 123 QLLE-------GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 316 RFICIKGSTGYI---------PPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365
+ G+ Y PPE LG +T D++ G + EMFT RP I
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RP---ILQ 228
Query: 366 GK 367
GK
Sbjct: 229 GK 230
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIKGSTG 325
L Y H + I H +LKP N+L++++ + DFG+AR +P N + +
Sbjct: 116 LSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL----W 168
Query: 326 YIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRP 359
Y PP+ LG E ST D++ G +L EM TG RP
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 153 IGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
+G G FG VY + G A KV + + + E + H NIV++ AF
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPL---NFNFLIKKKLDIAIDVACAL 268
Y+ + ++ +F G+++ + + RPL + K+ L+ AL
Sbjct: 73 ---YENNLW--ILIEFCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLE-------AL 116
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQNRFICIKGSTGYI 327
YLH + I H +LK N+L + + DFG+ A+ I +++ FI G+ ++
Sbjct: 117 NYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI---GTPYWM 170
Query: 328 PPEYDLGCEAST------YGDVYSFGILLLEM 353
PE + CE S DV+S GI L+EM
Sbjct: 171 APEVVM-CETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 28/220 (12%)
Query: 159 GSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKA-----AINIKHRNIVRVF---TAF 210
Y+ + D T +K + ++P GS + C A IN+ + + R F T
Sbjct: 5 SQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA 64
Query: 211 SGVDYQGARFKAVVYK--------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD--- 259
+ K V +K F P SLEE+ N +I +LD
Sbjct: 65 KRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER 124
Query: 260 ---IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
+ + C +++LH I H +LKPSN+++ + + DFG+AR
Sbjct: 125 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 181
Query: 317 FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
++ + Y PE LG D++S G ++ E+ G
Sbjct: 182 YVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 44/241 (18%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTT-IAVKVFNLIRPGGS-- 185
+Q +N K ++ + + + +G+G +GSV FD T + V V L RP S
Sbjct: 5 RQELN----KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSII 58
Query: 186 --KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDT 243
K E + ++KH N++ + F+ P SLEE+ T
Sbjct: 59 HAKRTYRELRLLKHMKHENVIGLLDVFT-----------------PARSLEEFNDVYLVT 101
Query: 244 NWRPLNFNFLIK-KKLD------IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296
+ + N ++K +KL + + L+Y+H I H +LKPSN+ ++++
Sbjct: 102 HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCE 158
Query: 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFT 355
+ DFG+AR D+ ++ + Y PE L + D++S G ++ E+ T
Sbjct: 159 LKILDFGLARH--TDDEMTGYVATR---WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
Query: 356 G 356
G
Sbjct: 214 G 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 14/100 (14%)
Query: 263 DVACALRYLH-CDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDKQNRFIC 319
++ A YLH D I + +LKP N+LLD++ GHV DFG A+ +P +R
Sbjct: 126 ELVLAFEYLHSKD----IIYRDLKPENLLLDNK--GHVKVTDFGFAKKVP-----DRTFT 174
Query: 320 IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ G+ Y+ PE D ++ G+LL E G P
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 34/164 (20%)
Query: 197 NIKHRNIVRVF-TAFSGVDYQGA------RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLN 249
N+ H +++R+ T SG + + +Y ++ S RPL
Sbjct: 113 NVNHPSVIRMKDTLVSG----AITCMVLPHYSSDLYTYLTKRS-------------RPLP 155
Query: 250 FNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
I + L I + LRYLH I H ++K N+ ++D +GD G A+F P
Sbjct: 156 ----IDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-P 207
Query: 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEM 353
+ F+ + G+ PE + ++ D++S GI+L EM
Sbjct: 208 VVAPA--FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 11/104 (10%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMAR-FLPAIDKQNRF 317
+ +++ AL +LH + I + +LK NVLLD E GH+ D+GM + + D + F
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTF 156
Query: 318 ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
C G+ YI PE G + D ++ G+L+ EM G P D
Sbjct: 157 -C--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 51/221 (23%), Positives = 80/221 (36%), Gaps = 42/221 (19%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVK--VFNLIRPGGSKSFKSEC---KAAINIKHRNIV 204
IG G +G+VY L G +A+K L G S E K + +H NIV
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 205 RVFTAFSGVDYQGARFKAVVYKFM-----------PNGSLEEWLRGKDDTNWRPLNFNFL 253
R+ G +V++ + P L
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPET---------------- 108
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
IK D+ + + +LH I H +LKP N+L+ + + DFG+AR
Sbjct: 109 IK---DLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY---SF 159
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMF 354
+ + + Y PE L +T D++S G + E+F
Sbjct: 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 55/240 (22%), Positives = 100/240 (41%), Gaps = 53/240 (22%)
Query: 134 NPSFKDLYNATNG---FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFK 189
+P +L++ + F+ IG G+FG+VY + +A+K + G +S +
Sbjct: 1 DPEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSY---SGKQSNE 57
Query: 190 S------ECKAAINIKHRNIVRVFTAFSGVDYQGARFK-AVVYKFMPN--GSLEEWLRGK 240
E + ++H N + +Y+G + + M GS + L
Sbjct: 58 KWQDIIKEVRFLQQLRHPNTI---------EYKGCYLREHTAWLVMEYCLGSASDIL--- 105
Query: 241 DDTNWRPLNFNFLIKKKLDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297
+ + +PL ++++IA L YLH + H ++K N+LL +
Sbjct: 106 -EVHKKPL-------QEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTV 154
Query: 298 HVGDFGMARFL-PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEM 353
+ DFG A + PA N F+ G+ ++ PE L + Y DV+S GI +E+
Sbjct: 155 KLADFGSASLVSPA----NSFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 8e-05
Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 6/96 (6%)
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
D+ L +LH +C I H +LKP N+L+ + DFG+AR Q
Sbjct: 112 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALT 165
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMF 354
+ + Y PE L +T D++S G + EMF
Sbjct: 166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 54/234 (23%)
Query: 152 LIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKS---ECKAAINIKHRNIVRVF 207
++G G +G V G +A+K F K+ E K ++H NIV +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 208 TAF--SGVDYQGARFKAVVYKFMPNG---SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
AF G Y +V++++ LE G R + L++
Sbjct: 67 EAFRRKGRLY-------LVFEYVERTLLELLEASPGGLPPDAVRSYIWQ-LLQ------- 111
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
A+ Y H I H ++KP N+L+ + + + DFG AR L A
Sbjct: 112 ----AIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP------- 157
Query: 323 STGYI------PPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
T Y+ PE +G + YG DV++ G ++ E+ G P +F G
Sbjct: 158 LTDYVATRWYRAPELLVG--DTNYGKPVDVWAIGCIMAELLDG-EP---LFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 47/213 (22%), Positives = 86/213 (40%), Gaps = 35/213 (16%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHRNIVRVF 207
IG G F VY T L D +A+K + +K+ + +C I++ H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKA-RQDCVKEIDLLKQLNHPNVIKYL 68
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL-------DI 260
+F + + L L D + + F +K+L
Sbjct: 69 DSF-----------------IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+ + A+ ++H + H ++KP+NV + + +GD G+ RF + K +
Sbjct: 112 FVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSL 166
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEM 353
G+ Y+ PE + D++S G LL EM
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 37/106 (34%), Positives = 53/106 (50%), Gaps = 11/106 (10%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMAR-FLPAIDKQNRF 317
A ++ AL +LH + I + +LK NVLLD + GH+ D+GM + L D + F
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTF 156
Query: 318 ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
G+ YI PE G E D ++ G+L+ EM G P D I
Sbjct: 157 C---GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 41/227 (18%)
Query: 157 NFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKA--AINIKHRNIVRVFTAFSGVD 214
NF SV G D T +K + ++P GS + C A AI ++ I ++ F
Sbjct: 9 NFYSVEIG---DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 215 YQGARFKAVVYK--------------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD- 259
+ ++ +V F P SLEE+ N +I+ +LD
Sbjct: 66 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 260 -----IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR-----FLP 309
+ + C +++LH I H +LKPSN+++ + + DFG+AR F+
Sbjct: 126 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
R+ Y PE LG D++S G ++ EM G
Sbjct: 183 TPYVVTRY--------YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 37/107 (34%), Positives = 51/107 (47%), Gaps = 15/107 (14%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A ++A L +LH I + +LK NV+LD E GH+ DFGM + +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTF 161
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
C G+ YI PE YG D ++FG+LL EM G P +G
Sbjct: 162 C--GTPDYIAPEI---IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
A ++ C L L + I + +LKP N+LLDD + D G+A +P + +
Sbjct: 108 AAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-- 162
Query: 321 KGSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRP 359
G+ GY+ PE + E T+ D + G L+ EM G P
Sbjct: 163 -GTVGYMAPEV-INNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 152 LIGAGNFGSVYNGTL-FDGTTIAVKVFN---LIRPGGSKSFKSECKAAI-NIKHRNIVRV 206
+IG G+FG V DG AVKV ++ K +E + N+KH +V +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+F + V F+ G L L+ ++ + P + + A ++A
Sbjct: 62 HYSFQTTEKL-----YFVLDFVNGGELFFHLQ-RERSFPEP-------RARFYAA-EIAS 107
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGST 324
AL YLH I + +LKP N+LLD + GHV DFG+ + A C G+
Sbjct: 108 ALGYLH---SINIVYRDLKPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFC--GTP 160
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE D + G +L EM G+ P
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 43/227 (18%)
Query: 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN-----------IKH 200
LI + S+Y G +F+ + ++ F K F K I+ I
Sbjct: 27 LIKENDQNSIYKG-IFNNKEVIIRTF--------KKFHKGHKVLIDITENEIKNLRRIDS 77
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
NI++++ + R +++ ++ G L E L + L+F K KLD+
Sbjct: 78 NNILKIYGFIIDIVDDLPRL-SLILEYCTRGYLREVLD-----KEKDLSF----KTKLDM 127
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL--PAIDKQNRFI 318
AID L L+ P + NL + L+ + + G+ + L P N +
Sbjct: 128 AIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV 185
Query: 319 CIKGSTGYIPPEY--DLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
Y + D+ E + D+YS G++L E+FTG P + +
Sbjct: 186 -------YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 30/79 (37%), Positives = 44/79 (55%), Gaps = 8/79 (10%)
Query: 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST----GYIPPEYDLGCE 336
H +L NVL+ + + + DFG+AR I + + +I KGST ++ PE
Sbjct: 262 HRDLAARNVLICEGKLVKICDFGLAR---DIMRDSNYIS-KGSTFLPLKWMAPESIFNNL 317
Query: 337 ASTYGDVYSFGILLLEMFT 355
+T DV+SFGILL E+FT
Sbjct: 318 YTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 36/223 (16%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFK-SECKAAINIKHRNIVRVFTAF 210
+G G + +VY G G +A+K +L G+ S E +KH NIVR+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLH--- 64
Query: 211 SGVDYQGARFKAV-VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK---KLDIAIDVAC 266
D K + V+++M + L++++ L+ N +K +L I
Sbjct: 65 ---DVIHTENKLMLVFEYM-DKDLKKYM--DTHGVRGALDPN-TVKSFTYQLLKGIAFCH 117
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIKGST 324
R LH D LKP N+L++ + DFG+AR +P N F +
Sbjct: 118 ENRVLHRD---------LKPQNLLINKRGELKLADFGLARAFGIPV----NTFSNEVVTL 164
Query: 325 GYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTG 366
Y P+ LG ST D++S G ++ EM TG RP +F G
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RP---LFPG 203
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 16/104 (15%)
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLP-AIDKQNRFI 318
++ AL +LH Q I + ++K N+LLD E GHV DFG+++ FL ++ F
Sbjct: 113 EIVLALDHLH---QLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSF- 166
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDV---YSFGILLLEMFTGIRP 359
C G+ Y+ PE G + +S G+L E+ TG P
Sbjct: 167 C--GTIEYMAPEVIRGGS-GGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 20/110 (18%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR-FLPAIDKQNRFICIKGST 324
C L+Y+H + H +LKP N+L++ + + DFG+AR F + F+ T
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-----T 167
Query: 325 GYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGK 367
Y+ PE L ++ T DV+S G +L E G +P +F GK
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 30/224 (13%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTI-AVKVFN---LIRPGGSKSFKSECKAAINIKHRN 202
F +IG G FG V L + + A+K+ N +++ + F+ E +N ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
I + AF Q +V + G L L +D P + ++ IAI
Sbjct: 63 ITTLHYAF-----QDENNLYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFYLAEMVIAI 115
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICI 320
D L Y+H D +KP N+L+D M GH+ DFG L + +
Sbjct: 116 DSVHQLHYVHRD---------IKPDNILMD--MNGHIRLADFGSCLKLMEDGTVQSSVAV 164
Query: 321 KGSTGYIPPEYDLGCE--ASTYG---DVYSFGILLLEMFTGIRP 359
G+ YI PE E YG D +S G+ + EM G P
Sbjct: 165 -GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 30/226 (13%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212
+G GN+GSVY + T IR +S ++ ++I H+ + F G
Sbjct: 9 LGKGNYGSVYK--VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 213 VDYQ-GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYL 271
+ GA + + Y M GSL++ G T P + ++++ I V L++L
Sbjct: 67 AFFIEGAVYMCMEY--MDAGSLDKLYAGGVATEGIPED---VLRR---ITYAVVKGLKFL 118
Query: 272 HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA-IDKQNRFICIKGSTGYIPPE 330
+ I H ++KP+NVL++ + DFG++ L A + K N G Y+ PE
Sbjct: 119 KEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYMAPE 171
Query: 331 YDLG---CEASTY---GDVYSFGILLLEMFTGIRP-----SDGIFT 365
+ TY DV+S G+ +LEM G P IF
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA 217
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 11/96 (11%)
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIKGST 324
L Y H + + H +LKP N+L+++ + DFG+AR +P N + +
Sbjct: 116 GLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL---- 168
Query: 325 GYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRP 359
Y PP+ LG + ST D++ G + EM TG RP
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG-RP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 27/216 (12%)
Query: 152 LIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNIVRV 206
++G G FG + G L + +R G S + F +E H NIVR+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
GV +G +V ++M NG+L+ +LR + + + + + +A
Sbjct: 72 ----EGVITRGNTM-MIVTEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLAS 118
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG- 325
++YL + H L VL++ +++ + F R L + + + G +
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPV 172
Query: 326 -YIPPEYDLGCEASTYGDVYSFGILLLE-MFTGIRP 359
+ PE S+ DV+SFGI++ E M G RP
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 39/221 (17%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNIVRVFT 208
IG G FG V G + G T A V +R S F E + +++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 209 AFSGV-DYQGARFKAVVYKFMPNGSLEEWLRGK---DDTNWRPLNFNFLIKKKLDIAIDV 264
+ V Y +V +F P G L+ +LR + P +A ++
Sbjct: 63 QCTEVTPY------LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-------RMACEI 109
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA----RFLPAIDKQNRFICI 320
A L +LH + H +L N LL ++ +GD+G++ + + ++ +
Sbjct: 110 ALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166
Query: 321 KGSTGYIPPEYD-------LGCEASTYGDVYSFGILLLEMF 354
+ +I PE L + + +V+S G+ + E+F
Sbjct: 167 R----WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 38/214 (17%)
Query: 153 IGAGNFGSVY---NGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G FG VY + G A K+ + + F E KH NIV ++ A
Sbjct: 13 LGDGAFGKVYKAQHKE--TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLN---FNFLIKKKLDIAIDVAC 266
+ Y+ + ++ +F G+L+ + + R L ++ ++ L+
Sbjct: 71 YF---YENKLW--ILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLE------- 114
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQNRFICIKGSTG 325
AL +LH + H +LK N+LL + + DFG+ A+ + K++ FI G+
Sbjct: 115 ALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPY 168
Query: 326 YIPPEYDLGCEAST---Y---GDVYSFGILLLEM 353
++ PE + CE Y D++S GI L+E+
Sbjct: 169 WMAPEV-VACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 3e-04
Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 33/164 (20%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKS--EC------KAAINIK-HRN 202
+G G FGSVY G +A+K K F S EC K+ + H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
IV++ F + F V+++M G+L + ++ + +P + + +I+ I
Sbjct: 60 IVKLKEVF--RENDELYF---VFEYM-EGNLYQLMKDRKG---KPFSES-VIR---SIIY 106
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306
+ L ++H + H +LKP N+L+ + + DFG+AR
Sbjct: 107 QILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 19/108 (17%)
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
L+Y+H + H +LKPSN+LL+ + DFG+AR F+ T Y
Sbjct: 118 GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL-----TEY 169
Query: 327 I------PPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
+ PE L + D++S G +L EM + RP +F GK
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RP---LFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 46/227 (20%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTT---IAVKVFNLIRPGGSKSFKSECKAAINIKHRNI 203
F+ IG G+FG VY G D T +A+K+ +L E + I +I
Sbjct: 6 FTKLERIGKGSFGEVYKG--IDNRTKEVVAIKIIDL----------EEAEDEI----EDI 49
Query: 204 VRVFTAFSGVD------YQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL 253
+ T S D Y G+ K ++ +++ GS + L+ PL ++
Sbjct: 50 QQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYI 103
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID- 312
I ++ L YLH + + H ++K +NVLL ++ + DFG+A L
Sbjct: 104 AT----ILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156
Query: 313 KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
K+N F+ G+ ++ PE D++S GI +E+ G P
Sbjct: 157 KRNTFV---GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 37/108 (34%), Positives = 46/108 (42%), Gaps = 21/108 (19%)
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA-RFLPAIDKQNR 316
+AID L Y+H D +KP NVLLD GH+ DFG R L D +
Sbjct: 113 LAIDSVHQLGYVHRD---------IKPDNVLLD--KNGHIRLADFGSCLRLLA--DGTVQ 159
Query: 317 FICIKGSTGYIPPEYDLGCEAST--YG---DVYSFGILLLEMFTGIRP 359
G+ YI PE E YG D +S G+ + EM G P
Sbjct: 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 41/218 (18%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
IG G G+V+ + G +A+K NL + + +E +K+ NIV +F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA-IDVAC---- 266
D VV +++ GSL + + + +D A I C
Sbjct: 87 VGDEL-----FVVMEYLAGGSLTD----------------VVTETCMDEAQIAAVCRECL 125
Query: 267 -ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQNRFICIKGST 324
AL +LH + + H ++K NVLL + + DFG A+ P K++ + G+
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTP 179
Query: 325 GYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
++ PE YG D++S GI+ +EM G P
Sbjct: 180 YWMAPEV---VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 37/115 (32%), Positives = 51/115 (44%), Gaps = 21/115 (18%)
Query: 263 DVAC--------ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAID 312
D AC AL +LH Q I + +LKP N+LLD + GHV DFG+ +
Sbjct: 100 DTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEG 154
Query: 313 KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
C G+ Y+ PE + D +S G L+ +M TG P FT +
Sbjct: 155 TVTHTFC--GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP----FTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 61/234 (26%), Positives = 93/234 (39%), Gaps = 53/234 (22%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTI-AVKV---FNLIRPGGSKSFKSECKAAINIKHRN 202
F +IG G FG V + A+K+ F +I+ S F E +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSL----------EEWLRGKDDTNWRPLNFNF 252
IV++ AF Q ++ +V ++MP G L E+W R F
Sbjct: 105 IVQLHYAF-----QDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWAR-------------F 146
Query: 253 LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPA 310
+ + +A+D ++ ++H D +KP N+LLD GH+ DFG + A
Sbjct: 147 YTAE-VVLALDAIHSMGFIHRD---------VKPDNMLLDKS--GHLKLADFGTCMKMDA 194
Query: 311 IDKQNRFICIKGSTGYIPPEYDLGCEAST--YG---DVYSFGILLLEMFTGIRP 359
+ R G+ YI PE L + YG D +S G+ L EM G P
Sbjct: 195 -NGMVRCDTAVGTPDYISPEV-LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 29/79 (36%), Positives = 42/79 (53%), Gaps = 8/79 (10%)
Query: 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST----GYIPPEYDLGCE 336
H +L NVLL I + DFG+AR I + ++ KGST ++ PE
Sbjct: 260 HRDLAARNVLLAQGKIVKICDFGLAR---DIMHDSNYVS-KGSTFLPVKWMAPESIFDNL 315
Query: 337 ASTYGDVYSFGILLLEMFT 355
+T DV+S+GILL E+F+
Sbjct: 316 YTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 153 IGAGNFGSV-YNGTLFDGTTIAVKVFNLIRPGGSKSFKS----ECKAAINIKHRNI---V 204
+G+G +G+V G +A+K L RP S+ F E + ++KH N+ +
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 205 RVFTAFSGVDYQGARFKA--VVYKFMPN--GSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
VFT +D RF +V FM G L + + +D FL+ + L
Sbjct: 81 DVFTPDLSLD----RFHDFYLVMPFMGTDLGKLMKHEKLSED------RIQFLVYQMLK- 129
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
L+Y+H I H +LKP N+ ++++ + DFG+AR D +
Sbjct: 130 ------GLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSE------ 171
Query: 321 KGSTGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTG 356
TGY+ PE L T D++S G ++ EM TG
Sbjct: 172 --MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 34/109 (31%), Positives = 49/109 (44%), Gaps = 10/109 (9%)
Query: 251 NFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA 310
N I L I V A++YLH + I H ++K N+ ++ +GDFG A F P
Sbjct: 178 NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF-PV 233
Query: 311 IDKQNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTG 356
N++ G+ PE YG D++S GI+L EM T
Sbjct: 234 DINANKYYGWAGTIATNAPEL---LARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 37/104 (35%), Positives = 49/104 (47%), Gaps = 15/104 (14%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH--VGDFGMARFLPAIDKQNRFI 318
A ++ AL +LH I + +LK NVLLD E GH + DFGM + K
Sbjct: 102 AAEITSALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTF 156
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
C G+ YI PE + YG D ++ G+LL EM G P
Sbjct: 157 C--GTPDYIAPEI---LQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 37/224 (16%)
Query: 153 IGAGNFGSVYNG---TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR----NIVR 205
+G+GNFG+V G T+AVK+ L + K E N+ + IVR
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKI--LKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ + +V + G L ++L+ N + K ++ V+
Sbjct: 61 MIGICEAESWM------LVMELAELGPLNKFLQK---------NKHVTEKNITELVHQVS 105
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
++YL + H +L NVLL + + DFG+++ L A + + + G
Sbjct: 106 MGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHG 158
Query: 326 YIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
P PE + S+ DV+SFG+L+ E F+ G +P G+
Sbjct: 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 61/252 (24%), Positives = 96/252 (38%), Gaps = 58/252 (23%)
Query: 147 FSSANLIGAGNFGSVYNGTLFD-GTTIAVKVF---NLIRPGGSKSFKSECKAAINIKHRN 202
F S +IG G FG V D G A+K+ +++ ++E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+V++F +F Q R ++ +F+P G + L KD + F + +AI
Sbjct: 63 VVKMFYSF-----QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYI---AETVLAI 114
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFL------------ 308
D L ++H D +KP N+LLD + GHV DFG+ L
Sbjct: 115 DAIHQLGFIHRD---------IKPDNLLLDAK--GHVKLSDFGLCTGLKKAHRTEFYRNL 163
Query: 309 ---PAID---------------KQNR---FICIKGSTGYIPPEYDLGCEASTYGDVYSFG 347
P D K+NR G+ YI PE + + D +S G
Sbjct: 164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223
Query: 348 ILLLEMFTGIRP 359
+++ EM G P
Sbjct: 224 VIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICI 320
++ AL +LH + I + ++K N+LLD GHV DFG+++ D+ R
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHE-DEVERAYSF 166
Query: 321 KGSTGYIPPEYDLGCEA--STYGDVYSFGILLLEMFTGIRP 359
G+ Y+ P+ G + D +S G+L+ E+ TG P
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 24/98 (24%), Positives = 48/98 (48%), Gaps = 5/98 (5%)
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
L + A+ Y+H + I H ++K N+ L + +GDFG+++ L + +
Sbjct: 104 LWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAE 159
Query: 318 ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
+ G+ Y+ PE G + + D+++ G +L E+ T
Sbjct: 160 TVV-GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 48/214 (22%), Positives = 86/214 (40%), Gaps = 28/214 (13%)
Query: 162 YNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIV--RVFTAFSGVDYQGAR 219
Y+ + D T +K + ++P GS + C A + RN+ ++ F +
Sbjct: 4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 63
Query: 220 FKAVVYK--------------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD------ 259
++ +V F P SLEE+ N +I+ +LD
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
+ + C +++LH I H +LKPSN+++ + + DFG+AR ++
Sbjct: 124 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 180
Query: 320 IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEM 353
+ Y PE LG D++S G ++ EM
Sbjct: 181 TR---YYRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 23/91 (25%), Positives = 43/91 (47%), Gaps = 13/91 (14%)
Query: 279 IAHCNLKPSNVLLDDEMIGHVGDFGMAR---FLPAIDKQNRFICIKG---------STGY 326
H +L P+N+ ++ + I + DFG+AR + P D ++ ++ + Y
Sbjct: 140 FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWY 199
Query: 327 IPPEYDLGCEASTYG-DVYSFGILLLEMFTG 356
PE +G E + D++S G + E+ TG
Sbjct: 200 RAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 61/234 (26%), Positives = 92/234 (39%), Gaps = 58/234 (24%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINIKH 200
IG G +G VY G +A+K L IR E + H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---------EISLLKELNH 57
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
NIVR+ V + + +V++F+ + L++++ T P LIK L
Sbjct: 58 PNIVRLLD----VVHSENKL-YLVFEFL-DLDLKKYMDSSPLTGLDPP----LIKSYLYQ 107
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF-IC 319
+ + Y H + H +LKP N+L+D E + DFG+AR F +
Sbjct: 108 LLQ---GIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR---------AFGVP 152
Query: 320 IKGSTG------YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTG 366
++ T Y PE LG ST D++S G + EM RP +F G
Sbjct: 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR-RP---LFPG 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST----GYIPPEYDLGCE 336
H +L N+LL I + DFG+AR I + ++ +KG+ ++ PE C
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLAR---DIRNDSNYV-VKGNARLPVKWMAPESIFNCV 292
Query: 337 ASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ DV+S+GILL E+F+ G P G+
Sbjct: 293 YTFESDVWSYGILLWEIFSLGSSPYPGM 320
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFL-PAIDKQNRFICIKGSTG 325
L+Y+H + H +LKP+NV ++ ++++ +GDFG+AR + P + +
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 326 YIPPEYDLGCEASTYG-DVYSFGILLLEMFTG 356
Y P L T D+++ G + EM TG
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST----GYIPPEYDLGCE 336
H +L N+LL + + + DFG+AR I K ++ KGS ++ PE
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYV-RKGSARLPLKWMAPESIFDKV 252
Query: 337 ASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+T DV+SFG+LL E+F+ G P G+
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASPYPGV 280
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 39/126 (30%), Positives = 58/126 (46%), Gaps = 23/126 (18%)
Query: 248 LNFNFL---IKKKLDIA----IDVACALRYLHCDCQPPIAHC--------NLKPSNVLLD 292
L F FL +KK +D + I + YL Q +A C +LKP N+L++
Sbjct: 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQG-LAFCHSHRVLHRDLKPQNLLIN 134
Query: 293 DEMIGHVGDFGMARF--LPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGIL 349
E + DFG+AR +P + + + Y PE LGC+ ST D++S G +
Sbjct: 135 TEGAIKLADFGLARAFGVPVRTYTHEVVTL----WYRAPEILLGCKYYSTAVDIWSLGCI 190
Query: 350 LLEMFT 355
EM T
Sbjct: 191 FAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 11/96 (11%)
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIKGST 324
L Y H + + H +LKP N+L+++ + DFG+AR +P N + +
Sbjct: 116 GLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL---- 168
Query: 325 GYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRP 359
Y PP+ LG E ST D++ G + EM +G RP
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG-RP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 58/224 (25%), Positives = 88/224 (39%), Gaps = 30/224 (13%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTI-AVKVFN---LIRPGGSKSFKSECKAAINIKHRN 202
F +IG G FG V + I A+K+ N +++ + F+ E +N +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
I + AF Q + +V + G L L +D P + ++ +AI
Sbjct: 63 ITTLHYAF-----QDENYLYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFYIAEMVLAI 115
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICI 320
L Y+H D +KP NVLLD M GH+ DFG + + +
Sbjct: 116 HSIHQLHYVHRD---------IKPDNVLLD--MNGHIRLADFGSCLKMNQDGTVQSSVAV 164
Query: 321 KGSTGYIPPEYDLGCE--ASTYG---DVYSFGILLLEMFTGIRP 359
G+ YI PE E YG D +S G+ + EM G P
Sbjct: 165 -GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 46/219 (21%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAI--NIKHRNIVRVFTA 209
+G G++ +VY G + +G +A+KV ++ G F + +A++ +KH NIV +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLR----GKDDTNWRPLNFNFLIKKKLDIAIDVA 265
V+++M + L +++ G N R F L
Sbjct: 72 I-----HTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR----------- 114
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG-----DFGMARF--LPAIDKQNRFI 318
L Y+H I H +LKP N+L I ++G DFG+AR +P+ + +
Sbjct: 115 -GLAYIH---GQHILHRDLKPQNLL-----ISYLGELKLADFGLARAKSIPSQTYSSEVV 165
Query: 319 CIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTG 356
+ Y PP+ LG + S+ D++ G + +EM G
Sbjct: 166 TL----WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 41/218 (18%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
IG G G+VY + G +A+K NL + + +E KH NIV +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS-- 84
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA-IDVAC---- 266
Y VV +++ GSL + + + +D I C
Sbjct: 85 ---YLVGDELWVVMEYLAGGSLTD----------------VVTETCMDEGQIAAVCRECL 125
Query: 267 -ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQNRFICIKGST 324
AL +LH + + H ++K N+LL + + DFG A+ P +Q++ + G+
Sbjct: 126 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTP 179
Query: 325 GYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
++ PE YG D++S GI+ +EM G P
Sbjct: 180 YWMAPEV---VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 14/103 (13%)
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
L+Y+H + H +LKPSN+LL+ + DFG+AR +K + + Y
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYR 175
Query: 328 PPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
PE L C S Y DV+S G + E+ +P +F GK
Sbjct: 176 APELLLNC--SEYTTAIDVWSVGCIFAELLGR-KP---LFPGK 212
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 46/220 (20%)
Query: 153 IGAGNFGSVYNGTLFDGTT---IAVKVFNLIRPGGS-----KSFKSECKAAINIKHRNIV 204
+G+G +GSV + +D +AVK L RP S ++++ E + ++KH N++
Sbjct: 23 VGSGAYGSVCSA--YDTRLRQKVAVK--KLSRPFQSLIHARRTYR-ELRLLKHMKHENVI 77
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK-KKLD---- 259
+ F+ P S+E + TN + N ++K +KL
Sbjct: 78 GLLDVFT-----------------PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHV 120
Query: 260 --IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ + L+Y+H I H +LKPSNV ++++ + DFG+AR A D+ +
Sbjct: 121 QFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGY 175
Query: 318 ICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTG 356
+ + Y PE L + D++S G ++ E+ G
Sbjct: 176 VATR---WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIKGSTG 325
L Y H Q + H +LKP N+L+ + + DFG+AR +P+ N + +
Sbjct: 116 LAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTL----W 168
Query: 326 YIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRP 359
Y PP+ LG E ST D++ G + EM TG RP
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 142 NATNGFSSANLIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSF-KSECKAAINIK 199
N + + +G+G +G VY L G AVK+ L PG S + E K
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECK 64
Query: 200 HRNIVRVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
H NIV F ++ +R K + ++ GSL++ + L ++ ++ L
Sbjct: 65 HCNIVAYFGSYL------SREKLWICMEYCGGGSLQDIYHVTGPLS--ELQIAYVCRETL 116
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA-IDKQNRF 317
L YLH + H ++K +N+LL D + DFG+A + A I K+ F
Sbjct: 117 Q-------GLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166
Query: 318 ICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEM 353
I G+ ++ PE + Y D+++ GI +E+
Sbjct: 167 I---GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 29/97 (29%), Positives = 45/97 (46%), Gaps = 8/97 (8%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK-G 322
+ C + +LH I + ++KP NVLLDD+ + D G+A L + I + G
Sbjct: 104 ITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK----DGKTITQRAG 156
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ GY+ PE S D ++ G + EM G P
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 32/101 (31%), Positives = 47/101 (46%), Gaps = 9/101 (8%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A ++A AL YLH I + +LKP N+LLD + GH+ DFG+ + I+
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK--ENIEHNGTTS 154
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G+ Y+ PE D + G +L EM G+ P
Sbjct: 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 55/232 (23%), Positives = 93/232 (40%), Gaps = 52/232 (22%)
Query: 152 LIGAGNFGSVYNGTLFD--GTTIAVKVFNLIRPGGSKSFKSECKAAI------------N 197
IG G FG VY G IAV V K+ K+ ++
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAV---------KTCKNCTSPSVREKFLQEAYIMRQ 63
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
H +IV++ GV + + +V + P G L +L+ N L+ LI
Sbjct: 64 FDHPHIVKLI----GVITENPVW--IVMELAPLGELRSYLQ----VNKYSLDLASLILYS 113
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
++ AL YL H ++ NVL+ +GDFG++R+ ++ ++ +
Sbjct: 114 YQLST----ALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYY 163
Query: 318 ICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
K S G +P PE ++ DV+ FG+ + E+ G++P G+
Sbjct: 164 ---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 46/227 (20%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTT---IAVKVFNLIRPGGSKSFKSECKAAINIKHRNI 203
F+ IG G+FG V+ G D T +A+K+ +L E + I +I
Sbjct: 6 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDL----------EEAEDEI----EDI 49
Query: 204 VRVFTAFSGVD------YQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL 253
+ T S D Y G+ K ++ +++ GS + L PL+ +
Sbjct: 50 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQI 103
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID- 312
I ++ L YLH + + H ++K +NVLL + + DFG+A L
Sbjct: 104 AT----ILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156
Query: 313 KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
K+N F+ G+ ++ PE + D++S GI +E+ G P
Sbjct: 157 KRNTFV---GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 47/175 (26%), Positives = 69/175 (39%), Gaps = 28/175 (16%)
Query: 184 GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMP--NGSLEEWLRGKD 241
G K+ E I HR I+ + A+ R+K+ V MP L ++
Sbjct: 129 GGKTPGREIDILKTISHRAIINLIHAY--------RWKSTVCMVMPKYKCDLFTYVDRSG 180
Query: 242 DTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301
PL I+++L AL YLH I H ++K N+ LD+ +GD
Sbjct: 181 PL---PLEQAITIQRRL------LEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGD 228
Query: 302 FGMARFLPAIDKQNRFICIKGSTGYIPPE---YDLGCEASTYGDVYSFGILLLEM 353
FG A L A + G+ PE D C D++S G++L EM
Sbjct: 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC---AKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 33/107 (30%), Positives = 49/107 (45%), Gaps = 25/107 (23%)
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
L+Y+H + H +LKPSN+L+++ + DFG+AR D Q TGY+
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ---DPQ--------MTGYV 166
Query: 328 PPEYDLGCEA----STYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
Y E Y D++S G + EM G +P +F GK
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KP---LFPGK 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.003
Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 14/104 (13%)
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
+ +LH I H +LK SN+LL++ I + DFG+AR + K + + + Y
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWY 172
Query: 327 IPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
PE LG A Y D++S G + E+ T +F GK
Sbjct: 173 RAPELLLG--AKEYSTAIDMWSVGCIFAELLTK----KPLFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 28/96 (29%), Positives = 44/96 (45%), Gaps = 16/96 (16%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR-----FLPAIDKQNRFICI 320
C +++LH I H +LKPSN+++ + + DFG+AR F+ R+
Sbjct: 129 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 182
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
Y PE LG D++S G ++ EM G
Sbjct: 183 -----YRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
IG G+ G V T G +AVK +L + + +E + H N+V ++ ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYL 271
D VV +F+ G+L + + T+ R +N ++ + + V AL YL
Sbjct: 90 VGDELW-----VVMEFLEGGALTDIV-----THTR-MNE----EQIATVCLSVLRALSYL 134
Query: 272 HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQNRFICIKGSTGYIPPE 330
H + H ++K ++LL + + DFG A+ + K+ + G+ ++ PE
Sbjct: 135 H---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV---GTPYWMAPE 188
Query: 331 YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
T D++S GI+++EM G P
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 367 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.51 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.27 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.2 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.19 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.09 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.03 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.02 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.01 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.83 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 98.75 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.74 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 98.71 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 98.68 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.61 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.59 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.58 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 98.57 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 98.55 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 98.54 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.52 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 98.5 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 98.48 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 98.46 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 98.46 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 98.45 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 98.45 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 98.45 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 98.44 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 98.43 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 98.43 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 98.43 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 98.43 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 98.43 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 98.43 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 98.41 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 98.41 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 98.4 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 98.39 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 98.39 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 98.39 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 98.39 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 98.39 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 98.37 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 98.37 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 98.37 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 98.37 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 98.35 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=355.64 Aligned_cols=200 Identities=29% Similarity=0.470 Sum_probs=177.1
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
..+|.+.+.||.|+||+||+|+ ..++..||||.+... .....+.+..|+.+|+.++|||||.+++++ ....+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence 4578889999999999999999 566899999999755 334566788999999999999999999997 44567
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC------
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE------ 294 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~------ 294 (367)
.|+|||||.||+|.+||+..+ .+++..+..++.|++.||++|| +++||||||||+|||++..
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~---------~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~ 151 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRG---------RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTS 151 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCC
Confidence 899999999999999999877 5778999999999999999999 9999999999999999764
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
-.+||+|||+|+.+.... .....+|+|.|||||++....|+.|+|+||+|+++|++++|+.||+..
T Consensus 152 ~~LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 152 PVLKIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred ceEEecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 468999999999886433 233467999999999999999999999999999999999999999843
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=356.02 Aligned_cols=220 Identities=38% Similarity=0.672 Sum_probs=190.0
Q ss_pred CCCCCChHHHHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeee
Q 017712 131 TINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210 (367)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 210 (367)
....+++.++..+|++|...+.||+|+||.||+|...+++.||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 44557899999999999999999999999999999999999999987754433145699999999999999999999999
Q ss_pred cccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCcee
Q 017712 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (367)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil 290 (367)
.+. ....+||+|||++|+|.++|...... .++|..+++|+.++|+||+|||+.+...||||||||+|||
T Consensus 141 ~e~----~~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNIL 209 (361)
T KOG1187|consen 141 LEG----GEHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNIL 209 (361)
T ss_pred ecC----CceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHee
Confidence 532 22579999999999999999886532 4689999999999999999999887778999999999999
Q ss_pred ecCCCceEEeccccccccCCCCCcceeeec-cCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICI-KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|+++++||+|||+|+..+.. ....... .||.+|+|||+...+..+.++|||||||+|+||+||+.|.+..
T Consensus 210 LD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 210 LDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 999999999999999765431 1111111 6999999999999999999999999999999999999988754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=337.72 Aligned_cols=202 Identities=29% Similarity=0.371 Sum_probs=179.6
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.++||+|+||+||.++ .++++.+|+|++++.. .........|..+|.+++||+||+++-.| ++..
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccCC
Confidence 4689999999999999999999 6679999999997432 23467788999999999999999999887 7778
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
.+|+|+||+.||.|..+|+... .|++..+..++.+|+.||.||| +.+||||||||+|||+|..|+++|
T Consensus 99 kLylVld~~~GGeLf~hL~~eg---------~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~L 166 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREG---------RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKL 166 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcC---------CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEE
Confidence 8999999999999999998776 6888989999999999999999 999999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||+|+..-... ..+...+||+.|||||++.+..++..+|.||||+++|||++|.+||.+-.
T Consensus 167 tDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 167 TDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred eccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 9999998543322 23334679999999999999999999999999999999999999997643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=352.85 Aligned_cols=199 Identities=26% Similarity=0.411 Sum_probs=181.0
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeec---CCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
..|...+.||+|||+.+|.++. .+|..||+|++.. .+....+...+|+++.+.|+|||||+++++| ++...
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 4699999999999999999995 8899999999963 4556778899999999999999999999998 55667
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.|+|.|+|++++|.++++... .+++.+++.+++||+.||.||| +++|||||||..|++++++.++||+
T Consensus 93 VYivLELC~~~sL~el~Krrk---------~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIg 160 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK---------PLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIG 160 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC---------CCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEec
Confidence 899999999999999999665 6889999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|||+|..+....... ...+|||.|+|||++....++..+||||+||+||.|+.|++||+.
T Consensus 161 DFGLAt~le~~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet 220 (592)
T KOG0575|consen 161 DFGLATQLEYDGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET 220 (592)
T ss_pred ccceeeeecCccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence 999999886543333 345699999999999999999999999999999999999999974
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-50 Score=329.38 Aligned_cols=209 Identities=23% Similarity=0.352 Sum_probs=176.0
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.+|+++++||.|+||+||++. ..+|..+|.|.++.. .....+.+..|+.+|++|+|||||++++.-. .++...+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchhh
Confidence 357888999999999999998 788999999998732 2334567889999999999999999998321 2344557
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEecCCCCCceeecCCCceEEe
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
+|+||||.+|+|...++...... ..++++.++.++.|++.||.++|+... .-|+||||||.||+++.+|.+||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qk-----r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQK-----RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhcc-----ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 99999999999999987543211 158899999999999999999995322 239999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||+++++.+... ...+..|||.||+||.+.+.+|+.+|||||+||++|||+.-..||.|-
T Consensus 171 DfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 171 DFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred cchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 9999998865332 234567999999999999999999999999999999999999999874
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=330.51 Aligned_cols=198 Identities=28% Similarity=0.369 Sum_probs=173.8
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC-CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
+.+..+.||+|+.|+||+++ ..+++.+|+|.+... ++...+++.+|+++++..+||+||++||+|.. ......+
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~----~~~~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS----NGEEISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe----CCceEEe
Confidence 45667899999999999999 567899999999633 34456889999999999999999999999953 2225799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+||||++|||++++...+ .+++.....|+.+|++||.|||. +++||||||||+|||++..|.+||+|||
T Consensus 156 ~mEYMDgGSLd~~~k~~g---------~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVG---------RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred ehhhcCCCCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecccc
Confidence 999999999999998765 57788899999999999999993 3899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
.++.+... ...+..||..|||||.+.+..|+.++||||||++++|+++|+.||..
T Consensus 225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~ 279 (364)
T KOG0581|consen 225 VSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPP 279 (364)
T ss_pred ccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCC
Confidence 99877443 33456799999999999999999999999999999999999999965
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=332.51 Aligned_cols=204 Identities=22% Similarity=0.366 Sum_probs=171.4
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc-------chhHHHHHHHHHHhCCCCCcceeeeeecccc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG-------GSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (367)
..+.|.+.+.||+|+||.|-+|. ..+++.||||+++..... .....++|+++|++|+|||||+++++|.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~--- 246 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE--- 246 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee---
Confidence 34567888999999999999998 778999999999742211 2233579999999999999999999984
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
...+.|+||||++||+|.+.+-.+. .+.+.....++.|++.|+.||| ++||+||||||+|||+..+
T Consensus 247 --~~ds~YmVlE~v~GGeLfd~vv~nk---------~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~ 312 (475)
T KOG0615|consen 247 --VPDSSYMVLEYVEGGELFDKVVANK---------YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSND 312 (475)
T ss_pred --cCCceEEEEEEecCccHHHHHHhcc---------ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccC
Confidence 4455699999999999999998776 4556777889999999999999 9999999999999999765
Q ss_pred ---CceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCC---CcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 017712 295 ---MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA---STYGDVYSFGILLLEMFTGIRPSDGIFTG 366 (367)
Q Consensus 295 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~~l~el~tg~~Pf~~~~~~ 366 (367)
..+||+|||+|+..+. .......+|||.|.|||++.+... ..+.|+||+||+||-+++|.+||.+-++.
T Consensus 313 ~e~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~ 387 (475)
T KOG0615|consen 313 AEDCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD 387 (475)
T ss_pred CcceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence 7899999999997653 233445679999999999987643 34779999999999999999999876654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=338.23 Aligned_cols=205 Identities=30% Similarity=0.493 Sum_probs=171.9
Q ss_pred CCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcc--hhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..+...+.||+|+||+||+|.+.....||+|++....... .+.|.+|+.+|.+++|||||+++|+|.... ...+
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~ 116 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLC 116 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceE
Confidence 3445556799999999999986555559999997543322 458999999999999999999999985422 1579
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC-eEecCCCCCceeecCCC-ceEEe
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP-IAHCNLKPSNVLLDDEM-IGHVG 300 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~-iiH~dlkp~Nil~~~~~-~~kl~ 300 (367)
+||||+++|+|.+++..... ..+++..++.++.||++||.||| +.+ ||||||||+|||++.++ ++||+
T Consensus 117 iVtEy~~~GsL~~~l~~~~~-------~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRK-------RKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred EEEEeCCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEEC
Confidence 99999999999999987411 15788999999999999999999 777 99999999999999997 99999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCcccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL--GCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
|||+++...... .......||+.|||||++. ...++.++||||||+++|||+||+.||.++..
T Consensus 187 DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 187 DFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred CCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 999998654321 2222356999999999999 56899999999999999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=311.93 Aligned_cols=198 Identities=26% Similarity=0.388 Sum_probs=177.5
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|+....||.|+||.|.+++ ..++..+|+|+++... ....+...+|..+|+.+.||+++++++.| .....
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCCe
Confidence 468888999999999999999 6679999999997433 23456678999999999999999999997 44567
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||.+||.|..+++... +|++..++.++.||+.||+||| +.+|++|||||+|||+|.+|.+||+
T Consensus 119 lymvmeyv~GGElFS~Lrk~~---------rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKit 186 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSG---------RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKIT 186 (355)
T ss_pred EEEEEeccCCccHHHHHHhcC---------CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEE
Confidence 899999999999999999877 6889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+|+.... .+...+|||.|+|||++...++...+|.|||||++|||+.|.+||..-.
T Consensus 187 DFGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 187 DFGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred eccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 9999997632 3556789999999999999999999999999999999999999996543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=330.79 Aligned_cols=205 Identities=22% Similarity=0.346 Sum_probs=179.3
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
..++|+++..||+|+||.||+|+ ..+|..+|+|+++.. +.+..+..+.|-.+|...++|.||++|-.| ++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 56789999999999999999999 667999999999743 345667788999999999999999999997 667
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
.++||||||++||++..+|.... .|++..+..++.+++.|++.|| +.|+|||||||+|+|||..|++|
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~---------~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiK 281 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKD---------TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIK 281 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcC---------cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEe
Confidence 78999999999999999998877 6889999999999999999999 99999999999999999999999
Q ss_pred EeccccccccCCC--------------------CCc-c------------------------eeeeccCCCcccCCcccc
Q 017712 299 VGDFGMARFLPAI--------------------DKQ-N------------------------RFICIKGSTGYIPPEYDL 333 (367)
Q Consensus 299 l~Dfg~~~~~~~~--------------------~~~-~------------------------~~~~~~gt~~y~aPE~~~ 333 (367)
|+|||+|..+... ... . -.....|||.|||||++.
T Consensus 282 LSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll 361 (550)
T KOG0605|consen 282 LSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL 361 (550)
T ss_pred eccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh
Confidence 9999998644210 000 0 011356999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 334 GCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 334 ~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+..|+..+|.||||||+|||+.|.+||.+-.
T Consensus 362 ~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~t 392 (550)
T KOG0605|consen 362 GKGYGKECDWWSLGCIMYEMLVGYPPFCSET 392 (550)
T ss_pred cCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999999998754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=332.36 Aligned_cols=207 Identities=27% Similarity=0.421 Sum_probs=181.5
Q ss_pred HhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeec---CCCcchhHHHHHHHHHHhC-CCCCcceeeeeeccccc
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL---IRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 215 (367)
....++|...+.||+|+|++|++|+ ..+++.+|||++.. .+....+....|-.+|.+| .||.|+++|-.|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF----- 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF----- 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----
Confidence 3445689999999999999999999 67899999999862 3444556677899999999 899999999887
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
++...+|+|+||+++|+|.++|+..+ .|++..++.++.+|+.||+||| ++|||||||||+|||+|+++
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~G---------sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dm 211 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYG---------SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDG 211 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhC---------cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCC
Confidence 55667899999999999999999887 6888889999999999999999 99999999999999999999
Q ss_pred ceEEeccccccccCCCCCc---------ce--eeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQ---------NR--FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++||+|||.|+.+...... .. ...+.||..|.+||++.....++.+|+|+|||++|+|+.|.+||.+..
T Consensus 212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 9999999999988543221 11 145779999999999999999999999999999999999999998754
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=325.70 Aligned_cols=205 Identities=25% Similarity=0.373 Sum_probs=177.1
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.+.|+.+++||+|+||.||+|+ ..+|+.||+|++.... ++...-..+||.||++|+||||+++.+..... ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 3467788999999999999999 7789999999998544 55667788999999999999999999987432 2457
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
+|||+|||+. +|.-++..... .|++.++..++.|++.||+|+| .+||+|||||.+|||||.+|.+||+
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~v--------kft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGV--------KFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCc--------ccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEec
Confidence 8999999965 99888876542 6889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+|+++...... ..+...-|..|.|||.+.|. .|+...|+||.||||.||++|++.|+|-.
T Consensus 261 DFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 261 DFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred cccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 99999987554332 23444468999999999885 68999999999999999999999999854
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=329.31 Aligned_cols=197 Identities=28% Similarity=0.456 Sum_probs=177.3
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|.+.+.||+|+||.||+|+ ..+.+.||+|.+.+... ...+.+++|++|++.++||||+.++++| ++....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 578889999999999999999 67789999999864332 3467799999999999999999999997 677889
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
|+|.||+.| +|..+|.... .++++.+..|+.|++.||.||| +++|+|||+||.|||++.++.+|++|
T Consensus 77 ~vVte~a~g-~L~~il~~d~---------~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~Klcd 143 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDG---------KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCD 143 (808)
T ss_pred EEEehhhhh-hHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeech
Confidence 999999966 9999998776 6889999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
||+|+.... .......+.|||.|||||...+.+|+..+|+||+||++||+++|++||-
T Consensus 144 Fg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 144 FGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred hhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 999997654 2334456789999999999999999999999999999999999999994
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=324.15 Aligned_cols=203 Identities=25% Similarity=0.408 Sum_probs=175.1
Q ss_pred hhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC----CC-cchhHHHHHHHHHHhCC-CCCcceeeeeecccc
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI----RP-GGSKSFKSECKAAINIK-HRNIVRVFTAFSGVD 214 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 214 (367)
...++|.+.+.||+|+||.|+.|. ..++..||+|+++.. .. ...+.+.+|+.++++++ ||||+++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~---- 89 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF---- 89 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE----
Confidence 345689999999999999999998 667899999977643 11 23556778999999999 99999999997
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
......++||||+.+|+|.+++.... ++.+.++..++.|++.|++|+| ++||+||||||+|||++.+
T Consensus 90 -~t~~~~~ivmEy~~gGdL~~~i~~~g---------~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~ 156 (370)
T KOG0583|consen 90 -ATPTKIYIVMEYCSGGDLFDYIVNKG---------RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGN 156 (370)
T ss_pred -ecCCeEEEEEEecCCccHHHHHHHcC---------CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCC
Confidence 44455899999999999999998854 5778999999999999999999 9999999999999999999
Q ss_pred -CceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCC-CC-cchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 295 -MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-AS-TYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 295 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+++||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+..
T Consensus 157 ~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 157 EGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred CCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 999999999998763 1223344567999999999999977 75 7789999999999999999999863
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=303.01 Aligned_cols=202 Identities=21% Similarity=0.311 Sum_probs=170.0
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
+.|+.+.++|+|+||.||+++ ..+|+.||||++..... .-.+-..+|++.|++++|||+|.+++.| ......
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 457788999999999999999 66799999999974332 2345578999999999999999999998 556778
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+||+|||+. ++.+-|...+. .++.+.+..++.|++.|+.|+| ++++|||||||+|||++.++.+||||
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~--------G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCD 144 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPN--------GVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCD 144 (396)
T ss_pred EEEeeecch-HHHHHHHhccC--------CCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEecc
Confidence 999999977 44444444432 3667888999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
||+|+.+.... ...+....|..|+|||.+.+ ..|++..||||+||++.||++|.+-|.|-++
T Consensus 145 FGFAR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD 207 (396)
T KOG0593|consen 145 FGFARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD 207 (396)
T ss_pred chhhHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence 99999886422 22333446889999999988 6899999999999999999999999988654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=312.65 Aligned_cols=205 Identities=29% Similarity=0.460 Sum_probs=172.0
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..+|...+.||+|+||.||++. .++|...|||.+...+....+.+.+|+.+|.+++|||||+++|..... .+ ...+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~--~~-~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR--EN-DEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc--cC-eeeE
Confidence 4467888999999999999999 445899999998755433367789999999999999999999974221 11 3679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-CCceEEec
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVGD 301 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-~~~~kl~D 301 (367)
+.|||+++|+|.+++..... .+++..+..++.||++||.||| ++|||||||||+|||++. ++.+||+|
T Consensus 93 i~mEy~~~GsL~~~~~~~g~--------~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaD 161 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG--------KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLAD 161 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEecc
Confidence 99999999999999987653 3778999999999999999999 999999999999999999 79999999
Q ss_pred cccccccCC-CCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 302 FGMARFLPA-IDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 302 fg~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
||+++.... ...........||+.|||||++..+ ....++|||||||++.||+||++||.+
T Consensus 162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 999987653 1112223346799999999999853 344699999999999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=323.47 Aligned_cols=208 Identities=26% Similarity=0.422 Sum_probs=174.3
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
+....+.+.+.+.||+|.||.||.|.+.....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|.. ..
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~ 274 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QE 274 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CC
Confidence 34444456667889999999999999888889999998854 2345789999999999999999999999843 33
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
.++||||||+.|+|.+||+..... .+...+.+.++.|||+|++||+ ++++|||||.++|||++++..+||
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~-------~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKI 344 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGG-------LLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKI 344 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCC-------ccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEE
Confidence 689999999999999999973322 4667889999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+|||+|+...+.... ......-+..|.|||.+..+.++.+||||||||+||||+| |+.|+.+..
T Consensus 345 sDFGLAr~~~d~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms 409 (468)
T KOG0197|consen 345 SDFGLARLIGDDEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS 409 (468)
T ss_pred cccccccccCCCcee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence 999999954332221 1111112567999999999999999999999999999998 999998765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=310.13 Aligned_cols=199 Identities=21% Similarity=0.380 Sum_probs=178.9
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.+|++.+.||+|.||.|-+|. ...|+.||||.++.. +..+.-.+++|++||+.|+||||+.+|+.| ++...
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCce
Confidence 468888999999999999998 578999999998743 334566789999999999999999999997 66778
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
+.+||||..+|.|++|+.... .+++.++..+++||..|+.|+| +++++|||||.+|||+|.|+++||+
T Consensus 128 IvivMEYaS~GeLYDYiSer~---------~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIA 195 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERG---------SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIA 195 (668)
T ss_pred EEEEEEecCCccHHHHHHHhc---------cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeee
Confidence 899999999999999998776 6889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||++..+... +....++|+|-|.+||+..+.+| ++..|-|||||+||.|+.|..||+|-
T Consensus 196 DFGLSNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 196 DFGLSNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred ccchhhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 99999877443 33345679999999999999987 68899999999999999999999984
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=319.72 Aligned_cols=198 Identities=22% Similarity=0.337 Sum_probs=178.2
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
...|....+||+|+.|.||.|+ ..+++.||+|++........+-+.+|+.+|+..+|+|||.+++.|. ....+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-----v~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-----VGDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-----ccceeE
Confidence 3467888899999999999998 6778999999999877777888999999999999999999999974 236689
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+|||||+||+|.+.+... .+++.++..|+++++.||+||| .++|+|||||.+|||++.+|.+||+||
T Consensus 347 VVMEym~ggsLTDvVt~~----------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT----------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred EEEeecCCCchhhhhhcc----------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeee
Confidence 999999999999998765 3778999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
|+|..+..... ......|||.|||||+.....|+++.||||||++++||+-|.+||-
T Consensus 414 GFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 414 GFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred eeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 99998765443 2334569999999999999999999999999999999999999995
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=309.08 Aligned_cols=212 Identities=24% Similarity=0.302 Sum_probs=181.7
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
+....+.|++...||.|..+.||+|+ ...+..||||+++..+.. ..+.+++|+..|+.++||||++++.+|. .
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-----v 95 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-----V 95 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-----e
Confidence 34456789999999999999999999 667899999999865544 3588999999999999999999999984 3
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
...+|+||.||.+||+.++++..-.. .+.+..+..|++++++||.||| .+|.||||||+.|||++.+|.+
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~-------Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~V 165 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPD-------GLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTV 165 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccc-------cccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcE
Confidence 45689999999999999999875533 4778899999999999999999 9999999999999999999999
Q ss_pred EEeccccccccCCCCCccee--eeccCCCcccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRF--ICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~~ 366 (367)
||+|||.+..+.+....... ....||+.|||||++.. ..|+.|+||||||++..||++|..||......
T Consensus 166 kLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 166 KLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred EEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 99999998766544322211 45579999999999654 46899999999999999999999999877643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=287.70 Aligned_cols=202 Identities=24% Similarity=0.378 Sum_probs=174.7
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.+|...+.||+|.||.||+|+ ..+|+.||||+++.. +.+......+|++.|+.++|+||+.++++| ......
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 467788999999999999999 678999999999743 334456778999999999999999999998 445567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
.||+||++. +|...++.... .++..++..++.++++||+||| .+.|+||||||.|+|++.+|.+||+|
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i--------~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiAD 144 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNI--------ILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIAD 144 (318)
T ss_pred EEEEEeccc-cHHHHhccccc--------ccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeec
Confidence 899999954 99999987653 5778899999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
||+|+.+.+........ .-|..|.|||.+.|. .|+...|+||.||++.||+-|.+-|.|-++
T Consensus 145 FGLAr~f~~p~~~~~~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD 207 (318)
T KOG0659|consen 145 FGLARFFGSPNRIQTHQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD 207 (318)
T ss_pred ccchhccCCCCcccccc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence 99999887654433222 358899999999886 589999999999999999999999988764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=297.40 Aligned_cols=204 Identities=25% Similarity=0.330 Sum_probs=175.2
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.++|+.++.|++|+||.||+|+ ..+++.||+|+++... .+..-.-.+|+.+|.+++|||||.+-....+.+ ...
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cce
Confidence 4567888999999999999999 6679999999998543 334455689999999999999999999987643 455
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.|+|||||+. +|..++..-.. +|...++..++.|+++||+||| .+.|+||||||+|+|++..|.+||+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q--------~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKia 219 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQ--------PFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIA 219 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccC--------CCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEec
Confidence 8999999965 99999987553 5888999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+|+.+++... ..+...-|..|.|||.+.+. .|++..|+||+|||+.||+++++-|.|-.
T Consensus 220 DFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 220 DFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred ccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 9999998866432 23334458899999999886 58999999999999999999999998754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=320.04 Aligned_cols=202 Identities=24% Similarity=0.320 Sum_probs=176.3
Q ss_pred hhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCC-CCCcceeeeeecccccC
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 216 (367)
...++|..+++||+|+||+|+++. ..+++.+|||++++.. ....+....|.+|+.... ||.++.++.+| +
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----Q 439 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----Q 439 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----c
Confidence 345689999999999999999999 5678999999998433 345677888988888775 99999999997 7
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
+..+.+.||||+.||++..+.+.. .|++..+..++..|+.||.||| +++||+||||.+|||+|.+|.
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~~~----------~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIHTD----------VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEecc----------cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCc
Confidence 788899999999999965544432 5889999999999999999999 999999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+||+|||+++... .....+.+++|||.|||||++.+..|+...|.|||||+||||+.|..||.|-
T Consensus 507 ~kiADFGlcKe~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd 571 (694)
T KOG0694|consen 507 VKIADFGLCKEGM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD 571 (694)
T ss_pred EEecccccccccC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999998543 2334555678999999999999999999999999999999999999999874
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=317.53 Aligned_cols=200 Identities=25% Similarity=0.358 Sum_probs=177.2
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
..-|++++.||.|+.|.|-+|+ ..+|+.+|||++.... ......+.+|+.+|+.+.|||++++|+.+ .+..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence 3458899999999999999999 6789999999997542 23456788999999999999999999996 6778
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
++|+|.||+++|.|++++..++ .+++.++.+++.||+.|+.|+| ..+|+||||||+|+|+|..+++||
T Consensus 86 ~lylvlEyv~gGELFdylv~kG---------~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKI 153 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKG---------PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKI 153 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEee
Confidence 8999999999999999998877 6889999999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+|..-..+ .-....+|+|.|.|||++.|.+| +.++||||+|||||.|+||+.||++-
T Consensus 154 ADFGMAsLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd 215 (786)
T KOG0588|consen 154 ADFGMASLEVPG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD 215 (786)
T ss_pred eccceeecccCC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence 999999854332 23344569999999999999987 57899999999999999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=316.37 Aligned_cols=203 Identities=24% Similarity=0.355 Sum_probs=172.1
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|. ..+++.+|+|++.... ......+.+|+.++.+++||||+++++.+ .....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 478899999999999999998 4568999999986422 22345678899999999999999999987 34556
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~ 143 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD---------TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLS 143 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEe
Confidence 899999999999999997654 4678899999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCc---------------------------------ceeeeccCCCcccCCccccCCCCCcchhHHHHH
Q 017712 301 DFGMARFLPAIDKQ---------------------------------NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFG 347 (367)
Q Consensus 301 Dfg~~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 347 (367)
|||+++.+...... .......||+.|+|||++.+..++.++||||||
T Consensus 144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlG 223 (363)
T cd05628 144 DFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223 (363)
T ss_pred eccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhH
Confidence 99998754321100 001234699999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 017712 348 ILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 348 ~~l~el~tg~~Pf~~~~ 364 (367)
|++|||++|+.||.+..
T Consensus 224 vil~ell~G~~Pf~~~~ 240 (363)
T cd05628 224 VIMYEMLIGYPPFCSET 240 (363)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=300.67 Aligned_cols=203 Identities=27% Similarity=0.381 Sum_probs=167.7
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
.|...+++|.|+||.||+|. ..+++.||||++-..+. --.+|+++|++++|||||++.-+|......+.-+..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667899999999999999 55679999999764332 22479999999999999999998866543334577899
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC-CceEEeccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-MIGHVGDFG 303 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~-~~~kl~Dfg 303 (367)
|||+|. +|.++++..... +..++.-.+.-++.||.+||.||| ..+|+||||||.|+|+|.+ |.+||||||
T Consensus 101 leymP~-tL~~~~r~~~~~-----~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRA-----NQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHhchH-HHHHHHHHHhhc-----CCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 999976 999999853211 114556667779999999999999 8999999999999999976 899999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.|+.+.......... .|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.|-.
T Consensus 172 SAK~L~~~epniSYi---cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 172 SAKVLVKGEPNISYI---CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS 230 (364)
T ss_pred cceeeccCCCceeEE---EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence 999987765554444 48999999998875 68999999999999999999999998854
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=310.09 Aligned_cols=203 Identities=22% Similarity=0.317 Sum_probs=173.3
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhH-HHHHHHHHHhCC-CCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS-FKSECKAAINIK-HRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 219 (367)
..++|.+.++||.|+||.||+|+ ..++..||||.++..-....+. -.+|+..|++|+ ||||+++.+.+.+ ...
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d----~~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD----NDR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc----cCc
Confidence 34578888999999999999999 7779999999987543333322 358999999999 9999999999853 334
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
.+++||||| ..+|+++++.+.. .|++..+..|+.||++||+|+| .+|+.|||+||+|||+..+..+||
T Consensus 84 ~L~fVfE~M-d~NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKi 151 (538)
T KOG0661|consen 84 ILYFVFEFM-DCNLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKI 151 (538)
T ss_pred eEeeeHHhh-hhhHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEe
Confidence 789999999 4599999987743 6999999999999999999999 999999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||+|+...+... .+....|..|+|||++.. ..|+.+.|+||+||+++|+.+=++-|.|..
T Consensus 152 aDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 152 ADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred cccccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 99999997654433 334446899999999765 568999999999999999999999998864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=301.80 Aligned_cols=209 Identities=22% Similarity=0.336 Sum_probs=169.9
Q ss_pred HhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--------------CcchhHHHHHHHHHHhCCCCCcce
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--------------PGGSKSFKSECKAAINIKHRNIVR 205 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~ 205 (367)
....|+|++...||+|.||.|-+|+ ..+++.||+|++.... ....+..++|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3456789999999999999999999 5679999999985321 112357899999999999999999
Q ss_pred eeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 017712 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (367)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlk 285 (367)
++++..+ ......|||+|||..|.+...=.... .+++.+++.++.+++.||+||| .+||||||||
T Consensus 173 LiEvLDD---P~s~~~YlVley~s~G~v~w~p~d~~---------els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIK 237 (576)
T KOG0585|consen 173 LIEVLDD---PESDKLYLVLEYCSKGEVKWCPPDKP---------ELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIK 237 (576)
T ss_pred EEEeecC---cccCceEEEEEeccCCccccCCCCcc---------cccHHHHHHHHHHHHHHHHHHH---hcCeeccccc
Confidence 9998754 45677899999998887643211111 2888999999999999999999 8999999999
Q ss_pred CCceeecCCCceEEeccccccccCCCCC---cceeeeccCCCcccCCccccCCC----CCcchhHHHHHHHHHHHHhCCC
Q 017712 286 PSNVLLDDEMIGHVGDFGMARFLPAIDK---QNRFICIKGSTGYIPPEYDLGCE----ASTYGDVYSFGILLLEMFTGIR 358 (367)
Q Consensus 286 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~tg~~ 358 (367)
|+|+|++++|++||+|||.+..+..... ........|||.|+|||...++. .+.+.||||+||+||.|+.|+.
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 9999999999999999999987643321 12223356999999999987732 3566799999999999999999
Q ss_pred CCCCCC
Q 017712 359 PSDGIF 364 (367)
Q Consensus 359 Pf~~~~ 364 (367)
||-+-+
T Consensus 318 PF~~~~ 323 (576)
T KOG0585|consen 318 PFFDDF 323 (576)
T ss_pred Ccccch
Confidence 996643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=326.94 Aligned_cols=225 Identities=25% Similarity=0.415 Sum_probs=185.1
Q ss_pred CChHHHHhhcCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceee
Q 017712 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVF 207 (367)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~ 207 (367)
+...-......+.+..+.||+|+||+||+|+.. +...||||.++..... ...+|++|++.+..++|||||+++
T Consensus 476 ~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 476 PDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred CccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 334444455566777889999999999999833 3468999999876665 678999999999999999999999
Q ss_pred eeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCC-----cchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEec
Q 017712 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP-----LNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHC 282 (367)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~-----~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~ 282 (367)
|.| ......++|+|||..|||.++|+......... ...+++..+.+.||.|||.|++||- ++.+|||
T Consensus 556 GVC-----~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHR 627 (774)
T KOG1026|consen 556 GVC-----REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHR 627 (774)
T ss_pred EEE-----ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCccccc
Confidence 999 44567899999999999999998654322111 1335888999999999999999999 8899999
Q ss_pred CCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 017712 283 NLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSD 361 (367)
Q Consensus 283 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~ 361 (367)
||-.+|+|+.++..+||+|||+++..-+.+.........-..+|||||.+..+.++++||||||||+|||+++ |+.||.
T Consensus 628 DLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 628 DLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred chhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc
Confidence 9999999999999999999999997655443322111112678999999999999999999999999999998 999999
Q ss_pred CCCCCC
Q 017712 362 GIFTGK 367 (367)
Q Consensus 362 ~~~~~~ 367 (367)
|+..++
T Consensus 708 glSn~E 713 (774)
T KOG1026|consen 708 GLSNQE 713 (774)
T ss_pred ccchHH
Confidence 987653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=303.33 Aligned_cols=198 Identities=28% Similarity=0.410 Sum_probs=170.8
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|.. .+++.+|+|++.... ......+.+|+.++++++||||+++++++ .....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 4688899999999999999994 468999999986422 22345688999999999999999999886 34557
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~ 143 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG---------RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLT 143 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEE
Confidence 899999999999999997654 4677888999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 144 Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 144 DFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred ecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999865321 122358999999999999889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.04 Aligned_cols=202 Identities=22% Similarity=0.315 Sum_probs=169.9
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||++. ..+++.||+|++... .......+.+|++++.+++||||++++++|. ....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCe
Confidence 478899999999999999998 567899999998632 2233467889999999999999999999973 4557
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~ 143 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD---------TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLS 143 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEe
Confidence 899999999999999997654 4677888899999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCc------------c---------------------------------eeeeccCCCcccCCccccCC
Q 017712 301 DFGMARFLPAIDKQ------------N---------------------------------RFICIKGSTGYIPPEYDLGC 335 (367)
Q Consensus 301 Dfg~~~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~ 335 (367)
|||+++.+...... . ......||+.|+|||++.+.
T Consensus 144 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 223 (377)
T cd05629 144 DFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223 (377)
T ss_pred ecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC
Confidence 99998643211000 0 00123589999999999988
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 336 EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 336 ~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.++.++|||||||++|||++|..||.+.
T Consensus 224 ~~~~~~DiwSlGvil~elltG~~Pf~~~ 251 (377)
T cd05629 224 GYGQECDWWSLGAIMFECLIGWPPFCSE 251 (377)
T ss_pred CCCCceeeEecchhhhhhhcCCCCCCCC
Confidence 9999999999999999999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=313.67 Aligned_cols=202 Identities=21% Similarity=0.277 Sum_probs=169.7
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.|++.+.||+|+||.||+|+ ..+++.+|+|++.... ......+.+|+.++.+++||||+++++++. .....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence 58888999999999999998 5568999999987432 233467889999999999999999999973 34568
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~D 144 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME---------VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTD 144 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEee
Confidence 99999999999999997654 4667888889999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCc---------------------------------------------ceeeeccCCCcccCCccccCCC
Q 017712 302 FGMARFLPAIDKQ---------------------------------------------NRFICIKGSTGYIPPEYDLGCE 336 (367)
Q Consensus 302 fg~~~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~ 336 (367)
||+++.+...... .......||+.|+|||++.+..
T Consensus 145 FGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 224 (381)
T cd05626 145 FGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG 224 (381)
T ss_pred CcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC
Confidence 9998643210000 0011245899999999999888
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 337 ASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 337 ~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++.++|||||||++|||++|..||.+..
T Consensus 225 ~~~~~DiwSlG~il~elltG~~Pf~~~~ 252 (381)
T cd05626 225 YTQLCDWWSVGVILFEMLVGQPPFLAPT 252 (381)
T ss_pred CCCccceeehhhHHHHHHhCCCCCcCCC
Confidence 9999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=313.60 Aligned_cols=202 Identities=23% Similarity=0.354 Sum_probs=171.6
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|+ ..+++.||+|++.... ......+.+|+.++..++||||++++++| .....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 478899999999999999999 4568999999997422 23445678999999999999999999997 34567
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~ 143 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD---------TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLS 143 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEe
Confidence 899999999999999997654 4778899999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcc------------------------------------eeeeccCCCcccCCccccCCCCCcchhHH
Q 017712 301 DFGMARFLPAIDKQN------------------------------------RFICIKGSTGYIPPEYDLGCEASTYGDVY 344 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 344 (367)
|||++..+....... ......||+.|+|||++.+..++.++|||
T Consensus 144 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 223 (364)
T cd05599 144 DFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223 (364)
T ss_pred ecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeee
Confidence 999987543211100 00123589999999999988999999999
Q ss_pred HHHHHHHHHHhCCCCCCCC
Q 017712 345 SFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 345 slG~~l~el~tg~~Pf~~~ 363 (367)
||||++|||++|..||.+.
T Consensus 224 SlG~il~el~~G~~Pf~~~ 242 (364)
T cd05599 224 SLGVIMYEMLVGYPPFCSD 242 (364)
T ss_pred cchhHHHHhhcCCCCCCCC
Confidence 9999999999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=302.65 Aligned_cols=203 Identities=22% Similarity=0.321 Sum_probs=177.0
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..|...+.||+|+||.||+|. ..+++.||+|++..... ...+.+++|+.++..++++||.++|+.+. ....++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl-----~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL-----KGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee-----ecccHH
Confidence 457777899999999999999 66799999999985443 35678999999999999999999999973 456679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++||||.||++.+.++... .+.+.++.-|+++++.||.||| .++.+|||||+.|||+..+|.+||+||
T Consensus 88 iiMey~~gGsv~~lL~~~~---------~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~Df 155 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN---------ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADF 155 (467)
T ss_pred HHHHHhcCcchhhhhccCC---------CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEec
Confidence 9999999999999998766 2356666778999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~~ 366 (367)
|.+..+....... ..+.|||.|||||++.+..|+.++||||||++.+||++|.+||..+.+.
T Consensus 156 gVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm 217 (467)
T KOG0201|consen 156 GVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM 217 (467)
T ss_pred ceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc
Confidence 9998775544333 4567999999999999889999999999999999999999999887653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=307.78 Aligned_cols=216 Identities=25% Similarity=0.358 Sum_probs=171.0
Q ss_pred hhcCCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhC-CCCCcceeeeeeccc
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAFSGV 213 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 213 (367)
...++|++.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++..+ +||||++++++|..
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~- 82 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK- 82 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC-
Confidence 3456899999999999999999973 2356899999874322 2346788999999999 89999999998742
Q ss_pred ccCCceeeeEEEEeccCCCHHHHhhCCCCCCC------------------------------------------------
Q 017712 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW------------------------------------------------ 245 (367)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------------------------------------------------ 245 (367)
.....+++|||+++|+|.+++........
T Consensus 83 ---~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 83 ---PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ---CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 33457899999999999999975321000
Q ss_pred -----CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeec
Q 017712 246 -----RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320 (367)
Q Consensus 246 -----~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 320 (367)
......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++..............
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence 000113677888999999999999999 899999999999999999999999999999865332221111223
Q ss_pred cCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 321 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
.+++.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 35678999999998899999999999999999997 999998743
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=297.83 Aligned_cols=200 Identities=25% Similarity=0.347 Sum_probs=168.9
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.|+..+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.++.+++|+||+++++++. .....
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeE
Confidence 36778899999999999998 5679999999986432 223346789999999999999999999873 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+++|||+++|+|.+++...... .+++..+..++.|++.||.||| +++|+||||||+|||+++++.+||+|
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~D 145 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNP-------GFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISD 145 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEee
Confidence 9999999999999887643211 4678889999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 146 fg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 146 LGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred CCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 99998653322 122345899999999999989999999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=307.28 Aligned_cols=198 Identities=25% Similarity=0.350 Sum_probs=171.4
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|+.++.+++||||+++++++. ...
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCC
Confidence 35788899999999999999994 56899999998632 2234567889999999999999999999873 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl 159 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKV 159 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEE
Confidence 6899999999999999997654 4667888889999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 160 ~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 160 TDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred eeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 9999998653321 2245899999999999988999999999999999999999999764
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=276.08 Aligned_cols=203 Identities=25% Similarity=0.418 Sum_probs=176.1
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
..++|++.+.||+|-||.||.|+ ..++..||+|++... ..+-..++.+|++|.+.|+||||+++|++|. +.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh-----d~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH-----DS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee-----cc
Confidence 34689999999999999999999 667889999998632 2334577899999999999999999999984 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...||++||.++|+|...|...... .|++.....+..|+|.||.|+| .++||||||||+|+|++..+.+|
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~-------~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lk 164 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMK-------RFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELK 164 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccc-------cccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCee
Confidence 5679999999999999999854432 5777888889999999999999 99999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+|||-+...+ .+.....+||..|.|||...+..++...|+|++|++.||++.|.+||..-.
T Consensus 165 iAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 165 IADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred ccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 99999987543 233344569999999999999999999999999999999999999997543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=287.29 Aligned_cols=209 Identities=24% Similarity=0.343 Sum_probs=172.4
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCC-cceeeeeecccc-cCCcee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRN-IVRVFTAFSGVD-YQGARF 220 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-~~~~~~ 220 (367)
.|...++||+|+||.||+|+ ..+|+.||+|+++.... +......+|+.++++++|+| |+.+++++.... +.....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 45666789999999999999 67799999999985443 45566789999999999999 999999985432 122347
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++|+||+ ..+|..++....... ..++...+..++.|++.||+||| +++|+||||||+|||++++|.+||+
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKla 162 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLA 162 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeee
Confidence 78999999 559999998765321 13445778999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
|||+|+.+.-... ......+|..|.|||++.+. .|++..||||+||++.||+++++-|.|..+
T Consensus 163 DFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 163 DFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred ccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 9999996542221 23334468889999999987 689999999999999999999999998753
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=303.82 Aligned_cols=194 Identities=22% Similarity=0.269 Sum_probs=165.4
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEE
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (367)
+.||+|+||.||+|+ ..+++.+|+|+++... ......+.+|+.++.+++||||+++++++ ......++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 368999999999998 4578999999987422 23345678899999999999999999987 34557899999
Q ss_pred eccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccc
Q 017712 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (367)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (367)
|+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~ 143 (323)
T cd05571 76 YANGGELFFHLSRER---------VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred CCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 999999999987654 4678889999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 144 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 144 EGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred ccccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 5322211 122345899999999999989999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=312.93 Aligned_cols=203 Identities=22% Similarity=0.308 Sum_probs=170.0
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|+ ..+++.||+|++... .......+.+|+.++.+++||||+++++.| .....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 468899999999999999998 556899999998632 122346688999999999999999999987 34567
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~ 143 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG---------IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLT 143 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEE
Confidence 899999999999999997654 4667888889999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCC-----------------------------------------cceeeeccCCCcccCCccccCCCCCc
Q 017712 301 DFGMARFLPAIDK-----------------------------------------QNRFICIKGSTGYIPPEYDLGCEAST 339 (367)
Q Consensus 301 Dfg~~~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 339 (367)
|||+|..+..... ........||+.|+|||++.+..++.
T Consensus 144 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 223 (376)
T cd05598 144 DFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 223 (376)
T ss_pred eCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCc
Confidence 9999753311000 00011245899999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 340 YGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 340 ~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++|||||||++|||++|+.||.+..
T Consensus 224 ~~DiwSlGvilyell~G~~Pf~~~~ 248 (376)
T cd05598 224 LCDWWSVGVILYEMLVGQPPFLADT 248 (376)
T ss_pred ceeeeeccceeeehhhCCCCCCCCC
Confidence 9999999999999999999997653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=306.54 Aligned_cols=198 Identities=22% Similarity=0.326 Sum_probs=171.5
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++..++||||+++++++ .....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 4688899999999999999994 468999999987432 23446788999999999999999999987 34456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~ 143 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLT 143 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEE
Confidence 899999999999999997654 4667888999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 144 Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 144 DFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred eCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 9999986533 1223458999999999999899999999999999999999999997653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=312.43 Aligned_cols=201 Identities=22% Similarity=0.314 Sum_probs=168.8
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.|+..+.||+|+||.||+|+ ..+++.+|+|++.... ......+.+|+.++++++||||+++++.|. .....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence 58888999999999999998 5568999999986422 223457889999999999999999999973 34568
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~D 144 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTD 144 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeE
Confidence 99999999999999987654 4667888889999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCC---------------------------------------------cceeeeccCCCcccCCccccCCC
Q 017712 302 FGMARFLPAIDK---------------------------------------------QNRFICIKGSTGYIPPEYDLGCE 336 (367)
Q Consensus 302 fg~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 336 (367)
||++..+..... ........||+.|+|||++.+..
T Consensus 145 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 224 (382)
T cd05625 145 FGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG 224 (382)
T ss_pred CCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC
Confidence 999754311000 00011235899999999999989
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 337 ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 337 ~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++.++|||||||++|||++|+.||.+.
T Consensus 225 ~~~~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 225 YTQLCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred CCCeeeEEechHHHHHHHhCCCCCCCC
Confidence 999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=306.88 Aligned_cols=199 Identities=25% Similarity=0.369 Sum_probs=170.9
Q ss_pred cCCCCCCCcccccCceEEEEEEec-C-CCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF-D-GTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|++.+.||+|+||.||+|... + +..||+|.+... .....+.+.+|+.++..++||||+++++++. ..
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----DE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----eC
Confidence 457889999999999999999843 3 368999998632 2234567889999999999999999999973 44
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ik 171 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK---------RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIK 171 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEE
Confidence 56899999999999999997654 4678888999999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 172 L~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 172 MTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred EecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 9999999865321 123458999999999998889999999999999999999999997643
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=310.13 Aligned_cols=202 Identities=25% Similarity=0.327 Sum_probs=169.6
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
..++|++.+.||+|+||.||+++ ..+++.+|+|++... .......+.+|+.+++.++||||+++++++ ...
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 34679999999999999999999 456889999998632 222345678999999999999999999987 345
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++|+|.+++... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+|
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~----------~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~k 182 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY----------DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLK 182 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEE
Confidence 6789999999999999999653 2567788899999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE----ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||++........ .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.
T Consensus 183 L~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 183 LADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred EEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 999999986543221 1222345899999999987643 678999999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=290.31 Aligned_cols=210 Identities=23% Similarity=0.349 Sum_probs=178.9
Q ss_pred HhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEee--cCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
......|...+.||+|+||.|+.+. ..+|+.||+|++. .......++..+|+.+++.++|+||+.+++.+.......
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 3445567778899999999999998 6779999999987 444556788899999999999999999999986645566
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
-...|+|+|+| +.+|...++.+. .++.+.+..++.|++.||.|+| +.+|+||||||.|++++.+..+
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~---------~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~l 164 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQ---------DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDL 164 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCc---------cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCE
Confidence 77889999999 669999998876 4778889999999999999999 8999999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|||+|+...........+...-|..|.|||++.. ..|+...||||.||++.||++|++-|.|-
T Consensus 165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~ 231 (359)
T KOG0660|consen 165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK 231 (359)
T ss_pred EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence 9999999998754322222233446889999999764 57899999999999999999999999874
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=301.09 Aligned_cols=194 Identities=21% Similarity=0.276 Sum_probs=164.9
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEE
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (367)
+.||+|+||.||+++ ..+++.||+|+++.. .......+.+|+.++..++||||++++++|. .....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence 368999999999998 457899999998742 2233456778999999999999999999873 3456799999
Q ss_pred eccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccc
Q 017712 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (367)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (367)
|+++|+|..++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 143 (323)
T cd05595 76 YANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred CCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhc
Confidence 999999999887654 4678889999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 144 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 144 EGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred cccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 532211 1122345899999999999989999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=305.46 Aligned_cols=208 Identities=28% Similarity=0.439 Sum_probs=177.1
Q ss_pred ChHHHHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeeccc
Q 017712 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGV 213 (367)
Q Consensus 136 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (367)
..++|.+..+.+.+...||+|.||+||+|++. -.||||+++.... ...+.|++|+..+++-+|.||+-+.|+|...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 44778888888999999999999999999854 4799999985444 3568899999999999999999999998432
Q ss_pred ccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
. ..||..+|+|.+|+.+++.... .|.....+.|+.||++|+.||| .++|||||||..||++.+
T Consensus 461 -----~-~AIiTqwCeGsSLY~hlHv~et--------kfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~ 523 (678)
T KOG0193|consen 461 -----P-LAIITQWCEGSSLYTHLHVQET--------KFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHE 523 (678)
T ss_pred -----c-eeeeehhccCchhhhhccchhh--------hhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEcc
Confidence 2 3899999999999999987663 6888999999999999999999 899999999999999999
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
++++||+|||++..-.............|...|||||++.. .+|++.+||||||+++|||+||..||..
T Consensus 524 ~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi 595 (678)
T KOG0193|consen 524 DLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI 595 (678)
T ss_pred CCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence 99999999999864322222222333457888999999763 5799999999999999999999999984
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=308.56 Aligned_cols=203 Identities=24% Similarity=0.362 Sum_probs=171.9
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||++. ..+++.||+|+++.. .......+.+|+.++..++||||+++++.+ .....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 468889999999999999998 456899999998632 223456788899999999999999999987 34567
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~ 143 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD---------TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLS 143 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEe
Confidence 899999999999999997654 4678889999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCc---------------------------------ceeeeccCCCcccCCccccCCCCCcchhHHHHH
Q 017712 301 DFGMARFLPAIDKQ---------------------------------NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFG 347 (367)
Q Consensus 301 Dfg~~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 347 (367)
|||+++.+...... .......||+.|+|||++.+..++.++||||||
T Consensus 144 DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlG 223 (360)
T cd05627 144 DFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223 (360)
T ss_pred eccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccc
Confidence 99998754321100 001134689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 017712 348 ILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 348 ~~l~el~tg~~Pf~~~~ 364 (367)
|++|||++|+.||.+..
T Consensus 224 vilyel~tG~~Pf~~~~ 240 (360)
T cd05627 224 VIMYEMLIGYPPFCSET 240 (360)
T ss_pred ceeeecccCCCCCCCCC
Confidence 99999999999997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=299.32 Aligned_cols=192 Identities=26% Similarity=0.345 Sum_probs=164.3
Q ss_pred ccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEec
Q 017712 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (367)
Q Consensus 153 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (367)
||+|+||.||+|+. .+++.||+|+++.. .......+.+|+.++.+++||||+++++++ ......++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 69999999999994 56889999998632 233456778999999999999999999887 3445679999999
Q ss_pred cCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccccc
Q 017712 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~ 143 (312)
T cd05585 76 NGGELFHHLQREG---------RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLN 143 (312)
T ss_pred CCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence 9999999997654 4678888999999999999999 899999999999999999999999999999754
Q ss_pred CCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 144 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 144 MKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred ccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 32221 222345899999999999989999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=300.46 Aligned_cols=194 Identities=22% Similarity=0.282 Sum_probs=165.5
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEE
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (367)
+.||+|+||.||++. ..+++.||+|++... .......+.+|+.+++.++||||+++++++ ......++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 368999999999998 557899999998742 223446778999999999999999999887 34556799999
Q ss_pred eccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccc
Q 017712 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (367)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (367)
|+++|+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 76 y~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~ 143 (328)
T cd05593 76 YVNGGELFFHLSRER---------VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK 143 (328)
T ss_pred CCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCc
Confidence 999999999887654 4678889999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 144 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 144 EGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred cCCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 532211 1222345899999999999888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=280.79 Aligned_cols=201 Identities=23% Similarity=0.362 Sum_probs=173.8
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeec--CCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.+++|++-+.||+|.|+.||++. ..+|+.+|+|+++. .+..+.+.+.+|++|...|+||||+++.+.+ ....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence 34578888899999999999987 56799999998863 3444678899999999999999999999885 6677
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec---CCCc
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DEMI 296 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~---~~~~ 296 (367)
+.|+|+|++.|++|..-+-.. +.+++..+-..+.||++||.|+| .++|||||+||+|+++. ....
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R---------~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~ 151 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAR---------EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAA 151 (355)
T ss_pred eeEEEEecccchHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCc
Confidence 889999999999997655433 26888888999999999999999 99999999999999993 4456
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+||+|||+|..+. .........|||.|||||++...+++..+|||+.||+||-|+.|.+||.|-
T Consensus 152 vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~ 215 (355)
T KOG0033|consen 152 VKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 215 (355)
T ss_pred eeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc
Confidence 8999999999876 333445567999999999999999999999999999999999999999873
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=302.05 Aligned_cols=205 Identities=21% Similarity=0.317 Sum_probs=169.7
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||+|+||.||+|+ ..++..||+|.+... .......+.+|+.++++++||||+++++++...........+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 47788999999999999999 557899999998632 223345688999999999999999999987654433445679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+ +++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 81 lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Df 147 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND---------DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDF 147 (338)
T ss_pred EEEecC-CCCHHHHHHhcc---------cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccC
Confidence 999999 469999987654 4678889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCc-ceeeeccCCCcccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 999754322211 11223458999999999876 57899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=306.78 Aligned_cols=205 Identities=25% Similarity=0.311 Sum_probs=170.7
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (367)
+....++|++.+.||+|+||.||+++ ..+++.+|+|++... .......+.+|+.++..++||||+++++.+
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~----- 112 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF----- 112 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----
Confidence 34445789999999999999999999 456889999998632 222345678899999999999999999987
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
......++||||+++|+|.+++... .+++..+..++.||+.||.||| +++|+||||||+|||++.++
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~~----------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSNY----------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCC
Confidence 3456789999999999999998653 2567778889999999999999 89999999999999999999
Q ss_pred ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE----ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.+||+|||+++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.
T Consensus 180 ~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 180 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred CEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 999999999986543221 1122345899999999987543 788999999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=294.67 Aligned_cols=203 Identities=25% Similarity=0.403 Sum_probs=167.9
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
..++|++.+.||+|+||.||+|+. .+++.+|+|+++.... .....+.+|+.+++.++||||+++++++. ....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~ 77 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKET 77 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCe
Confidence 357899999999999999999994 4789999999874332 23456789999999999999999999973 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||++ ++|.+++..... .++...+..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 145 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLA 145 (303)
T ss_pred EEEEEECCC-cCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEC
Confidence 799999995 688888865432 3667888999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus 146 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 146 DFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred CCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999875432211 11233478999999998754 57889999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=287.60 Aligned_cols=206 Identities=25% Similarity=0.373 Sum_probs=175.5
Q ss_pred CCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
+.|++++.||+|.-|.||+++.. ++..+|+|++.... .....+.+.|.+||+.++||.++.+|..| +...+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccce
Confidence 45777889999999999999944 46899999997433 33456678899999999999999999997 66788
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++||||+||+|..+++.+... .|++..+..++.+++.||+||| -.|||.|||||+|||+.++|++.|+
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~-------~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLs 221 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGK-------RFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLS 221 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCC-------ccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEee
Confidence 89999999999999998876644 6889999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCC---------------------------------CCC---------------------cceeeeccCCCcc
Q 017712 301 DFGMARFLPA---------------------------------IDK---------------------QNRFICIKGSTGY 326 (367)
Q Consensus 301 Dfg~~~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y 326 (367)
||.++..... ... ......+.||-.|
T Consensus 222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY 301 (459)
T KOG0610|consen 222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY 301 (459)
T ss_pred eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence 9998754311 000 0011245689999
Q ss_pred cCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 327 ~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
+|||++.|..++...|.|+|||++|||+.|..||.|-..
T Consensus 302 lAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~ 340 (459)
T KOG0610|consen 302 LAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN 340 (459)
T ss_pred ccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc
Confidence 999999999999999999999999999999999998654
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=298.15 Aligned_cols=200 Identities=24% Similarity=0.270 Sum_probs=167.5
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCC-CcceeeeeecccccCCcee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHR-NIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 220 (367)
+|++.+.||+|+||.||+|. ..+++.||+|++... .....+.+..|..++..++|+ +|+++++++. ....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence 47888999999999999998 446789999998742 233456778899999999765 5788888863 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~ 143 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG---------KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIA 143 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEe
Confidence 799999999999999987654 4667889999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+..
T Consensus 144 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 144 DFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred ecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 999987432211 12234468999999999999899999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=304.48 Aligned_cols=190 Identities=26% Similarity=0.435 Sum_probs=165.2
Q ss_pred CCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 146 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
....++-||.|+.|.||+|++ .++.||||+++..+ ..+|+-|++|+||||+.+.|+|. .....+|||
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt-----qsPcyCIiM 191 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT-----QSPCYCIIM 191 (904)
T ss_pred HhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec-----CCceeEEee
Confidence 334467799999999999985 56889999876433 34678899999999999999994 345679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
|||+.|.|.++|+... .+.....+.+..+||.|+.||| .+.|||||||.-||||..+..+||+|||.+
T Consensus 192 EfCa~GqL~~VLka~~---------~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAGR---------PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred eccccccHHHHHhccC---------ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccch
Confidence 9999999999999876 4556778889999999999999 889999999999999999999999999999
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+.+... .....++||..|||||++...+.+.|.|||||||+||||+||..||.++
T Consensus 260 ~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 260 KELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred Hhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 877543 2335677999999999999999999999999999999999999999765
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=304.81 Aligned_cols=209 Identities=26% Similarity=0.388 Sum_probs=175.2
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEecC--C--CE-EEEEEeec---CCCcchhHHHHHHHHHHhCCCCCcceeeee
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLFD--G--TT-IAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVFTA 209 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 209 (367)
+.|....++..+.++||+|+||.||+|++.. + .. ||+|..+. ........|.+|+++|++++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4567777788888999999999999998332 2 23 89999874 234466789999999999999999999999
Q ss_pred ecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 017712 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNV 289 (367)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Ni 289 (367)
+. ....+++|||+|+||+|.++|+.... .++..+.+.++.+.+.||+||| ++++|||||-.+|+
T Consensus 230 a~-----~~~Pl~ivmEl~~gGsL~~~L~k~~~--------~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNc 293 (474)
T KOG0194|consen 230 AV-----LEEPLMLVMELCNGGSLDDYLKKNKK--------SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNC 293 (474)
T ss_pred Ec-----CCCccEEEEEecCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHh
Confidence 73 34567999999999999999998763 3778899999999999999999 99999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 290 LLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 290 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|++.++.+||+|||+++.-..-.... ....-+..|+|||.+....++.++|||||||++||+++ |..||.|..
T Consensus 294 L~~~~~~vKISDFGLs~~~~~~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 294 LYSKKGVVKISDFGLSRAGSQYVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred eecCCCeEEeCccccccCCcceeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 99999999999999997542111111 01123678999999999999999999999999999998 899999875
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=306.44 Aligned_cols=202 Identities=26% Similarity=0.317 Sum_probs=168.9
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
..++|++.+.||+|+||.||+++ ..+++.+|+|++... .......+.+|+.+++.++||||+++++++ ...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 34678999999999999999998 456899999998632 223345578899999999999999999887 345
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++|+|.+++... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~----------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~k 182 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY----------DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLK 182 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEE
Confidence 6789999999999999998653 2567788889999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC----EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||++........ .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.
T Consensus 183 L~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 183 LADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred EEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 999999976533221 112234589999999998653 3788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=291.77 Aligned_cols=201 Identities=25% Similarity=0.388 Sum_probs=167.1
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|++.+.||+|+||.||+|. ..+++.||+|.++... ......+.+|+.++++++||||+++++++. .....+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEE
Confidence 578999999999999999998 4568999999987433 233456789999999999999999999873 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||++ ++|.+++..... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 80 lv~e~~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Df 147 (288)
T cd07871 80 LVFEYLD-SDLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADF 147 (288)
T ss_pred EEEeCCC-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcC
Confidence 9999996 599998865432 3567888999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+++....... ......|++.|+|||.+.+ ..++.++|||||||++|+|+||+.||.+..
T Consensus 148 G~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 148 GLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred cceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99975432221 1122347899999998875 468899999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=299.27 Aligned_cols=203 Identities=24% Similarity=0.350 Sum_probs=178.8
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc--chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|...+++|+|+||.++.++ ..+++.+++|.+...+.. ......+|+.++++++|||||.+.+.|. .+..+.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence 578899999999999999998 556889999999854433 3456789999999999999999999984 455668
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+|+|+||+||+|.+.+...... .|+++.+..++.|++.|+.||| +++|+|||||+.||+++.++.+||+|
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~-------~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgD 149 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGV-------LFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGD 149 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhc-------cccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecc
Confidence 9999999999999999876632 6889999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|+.+.+... ......|||.||+||.+.+.+|..|+|||||||++|||++-+++|.+.
T Consensus 150 fGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~ 209 (426)
T KOG0589|consen 150 FGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS 209 (426)
T ss_pred hhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence 999998765431 233456999999999999999999999999999999999999999764
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=297.13 Aligned_cols=194 Identities=25% Similarity=0.339 Sum_probs=163.8
Q ss_pred CcccccCceEEEEEEe----cCCCEEEEEEeecC----CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 151 NLIGAGNFGSVYNGTL----FDGTTIAVKVFNLI----RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+.||+|+||.||+++. .+++.||+|+++.. .......+.+|+.++..++||||++++++|. .....+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence 5799999999999984 35789999998742 1223456788999999999999999999873 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 77 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df 144 (323)
T cd05584 77 LILEYLSGGELFMHLEREG---------IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDF 144 (323)
T ss_pred EEEeCCCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeC
Confidence 9999999999999997654 3567788889999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 145 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 145 GLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred cCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 99875432221 122345899999999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=305.33 Aligned_cols=205 Identities=29% Similarity=0.426 Sum_probs=172.5
Q ss_pred CCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC-CCcchhHHHHHHHHHHhCCCCCcceeeeeecccc-cCCceeeeE
Q 017712 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD-YQGARFKAV 223 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l 223 (367)
|...+.||+|+||.||+|+ ..+|+.||||.++.. .....+..-+|+++|++++|||||++++.-.+.. +.......+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4556789999999999999 778999999999743 3345678889999999999999999998853321 112455689
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec--CCC--ceEE
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD--DEM--IGHV 299 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~--~~~--~~kl 299 (367)
+||||++|||..+|+..... ..+++.+.+.++.+++.||.||| .++|+||||||.||++- .+| .-||
T Consensus 95 vmEyC~gGsL~~~L~~PEN~------~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENA------YGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred EEeecCCCcHHHHhcCcccc------cCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEee
Confidence 99999999999999876532 26889999999999999999999 99999999999999983 333 4599
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||.|+.+.+.. ...+..||+.|.+||.... ..|+..+|.|||||++|+++||..||...
T Consensus 166 tDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 166 TDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9999999775533 5667789999999999884 78899999999999999999999999643
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=297.36 Aligned_cols=200 Identities=24% Similarity=0.263 Sum_probs=167.0
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCcee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (367)
+|.+.+.||+|+||.||+|. ..+++.+|+|++.... ......+..|..++..+ +||+|+++++++ .....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 47788999999999999998 4467899999987432 22334567788888777 589999999887 34456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~ 143 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG---------RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIA 143 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEc
Confidence 799999999999999987654 4678889999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+..
T Consensus 144 DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 144 DFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred cCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 999997543211 12223458999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=304.23 Aligned_cols=203 Identities=26% Similarity=0.375 Sum_probs=173.4
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|+. .+++.||+|+++.. .......+.+|+.++..++||||+++++++ .....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 4688999999999999999994 46899999998742 223456788999999999999999999887 34556
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~ 143 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLA 143 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEee
Confidence 899999999999999997653 4678889999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCC---------------------------cceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHH
Q 017712 301 DFGMARFLPAIDK---------------------------QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEM 353 (367)
Q Consensus 301 Dfg~~~~~~~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el 353 (367)
|||++........ ........||+.|+|||++.+..++.++|||||||++|||
T Consensus 144 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 223 (350)
T cd05573 144 DFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223 (350)
T ss_pred cCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhh
Confidence 9999986644320 0112234589999999999999999999999999999999
Q ss_pred HhCCCCCCCCC
Q 017712 354 FTGIRPSDGIF 364 (367)
Q Consensus 354 ~tg~~Pf~~~~ 364 (367)
++|+.||.+..
T Consensus 224 l~g~~Pf~~~~ 234 (350)
T cd05573 224 LYGFPPFYSDT 234 (350)
T ss_pred ccCCCCCCCCC
Confidence 99999997643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=294.95 Aligned_cols=195 Identities=26% Similarity=0.353 Sum_probs=162.4
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHh-CCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAIN-IKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|+ ..+++.||+|.++... ....+.+..|..++.. .+||||+++++++ ......++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 368999999999998 4568899999987422 2334455667777665 4899999999987 3445689999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~gg~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a 143 (316)
T cd05592 76 EYLNGGDLMFHIQSSG---------RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMC 143 (316)
T ss_pred cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCC
Confidence 9999999999987654 4678888999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 144 KENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred eECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 7543322 12223458999999999999889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=298.66 Aligned_cols=194 Identities=22% Similarity=0.269 Sum_probs=164.4
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEE
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (367)
+.||+|+||.||++. ..+++.+|+|++... .......+.+|++++..++||||+++++++ ......++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 368999999999998 557899999998742 222345678899999999999999999887 34456899999
Q ss_pred eccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEecCCCCCceeecCCCceEEeccccc
Q 017712 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
|+++|+|.+++.... .+++..+..++.||+.||.||| + .+|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~ 143 (325)
T cd05594 76 YANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLC 143 (325)
T ss_pred CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCC
Confidence 999999999887654 4678889999999999999999 6 79999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 144 KEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred eecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 75322211 122345899999999999989999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=291.11 Aligned_cols=201 Identities=23% Similarity=0.302 Sum_probs=168.5
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|++.+.||+|+||.||+|+. .+++.+|+|++.... ....+.+.+|+.++..++||||+++++++ ......
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 4788999999999999999994 468899999987432 23456788999999999999999999987 344567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||++++.+..+..... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~D 143 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCD 143 (287)
T ss_pred EEEEecCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEee
Confidence 99999999877765544322 4667888999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||++......... ......|++.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 144 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 144 FGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred ccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 9999876432211 122345899999999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=297.51 Aligned_cols=202 Identities=26% Similarity=0.309 Sum_probs=168.8
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+++ ..+++.||+|++... .......+.+|+.++..++||||+++++++ .....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 478899999999999999999 456899999998632 223445688999999999999999999987 34467
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++..... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 144 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLA 144 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEE
Confidence 8999999999999999975321 4678888999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||++..+...... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.
T Consensus 145 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 145 DFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 99998765432221 1122358999999999863 35688999999999999999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=289.26 Aligned_cols=206 Identities=22% Similarity=0.322 Sum_probs=168.6
Q ss_pred CCCCCCCcccccCceEEEEEEe--cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhC---CCCCcceeeeeecccccCC
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL--FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINI---KHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~ 217 (367)
++|++.+.||+|+||.||+|+. .+++.||+|.++... ......+.+|+.++..+ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999984 346889999987432 22334567788877766 6999999999885433344
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....+++|||++ ++|.+++...... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCE
Confidence 566899999995 6999998754321 3667889999999999999999 8999999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|++||.+..
T Consensus 150 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 150 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred EEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 99999999765432 12223458999999999988889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=296.10 Aligned_cols=197 Identities=25% Similarity=0.355 Sum_probs=164.4
Q ss_pred CCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHH---HhCCCCCcceeeeeecccccCCce
Q 017712 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAA---INIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
|++.+.||+|+||.||+|. ..+++.||+|+++... ....+.+.+|++++ ..++||||+++++++ ....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 5677899999999999998 4568999999987432 22345666776665 456899999999987 3445
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++++|..++... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL 142 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD----------VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKI 142 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEe
Confidence 689999999999999888643 3678899999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++....... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.
T Consensus 143 ~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 143 ADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred CcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 99999875322221 122345899999999999989999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=296.03 Aligned_cols=193 Identities=24% Similarity=0.281 Sum_probs=163.9
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|+ ..+++.||+|+++... ......+.+|..++..+ +||||++++++| ......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 368999999999998 4568999999997432 22345678899999888 799999999987 3445679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|.+++.... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++
T Consensus 76 e~~~~g~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~ 143 (329)
T cd05588 76 EFVSGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMC 143 (329)
T ss_pred eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccc
Confidence 9999999999887554 4778999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||+.
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 144 KEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 7432211 122234589999999999998999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=294.65 Aligned_cols=195 Identities=26% Similarity=0.311 Sum_probs=164.0
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|+ ..+++.||+|++... .......+..|..++..+ +||||+++++++ ......++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 368999999999999 456899999998732 223455677888888876 699999999987 3445679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|.+++.... .+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++
T Consensus 76 Ey~~~g~L~~~i~~~~---------~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~ 143 (320)
T cd05590 76 EFVNGGDLMFHIQKSR---------RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC 143 (320)
T ss_pred cCCCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCC
Confidence 9999999999987654 4678889999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 144 KEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred eecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 75322111 1223458999999999998889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=310.66 Aligned_cols=205 Identities=21% Similarity=0.276 Sum_probs=171.2
Q ss_pred CCCCCCcccccCceEEEEEEe-cC-CCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FD-GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.|.+.+.||+|+||.||+|.. .+ +..||+|.+..........+.+|+.+++.++||||++++++|. .....++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence 388889999999999999983 34 6788998775544444567788999999999999999999973 3456899
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
||||+++|+|.+++...... ...+++.++..++.|++.||.||| +++|+||||||+|||++.++.+||+|||
T Consensus 143 v~E~~~gg~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFg 214 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKE-----HLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFG 214 (478)
T ss_pred EEECCCCCCHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCc
Confidence 99999999999988643210 114678889999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+++.+.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 215 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 215 FSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred CceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 998764432222233445899999999999989999999999999999999999999764
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=295.58 Aligned_cols=195 Identities=24% Similarity=0.290 Sum_probs=163.9
Q ss_pred CcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|+. .+++.||+|++... .......+..|.+++..+ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence 3689999999999984 46889999998742 223445677888888866 7999999999973 345679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|..++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 76 E~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~ 143 (321)
T cd05591 76 EYVNGGDLMFQIQRSR---------KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMC 143 (321)
T ss_pred eCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccc
Confidence 9999999999987654 4667888999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 144 KEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred eecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 75432221 1223458999999999998899999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.78 Aligned_cols=200 Identities=23% Similarity=0.280 Sum_probs=167.3
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCcee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 220 (367)
+|+..+.||+|+||.||+|. ..+++.||+|++... .......+..|..++..+. |++|+++++++ .....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 36777899999999999998 457899999998742 2234456778888888886 57788888886 33456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++.... .+++.++..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~ 143 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG---------KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIA 143 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEe
Confidence 799999999999999987654 4778899999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 144 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 144 DFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred ccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 9999875432211 1223458999999999998889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=294.02 Aligned_cols=198 Identities=25% Similarity=0.319 Sum_probs=169.9
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|++.+.||+|+||.||+++ ..++..+|+|.+..... .....+.+|++++.+++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 4689999999999999999999 44688999999874322 23467899999999999999999999973 34467
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCC-CeEecCCCCCceeecCCCceEEe
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~-~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
+++|||+++++|.+++.... .+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~ 146 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK---------RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLC 146 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEc
Confidence 99999999999999997654 4667888999999999999999 54 69999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|||++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 147 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999997653321 1233589999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=298.09 Aligned_cols=202 Identities=24% Similarity=0.303 Sum_probs=168.8
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+++ ..+++.+|+|++... .......+.+|..++..++|+||+++++++ .....
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 478899999999999999999 456889999998632 122345578899999999999999999987 34567
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~ 144 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLA 144 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEE
Confidence 8999999999999999976321 4667888889999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 145 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 145 DFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred eccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 99999765432211 1223458999999999875 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=295.26 Aligned_cols=193 Identities=23% Similarity=0.274 Sum_probs=162.9
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|+ ..+++.+|+|+++... ......+.+|+.++.++ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence 369999999999999 4568899999987432 22345677888888776 7999999999873 345679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|..++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||++
T Consensus 76 E~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~ 143 (329)
T cd05618 76 EYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 143 (329)
T ss_pred eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 9999999999887654 4678889999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 144 KEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 75322211 12234589999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=292.87 Aligned_cols=201 Identities=26% Similarity=0.406 Sum_probs=176.3
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc---chhHHHHHHHHHHhCC-CCCcceeeeeecccccCC
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 217 (367)
....|++.+.||+|.||.||+++ ..+|+.+|+|.+...... ....+.+|+.+|+++. |||||.+++.| +.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----ED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ec
Confidence 45578888999999999999999 556999999999754443 3468999999999998 99999999998 44
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC----
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---- 293 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~---- 293 (367)
....++|||++.||.|.+.+... .+++..+..++.|++.|+.||| +.||+||||||+|+|+..
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~----------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~ 174 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK----------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEG 174 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc----------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCC
Confidence 55789999999999999998764 1778999999999999999999 899999999999999953
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++.+|++|||++..... .......+||+.|+|||++....++..+||||+||++|.|++|..||.+-.
T Consensus 175 ~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 175 SGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred CCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 35799999999997754 344556779999999999999999999999999999999999999998765
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=291.42 Aligned_cols=213 Identities=22% Similarity=0.293 Sum_probs=168.6
Q ss_pred cCCCCCCCcccccCceEEEEEEecC-----------------CCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFD-----------------GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVR 205 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 205 (367)
.++|.+.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999997432 34699999874322 23457899999999999999999
Q ss_pred eeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC----------CCcchhhhHHHHHHHHHHHHHHHHHhhhCC
Q 017712 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW----------RPLNFNFLIKKKLDIAIDVACALRYLHCDC 275 (367)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~ 275 (367)
+++++.. ....+++|||+++|+|.+++........ ......+++..+..++.|++.||.|||
T Consensus 84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--- 155 (304)
T cd05096 84 LLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--- 155 (304)
T ss_pred EEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---
Confidence 9999843 3457999999999999999865431110 011124667888999999999999999
Q ss_pred CCCeEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh
Q 017712 276 QPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355 (367)
Q Consensus 276 ~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t 355 (367)
+.+|+||||||+|||++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++
T Consensus 156 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 88999999999999999999999999999986543322111122235778999999988889999999999999999986
Q ss_pred --CCCCCCCCC
Q 017712 356 --GIRPSDGIF 364 (367)
Q Consensus 356 --g~~Pf~~~~ 364 (367)
+..||.+..
T Consensus 236 ~~~~~p~~~~~ 246 (304)
T cd05096 236 LCKEQPYGELT 246 (304)
T ss_pred ccCCCCCCcCC
Confidence 667887654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=294.04 Aligned_cols=194 Identities=24% Similarity=0.284 Sum_probs=164.2
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|. ..+++.+|+|+++... ......+.+|+.++.++ +||||+++++++ ......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 369999999999998 4568899999997432 22345678899998888 699999999987 3445689999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|..++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~ 143 (327)
T cd05617 76 EYVNGGDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMC 143 (327)
T ss_pred eCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccc
Confidence 9999999999887554 4778899999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||+..
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 144 KEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred eeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 7532211 1223345899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=296.07 Aligned_cols=199 Identities=25% Similarity=0.348 Sum_probs=166.8
Q ss_pred CCCCCCcccccCceEEEEEEe----cCCCEEEEEEeecC----CCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccC
Q 017712 146 GFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLI----RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 216 (367)
+|++.+.||+|+||.||+++. .+++.+|+|++... .....+.+.+|+.++..+ +||||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 478889999999999999873 35889999998632 222345678899999999 599999999887 3
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
.....+++|||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~ 143 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD---------NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGH 143 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCC
Confidence 4456799999999999999997654 4678889999999999999999 899999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||..||..
T Consensus 144 ~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 144 VVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred EEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 999999999865332221 22234689999999998865 478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=291.14 Aligned_cols=194 Identities=26% Similarity=0.391 Sum_probs=162.2
Q ss_pred CcccccCceEEEEEEe-cCCCEEEEEEeecCC---CcchhHHHHHHHHHHh-CCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAIN-IKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|+. .+++.||+|+++... ......+..|..++.. ++||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 3689999999999994 468899999987431 2334556778888776 48999999999973 345689999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|.+++.... .+++.++..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 76 ey~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 143 (316)
T cd05619 76 EYLNGGDLMFHIQSCH---------KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMC 143 (316)
T ss_pred eCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcc
Confidence 9999999999997643 4667888899999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 144 KENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred eECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 7532211 1223345899999999999889999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=309.20 Aligned_cols=214 Identities=25% Similarity=0.368 Sum_probs=175.9
Q ss_pred hhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeeccccc---
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY--- 215 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 215 (367)
...++|.+.+.||+|+||.||+|+ ..+++.||+|.+.... ......+.+|+.++..++|+||++++..+...+.
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345689999999999999999998 5679999999986432 2344567899999999999999999887643221
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
......++||||+++|+|.+++...... ...+++..+..++.|++.||.||| +++|+||||||+|||++.++
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNG 180 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCC
Confidence 1122468999999999999999754311 114778889999999999999999 89999999999999999999
Q ss_pred ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999998764432222223456899999999999989999999999999999999999999764
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=298.94 Aligned_cols=202 Identities=25% Similarity=0.274 Sum_probs=170.4
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||++. ..+++.+|+|+++... ......+.+|+.++..++||||+++++++. ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-----DKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCe
Confidence 468889999999999999998 4578999999987432 224456889999999999999999998873 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~ 144 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLA 144 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEec
Confidence 7999999999999999976532 4678888999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCcccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL------GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||++..+...... ......||+.|+|||++. ...++.++|||||||++|||++|..||.+.
T Consensus 145 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 145 DFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred cCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 99999866433222 222345899999999986 456788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=292.10 Aligned_cols=194 Identities=28% Similarity=0.385 Sum_probs=162.8
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|+ ..+++.||+|.++... ......+..|..++..+ +||||+++++++ ......++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 369999999999999 4568999999987421 23445667788887754 899999999987 3455789999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 76 E~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~ 143 (316)
T cd05620 76 EFLNGGDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMC 143 (316)
T ss_pred CCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCC
Confidence 9999999999987654 4667888999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 144 KENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred eecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 7432211 1223345899999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=286.29 Aligned_cols=195 Identities=22% Similarity=0.321 Sum_probs=164.9
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecCCCcc---hhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEe
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG---SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (367)
..||+|++|.||+|.. +++.||+|.++...... .+.+.+|+.++.+++||||+++++++.+.. ......+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEEe
Confidence 5799999999999985 78999999987543333 467789999999999999999999985421 223467899999
Q ss_pred ccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEecCCCCCceeecCCCceEEecccccc
Q 017712 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (367)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (367)
+++|+|.+++.... .+++...+.++.|++.||.||| + .+++||||||+||++++++.+||+|||+++
T Consensus 104 ~~~g~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 104 CTRGYLREVLDKEK---------DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred CCCCcHHHHHhhCC---------CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence 99999999997654 4667888999999999999999 5 488999999999999999999999999998
Q ss_pred ccCCCCCcceeeeccCCCcccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 307 FLPAIDKQNRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
...... ....|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 172 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 172 ILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred hhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 653321 12347899999999876 678999999999999999999999998754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=269.46 Aligned_cols=219 Identities=21% Similarity=0.264 Sum_probs=182.9
Q ss_pred HhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
....++|.+.+.||+|||+.||.++ ..+++.+|+|++...+..+.+..++|++..++++|||+++++++......+...
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3456789999999999999999998 778999999999877767788899999999999999999999998766666778
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..|++++|...|+|.+.+....... -.+++.+++.|+.++++||.+||.. ..++.||||||.|||+.+++.++|
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg-----~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKG-----NFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcC-----CccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEE
Confidence 8999999999999999987644221 1588999999999999999999932 234999999999999999999999
Q ss_pred eccccccccCCCCCc-------ceeeeccCCCcccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQ-------NRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
.|||.+....-.-.. ........|..|+|||.+. +...+.++|||||||+||+|+.|..||+.++.
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 999998755321110 1112334689999999875 34578999999999999999999999987654
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=293.63 Aligned_cols=194 Identities=28% Similarity=0.334 Sum_probs=160.4
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHH-HHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECK-AAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|+ ..+++.||+|++.... ......+.+|.. +++.++||||+++++.+. .....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence 368999999999999 4578999999986322 122344555554 457799999999998873 345679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~ 143 (323)
T cd05575 76 DYVNGGELFFHLQRER---------SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLC 143 (323)
T ss_pred cCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCC
Confidence 9999999999987654 4667888899999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 144 KEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred cccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 7532221 1222345899999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.83 Aligned_cols=217 Identities=26% Similarity=0.371 Sum_probs=171.3
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecCC-CcchhHHHHHHHHHHhC-CCCCcceeeeeec
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFS 211 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 211 (367)
|....++|++.+.||+|+||.||+|+. .++..||+|.++... ......+.+|+.+++.+ +||||++++++|.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 334456799999999999999999873 223579999987432 22345688999999999 8999999999973
Q ss_pred ccccCCceeeeEEEEeccCCCHHHHhhCCCCC------------------------------------------------
Q 017712 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDT------------------------------------------------ 243 (367)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------ 243 (367)
.....+++|||+++|+|.+++......
T Consensus 113 -----~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (374)
T cd05106 113 -----HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV 187 (374)
T ss_pred -----CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence 345679999999999999998643210
Q ss_pred -------------CCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccCC
Q 017712 244 -------------NWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA 310 (367)
Q Consensus 244 -------------~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 310 (367)
........+++..++.++.|++.||.||| +++|+||||||+|||+++++.+||+|||+++....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 00011234778889999999999999999 89999999999999999999999999999986543
Q ss_pred CCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 311 IDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
...........++..|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus 265 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred CcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 221111112234567999999988899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=295.16 Aligned_cols=202 Identities=23% Similarity=0.281 Sum_probs=167.6
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+++ ..+++.+|+|++... .......+.+|+.++..++|+||+++++++ .....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 468889999999999999998 445788999998632 222344578899999999999999999987 34456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~ 144 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLA 144 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEe
Confidence 7999999999999999976322 4667888899999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||++..+..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||.+.
T Consensus 145 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 145 DFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred ecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 9999875533221 1122345899999999986 345788999999999999999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=271.75 Aligned_cols=197 Identities=25% Similarity=0.393 Sum_probs=169.6
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC----cc----hhHHHHHHHHHHhC-CCCCcceeeeeecccc
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP----GG----SKSFKSECKAAINI-KHRNIVRVFTAFSGVD 214 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 214 (367)
+.|...+.||.|..+.|-++. ..+++..|+|++..... .. .+.-.+|+.||+++ .||+|+++.++|
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y---- 92 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY---- 92 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec----
Confidence 456777889999999999887 66789999999863221 11 24456899999997 699999999996
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
++..+.++|+|.|+.|.|+|||...- .+++++...|++|+.+|++||| .++||||||||+|||+|++
T Consensus 93 -es~sF~FlVFdl~prGELFDyLts~V---------tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn 159 (411)
T KOG0599|consen 93 -ESDAFVFLVFDLMPRGELFDYLTSKV---------TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDN 159 (411)
T ss_pred -cCcchhhhhhhhcccchHHHHhhhhe---------eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccc
Confidence 66778899999999999999998765 6889999999999999999999 9999999999999999999
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCccccC------CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG------CEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
.++||+|||+|..+..+... ...+|||+|+|||.+.- ..|+...|+||+||++|.|+.|.+||.
T Consensus 160 ~~i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 160 MNIKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred cceEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 99999999999988665433 34569999999998753 357889999999999999999999994
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=298.44 Aligned_cols=193 Identities=24% Similarity=0.304 Sum_probs=164.5
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.++|++.+.||+|+||.||+|. ..+++.||+|... ...+.+|++++++++||||++++++|. .....+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeE
Confidence 4579999999999999999998 5678999999743 345789999999999999999999873 345678
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+++|++ .++|.+++.... .+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 160 lv~e~~-~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAKR---------NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred EEEecC-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeC
Confidence 999999 579999887654 4667889999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
|+++...... ........||+.|+|||++.+..++.++|||||||++|||++|..||-
T Consensus 227 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 227 GAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred Cccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 9997543221 112233468999999999999899999999999999999999998864
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=294.12 Aligned_cols=194 Identities=29% Similarity=0.351 Sum_probs=161.1
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHH-HHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECK-AAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|+ ..+++.+|+|++.... ......+..|.. +++.++||||+++++.+ ......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 368999999999998 5578999999986421 223345555654 46778999999999887 3345679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|..++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~ 143 (325)
T cd05604 76 DFVNGGELFFHLQRER---------SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLC 143 (325)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCc
Confidence 9999999999887654 4678889999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 144 KEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred ccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 75322111 222345899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=292.64 Aligned_cols=194 Identities=28% Similarity=0.341 Sum_probs=160.0
Q ss_pred CcccccCceEEEEEEe-cCCCEEEEEEeecCC---CcchhHHHHHHH-HHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECK-AAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|+. .+++.+|+|++.... ......+.+|.. +++.++||||+++++++. .....++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence 3699999999999994 568999999986322 222344555554 577899999999998873 345679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++++|..++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~ 143 (321)
T cd05603 76 DYVNGGELFFHLQRER---------CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLC 143 (321)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCC
Confidence 9999999998887544 4667888889999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|..||.+.
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 144 KEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred ccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 7532211 1122345899999999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=285.84 Aligned_cols=200 Identities=25% Similarity=0.348 Sum_probs=168.5
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
+|++.++||+|+||.||++. ..+++.||+|.+..... .....+.+|+.++++++||||+++++.+. .....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence 47788999999999999998 45689999999864221 22345778999999999999999999873 34568
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+++|||+++|+|.+++...... .+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~D 145 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNP-------GFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISD 145 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEee
Confidence 9999999999999888643211 4678889999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||++........ .....|++.|+|||++.+..++.++||||+||++|||++|..||.+.
T Consensus 146 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 146 LGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred CCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 999986533221 12335899999999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=292.22 Aligned_cols=194 Identities=28% Similarity=0.330 Sum_probs=159.3
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHH-HHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECK-AAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|+ ..+++.+|+|++.... ......+..|.. +++.++||||+++++++. .....+++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence 368999999999999 4467899999986422 122234444444 467789999999999873 345679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++++|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a 143 (325)
T cd05602 76 DYINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC 143 (325)
T ss_pred eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCC
Confidence 9999999999997654 4667788889999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 144 KENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred cccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 75432211 222345899999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=284.45 Aligned_cols=196 Identities=28% Similarity=0.326 Sum_probs=163.2
Q ss_pred ccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEec
Q 017712 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (367)
Q Consensus 153 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (367)
||+|+||.||++. ..+++.+|+|.+..... ...+.+..|+.+++.++||||+++++++ ......+++|||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 6999999999998 45789999999864322 2235678899999999999999999887 3345679999999
Q ss_pred cCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccccc
Q 017712 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
++|+|.+++..... .+..+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||++..+
T Consensus 76 ~~g~L~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 147 (280)
T cd05608 76 NGGDLRYHIYNVDE-----ENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147 (280)
T ss_pred CCCCHHHHHHhccc-----cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence 99999988754221 1114778899999999999999999 899999999999999999999999999999765
Q ss_pred CCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 148 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 148 KDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred CCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 433221 22345899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=296.13 Aligned_cols=217 Identities=27% Similarity=0.339 Sum_probs=171.9
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecCC-CcchhHHHHHHHHHHhC-CCCCcceeeeeec
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFS 211 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 211 (367)
+....++|++.+.||+|+||.||+|+. .++..||+|+++... ....+.+.+|+.++..+ +||||++++++|.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 344456799999999999999999963 245689999986432 23456788999999999 8999999999973
Q ss_pred ccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCC---------------------------------------------
Q 017712 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR--------------------------------------------- 246 (367)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~--------------------------------------------- 246 (367)
.....++||||+++|+|.+++.........
T Consensus 110 -----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (375)
T cd05104 110 -----VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD 184 (375)
T ss_pred -----cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence 344579999999999999999753210000
Q ss_pred ---------------------CcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 247 ---------------------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 247 ---------------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
.....+++..++.++.||+.||.||| +++++||||||+|||++.++.+||+|||++
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 261 (375)
T cd05104 185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 261 (375)
T ss_pred cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccc
Confidence 00113677888999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred eeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 86543222111112234667999999999999999999999999999998 899997754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=289.16 Aligned_cols=194 Identities=25% Similarity=0.304 Sum_probs=163.9
Q ss_pred CcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|.. .+++.+|+|+++.. .......+.+|..++..+ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 3689999999999984 46889999998742 233455677899998887 6999999999873 345689999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|..++.... .+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||++
T Consensus 76 e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 143 (318)
T cd05570 76 EYVNGGDLMFHIQRSG---------RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMC 143 (318)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCC
Confidence 9999999999987654 4778899999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 144 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 144 KEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred eecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 75322111 122335899999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=306.95 Aligned_cols=211 Identities=22% Similarity=0.268 Sum_probs=173.0
Q ss_pred CCCCCCCcccccCceEEEEEEecCC-CEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccc-cCC-cee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFDG-TTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVD-YQG-ARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~-~~~ 220 (367)
.++++.+.|.+|||+.||.|....+ ..+|+|++-..++.....+.+|+++|++|+ |+|||.+++...... ..+ ...
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4567788999999999999996555 999999998777778899999999999997 999999999432222 222 356
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+|+||||.||+|-++|+..... .|++.++++|+.|+++|+.+||.. +.+|||||||-+||||+.++..|||
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~-------~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQT-------RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhc-------cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence 78999999999999999865432 588999999999999999999954 6779999999999999999999999
Q ss_pred ccccccccCCCCCcc-------eeeeccCCCcccCCccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQN-------RFICIKGSTGYIPPEYD---LGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||.+.-........ ......-|+-|+|||.+ .+.++++|+|||||||+||.|+....||++-
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 999986432211110 00112248999999975 4678999999999999999999999999764
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=288.85 Aligned_cols=203 Identities=26% Similarity=0.430 Sum_probs=168.0
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCC----EEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGT----TIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
++|++.+.||+|+||.||+|.. .++. .||+|.++... ....+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence 4699999999999999999984 3343 48999986433 2345678899999999999999999999843
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++++||+++|+|.+++..... .+++..++.++.|++.||+||| +++|+||||||+|||++.++.+|
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~k 149 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVK 149 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEE
Confidence 235799999999999999986542 3567788899999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||++..
T Consensus 150 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred EccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999987654332222222234668999999999899999999999999999998 999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=293.36 Aligned_cols=194 Identities=27% Similarity=0.356 Sum_probs=165.1
Q ss_pred CcccccCceEEEEEEe----cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 151 NLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
+.||+|+||.||+++. .+++.+|+|++.... ......+.+|++++.+++||||+++++++. .....++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence 5799999999999873 358999999987432 223456778999999999999999999873 34567999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 77 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 144 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGL 144 (318)
T ss_pred EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccC
Confidence 99999999999987544 4678899999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.
T Consensus 145 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 145 SKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred CcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 87653321 1223346899999999999888899999999999999999999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=281.65 Aligned_cols=200 Identities=23% Similarity=0.340 Sum_probs=175.7
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
-|.+..+||+|+||.||+|. ...|+.+|+|.+.. ..+.+.+.+|+.+|.+++.|++|++||.+. ....+|+|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYF-----K~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYF-----KHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhc-----cCCceEee
Confidence 36677899999999999998 66799999999864 346788999999999999999999999973 34568999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
||||..|++.++++.... .++++++..++...+.||+||| ...-||||||..|||++.+|.+||+|||.
T Consensus 107 MEYCGAGSiSDI~R~R~K--------~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRK--------PLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGV 175 (502)
T ss_pred hhhcCCCcHHHHHHHhcC--------CccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccc
Confidence 999999999999987653 6889999999999999999999 78889999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
|..+.+.-. ......|||.|||||++..-.|+.++||||||++..||..|++||.++..
T Consensus 176 AGQLTDTMA--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP 234 (502)
T KOG0574|consen 176 AGQLTDTMA--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP 234 (502)
T ss_pred cchhhhhHH--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence 987643211 12235699999999999999999999999999999999999999998764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=289.70 Aligned_cols=199 Identities=26% Similarity=0.343 Sum_probs=169.5
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|++.+.||+|+||.||++.. .++..+|+|.+.... ......+.+|++++++++||||++++++|. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence 46899999999999999999994 468889999887432 233467899999999999999999999984 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEecCCCCCceeecCCCceEEe
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
+++|||+++++|.+++.... .+++..+..++.|++.||.||| + .+++||||||+|||++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~ 146 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLC 146 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEe
Confidence 99999999999999997644 3567788899999999999999 5 479999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||++..+.... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 147 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 147 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred eCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 999987553221 12235899999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=272.40 Aligned_cols=209 Identities=24% Similarity=0.393 Sum_probs=177.8
Q ss_pred CCChHHHHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCCcceeeeeec
Q 017712 134 NPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFS 211 (367)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 211 (367)
...|.+.+..++ +.||+|+|+.|-.+. ..++..+|||++.+.....+.+..+|++++.+.+ |+||++++++|
T Consensus 72 ~g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF- 145 (463)
T KOG0607|consen 72 SGKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF- 145 (463)
T ss_pred cchHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-
Confidence 345889888875 689999999999988 8899999999998877778889999999999985 99999999998
Q ss_pred ccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee
Q 017712 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (367)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~ 291 (367)
++....|||||-|.||+|..+|.... .|++.++..+..+|+.||.||| .+||.||||||+|||.
T Consensus 146 ----Edd~~FYLVfEKm~GGplLshI~~~~---------~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC 209 (463)
T KOG0607|consen 146 ----EDDTRFYLVFEKMRGGPLLSHIQKRK---------HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILC 209 (463)
T ss_pred ----cccceEEEEEecccCchHHHHHHHhh---------hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceee
Confidence 44566799999999999999998776 7899999999999999999999 9999999999999999
Q ss_pred cCCC---ceEEeccccccccCCC-----CCcceeeeccCCCcccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCC
Q 017712 292 DDEM---IGHVGDFGMARFLPAI-----DKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIR 358 (367)
Q Consensus 292 ~~~~---~~kl~Dfg~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~ 358 (367)
.+.. -+||+||.+....... ..........|+..|||||+.. ...|+.++|.|||||++|-|++|.+
T Consensus 210 ~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYp 289 (463)
T KOG0607|consen 210 ESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYP 289 (463)
T ss_pred cCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCC
Confidence 6544 4799999887543221 1223334567899999999742 3358999999999999999999999
Q ss_pred CCCCCC
Q 017712 359 PSDGIF 364 (367)
Q Consensus 359 Pf~~~~ 364 (367)
||.|--
T Consensus 290 PFvG~C 295 (463)
T KOG0607|consen 290 PFVGHC 295 (463)
T ss_pred CccCcc
Confidence 998854
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=299.52 Aligned_cols=204 Identities=26% Similarity=0.361 Sum_probs=163.4
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc---CCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY---QGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~ 219 (367)
..+|++.+.||+|+||.||+|.. .+++.||+|.+... .....+|+.+++.++||||+++++++..... ....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999984 56899999987532 2334679999999999999999988744322 2234
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-ceE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IGH 298 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~-~~k 298 (367)
+.+++|||++ ++|.+++...... ...+++..+..++.||+.||.||| +++|+||||||+|||++.++ .+|
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARN-----NHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCcee
Confidence 5779999996 4787776532110 114678889999999999999999 89999999999999998664 799
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+|+.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.
T Consensus 212 L~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 212 LCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred eeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999986643222 1234579999999998764 6899999999999999999999999875
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.15 Aligned_cols=211 Identities=25% Similarity=0.303 Sum_probs=170.5
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.++||+|+||.||+|. ..+++.||+|++..... ...+.+.+|++++++++||||+++++++. ....
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 578999999999999999998 45689999999864222 23457899999999999999999999873 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCC--CCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTN--WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
.+++|||+++++|.+++....... .......++...++.++.|++.||+||| +++|+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEE
Confidence 799999999999999986422110 0111123556778899999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCc----------------ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQ----------------NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+||..||.+
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999865211100 001123589999999999999999999999999999999999999975
Q ss_pred C
Q 017712 363 I 363 (367)
Q Consensus 363 ~ 363 (367)
.
T Consensus 234 ~ 234 (932)
T PRK13184 234 K 234 (932)
T ss_pred c
Confidence 3
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=279.63 Aligned_cols=193 Identities=25% Similarity=0.340 Sum_probs=161.8
Q ss_pred ccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEec
Q 017712 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (367)
Q Consensus 153 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (367)
||+|+||.||+++ ..+++.+|+|.+.... ......+..|++++.+++||||+++++++ ......+++|||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 6999999999998 4568999999986321 12234556799999999999999999887 3445689999999
Q ss_pred cCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccccc
Q 017712 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
++++|.+++...... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++...
T Consensus 76 ~g~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~ 145 (277)
T cd05607 76 NGGDLKYHIYNVGER-------GLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145 (277)
T ss_pred CCCCHHHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence 999999888654321 3567888889999999999999 899999999999999999999999999999765
Q ss_pred CCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.... ......|++.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 146 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 146 KDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred CCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 4322 222345899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=281.54 Aligned_cols=204 Identities=24% Similarity=0.315 Sum_probs=167.6
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhC---CCCCcceeeeeecccccCCce
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINI---KHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 219 (367)
+|++.+.||+|+||.||+|+ ..+++.+|+|.++... ......+.+|+.+++++ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47888999999999999998 4578999999987432 22234566788877765 799999999988654444456
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||++ ++|.+++...... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl 149 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPP-------GLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKL 149 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 6899999996 5899988754321 3678899999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 150 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 150 ADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred CccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 99999986543221 12234789999999999888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=295.55 Aligned_cols=197 Identities=28% Similarity=0.380 Sum_probs=168.5
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-C-----CCcceeeeeecccccCCc
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-H-----RNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~ 218 (367)
+|.+.+.||+|+||.|.+|. ..+++.||||+++... ....+-..|+.+|..|+ | -|+|+++++| ...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----ccc
Confidence 67889999999999999999 6679999999998533 34556678999999986 3 4899999998 445
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC--Cc
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE--MI 296 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~--~~ 296 (367)
++.|||+|.+ ..+|.++|+.+.-. .|+...++.++.||+.||.+|| ..+|||+||||+||||.+. ..
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~-------Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFR-------GLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCc
Confidence 6789999999 66999999987643 4788999999999999999999 9999999999999999543 47
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+||+|||.|...... .. ....+..|+|||++.|.+|+.+.||||||||+.||++|.+-|.|-.
T Consensus 330 vKVIDFGSSc~~~q~----vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQR----VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred eeEEecccccccCCc----ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 899999999865332 22 3346889999999999999999999999999999999999888753
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=292.59 Aligned_cols=204 Identities=22% Similarity=0.282 Sum_probs=168.0
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||+|+||.||++. ..+++.||+|.+... .....+.+.+|+.++..++||||+++++++...........+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999998 457899999998632 222346788999999999999999999998544322233679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+. ++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Df 147 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDF 147 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccc
Confidence 9999995 68888886544 4678889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+++....... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.
T Consensus 148 g~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 148 GLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred cceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 99986533221 112223478899999998874 4789999999999999999999999765
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=279.97 Aligned_cols=204 Identities=21% Similarity=0.345 Sum_probs=167.5
Q ss_pred cCCCCCCCcccccCceEEEEEEe----cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|++.+.||+|+||.||+|.. ..+..||+|.++.... .....+.+|+.++.+++||||+++++++. ..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence 34688899999999999999973 2357899999875322 23457889999999999999999999973 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++|+|.+++..... .+++..++.++.|++.||+||| +++++||||||+||+++.++.+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~ 147 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCK 147 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEE
Confidence 567999999999999999976431 4678889999999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++|||.+........ .......++..|+|||.+.+..++.++|||||||++||+++ |..||.+..
T Consensus 148 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 148 ISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred ECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 999998765322111 11112234678999999999899999999999999999775 999997653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=284.14 Aligned_cols=205 Identities=20% Similarity=0.256 Sum_probs=161.9
Q ss_pred CCcccccCceEEEEEEec---CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEE
Q 017712 150 ANLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (367)
..+||+|+||.||+|+.. +++.+|+|.+... .....+.+|+.++++++||||+++++.+.. ......+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 468999999999999843 4688999988632 234567899999999999999999998753 23456799999
Q ss_pred eccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee----cCCCceEEecc
Q 017712 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIGHVGDF 302 (367)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~----~~~~~~kl~Df 302 (367)
|+. ++|.+++..............+++..+..++.|++.||.||| +++|+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 984 589888764332111112224778889999999999999999 8999999999999999 45678999999
Q ss_pred ccccccCCCCCc-ceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+++........ .......||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999866432211 122234579999999998774 5789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=290.68 Aligned_cols=203 Identities=22% Similarity=0.268 Sum_probs=167.2
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (367)
..++|++.+.||+|+||.||++. ..+++.+|+|.+... .......+.+|+.+++.++||||+++++++..... ...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 35789999999999999999998 456899999998632 22345678899999999999999999998754321 122
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++ +|.+.+.. .++...+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~k 163 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 163 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEE
Confidence 356999999964 67666642 2556778889999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.
T Consensus 164 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 164 ILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred EecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999997543221 112235799999999999989999999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=284.51 Aligned_cols=203 Identities=22% Similarity=0.362 Sum_probs=177.2
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc--chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.=|.+.+.||+|.|+.|-+|+ ..+|..||||++...+.. ....+.+|++.|+.++|||||++|+.. ++...+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTKl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTKL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccceE
Confidence 457888999999999999998 789999999999754433 346788999999999999999999985 666778
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee-cCCCceEEe
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL-DDEMIGHVG 300 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~-~~~~~~kl~ 300 (367)
|||+|+-++|+|++||-.... .+.++.+.+++.||+.|+.|+| +..+|||||||+|+++ .+-|.+||.
T Consensus 93 yLiLELGD~GDl~DyImKHe~--------Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLT 161 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEE--------GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLT 161 (864)
T ss_pred EEEEEecCCchHHHHHHhhhc--------cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEee
Confidence 999999999999999987654 4778889999999999999999 8999999999999987 567899999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEAS-TYGDVYSFGILLLEMFTGIRPSDGIFTG 366 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~tg~~Pf~~~~~~ 366 (367)
|||++..+.++.. ....+|+..|.|||++.+..|+ +..|||||||+||-|++|++||+...+.
T Consensus 162 DFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS 225 (864)
T KOG4717|consen 162 DFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS 225 (864)
T ss_pred eccccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch
Confidence 9999987755443 3445699999999999999886 5679999999999999999999987764
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=292.86 Aligned_cols=217 Identities=25% Similarity=0.341 Sum_probs=172.3
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCC-CcchhHHHHHHHHHHhCC-CCCcceeeeee
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIK-HRNIVRVFTAF 210 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 210 (367)
.+....++|.+.++||+|+||.||+|+.. .+..||+|+++... ....+.+.+|+.++.+++ ||||++++++|
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 44555678999999999999999999742 13469999986432 233567899999999996 99999999998
Q ss_pred cccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCC--------------------------------------------
Q 017712 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-------------------------------------------- 246 (367)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------------------------------------------- 246 (367)
. .....++||||+++|+|.+++.........
T Consensus 111 ~-----~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 111 T-----KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred c-----cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 3 345679999999999999998653210000
Q ss_pred -------------------------------------------CcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecC
Q 017712 247 -------------------------------------------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283 (367)
Q Consensus 247 -------------------------------------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~d 283 (367)
.....+++..++.++.|++.||.||| +.+++|||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~d 262 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRD 262 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCC
Confidence 00013667788899999999999999 89999999
Q ss_pred CCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 017712 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDG 362 (367)
Q Consensus 284 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~ 362 (367)
|||+|||+++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 263 ikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 263 LAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred CChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 999999999999999999999986543222222222346788999999998889999999999999999997 9999976
Q ss_pred C
Q 017712 363 I 363 (367)
Q Consensus 363 ~ 363 (367)
.
T Consensus 343 ~ 343 (400)
T cd05105 343 M 343 (400)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=281.45 Aligned_cols=212 Identities=25% Similarity=0.427 Sum_probs=170.7
Q ss_pred CCCCCCCcccccCceEEEEEEecC-C-----CEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFD-G-----TTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
++|++.+.||+|+||.||+|.... + ..+|+|.+..... .....+.+|+.++.+++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence 468889999999999999998432 2 5799998864332 23456889999999999999999999873 3
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCC-------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCcee
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil 290 (367)
....+++|||+++++|.+++........ ......+++..++.++.|++.||.||| +++++|+||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEE
Confidence 3457899999999999999976432111 011124778889999999999999999 899999999999999
Q ss_pred ecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999976543322222222345788999999988889999999999999999998 999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=312.32 Aligned_cols=211 Identities=27% Similarity=0.438 Sum_probs=173.5
Q ss_pred cCCCCCCCcccccCceEEEEEEecC--CC----EEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFD--GT----TIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
..+.++...||+|+||.||.|...+ +. .||+|.++... .+....|.+|+.+|+.++|||||+++|.+.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~---- 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD---- 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC----
Confidence 3456677899999999999998432 33 48999887543 4466789999999999999999999999853
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
....+|++|||++|+|..||+........ ...++....+.++.|||+|+.||+ ++++|||||..+|+|++....
T Consensus 767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~ 840 (1025)
T KOG1095|consen 767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRV 840 (1025)
T ss_pred -CCCcEEEehhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCc
Confidence 45569999999999999999987543333 235788999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+||+|||+|+.+...+.........-...|||||.+....++.|+|||||||++||++| |..||.+..
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~ 909 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS 909 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence 99999999995533322211111112468999999999999999999999999999998 999997654
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=290.23 Aligned_cols=194 Identities=27% Similarity=0.375 Sum_probs=159.1
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|+..+.||+|+||.||+|+ ..+++.||+|++..... .....+.+|+++++.++|+||+++++++ ......+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEE
Confidence 356777899999999999998 45689999999864332 2346788999999999999999999987 3445679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+.. ...+..+..++.||+.||.||| +++|+||||||+|||+++++.+||+||
T Consensus 149 lv~e~~~~~~L~~~~-------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~Df 212 (353)
T PLN00034 149 VLLEFMDGGSLEGTH-------------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADF 212 (353)
T ss_pred EEEecCCCCcccccc-------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccc
Confidence 999999999986532 1235667789999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----CEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
|+++.+..... ......||..|+|||++.. ...+.++|||||||++|||++|+.||.
T Consensus 213 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 213 GVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred ccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 99986543221 1123458999999998743 234568999999999999999999996
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=280.91 Aligned_cols=215 Identities=25% Similarity=0.370 Sum_probs=170.4
Q ss_pred hhcCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccc
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (367)
..+++|++.+.||+|+||.||+|... ++..+|+|.++... ......+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~---- 78 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 78 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE----
Confidence 34678999999999999999998732 35679999876322 22345688999999999999999999987
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCC-CCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTN-WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
......+++|||+++++|.+++....... .......+++..+..++.|++.||.||| +.+++|+||||+||++++
T Consensus 79 -~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~ 154 (277)
T cd05062 79 -SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAE 154 (277)
T ss_pred -cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcC
Confidence 33456799999999999999997533110 0111123567788999999999999999 889999999999999999
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999876543222111112235778999999998889999999999999999999 789997754
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=279.39 Aligned_cols=200 Identities=26% Similarity=0.362 Sum_probs=168.1
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.|+..+.||+|+||.||++. ..+++.+|+|.+..... .....+.+|+.++.+++|+||+++++.+. .....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence 36777899999999999998 55789999999864322 12345778999999999999999999873 34568
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+++|||+++++|.+++...... .+++..++.++.|++.||.||| +.+|+||||||+||++++++.++|+|
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~D 145 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEA-------GFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISD 145 (285)
T ss_pred EEEEEecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEee
Confidence 9999999999999988643321 4678889999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||++........ .....|+..|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 146 fg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 146 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred ccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 999876533221 12235899999999999889999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=279.11 Aligned_cols=199 Identities=25% Similarity=0.357 Sum_probs=167.6
Q ss_pred CCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
|+..+.||+|+||.||+|. ..+++.+|+|.+..... .....+.+|++++.+++|+||+++++.+. .....+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEEE
Confidence 6667889999999999998 45789999999864322 22345788999999999999999998873 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++...... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+||
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Df 146 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNP-------GFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDL 146 (285)
T ss_pred EEEEeccCccHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecC
Confidence 999999999999888643311 4778899999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++........ .....|+..|+|||++.+..++.++|+||||+++|+|++|..||.+.
T Consensus 147 g~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 147 GLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred CcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 99876533221 12335899999999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=288.19 Aligned_cols=215 Identities=25% Similarity=0.359 Sum_probs=170.7
Q ss_pred hcCCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhC-CCCCcceeeeeecccc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAFSGVD 214 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 214 (367)
..++|++.+.||+|+||.||+|.. .+++.||+|+++.... ...+.+.+|+.++.++ +||||++++++|.
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~--- 81 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT--- 81 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe---
Confidence 345799999999999999999962 2347899999864322 2345678899999999 8999999999874
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCC-------------------------------------------------
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNW------------------------------------------------- 245 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------------------------------------------------- 245 (367)
......+++|||+++++|.+++........
T Consensus 82 -~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 82 -KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred -cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 334567899999999999999864321000
Q ss_pred ---CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccC
Q 017712 246 ---RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322 (367)
Q Consensus 246 ---~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 322 (367)
......+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++.+.............+
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 000114678889999999999999999 89999999999999999999999999999987643322222222345
Q ss_pred CCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 323 t~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 678999999999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=293.84 Aligned_cols=197 Identities=22% Similarity=0.236 Sum_probs=167.3
Q ss_pred cCCCCCCCcccccCceEEEEEEec---CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
..+|.+.+.||+|+||.||++... .+..||+|.+... ....+|+.++++++||||+++++++. ....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR-----WKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe-----eCCE
Confidence 457999999999999999999732 3578999987532 34568999999999999999999873 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++||++. ++|.+++.... .+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~ 227 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLG 227 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEc
Confidence 799999994 68999885443 4778899999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 228 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 999998665433333333456899999999999989999999999999999999999999764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=311.42 Aligned_cols=206 Identities=28% Similarity=0.351 Sum_probs=180.5
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeec---CCCcchhHHHHHHHHHHhCCCCCcceeeeeeccc
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGV 213 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (367)
.++....++|.+.++||+|+||.|..++ ..+++.||+|+++. .+......|..|-.+|..-+.+-|++++-.|
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF--- 144 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF--- 144 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh---
Confidence 4555667889999999999999999999 56789999999975 4445667889999999999999999999887
Q ss_pred ccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
++..++|+|||||+||+|-.++.... .++++.+..++..|+.||.-|| +.|+|||||||+|||+|.
T Consensus 145 --QD~~~LYlVMdY~pGGDlltLlSk~~---------~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 145 --QDERYLYLVMDYMPGGDLLTLLSKFD---------RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDK 210 (1317)
T ss_pred --cCccceEEEEecccCchHHHHHhhcC---------CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecc
Confidence 66788999999999999999998765 5788999999999999999999 999999999999999999
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----CEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
+|++||+|||.|-.+...+ ........|||.|++||++.. +.|++.+|.||+||++|||+.|..||.
T Consensus 211 ~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 211 SGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred cCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 9999999999997765433 334445679999999999763 568999999999999999999999995
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=280.14 Aligned_cols=213 Identities=25% Similarity=0.389 Sum_probs=172.3
Q ss_pred cCCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
.++|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|+.++.+++||||+++++++. .
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence 35788899999999999999973 234568999887554445677999999999999999999999974 3
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCC----CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNW----RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
....+++|||+++++|.+++........ ......+++..++.++.|++.||+||| +++++||||||+||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~ 155 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGE 155 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEcc
Confidence 4567999999999999999975432110 011124788899999999999999999 899999999999999999
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999986543222111122235678999999998889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=279.59 Aligned_cols=213 Identities=27% Similarity=0.445 Sum_probs=172.2
Q ss_pred cCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
.++|.+.+.||+|+||.||+|... +++.+|+|.++..... ..+.+.+|++++.+++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE---- 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec----
Confidence 346888899999999999999843 3578999998754333 45789999999999999999999999743
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCC-----CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNW-----RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~ 291 (367)
....+++|||+++++|.+++........ ......+++..+..++.|++.||.||| +++++||||||+||++
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili 155 (280)
T cd05049 80 -GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLV 155 (280)
T ss_pred -CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEE
Confidence 3567999999999999999976532110 111224778889999999999999999 8999999999999999
Q ss_pred cCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999975533221111112235678999999999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=281.72 Aligned_cols=200 Identities=23% Similarity=0.375 Sum_probs=165.5
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|.+.+.||+|+||.||+|+ ..+++.+|+|.++.... .....+.+|+.++++++||||+++++++. .....+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence 578899999999999999998 45688999999874332 23456789999999999999999999973 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++ +|.+++..... .++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Df 148 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADF 148 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcc
Confidence 99999964 89888865432 3567788889999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+++........ .....+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||.+.
T Consensus 149 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 149 GLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred ccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999754322211 122347889999998865 45789999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=275.58 Aligned_cols=201 Identities=22% Similarity=0.304 Sum_probs=169.6
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.++|++.+.||+|+||.||+|+ ..+++.+|+|++..........+.+|+.++.+++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEE
Confidence 3579999999999999999999 4678999999987554445567889999999999999999999874 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 83 iv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~df 150 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADF 150 (267)
T ss_pred EEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcC
Confidence 9999999999999987544 4667889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++......... .....|++.|+|||.+. ...++.++|||||||++|||++|..||...
T Consensus 151 g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 151 GVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred ccceeecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999865332211 12234788999999874 345778999999999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=289.18 Aligned_cols=203 Identities=21% Similarity=0.265 Sum_probs=168.0
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (367)
..++|++.+.||+|+||.||++. ...++.||+|++... .......+.+|+.+++.++||||+++++++..... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45689999999999999999998 456889999998642 22344678899999999999999999998743221 223
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||++ ++|.+++.. .++...+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh-----------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEE
Confidence 45799999995 478777743 2456778889999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 167 L~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 167 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred EEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 99999998653321 112345899999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.50 Aligned_cols=203 Identities=26% Similarity=0.398 Sum_probs=165.8
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCC----EEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGT----TIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
++|++.+.||+|+||.||+|.. .++. .+++|.+..... .....+..|+..+.+++||||+++++++.+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------ 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence 4688889999999999999984 3444 477777653222 223567788889999999999999998632
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++++||+++|+|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+|
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~k 149 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQ 149 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEE
Confidence 235789999999999999975432 4678889999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999986644332222223346778999999988889999999999999999998 999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=288.21 Aligned_cols=203 Identities=26% Similarity=0.407 Sum_probs=176.5
Q ss_pred HhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
......|.+..+||+|.|+.|.+|+ ..++..||+|.+..... .....+.+|+++|+.++|||||+++.+. ..
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t 126 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ET 126 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----ee
Confidence 3456689999999999999999999 66799999999874332 2345688999999999999999999986 55
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
...+|+||||+.+|.+++|+.... ...+..+..++.|+..|++||| ++.|+|||||++|||++.+.++
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~g---------r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKHG---------RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNI 194 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhcc---------cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccce
Confidence 667899999999999999999877 3445778889999999999999 8999999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|||++..+.... .....+|++.|.|||+..+..+ ++++|+||+|+++|.|+.|..||+|-
T Consensus 195 kIaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 195 KIADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred eeeccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 999999999875433 2334569999999999998776 68899999999999999999999974
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=288.60 Aligned_cols=203 Identities=21% Similarity=0.243 Sum_probs=167.4
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (367)
..++|++.+.||+|+||.||++. ...++.+|+|.+.... ......+.+|+.+++.++||||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999998 4568999999986432 2234677889999999999999999998753321 223
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++ +|.+++.. .++...+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~k 159 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEE
Confidence 456899999964 77777643 3556778889999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 160 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 160 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred EeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998653321 112335899999999999989999999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=273.07 Aligned_cols=202 Identities=26% Similarity=0.398 Sum_probs=168.7
Q ss_pred CCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
++|++.+.||+|+||.||++...++..+|+|.+... ......+.+|+.++++++||||+++++++. .....+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEE
Confidence 467888999999999999999777788999987633 223567899999999999999999999873 34567999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
|||+++|+|.+++..... .+++..+..++.|++.||.||| +++++||||||+||++++++.+||+|||.
T Consensus 78 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~ 146 (256)
T cd05114 78 TEFMENGCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGM 146 (256)
T ss_pred EEcCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCC
Confidence 999999999999875431 3667888999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+..
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 147 TRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred ccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 9865332211 1112234568999999988889999999999999999999 999997653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=274.85 Aligned_cols=205 Identities=29% Similarity=0.418 Sum_probs=171.2
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..++|++.+.||+|+||.||+|...+++.||+|.++... ...+.+.+|+.++++++||||+++++++. .....+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCee
Confidence 346788999999999999999997777889999986433 24567899999999999999999999873 345579
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++...... .+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+||
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~df 147 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGR-------ALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADF 147 (261)
T ss_pred eeeecccCCcHHHHHhccCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCc
Confidence 999999999999999764311 4678889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|+++........ .......+..|+|||++.+..++.++||||||+++|||+| |+.||.+..
T Consensus 148 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 148 GLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred ceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999876432111 1111123457999999998889999999999999999999 999998754
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=276.39 Aligned_cols=203 Identities=26% Similarity=0.440 Sum_probs=170.3
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++.+. .....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEE
Confidence 45788999999999999999997788899999876432 24578899999999999999999998873 3455799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||+++++|.+++...... .+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||
T Consensus 79 v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg 148 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGG-------KVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFG 148 (261)
T ss_pred EEecCCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCc
Confidence 99999999999999754321 4567788899999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
++......... ......++..|+|||++.+..++.++|||||||++|+|+| |..||.+.
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 149 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred cceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 99865432211 1112235678999999988889999999999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=277.53 Aligned_cols=212 Identities=23% Similarity=0.380 Sum_probs=169.5
Q ss_pred CCCCCCCcccccCceEEEEEEe-----cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
++|++.+.||+|+||.||+|.. .++..+|+|.+..... .....+.+|+.++++++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence 4678889999999999999973 2457899999874332 23367889999999999999999999873 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCC--------CCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCcee
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTN--------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~--------~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil 290 (367)
...+++|||+++++|.+++....... .......+++..++.++.|++.||.||| +++++||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEE
Confidence 45799999999999999986432100 0111224678888999999999999999 899999999999999
Q ss_pred ecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.+..
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999986543322222223335678999999988889999999999999999998 999997653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=288.92 Aligned_cols=192 Identities=27% Similarity=0.293 Sum_probs=157.8
Q ss_pred ccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhC---CCCCcceeeeeecccccCCceeeeEEE
Q 017712 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI---KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 153 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
||+|+||.||+|+ ..+++.||+|++.... ......+..|..++.+. +||||+++++.+ ......++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 6999999999998 4568999999986321 12233455677777665 699999999987 3445679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a 143 (330)
T cd05586 76 DYMSGGELFWHLQKEG---------RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLS 143 (330)
T ss_pred cCCCCChHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcC
Confidence 9999999999987654 4678899999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 144 KANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred cCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 75432221 12234589999999998764 4789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=271.79 Aligned_cols=202 Identities=24% Similarity=0.388 Sum_probs=170.2
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc-----chhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG-----GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
++|.+.+.||+|++|.||+|. ..+++.+|+|.+...... ....+.+|+.++++++||||+++++++. ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence 578999999999999999998 456899999998643221 2356889999999999999999999974 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++++||+++++|.+++.... .++...+..++.|++.||.||| +.+++|+||+|+||++++++.++
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~ 144 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG---------ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVK 144 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 47899999999999999987654 3667888899999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcce-eeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNR-FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++.......... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred EeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 999999976543221111 12234788999999999988999999999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=284.93 Aligned_cols=202 Identities=21% Similarity=0.299 Sum_probs=167.4
Q ss_pred hhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CC
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QG 217 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 217 (367)
...++|++.+.||+|+||.||+|. ..+++.||+|.+..... .....+.+|+.++++++||||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 345789999999999999999998 45788999999864221 234567789999999999999999998743221 12
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....+++++++ +++|.+++... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ----------KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCE
Confidence 24468999988 78999887643 3678889999999999999999 8999999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 158 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 158 RILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred EEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999865321 123358999999999877 4688999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=275.44 Aligned_cols=204 Identities=25% Similarity=0.425 Sum_probs=167.8
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCC----EEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGT----TIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
.++|++.+.||+|+||.||+|+ ..+++ .||+|.++... ......+.+|+.++..++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 4578889999999999999998 34444 48999986432 2345678899999999999999999998742
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
...++++||+++|+|.+++..... .+++..++.++.|++.||.||| +++++||||||+||++++++.+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~ 148 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHV 148 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcE
Confidence 235799999999999999976432 4678899999999999999999 8999999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
||+|||+++...............+++.|+|||...+..++.++|||||||++|||++ |..||++..
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999987643222211222234678999999988889999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=297.60 Aligned_cols=201 Identities=22% Similarity=0.305 Sum_probs=163.2
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCC------CCcceeeeeecc
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH------RNIVRVFTAFSG 212 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~ 212 (367)
+...+++|++.++||+|+||.||+|. ..+++.||||+++... .....+..|+.++..++| +++++++++|.
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~- 201 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ- 201 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE-
Confidence 34456789999999999999999998 4568899999986432 233456678888877754 45888888873
Q ss_pred cccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEecCCCCCceee
Q 017712 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLL 291 (367)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH~dlkp~Nil~ 291 (367)
......++|||++ +++|.+++.... .+++..+..|+.||+.||.||| . .+||||||||+|||+
T Consensus 202 ---~~~~~~~iv~~~~-g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl 265 (467)
T PTZ00284 202 ---NETGHMCIVMPKY-GPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILM 265 (467)
T ss_pred ---cCCceEEEEEecc-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEE
Confidence 2345678999988 789999887654 4678889999999999999999 6 599999999999999
Q ss_pred cCCC----------------ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh
Q 017712 292 DDEM----------------IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355 (367)
Q Consensus 292 ~~~~----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t 355 (367)
+.++ .+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt 340 (467)
T PTZ00284 266 ETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT 340 (467)
T ss_pred ecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh
Confidence 8665 499999998864321 1223468999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 017712 356 GIRPSDGI 363 (367)
Q Consensus 356 g~~Pf~~~ 363 (367)
|+.||++.
T Consensus 341 G~~pf~~~ 348 (467)
T PTZ00284 341 GKLLYDTH 348 (467)
T ss_pred CCCCCCCC
Confidence 99999764
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=273.61 Aligned_cols=212 Identities=25% Similarity=0.361 Sum_probs=169.2
Q ss_pred CCCCCcccccCceEEEEEEec-C---CCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCce
Q 017712 147 FSSANLIGAGNFGSVYNGTLF-D---GTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGAR 219 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 219 (367)
|++.+.||+|+||.||+|... + +..+|+|.++.... .....+.+|+..++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999843 2 37799999874322 234678999999999999999999998754332 2234
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++++||+++++|..++....... ....+++..+..++.|++.||.||| +.+++||||||+||++++++.+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGG---LPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccC---CcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEE
Confidence 5799999999999999986543111 1114678889999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999986543322211122234678999999988889999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=272.41 Aligned_cols=204 Identities=24% Similarity=0.357 Sum_probs=169.2
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-----cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-----GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
++|++.+.||+|+||.||+|. ..++..||+|.+..... .....+.+|+.++.+++||||+++++++.. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence 478899999999999999998 45689999998863221 123578889999999999999999998743 123
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~ 146 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG---------ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVK 146 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEE
Confidence 45789999999999999987544 3567788899999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++........ .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.
T Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 147 LGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 9999999865432111 1122334788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=277.91 Aligned_cols=199 Identities=22% Similarity=0.316 Sum_probs=171.3
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.+|++.+.||+|+||.||+|. ..+++.+|+|.+........+.+.+|+.+++.++||||+++++.|. .....++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEEE
Confidence 478888999999999999998 4578999999988655556678899999999999999999999874 2446799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
||||+++++|.+++... .+++.++..++.|++.||.||| +.+++||||||+||+++.++.+||+|||
T Consensus 95 v~e~~~~~~L~~~~~~~----------~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg 161 (296)
T cd06654 95 VMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (296)
T ss_pred eecccCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccc
Confidence 99999999999998643 2557788999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++......... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.
T Consensus 162 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 162 FCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred cchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 98765332211 12234789999999998888899999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=273.48 Aligned_cols=205 Identities=25% Similarity=0.415 Sum_probs=169.9
Q ss_pred cCCCCCCCcccccCceEEEEEEec----CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|++.+.||+|+||.||+|... +...+|+|.++.... .....+.+|+.++.+++||||+++++++. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cC
Confidence 357889999999999999999853 245799998864332 23467889999999999999999999873 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++++|.+++..... .+++..+..++.|++.||.||| +++|+|+||||+||++++++.+|
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~ 146 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCK 146 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEE
Confidence 557999999999999999976432 4678889999999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 147 VSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred ECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 999999987752222222222334678999999998889999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=279.08 Aligned_cols=203 Identities=20% Similarity=0.264 Sum_probs=160.5
Q ss_pred CcccccCceEEEEEEec---CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEe
Q 017712 151 NLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (367)
.+||+|+||.||+|+.. ++..+|+|.+... .....+.+|+.++++++||||+++++++.. ......+++|||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEee
Confidence 57999999999999843 4578999987632 234567899999999999999999998753 234567999999
Q ss_pred ccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee----cCCCceEEeccc
Q 017712 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIGHVGDFG 303 (367)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~----~~~~~~kl~Dfg 303 (367)
++ ++|.+++..............+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 85 588888764322111112224778889999999999999999 8999999999999999 566799999999
Q ss_pred cccccCCCCCc-ceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 304 MARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 304 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||++||.+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99866432211 112234579999999998764 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=277.69 Aligned_cols=212 Identities=26% Similarity=0.418 Sum_probs=171.3
Q ss_pred CCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence 35778899999999999999732 34568999886544445577899999999999999999999973 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCC-------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~ 291 (367)
...+++|||+++++|.+++........ ......+++..++.++.|++.||+||| +++++||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEE
Confidence 557999999999999999976432100 011124778899999999999999999 8999999999999999
Q ss_pred cCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||+| |..||....
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999976543322211222346788999999998889999999999999999999 999996643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=274.00 Aligned_cols=195 Identities=28% Similarity=0.342 Sum_probs=165.1
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|++.++||+|+||.||+|. ..+++.+|+|.+.... ......+.+|+.++.+++||||+++++++.. ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEE
Confidence 367888999999999999998 5678999999986432 2234568899999999999999999999843 34568
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|..+. .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+||
T Consensus 76 lv~e~~~~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~df 139 (279)
T cd06619 76 ICTEFMDGGSLDVYR-------------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDF 139 (279)
T ss_pred EEEecCCCCChHHhh-------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeC
Confidence 999999999997652 2446778889999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|++....... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 140 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 197 (279)
T cd06619 140 GVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197 (279)
T ss_pred Ccceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence 9997653321 122358999999999999889999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=275.25 Aligned_cols=204 Identities=28% Similarity=0.451 Sum_probs=173.6
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
..+|++.+.||.|+||.||+|...+++.+|+|.+..........+.+|+.+++.++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeEE
Confidence 45688899999999999999997779999999987655545678999999999999999999999873 3455799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||+++++|.+++...... .+++..+..++.|++.||.||| +++++|+||||+||++++++.+||+|||
T Consensus 80 v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g 149 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQ-------VLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFG 149 (261)
T ss_pred EEeecccCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEcccc
Confidence 99999999999999764321 4677889999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
.+.......... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 150 ~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 150 LARLIKEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred chhhcCCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 997654322111 12235678999999988889999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=269.66 Aligned_cols=198 Identities=27% Similarity=0.369 Sum_probs=161.8
Q ss_pred CcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEec
Q 017712 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (367)
+.||+|+||.||+|+ ..+++.+|+|.+.... ......+.+|++++++++||||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence 368999999999998 4578999999876332 234567899999999999999999999974 345679999999
Q ss_pred cCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccccc
Q 017712 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
++++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++...
T Consensus 76 ~~~~L~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 144 (252)
T cd05084 76 QGGDFLTFLRTEGP--------RLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREE 144 (252)
T ss_pred cCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccc
Confidence 99999999865431 3567889999999999999999 899999999999999999999999999998754
Q ss_pred CCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 145 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 145 EDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred ccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 32111111111123456999999998889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=290.86 Aligned_cols=195 Identities=20% Similarity=0.226 Sum_probs=163.9
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
...+|.+.+.||+|+||.||+|.. .+++.||+|... ...+.+|++++++++||||+++++++. .....
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~ 235 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRV-----VGGLT 235 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEE
Confidence 345799999999999999999994 458899999632 234678999999999999999999873 34557
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+++||++ .++|.+++..... .+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 236 ~lv~e~~-~~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~D 303 (461)
T PHA03211 236 CLVLPKY-RSDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGD 303 (461)
T ss_pred EEEEEcc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcc
Confidence 8999999 5799998865432 4778999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf 360 (367)
||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 99998654332222222346899999999999999999999999999999999988665
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=277.96 Aligned_cols=197 Identities=27% Similarity=0.335 Sum_probs=168.0
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|++.+.||+|+||.||++. ..++..+|+|.+.... ......+.+|++++.+++||||++++++|. .....+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence 468899999999999999998 4568889999886432 223456889999999999999999999983 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEecCCCCCceeecCCCceEEec
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++|||+++++|.+++.... .+++..+..++.|++.||.||| + .+++|+||||+||+++.++.+||+|
T Consensus 76 lv~ey~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~d 143 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAG---------RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCD 143 (308)
T ss_pred EEeeccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEcc
Confidence 9999999999999997654 4667888999999999999999 5 5899999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
||++....... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+
T Consensus 144 fg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 144 FGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred CCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 99987553221 1223578999999999888899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=271.34 Aligned_cols=202 Identities=26% Similarity=0.434 Sum_probs=168.6
Q ss_pred CCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
++|.+.+.||+|+||.||+|...++..+|+|.+.... .....+.+|+.++.+++||||+++++++. .....+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEE
Confidence 4577889999999999999987677789999876432 34567899999999999999999999973 33456999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
|||+++++|.+++..... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||.
T Consensus 78 ~e~~~~~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~ 146 (256)
T cd05113 78 TEYMSNGCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGL 146 (256)
T ss_pred EEcCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCcc
Confidence 999999999999975432 3678889999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 147 SRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred ceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 876533221 11112234667999999988889999999999999999998 999997653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=291.65 Aligned_cols=197 Identities=26% Similarity=0.389 Sum_probs=168.2
Q ss_pred cccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEeccC
Q 017712 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPN 230 (367)
Q Consensus 152 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 230 (367)
+||+|.||+||-|+ ..+...+|||-+........+-+..|+...++|+|.|||+++|++ ....+.-+.||-.||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 69999999999999 666788999998766666677888999999999999999999997 445577899999999
Q ss_pred CCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec-CCCceEEeccccccccC
Q 017712 231 GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLP 309 (367)
Q Consensus 231 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 309 (367)
|+|.++|+.+-. +. .-.+..+-.+..||++||.||| .+.|||||||-+|+|++ -.|.+||+|||.++.+.
T Consensus 657 GSLSsLLrskWG----Pl--KDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 657 GSLSSLLRSKWG----PL--KDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred CcHHHHHHhccC----CC--ccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 999999986532 11 2246777788999999999999 99999999999999995 57999999999999886
Q ss_pred CCCCcceeeeccCCCcccCCccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 310 AIDKQNRFICIKGSTGYIPPEYDLGC--EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
..+... ..+.||..|||||++..+ .|+..+|||||||++.||.||++||..+-
T Consensus 728 ginP~T--ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 728 GINPCT--ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred cCCccc--cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 554433 345599999999998765 48899999999999999999999997653
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=274.78 Aligned_cols=200 Identities=23% Similarity=0.308 Sum_probs=169.3
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
++|++.+.||+|+||.||+|. ..+++.+|+|.++.........+.+|+.+++.++||||+++++.+. .....++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence 467888899999999999998 4568999999987654445567889999999999999999999873 3456799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||+++++|.+++.... .+++.+++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||
T Consensus 84 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg 151 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTG---------PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFG 151 (267)
T ss_pred EEeccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcce
Confidence 999999999999987654 4678899999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++........ ......|++.|+|||++. ...++.++|+|||||++|+|++|..||...
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 152 VSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred eeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 9876533211 122345899999999874 445788999999999999999999998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=284.29 Aligned_cols=195 Identities=24% Similarity=0.305 Sum_probs=162.9
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.++.|.....+|.|+|+.|-.+. ..+++..++|++... ...-.+|+.++... +||||+++++.+ .....
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeeccee-----cCCce
Confidence 35678888889999999998888 567899999998743 22335677666555 799999999997 55667
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee-cCCCceEE
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL-DDEMIGHV 299 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~-~~~~~~kl 299 (367)
.|+|||.+.++-|.+.+...+ .+. .++..|+.+|+.|+.||| .+|+|||||||+|||+ ++.++++|
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~---------~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrl 457 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP---------EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRL 457 (612)
T ss_pred eeeeehhccccHHHHHHHhcc---------hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEE
Confidence 899999999999888887665 233 678889999999999999 8999999999999999 68999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||.++..... ....+=|..|.|||++....++..+|+||||++||+|++|+.||..-.
T Consensus 458 tyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 458 TYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred EEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 999999876443 112234788999999999999999999999999999999999997543
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=270.18 Aligned_cols=202 Identities=27% Similarity=0.412 Sum_probs=167.3
Q ss_pred CCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
.+|++.+.||+|+||.||+|...++..+|+|.+.... .....+.+|+.++++++||||+++++++. .....+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEEE
Confidence 3578889999999999999987777789999876322 23457889999999999999999999873 34567999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
|||+++++|.+++..... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~ 146 (256)
T cd05059 78 TEYMANGCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGL 146 (256)
T ss_pred EecCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCccc
Confidence 999999999999975432 4678889999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||++..
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 206 (256)
T cd05059 147 ARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206 (256)
T ss_pred ceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence 9765322111 1111123457999999998889999999999999999999 899997643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=272.14 Aligned_cols=212 Identities=25% Similarity=0.341 Sum_probs=166.6
Q ss_pred CCCCCcccccCceEEEEEEecC-CC--EEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCcee
Q 017712 147 FSSANLIGAGNFGSVYNGTLFD-GT--TIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGARF 220 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 220 (367)
|.+.+.||+|+||.||+|...+ +. .+|+|.++.. +......+.+|+.+++.++||||+++++.+..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999998543 33 6899988643 23345678899999999999999999998743221 22335
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||+++|+|.+++...... .....+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLG---DCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhccc---CCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEEC
Confidence 68999999999999987532211 01114678889999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|||+++...............+++.|+|||...+..++.++||||||+++|||++ |..||.+..
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 219 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999987643322111122235678999999999889999999999999999999 899997653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=270.74 Aligned_cols=204 Identities=23% Similarity=0.374 Sum_probs=169.9
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-----cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-----GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.+|+..+.||+|+||.||+|. ..++..+|+|.+..... .....+.+|+.++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 478999999999999999998 45689999998864321 123568899999999999999999998743 223
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++++||+++++|.+++.... .+++.....++.|++.||.||| +.+++||||||+||+++.++.+|
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~ 146 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG---------ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVK 146 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEE
Confidence 56789999999999999997644 3567788899999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCC-cceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDK-QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++.+..... ........++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred EccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 999999976533211 11122234788999999999888999999999999999999999999765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=272.44 Aligned_cols=203 Identities=26% Similarity=0.450 Sum_probs=168.8
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.++|++.+.||+|+||.||+|+..+...||+|.++... ...+.+.+|++++.+++||||+++++.+. ....++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcEE
Confidence 45789999999999999999987666789999987432 23467899999999999999999998752 234689
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||+++|+|.+++...... .+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg 147 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGK-------YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 147 (262)
T ss_pred EEEcCCCCcHHHHHhhcccc-------CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCC
Confidence 99999999999999753211 3567888999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
.++........ ......++..|+|||+..+..++.++||||||+++|+|+| |..||.+..
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred ceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99765432211 1112335678999999988889999999999999999999 888997653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=275.00 Aligned_cols=197 Identities=27% Similarity=0.375 Sum_probs=170.4
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||++. ..+++.+|+|.+.... ....+.+.+|++++++++||||+++++++. ....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence 468889999999999999998 4468999999986422 234567889999999999999999999873 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||+++++|.+++.... .++...+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~ 143 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG---------RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKIT 143 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEe
Confidence 799999999999999997654 4678888999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||++...... .....|++.|+|||.+.+...+.++||||||+++|+|++|..||.+.
T Consensus 144 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 144 DFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred eCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 99999865432 12234789999999998888899999999999999999999999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=275.05 Aligned_cols=203 Identities=21% Similarity=0.290 Sum_probs=172.1
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
..++|++.+.||+|+||.||+|.. .++..+|+|.+........+.+.+|+.++++++||||+++++.+. .....
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKL 77 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeE
Confidence 456799999999999999999984 468999999987655555678899999999999999999999974 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+++|||+++++|.+++..... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d 146 (280)
T cd06611 78 WILIEFCDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLAD 146 (280)
T ss_pred EEEeeccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEcc
Confidence 999999999999999875432 4678899999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||++......... .....|++.|+|||.+. ...++.++|+||||+++|+|++|+.||.+.
T Consensus 147 ~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 147 FGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred Cccchhhcccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 9998765332221 12334789999999874 345678999999999999999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=275.15 Aligned_cols=200 Identities=22% Similarity=0.314 Sum_probs=172.1
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..+|++.+.||+|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||++++++|. .....+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence 3578899999999999999999 4679999999997655556677899999999999999999999974 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||+++++|.+++... .+++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+||
T Consensus 93 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Df 159 (297)
T cd06656 93 VVMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 159 (297)
T ss_pred EeecccCCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcC
Confidence 999999999999998643 2557788999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++......... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.
T Consensus 160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred ccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 998765332221 12234788999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=276.53 Aligned_cols=215 Identities=23% Similarity=0.341 Sum_probs=169.2
Q ss_pred hhcCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccc
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (367)
...++|++.+.||+|+||.||+|... .+..||+|.++.... .....+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--- 79 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS--- 79 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence 45678999999999999999999632 245899998763322 23346788999999999999999999873
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCC-CcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
.....+++|||+++|+|.+++......... ......+...+..++.|++.||.||| +++++||||||+||+++.
T Consensus 80 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~ 154 (288)
T cd05061 80 --KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAH 154 (288)
T ss_pred --CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcC
Confidence 334579999999999999999753321110 11113456778889999999999999 899999999999999999
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999986543222211112234678999999998889999999999999999998 789997654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=272.63 Aligned_cols=209 Identities=25% Similarity=0.367 Sum_probs=171.1
Q ss_pred hhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCC-c
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG-A 218 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~-~ 218 (367)
.+++.|++.+.||+|+||.||+|. ..+++.+|+|.+.... .....+.+|+.++.++ +||||++++++|....... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 345678889999999999999998 4568899999986433 3456788999999998 7999999999986432221 3
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++++|.+++...... .+++..+..++.|++.||.||| +++++|+||||+||++++++.+|
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~ 151 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVK 151 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEE
Confidence 4678999999999999998764311 4668888999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||++........ ......|++.|+|||++. +..++.++|||||||++|||++|..||...
T Consensus 152 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 152 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred EccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999999976533221 122345889999999986 335788999999999999999999999654
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=284.54 Aligned_cols=208 Identities=24% Similarity=0.305 Sum_probs=175.5
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.+...+.++||+|.||+|.++....+..||+|.++..... ....|.+|+++|.+|+||||+.+++.|.. ...++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----DePic 611 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----DDPLC 611 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----CCchH
Confidence 3456777899999999999999888899999999854433 45889999999999999999999999953 34579
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+++|||++|+|.+++..+.... ...+..+.|+.||+.|++||. +.++|||||.+.|+|++.++++||+||
T Consensus 612 mI~EYmEnGDLnqFl~aheapt-------~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPT-------AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcc-------cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCc
Confidence 9999999999999998774321 233456679999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT--GIRPSDGIFTG 366 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~Pf~~~~~~ 366 (367)
|+++.+-+.+.........-..+|||||.+.-+.++++||||+||+++||+++ ...||..+.++
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 99997765554433322234678999999999999999999999999999864 88999887765
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=305.59 Aligned_cols=214 Identities=22% Similarity=0.297 Sum_probs=169.9
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeeccccc
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (367)
+.....++|.+.+.||+|+||.||+|. ..++..+|+|.+.... ......+..|+.++.+++||||++++++|..
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d--- 83 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN--- 83 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---
Confidence 334455789999999999999999999 4567889999886432 2345678899999999999999999998753
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCC----CCCeEecCCCCCceee
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC----QPPIAHCNLKPSNVLL 291 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~----~~~iiH~dlkp~Nil~ 291 (367)
......++||||+++|+|.++|...... ...+++..++.|+.||+.||.|||+.. ..+||||||||+|||+
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~-----~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKM-----FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 2345679999999999999998753211 014778899999999999999999321 1459999999999999
Q ss_pred cC-----------------CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccC--CCCCcchhHHHHHHHHHH
Q 017712 292 DD-----------------EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLE 352 (367)
Q Consensus 292 ~~-----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~e 352 (367)
+. ...+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE 235 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence 64 34589999999986533221 123458999999999864 357899999999999999
Q ss_pred HHhCCCCCCCC
Q 017712 353 MFTGIRPSDGI 363 (367)
Q Consensus 353 l~tg~~Pf~~~ 363 (367)
|+||..||...
T Consensus 236 LLTGk~PF~~~ 246 (1021)
T PTZ00266 236 LCSGKTPFHKA 246 (1021)
T ss_pred HHHCCCCCCcC
Confidence 99999999753
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=267.62 Aligned_cols=202 Identities=22% Similarity=0.278 Sum_probs=174.7
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.-++|..+++||+|.||.|-+++ ..+++.+|+|+++..-. .....-..|-++|...+||.+..+--.| +..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence 34678999999999999999999 77899999999874322 2234456788999999999999887765 667
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
..+|.||||..||.|.-+|.... .|++.....+-..|+.||.||| +++||.||||.+|+|+|.+|++|
T Consensus 241 drlCFVMeyanGGeLf~HLsrer---------~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIK 308 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRER---------VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIK 308 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhh---------cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceE
Confidence 78899999999999998887655 5788888889999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++.- ..........+|||.|+|||++....|+...|.|.+||++|||++|+.||..-
T Consensus 309 itDFGLCKE~--I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 309 ITDFGLCKEE--IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred eeecccchhc--ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 9999999843 23334455678999999999999999999999999999999999999999653
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=289.36 Aligned_cols=195 Identities=22% Similarity=0.302 Sum_probs=165.4
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
-|..++.||.|+||.||-|+ ..+...||||.++-.- ......+.+|+..|.+++|||++.+-|||. .....
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccchH
Confidence 46667889999999999999 6778999999987322 234567899999999999999999999974 34557
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
||||||| -|+-.|++.-... ++.+.++..|+.+.+.||+||| +.+.||||||..|||+++.|.+||+|
T Consensus 102 WLVMEYC-lGSAsDlleVhkK--------plqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaD 169 (948)
T KOG0577|consen 102 WLVMEYC-LGSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLAD 169 (948)
T ss_pred HHHHHHH-hccHHHHHHHHhc--------cchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeecc
Confidence 9999999 6688887765442 5778899999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||.|....+ ..++.|||.|||||++. .+.|+-++||||||++..||..+++|.-..
T Consensus 170 FGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 170 FGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred ccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence 999875432 22456999999999976 467999999999999999999999997543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=277.47 Aligned_cols=202 Identities=27% Similarity=0.351 Sum_probs=175.1
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
..+.|+.-++||+||||.||-++ ..+|+.+|.|.+...+ ........+|-.+|.+++.+.||.+-..| ++.
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTk 257 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETK 257 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCC
Confidence 44678889999999999999998 5679999999885322 22334567899999999999999998776 667
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
..+++|+..|+||+|.-+|...... .|+++.++.++.+|+.||++|| +.+||.||+||+|||+|+.|+++
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~-------gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNP-------GFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCC-------CCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeE
Confidence 7889999999999999888765532 5889999999999999999999 99999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+|+|+|..++..... ....||.+|||||++....|+...|.|||||++|||+.|+.||..
T Consensus 328 ISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred eeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 9999999977654332 333699999999999999999999999999999999999999964
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=270.21 Aligned_cols=201 Identities=27% Similarity=0.407 Sum_probs=168.7
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcc---------hhHHHHHHHHHHhCCCCCcceeeeeeccccc
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG---------SKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (367)
+|.+...||+|+||.||+|. ..+++.+|+|.+....... .+.+.+|+.++++++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL---- 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence 47778899999999999998 4568999999886433221 256789999999999999999999974
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
.....+++|||+++++|.+++.... .++...+..++.|++.||+||| +.+++||||+|+||++++++
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~ 143 (267)
T cd06628 77 -DADHLNIFLEYVPGGSVAALLNNYG---------AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKG 143 (267)
T ss_pred -eCCccEEEEEecCCCCHHHHHHhcc---------CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCC
Confidence 3456789999999999999997654 4667888899999999999999 89999999999999999999
Q ss_pred ceEEeccccccccCCCCCc----ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQ----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.+||+|||.++........ .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 144 GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 9999999999866432111 1112234788999999999888999999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=273.79 Aligned_cols=203 Identities=24% Similarity=0.306 Sum_probs=169.9
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
..+.|++.+.||+|+||.||+|.. .+++.+++|.+........+.+.+|+.+++.++||||+++++.+. .....
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 84 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKL 84 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeE
Confidence 346799999999999999999994 458999999987655556678889999999999999999999873 33467
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+++|||+++++|..++..... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~d 153 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELDR--------GLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLAD 153 (292)
T ss_pred EEEEecCCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEcc
Confidence 999999999999988764332 3667889999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||++........ ......+++.|+|||++. ...++.++|||||||++|+|++|..||.+.
T Consensus 154 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 154 FGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred Cccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 999875432211 112334788999999985 344678899999999999999999999654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=270.01 Aligned_cols=203 Identities=21% Similarity=0.296 Sum_probs=173.6
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.++|++.+.||+|+||.||+|.. .+++.+++|.+........+.+.+|+.++++++||||+++++++. .....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL-----RRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE-----eCCEEE
Confidence 36788899999999999999984 567899999998655556788999999999999999999999873 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++..... .+++..+..++.|++.||.||| +++++|+||+|+||++++++.+||+||
T Consensus 77 l~~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~ 145 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTRG--------PLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADF 145 (262)
T ss_pred EEEeCCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECcc
Confidence 99999999999999876421 4678889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC---EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|.+........ ......++..|+|||.+.+. .++.++|+||||+++|+|+||..||.+..
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 146 GVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred ccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99876543221 11223478899999998776 78899999999999999999999997754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=270.62 Aligned_cols=202 Identities=26% Similarity=0.399 Sum_probs=167.6
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.+|++.+.||+|+||.||+|. ..+++.+|+|.+... ......+.+|++++.+++||||+++++++. .....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEE
Confidence 457788899999999999998 456889999998643 234567899999999999999999999873 3345689
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||+++++|.+++...... .+++..++.++.|++.||+||| +++++||||||+||++++++.+||+|||
T Consensus 80 v~e~~~~~~L~~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~ 149 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQ-------EVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFG 149 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCc
Confidence 99999999999998754321 3667888999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 150 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 150 LSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred cccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99865432211 1111223567999999998899999999999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=274.30 Aligned_cols=199 Identities=23% Similarity=0.330 Sum_probs=172.3
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.+|++.+.||.|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||+++++++. .....++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence 468888999999999999998 5678999999997655556678899999999999999999999973 3456799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
++||+++++|.+++... .+++.++..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||
T Consensus 94 v~e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg 160 (296)
T cd06655 94 VMEYLAGGSLTDVVTET----------CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFG 160 (296)
T ss_pred EEEecCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCc
Confidence 99999999999988643 3668899999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++......... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 161 FCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred cchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 98765433221 12234788999999998888999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=268.06 Aligned_cols=202 Identities=25% Similarity=0.358 Sum_probs=170.9
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||+|++|.||+|. ..+++.+++|.+... .......+.+|++++++++||||+++++++. .....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 47778899999999999998 456899999998643 2335677889999999999999999999873 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++...... .++...+..++.|++.||.||| +.+++|+||||+||+++.++.+||+||
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df 145 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGR-------PLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDL 145 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEccc
Confidence 999999999999999764211 4667888999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+++.+....... ....|++.|+|||+..+..++.++|+||||+++|+|++|+.||....
T Consensus 146 ~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 146 GVAKLLSDNTNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred ccceeccCccchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9988664432221 23357889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=269.44 Aligned_cols=204 Identities=25% Similarity=0.426 Sum_probs=171.2
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..++|++.++||+|+||.||+|...+++.+|+|.+.... .....+.+|+.++++++||||+++++++. ....+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcE
Confidence 456789999999999999999998788999999987433 34567899999999999999999998752 23469
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++...... .+++.++..++.|++.||+||| +.+++||||||+||++++++.++|+||
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~df 146 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGI-------KLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADF 146 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccC
Confidence 999999999999998754321 4667888999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|++......... ......++..|+|||++.+..++.++||||||+++||+++ |+.||.+..
T Consensus 147 g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 147 GLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred cceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 999765422211 1112235678999999988889999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=273.53 Aligned_cols=212 Identities=25% Similarity=0.388 Sum_probs=170.5
Q ss_pred CCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.+|+..++||+|+||.||++.. .++..+|+|.+..........+.+|++++..++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence 4678889999999999999963 235688999887655556678999999999999999999999873 33
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCC------CCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTN------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~ 292 (367)
...+++|||+++++|.+++....... .......+++..++.++.|++.||+||| +++++||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEc
Confidence 45799999999999999997643210 0001114678889999999999999999 89999999999999999
Q ss_pred CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 999999999999875533221111112234678999999998899999999999999999998 999996643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=274.86 Aligned_cols=200 Identities=24% Similarity=0.384 Sum_probs=165.7
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|.+.+.||+|+||.||+|+ ..+++.||+|.+.... ......+.+|+.++++++||||+++++++. .....+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeEE
Confidence 578899999999999999998 4468999999987433 233456789999999999999999999973 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||++ ++|.+++..... .+++..+..++.|++.||.||| +++++|+||||+||+++.++.+||+||
T Consensus 81 lv~e~~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 148 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADF 148 (301)
T ss_pred EEEeccc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcC
Confidence 9999996 599998865432 3567888999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++........ ......+++.|+|||.+.+. .++.++|||||||++|+|+||++||.+.
T Consensus 149 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 149 GLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred cchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99975432211 11223468899999987654 5788999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=278.24 Aligned_cols=216 Identities=26% Similarity=0.364 Sum_probs=170.5
Q ss_pred HhhcCCCCCCCcccccCceEEEEEEec--------CCCEEEEEEeecCC-CcchhHHHHHHHHHHhC-CCCCcceeeeee
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAF 210 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 210 (367)
....++|.+.+.||+|+||.||++... +...+|+|.+.... ......+.+|+.++.++ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 334467999999999999999999732 23569999987432 23345688899999999 799999999997
Q ss_pred cccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC-------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecC
Q 017712 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283 (367)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~d 283 (367)
. .....+++|||+++|+|.+++........ ......+++.+++.++.|++.||+||| +++++|||
T Consensus 94 ~-----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~d 165 (307)
T cd05098 94 T-----QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRD 165 (307)
T ss_pred e-----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCccccc
Confidence 3 33467999999999999999976432110 001114678889999999999999999 89999999
Q ss_pred CCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 017712 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDG 362 (367)
Q Consensus 284 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~ 362 (367)
|||+||+++.++.+||+|||.++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred ccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 999999999999999999999976543222221222224568999999988889999999999999999998 8899876
Q ss_pred CC
Q 017712 363 IF 364 (367)
Q Consensus 363 ~~ 364 (367)
..
T Consensus 246 ~~ 247 (307)
T cd05098 246 VP 247 (307)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=268.29 Aligned_cols=201 Identities=25% Similarity=0.366 Sum_probs=169.5
Q ss_pred CCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCc------chhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 146 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
+|++.+.||+|+||.||+|...+++.+|+|.+...... ....+.+|++++++++|+||+++++++. ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cCC
Confidence 47888999999999999999778999999988643221 2356889999999999999999999974 346
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++++||+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l 143 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRFG---------PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKL 143 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEe
Confidence 7899999999999999997644 3567888899999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCC----cceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDK----QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||++........ ........|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred ccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 99999876532111 11122345789999999999888999999999999999999999999753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=273.47 Aligned_cols=211 Identities=27% Similarity=0.359 Sum_probs=167.9
Q ss_pred cCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
.++|.+.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---- 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 467899999999999999999843 467889998764332 234568999999999999999999998743
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM- 295 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~- 295 (367)
....+++|||+++++|.+++......... ...+++..++.++.||+.||.||| +++++||||||+||+++.++
T Consensus 81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~ 154 (277)
T cd05036 81 -RLPRFILLELMAGGDLKSFLRENRPRPER--PSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGP 154 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHHhCCCCCC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCC
Confidence 34468999999999999999765422111 124778899999999999999999 88999999999999998654
Q ss_pred --ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 296 --IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 296 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||++..
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 589999999986532221111111123567999999998889999999999999999997 999998653
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=275.59 Aligned_cols=207 Identities=28% Similarity=0.396 Sum_probs=169.4
Q ss_pred hcCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCC-CcchhHHHHHHHHHHhC-CCCCcceeeeeecccc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVD 214 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 214 (367)
..++|.+.+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 109 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT--- 109 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe---
Confidence 3457899999999999999999731 34579999886432 22346789999999999 7999999999874
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
.....+++|||+++|+|.+++...... .+++.++..++.|++.||.||| +++++|+||||+||+++.+
T Consensus 110 --~~~~~~lv~e~~~~~~L~~~i~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~ 177 (302)
T cd05055 110 --IGGPILVITEYCCYGDLLNFLRRKRES-------FLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHG 177 (302)
T ss_pred --cCCceEEEEEcCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCC
Confidence 334579999999999999999754321 2678899999999999999999 8899999999999999999
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|+|++ |..||.+..
T Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 9999999999986643322111112235678999999998889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=269.22 Aligned_cols=203 Identities=27% Similarity=0.458 Sum_probs=169.6
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|||++++++++. ....++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEE
Confidence 457889999999999999999977788899999875333 4567899999999999999999998862 233689
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||+++++|.+++...... .+++..+..++.|++.||.||| +++++||||||+||++++++.++|+|||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg 147 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGR-------ALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFG 147 (260)
T ss_pred EEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCce
Confidence 99999999999999754321 4678889999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++..+...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred eeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99865432211 1112234567999999988889999999999999999999 999997643
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=274.61 Aligned_cols=214 Identities=25% Similarity=0.346 Sum_probs=170.7
Q ss_pred hcCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeeccccc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (367)
..++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++..++||||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~---- 79 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc----
Confidence 3457889999999999999999843 24789999976332 223457889999999999999999999974
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCC-CcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
.....+++|||+++++|.+++......... .....+++..+..++.|++.||.||| +.+++||||||+||+++.+
T Consensus 80 -~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~ 155 (277)
T cd05032 80 -TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAED 155 (277)
T ss_pred -CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCC
Confidence 335679999999999999999754321110 01113567888999999999999999 8999999999999999999
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+.+||+|||+++...............++..|+|||.+.+..++.++|||||||++||++| |..||.+..
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 9999999999976543322212222345788999999988889999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=291.27 Aligned_cols=205 Identities=20% Similarity=0.260 Sum_probs=174.3
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
..+.|.++..||.|+||.||+|. ..++-..|.|++...+....+.+.-|++||..++||+||++++.|+ ..+.+
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkL 104 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKL 104 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCce
Confidence 34557778889999999999998 4445666788888777778899999999999999999999999873 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
|++.|||.||-.+.++-.-.. .+.+.++.-+++|++.||.||| +++|||||||..|||++-+|.++|+|
T Consensus 105 wiliEFC~GGAVDaimlEL~r--------~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLAD 173 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLELGR--------VLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLAD 173 (1187)
T ss_pred EEEEeecCCchHhHHHHHhcc--------ccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeec
Confidence 999999999999888765442 5888999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccc-----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYD-----LGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
||.+..... .......+.|||+|||||+. ...+|+.++||||||++|.||..+.+|.+.+..
T Consensus 174 FGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 174 FGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred ccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 999865422 12233456799999999984 456899999999999999999999999987754
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=272.08 Aligned_cols=200 Identities=23% Similarity=0.298 Sum_probs=166.4
Q ss_pred CCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 147 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
|++.+.||+|+||.||+|.. .++..+++|.+..........+.+|+++++.++||||+++++++. .....++++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEEE
Confidence 56778899999999999994 457888999886544445677889999999999999999999874 345679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++++|..++..... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 82 e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 150 (282)
T cd06643 82 EFCAGGAVDAVMLELER--------PLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVS 150 (282)
T ss_pred EecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccc
Confidence 99999999998765321 4678889999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
........ ......|++.|+|||++. +..++.++|||||||++|+|++|..||.+..
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 151 AKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred cccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 76533221 122335789999999974 3456789999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=280.91 Aligned_cols=215 Identities=25% Similarity=0.341 Sum_probs=169.3
Q ss_pred hcCCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhC-CCCCcceeeeeecccc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAFSGVD 214 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 214 (367)
..++|++.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 82 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec--
Confidence 346799999999999999999962 3468899999874332 2345688999999999 68999999998742
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCC------------------------------------------------
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR------------------------------------------------ 246 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------------------------------------------------ 246 (367)
.....+++|||+++|+|.+++.........
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 83 --PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred --CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 334568999999999999998753210000
Q ss_pred ----------CcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccCCCCCcce
Q 017712 247 ----------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316 (367)
Q Consensus 247 ----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 316 (367)
.....+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence 00113567788899999999999999 89999999999999999999999999999986533222111
Q ss_pred eeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 317 FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 112235678999999988889999999999999999997 999997653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=273.60 Aligned_cols=211 Identities=24% Similarity=0.352 Sum_probs=168.0
Q ss_pred CCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 146 GFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+.+|+.+++.++||||+++++.+. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 4778899999999999999732 235688888764332 23467889999999999999999999873 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCC---------------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecC
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNW---------------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~d 283 (367)
...++++||+++++|.+++........ ......+++..++.++.|++.||.||| +++++|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhh
Confidence 457999999999999999875321110 011124778889999999999999999 89999999
Q ss_pred CCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 017712 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDG 362 (367)
Q Consensus 284 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~ 362 (367)
|||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986543322211222335678999999988889999999999999999998 9999986
Q ss_pred CC
Q 017712 363 IF 364 (367)
Q Consensus 363 ~~ 364 (367)
..
T Consensus 233 ~~ 234 (290)
T cd05045 233 IA 234 (290)
T ss_pred CC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=273.19 Aligned_cols=199 Identities=32% Similarity=0.503 Sum_probs=161.5
Q ss_pred CCcccccCceEEEEEEec-----CCCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 150 ANLIGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.+.||.|.||.||+|... .+..|+||.++..... ..+.+.+|++.+.+++||||+++++++. .....++
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~l 78 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLFL 78 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----ccccccc
Confidence 467999999999999955 3678999999653322 3688999999999999999999999985 2334799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
|+||+++|+|.++|...... .+++..+..|+.|++.||.||| +++++|+||+|+||+++.++.+||+|||
T Consensus 79 v~e~~~~g~L~~~L~~~~~~-------~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~ 148 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKE-------PLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFG 148 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTT-------TSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTT
T ss_pred cccccccccccccccccccc-------cccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 99999999999999886211 5778899999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
++................+...|+|||.+....++.++||||||+++||+++ |+.||.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9987632222211222235778999999988889999999999999999999 78999765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=273.71 Aligned_cols=211 Identities=22% Similarity=0.365 Sum_probs=168.2
Q ss_pred CCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 146 GFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
+|++.+.||+|+||.||+|... +++.||+|.++..... ....+.+|+.++..++||||+++++++. ..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~ 80 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----KE 80 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC
Confidence 4677789999999999999842 2578999998743322 3456889999999999999999999973 33
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCC-------CCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDT-------NWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~ 291 (367)
...++++||+++++|.+++...... ........+++..+..++.|++.||.||| +++++||||||+||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLV 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEe
Confidence 4578999999999999998643210 00111224677888999999999999999 8999999999999999
Q ss_pred cCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 231 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231 (283)
T ss_pred cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999886543332222222335778999999988889999999999999999998 889998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=274.67 Aligned_cols=213 Identities=23% Similarity=0.282 Sum_probs=167.6
Q ss_pred cCCCCCCCcccccCceEEEEEEecC---------------CCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFD---------------GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVF 207 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~ 207 (367)
.++|++.+.||+|+||.||++.... ...||+|.++... ......+.+|++++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999987422 2358999986432 22345788999999999999999999
Q ss_pred eeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC---CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC
Q 017712 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (367)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dl 284 (367)
+++. .....+++|||+++++|.+++........ ......+++..++.++.|++.||.||| +.+++|+||
T Consensus 84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dl 155 (295)
T cd05097 84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDL 155 (295)
T ss_pred EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeecccc
Confidence 9974 34567999999999999999865431110 001113567888999999999999999 899999999
Q ss_pred CCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCC
Q 017712 285 KPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT--GIRPSDG 362 (367)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~Pf~~ 362 (367)
||+||++++++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999999999976543222111112234678999999988889999999999999999988 6788876
Q ss_pred CC
Q 017712 363 IF 364 (367)
Q Consensus 363 ~~ 364 (367)
..
T Consensus 236 ~~ 237 (295)
T cd05097 236 LS 237 (295)
T ss_pred cC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=269.23 Aligned_cols=201 Identities=22% Similarity=0.297 Sum_probs=156.5
Q ss_pred cccccCceEEEEEEecC---CCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEe
Q 017712 152 LIGAGNFGSVYNGTLFD---GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (367)
Q Consensus 152 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (367)
.||+|+||.||+|...+ ...+|+|.+..... .....+.+|+.+++.++||||+++++.+. .....+++|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEEe
Confidence 58999999999997433 35678887653322 23456789999999999999999999873 34567999999
Q ss_pred ccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccc
Q 017712 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (367)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (367)
+++|+|.+++........ ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..
T Consensus 77 ~~~g~L~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 149 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVA----QMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALE 149 (269)
T ss_pred CCCCcHHHHHHhcccccc----ccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccc
Confidence 999999999976542111 12446778889999999999999 89999999999999999999999999999875
Q ss_pred cCCCCCcceeeeccCCCcccCCccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 308 LPAIDKQNRFICIKGSTGYIPPEYDLG-------CEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
..............+++.|+|||+... ..++.++|||||||++|||++ |..||....
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 150 QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred cccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 432211111122335678999998642 356789999999999999999 888987653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=272.68 Aligned_cols=204 Identities=25% Similarity=0.276 Sum_probs=172.6
Q ss_pred HhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhC-CCCCcceeeeeeccccc
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 215 (367)
.....+|..+.+||+|+||.|.+|. ..+.+.+|||+++.. ...+.+.-..|-++|... +-|.+++++.+|
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF----- 419 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF----- 419 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----
Confidence 4455678889999999999999998 455788999998732 233444456677777665 578999999887
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
++...+|.||||+.||+|--.+++.+ .|-+..+..++.+|+-||-+|| ++|||.||||.+|||+|.+|
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ~G---------kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eG 487 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQVG---------KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEG 487 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHHhc---------ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCC
Confidence 56667899999999999999888776 4667778889999999999999 99999999999999999999
Q ss_pred ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++||+|||+++.-- -....+...+|||.|+|||++...+|+..+|.|||||+||||+.|++||+|-
T Consensus 488 HiKi~DFGmcKEni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 488 HIKIADFGMCKENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred ceEeeecccccccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999998432 2334455677999999999999999999999999999999999999999984
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=283.24 Aligned_cols=217 Identities=23% Similarity=0.296 Sum_probs=172.2
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCC-CCCcceeeeee
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIK-HRNIVRVFTAF 210 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 210 (367)
.+....++|.+.+.||+|+||.||+|+.. .+..||+|+++.... ...+.+.+|+.++.++. ||||++++++|
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 35556678889999999999999999843 346899999974322 23457889999999997 99999999998
Q ss_pred cccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC---------------------------------------------
Q 017712 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW--------------------------------------------- 245 (367)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------------------------------------- 245 (367)
.. ....++||||+++|+|.++++.......
T Consensus 111 ~~-----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (401)
T cd05107 111 TK-----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE 185 (401)
T ss_pred cc-----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence 43 3457999999999999999975431000
Q ss_pred --------------------------------------------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEe
Q 017712 246 --------------------------------------------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAH 281 (367)
Q Consensus 246 --------------------------------------------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH 281 (367)
......+++..++.++.|++.||.||| +.+++|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH 262 (401)
T cd05107 186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVH 262 (401)
T ss_pred ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCc
Confidence 000113567788899999999999999 899999
Q ss_pred cCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 017712 282 CNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPS 360 (367)
Q Consensus 282 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf 360 (367)
|||||+|||+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999986533222111122346788999999998889999999999999999998 89999
Q ss_pred CCC
Q 017712 361 DGI 363 (367)
Q Consensus 361 ~~~ 363 (367)
.+.
T Consensus 343 ~~~ 345 (401)
T cd05107 343 PEL 345 (401)
T ss_pred CCC
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=271.27 Aligned_cols=201 Identities=26% Similarity=0.366 Sum_probs=165.9
Q ss_pred CC-CCCCcccccCceEEEEEE-----ecCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 146 GF-SSANLIGAGNFGSVYNGT-----LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 146 ~~-~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
+| +..+.||+|+||.||++. ..++..+|+|.++.... .....+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGG 80 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence 44 788999999999998764 24578899999874332 245678899999999999999999998743 234
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++++|.+++... .+++.++..++.|++.||.||| +++++||||||+||++++++.+|
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~----------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~ 147 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH----------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVK 147 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEE
Confidence 4678999999999999998653 3678899999999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcce-eeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNR-FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+|||+++.......... .....++..|+|||.+.+..++.++||||||+++|||+||..||..
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred EeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 999999986643222111 1112346679999999888899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=269.45 Aligned_cols=202 Identities=22% Similarity=0.314 Sum_probs=158.4
Q ss_pred CcccccCceEEEEEEec---CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEE
Q 017712 151 NLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (367)
+.||+|+||.||+|... ++..+|+|.++.... .....+.+|+.++++++||||+++++++.. ....+++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEE
Confidence 35899999999999843 346789998864332 233578899999999999999999998743 345689999
Q ss_pred eccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccc
Q 017712 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (367)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (367)
|+++|+|.+++....... ....++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.
T Consensus 76 ~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~ 148 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSH 148 (269)
T ss_pred CCCCCcHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccc
Confidence 999999999997543211 113445677889999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcceeeeccCCCcccCCccccCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGC-------EASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
...............|+..|+|||++.+. .++.++||||||+++|||++ |..||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 54322221112223467889999987642 35789999999999999996 999997653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=266.22 Aligned_cols=196 Identities=26% Similarity=0.398 Sum_probs=160.6
Q ss_pred cccccCceEEEEEEec---CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEe
Q 017712 152 LIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (367)
Q Consensus 152 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (367)
.||+|+||.||+|... ++..||+|++..... ...+.+.+|+.++++++||||+++++++. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 3899999999999743 355799999874432 23466889999999999999999999863 2346899999
Q ss_pred ccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccc
Q 017712 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (367)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (367)
+++++|.+++..... .+++..++.++.|++.||.||| +++++||||||+||+++.++.+||+|||++..
T Consensus 76 ~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 144 (257)
T cd05115 76 ASGGPLNKFLSGKKD--------EITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKA 144 (257)
T ss_pred CCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCcccc
Confidence 999999999875332 4678899999999999999999 89999999999999999999999999999986
Q ss_pred cCCCCCcce-eeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 308 LPAIDKQNR-FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 308 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
......... .....+++.|+|||.+.+..++.++||||||+++|++++ |..||.+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 145 LGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred ccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 543322111 111223578999999988889999999999999999996 999997654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=268.38 Aligned_cols=203 Identities=22% Similarity=0.371 Sum_probs=168.9
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|+ ..+++.+|+|.+.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 578999999999999999999 5578999999876422 2234568899999999999999999998743 346
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++++||+++++|.+++...... ...++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~ 148 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQ-----KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLG 148 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEEC
Confidence 78999999999999988642210 013667888999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|||++......... .....|++.|+|||.+.+..++.++|+||||+++|||++|..||.+
T Consensus 149 d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 149 DLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred ccccceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 99998866432211 1223478899999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=267.01 Aligned_cols=204 Identities=23% Similarity=0.352 Sum_probs=169.6
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-----CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-----PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.+|++.+.||+|+||.||+|. ..+++.+|+|.+.... ......+.+|+.++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence 478999999999999999998 4568999999875321 2234578899999999999999999998743 223
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++++||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~ 146 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG---------ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVK 146 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEE
Confidence 45689999999999999987543 3567788899999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCC-cceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDK-QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++....... ........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 999999986533211 11112345788999999999888899999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=270.18 Aligned_cols=204 Identities=26% Similarity=0.380 Sum_probs=167.8
Q ss_pred cCCCCCCCcccccCceEEEEEEe-----cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
..+|++.+.||+|+||.||++.. .++..||+|.+........+.+.+|++++.+++||||+++++++.. .+.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCC
Confidence 35788899999999999999873 3578999999876555556788999999999999999999998743 233
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||++++++.+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~ 148 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVK 148 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEE
Confidence 457899999999999999975431 3667888999999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCccee-eeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRF-ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
|+|||++............ ....++..|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 9999999876433221111 11123456999999988889999999999999999999877754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=268.26 Aligned_cols=205 Identities=26% Similarity=0.428 Sum_probs=172.0
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..++|.+.+.||+|+||.||+|...+++.+|+|.+.... ...+.+.+|+.++++++||||+++++++. .....+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceE
Confidence 456899999999999999999997777889999987433 34577899999999999999999999873 335579
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++...... .+++..+..++.|++.||.||| +++++|+||||+||++++++.+||+||
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~-------~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~ 147 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGK-------KLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADF 147 (261)
T ss_pred EEEeccCCCCHHHHHhccccC-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECcc
Confidence 999999999999999764321 4678889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|.+..+...... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+..
T Consensus 148 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 148 GLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred ccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999866432111 1112224568999999998889999999999999999998 999997653
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=267.51 Aligned_cols=201 Identities=21% Similarity=0.336 Sum_probs=169.9
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
+|++.+.||+|+||.||++. ..+++.+|+|.++... ....+.+.+|+.+++.++||||+++++.+. .....++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEE
Confidence 47788999999999999998 4578999999986432 334567889999999999999999999873 4457899
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||+++++|.+++...... .+++..++.++.|++.||.||| +++++|+||||+||++++++.++|+|||
T Consensus 76 v~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg 145 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGK-------LFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFG 145 (255)
T ss_pred EEeeCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccC
Confidence 99999999999988653321 3667888999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.+......... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 146 SARLLTSPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred cceeecccccc--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence 99765432211 12245788999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=265.07 Aligned_cols=202 Identities=26% Similarity=0.345 Sum_probs=169.5
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||+|++|.||++. ..+++.+|+|.+..... ...+.+.+|++++++++|||++++++.+. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 47888999999999999998 45678999999864322 23456889999999999999999998763 2334578
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++...... .+++.++..++.|++.||++|| +.+++|+||||+||+++.++.++|+||
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~-------~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df 146 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGK-------LLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDL 146 (257)
T ss_pred EEecccCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecc
Confidence 999999999999999753211 4678899999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++........ ......|++.|+|||++.+..++.++||||||+++++|++|+.||.+.
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 147 GIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred cceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 99986643222 122345789999999999988999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=274.69 Aligned_cols=209 Identities=24% Similarity=0.384 Sum_probs=165.9
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCC--EEEEEEeecCC-CcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGT--TIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|++.+.||+|+||.||+|.. .++. .+|+|.++... ......+.+|+.++.++ +||||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CC
Confidence 35788899999999999999984 3454 45777765322 22445788999999999 8999999999973 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCC-------CcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~ 291 (367)
...+++|||+++++|.+++......... .....+++..++.++.|++.||+||| +++++||||||+|||+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEe
Confidence 5679999999999999999765321110 11124778899999999999999999 8999999999999999
Q ss_pred cCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
+.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||.+.
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred cCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 999999999999986432111 1111124567999999988889999999999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=265.89 Aligned_cols=195 Identities=25% Similarity=0.382 Sum_probs=161.2
Q ss_pred cccccCceEEEEEEe---cCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEE
Q 017712 152 LIGAGNFGSVYNGTL---FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (367)
Q Consensus 152 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (367)
.||+|+||.||+|.. .+++.+|+|+++.... ...+.+.+|+.+++.++||||+++++++.. ...+++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 589999999999963 4578899999864332 234678899999999999999999998632 34589999
Q ss_pred eccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccc
Q 017712 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (367)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (367)
|+++++|.+++.... .+++..+..++.|++.||.||| +++++||||||.||++++++.+||+|||+++
T Consensus 76 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~ 143 (257)
T cd05116 76 LAELGPLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSK 143 (257)
T ss_pred cCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCcccc
Confidence 999999999997544 4678889999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCcc-eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 307 FLPAIDKQN-RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 307 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
......... ......++..|+|||.+....++.++|||||||++|||++ |..||.+..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 144 ALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred ccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 664332211 1112224578999999988888999999999999999998 999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=270.98 Aligned_cols=216 Identities=21% Similarity=0.293 Sum_probs=174.8
Q ss_pred hHHHHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccc
Q 017712 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVD 214 (367)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 214 (367)
+..+....++|++.+.||+|+||.||++. ..+++.+|+|.+.... .....+.+|+.++.++ +||||+++++++....
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34555677899999999999999999998 4568899999876422 2345688899999999 6999999999886544
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
.......+++|||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++||||||+||+++++
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTE 160 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCC
Confidence 44556789999999999999987642110 014667888899999999999999 8899999999999999999
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+.+||+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||.+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred CCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999986543221 1122358999999998753 34788999999999999999999999754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=271.27 Aligned_cols=213 Identities=23% Similarity=0.335 Sum_probs=172.2
Q ss_pred hcCCCCCCCcccccCceEEEEEEecC-----CCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccC
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFD-----GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
..++|++.+.||+|+||.||+|.... +..|++|.+.... ......+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---- 79 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE---- 79 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 34678899999999999999998544 6889999886432 2345678899999999999999999998743
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
.....+++++|+++++|.+++........ .....+++..+..++.|++.||+||| +++++||||||+||++++++.
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEA-NNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhcccccc-ccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCc
Confidence 23556899999999999999876432110 01124778899999999999999999 899999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
+||+|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||.+.
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 99999999986543322211122235678999999988889999999999999999999 99999764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=266.81 Aligned_cols=203 Identities=27% Similarity=0.435 Sum_probs=168.4
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.++|.+...||+|+||.||+|....+..+|+|.+.... ...+.+.+|+.++++++|||++++++++. ....++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence 35688889999999999999997677789999876432 24567899999999999999999998862 234689
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||+++++|.+++...... .+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg 147 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGK-------YLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFG 147 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCc
Confidence 99999999999999754321 3567888999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++......... ......++..|+|||...+..++.++||||||+++|+|+| |..||.+..
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred cceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99765432211 1112235678999999988889999999999999999999 999997754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=265.48 Aligned_cols=201 Identities=22% Similarity=0.336 Sum_probs=172.4
Q ss_pred cCCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.++|++.+.||+|+||.||+|... +++.+++|.+..... .+.+.+|++++++++||||+++++++. .....+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEE
Confidence 468999999999999999999954 489999999874322 678999999999999999999999974 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+++||+++++|.+++..... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+||
T Consensus 75 l~~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~df 143 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITNK--------TLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADF 143 (256)
T ss_pred EEEecCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEccc
Confidence 99999999999999865332 4678899999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|++........ ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 144 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 144 GVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred ccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 99986644321 1222347889999999998889999999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=272.79 Aligned_cols=215 Identities=26% Similarity=0.380 Sum_probs=171.4
Q ss_pred hhcCCCCCCCcccccCceEEEEEEec--------CCCEEEEEEeecCC-CcchhHHHHHHHHHHhC-CCCCcceeeeeec
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFS 211 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 211 (367)
...++|.+.+.||+|+||.||+|+.. ++..+|+|.+.... ......+.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567888999999999999999731 23579999886432 23456788999999999 8999999999873
Q ss_pred ccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCC-------CcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC
Q 017712 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (367)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dl 284 (367)
.....+++|||+++|+|.+++......... .....+++..++.++.|++.||.||| +++++||||
T Consensus 92 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dl 163 (304)
T cd05101 92 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDL 163 (304)
T ss_pred -----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeeccc
Confidence 345679999999999999999764321100 01124677889999999999999999 899999999
Q ss_pred CCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 285 KPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987644332222222335678999999988889999999999999999998 88898765
Q ss_pred C
Q 017712 364 F 364 (367)
Q Consensus 364 ~ 364 (367)
.
T Consensus 244 ~ 244 (304)
T cd05101 244 P 244 (304)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=265.62 Aligned_cols=203 Identities=22% Similarity=0.375 Sum_probs=170.7
Q ss_pred CCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|... +++.+|+|.++... ....+.+.+|++++++++|+||+++++++.. ...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 57999999999999999999954 79999999886322 2235678999999999999999999999743 356
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||+++++|.+++...... ...++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~ 148 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLG 148 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEe
Confidence 79999999999999998653211 114678889999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|||++..+...... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+
T Consensus 149 d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 149 DLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred ccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 99998765432221 1223478899999999888899999999999999999999999954
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=269.71 Aligned_cols=203 Identities=25% Similarity=0.439 Sum_probs=167.9
Q ss_pred CCCCCCCcccccCceEEEEEEec-CCC----EEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-DGT----TIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.+|++.+.||+|+||.||+|... ++. .+|+|....... .....+.+|+.++.+++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 56888899999999999999843 333 589998764432 234678899999999999999999999743
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++|+|.+++..... .+++..++.++.|++.||+||| +++++||||||+||+++.++.+|
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~k 149 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVK 149 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEE
Confidence 456899999999999999976432 3678889999999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|+|||.++...............++..|+|||.+....++.++|+||||+++||+++ |..||++..
T Consensus 150 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred ECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 999999987653322221112223567999999988889999999999999999998 999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=275.82 Aligned_cols=201 Identities=20% Similarity=0.146 Sum_probs=161.8
Q ss_pred CCCccccc--CceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 149 SANLIGAG--NFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 149 ~~~~lg~G--~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
++++||+| +|++||++. ..+++.||+|.+..... .....+.+|+.+++.++||||++++++|. .....++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 45789999 788999998 56789999999874322 23456778999999999999999999984 3456799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
||||+++|+|.+++...... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.++++||+
T Consensus 77 v~e~~~~~~l~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~ 146 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMD-------GMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLR 146 (327)
T ss_pred EEeccCCCcHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccc
Confidence 99999999999998654321 3667889999999999999999 8999999999999999999999999998
Q ss_pred cccccCCCCCcc-----eeeeccCCCcccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 304 MARFLPAIDKQN-----RFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 304 ~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.+.......... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred hhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 754432111100 1112236778999999876 358899999999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=266.65 Aligned_cols=207 Identities=25% Similarity=0.335 Sum_probs=168.5
Q ss_pred HhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
+..++++.....||+|+||.||+|. ..++..||+|.+........+.+.+|+.++.+++||||+++++++. ...
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 78 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENG 78 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCC
Confidence 3455666666789999999999998 4567889999987655555678899999999999999999999873 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-CCceE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGH 298 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-~~~~k 298 (367)
..++++||+++++|.+++...... ...+...+..++.|++.||.||| +++|+||||||+||+++. ++.+|
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~ 149 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVK 149 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEE
Confidence 679999999999999999754210 01256778889999999999999 899999999999999976 67999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE--ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||.+......... .....|++.|+|||++.+.. ++.++||||||+++|+|++|..||...
T Consensus 150 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 150 ISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred EecchhheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999998765432221 12234789999999986643 788999999999999999999999754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=262.93 Aligned_cols=197 Identities=30% Similarity=0.431 Sum_probs=162.9
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEecc
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMP 229 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 229 (367)
++||+|+||.||+|...++..+|+|.++..... ....+.+|++++.+++||||+++++++. .....+++|||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECCC
Confidence 368999999999999778899999998643322 2346889999999999999999999873 3345799999999
Q ss_pred CCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccC
Q 017712 230 NGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309 (367)
Q Consensus 230 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 309 (367)
+++|.+++..... .+++..++.++.|++.||.||| +++++|+||||+||+++.++.+||+|||++....
T Consensus 76 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 76 GGDFLSFLRKKKD--------ELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred CCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecc
Confidence 9999999875432 3567888999999999999999 8999999999999999999999999999987543
Q ss_pred CCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
..... ......++..|+|||++.+..++.++||||||+++|++++ |..||.+..
T Consensus 145 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 145 DGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred ccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 22111 1111224567999999988889999999999999999998 999997653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=274.68 Aligned_cols=215 Identities=26% Similarity=0.372 Sum_probs=170.0
Q ss_pred hhcCCCCCCCcccccCceEEEEEEec--------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhC-CCCCcceeeeeec
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAFS 211 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 211 (367)
...++|.+.+.||+|+||.||+|+.. ....+|+|.++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34467889999999999999999731 245789998874322 2345688999999999 6999999999873
Q ss_pred ccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC-------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC
Q 017712 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (367)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dl 284 (367)
.....+++|||+++|+|.+++........ ......+++.+++.++.|++.||.||| +++++||||
T Consensus 89 -----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dl 160 (314)
T cd05099 89 -----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDL 160 (314)
T ss_pred -----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccc
Confidence 33457999999999999999976432100 001124778889999999999999999 899999999
Q ss_pred CCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 285 KPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred cceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986643322222222234567999999988889999999999999999999 89999765
Q ss_pred C
Q 017712 364 F 364 (367)
Q Consensus 364 ~ 364 (367)
.
T Consensus 241 ~ 241 (314)
T cd05099 241 P 241 (314)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=268.07 Aligned_cols=203 Identities=26% Similarity=0.452 Sum_probs=166.0
Q ss_pred CCCCCCCcccccCceEEEEEEec-CC---CEEEEEEeecC-CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-DG---TTIAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
+.|++.+.||+|+||.||+|... ++ ..||+|.+... .......|.+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence 35778899999999999999843 33 36999998643 223456799999999999999999999987 3345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++++|.+++..... .+++.+++.++.|++.||.||| +++++|+||||+||+++.++.+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl 147 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKV 147 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEE
Confidence 67999999999999999976432 3677889999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeecc---CCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIK---GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
+|||++................ .+..|+|||++.+..++.++|||||||++||+++ |..||.+.
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 148 SDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred CCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 9999987654332221111111 2457999999998889999999999999999886 99999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=271.93 Aligned_cols=202 Identities=23% Similarity=0.295 Sum_probs=167.8
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||++. ..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+ .....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 468889999999999999998 4568899999986432 22345678999999999999999999987 34457
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||+++++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~ 143 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLT 143 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEe
Confidence 799999999999999997654 4667888899999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCC-------------cceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDK-------------QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||+++....... ........|+..|+|||.+.+..++.++|+||||+++|||++|..||.+.
T Consensus 144 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 144 DFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred eCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999863211000 00011234688899999998888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=270.41 Aligned_cols=198 Identities=29% Similarity=0.513 Sum_probs=166.4
Q ss_pred CCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchh--HHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 147 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSK--SFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
|++.+.||+|+||.||+++. .+++.+|+|.+......... ...+|+.++.+++||||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 45678999999999999994 45678999999854433222 33569999999999999999999743 556789
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||+++++|.+++.... .++...+..++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||
T Consensus 76 v~~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg 143 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNK---------PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFG 143 (260)
T ss_dssp EEEEETTEBHHHHHHHHS---------SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGT
T ss_pred cccccccccccccccccc---------cccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 999999999999998333 4678999999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCcccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDL-GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.+.... ..........++..|+|||.+. +...+.++||||+|+++|+|++|..||.+.
T Consensus 144 ~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 144 SSVKLS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp TTEEST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 997541 1222333445799999999998 788999999999999999999999999865
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=274.04 Aligned_cols=217 Identities=26% Similarity=0.386 Sum_probs=172.1
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCC-CcchhHHHHHHHHHHhC-CCCCcceeeeeec
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFS 211 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 211 (367)
+....++|++.+.||+|+||.||++... ....+|+|.+.... ......+.+|+.++.++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3444567889999999999999999843 23678999886432 22345688999999999 8999999999873
Q ss_pred ccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC-------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC
Q 017712 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (367)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dl 284 (367)
.....+++|||+++|+|.+++........ ......+++..++.++.|++.||+||| +++|+||||
T Consensus 87 -----~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dl 158 (293)
T cd05053 87 -----QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDL 158 (293)
T ss_pred -----CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCcccccc
Confidence 34467999999999999999975421100 011225778899999999999999999 899999999
Q ss_pred CCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 285 KPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
||+||++++++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred ceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 99999999999999999999987654322222222234678999999988889999999999999999997 99999765
Q ss_pred C
Q 017712 364 F 364 (367)
Q Consensus 364 ~ 364 (367)
.
T Consensus 239 ~ 239 (293)
T cd05053 239 P 239 (293)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=270.35 Aligned_cols=216 Identities=24% Similarity=0.287 Sum_probs=174.5
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeeccccc
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 215 (367)
.++...+++|++.+.||+|+||.||++. ..+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...+.
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 3445567899999999999999999999 4578999999986432 2346678899999998 89999999999865443
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
......+++|||+++++|.++++..... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLIC-----GQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEG 165 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCC
Confidence 3445679999999999999988642110 014678889999999999999999 89999999999999999999
Q ss_pred ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-----EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.+||+|||++.......... ....|+..|+|||.+... .++.++|||||||++|+|++|+.||....
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred CEEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 99999999988654322211 123478899999987543 36889999999999999999999997653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=268.92 Aligned_cols=203 Identities=23% Similarity=0.369 Sum_probs=165.3
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++++|.+.+.||+|+||.||+|. ..+++.+|+|.+..... .....+.+|+.+++.++|+||+++++++. ....
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCe
Confidence 35789999999999999999998 45689999999864332 23346789999999999999999999973 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||+. ++|.+++..... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~ 145 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPG--------GLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLA 145 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEe
Confidence 799999995 688777654321 3456778889999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+++........ .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||++..
T Consensus 146 Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 146 DFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred ccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 99998754332211 1223468899999998764 57889999999999999999999997653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=279.42 Aligned_cols=191 Identities=22% Similarity=0.333 Sum_probs=159.4
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..+|++.+.||+|+||.||+|+. .+++.||+|+... .....|+.++++++||||+++++++. .....+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 133 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITC 133 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEE-----eCCeeE
Confidence 45799999999999999999994 4578899997432 23457999999999999999999974 344578
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+|||++ .++|.+++..... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 134 lv~e~~-~~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~Df 201 (357)
T PHA03209 134 MVLPHY-SSDLYTYLTKRSR--------PLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDL 201 (357)
T ss_pred EEEEcc-CCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecC
Confidence 999999 5689888865432 4678899999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf 360 (367)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 202 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 202 GAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999753221 1122345899999999999989999999999999999999855544
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=271.66 Aligned_cols=203 Identities=26% Similarity=0.427 Sum_probs=165.5
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCC----EEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGT----TIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
++|+..+.||+|+||.||+|.. .++. .+|+|.+..... .....+.+|+.++..++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------ 80 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS------ 80 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC------
Confidence 4678889999999999999984 3444 578888764322 223468899999999999999999998742
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++++||+++|+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~k 149 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVK 149 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceE
Confidence 124789999999999999875432 3667888999999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 150 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 150 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred EccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999986643322222222335678999999998889999999999999999997 999997753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=272.53 Aligned_cols=197 Identities=23% Similarity=0.332 Sum_probs=166.2
Q ss_pred CCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 147 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
|.....||+|+||.||++.. .++..+|+|.+........+.+.+|+.+++.++||||+++++.+. .....+++|
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv~ 98 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVVM 98 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEEE
Confidence 33346799999999999984 568999999987544445667889999999999999999999873 345679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++++|.+++... .+++.++..++.|++.||.||| +++++||||||+||++++++.+||+|||++
T Consensus 99 e~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~ 165 (292)
T cd06658 99 EFLEGGALTDIVTHT----------RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFC 165 (292)
T ss_pred eCCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcch
Confidence 999999999988543 3567888999999999999999 889999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
......... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.+.
T Consensus 166 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 221 (292)
T cd06658 166 AQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221 (292)
T ss_pred hhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 755332221 12234789999999998888999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=268.23 Aligned_cols=201 Identities=23% Similarity=0.329 Sum_probs=167.9
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|+....||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++. .....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 4688899999999999999994 468999999886432 223456789999999999999999999873 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+++|||+++++|..++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~d 143 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPR---------GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCD 143 (286)
T ss_pred EEEEeccCccHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECc
Confidence 99999999988888775443 4678899999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||++......... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+..
T Consensus 144 fg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 144 FGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred cccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9999876443211 122346888999999876 457889999999999999999999997653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=268.15 Aligned_cols=201 Identities=23% Similarity=0.326 Sum_probs=165.3
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||+|++|.||+|+. .++..||+|.++... ......+.+|+.++.+++||||+++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 477889999999999999984 568999999986432 223467889999999999999999999973 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||++ ++|.+++...... ..+++..+..++.|++.||.||| +++++|+||||+||+++.++.+||+||
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~df 145 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKG------QYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADF 145 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCC------CcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcc
Confidence 9999996 6898888653311 14678889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++........ ......+++.|+|||.+.+. .++.++|||||||++|+|+||+.||.+.
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 146 GLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred cceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99975532211 11223468899999988654 4688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=276.90 Aligned_cols=203 Identities=22% Similarity=0.238 Sum_probs=169.0
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeec--CCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 219 (367)
....|+++++||+||.+.||++...+.+.+|+|.+.. ........|.+|+..|.+|+ |.+|+++++|- -+..
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~ 433 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDG 433 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCc
Confidence 4457999999999999999999988888899888763 33345678999999999995 99999999996 3467
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
++|+||||- ..+|..+|+...... +.-.+..+..|++.|+.++| .+||||.||||+|+|+- .|.+||
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~--------~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKL 500 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSID--------PDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKL 500 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCC--------chHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEe
Confidence 899999987 669999998876421 11156778999999999999 99999999999999996 567999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCC-----------CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-----------ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+|.........-.....+||+.||+||.+.... .+.+||||||||+||+|+.|+.||..+
T Consensus 501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 9999999876655544445667999999999875432 467899999999999999999999754
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=267.58 Aligned_cols=199 Identities=22% Similarity=0.319 Sum_probs=170.7
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|++.+.||.|+||.||+|. ..+++.+|+|.+.... ......+.+|+.+++.++||||+++++++. .....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence 468888999999999999999 4468999999987433 334567889999999999999999999874 335689
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+++||+++++|.+++... .+++..+..++.|++.||.||| +++++|+||+|+||++++++.++|+||
T Consensus 76 ~v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~ 142 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG----------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADF 142 (274)
T ss_pred EEEEeeCCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccc
Confidence 999999999999998754 3567889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+++....... ......|++.|+|||++.+..++.++||||||+++|+|+||..||.+.
T Consensus 143 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 143 GVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred ccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99987654321 122334788999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=271.61 Aligned_cols=212 Identities=22% Similarity=0.279 Sum_probs=167.9
Q ss_pred CCCCCCCcccccCceEEEEEEec-----------------CCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCccee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-----------------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRV 206 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~ 206 (367)
++|++.+.||+|+||.||++... +...+|+|.+.... ......+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999998522 23468999987432 2345678999999999999999999
Q ss_pred eeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC--CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC
Q 017712 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW--RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (367)
Q Consensus 207 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dl 284 (367)
++++.. ....+++|||+++++|.+++........ ......+++..+..++.|++.||+||| +.+++|+||
T Consensus 85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl 156 (296)
T cd05095 85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDL 156 (296)
T ss_pred EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccC
Confidence 999743 3457999999999999999976442211 011124667889999999999999999 889999999
Q ss_pred CCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCC
Q 017712 285 KPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT--GIRPSDG 362 (367)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~Pf~~ 362 (367)
||+||+++.++.++|+|||+++.+.............+++.|+|||...+..++.++|||||||++|||++ |..||..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999986543221111111224678999999888889999999999999999998 7789875
Q ss_pred CC
Q 017712 363 IF 364 (367)
Q Consensus 363 ~~ 364 (367)
..
T Consensus 237 ~~ 238 (296)
T cd05095 237 LS 238 (296)
T ss_pred cC
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=270.12 Aligned_cols=209 Identities=24% Similarity=0.392 Sum_probs=165.2
Q ss_pred CCCCCCCcccccCceEEEEEEec-CC--CEEEEEEeecCC-CcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCce
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-DG--TTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 219 (367)
++|++.+.||+|+||.||+|... ++ ..+++|.++... ....+.+.+|+.++.++ +||||+++++++. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence 57889999999999999999843 33 347888876322 23446788999999999 7999999999873 344
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCC-------CcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~ 292 (367)
..++++||+++++|.+++......... .....+++..++.++.|++.||+||| +++++||||||+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEEC
Confidence 579999999999999999764321100 01114778889999999999999999 89999999999999999
Q ss_pred CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
.++.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred CCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999986432111 1111123557999999988889999999999999999997 999997653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=272.12 Aligned_cols=205 Identities=26% Similarity=0.353 Sum_probs=170.4
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCc---chhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|.. .+++.+|+|.+...... ....+.+|++++..++||||+++++.+ .....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 3688889999999999999994 45899999998743322 345688999999999999999999987 34456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||+.+++|.+++...... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~ 145 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGK-------CLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLS 145 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCC-------ccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEe
Confidence 79999999999999998754321 4678888999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcc---------------------------eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHH
Q 017712 301 DFGMARFLPAIDKQN---------------------------RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEM 353 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el 353 (367)
|||++.......... ......|+..|+|||++.+..++.++||||||+++|+|
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l 225 (316)
T cd05574 146 DFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225 (316)
T ss_pred ecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHH
Confidence 999987553221100 01123478899999999988899999999999999999
Q ss_pred HhCCCCCCCCC
Q 017712 354 FTGIRPSDGIF 364 (367)
Q Consensus 354 ~tg~~Pf~~~~ 364 (367)
++|..||.+..
T Consensus 226 ~~g~~pf~~~~ 236 (316)
T cd05574 226 LYGTTPFKGSN 236 (316)
T ss_pred hhCCCCCCCCc
Confidence 99999997653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=264.04 Aligned_cols=197 Identities=28% Similarity=0.442 Sum_probs=165.6
Q ss_pred CCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
++|++.+.||+|+||.||++.. .+..+|+|.++.. ...+.+.+|+.++++++|+|++++++++. ......+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEEE
Confidence 4788899999999999999974 4788999987632 23567899999999999999999998763 334457999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
|||+++++|.+++...... .+++..++.++.|++.||+||| +++++||||||+||++++++.+||+|||+
T Consensus 79 ~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~ 148 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGL 148 (256)
T ss_pred EECCCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCcc
Confidence 9999999999999764321 3567888999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
+........ ...++..|+|||++.+..++.++|||||||++|+|++ |+.||...
T Consensus 149 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 149 TKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 875433211 1224567999999988889999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=259.92 Aligned_cols=204 Identities=25% Similarity=0.369 Sum_probs=171.4
Q ss_pred HhhcCCCCCC-CcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCC
Q 017712 141 YNATNGFSSA-NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 141 ~~~~~~~~~~-~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 217 (367)
+..+++|++. ++||-|-.|.|-.+. ..+++.+|+|++. +....++|++..-+. .|||||.+++.|. ..+.+
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVye-Ns~~~ 130 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYE-NSYQG 130 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhh-hhccC
Confidence 3455667654 579999999999988 6789999999976 345678899875554 6999999999984 33567
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec---CC
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DE 294 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~---~~ 294 (367)
...+.+|||.|+||.|+..+..+... .|+++++..|+.||+.|+.||| +.+|.||||||+|+|.. .|
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~-------afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQ-------AFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccc-------cchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCC
Confidence 77889999999999999999887643 6999999999999999999999 89999999999999995 46
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
..+||+|||+|+.-.. .......+-||.|.|||++-...|+..+|+||+||++|-|++|.+||..-
T Consensus 201 a~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred cceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 6789999999985432 22233344699999999999999999999999999999999999999653
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=266.36 Aligned_cols=204 Identities=23% Similarity=0.378 Sum_probs=170.2
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|. ..+++.+|+|.+..... .....+.+|+.+++.++||||+++++++. ....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 468888999999999999999 56799999998764322 23457889999999999999999999873 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||+++++|.+++...... ...+++..+..++.|++.||.||| +++++|+||||+||+++.++.++|+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~ 148 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLG 148 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEC
Confidence 78999999999999998642210 114678889999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||++......... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.
T Consensus 149 dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 149 DLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred cchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99998765432221 12335789999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=277.90 Aligned_cols=202 Identities=25% Similarity=0.424 Sum_probs=172.0
Q ss_pred CCCCCCcccccCceEEEEEEec---CC--CEEEEEEeec-CCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 146 GFSSANLIGAGNFGSVYNGTLF---DG--TTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~---~~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
...+.++||+|.||.||+|... .| -.||||..+. ..+.+.+.|..|+.+|+.++||||++++|.|.. .
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~ 463 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------Q 463 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------c
Confidence 3455678999999999999832 22 3588999885 455678899999999999999999999999854 4
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..|+|||.++-|.|.+||+.+.. .++......++.||+.||.||| +.+.|||||...|||+.....+||
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~--------sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKD--------SLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred ceeEEEecccchhHHHHHHhccc--------cchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeee
Confidence 46999999999999999987764 4677788889999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~~ 365 (367)
+|||+++.+......... ...-+..|||||.+.-..++..||||-|||++||+++ |..||+|...
T Consensus 533 aDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN 598 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN 598 (974)
T ss_pred cccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc
Confidence 999999988665443332 2223567999999999999999999999999999986 9999999753
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=262.93 Aligned_cols=201 Identities=21% Similarity=0.329 Sum_probs=171.1
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|+..+.||+|+||.||.++ ..+++.+++|.+.... ......+.+|++++++++|+||+++++++. .....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 47888999999999999988 5668999999986432 344567889999999999999999999984 345689
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++...... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+||
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~ 145 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQ-------LFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDF 145 (256)
T ss_pred EEEEecCCCcHHHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcC
Confidence 999999999999999765311 4678889999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 146 GISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred cceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 99986543321 112334789999999998888899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=262.96 Aligned_cols=205 Identities=28% Similarity=0.442 Sum_probs=168.5
Q ss_pred CcccccCceEEEEEEecC----CCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|.... +..+++|.++..... ....+.+|++.+..++|+||+++++++. .....+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 468999999999998433 889999998754333 3678899999999999999999999874 355679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++++|.+++..............+++..+..++.|++.||.||| +++++|+||||+||+++.++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccc
Confidence 99999999999987521100000115788999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
................+++.|+|||.+....++.++||||||+++|+|++ |..||.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 87654332222233446889999999988889999999999999999999 69999765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=271.28 Aligned_cols=194 Identities=22% Similarity=0.315 Sum_probs=165.4
Q ss_pred CCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEec
Q 017712 150 ANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (367)
...||+|+||.||+|. ..+++.+|+|.+........+.+.+|+.++..++||||+++++++. .....++++||+
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~e~~ 100 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLMEFL 100 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEEecC
Confidence 3469999999999998 4578999999987555555677889999999999999999999873 345679999999
Q ss_pred cCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccccc
Q 017712 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
++++|.+++... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++...
T Consensus 101 ~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 101 QGGALTDIVSQT----------RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred CCCCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 999999987543 3567889999999999999999 899999999999999999999999999998755
Q ss_pred CCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
...... .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 168 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 168 SKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred cccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 432211 12244789999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=265.89 Aligned_cols=204 Identities=25% Similarity=0.403 Sum_probs=167.0
Q ss_pred CCCCCCCcccccCceEEEEEEec-C---CCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-D---GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.+|++.+.||+|+||.||+|... + +..+|+|.++... ......+.+|+.++.+++||||+++++++. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence 46888899999999999999842 2 3478999886432 223467899999999999999999999973 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++++|.+++..... .+++.++..++.|++.||+||| +++++||||||+||+++.++.++|
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l 147 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKV 147 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEe
Confidence 67999999999999999976432 3667888999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCccee-eeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRF-ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+|||++............ ....++..|+|||.+.+..++.++|+||||+++|++++ |..||.+..
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 148 SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred CCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 999999876443221111 11123567999999998889999999999999999886 999997653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=268.70 Aligned_cols=202 Identities=24% Similarity=0.386 Sum_probs=166.0
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|++.+.||+|++|.||+|.. .+++.||+|.+..... .....+.+|++++++++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeE
Confidence 36788999999999999999994 4689999999874332 23355778999999999999999999973 44578
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||++ ++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|
T Consensus 79 ~lv~e~~~-~~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d 146 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLAD 146 (291)
T ss_pred EEEEecCC-CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECc
Confidence 99999997 499998875432 3567888999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+..
T Consensus 147 fg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 147 FGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 9998754321111 112235788999999875 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=264.38 Aligned_cols=204 Identities=25% Similarity=0.408 Sum_probs=169.8
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..++|++.+.||+|+||.||++...++..+|+|.+... ......+.+|+.++++++|+||+++++.+.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence 45678999999999999999998777788999987642 2235678899999999999999999998732 4568
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++...... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+||
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~ 146 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADF 146 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCcc-------ccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCC
Confidence 999999999999999764321 3567788899999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|.+..+...... ......++..|+|||++....++.++|+|||||++|+++| |..||.+..
T Consensus 147 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 147 GLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred cceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 999765432211 1112235677999999988889999999999999999999 999997653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=263.66 Aligned_cols=191 Identities=24% Similarity=0.310 Sum_probs=155.9
Q ss_pred CcccccCceEEEEEEecC-------------CCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 151 NLIGAGNFGSVYNGTLFD-------------GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
+.||+|+||.||+|+..+ ...+++|.+..........+.+|+.++..++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~----- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR----- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 368999999999998432 23588898765544555678899999999999999999999743
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc-
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI- 296 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~- 296 (367)
....+++|||+++++|..++..... .+++..++.++.|++.||+||| +++|+||||||+|||++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~ 144 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKSD--------VLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGID 144 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCcc
Confidence 3456899999999999998865432 4677889999999999999999 899999999999999987654
Q ss_pred ------eEEeccccccccCCCCCcceeeeccCCCcccCCcccc-CCCCCcchhHHHHHHHHHHHH-hCCCCCCCC
Q 017712 297 ------GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-GCEASTYGDVYSFGILLLEMF-TGIRPSDGI 363 (367)
Q Consensus 297 ------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~-tg~~Pf~~~ 363 (367)
+|++|||++....... ...++..|+|||.+. +..++.++|||||||++|||+ +|..||.+.
T Consensus 145 ~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 145 GECGPFIKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred CCCCceeEeCCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 8999999987543221 224688899999887 456889999999999999998 588898654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=269.14 Aligned_cols=200 Identities=27% Similarity=0.315 Sum_probs=169.7
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|++.+.||+|+||.||++. ..+++.+|+|++.... ......+.+|++++..++||||+++++++. .....+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence 468888999999999999998 4568999999886433 334578899999999999999999999974 335679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++.... .+++..+..++.+++.||.|||+ ..+++||||||+||++++++.++|+||
T Consensus 80 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~ 148 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDF 148 (284)
T ss_pred EEEecCCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccC
Confidence 9999999999999987644 46678889999999999999993 258999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|++........ ....|+..|+|||++.+..++.++|||||||++|+|++|..||+...
T Consensus 149 gl~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 149 GVSGELINSIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred Ccccchhhhcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 99875422211 12358999999999988889999999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=268.67 Aligned_cols=199 Identities=23% Similarity=0.323 Sum_probs=171.0
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
++|.+.+.||+|+||.||++. ..+++.+|+|.+........+.+.+|+.++++++||||+++++.+. .....++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEEE
Confidence 578889999999999999998 4578899999987555555677899999999999999999999874 3456799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
|+||+++++|.+++... .+++.++..++.|++.||.||| +++++|+||||+||+++.++.+||+|||
T Consensus 94 v~e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg 160 (293)
T cd06647 94 VMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 160 (293)
T ss_pred EEecCCCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCc
Confidence 99999999999998753 2557788899999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++......... .....|++.|+|||.+.+..++.++|+||||+++|++++|+.||.+.
T Consensus 161 ~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 161 FCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred ceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 98765433222 12234788999999998888899999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=274.35 Aligned_cols=217 Identities=26% Similarity=0.367 Sum_probs=171.0
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEec--------CCCEEEEEEeecCC-CcchhHHHHHHHHHHhC-CCCCcceeeee
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTA 209 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 209 (367)
+.....+|.+.+.||+|+||.||+|... ....+|+|.++... ......+.+|+.++.++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3444557899999999999999999732 12368999876432 22356788999999999 79999999999
Q ss_pred ecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC-------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEec
Q 017712 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHC 282 (367)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~ 282 (367)
|. .....++++||+++|+|.+++........ ......+++..++.++.|++.||.||| +++++||
T Consensus 87 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~ 158 (334)
T cd05100 87 CT-----QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHR 158 (334)
T ss_pred Ec-----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 73 34467999999999999999976431100 011124677888999999999999999 8999999
Q ss_pred CCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 017712 283 NLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSD 361 (367)
Q Consensus 283 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~ 361 (367)
||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 159 DLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred ccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999986543322222222234567999999999889999999999999999998 899997
Q ss_pred CCC
Q 017712 362 GIF 364 (367)
Q Consensus 362 ~~~ 364 (367)
+..
T Consensus 239 ~~~ 241 (334)
T cd05100 239 GIP 241 (334)
T ss_pred CCC
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=268.93 Aligned_cols=213 Identities=25% Similarity=0.402 Sum_probs=169.7
Q ss_pred cCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
.++|++.+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+.++.+++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~----- 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA----- 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence 467999999999999999999842 467899999864322 23466889999999999999999999874
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCC-------------CcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecC
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWR-------------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~d 283 (367)
.....+++|||+++++|.+++......... .....+++..++.++.|++.||.||| +++++|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~d 155 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRD 155 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence 334569999999999999999753311000 11124678889999999999999999 89999999
Q ss_pred CCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 017712 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDG 362 (367)
Q Consensus 284 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~ 362 (367)
|||+||+++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875533221111111224667999999988889999999999999999997 8889976
Q ss_pred CC
Q 017712 363 IF 364 (367)
Q Consensus 363 ~~ 364 (367)
..
T Consensus 236 ~~ 237 (288)
T cd05050 236 MA 237 (288)
T ss_pred CC
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=267.90 Aligned_cols=201 Identities=24% Similarity=0.367 Sum_probs=165.9
Q ss_pred CCCCCCcccccCceEEEEEEe-----cCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.|++.+.||+|+||.||+++. .++..||+|.++... ......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCC
Confidence 468889999999999999973 357889999987443 2344678999999999999999999998743 2235
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l 150 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKI 150 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEE
Confidence 57899999999999999865431 3667889999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 017712 300 GDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf 360 (367)
+|||+++.+...... .......++..|+|||.+.+..++.++||||||+++|+|+|+..|+
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred CCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 999999866433221 1112234677899999998888999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=275.34 Aligned_cols=206 Identities=22% Similarity=0.307 Sum_probs=169.9
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
..++|++.+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.++++++||||+++++++..........
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 35789999999999999999998 5578999999986422 224456788999999999999999999876544445566
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++++||++ ++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~----------~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQ----------HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred EEEEehhcc-cCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEC
Confidence 799999995 5888887643 3678889999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcc-eeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 301 DFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|||++.......... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999997654322111 1122457899999998654 4688999999999999999999999965
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=266.48 Aligned_cols=200 Identities=21% Similarity=0.340 Sum_probs=169.1
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..|+..+.||+|+||.||+|.. .++..+|+|.+.... ......+.+|+.++++++||||+++++++. .....+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEE
Confidence 3577788999999999999984 468899999987432 234567889999999999999999999974 345689
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||+++++|.+++... .++..++..++.|++.||+||| +.+++|+||+|+||+++.++.++|+||
T Consensus 79 lv~e~~~~~~L~~~i~~~----------~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~df 145 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG----------PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADF 145 (277)
T ss_pred EEEecCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEccc
Confidence 999999999999998653 2556788889999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|++......... .....++..|+|||++.+..++.++|+||||+++|||++|..||.+..
T Consensus 146 g~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 146 GVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred ccceeccCCccc--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999765432211 122347888999999988889999999999999999999999997653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=268.16 Aligned_cols=202 Identities=25% Similarity=0.293 Sum_probs=166.4
Q ss_pred CCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecC-CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.++.+++||||+++++++. .....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEE
Confidence 36888999999999999999944 7899999988643 2233467889999999999999999999873 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|..++..... ...+++..+..++.|++.||.|||+ +.+++|+||||+||+++.++.+||+||
T Consensus 76 lv~e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~df 147 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDF 147 (286)
T ss_pred EEEeecCCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeec
Confidence 99999999999999876421 0146788999999999999999993 259999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCC------CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE------ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++..+..... ....|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...
T Consensus 148 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 148 GVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred CCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 99976533211 1234788999999986543 478999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=264.77 Aligned_cols=200 Identities=29% Similarity=0.442 Sum_probs=166.0
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc----------chhHHHHHHHHHHhCCCCCcceeeeeecccc
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG----------GSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (367)
+|.+.+.||+|+||.||+|. ..+++.+|+|.++..... ..+.+.+|+.++..++||||+++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 47788999999999999998 456899999987532111 1246788999999999999999999873
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
.....++||||+++++|.+++.... .++...+..++.|++.||.||| +++++|+||+|+||+++.+
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~ 144 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDAD 144 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCC
Confidence 3456799999999999999997653 4667888889999999999999 8999999999999999999
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE--ASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+.++|+|||++................|+..|+|||.+.... ++.++|+||||+++|++++|..||..
T Consensus 145 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 145 GICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred CeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 999999999997654322222223345788999999987654 78999999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=268.75 Aligned_cols=199 Identities=22% Similarity=0.335 Sum_probs=167.0
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.|+..+.||+|+||.||+|. ..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence 35556789999999999998 4568899999886332 234467889999999999999999999874 3456799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
||||+++++|.+++... .+++..+..++.|++.||.||| +++++|+||+|+||++++++.++|+|||
T Consensus 80 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06642 80 IMEYLGGGSALDLLKPG----------PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFG 146 (277)
T ss_pred EEEccCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEcccc
Confidence 99999999999998643 3567888899999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++..+..... ......|+..|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 147 VAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred ccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9976543221 1122347889999999998889999999999999999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=269.45 Aligned_cols=213 Identities=23% Similarity=0.279 Sum_probs=169.8
Q ss_pred cCCCCCCCcccccCceEEEEEEecC-----------------CCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFD-----------------GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVR 205 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 205 (367)
.++|++.+.||+|+||.||+|.... +..||+|.+..... ...+.+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999987322 24689998874332 34567889999999999999999
Q ss_pred eeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCC--CcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecC
Q 017712 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR--PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283 (367)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~d 283 (367)
+++++. .....+++|||+++++|.+++......... .....+++..++.++.|++.||+||| +.+++|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~d 155 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRD 155 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccc
Confidence 999974 335679999999999999999764311100 01114678889999999999999999 89999999
Q ss_pred CCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh--CCCCCC
Q 017712 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT--GIRPSD 361 (367)
Q Consensus 284 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~Pf~ 361 (367)
|||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986543322222223345778999999988889999999999999999998 778886
Q ss_pred CCC
Q 017712 362 GIF 364 (367)
Q Consensus 362 ~~~ 364 (367)
...
T Consensus 236 ~~~ 238 (296)
T cd05051 236 HLT 238 (296)
T ss_pred CcC
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=262.60 Aligned_cols=198 Identities=30% Similarity=0.429 Sum_probs=165.1
Q ss_pred CcccccCceEEEEEEecC--C--CEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGTLFD--G--TTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|++|.||+|...+ + ..+|+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 368999999999998432 3 3689999875554 456788999999999999999999998742 5679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++++|.+++..... ..+++..+..++.|++.||.||| +++++|+||||+||+++.++.+||+|||++
T Consensus 75 e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~ 144 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLM 144 (257)
T ss_pred EecCCCcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccc
Confidence 99999999999976542 14678889999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCcc-eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 306 RFLPAIDKQN-RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 306 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+.+....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 205 (257)
T cd05040 145 RALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205 (257)
T ss_pred ccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 8764422211 1112346788999999998889999999999999999999 999997653
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=278.90 Aligned_cols=198 Identities=25% Similarity=0.422 Sum_probs=165.6
Q ss_pred CCCCcccccCceEEEEEE-ecCCCEEEEEEee----cCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 148 SSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN----LIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 148 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+...+||+|+|-+||+|. -.+|..||=-.++ ..++...++|..|+..|+.|+||||+++|+++.+.. .....
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceee
Confidence 344679999999999998 3457777632222 233445689999999999999999999999997643 35678
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-CCceEEec
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVGD 301 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-~~~~kl~D 301 (367)
+|+|.+..|+|..|++... ..+.+.+..+++||++||.|||++ ..+|||||||.+||+++. -|.+||+|
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~---------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHR---------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred eeeecccCCcHHHHHHHhc---------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecc
Confidence 9999999999999999877 456778899999999999999987 789999999999999975 48999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|+|+.... .......|||.|||||... ..|+...||||||++++||+|+.+||...
T Consensus 190 LGLAtl~r~----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC 246 (632)
T KOG0584|consen 190 LGLATLLRK----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC 246 (632)
T ss_pred hhHHHHhhc----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh
Confidence 999987533 2233456999999999887 67999999999999999999999999754
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=260.70 Aligned_cols=198 Identities=28% Similarity=0.474 Sum_probs=168.8
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.++|++.+.||+|+||.||+|.. .++.+|+|.+..... ..+.+.+|+.++++++|+||+++++++.. ....++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEE
Confidence 45788899999999999999984 478999999875433 46788999999999999999999999742 456799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||+++++|.+++...... .+++..+..++.|++.||.||| +++++|+||||+||+++.++.+||+|||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g 147 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRA-------VITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFG 147 (256)
T ss_pred EEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccc
Confidence 99999999999999765421 3668889999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
.++....... ...++..|+|||++.+..++.++||||||+++|++++ |..||...
T Consensus 148 ~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 148 LAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred cccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9986532211 1224567999999988889999999999999999997 99999765
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=265.19 Aligned_cols=202 Identities=23% Similarity=0.384 Sum_probs=166.2
Q ss_pred CCCCCCCcccccCceEEEEEEecC----CCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
++|.+.+.||+|+||.||+|...+ ...+|+|...... ....+.+.+|+.++++++||||+++++++.. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence 468888999999999999998432 3568999876443 2345678999999999999999999998742 2
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++++|.+++..... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l 148 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKL 148 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEE
Confidence 35899999999999999976432 3678889999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+|||+++......... .....++..|+|||.+....++.++||||||+++||+++ |..||.+..
T Consensus 149 ~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 149 GDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999998654332111 112224568999999988889999999999999999986 999997654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=266.45 Aligned_cols=214 Identities=23% Similarity=0.337 Sum_probs=172.7
Q ss_pred hHHHHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccc
Q 017712 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVD 214 (367)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 214 (367)
+.+.....+.|++.+.||+|+||.||+|. ..+++.+|+|.+.... .....+..|+.++.++ +||||+++++++....
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 34445566789999999999999999999 4568999999986432 2345688899999998 7999999999985422
Q ss_pred c-CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 215 Y-QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 215 ~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
. ......+++|||+++|+|.+++...... .+++..+..++.|++.||.||| +.+++|+||+|+||++++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~ 156 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-------ALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTE 156 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECC
Confidence 1 2345779999999999999998754321 3557778889999999999999 899999999999999999
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++.++|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|..||.+.
T Consensus 157 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 157 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred CCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 99999999999875532211 112345789999999875 345788999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=265.14 Aligned_cols=205 Identities=26% Similarity=0.420 Sum_probs=166.7
Q ss_pred cCCCCCCCcccccCceEEEEEEec-CCC---EEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF-DGT---TIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|+..+.||+|+||.||+|+.. ++. .+|+|.+.... ......+.+|++++.+++||||+++++++. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cC
Confidence 457888899999999999999843 333 68999886432 233567889999999999999999999974 33
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++++|.+++..... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~k 147 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECK 147 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEE
Confidence 457999999999999999975432 4677888999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCccee-eeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRF-ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|+|||++............ .....+..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 148 VSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred ECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 9999999866432221111 11123457999999988889999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=261.14 Aligned_cols=199 Identities=28% Similarity=0.401 Sum_probs=168.4
Q ss_pred CCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCC-----cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 146 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-----GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
+|+..+.||+|+||.||+|... +++.|++|.+..... ...+.+.+|+.+++.++||||+++++++. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 4777889999999999999954 789999999864331 23467889999999999999999999873 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++++||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl 143 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKL 143 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 6799999999999999997644 3667888899999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||++....... ......|++.|+|||.+.... ++.++|+||||+++|+|++|..||....
T Consensus 144 ~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 144 ADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred ccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 9999987654322 122344788999999987766 8899999999999999999999996643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=265.02 Aligned_cols=211 Identities=21% Similarity=0.315 Sum_probs=169.6
Q ss_pred CCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
++|++...||+|+||.||+|+.. +.+.+++|.+...... ....+.+|++++.+++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR-----E 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----C
Confidence 57888999999999999999843 3467999988654433 4567999999999999999999999873 3
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....+++|||+++++|.+++..............+++..+..++.|++.||.||| +.+++||||||+||+++.++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcE
Confidence 4567999999999999999976542111111124678899999999999999999 8999999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+++|||++........ .......++..|+|||.+.+...+.++||||||+++|+|++ |..||.++.
T Consensus 157 ~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~ 223 (275)
T cd05046 157 KVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223 (275)
T ss_pred EEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence 9999999875432211 11122235677999999988888999999999999999998 888997654
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=260.58 Aligned_cols=198 Identities=30% Similarity=0.419 Sum_probs=163.4
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEecc
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMP 229 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 229 (367)
++||+|+||.||++...+++.||+|.+...... ....+.+|++++++++||||+++++++. .....+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcCC
Confidence 368999999999999666999999988754333 4567899999999999999999999873 3456799999999
Q ss_pred CCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccC
Q 017712 230 NGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309 (367)
Q Consensus 230 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 309 (367)
+++|.+++..... .++...++.++.+++.||.||| +++++||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~l~~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 76 GGSLLTFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred CCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 9999999965432 3567888999999999999999 8999999999999999999999999999997653
Q ss_pred CCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
............++..|+|||.+.+..++.++|+||||+++|+|+| |..||.+..
T Consensus 145 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 145 GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred CCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 2111111111123567999999988889999999999999999999 899997653
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=265.37 Aligned_cols=191 Identities=24% Similarity=0.295 Sum_probs=153.8
Q ss_pred cccccCceEEEEEEecC-------------------------CCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCccee
Q 017712 152 LIGAGNFGSVYNGTLFD-------------------------GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206 (367)
Q Consensus 152 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 206 (367)
.||+|+||.||+|.... ...||+|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999987311 13588898865443345678889999999999999999
Q ss_pred eeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCC
Q 017712 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKP 286 (367)
Q Consensus 207 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp 286 (367)
++++.. ....++||||+++|+|..++..... .+++..++.++.|++.||+||| +++|+||||||
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp 145 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKEKG--------RVPVAWKITVAQQLASALSYLE---DKNLVHGNVCA 145 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCc
Confidence 999843 3456899999999999999865332 3567888999999999999999 89999999999
Q ss_pred CceeecCCC-------ceEEeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHH-hCC
Q 017712 287 SNVLLDDEM-------IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMF-TGI 357 (367)
Q Consensus 287 ~Nil~~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~-tg~ 357 (367)
+||+++..+ .+|++|||.+....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|.
T Consensus 146 ~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~ 219 (274)
T cd05076 146 KNILLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219 (274)
T ss_pred ccEEEeccCcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999997543 47999999886432211 1236788999998865 56899999999999999995 799
Q ss_pred CCCCCCC
Q 017712 358 RPSDGIF 364 (367)
Q Consensus 358 ~Pf~~~~ 364 (367)
.||.+..
T Consensus 220 ~p~~~~~ 226 (274)
T cd05076 220 VPLKERT 226 (274)
T ss_pred CCccccC
Confidence 9997653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=263.17 Aligned_cols=200 Identities=25% Similarity=0.366 Sum_probs=167.6
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc------chhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
+|+..+.||+|+||.||+|. ..+++.+|+|.+...... ..+.+.+|+..+++++||||+++++++. ..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence 47888999999999999998 567899999998743321 2467889999999999999999999973 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-ce
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IG 297 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~-~~ 297 (367)
...++++||+++++|.+++.... .+++..+..++.|++.||.||| +++++|+||+|+||+++.++ .+
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~ 143 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRL 143 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 56799999999999999997644 4667888999999999999999 89999999999999998775 58
Q ss_pred EEeccccccccCCCCCcc--eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQN--RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
||+|||.+.......... ......|+..|+|||.+.+..++.++||||+|+++|+|++|..||..
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 144 RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred EEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 999999997664331111 11123478899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=266.87 Aligned_cols=207 Identities=22% Similarity=0.255 Sum_probs=155.0
Q ss_pred cCCCCCCCcccccCceEEEEEEecC----CCEEEEEEeecCCCcch-h----------HHHHHHHHHHhCCCCCcceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRPGGS-K----------SFKSECKAAINIKHRNIVRVFT 208 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-~----------~~~~E~~~l~~l~h~niv~~~~ 208 (367)
.++|.+.++||+|+||.||+|...+ +..+|+|+......... + ....+...+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998443 45667775432222110 1 1122334455678999999998
Q ss_pred eecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCc
Q 017712 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSN 288 (367)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~N 288 (367)
++.... ....+.+++++++ ..++.+.+.... .+++..+..++.|++.||+||| +.+|+||||||+|
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~N 156 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKL-VENTKEIFKRIK---------CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPEN 156 (294)
T ss_pred eeeEec-CCceEEEEEEehh-ccCHHHHHHhhc---------cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHH
Confidence 764322 2233557888877 346766665432 2346678889999999999999 8999999999999
Q ss_pred eeecCCCceEEeccccccccCCCCCc-----ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 289 VLLDDEMIGHVGDFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 289 il~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||++.++.++|+|||+|+.+...... .......||+.|+|||+..+..++.++|||||||++|||++|..||.+.
T Consensus 157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999866432211 1112345899999999999999999999999999999999999999876
Q ss_pred C
Q 017712 364 F 364 (367)
Q Consensus 364 ~ 364 (367)
.
T Consensus 237 ~ 237 (294)
T PHA02882 237 G 237 (294)
T ss_pred c
Confidence 3
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=264.34 Aligned_cols=199 Identities=27% Similarity=0.356 Sum_probs=171.2
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
+|++.+.||+|+||.||+|.. .+++.+|+|.+..... ...+.+.+|++++++++||||+++++++ ......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 477889999999999999994 4689999999874322 3457889999999999999999999886 445678
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++++||+++++|.+++.... .+++..+..++.|+++||.||| +++++|+||+|+||++++++.++|+|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d 143 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITD 143 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEee
Confidence 99999999999999997653 4668889999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||.+....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 144 ~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 144 FNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred cccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 99988654332 1223447889999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=260.92 Aligned_cols=196 Identities=28% Similarity=0.422 Sum_probs=161.2
Q ss_pred CcccccCceEEEEEEe-cC---CCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGTL-FD---GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~-~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|.. .. +..+|+|.+..... ...+.+.+|+.++++++||||+++++++.. ...+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence 4699999999999973 22 26899999874333 245678899999999999999999998632 2468999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++++|.+++.... .+++..+..++.|++.||.||| ..+++|+||||+||+++.++.+||+|||++
T Consensus 75 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~ 142 (257)
T cd05060 75 ELAPLGPLLKYLKKRR---------EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMS 142 (257)
T ss_pred EeCCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEecccccc
Confidence 9999999999997654 4668889999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCCcc-eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 306 RFLPAIDKQN-RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 306 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 143 RALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred ceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 8664332211 1111223467999999988889999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=265.00 Aligned_cols=200 Identities=24% Similarity=0.348 Sum_probs=168.3
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||+|+||.||+|.. .+++.+|+|++.... ......+.+|+.++++++||||+++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence 478889999999999999994 568999999987543 334567899999999999999999999973 355679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+|+||+ +++|.+++..... .+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~df 143 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEER--------PLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADF 143 (286)
T ss_pred EEeccc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeee
Confidence 999999 9999999875431 4778899999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|.+........ .......|+..|+|||.+.+. .++.++||||+|+++|+|++|.+||.+.
T Consensus 144 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 144 GLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred eecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 99986644321 112234578999999998654 4688999999999999999998888654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=263.32 Aligned_cols=192 Identities=25% Similarity=0.318 Sum_probs=155.0
Q ss_pred cccccCceEEEEEEe-cCCCEEEEEEeecCCCc---chhHHHHHHHHHH---hCCCCCcceeeeeecccccCCceeeeEE
Q 017712 152 LIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAI---NIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 152 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
.||+|+||.||++.. .+++.+|+|.+...... ....+.+|..++. ..+||||+++++++. .....++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 489999999999984 56899999988643221 1223444544333 347999999998873 34467999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||+
T Consensus 76 ~e~~~~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~ 143 (279)
T cd05633 76 LDLMNGGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 143 (279)
T ss_pred EecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCc
Confidence 99999999999987654 4778899999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCcccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDL-GCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+........ ....|++.|+|||.+. +..++.++|||||||++|+|++|..||.+..
T Consensus 144 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 144 ACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred ceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 875533211 2235899999999886 4568899999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=267.33 Aligned_cols=199 Identities=22% Similarity=0.353 Sum_probs=166.1
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|++.+.||+|+||.||+|.. .+++.+|+|.+..... ...+.+.+|++++..++||||+++++++ ......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 4688889999999999999995 4689999998763222 2356788999999999999999999997 345567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++++||+++++|.++..... .+++.++..++.|++.||.||| +.+++|+||+|+||++++++.++|+|
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~d 143 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN---------GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCD 143 (286)
T ss_pred EEEEecCCccHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEe
Confidence 99999999999988775443 3668889999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
||++......... .....++..|+|||++.+. .++.++||||||+++|||++|.+||.+
T Consensus 144 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 144 FGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred eeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 9998865433221 1223478899999998753 467889999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=265.97 Aligned_cols=197 Identities=22% Similarity=0.336 Sum_probs=162.5
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||+|+||.||+|+. .+|+.+|+|.+.... ......+.+|+.++++++||||+++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence 477888999999999999994 568999999986432 223456788999999999999999999873 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+++||++ ++|.+++..... .+++..+..++.||++||.||| +++++||||||+||+++.++.+||+||
T Consensus 76 lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~df 143 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNG--------DIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADF 143 (284)
T ss_pred EEEecCC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECcc
Confidence 9999996 588888764321 4678889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
|+++.+..... ......+++.|+|||.+.+. .++.++|||||||++|+|+||..||.
T Consensus 144 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 144 GLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred chhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 99986543221 11223468899999998764 46899999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=259.99 Aligned_cols=201 Identities=26% Similarity=0.333 Sum_probs=173.0
Q ss_pred CCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|++.+.||+|++|.||+|+.. +++.+++|++..... .....+.+|+..+.+++||||+++++++. .....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence 46888999999999999999944 599999999875433 34678999999999999999999999974 346689
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEecCCCCCceeecCCCceEEec
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++|||+++++|.+++.... .+++..++.++.|++.||.||| + .+++|+||+|+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~d 143 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIAD 143 (264)
T ss_pred EEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999997653 4678889999999999999999 8 9999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||.+.......... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 144 f~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 144 FGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99998664332221 12347889999999988889999999999999999999999997663
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=261.90 Aligned_cols=206 Identities=22% Similarity=0.334 Sum_probs=172.0
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|++.+.||.|+||.||+|. ..++..+|+|++.... ......+.+|+.+++.++|+||+++++.+. .....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEE
Confidence 478899999999999999998 4568899999986433 225577899999999999999999998873 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+++|++++++|.+++...... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+||
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df 146 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPR------GGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADF 146 (267)
T ss_pred EEEeccCCCcHHHHHHHhccc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccc
Confidence 999999999999999754310 03667888899999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcc--eeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQN--RFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|++..+....... ......|+..|+|||++... .++.++|+||||+++|+|++|+.||.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred chHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 9997665433221 12233578899999998776 78999999999999999999999997654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=261.70 Aligned_cols=200 Identities=20% Similarity=0.277 Sum_probs=154.1
Q ss_pred cccccCceEEEEEEecCC---CEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEe
Q 017712 152 LIGAGNFGSVYNGTLFDG---TTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (367)
Q Consensus 152 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (367)
.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.++..++||||+++++.|. .....+++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence 589999999999974443 345666665332 234567899999999999999999999974 33457999999
Q ss_pred ccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccc
Q 017712 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (367)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (367)
+++|+|.+++....... ..++...+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++..
T Consensus 77 ~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 77 CELGDLKSYLSQEQWHR-----RNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred CCCCcHHHHHHhhhccc-----ccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccc
Confidence 99999999997643210 12445667889999999999999 88999999999999999999999999999864
Q ss_pred cCCCCCcceeeeccCCCcccCCccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 308 LPAIDKQNRFICIKGSTGYIPPEYDLG-------CEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
..............|+..|+|||++.. ..++.++||||||+++|||++ |..||.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 322111111123347889999998753 235788999999999999997 577886543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=263.96 Aligned_cols=211 Identities=23% Similarity=0.343 Sum_probs=172.1
Q ss_pred hhcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeeccccc-CCc
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDY-QGA 218 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~ 218 (367)
..+++|++.+.||+|++|.||+|.. .+++.+++|.+..... ..+.+.+|+.+++++ +||||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 3568999999999999999999994 4678999999874432 456789999999999 79999999999865432 235
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++++|.+++...... +..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~ 153 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKK-----GKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVK 153 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEE
Confidence 5679999999999999988653200 114678889999999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||++........ ......|++.|+|||++.. ..++.++||||||+++|+|++|..||.+.
T Consensus 154 l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 154 LVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred ECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 999999876543221 1223347889999998754 24678899999999999999999999754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=259.99 Aligned_cols=201 Identities=28% Similarity=0.409 Sum_probs=170.3
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCc--chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||+|+||.||+|.. .+++.+++|.++..... ....+.+|+.++++++|+||+++++.+ ......+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 478889999999999999984 47899999998754443 567889999999999999999999986 3345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+++||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+||
T Consensus 76 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~ 143 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDF 143 (264)
T ss_pred EEEecCCCCcHHHHHhhcC---------CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccc
Confidence 9999999999999997653 3557788889999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcce--eeeccCCCcccCCccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNR--FICIKGSTGYIPPEYDLGCE---ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++........... .....+++.|+|||++.+.. .+.++||||||+++|++++|..||.+.
T Consensus 144 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 144 GCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred ccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 99987644322111 11245788999999988766 789999999999999999999999765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=253.06 Aligned_cols=199 Identities=24% Similarity=0.308 Sum_probs=160.0
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeec-CCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-IRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+.+.+..||.|+.|.|++++ ..+|..+|||.+.. .+....++++..+.++.+.+ .|.||+.+|+|.. ....+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-----n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-----NTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-----CchHH
Confidence 34456779999999999999 56689999999863 33345667777787766654 8999999999853 34568
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+.||.| ...++.+++.-.. ++++..+-++..-++.||.||.. +++|+|||+||+|||+|+.|++||+||
T Consensus 168 IcMelM-s~C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred HHHHHH-HHHHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecc
Confidence 889988 4466666654332 47777777888999999999985 789999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC---EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++..+.+.... ....|.+.|||||.+.-. .|+.++||||||++++||+||..||.+-
T Consensus 237 GIsGrlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c 297 (391)
T KOG0983|consen 237 GISGRLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC 297 (391)
T ss_pred cccceeeccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence 999877543322 234589999999987643 5889999999999999999999999874
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=260.86 Aligned_cols=197 Identities=28% Similarity=0.432 Sum_probs=156.7
Q ss_pred CcccccCceEEEEEEec----CCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.. .....+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 36899999999999842 24579999875322 2345678899999999999999999997632 234568999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++++|.+++..... ..++..++.++.|++.||.||| +.+++||||||+|||+++++.+||+|||++
T Consensus 77 e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~ 145 (262)
T cd05058 77 PYMKHGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLA 145 (262)
T ss_pred ecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCcccc
Confidence 99999999999975432 2345677889999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCc--ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 017712 306 RFLPAIDKQ--NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDG 362 (367)
Q Consensus 306 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~ 362 (367)
+........ .......+++.|+|||.+.+..++.++||||||+++|||++ |.+||..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 146 RDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred ccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 754321110 11112235678999999988889999999999999999999 5666754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=259.49 Aligned_cols=201 Identities=25% Similarity=0.453 Sum_probs=167.5
Q ss_pred CCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
++|++.+.||+|+||.||+|...++..+|+|.+.... .....+.+|++++++++||||+++++++. .....+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEEE
Confidence 4678889999999999999987668899999876322 23467899999999999999999999873 34467999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
|||+++++|.+++..... .++++.+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 78 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~ 146 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGM 146 (256)
T ss_pred EEcCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcc
Confidence 999999999999875432 3567888999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 147 TRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred eeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 8765332111 1112224568999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=303.34 Aligned_cols=206 Identities=28% Similarity=0.377 Sum_probs=170.6
Q ss_pred HhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
.+.+-+|+....||.|.||.||.|. ..+|...|+|-++... ....+...+|..++..++|||+|++||.-. .
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv-----H 1305 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV-----H 1305 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee-----c
Confidence 3456688999999999999999999 7779999999876322 334567889999999999999999999853 3
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....+|.||||++|+|.+.+.... ..++.....+..|++.|++||| +.|||||||||+||+++.+|.+
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~gr---------i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~i 1373 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHGR---------IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLI 1373 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhcc---------hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcE
Confidence 445689999999999999997654 2334455567889999999999 8999999999999999999999
Q ss_pred EEeccccccccCCCC--CcceeeeccCCCcccCCccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 298 HVGDFGMARFLPAID--KQNRFICIKGSTGYIPPEYDLGCE---ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++|||.|..+.... -........||+.|||||++.+.. ...++||||+||++.||+||+.||..+
T Consensus 1374 K~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1374 KYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred EeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence 999999998775432 112233456999999999998653 567789999999999999999999764
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=262.46 Aligned_cols=199 Identities=24% Similarity=0.381 Sum_probs=168.0
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC-CCcchhHHHHHHHHHHhCC---CCCcceeeeeecccccCCcee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI-RPGGSKSFKSECKAAINIK---HRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 220 (367)
.|+..+.||+|+||.||+|. ..+++.+|+|.++.. .......+.+|+.++++++ |||++++++++. ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 47788899999999999999 467899999998643 2334567889999999986 999999999873 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||+++++|.+++... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~ 143 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG----------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLC 143 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc----------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEc
Confidence 79999999999999998653 3567888999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||++......... .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..||.+..
T Consensus 144 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 144 DFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred cCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999876543321 2233588899999988654 46889999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=259.12 Aligned_cols=199 Identities=19% Similarity=0.261 Sum_probs=161.2
Q ss_pred HHHHhhcCCCCCCCcc--cccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHh-CCCCCcceeeeeeccc
Q 017712 138 KDLYNATNGFSSANLI--GAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN-IKHRNIVRVFTAFSGV 213 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~ 213 (367)
.+.....++|++.+.+ |+|+||.||++. ..++..+|+|.+....... .|+..... .+||||++++++|..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~- 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT- 80 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec-
Confidence 3344445677777776 999999999998 5578899999986432211 12222222 279999999999843
Q ss_pred ccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
....++||||+++++|.+++.... .+++.++..++.|++.||.||| +.+++||||||+||+++.
T Consensus 81 ----~~~~~iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~ 144 (267)
T PHA03390 81 ----LKGHVLIMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDR 144 (267)
T ss_pred ----CCeeEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeC
Confidence 346799999999999999997654 4678999999999999999999 899999999999999999
Q ss_pred CC-ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 294 EM-IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 294 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++ .++|+|||++....... ...|+..|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 145 ~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 145 AKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred CCCeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 88 99999999987653221 2347899999999998889999999999999999999999997553
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=259.57 Aligned_cols=189 Identities=23% Similarity=0.359 Sum_probs=156.8
Q ss_pred CcccccCceEEEEEEecC-C----------CEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 151 NLIGAGNFGSVYNGTLFD-G----------TTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
+.||+|+||.||+|...+ + ..+++|.+...... ...+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 368999999999999543 3 25788876643332 6788999999999999999999998743 3
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC----
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM---- 295 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~---- 295 (367)
..+++|||+++|+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~ 142 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEG 142 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccC
Confidence 45899999999999999976542 3667888999999999999999 89999999999999999887
Q ss_pred ---ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC--CCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 296 ---IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC--EASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 296 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
.+||+|||++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...
T Consensus 143 ~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 143 YVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred CceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 799999999986533 1122367789999998876 78999999999999999999 68888665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=265.51 Aligned_cols=202 Identities=30% Similarity=0.420 Sum_probs=168.4
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHh--CCCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN--IKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
....++.++||+|.||.||+|.+ +++.||||++.. .....|++|-+|.+. ++|+||+++++.-...... ....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence 34566778999999999999985 459999999863 456778888888775 5899999999886443322 4467
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCC------CCCeEecCCCCCceeecCCC
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC------QPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~------~~~iiH~dlkp~Nil~~~~~ 295 (367)
+||++|.+.|+|.+||+.+. .+|.+..+|+..+++||+|||+.. +.+|+|||||+.|||+.+|+
T Consensus 284 wLVt~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl 353 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL 353 (534)
T ss_pred eEEeeeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence 99999999999999998764 778999999999999999999643 46799999999999999999
Q ss_pred ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCC-CC-----cchhHHHHHHHHHHHHhCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-AS-----TYGDVYSFGILLLEMFTGIRPS 360 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~~l~el~tg~~Pf 360 (367)
++-|+|||+|..+.............||.+|||||++.+.. +. .+.||||+|.+|||++++..-+
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 99999999999887766666666678999999999988753 22 3579999999999999976544
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=258.35 Aligned_cols=200 Identities=24% Similarity=0.433 Sum_probs=168.1
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|+..+.||+|+||.||++. ..+++.+|+|.+.... ......+.+|++++++++||||+++++.+. .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence 47788999999999999998 4578999999986432 234567889999999999999999999873 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC-CceEEec
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-MIGHVGD 301 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~-~~~kl~D 301 (367)
+||||+++++|.+++...... .+++..+..++.|++.||.||| +++++|+||+|+||+++++ +.+||+|
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d 145 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNS-------LLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGD 145 (256)
T ss_pred EEEecCCCCCHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcc
Confidence 999999999999999764321 3678889999999999999999 8999999999999999754 4679999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||.+......... ....|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 146 ~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 146 FGISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred CCCceecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 9999866433221 1234788999999999888899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=263.66 Aligned_cols=209 Identities=21% Similarity=0.274 Sum_probs=167.3
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.+++++. ||||+++++++...+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468889999999999999999 4568999999876432 223467889999999995 699999999886544333445
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-CCceEE
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHV 299 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-~~~~kl 299 (367)
.+++|||+++ +|.+++....... ...+++..++.++.||+.||.||| +++++||||||+||+++. ++.+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl 152 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGP----GRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKI 152 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEE
Confidence 7999999975 8999886543210 114678899999999999999999 899999999999999998 899999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.
T Consensus 153 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 153 ADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred eecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999876532211 1112236788999998865 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=261.67 Aligned_cols=199 Identities=21% Similarity=0.326 Sum_probs=167.7
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
-|+..+.||+|+||.||+|. ..++..+|+|.+.... ......+.+|+.++.+++||||+++++++. .....++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence 36678899999999999998 4568999999876332 223467889999999999999999999973 3456799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
||||+++++|.+++... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 80 v~e~~~~~~l~~~i~~~----------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg 146 (277)
T cd06641 80 IMEYLGGGSALDLLEPG----------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFG 146 (277)
T ss_pred EEEeCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecc
Confidence 99999999999998643 3567889999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++..+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+..
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 147 VAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred cceecccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 98765432211 122347889999999988888999999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=264.91 Aligned_cols=200 Identities=23% Similarity=0.324 Sum_probs=165.8
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCc-----chhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG-----GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
+|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.++++++||||+++++++. ...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence 477888999999999999984 46899999998743322 2345678999999999999999999974 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+ +++|.+++..... .+++..+..++.|+++||.||| +++++|+||||+||+++.++.+||
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~--------~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l 143 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSI--------VLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKL 143 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEE
Confidence 779999999 8999999976431 3678889999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||+++........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+..
T Consensus 144 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 144 ADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred ccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 999999866443211 122235788999998855 457889999999999999999988886543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=260.36 Aligned_cols=202 Identities=25% Similarity=0.400 Sum_probs=159.6
Q ss_pred CcccccCceEEEEEEec-CCC--EEEEEEeecCC-CcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGTLF-DGT--TIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|... ++. .+++|.++... ......+.+|+.++.++ +||||+++++++. .....+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence 36899999999999853 443 46888876432 23446788999999999 8999999999974 344579999
Q ss_pred EeccCCCHHHHhhCCCCCCCC-------CcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 226 KFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
||+++|+|.+++......... .....+++..+..++.|++.||+||| +++++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEE
Confidence 999999999999764321110 01114678899999999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
|+|||++....... .......+..|+|||++....++.++||||||+++|||++ |..||.+.
T Consensus 153 l~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 153 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred ECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 99999986322111 1111223567999999988889999999999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=288.57 Aligned_cols=204 Identities=26% Similarity=0.457 Sum_probs=173.7
Q ss_pred CCCCCCCcccccCceEEEEEEec----CCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
+...+.++||.|.||+||+|+++ ....||||.++... +.....|+.|+.||.+++||||+++-|.. ....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~ 703 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSK 703 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCc
Confidence 34567889999999999999943 24679999998543 34677899999999999999999999996 4556
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+||.|||++|+|+.+|+.+.. .|+.-+...++++|+.|+.||- +.++|||||...|||++.+..+|+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DG--------qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKV 772 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKV 772 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCC--------ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEe
Confidence 78999999999999999998764 5778889999999999999999 999999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccC--CCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKG--STGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~~ 365 (367)
+|||+++.+.+.. .......-| ..+|.|||.+....++..|||||||++|||.++ |..||-+...
T Consensus 773 sDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 773 SDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred ccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 9999999876544 222222212 568999999999999999999999999999886 9999876653
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=258.93 Aligned_cols=200 Identities=25% Similarity=0.366 Sum_probs=168.7
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||+|+||.+|+++ ..+++.+|+|.+.... ......+.+|+.++++++||||+++++++ ......+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 47888999999999999998 4578999999987432 23446789999999999999999999987 3445789
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+++||+++++|.+++...... .+++.+++.++.|++.||.||| +++++|+||+|+||+++.++.++|+||
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~ 145 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGV-------LFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDF 145 (256)
T ss_pred EEEecCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeec
Confidence 999999999999998754321 3567888999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|++......... .....|++.|+|||++.+...+.++|+|||||++++|++|+.||..
T Consensus 146 ~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 146 GIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred cceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 999765432211 1123478899999999888899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=262.72 Aligned_cols=200 Identities=25% Similarity=0.380 Sum_probs=164.8
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|+..+.||.|++|.||+|+. .+++.+|+|.+.... ......+.+|++++++++||||+++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 478889999999999999984 568999999886432 223457889999999999999999999873 445679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+. ++|.+++...... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+||+||
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~-------~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~df 144 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPLS-------GIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 144 (284)
T ss_pred EEeeccc-cCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeec
Confidence 9999995 6899988654321 4678889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++........ ......+++.|+|||.+.+.. ++.++||||||+++|+|+||+.||.+.
T Consensus 145 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 145 GLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred cchhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99876533221 112223688899999887644 588899999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=271.01 Aligned_cols=202 Identities=22% Similarity=0.284 Sum_probs=167.2
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (367)
..++|++.+.||+|+||.||+|. ..+++.+|+|.+... .......+.+|+.++++++||||++++++|..... .+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 45789999999999999999999 457899999998632 22344567789999999999999999998753321 223
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+. ++|.+++... ++...+..++.|++.||+||| +.+++||||||+||+++.++.+|
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEE
Confidence 45799999995 5888887532 456778889999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+|||+++....... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||.+
T Consensus 159 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 159 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred EccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 999999986543221 1223478899999999998999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=260.56 Aligned_cols=212 Identities=24% Similarity=0.366 Sum_probs=166.5
Q ss_pred CCCCCcccccCceEEEEEEec----CCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC-ce
Q 017712 147 FSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG-AR 219 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~-~~ 219 (367)
|.+.+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|++++++++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999732 36889999986432 234567889999999999999999999875432111 22
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++++|+++|+|.+++...... .....++...+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG---EEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc---CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEE
Confidence 357889999999999887543211 01124677888999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+|||+++...............+++.|++||.+....++.++||||||+++|+|++ |..||.+..
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 99999986543222111122235678999999988889999999999999999999 899997653
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=261.59 Aligned_cols=193 Identities=28% Similarity=0.361 Sum_probs=162.2
Q ss_pred ccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEec
Q 017712 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (367)
Q Consensus 153 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (367)
||+|+||.||++. ..+++.+|+|.+.... ......+.+|++++++++||||+++++.+. .....+++|||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecC
Confidence 6899999999998 4568999999986422 223455678999999999999999998873 345679999999
Q ss_pred cCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccccc
Q 017712 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
++++|.+++...... .+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||.+...
T Consensus 76 ~~~~L~~~l~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~ 145 (277)
T cd05577 76 NGGDLKYHIYNVGEP-------GFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL 145 (277)
T ss_pred CCCcHHHHHHHcCcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence 999999998764421 4678889999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.+.
T Consensus 146 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 146 KGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred ccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 4311 112234788999999998888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=261.80 Aligned_cols=197 Identities=23% Similarity=0.323 Sum_probs=167.4
Q ss_pred CCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
|...+.||+|++|.||++. ..+++.+++|.+........+.+.+|+.++..++||||+++++++. .....++++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEEE
Confidence 4445789999999999998 4578999999987554445667889999999999999999999874 345679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++++|.+++... .++...+..++.|++.||+||| +++++||||+|+||+++.++.++|+|||.+
T Consensus 96 e~~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~ 162 (285)
T cd06648 96 EFLEGGALTDIVTHT----------RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFC 162 (285)
T ss_pred eccCCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccc
Confidence 999999999998762 3567888999999999999999 899999999999999999999999999988
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
......... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 163 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 163 AQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred hhhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 755332211 12234889999999998888999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=261.60 Aligned_cols=199 Identities=27% Similarity=0.348 Sum_probs=169.2
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|++++++++||||+++++.+. .....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEE
Confidence 3677888999999999999994 468999999987543 234567889999999999999999999873 336789
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEecCCCCCceeecCCCceEEec
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+++||+++++|.+++..... .+++..+..++.|++.||.||| + .+++|+||||+||++++++.++|+|
T Consensus 76 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d 144 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQG--------RIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCD 144 (265)
T ss_pred EEEEecCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEee
Confidence 99999999999999976421 4667888899999999999999 7 8999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||.+......... ...++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 145 ~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 145 FGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred cccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 9998765322111 145788999999999989999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=263.81 Aligned_cols=201 Identities=23% Similarity=0.317 Sum_probs=168.0
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|++.+.||+|+||.||+|.. .+++.||+|.++.. .....+.+.+|++++++++||||+++++++.. ....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 3688899999999999999984 46889999988643 23345778999999999999999999999843 4567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+++|||++++.+..+..... .++...+..++.|++.||.||| ..+++|+||+|+||++++++.+||+|
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d 143 (288)
T cd07833 76 YLVFEYVERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCD 143 (288)
T ss_pred EEEEecCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEe
Confidence 99999998877766655433 3668889999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||++......... ......++..|+|||++.+. .++.++||||||+++|+|++|..||.+.
T Consensus 144 ~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 144 FGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred eecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999876443321 12223478889999999887 7899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=273.94 Aligned_cols=210 Identities=26% Similarity=0.411 Sum_probs=178.2
Q ss_pred CChHHHHhhcCCCCCCCcccccCceEEEEEEecC-CCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeeccc
Q 017712 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGV 213 (367)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (367)
+..++|+....+.....+||-|.||.||.|.++. .-.||||.++.. .-..++|+.|+.+|+.++|||+|+++|.|.
T Consensus 257 Pn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT-- 333 (1157)
T KOG4278|consen 257 PNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-- 333 (1157)
T ss_pred CCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhc--
Confidence 4557788888888888999999999999999544 678999998743 335789999999999999999999999983
Q ss_pred ccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
.+...|||.|||..|+|.+||+..... .++.-..+.++.||..|++||. .+++|||||...|+|+.+
T Consensus 334 ---~EpPFYIiTEfM~yGNLLdYLRecnr~-------ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgE 400 (1157)
T KOG4278|consen 334 ---HEPPFYIITEFMCYGNLLDYLRECNRS-------EVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGE 400 (1157)
T ss_pred ---cCCCeEEEEecccCccHHHHHHHhchh-------hcchhHHHHHHHHHHHHHHHHH---Hhhhhhhhhhhhhccccc
Confidence 345679999999999999999875532 2344556788999999999999 899999999999999999
Q ss_pred CCceEEeccccccccCCCCCcceeeeccC---CCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKG---STGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+..+|++|||++++.... .++...| ...|.|||.+..+.++.|+|||+|||+|||+.| |..||.|+-
T Consensus 401 nhiVKvADFGLsRlMtgD----TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 401 NHIVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 471 (1157)
T ss_pred cceEEeeccchhhhhcCC----ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 999999999999976432 2222233 457999999999999999999999999999998 999999874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=233.47 Aligned_cols=199 Identities=23% Similarity=0.347 Sum_probs=165.1
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|...++||+|.||+||+|+ ..+++.||+|.++.. .++-.....+|+-+++.++|.|||++++.. .......
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 45667889999999999999 566899999998743 344557789999999999999999999985 4556778
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+|+||| ..+|..|...-.. .+..+.+..++.|+++||.|+| ++++.|||+||.|.|++.+|.+|++||
T Consensus 78 lvfe~c-dqdlkkyfdslng--------~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladf 145 (292)
T KOG0662|consen 78 LVFEFC-DQDLKKYFDSLNG--------DLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADF 145 (292)
T ss_pred EeHHHh-hHHHHHHHHhcCC--------cCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEeccc
Confidence 999999 5589888865432 4667888999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCC-CCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
|+++.++-.-.. .....-|..|.+|.++.+.. |++..|+||.||++.|+.. |++.|.|.
T Consensus 146 glarafgipvrc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 146 GLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred chhhhcCCceEe--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 999976543221 12223588899999998864 7889999999999999986 77777663
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=259.60 Aligned_cols=195 Identities=27% Similarity=0.454 Sum_probs=164.3
Q ss_pred CCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
++|++.+.||+|+||.||++. .+++.+|+|.++.. .....+.+|+.++++++||||+++++++.. ...+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE-YTGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc-cCCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEEE
Confidence 468889999999999999987 57788999998642 235678999999999999999999998742 225899
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
|||+++++|.+++...... .+++..++.++.|++.||.||| +++++||||||+||+++.++.+||+|||+
T Consensus 77 ~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~ 146 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRA-------LVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGL 146 (254)
T ss_pred EECCCCCCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCcc
Confidence 9999999999999764321 3567888999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
+....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.
T Consensus 147 ~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 147 ARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred ceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 87543211 11224567999999988889999999999999999998 99999765
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=269.91 Aligned_cols=205 Identities=22% Similarity=0.276 Sum_probs=169.7
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.++|.+.+.||+|+||.||+|+ ..+++.||+|.+... .......+.+|+.+++.++||||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4579999999999999999998 557899999998642 2223456788999999999999999999875543333356
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++++||+. ++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---------TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEC
Confidence 799999995 79999987654 4778899999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||++........ ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 151 DFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 9999986543221 1122347889999998765 46889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=256.34 Aligned_cols=201 Identities=27% Similarity=0.458 Sum_probs=167.5
Q ss_pred CCCCCcccccCceEEEEEEecC-----CCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 147 FSSANLIGAGNFGSVYNGTLFD-----GTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
|++.+.||+|+||.||++.... +..+|+|.+...... ..+.+.+|+..+..++||||+++++++.. ...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCe
Confidence 4567889999999999998433 388999998754433 56788999999999999999999999743 356
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||+++++|.+++...... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~ 145 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPK-------ELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKIS 145 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhc-------cCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEc
Confidence 79999999999999999765421 1678899999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
|||++............ ...+++.|+|||.+.+..++.++||||||+++++|++ |..||.+.
T Consensus 146 dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 146 DFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred ccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999866543221111 2236789999999988889999999999999999998 88998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=264.41 Aligned_cols=204 Identities=26% Similarity=0.333 Sum_probs=167.0
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
..++|++.+.||+|+||.||+|. ..+++.||+|.++.... .....+.+|+.++++++|+||+++++++.+ ....
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCC
Confidence 35689999999999999999999 45689999999874332 223456789999999999999999999753 2234
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+. ++|.+++..... .+++.++..++.|++.||.||| +.+++||||||+||+++.++.+||
T Consensus 82 ~~~lv~e~~~-~~l~~~l~~~~~--------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 82 SIFLVMEYCE-QDLASLLDNMPT--------PFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred eEEEEEecCC-CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 5799999996 589888875321 4778899999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||++......... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 150 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 150 ADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999876433211 112235778999999865 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=265.20 Aligned_cols=208 Identities=23% Similarity=0.321 Sum_probs=167.0
Q ss_pred CCCCCCcccccCceEEEEEEe-c--CCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-F--DGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
+|++.+.||+|+||.||+|.. . +++.||+|.+.... ......+.+|+.++.+++||||+++++++.. ....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence 477888999999999999994 3 58999999987533 3445678899999999999999999999853 2235
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC----CC
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD----EM 295 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~----~~ 295 (367)
..++||||++ ++|.+++....... ...+++..+..++.|++.||.||| +.+++||||||+||+++. ++
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~ 149 (316)
T cd07842 78 SVYLLFDYAE-HDLWQIIKFHRQAK----RVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERG 149 (316)
T ss_pred eEEEEEeCCC-cCHHHHHHhhccCC----CcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccc
Confidence 6899999996 47877775432111 114678889999999999999999 899999999999999999 99
Q ss_pred ceEEeccccccccCCCCC-cceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDK-QNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.+||+|||++........ ........+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+..
T Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 999999999986643222 1111223468899999987664 57899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=259.47 Aligned_cols=191 Identities=24% Similarity=0.305 Sum_probs=155.2
Q ss_pred cccccCceEEEEEE-ecCCCEEEEEEeecCCCc---chhHHHHHHH---HHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG---GSKSFKSECK---AAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 152 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
.||+|+||.||+|. ..+++.||+|.+...... ....+..|.. .+...+||||+++++++. .....++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence 48999999999998 456899999998643221 1222344433 344458999999998873 34567999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+
T Consensus 76 ~e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~ 143 (278)
T cd05606 76 LDLMNGGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 143 (278)
T ss_pred EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcC
Confidence 99999999999987544 4778999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+..+..... ....|+..|+|||.+.+. .++.++||||+|+++|+|++|..||.+.
T Consensus 144 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 144 ACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred ccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 876533221 123589999999998754 6889999999999999999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=257.66 Aligned_cols=208 Identities=23% Similarity=0.296 Sum_probs=171.2
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||.|+||.||++. ..+++.+|+|.+.... ....+.+.+|++++++++||||+++++++.. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 47788999999999999998 5578899999986432 2345678899999999999999999987743 2345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCC--CCCeEecCCCCCceeecCCCceEEe
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC--QPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~--~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
++|||+++++|.+++..... ....+++..++.++.|++.||.|||... +.+++|+||+|+||++++++.+||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKK-----ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred EEehhccCCCHHHHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEe
Confidence 99999999999999865321 0114678889999999999999999432 5689999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||++......... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.
T Consensus 153 d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 153 DFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred cccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 99999876443321 12235799999999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=263.78 Aligned_cols=208 Identities=24% Similarity=0.319 Sum_probs=167.2
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeeccccc---CC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY---QG 217 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 217 (367)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.++++++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 4578999999999999999999 4568999999886432 2233456789999999999999999998754321 12
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....+++|||+. ++|.+++..... .+++.++..++.|++.||.||| +++++|+||||+||+++.++.+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNV--------KFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGIL 158 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcE
Confidence 345699999995 588888765431 4678899999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCc--ceeeeccCCCcccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|||++......... .......++..|+|||.+.+.. ++.++||||||+++|+|++|..||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999866432221 1112234678899999886653 688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=260.65 Aligned_cols=203 Identities=30% Similarity=0.425 Sum_probs=161.9
Q ss_pred CcccccCceEEEEEEecC-------CCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 151 NLIGAGNFGSVYNGTLFD-------GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence 368999999999998432 2578999876432 2345678899999999999999999998743 34579
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-----ce
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-----IG 297 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~-----~~ 297 (367)
++|||+++++|.+++........ ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~ 150 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERF--GPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVV 150 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhccc--CCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcce
Confidence 99999999999999975432110 1113677889999999999999999 88999999999999999877 89
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 151 KIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred EECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 9999999976543222111112235678999999998899999999999999999998 99999754
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=262.09 Aligned_cols=204 Identities=26% Similarity=0.274 Sum_probs=168.8
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|...+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++||||++++++|.. ......+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 4677888999999999999994 5689999999874322 345678999999999999999999998743 2234578
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++...... ...++...+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+||
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeec
Confidence 999999999999887532210 114677888999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++........ ....++..|+|||.+.+..++.++||||||+++|+|++|..||+..
T Consensus 150 g~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 150 GVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 99875432211 1234688899999998888999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=261.81 Aligned_cols=201 Identities=24% Similarity=0.309 Sum_probs=160.7
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-cchhHHHHHHHH-HHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKA-AINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|++.+.||+|+||.||+|. ..+++.||+|.++.... .....+..|+.+ ++.++||||+++++++. .....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence 468889999999999999998 45699999999874322 233455666665 56678999999999974 34457
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCC-CeEecCCCCCceeecCCCceEEe
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~-~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
+++|||++ |+|.+++...... ...+++..+..++.|++.||.||| ++ +++||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~ 146 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDK-----GLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLC 146 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEe
Confidence 99999995 6898887643211 115778999999999999999999 76 99999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG----CEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|||++........ .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||..
T Consensus 147 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 147 DFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 9999986533211 122347889999998865 3468899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=262.24 Aligned_cols=202 Identities=26% Similarity=0.335 Sum_probs=167.0
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|++.+.||+|+||.||+|.. .+++.+|+|.++.... .....+.+|+.++.+++||||+++++++... .....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence 4788899999999999999994 4688999999874332 2334567899999999999999999987532 23678
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+++|||++ ++|.+++..... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d 149 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICD 149 (293)
T ss_pred EEEehhcC-cCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEee
Confidence 99999996 599998875432 4778899999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||++........ ......+++.|+|||.+.+. ..+.++|+||||+++|+|++|..||.+.
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 150 FGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred cCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999986644321 11223468899999998764 4688999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=261.57 Aligned_cols=205 Identities=26% Similarity=0.384 Sum_probs=169.4
Q ss_pred CCCCCCCcccccCceEEEEEEec-----CCCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
..|++.+.||+|+||.||+|+.. ++..+|+|.++..... ....+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 35777889999999999999843 3688999998754443 46789999999999999999999998743 234
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++++|.+++..... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~ 149 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVK 149 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEE
Confidence 567999999999999999976442 3678889999999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcce-eeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNR-FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||.+........... .....++..|+|||.+.+..++.++||||||+++|||+||..||...
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred EcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 999999987653221111 11122456799999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=269.08 Aligned_cols=206 Identities=24% Similarity=0.321 Sum_probs=169.8
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.++.+++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 4689999999999999999998 5569999999987432 234567788999999999999999999875432 33456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+. ++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ---------PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEec
Confidence 799999995 69999987554 4678899999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcc--eeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQN--RFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||++.......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 999997654322111 1122357889999998765 45789999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=254.08 Aligned_cols=207 Identities=21% Similarity=0.275 Sum_probs=167.4
Q ss_pred CCCCCCCcccccCceEEEEEE-ecC----CCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFD----GTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
..|+....||+|.||.||+|. .++ .+.+|+|.++..+. +......+|+..++.++|||++.+...|.. .
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~----~ 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS----H 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc----c
Confidence 468888999999999999996 222 24789999985433 345677899999999999999999998853 3
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC---
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE--- 294 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~--- 294 (367)
....++++||.+. +|.++|+-......+ .++...+..|+.||+.|+.||| ++-|+||||||+|||+..+
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~----~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgpe 171 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAK----QLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPE 171 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhc----cCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCc
Confidence 5678999999965 999999765543222 4666778899999999999999 8899999999999999877
Q ss_pred -CceEEeccccccccCCCCCcc-eeeeccCCCcccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 295 -MIGHVGDFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 295 -~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|.+||+|||+++.+.+.-..- ......-|..|.|||.+.|.. |++..||||.||++.||+|-.+-|.|-
T Consensus 172 rG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 172 RGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999999999875432111 112233588899999999875 788889999999999999999988764
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=260.86 Aligned_cols=199 Identities=23% Similarity=0.334 Sum_probs=165.1
Q ss_pred CCCCCCcccccCceEEEEEEe----cCCCEEEEEEeecCC----CcchhHHHHHHHHHHhC-CCCCcceeeeeecccccC
Q 017712 146 GFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 216 (367)
+|++.+.||+|+||.||++.. .++..||+|.+.... ....+.+.+|+.++.++ +||||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 477889999999999999984 368999999987422 22346788999999999 599999999887 3
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
.....+++|||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~ 143 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE---------RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGH 143 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCC
Confidence 3456789999999999999997654 4667888889999999999999 899999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC--EASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+||+|||++......... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||..
T Consensus 144 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 144 VVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred EEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 999999999765432211 12234578999999998753 467889999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=272.41 Aligned_cols=213 Identities=22% Similarity=0.291 Sum_probs=176.4
Q ss_pred ChHHHHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeec
Q 017712 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFS 211 (367)
Q Consensus 136 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 211 (367)
.++.-....+-|..++.||-|+||+|.+++ .++...+|.|.+++.. .......+.|-.||...+.+-||++|-.|
T Consensus 620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF- 698 (1034)
T KOG0608|consen 620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF- 698 (1034)
T ss_pred HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-
Confidence 344444555668889999999999999998 5567889999886432 22345567899999999999999999887
Q ss_pred ccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee
Q 017712 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (367)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~ 291 (367)
++...+|+||+|++||++-.+|-..+ -|.+..++.++.++..|+++.| +.|+|||||||+||||
T Consensus 699 ----QDkdnLYFVMdYIPGGDmMSLLIrmg---------IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILI 762 (1034)
T KOG0608|consen 699 ----QDKDNLYFVMDYIPGGDMMSLLIRMG---------IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILI 762 (1034)
T ss_pred ----ccCCceEEEEeccCCccHHHHHHHhc---------cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEE
Confidence 55667899999999999999987766 5788888999999999999999 9999999999999999
Q ss_pred cCCCceEEeccccccccCCCCC--------cc--------------------------------eeeeccCCCcccCCcc
Q 017712 292 DDEMIGHVGDFGMARFLPAIDK--------QN--------------------------------RFICIKGSTGYIPPEY 331 (367)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~--------~~--------------------------------~~~~~~gt~~y~aPE~ 331 (367)
|.+|++||+|||+|.-+.-... +. ......||+.|+|||+
T Consensus 763 DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapev 842 (1034)
T KOG0608|consen 763 DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEV 842 (1034)
T ss_pred ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHH
Confidence 9999999999999975421100 00 0113459999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 332 DLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 332 ~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
+....++..+|.||.||+||||+.|+.||..-..
T Consensus 843 l~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 843 LARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred hcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence 9999999999999999999999999999975543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=255.56 Aligned_cols=200 Identities=26% Similarity=0.248 Sum_probs=157.2
Q ss_pred CCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-cchhHHHHHHHHHHh-CCCCCcceeeeeecccccCCceeeeEE
Q 017712 148 SSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAIN-IKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 148 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
+.+..||.|+||.|++-. ...|+..|||+++.... ...++++.|.+...+ -+.||||++||.+. .+...|+.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F-----~EGdcWiC 141 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF-----SEGDCWIC 141 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh-----cCCceeee
Confidence 334679999999999987 56799999999985443 456778888876554 57999999999973 34567999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
||+| ..||+.+-+.-... ....+++...-.|+.-.+.||.||-. ...|||||+||+|||++..|.+||||||+
T Consensus 142 MELM-d~SlDklYk~vy~v----q~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 142 MELM-DISLDKLYKRVYSV----QKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred HHHH-hhhHHHHHHHHHHH----HhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccc
Confidence 9999 55776654321110 11146667677788888999999985 57899999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+..+...- ..+...|...|||||.+.. ..++.+|||||||++|||++||+.|+++
T Consensus 215 cGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 215 CGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred hHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 98664321 2233458899999998764 3589999999999999999999999875
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=282.39 Aligned_cols=204 Identities=20% Similarity=0.221 Sum_probs=155.8
Q ss_pred hcCCCCCCCcccccCceEEEEEEecC--CCEEEEEEee-----------------cCCCcchhHHHHHHHHHHhCCCCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFD--GTTIAVKVFN-----------------LIRPGGSKSFKSECKAAINIKHRNI 203 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~-----------------~~~~~~~~~~~~E~~~l~~l~h~ni 203 (367)
..++|++.+.||+|+||.||+|.... +...+.|.+. .........+.+|+.++.+++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999986322 2222222110 0111234567899999999999999
Q ss_pred ceeeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecC
Q 017712 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283 (367)
Q Consensus 204 v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~d 283 (367)
+++++++. .....+++++++ .++|.+++........ .......+..++.|++.||.||| +++|+|||
T Consensus 226 v~l~~~~~-----~~~~~~lv~e~~-~~~l~~~l~~~~~~~~----~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrD 292 (501)
T PHA03210 226 LKIEEILR-----SEANTYMITQKY-DFDLYSFMYDEAFDWK----DRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRD 292 (501)
T ss_pred CcEeEEEE-----ECCeeEEEEecc-ccCHHHHHhhcccccc----ccccHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 99999974 334568999998 5688888765431110 02235667889999999999999 89999999
Q ss_pred CCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 017712 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360 (367)
Q Consensus 284 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf 360 (367)
|||+|||++.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 293 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 293 IKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999876432221 112345899999999999999999999999999999999987644
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=261.03 Aligned_cols=191 Identities=25% Similarity=0.364 Sum_probs=154.9
Q ss_pred CcccccCceEEEEEEecC--------CCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 151 NLIGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence 368999999999997422 23488888764444455678899999999999999999999843 34568
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc------
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI------ 296 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~------ 296 (367)
+||||+++|+|.+++..... .+++..++.++.|++.||+||| +++|+||||||+||+++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~ 144 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNP 144 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCC
Confidence 99999999999999976542 3567888999999999999999 899999999999999987664
Q ss_pred --eEEeccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCC-CCCCCC
Q 017712 297 --GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGI-RPSDGI 363 (367)
Q Consensus 297 --~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~-~Pf~~~ 363 (367)
++++|||++...... ....+++.|+|||++.+. .++.++||||||+++|+|++|. .||...
T Consensus 145 ~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 145 PFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred ceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 699999998654321 123478899999998874 5789999999999999999984 666543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=272.43 Aligned_cols=201 Identities=25% Similarity=0.357 Sum_probs=175.0
Q ss_pred CCCCCCCcccccCceEEEEEEecCC-CEEEEEEeec---CCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFDG-TTIAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.+++....||-|+||.|=++..... ..+|+|+++. ......+....|-.+|...+.|.||++|..| .+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence 3556677899999999999884443 3478888763 3444567788999999999999999999987 55678
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.|++||-|-||.|...|+..+ .|....+..++..+++|++||| +++||.|||||+|.++|.+|.+||.
T Consensus 495 vYmLmEaClGGElWTiLrdRg---------~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLV 562 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG---------SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLV 562 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC---------CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEe
Confidence 899999999999999999877 5777788889999999999999 9999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
|||+|+.+.... .+..++|||.|.|||++....++..+|.||||+++|||++|.+||.+.-+
T Consensus 563 DFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 563 DFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred ehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 999999886544 34456799999999999999999999999999999999999999998644
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=257.00 Aligned_cols=192 Identities=28% Similarity=0.341 Sum_probs=163.9
Q ss_pred ccccCceEEEEEEe-cCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEec
Q 017712 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (367)
Q Consensus 153 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (367)
||.|+||.||+|+. .+++.+|+|.+..... ...+.+.+|+.++++++||||+++++.+. .....++++||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 69999999999994 4589999999864322 23467899999999999999999999873 345679999999
Q ss_pred cCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccccc
Q 017712 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
++++|.+++.... .++...+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++...
T Consensus 76 ~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~ 143 (262)
T cd05572 76 LGGELWTILRDRG---------LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143 (262)
T ss_pred CCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCccccc
Confidence 9999999997654 3667888999999999999999 899999999999999999999999999999866
Q ss_pred CCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+..
T Consensus 144 ~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 144 KSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred Cccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 4432 1122357889999999988889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=260.06 Aligned_cols=202 Identities=24% Similarity=0.350 Sum_probs=166.2
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
+|++.+.||+|++|.||+|+. .+++.+|+|.++... ......+.+|+.++++++||||+++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence 578889999999999999994 468999999987433 2345677899999999999999999999743 356799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||+++ +|.+++...... ..+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||
T Consensus 76 v~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g 145 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGVR------GALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFG 145 (284)
T ss_pred EEecCCc-cHHHHHHhcCCC------CCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecc
Confidence 9999975 899988654321 14678899999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+..
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 146 LARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred hhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9975533211 11223468889999987664 56889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=261.96 Aligned_cols=193 Identities=22% Similarity=0.318 Sum_probs=164.5
Q ss_pred CcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEecc
Q 017712 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMP 229 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 229 (367)
.+||+|+||.||++.. .++..+|+|.+..........+.+|+.+++.++||||+++++.+. .....+++|||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEEecCC
Confidence 5699999999999984 578999999986544445667899999999999999999999874 3456799999999
Q ss_pred CCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccC
Q 017712 230 NGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309 (367)
Q Consensus 230 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 309 (367)
+++|.+++... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 101 ~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~ 167 (292)
T cd06657 101 GGALTDIVTHT----------RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167 (292)
T ss_pred CCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecc
Confidence 99999987543 2567888999999999999999 8899999999999999999999999999987654
Q ss_pred CCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
..... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.
T Consensus 168 ~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 168 KEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred ccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 32211 22345789999999998888899999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=257.65 Aligned_cols=199 Identities=25% Similarity=0.351 Sum_probs=164.6
Q ss_pred CCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
|++.+.||.|++|.||+|. ..++..||+|++.... ......+.+|+.+++.++|||++++++++. .....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 5678899999999999998 4579999999987433 223467889999999999999999999973 3467799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||++ ++|.+++...... .+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||
T Consensus 76 v~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~ 144 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPLT-------GLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFG 144 (283)
T ss_pred EEeccC-cCHHHHHhhCCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecc
Confidence 999994 6999998765421 4678889999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++......... .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||.+.
T Consensus 145 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 145 LARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred cccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99755322111 1222368889999987664 5688999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=258.85 Aligned_cols=202 Identities=24% Similarity=0.325 Sum_probs=172.0
Q ss_pred hcCCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.+++|+....||+|++|.||+|... ++..+++|.+..... ....+.+|++.++.++|+||+++++++.. ....
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-----GDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEE
Confidence 4567888899999999999999954 689999999875443 46778899999999999999999999743 3567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++++||+++++|.+++..... .++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d 159 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFV--------RMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLAD 159 (286)
T ss_pred EEEEeccCCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECc
Confidence 999999999999999986541 4677889999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||++......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+.
T Consensus 160 ~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 160 FGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred cchhhhhccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 9998755432211 12234788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=267.17 Aligned_cols=194 Identities=27% Similarity=0.441 Sum_probs=165.5
Q ss_pred CCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEE
Q 017712 150 ANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (367)
.++||+|.||+||-|+ .++|+.||||++.+.+ ......+++|+.||..+.||.||.+--.| ++....++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEeh
Confidence 4689999999999998 6789999999997433 34557899999999999999999987776 56677899999
Q ss_pred eccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC---CCceEEeccc
Q 017712 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EMIGHVGDFG 303 (367)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~---~~~~kl~Dfg 303 (367)
-+ .|+..+.|-..... ++++.....+..||+.||.||| .++|+|+||||+|||+.. --.+||+|||
T Consensus 644 Kl-~GDMLEMILSsEkg-------RL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFG 712 (888)
T KOG4236|consen 644 KL-HGDMLEMILSSEKG-------RLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFG 712 (888)
T ss_pred hh-cchHHHHHHHhhcc-------cchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeecccc
Confidence 99 66877777655433 5777777888999999999999 899999999999999954 3578999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+|+.++... ......|||.|+|||++....|...-|+||.||++|--++|..||-.
T Consensus 713 fARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 713 FARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred ceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 999875432 22356799999999999999999999999999999999999999954
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=259.34 Aligned_cols=200 Identities=25% Similarity=0.336 Sum_probs=162.1
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|++.+.||+|++|.||+|.. .+++.+|+|.+..... .....+.+|++++++++||||+++++++. .....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 4788899999999999999984 4789999999864322 23467889999999999999999999973 34568
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-CCceEEe
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVG 300 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-~~~~kl~ 300 (367)
++||||++ ++|.+++...... .+++..+..++.||+.||+||| +++++|+||+|+||+++. ++.+||+
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~ 145 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDF-------AKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLA 145 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCC-------CcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEc
Confidence 99999995 5888887654321 3456778889999999999999 889999999999999985 5678999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|||++........ ......+++.|+|||++.+. .++.++||||||+++|+|+||..||.+
T Consensus 146 dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 146 DFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred ccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999975533211 11223468899999988664 578899999999999999999999964
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=261.05 Aligned_cols=197 Identities=21% Similarity=0.291 Sum_probs=162.8
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
...|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++||||++++++|.. ..
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CC
Confidence 34688889999999999999984 4689999999864322 233568899999999999999999999843 34
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++|+||++ |+|.+++..... .+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL 156 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHKK--------PLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKL 156 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEE
Confidence 5789999996 678777754321 3667889999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||++....... ...|++.|+|||++. ...++.++||||||+++|||+||..||.+.
T Consensus 157 ~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 157 ADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred eecCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 9999987543221 234788999999874 356788999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=264.86 Aligned_cols=215 Identities=26% Similarity=0.401 Sum_probs=175.2
Q ss_pred CCChHHHHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---C----cchhHHHHHHHHHHhCCCCCcce
Q 017712 134 NPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---P----GGSKSFKSECKAAINIKHRNIVR 205 (367)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~----~~~~~~~~E~~~l~~l~h~niv~ 205 (367)
+..|++.....++|-++.+||+|||+.||+|. +...+.||+|+-...+ . .-.+...+|.+|.+.|+||.||+
T Consensus 452 nSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 452 NSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred hhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence 34455555556678889999999999999998 5668899999865322 1 12345678999999999999999
Q ss_pred eeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 017712 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (367)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlk 285 (367)
+|++|. .+....|-|+|||+|-+|+-||+... .++++++..|+.||+.||.||..- +.+|||-|||
T Consensus 532 lYDyfs----lDtdsFCTVLEYceGNDLDFYLKQhk---------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLK 597 (775)
T KOG1151|consen 532 LYDYFS----LDTDSFCTVLEYCEGNDLDFYLKQHK---------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLK 597 (775)
T ss_pred eeeeee----eccccceeeeeecCCCchhHHHHhhh---------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccC
Confidence 999984 33445689999999999999999877 688999999999999999999944 7899999999
Q ss_pred CCceee---cCCCceEEeccccccccCCCCCc-----ceeeeccCCCcccCCccccCC----CCCcchhHHHHHHHHHHH
Q 017712 286 PSNVLL---DDEMIGHVGDFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLGC----EASTYGDVYSFGILLLEM 353 (367)
Q Consensus 286 p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~el 353 (367)
|.|||+ +..|.+||+|||+++........ .-+....||..|++||.+.-+ .++.+.||||.||++|.+
T Consensus 598 PgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQC 677 (775)
T KOG1151|consen 598 PGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQC 677 (775)
T ss_pred CccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhh
Confidence 999999 45688999999999987543222 122345689999999986543 468899999999999999
Q ss_pred HhCCCCCCC
Q 017712 354 FTGIRPSDG 362 (367)
Q Consensus 354 ~tg~~Pf~~ 362 (367)
+.|+.||..
T Consensus 678 lYGrKPFGh 686 (775)
T KOG1151|consen 678 LYGRKPFGH 686 (775)
T ss_pred hccCCCCCC
Confidence 999999954
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=255.64 Aligned_cols=201 Identities=25% Similarity=0.392 Sum_probs=168.0
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||+|+||.||+|. ..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 47788899999999999999 4568899999986432 23456788999999999999999999987 3445679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-ceEEec
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IGHVGD 301 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~-~~kl~D 301 (367)
+++||+++++|.+++...... .+++..+..++.|++.||.||| +.+++|+||||+||++++++ .+||+|
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d 145 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGV-------LFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGD 145 (257)
T ss_pred EEEecCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecc
Confidence 999999999999998754321 3567889999999999999999 88999999999999998875 469999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||.+........ ......|++.|+|||+..+..++.++|+||||+++|+|++|..||.+.
T Consensus 146 ~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 146 FGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred cccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 999976643221 112234889999999998888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=265.23 Aligned_cols=204 Identities=24% Similarity=0.335 Sum_probs=166.1
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC--CCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 218 (367)
..++|++.+.||+|+||.||+|.. .+++.+|+|.+... .......+.+|+.++.++ +||||++++++|.. ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 346788899999999999999984 46889999988532 223345677899999999 99999999998743 233
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||++ ++|.+++... .+.+..+..++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~k 147 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN----------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVK 147 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEE
Confidence 45799999996 5999988654 2456777889999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCc---ceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQ---NRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||++......... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.
T Consensus 148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred EeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999866443221 12223457889999998765 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=255.06 Aligned_cols=191 Identities=23% Similarity=0.341 Sum_probs=157.0
Q ss_pred CcccccCceEEEEEEe-cCCCEEEEEEeecCCCc---chhHHHHHHHHH-HhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAA-INIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|.. .+++.+|+|.+...... ....+..|..++ ...+||||+++++++. .....++++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 4689999999999984 56899999998643221 122344554443 4558999999999973 345689999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++
T Consensus 77 e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 144 (260)
T cd05611 77 EYLNGGDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLS 144 (260)
T ss_pred eccCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccc
Confidence 9999999999997654 4667888999999999999999 889999999999999999999999999998
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
..... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.+..
T Consensus 145 ~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 145 RNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred eeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 75432 112347889999999988888999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=263.02 Aligned_cols=203 Identities=23% Similarity=0.326 Sum_probs=167.9
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccc
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (367)
.++...+++|++.+.||+|+||.||+|. ..+++.+|+|.+... .....+.+.+|+.++..++||||++++++|..
T Consensus 3 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-- 80 (328)
T cd07856 3 GTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS-- 80 (328)
T ss_pred cceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec--
Confidence 3455678899999999999999999998 557999999987532 22345678899999999999999999998742
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
.....++++||+ +++|.+++... .++...+..++.|++.||.||| +.+++||||+|+||+++++
T Consensus 81 --~~~~~~lv~e~~-~~~L~~~~~~~----------~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~ 144 (328)
T cd07856 81 --PLEDIYFVTELL-GTDLHRLLTSR----------PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINEN 144 (328)
T ss_pred --CCCcEEEEeehh-ccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCC
Confidence 234578999998 66999888643 2456777889999999999999 8999999999999999999
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+.+||+|||.+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.
T Consensus 145 ~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 145 CDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred CCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999998754221 112346888999998766 56899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.49 Aligned_cols=200 Identities=27% Similarity=0.403 Sum_probs=161.4
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC-CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccC-----
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ----- 216 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----- 216 (367)
.++|+.+.+||+||||.||+++ .-||+.||||++... +......+.+|+..+++|+|||||++|..+...+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 4568889999999999999999 678999999998743 233456788999999999999999998665432100
Q ss_pred --------------------------------------------------------------------------------
Q 017712 217 -------------------------------------------------------------------------------- 216 (367)
Q Consensus 217 -------------------------------------------------------------------------------- 216 (367)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ---------------------Cc--------eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHH
Q 017712 217 ---------------------GA--------RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267 (367)
Q Consensus 217 ---------------------~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~ 267 (367)
.+ ..+||-||||+..+|.+++..+.... ......+++++|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--------~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--------QRDEAWRLFREILEG 709 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--------hhHHHHHHHHHHHHH
Confidence 01 35688899999988888887654210 356778899999999
Q ss_pred HHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccC----------------CCCCcceeeeccCCCcccCCcc
Q 017712 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP----------------AIDKQNRFICIKGSTGYIPPEY 331 (367)
Q Consensus 268 L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~ 331 (367)
|.|+| ++|||||||||.||++++++.+||+|||+|.... ........+...||.-|+|||+
T Consensus 710 LaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 99999 8999999999999999999999999999998721 0111223456679999999999
Q ss_pred ccCCC---CCcchhHHHHHHHHHHHH
Q 017712 332 DLGCE---ASTYGDVYSFGILLLEMF 354 (367)
Q Consensus 332 ~~~~~---~~~~~DvwslG~~l~el~ 354 (367)
+.+.. |+.|+|+|||||+++||+
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~ 812 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEML 812 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHh
Confidence 87654 999999999999999998
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=252.22 Aligned_cols=204 Identities=25% Similarity=0.384 Sum_probs=173.0
Q ss_pred CCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|+..+.||+|++|.||+|... +++.+++|.+..... ...+.+.+|+.++++++||||+++++.+... .....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence 4777889999999999999954 789999999875432 3467889999999999999999999987432 125679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+++||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 78 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~ 145 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADF 145 (260)
T ss_pred EEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccc
Confidence 9999999999999997654 4678889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|.+................++..|+|||.+.+...+.++||||||+++++|++|..||.+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99987654432111223457889999999988889999999999999999999999997653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=255.41 Aligned_cols=194 Identities=27% Similarity=0.405 Sum_probs=163.5
Q ss_pred ccccCceEEEEEEec-CCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEec
Q 017712 153 IGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (367)
Q Consensus 153 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (367)
||+|+||.||++... +++.+++|.+..... .....+.+|++++.+++||||+++++.+ ......++++||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 689999999999954 589999999864332 3456788999999999999999999886 3456679999999
Q ss_pred cCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccccc
Q 017712 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++...
T Consensus 76 ~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~ 143 (265)
T cd05579 76 PGGDLASLLENVG---------SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVG 143 (265)
T ss_pred CCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence 9999999997644 4678889999999999999999 899999999999999999999999999998754
Q ss_pred CCCCC------cceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 309 PAIDK------QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 309 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
..... ........++..|+|||.......+.++||||||+++|+|++|..||...
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 144 LVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred ccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 33211 11222344788999999998888899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=250.23 Aligned_cols=199 Identities=23% Similarity=0.281 Sum_probs=171.7
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeec---CCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL---IRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 218 (367)
-++|.++.+||+|+|++|..++ ..+.+.+|+|+++. ....+.+-.+.|-.+..+. +||.+|.++.+| +++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----qte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----QTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----ccc
Confidence 4679999999999999999998 66789999999873 2333455566676666654 799999999886 677
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
..+++|.||.+||+|--+++.+. .++++.+..+...|+.||.||| ++|||.||||.+|+|+|..|.+|
T Consensus 324 srlffvieyv~ggdlmfhmqrqr---------klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghik 391 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIK 391 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhh---------cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCcee
Confidence 78899999999999988887665 6889999999999999999999 99999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
|+|+|+++.--. ....+..++|||.|+|||++.+..|....|.|+|||+++||+.|+.||+
T Consensus 392 ltdygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 392 LTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred ecccchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 999999984322 2233445679999999999999999999999999999999999999997
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=264.46 Aligned_cols=206 Identities=22% Similarity=0.326 Sum_probs=168.4
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccc
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (367)
.++...+++|++.+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+.++.+++||||+++++++....
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 4456677899999999999999999998 4578999999986422 223456788999999999999999999874322
Q ss_pred c-CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 215 Y-QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 215 ~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
. ......+++++++ +++|.+++... .+++..+..++.|++.||.||| +++++||||||+||+++.
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 155 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcC
Confidence 1 1223467888877 78999887643 3667888999999999999999 899999999999999999
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
++.+||+|||+++..... .....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999998754321 122347889999998766 4678899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=251.02 Aligned_cols=199 Identities=28% Similarity=0.417 Sum_probs=170.9
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||+|++|.||++.. .+++.+++|.+..... .....+.+|++++.+++|||++++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 477889999999999999984 4688999999875443 35567899999999999999999999873 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+||
T Consensus 76 ~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~ 143 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADF 143 (254)
T ss_pred EEEecCCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEecc
Confidence 9999999999999987653 4678889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|.+......... .....++..|+|||...+..++.++||||||+++|+|++|..||...
T Consensus 144 ~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 144 GVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred ccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 999876543322 12234788999999988888899999999999999999999999754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=249.90 Aligned_cols=199 Identities=25% Similarity=0.386 Sum_probs=171.6
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
.|+..+.||+|++|.||++.. .++..+++|++..........+.+|+..+.+++|||++++++++.. ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEEE
Confidence 367788999999999999995 4689999999876554466789999999999999999999998743 3567999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
+||+++++|.+++..... .+++..+..++.|++.||.+|| ..+++|+||+|+||++++++.++|+|||.
T Consensus 76 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~ 144 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQ--------TLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGL 144 (253)
T ss_pred EecCCCCcHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccc
Confidence 999999999999876531 4678889999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+........ .....++..|+|||.+.+...+.++|+||||+++|+|++|..||...
T Consensus 145 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 145 SAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred ccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 986644321 22334788999999998888899999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=257.89 Aligned_cols=207 Identities=25% Similarity=0.316 Sum_probs=166.9
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccc-----
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD----- 214 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 214 (367)
..++|++.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 456899999999999999999994 468999999987432 233456788999999999999999999875432
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
.......++++||+++ +|..++..... .+++..+..++.|++.||.||| +.+|+|+||||+||+++++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~ 152 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLV--------HFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNK 152 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence 0123367999999975 77777765321 4678899999999999999999 8999999999999999999
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+.+||+|||++......... ......++..|+|||.+.+. .++.++|||||||++|+|++|++||..
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 153 GQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred CcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999866433221 11122357789999987653 568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=260.29 Aligned_cols=208 Identities=24% Similarity=0.336 Sum_probs=166.9
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeeccccc---CC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY---QG 217 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 217 (367)
.++|++.+.||+|+||.||+|. ..+++.+|+|.+..... .....+.+|++++++++||||+++++.+..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4689999999999999999999 45689999999864322 233567899999999999999999988754321 12
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....++++||+. ++|...+..... .+++..+..++.|+++||.||| +.+++|+||||+||++++++.+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~--------~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSV--------KLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGIL 154 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCE
Confidence 345789999995 478777764321 4778999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccCCCCCc---------ceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQ---------NRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|||+++........ .......|++.|+|||.+.+. .++.++|||||||++|||++|++||.+.
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999765432211 111223468889999987654 5789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=254.00 Aligned_cols=201 Identities=25% Similarity=0.405 Sum_probs=164.2
Q ss_pred CCCCCCcccccCceEEEEEEec--CCCEEEEEEeecCCC----------cchhHHHHHHHHHHh-CCCCCcceeeeeecc
Q 017712 146 GFSSANLIGAGNFGSVYNGTLF--DGTTIAVKVFNLIRP----------GGSKSFKSECKAAIN-IKHRNIVRVFTAFSG 212 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 212 (367)
+|++.+.||+|+||.||+|... .++.+|+|.+..... .....+.+|+.++.+ ++||||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 4788899999999999999954 378899998863221 123456778888765 79999999999873
Q ss_pred cccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEecCCCCCceee
Q 017712 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLL 291 (367)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH~dlkp~Nil~ 291 (367)
.....+++|||+++++|.+++...... ...+++..+..++.|++.||.||| . .+++|+||+|+||++
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~ 147 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEK-----KQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIML 147 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEE
Confidence 345789999999999999987532110 114677889999999999999999 5 689999999999999
Q ss_pred cCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+.++.+||+|||.+....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 148 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 148 GEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred CCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 999999999999998654322 22334578899999999988899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=264.67 Aligned_cols=206 Identities=22% Similarity=0.323 Sum_probs=166.3
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccC------
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ------ 216 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------ 216 (367)
.++|.+.+.||.|+||.||+|. ..+++.||+|.+........+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 4689999999999999999998 456899999998766556667889999999999999999999876432111
Q ss_pred ---CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec-
Q 017712 217 ---GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD- 292 (367)
Q Consensus 217 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~- 292 (367)
.....+++|||++ ++|.+++... .+++..+..++.|++.||.||| +.+++||||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~ 149 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----------PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINT 149 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcC
Confidence 1235789999996 5998888643 3667889999999999999999 89999999999999997
Q ss_pred CCCceEEeccccccccCCCCCcc-eeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 293 DEMIGHVGDFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.++.+||+|||.+..+....... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 45678999999997653321111 1112246888999998654 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=263.33 Aligned_cols=206 Identities=21% Similarity=0.273 Sum_probs=171.5
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||+|+||.||+|+. .+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 578889999999999999994 458999999987433 33456789999999999999999999998554323344679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||++ ++|.+++.... .+++..+..++.|++.||.||| +++++||||||.||+++.++.++|+||
T Consensus 81 lv~e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~df 147 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDF 147 (330)
T ss_pred EEecchh-hhHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccc
Confidence 9999996 58999987654 4778889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCc-ceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|++......... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+..
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 999876443210 112223478899999999887 78999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=255.17 Aligned_cols=198 Identities=22% Similarity=0.270 Sum_probs=160.3
Q ss_pred CCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCceeeeE
Q 017712 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
|++.+.||+|+||.||+|. ..+++.+|+|.++... ........+|+.++.++. ||||+++++++.+. .....++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 5677889999999999998 5578999999986432 222334557888898885 99999999998532 2256799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||++ ++|.+++..... .+++..+..++.|++.||.||| +.+++||||+|+||+++. +.+||+|||
T Consensus 78 v~e~~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 78 VFELMD-MNLYELIKGRKR--------PLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred EEecCC-ccHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecc
Confidence 999996 588888865431 4678899999999999999999 889999999999999999 999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+++........ ....+++.|+|||.+.. ..++.++|||||||++|||++|..||.+.
T Consensus 145 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 145 SCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred cccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 99866433222 12347889999997654 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=236.01 Aligned_cols=205 Identities=22% Similarity=0.285 Sum_probs=160.8
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeec-CCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-IRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 219 (367)
..+....+..||+|+||.|-+-+ ..+|+..|+|.+.. ......++..+|+.+..+. .+|.+|.+||.. ....
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~reg 118 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FREG 118 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hccc
Confidence 34445556789999999998777 67899999999873 2333456778898876654 799999999986 3456
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++.||.| ..||..+-+..-.. ....++.-+-+|+..++.||.|||+ +..+||||+||+|||++.+|.+|+
T Consensus 119 dvwIcME~M-~tSldkfy~~v~~~-----g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKi 190 (282)
T KOG0984|consen 119 DVWICMELM-DTSLDKFYRKVLKK-----GGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKI 190 (282)
T ss_pred cEEEeHHHh-hhhHHHHHHHHHhc-----CCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEE
Confidence 689999999 45887664432111 1146677788899999999999997 678999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG----CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||||.+-.+.+.- ..+...|...|||||.+.. ..|+.+|||||||++++||.+++.||+.-
T Consensus 191 CDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 191 CDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 9999998764321 1122348889999998754 36899999999999999999999999754
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=258.25 Aligned_cols=195 Identities=23% Similarity=0.296 Sum_probs=161.5
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.|...+.||+|+||.||+|+ ..++..+|+|.+..... .....+.+|++++++++|||++++++++. .....
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeE
Confidence 36778899999999999998 45689999999864322 23356889999999999999999999974 33457
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+++|||++ |+|.+++..... .+++.++..++.|++.||.||| +++++||||+|+||+++.++.+||+|
T Consensus 101 ~lv~e~~~-g~l~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~d 168 (317)
T cd06635 101 WLVMEYCL-GSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLAD 168 (317)
T ss_pred EEEEeCCC-CCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEec
Confidence 99999996 588887754321 3668889999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||++...... ....|++.|+|||++. ...++.++|||||||++|+|++|..||.+.
T Consensus 169 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 169 FGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred CCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 9998754321 1234788999999974 456889999999999999999999998664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=262.08 Aligned_cols=204 Identities=21% Similarity=0.292 Sum_probs=167.4
Q ss_pred HhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-C
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-Q 216 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~ 216 (367)
....++|++.+.||+|+||.||+|. ..++..||+|.+.... ......+.+|+.++++++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 3456789999999999999999998 5578999999985322 1233567899999999999999999998753221 1
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
.....+++|||+ +++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~----------~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE----------KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCE 156 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCC
Confidence 123468999999 77999888643 3668889999999999999999 899999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+||+|||++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.
T Consensus 157 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 157 LKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred EEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998653211 22346889999999876 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=256.17 Aligned_cols=202 Identities=28% Similarity=0.460 Sum_probs=171.4
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCce
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 219 (367)
++|.+.+.||+|+||.||+|.. .+++.+|+|++... .......+.+|+.++.+++ ||||+++++.+ ....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 4688899999999999999994 47999999998642 2233467889999999998 99999999987 3445
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l 143 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKI 143 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEe
Confidence 6799999999999999998654 4778899999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCc------------------ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 300 GDFGMARFLPAIDKQ------------------NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
+|||++......... .......|+..|+|||...+...+.++|+||||++++++++|..||.
T Consensus 144 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (280)
T cd05581 144 TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223 (280)
T ss_pred cCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 999999866443211 12223457889999999888889999999999999999999999997
Q ss_pred CC
Q 017712 362 GI 363 (367)
Q Consensus 362 ~~ 363 (367)
..
T Consensus 224 ~~ 225 (280)
T cd05581 224 GS 225 (280)
T ss_pred Cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=272.92 Aligned_cols=216 Identities=22% Similarity=0.322 Sum_probs=183.8
Q ss_pred hHHHHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccc
Q 017712 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVD 214 (367)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 214 (367)
+..+...++.|.+.+.||.|.+|.||+++ .++++..|+|+...... ..+++..|.++++.+ .|||++.+|++|...+
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 33445567789999999999999999999 77899999999875443 456778888898887 6999999999998777
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
......+|||||||.+||..|+++..... .+.+..+..|++.++.||.||| .+.++|||||-.|||++.+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~-------rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGN-------RLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTEN 159 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhccc-------chhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEecc
Confidence 77788899999999999999999876522 5778899999999999999999 8999999999999999999
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-----EASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
+.+||.|||.+..+...-. ......|||.|||||++... .|+..+|+||||++..||.-|.+|+.+...
T Consensus 160 ~~VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred CcEEEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 9999999999987754322 22345699999999997643 467889999999999999999999976543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=260.86 Aligned_cols=204 Identities=21% Similarity=0.252 Sum_probs=163.9
Q ss_pred CCCCCCcccccCceEEEEEEe-cC--CCEEEEEEeecCC--CcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCce
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FD--GTTIAVKVFNLIR--PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 219 (367)
+|++.+.||+|+||.||++.. .+ +..+|+|.+.... ....+.+.+|+.++.++ +||||+++++.+.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 477788999999999999993 34 7889999886322 22345678899999999 5999999998754321 2334
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++++|+. ++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEe
Confidence 5688899885 69999987544 4678889999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCc--ceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++.+...... .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 999999866432211 11123458899999998765 46889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=255.15 Aligned_cols=201 Identities=26% Similarity=0.374 Sum_probs=165.6
Q ss_pred CCCCCcccccCceEEEEEEec-CCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 147 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++|||++++++++... .....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 567789999999999999844 58999999998543 33456788999999999999999999997432 1357899
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
++||++ ++|.+++..... .+++..++.++.|++.||+||| +.+++|+||+|+||++++++.+||+|||
T Consensus 78 v~e~~~-~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g 145 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPEV--------KFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFG 145 (287)
T ss_pred Eecccc-ccHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEcccc
Confidence 999997 489998875421 4678889999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||++.
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 146 LARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred ceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9986644321 11222346788999998765 35789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=254.84 Aligned_cols=204 Identities=23% Similarity=0.318 Sum_probs=166.3
Q ss_pred CCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCC--cchhHHHHHHHHHHhC---CCCCcceeeeeecccccCCcee
Q 017712 147 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGSKSFKSECKAAINI---KHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 220 (367)
|++.+.||+|+||.||+|+.. +++.+|+|.++.... .....+.+|+.++.++ +||||+++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999954 589999999873322 2234567788777666 6999999999986654434445
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||++ ++|.+++...... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~-------~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~ 149 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKP-------GLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIA 149 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEe
Confidence 899999996 5899988754321 4678899999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||.+..+...... ....++..|+|||.+.+..++.++|+|||||++|+|++|.+||++..
T Consensus 150 dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 150 DFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred ccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 99999766432221 12236888999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=260.03 Aligned_cols=202 Identities=22% Similarity=0.338 Sum_probs=162.9
Q ss_pred cCCCC-CCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcc--------------hhHHHHHHHHHHhCCCCCcceee
Q 017712 144 TNGFS-SANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG--------------SKSFKSECKAAINIKHRNIVRVF 207 (367)
Q Consensus 144 ~~~~~-~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~ 207 (367)
.++|. +.+.||+|+||.||+|. ..+++.||+|.+....... ...+.+|++++..++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 45679999999999998 4568999999986432211 12477899999999999999999
Q ss_pred eeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCC
Q 017712 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPS 287 (367)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~ 287 (367)
+++. .....+++|||++ ++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+
T Consensus 87 ~~~~-----~~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~ 148 (335)
T PTZ00024 87 DVYV-----EGDFINLVMDIMA-SDLKKVVDRKI---------RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPA 148 (335)
T ss_pred EEEe-----cCCcEEEEEeccc-cCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHH
Confidence 9973 3456799999996 69999987543 4678889999999999999999 899999999999
Q ss_pred ceeecCCCceEEeccccccccCCCC------------CcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHH
Q 017712 288 NVLLDDEMIGHVGDFGMARFLPAID------------KQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMF 354 (367)
Q Consensus 288 Nil~~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~ 354 (367)
||+++.++.+||+|||.+....... .........+++.|+|||.+.+. .++.++|||||||++|+|+
T Consensus 149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~ 228 (335)
T PTZ00024 149 NIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228 (335)
T ss_pred HeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999999997654110 01111223367889999998764 4689999999999999999
Q ss_pred hCCCCCCCC
Q 017712 355 TGIRPSDGI 363 (367)
Q Consensus 355 tg~~Pf~~~ 363 (367)
+|..||.+.
T Consensus 229 tg~~p~~~~ 237 (335)
T PTZ00024 229 TGKPLFPGE 237 (335)
T ss_pred hCCCCCCCC
Confidence 999999754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=274.06 Aligned_cols=202 Identities=26% Similarity=0.421 Sum_probs=173.1
Q ss_pred CCCCCcccccCceEEEEEEe-cC----CCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 147 FSSANLIGAGNFGSVYNGTL-FD----GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~-~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
....++||+|+||+||+|.+ .. +-+||+|++.... .....++.+|+.+|.+++|||+++++++|... .
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------T 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------h
Confidence 44568899999999999983 23 3578999987433 34578899999999999999999999998532 2
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
..||++|++.|+|.+|++..+. .+-.+..+.+..||++|+.||| .++++||||-.+|||+.....+|+.
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~--------~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkit 840 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRD--------NIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKIT 840 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhc--------cccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEE
Confidence 6899999999999999987654 3556788999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~~ 365 (367)
|||+++.+.............-.+.|||-|.+....++.++|||||||++||++| |..|++|+..
T Consensus 841 dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 841 DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 9999998877665544444344678999999999999999999999999999998 9999999864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=258.46 Aligned_cols=202 Identities=26% Similarity=0.263 Sum_probs=158.9
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|...+.||+|+||.||++. ..+++.+|+|.+.... ......+.+|+.++.++. ||||+++++++. .....+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcEE
Confidence 45667889999999999998 4568999999986432 234567889999999996 999999999873 234568
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+. ++|.++...... .....+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+||
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYE----VLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred EEEeccc-CCHHHHHHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeec
Confidence 9999985 466554321100 000147788899999999999999993 259999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC---EASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+++.+...... ....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||..
T Consensus 153 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 153 GISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred chhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 999765432211 223478899999998776 688999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=269.83 Aligned_cols=205 Identities=26% Similarity=0.395 Sum_probs=172.5
Q ss_pred CCCCCCCcccccCceEEEEEEecC--C--CEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFD--G--TTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
....+.++||+|.||.|++|.+.. | ..||||.++..... ....|++|+.+|.+|+|||++++||...+ .
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------q 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------Q 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------c
Confidence 445667899999999999998542 3 46899999866655 67899999999999999999999999754 3
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
...+|||+++.|+|.+.|+..... .|.....-.++.|||.|+.||. .++.|||||-..|+|+.....+||
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~-------~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI 253 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKA-------ILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKI 253 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhcccc-------ceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeee
Confidence 458999999999999999873322 4667777889999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceee-eccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFI-CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~~ 365 (367)
+|||+.+.++......... ...-...|.|||.+....++.+||||+|||++|||+| |..||-|...
T Consensus 254 ~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 254 CDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred ecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 9999999887654433221 1123567999999999999999999999999999998 8999988653
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=248.18 Aligned_cols=203 Identities=25% Similarity=0.415 Sum_probs=171.5
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||.|+||.||++.. .++..+|+|.+..... .....+.+|+++++.++|||++++++.+. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 477889999999999999994 4689999999875433 45567889999999999999999999874 336779
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+++||+++++|.+++..... ....+++..+..++.+++.||.||| +.+++|+||+|+||++++++.++|+||
T Consensus 76 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~ 147 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKK-----EGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDF 147 (258)
T ss_pred EEEEecCCCcHHHHHHHhhc-----cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCc
Confidence 99999999999999976431 0115778899999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|.+........ ......|++.|+|||...+..++.++|+||+|+++++|++|..||...
T Consensus 148 ~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 148 GISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred cceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 99986644321 122235788999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=259.10 Aligned_cols=199 Identities=24% Similarity=0.283 Sum_probs=158.4
Q ss_pred Cccccc--CceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAG--NFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G--~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
..||+| +||.||++. ..+++.||+|++..... ...+.+.+|+.+++.++||||++++++|. .....++++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence 356666 999999998 45799999999874332 23467889999999999999999999984 345679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++++|.+++...... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+|++||+.+
T Consensus 79 e~~~~~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~ 148 (328)
T cd08226 79 PFMAYGSANSLLKTYFPE-------GMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHL 148 (328)
T ss_pred ecccCCCHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHH
Confidence 999999999998764321 3667888899999999999999 899999999999999999999999999865
Q ss_pred cccCCCCCcce-----eeeccCCCcccCCccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 306 RFLPAIDKQNR-----FICIKGSTGYIPPEYDLGC--EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 306 ~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
........... .....++..|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 149 YSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred hhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 43322111100 0111246679999998764 47899999999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=254.87 Aligned_cols=198 Identities=24% Similarity=0.346 Sum_probs=163.9
Q ss_pred CCCCCCcccccCceEEEEEEe----cCCCEEEEEEeecCC----CcchhHHHHHHHHHHhC-CCCCcceeeeeecccccC
Q 017712 146 GFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 216 (367)
+|++.+.||+|+||.||+++. .+++.+|+|.++... ....+.+.+|+.++.++ +||||+++++.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 467788999999999999873 357889999986322 22345688999999999 599999999886 3
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
.....++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|.||+++.++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~ 143 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGH 143 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCC
Confidence 4456789999999999999987543 4667888899999999999999 899999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCC--CCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE--ASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
++|+|||+++.+...... ......|+..|+|||...+.. .+.++||||||+++|+|++|..||.
T Consensus 144 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 144 VVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred EEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 999999998765432211 112345789999999987655 7889999999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=259.29 Aligned_cols=200 Identities=23% Similarity=0.330 Sum_probs=162.8
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 219 (367)
.++|.+.+.||+|+||.||+|+ ..+++.||+|.+... .......+.+|+.++..++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 4689999999999999999998 457899999998632 12234567899999999999999999998754321 1223
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++++||+. .+|..++.. .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMGH-----------PLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred eEEEEecccc-cCHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 4589999995 477776531 3567888899999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++...... ....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 159 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 159 LDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred eeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999987543211 12346888999999876 45889999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=256.63 Aligned_cols=198 Identities=22% Similarity=0.179 Sum_probs=157.0
Q ss_pred CCcccccCceEEEEEEecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEe
Q 017712 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (367)
.+.+|.|+++.||++. .+++.+|+|+++.. .......+.+|+.+++.++||||+++++++. .....+++|||
T Consensus 7 ~~~~~~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~ 80 (314)
T cd08216 7 GKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPL 80 (314)
T ss_pred hHhhcCCceEEEEEec-CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEec
Confidence 3344455555555554 47999999998753 3345578999999999999999999999873 34567999999
Q ss_pred ccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccc
Q 017712 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (367)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (367)
+++++|.+++...... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||.+..
T Consensus 81 ~~~~~l~~~l~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~ 150 (314)
T cd08216 81 MAYGSCEDLLKTHFPE-------GLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVS 150 (314)
T ss_pred cCCCCHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCcccee
Confidence 9999999999754321 3567888899999999999999 89999999999999999999999999998875
Q ss_pred cCCCCCc-----ceeeeccCCCcccCCccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 308 LPAIDKQ-----NRFICIKGSTGYIPPEYDLGC--EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 308 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
....... .......++..|+|||++... .++.++|||||||++|||++|+.||.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred eccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 5322111 111223467789999998763 5788999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=249.39 Aligned_cols=201 Identities=26% Similarity=0.355 Sum_probs=168.9
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|++.+.||+|+||.||++. ..+++.+|+|.+.... ......+.+|++++++++||||+++++++. .....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 47788999999999999998 5578899999987432 233556788999999999999999998874 336679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+++||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++|+||+|.||+++.++.+||+||
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~ 147 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKK-----RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDL 147 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeec
Confidence 999999999999998653210 114677888999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+.
T Consensus 148 g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 148 GISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred cchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9998664431 11234788999999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=253.60 Aligned_cols=200 Identities=24% Similarity=0.329 Sum_probs=161.3
Q ss_pred hcCCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCC-CcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 219 (367)
..++|++.+.||+|+||.||+|... +++.+|+|.++... ......+..|+.++.+.. ||||+++++++. ...
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~ 87 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDS 87 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCC
Confidence 3467888999999999999999955 48999999987432 223455677887776664 999999999973 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEecCCCCCceeecCCCceE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH~dlkp~Nil~~~~~~~k 298 (367)
..+++|||+ +++|.+++..... .+++..+..++.|++.||.||| + .+++||||+|+||++++++.+|
T Consensus 88 ~~~~v~e~~-~~~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~k 155 (296)
T cd06618 88 DVFICMELM-STCLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVK 155 (296)
T ss_pred eEEEEeecc-CcCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEE
Confidence 679999998 4578777654321 4677888899999999999999 5 5999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE----ASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+|||++..+...... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..
T Consensus 156 L~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 156 LCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred ECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 9999998765432221 2234688999999987654 78899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=262.02 Aligned_cols=200 Identities=21% Similarity=0.298 Sum_probs=170.7
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--------CcchhHHHHHHHHHHhCC---CCCcceeeeee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--------PGGSKSFKSECKAAINIK---HRNIVRVFTAF 210 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~ 210 (367)
...+|...+.+|+|+||.|+.|. ..+...|++|.+.+.+ .......-.|++||..++ |+||+|++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 34568999999999999999999 5567889999886432 223344568999999997 99999999998
Q ss_pred cccccCCceeeeEEEEec-cCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 017712 211 SGVDYQGARFKAVVYKFM-PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNV 289 (367)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Ni 289 (367)
++..+.||+||-- ++.+|+++|..++ .+++.++..|+.||+.|+++|| +.+|||||||-+|+
T Consensus 639 -----Eddd~yyl~te~hg~gIDLFd~IE~kp---------~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenv 701 (772)
T KOG1152|consen 639 -----EDDDYYYLETEVHGEGIDLFDFIEFKP---------RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENV 701 (772)
T ss_pred -----ecCCeeEEEecCCCCCcchhhhhhccC---------ccchHHHHHHHHHHHhcccccc---ccCceecccccccE
Confidence 4556779999865 5678999998877 6788999999999999999999 99999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 290 LLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 290 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.++.+|-+||+|||.|....+ ..+..+.||..|.|||++.|..| +..-|||++|++||.++....||..+
T Consensus 702 ivd~~g~~klidfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyni 772 (772)
T KOG1152|consen 702 IVDSNGFVKLIDFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYNI 772 (772)
T ss_pred EEecCCeEEEeeccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcCC
Confidence 999999999999999976533 34556779999999999999887 45579999999999999999999764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=251.94 Aligned_cols=199 Identities=25% Similarity=0.372 Sum_probs=160.0
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHh--CCCCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN--IKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
...+..+.+.||+|.||+||+|. +.|..||||+|... +...+.+|.+|... |+|+||+.+++.-... ......
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~-wrGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQ 283 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGR-WRGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQ 283 (513)
T ss_pred hhheeEEEEEecCccccceeecc-ccCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEE
Confidence 34567788999999999999998 56889999999743 34567777777765 6999999999874332 244567
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhC-----CCCCeEecCCCCCceeecCCC
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD-----CQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~-----~~~~iiH~dlkp~Nil~~~~~ 295 (367)
+|||.+|.+.|||+|||... .++.+..++++..+|.||+|||.+ -+..|.|||||+.|||+.+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r~----------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN----------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred EEEeeecccCCcHHHHHhhc----------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 89999999999999999875 367889999999999999999943 367899999999999999999
Q ss_pred ceEEeccccccccCCCCCc--ceeeeccCCCcccCCccccCCC----C--CcchhHHHHHHHHHHHHhC
Q 017712 296 IGHVGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGCE----A--STYGDVYSFGILLLEMFTG 356 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslG~~l~el~tg 356 (367)
.+-|+|+|+|....+.... .......||.+|||||++.... + -..+||||||.++||++.+
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 9999999999766443221 2223456999999999976532 1 2458999999999999754
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=251.19 Aligned_cols=198 Identities=25% Similarity=0.363 Sum_probs=165.2
Q ss_pred CCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 147 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
|++.+.||+|++|.||+|.. .+++.+++|.+..... .....+.+|+.++++++||||+++++++. .....++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence 56678899999999999984 5789999999864332 24567889999999999999999999873 3466799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
++||+++ +|.+++..... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||
T Consensus 76 v~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~ 143 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQR--------GLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFG 143 (283)
T ss_pred EEeccCC-CHHHHHHhhcc--------cCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeee
Confidence 9999965 88888876431 4678889999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.+....... .......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||.+.
T Consensus 144 ~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 144 LARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred eeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 998664432 112223478889999998776 7889999999999999999999999653
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=245.38 Aligned_cols=210 Identities=24% Similarity=0.327 Sum_probs=173.6
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEee--cCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC---
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG--- 217 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~--- 217 (367)
.+.|....+||+|.||+||+|+ ..+++.||+|++- ..+.+......+|+.+|..++|+|++.+++.|.......
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 3456667889999999999999 5668889998764 345556677789999999999999999999886654333
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....|+||.+|+. +|..+|..... .|+..++..++.++..||.|+| +..|+|||+||+|+|++.++.+
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~v--------r~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKV--------RFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGIL 163 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccc--------cccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceE
Confidence 2347999999965 99998876532 6888999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccCCCCCc--ceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
||+|||+++.+...... +..+...-|..|.+||.+.|. .++++.|||..||++.||+||.+-|+|-..
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 99999999877544332 223333358899999998875 589999999999999999999999988654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=251.67 Aligned_cols=194 Identities=24% Similarity=0.298 Sum_probs=159.8
Q ss_pred CCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
|...+.||+|+||.||+|+ ..+++.+++|.+..... .....+.+|+.++..++|||++++++++. .....+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEE
Confidence 5556789999999999998 45689999999864322 22356788999999999999999999974 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+. ++|.+++..... .+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.+||+||
T Consensus 98 lv~e~~~-~~l~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~df 165 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADF 165 (313)
T ss_pred EEEecCC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeec
Confidence 9999995 588887764331 3667888999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++...... ....|+..|+|||++. ...++.++|||||||++|+|++|..||.+.
T Consensus 166 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 166 GSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred CCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 998643221 1234788999999974 356788999999999999999999999654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=254.02 Aligned_cols=196 Identities=22% Similarity=0.324 Sum_probs=161.2
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
+.|+..+.||+|+||.||+|+ ..++..+|+|.+..... .....+.+|+++++.++|||++++++++.. ...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence 347777889999999999999 45688999999863222 233567889999999999999999998743 356
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+. |+|.+++..... .+++.++..++.|++.||.||| +.+++||||+|+||+++.++.+||+
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~~--------~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~ 157 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLG 157 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEEC
Confidence 799999996 688887754321 3667888999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||++...... ....|++.|+|||.+. ...++.++|||||||++|+|++|..||.+.
T Consensus 158 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 158 DFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred CcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 99998765322 1234788999999874 345788999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=288.82 Aligned_cols=192 Identities=27% Similarity=0.472 Sum_probs=159.5
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
...|...+.||+|+||.||+|+. .++..||+|.+..... ....|++.+++++||||++++++|.. ....+
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~ 759 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAY 759 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCE
Confidence 34577888999999999999984 6789999999864322 22456889999999999999999843 34569
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||+++|+|.++++. +++..+..++.|++.||+|||..++.+|+||||||+||+++.++.+++. |
T Consensus 760 lv~Ey~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~ 826 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826 (968)
T ss_pred EEEeCCCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence 99999999999999963 4578889999999999999997667799999999999999999888875 6
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|.+...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||+..
T Consensus 827 ~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 827 SLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred ccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 655432111 1124789999999999999999999999999999999999999654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=249.21 Aligned_cols=198 Identities=23% Similarity=0.315 Sum_probs=162.6
Q ss_pred CCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCceeeeE
Q 017712 147 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
|++.+.||+|++|.||+|+. .+++.+++|.+..... .......+|+..+.+++ ||||+++++++.. ....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence 56778999999999999995 4578999999864322 12234567999999999 9999999999743 456799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||+ +|+|.+++...... .+++..+..++.|++.||.||| +++++|+||+|+||++++++.++|+|||
T Consensus 76 v~e~~-~~~l~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~ 144 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGK-------PFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFG 144 (283)
T ss_pred EEecC-CCCHHHHHHhcccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecc
Confidence 99999 88999988765411 4678889999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.+......... ....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||.+.
T Consensus 145 ~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 145 LAREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred cceeccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 99865432221 22347889999998754 45789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=249.24 Aligned_cols=198 Identities=26% Similarity=0.370 Sum_probs=165.4
Q ss_pred CCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 147 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
|+..+.||+|+||.||+|+. .+++.+|+|.+.... ....+.+.+|+.++++++||||+++++++. .....++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 55678899999999999994 458999999987542 334567889999999999999999999873 3356799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
++||++ ++|.+++..... .+++..+..++.|++.||.||| +++++||||+|+||++++++.+||+|||
T Consensus 76 v~e~~~-~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g 143 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRPG--------PLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFG 143 (282)
T ss_pred EecCcC-cCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCC
Confidence 999997 599999976531 4678899999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.+........ ......++..|+|||.+.+. .++.++||||||+++||+++|..||.+.
T Consensus 144 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 144 LARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred cccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 9986543221 11222357789999998776 7899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=243.52 Aligned_cols=192 Identities=31% Similarity=0.389 Sum_probs=163.6
Q ss_pred ccccCceEEEEEEe-cCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEec
Q 017712 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (367)
Q Consensus 153 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (367)
||+|+||.||++.. .+++.+|+|.+..... .....+.+|+.++++++||||+++++.+ ......+++|||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 69999999999984 4589999999874322 2345788999999999999999999886 4456789999999
Q ss_pred cCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccccc
Q 017712 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 76 ~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 143 (250)
T cd05123 76 PGGELFSHLSKEG---------RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKEL 143 (250)
T ss_pred CCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceec
Confidence 9999999997654 4667888999999999999999 899999999999999999999999999999865
Q ss_pred CCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
..... ......++..|+|||...+...+.++|+||||+++|++++|..||...
T Consensus 144 ~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 144 SSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred ccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 43221 122344788999999998888899999999999999999999999654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=258.26 Aligned_cols=202 Identities=20% Similarity=0.320 Sum_probs=166.2
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (367)
..++|++...||+|++|.||+|+. .+++.||+|.+... .......+.+|+.++++++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 457899999999999999999994 46889999988632 22234567789999999999999999987743222 222
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++++||+ +++|.+++... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+|
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~k 158 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ----------KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELK 158 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEE
Confidence 3479999998 67999998753 3678889999999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.
T Consensus 159 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 159 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred Ecccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999865332 122347888999998765 36788999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=274.66 Aligned_cols=146 Identities=28% Similarity=0.367 Sum_probs=126.4
Q ss_pred cCCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|.+.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++..++||||+++++++ ....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 357889999999999999999944 689999999874322 2236788999999999999999999886 3345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++++|.+++.... .+++..++.++.||+.||.||| .++|+||||||+|||++.++.+||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~---------~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL 145 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG---------YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKL 145 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEE
Confidence 6899999999999999997544 3567788999999999999999 889999999999999999999999
Q ss_pred ecccccc
Q 017712 300 GDFGMAR 306 (367)
Q Consensus 300 ~Dfg~~~ 306 (367)
+|||+++
T Consensus 146 ~DFGls~ 152 (669)
T cd05610 146 TDFGLSK 152 (669)
T ss_pred EeCCCCc
Confidence 9999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=245.48 Aligned_cols=201 Identities=22% Similarity=0.325 Sum_probs=160.9
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC-----CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI-----RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
+|.+.+.||+|+||.||++.. ..+..+++|.++.. +......+..|+.++++++||||+++++++. ...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence 478889999999999999984 33455666665532 2223445778999999999999999999874 334
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++++||+++++|.+++..... ....+++..+..++.|++.||.||| +.+++|+||+|+||++++ +.+||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l 146 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKH-----TGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKI 146 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhh-----cccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEee
Confidence 57999999999999998864221 0114778899999999999999999 899999999999999975 56999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+|||.+........ ......|++.|+|||...+..++.++|+||||+++|+|++|..||.+
T Consensus 147 ~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 147 GDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred cccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999876543222 11233478899999999888889999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=240.80 Aligned_cols=180 Identities=21% Similarity=0.135 Sum_probs=150.6
Q ss_pred cCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEeccCCCHH
Q 017712 156 GNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLE 234 (367)
Q Consensus 156 G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 234 (367)
|.+|.||+++ ..+++.+|+|.+.... .+.+|...+....||||+++++++. .....+++|||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHH
Confidence 8999999999 5678999999986432 2345566666678999999999873 345679999999999999
Q ss_pred HHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccCCCCCc
Q 017712 235 EWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314 (367)
Q Consensus 235 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 314 (367)
+++.... .+++..+..++.|++.||.||| +++++||||||+||+++.++.++++|||.+.......
T Consensus 74 ~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-- 139 (237)
T cd05576 74 SHISKFL---------NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-- 139 (237)
T ss_pred HHHHHhc---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--
Confidence 9987644 3678889999999999999999 8999999999999999999999999999886543311
Q ss_pred ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
....++..|+|||.+.+..++.++||||+|+++|||++|..||..
T Consensus 140 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 140 ---DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ---ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 122357789999999888889999999999999999999988754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=245.51 Aligned_cols=200 Identities=24% Similarity=0.318 Sum_probs=165.0
Q ss_pred hhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCC--C----Ccceeeeeecccc
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH--R----NIVRVFTAFSGVD 214 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~~~~~~~~~~ 214 (367)
..+++|.+..++|+|.||.|-.+. ...+..||+|+++.... -.+..+-|++++.++.+ | .+|++.++|
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF---- 160 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWF---- 160 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh----
Confidence 347899999999999999999998 44578999999875432 34566789999999842 2 267777776
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD- 293 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~- 293 (367)
+-.++.++|+|.+ |.|+.++|..+.-. +|+...+..|+.|++++++||| +.+++|-||||+|||+.+
T Consensus 161 -dyrghiCivfell-G~S~~dFlk~N~y~-------~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 161 -DYRGHICIVFELL-GLSTFDFLKENNYI-------PFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSS 228 (415)
T ss_pred -hccCceEEEEecc-ChhHHHHhccCCcc-------ccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEecc
Confidence 4566789999998 77999999876532 6889999999999999999999 999999999999999831
Q ss_pred -------------------CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHH
Q 017712 294 -------------------EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMF 354 (367)
Q Consensus 294 -------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~ 354 (367)
+..+|++|||.|+...... .....|..|.|||++.+-+++..+||||+||+|+||.
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 3458999999998643221 2344699999999999999999999999999999999
Q ss_pred hCCCCCCCC
Q 017712 355 TGIRPSDGI 363 (367)
Q Consensus 355 tg~~Pf~~~ 363 (367)
||...|++=
T Consensus 304 tG~~LFqtH 312 (415)
T KOG0671|consen 304 TGETLFQTH 312 (415)
T ss_pred ccceecccC
Confidence 999988753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=255.16 Aligned_cols=217 Identities=24% Similarity=0.248 Sum_probs=155.8
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-----------------cCCCEEEEEEeecCCCcchhH--------------HHHH
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-----------------FDGTTIAVKVFNLIRPGGSKS--------------FKSE 191 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 191 (367)
..++|++.++||+|+||.||+|.. ..++.||||.++.......+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 567899999999999999999963 235679999987543333333 3346
Q ss_pred HHHHHhCCCCCc-----ceeeeeeccccc---CCceeeeEEEEeccCCCHHHHhhCCCCCC---------------CCCc
Q 017712 192 CKAAINIKHRNI-----VRVFTAFSGVDY---QGARFKAVVYKFMPNGSLEEWLRGKDDTN---------------WRPL 248 (367)
Q Consensus 192 ~~~l~~l~h~ni-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------~~~~ 248 (367)
+..+.+++|.++ ++++++|..... ......++||||+++++|.++++...... ....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 667777643211 12345799999999999999997532110 0001
Q ss_pred chhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccC
Q 017712 249 NFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328 (367)
Q Consensus 249 ~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 328 (367)
...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......... ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 113456778889999999999999 889999999999999999999999999999755332211 1112235889999
Q ss_pred CccccCCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCCC
Q 017712 329 PEYDLGCEA----------------------STYGDVYSFGILLLEMFTGIR-PSDGI 363 (367)
Q Consensus 329 PE~~~~~~~----------------------~~~~DvwslG~~l~el~tg~~-Pf~~~ 363 (367)
||.+..... ..+.||||+||++++|++|.. ||.++
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~ 436 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI 436 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch
Confidence 998754321 124699999999999999875 77653
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-33 Score=223.81 Aligned_cols=194 Identities=20% Similarity=0.323 Sum_probs=162.5
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 220 (367)
..++|++.+++|+|.|++||.|. ..+++.++||++++. ..+.+.+|+.||..|. ||||+++++...++ ....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccC
Confidence 56789999999999999999998 667899999998754 4577899999999997 99999999997653 3455
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-CCceEE
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHV 299 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-~~~~kl 299 (367)
+.|++||+.+.+...+.. .++.-.+...+.+++.||.|+| +.||.|||+||.|+++|. .-.++|
T Consensus 110 paLiFE~v~n~Dfk~ly~------------tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP------------TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred chhHhhhhccccHHHHhh------------hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeee
Confidence 789999999887766543 3555678889999999999999 999999999999999985 457899
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPS 360 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf 360 (367)
+|+|+|.+.......+. ...+..|--||.+..- .++.+-|+|||||++..|+..+.||
T Consensus 175 IDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF 233 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 233 (338)
T ss_pred eecchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc
Confidence 99999998865443332 2246778899998764 5788889999999999999999998
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-34 Score=238.17 Aligned_cols=202 Identities=21% Similarity=0.303 Sum_probs=162.6
Q ss_pred CCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.+..+.||-|+||.||.++ -++|+.||+|++... +....+.+.+|+..+...+|.|++..++.......+--..+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3445789999999999998 567999999988632 2234578899999999999999999887753332222334578
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+.|.| ..+|..++-... .++.+.+.-+..||++||.||| +.+|.||||||.|+|++.|..+||+|||
T Consensus 135 ~TELm-QSDLHKIIVSPQ---------~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFG 201 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSPQ---------ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFG 201 (449)
T ss_pred HHHHH-HhhhhheeccCC---------CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccc
Confidence 89988 558988887655 5677788889999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+++.....+.. ..+...-|..|.|||++.|. .|+...||||.||++.||+.++..|+.
T Consensus 202 LARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 202 LARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred cccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 99865433222 22223358899999999986 478999999999999999999888864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=261.92 Aligned_cols=217 Identities=29% Similarity=0.398 Sum_probs=174.0
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEEec--------CCCEEEEEEeecCC-CcchhHHHHHHHHHHhC-CCCCcceeee
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFT 208 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~ 208 (367)
.++...++..+.+.||+|.||.|++|... ....||||.++... ....+.+..|+++|+.+ +||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45566666777789999999999999732 14578999987433 34567899999999998 5999999999
Q ss_pred eecccccCCceeeeEEEEeccCCCHHHHhhCCC-CCCCCCc----c--hhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEe
Q 017712 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD-DTNWRPL----N--FNFLIKKKLDIAIDVACALRYLHCDCQPPIAH 281 (367)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~----~--~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH 281 (367)
+|.. ....++|+||+..|+|.++++... ....... + ..++....+.++.|||.|++||+ +.++||
T Consensus 370 ~~t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vH 441 (609)
T KOG0200|consen 370 ACTQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVH 441 (609)
T ss_pred eecc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccc
Confidence 9843 566799999999999999998776 1111000 1 13788899999999999999999 889999
Q ss_pred cCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccC--CCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCC
Q 017712 282 CNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG--STGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIR 358 (367)
Q Consensus 282 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~ 358 (367)
|||-.+|||+.++..+||+|||+|+.......... ....| ...|||||.+....++.+||||||||+|||++| |..
T Consensus 442 RDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 442 RDLAARNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhhhhhhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 99999999999999999999999986543322211 11112 345999999999999999999999999999998 999
Q ss_pred CCCCCC
Q 017712 359 PSDGIF 364 (367)
Q Consensus 359 Pf~~~~ 364 (367)
||.|+.
T Consensus 521 PYp~~~ 526 (609)
T KOG0200|consen 521 PYPGIP 526 (609)
T ss_pred CCCCCC
Confidence 998853
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=257.03 Aligned_cols=212 Identities=19% Similarity=0.181 Sum_probs=144.5
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cC----CCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-C
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FD----GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-Q 216 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~ 216 (367)
..++|++.+.||+|+||.||+|+. .+ +..||+|++.... ..+...+| .+....+.+++.+...+..... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999994 45 6899999875322 12222222 1222233334333332221111 3
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCC-----------CCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTN-----------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlk 285 (367)
.....++++||+++++|.+++....... ............+..++.|++.||.||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 4556799999999999999987543100 0000011223446679999999999999 8999999999
Q ss_pred CCceeecC-CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC----------------------CCCcchh
Q 017712 286 PSNVLLDD-EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC----------------------EASTYGD 342 (367)
Q Consensus 286 p~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 342 (367)
|+|||++. ++.+||+|||+|+.+...... ......|++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 689999999999865432211 12234589999999965322 1334569
Q ss_pred HHHHHHHHHHHHhCCCCCCC
Q 017712 343 VYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 343 vwslG~~l~el~tg~~Pf~~ 362 (367)
||||||++|||+++..|++.
T Consensus 362 VwSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch
Confidence 99999999999998877653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=225.80 Aligned_cols=199 Identities=29% Similarity=0.456 Sum_probs=167.1
Q ss_pred CCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 147 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
|.+.+.||+|++|.||++... +++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++. .....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence 556788999999999999955 4899999998755444 5678899999999999999999999873 33567899
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
+||+++++|.+++..... .+++..+..++.+++.+|.+|| +.+++|+||+|.||+++.++.++|+|||.
T Consensus 76 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~ 144 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG--------KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGL 144 (225)
T ss_pred EeccCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCce
Confidence 999999999999976541 1557788899999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYD-LGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+......... ......++..|++||.. ....++.++|+||||+++++|++|+.||.+
T Consensus 145 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 145 ARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 9876543200 11223467889999998 666778899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=222.55 Aligned_cols=186 Identities=31% Similarity=0.459 Sum_probs=159.9
Q ss_pred CceEEEEEEec-CCCEEEEEEeecCCCcc-hhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEeccCCCHH
Q 017712 157 NFGSVYNGTLF-DGTTIAVKVFNLIRPGG-SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLE 234 (367)
Q Consensus 157 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 234 (367)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+||+++++++.. ....++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 58999999954 58999999987554444 6889999999999999999999998742 35679999999999999
Q ss_pred HHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccCCCCCc
Q 017712 235 EWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314 (367)
Q Consensus 235 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 314 (367)
+++.... .++...+..++.+++.++.||| +.+++|+||+|.||++++++.++|+|||.+.......
T Consensus 76 ~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-- 141 (244)
T smart00220 76 DLLKKRG---------RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-- 141 (244)
T ss_pred HHHHhcc---------CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--
Confidence 9987644 2567888999999999999999 8899999999999999999999999999998764432
Q ss_pred ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
......++..|+|||...+..++.++||||||++++++++|..||..
T Consensus 142 -~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 142 -LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred -ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22233478899999999888889999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=219.12 Aligned_cols=196 Identities=20% Similarity=0.330 Sum_probs=155.8
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.+.|.+.+.||+|.||.+.++. ...++.+++|.+.. .......|.+|.-.--.| .|.||+.-|+.- +++..+.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceE
Confidence 4578889999999999999999 45688999998863 223567888888765555 589999988765 4666788
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec--CCCceEE
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD--DEMIGHV 299 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~--~~~~~kl 299 (367)
+.++||+|.|+|.+-+...+ +-+.....++.|+++|+.||| +.++||||||.+|||+- +...+||
T Consensus 98 vF~qE~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred EEeeccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEe
Confidence 89999999999998876644 346667789999999999999 89999999999999993 4458999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-----EASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+|||.++..+..-.. ..-+-.|.+||..... ...+.+|+|.||+++|.++||++||+.
T Consensus 165 cDFG~t~k~g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 165 CDFGLTRKVGTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred eecccccccCceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 999999854332211 1125568899975432 246789999999999999999999974
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=224.77 Aligned_cols=219 Identities=21% Similarity=0.236 Sum_probs=176.9
Q ss_pred hHHHHhhcCCCCCCCcccccCceEEEEEEecC------CCEEEEEEeec-CCCcchhHHHHHHHHHHhCCCCCcceeeee
Q 017712 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIVRVFTA 209 (367)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 209 (367)
.+++.....++++..++-+|.||.||+|.+.+ .+.|-+|.++. .++-+...+..|...+..+.|||+..+.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45666667788999999999999999996433 34556676652 233355678889999999999999999998
Q ss_pred ecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 017712 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNV 289 (367)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Ni 289 (367)
+. +....+++++.++.-|+|..++....... ......++..+...++.|++.|++||| ++++||.||..+|.
T Consensus 356 ~i----e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~-~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNC 427 (563)
T KOG1024|consen 356 SI----EDYATPFVLYPATGVGNLKSFLQICRGDD-PSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNC 427 (563)
T ss_pred Ee----eccCcceEEEeccCcchHHHHHHHhccCC-CccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcc
Confidence 85 34566789999999999999998433211 122235677888999999999999999 99999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 290 LLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 290 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
++|+...+||+|-.+++.+-+.+...--.....+..||+||.+....++..+|||||||+||||+| |+.|+.++
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI 502 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI 502 (563)
T ss_pred eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence 999999999999999998766554322222335678999999999999999999999999999998 99999776
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-31 Score=233.44 Aligned_cols=204 Identities=24% Similarity=0.284 Sum_probs=167.5
Q ss_pred hhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC------CCCcceeeeeecccc
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK------HRNIVRVFTAFSGVD 214 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~ 214 (367)
...++|.+....|+|-|+.|.+|. ...++.||||++.... -..+.-+.|+++|++|+ --|+++++..|
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F---- 503 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF---- 503 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh----
Confidence 345678888889999999999998 4447899999997532 23455678999999994 34788888876
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
...+++|||+|-+ ..+|.++|+..+. +..+....+..++.|+..||.+|- ..+|+|.||||.|||+++.
T Consensus 504 -~hknHLClVFE~L-slNLRevLKKyG~------nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 504 -KHKNHLCLVFEPL-SLNLREVLKKYGR------NVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNES 572 (752)
T ss_pred -hhcceeEEEehhh-hchHHHHHHHhCc------ccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccC
Confidence 4567889999988 5699999987663 225677888999999999999999 8899999999999999865
Q ss_pred -CceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 295 -MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 295 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
..+||||||.|...... ..+...-+..|.|||++.|.+|+...|+||.||+||||.||+.-|.|-+.
T Consensus 573 k~iLKLCDfGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred cceeeeccCccccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 56799999999765432 22223346779999999999999999999999999999999999988654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=244.18 Aligned_cols=200 Identities=23% Similarity=0.358 Sum_probs=157.2
Q ss_pred CCCCCcccccCce-EEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceeeeEE
Q 017712 147 FSSANLIGAGNFG-SVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 147 ~~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
|...+.+|.|+.| .||+|. ..++.||||++-. +......+|+..|..- +|||||++|+.- .+..+.||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~-ye~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGV-YEGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEe-eCCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 4445678899887 569997 6789999998752 2344567999998887 599999998773 567788999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-----CCceEE
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-----EMIGHV 299 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-----~~~~kl 299 (367)
.|.| ..+|.+++........... .-..+.+..|++.||+||| +.+||||||||.||||+. ...++|
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~-----~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQS-----DIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcc-----cccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEe
Confidence 9999 5699999988511110000 0234667889999999999 889999999999999965 257899
Q ss_pred eccccccccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG-IRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg-~~Pf~~~~ 364 (367)
+|||+|+.+...... .......||-+|+|||.+.....+..+||+|+||++|+.++| ..||....
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence 999999988654432 233456699999999999998888899999999999999985 99996543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-31 Score=241.05 Aligned_cols=200 Identities=22% Similarity=0.316 Sum_probs=173.6
Q ss_pred hhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
+..++|.+...+|.|+||.||+++ ...++..|+|+++.....+..-++.|+-+++..+||||+.+++.+ .....
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dk 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDK 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcC
Confidence 456789999999999999999999 677999999999988888888899999999999999999999997 34556
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.|+.||||.+|+|.+.-+... .+++.++..+++..+.||.||| +.+-+|||||-.||++++.+.+|++
T Consensus 87 lwicMEycgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvkla 154 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLA 154 (829)
T ss_pred cEEEEEecCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeec
Confidence 799999999999999776655 6888899999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPS 360 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~Pf 360 (367)
|||.+..+... -.....+.||+.|||||+.. .+.|...+|||++|++..|+..-.+|-
T Consensus 155 Dfgvsaqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 155 DFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred ccCchhhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 99998766432 22233556999999999853 457899999999999999998776664
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=216.57 Aligned_cols=200 Identities=22% Similarity=0.281 Sum_probs=160.0
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 219 (367)
..+|.-+..+|.|+- .|..+- .-.+++||+|.+... .....++..+|...+..++|+||++++.+|..... ....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777788898887 555554 335789999987522 23345677899999999999999999999854322 2234
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..|+|||+| ..+|...+.. .+.-+.+..|..|++.|+.||| +.+|+||||||+||++..+..+||
T Consensus 95 e~y~v~e~m-~~nl~~vi~~-----------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi 159 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM-----------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKI 159 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH-----------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheee
Confidence 568999999 5699888763 2334667889999999999999 999999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
.|||+|+.... .-..+....|..|.|||++.+..+...+||||+||++.||++|..-|.|
T Consensus 160 ~dfg~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 160 LDFGLARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred ccchhhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 99999985422 1223334578899999999998999999999999999999999988875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=221.60 Aligned_cols=136 Identities=21% Similarity=0.320 Sum_probs=113.5
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-----C---CCcceeeeeecccc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-----H---RNIVRVFTAFSGVD 214 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~~~ 214 (367)
..+|.+.++||-|.|++||+|. ..+.+.||+|+.+... .-.+....||++|++++ | ..||++++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs- 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS- 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-
Confidence 3689999999999999999998 5678999999987432 23466788999999872 3 4699999999654
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~ 291 (367)
..+..+.++|+|++ |-+|..+|....-. .++...+.+|+.||+.||.|||.. .||||-||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~Yr-------Glpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYR-------GLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCC-------CCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 36778899999999 77999998765422 467788999999999999999985 499999999999998
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=203.93 Aligned_cols=204 Identities=22% Similarity=0.381 Sum_probs=171.5
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 220 (367)
..-+|.+.++||+|+||.++.|+ +.+++.||||.-.. .....++..|.+..+.|. .++|..+|-+ .+...+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~ 98 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKY 98 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeee-----ccccch
Confidence 34479999999999999999999 78899999997442 234567888999888885 6899998855 355667
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-----CC
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-----EM 295 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-----~~ 295 (367)
-.||+|++ |.||.|++.-... .|+.+.++.+|.|++.-++|+| .+.+|.|||||+|+||.. ..
T Consensus 99 NiLVidLL-GPSLEDLFD~CgR--------~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n 166 (449)
T KOG1165|consen 99 NILVIDLL-GPSLEDLFDLCGR--------RFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDAN 166 (449)
T ss_pred hhhhhhhh-CcCHHHHHHHhcC--------cccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCc
Confidence 78999998 8899998764332 6999999999999999999999 899999999999999954 34
Q ss_pred ceEEeccccccccCCCCCcce-----eeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQNR-----FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
.+.++|||+|+.+.+...... .....||.+||+--...+.+.+.+.|+-|||-++++.+.|..||+|+-.
T Consensus 167 ~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 167 VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred eEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 688999999998866543322 2355699999999999999999999999999999999999999999853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=196.23 Aligned_cols=183 Identities=28% Similarity=0.505 Sum_probs=152.9
Q ss_pred ccccCceEEEEEEec-CCCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEeccC
Q 017712 153 IGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPN 230 (367)
Q Consensus 153 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 230 (367)
||+|++|.||++... +++.+++|++...... ....+.+|++.+..++|++|+++++++. .....++++|++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence 689999999999954 4899999998754332 3467999999999999999999999973 23567999999999
Q ss_pred CCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-CCceEEeccccccccC
Q 017712 231 GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVGDFGMARFLP 309 (367)
Q Consensus 231 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~ 309 (367)
++|.+++..... .++...+..++.+++.+|.+|| +.+++|+||+|.||+++. ++.++|+|||.+....
T Consensus 76 ~~l~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~ 144 (215)
T cd00180 76 GSLKDLLKENEG--------KLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT 144 (215)
T ss_pred CcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEcc
Confidence 999999876521 3667889999999999999999 889999999999999999 8999999999998654
Q ss_pred CCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHH
Q 017712 310 AIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEM 353 (367)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el 353 (367)
.... ......+...|++||..... ..+.++|+|++|++++++
T Consensus 145 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 145 SDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 3321 12223468889999998877 788999999999999887
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=211.56 Aligned_cols=198 Identities=24% Similarity=0.365 Sum_probs=159.7
Q ss_pred cCCCCCCCcccccCceEEEEEEe-c---CCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-F---DGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 218 (367)
.+.|...++||+|+|+.||++.. . ..+.||+|.+...+ ....+.+|++.|..+. +.||+++.+++ ...
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnn 107 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCF-----RNN 107 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhh-----ccC
Confidence 45678889999999999999983 2 46889999987433 4567899999999984 89999999986 455
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-CCce
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIG 297 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-~~~~ 297 (367)
....+|+||++.-+..++... ++..++..+++.++.||.++| .+|||||||||.|+|.+. -+.-
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg 172 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRG 172 (418)
T ss_pred CeeEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCc
Confidence 667999999999999888764 446788899999999999999 999999999999999975 3566
Q ss_pred EEeccccccccC-----------------C-CCC------------cc------------eeeeccCCCcccCCccccCC
Q 017712 298 HVGDFGMARFLP-----------------A-IDK------------QN------------RFICIKGSTGYIPPEYDLGC 335 (367)
Q Consensus 298 kl~Dfg~~~~~~-----------------~-~~~------------~~------------~~~~~~gt~~y~aPE~~~~~ 335 (367)
.|.|||+|.... . ... .. ......||++|.|||++...
T Consensus 173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~ 252 (418)
T KOG1167|consen 173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC 252 (418)
T ss_pred eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence 899999987210 0 000 00 00123599999999998876
Q ss_pred C-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 336 E-ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 336 ~-~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+ .+++.||||.||+++.+++++.||-..
T Consensus 253 ~~QttaiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 253 PRQTTAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred cCcCCccceeeccceeehhhccccccccC
Confidence 4 688899999999999999999999543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=212.90 Aligned_cols=166 Identities=20% Similarity=0.184 Sum_probs=127.4
Q ss_pred hhcCCCCCCCcccccCceEEEEEEec--CCCEEEEEEeecC-----CCcchhHHHHHHHHHHhCCCCCcce-eeeeeccc
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTLF--DGTTIAVKVFNLI-----RPGGSKSFKSECKAAINIKHRNIVR-VFTAFSGV 213 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~ 213 (367)
...++|.+.+.||+|+||.||+|... +++.+|+|++... .......+.+|++++.+++|+|++. +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34568999999999999999999843 5777899986532 1123456899999999999999985 4432
Q ss_pred ccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC-CCCceeec
Q 017712 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL-KPSNVLLD 292 (367)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dl-kp~Nil~~ 292 (367)
...++||||+++++|.. +.... ...++.|+++||.||| ++||+|||| ||+|||++
T Consensus 91 -----~~~~LVmE~~~G~~L~~-~~~~~---------------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~ 146 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLHL-ARPHG---------------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMG 146 (365)
T ss_pred -----CCcEEEEEccCCCCHHH-hCccc---------------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEc
Confidence 12589999999999963 21100 1346789999999999 899999999 99999999
Q ss_pred CCCceEEeccccccccCCCCCcce------eeeccCCCcccCCccccCC
Q 017712 293 DEMIGHVGDFGMARFLPAIDKQNR------FICIKGSTGYIPPEYDLGC 335 (367)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 335 (367)
.++.+||+|||+|+.+........ .....+++.|+|||++...
T Consensus 147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999999999987754322111 1345578899999987643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=196.02 Aligned_cols=205 Identities=22% Similarity=0.325 Sum_probs=168.6
Q ss_pred hhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCC-CCcceeeeeecccccCCce
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH-RNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~ 219 (367)
...++|.+.++||+|+||.+|.|. ..+|..||+|.-+. .....++..|..+...|+| ..|+.+..+. .+..
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ 84 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKD 84 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccc
Confidence 345689999999999999999999 77899999998542 2234567889999999875 5566666554 4566
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec---CCCc
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DEMI 296 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~---~~~~ 296 (367)
+..+||+.+ |.||.+++.-... .|+.+.++.++-|++.-++|+| .+++|||||||+|+|.. ....
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R--------~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~k 152 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSR--------RFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNK 152 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhh--------hhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccce
Confidence 779999998 8899998865432 6889999999999999999999 89999999999999985 3456
Q ss_pred eEEeccccccccCCCCCccee-----eeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRF-----ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
+.|+|||+|+.+.+....... ....||.+|.+--...+...+.+.|+-|+|.+|.+.-.|..||+|+..
T Consensus 153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 889999999987654433221 234589999998888888888999999999999999999999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=208.24 Aligned_cols=205 Identities=23% Similarity=0.281 Sum_probs=166.6
Q ss_pred CCCCCCcccccCceEEEEEEecC--CCEEEEEEeecCCCcchhHHHHHHHHHHhCCC----CCcceeeeeecccccCCce
Q 017712 146 GFSSANLIGAGNFGSVYNGTLFD--GTTIAVKVFNLIRPGGSKSFKSECKAAINIKH----RNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 219 (367)
+|.+.+.||+|+||.||.+.... ...+|+|............+..|+.++..+.. +++.++++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 79999999999999999999544 35789998775444333378899999999873 58888888752 3456
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC-----
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE----- 294 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~----- 294 (367)
+.++||+.+ |.+|.++....... .|+...++.|+.|++.+|.+|| +.|++||||||+|+++...
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~-------~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~ 163 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPG-------RFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEV 163 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCC-------CcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCccc
Confidence 779999988 88999988654411 6888999999999999999999 9999999999999999754
Q ss_pred CceEEeccccccccC--CCCCc------ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 295 MIGHVGDFGMARFLP--AIDKQ------NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~--~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
..+.|.|||+++... ..... .......||..|+++....+...+.+.|+||++.++.++..|..||.++..
T Consensus 164 ~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 164 RTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred ceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 468999999998332 22111 111235599999999999999999999999999999999999999987764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-26 Score=228.15 Aligned_cols=154 Identities=18% Similarity=0.284 Sum_probs=113.9
Q ss_pred hCCC-CCcceeeeeeccccc--CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhh
Q 017712 197 NIKH-RNIVRVFTAFSGVDY--QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHC 273 (367)
Q Consensus 197 ~l~h-~niv~~~~~~~~~~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~ 273 (367)
.++| +||.+++++|..... ......+.++||+ +++|.++|..... .+++.+++.++.||+.||.|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH- 97 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR--------SVDAFECFHVFRQIVEIVNAAH- 97 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc--------cccHHHHHHHHHHHHHHHHHHH-
Confidence 3456 588888887622211 1123457778887 6699999975321 4778899999999999999999
Q ss_pred CCCCCeEecCCCCCceeecC-------------------CCceEEeccccccccCCCCC--------------cceeeec
Q 017712 274 DCQPPIAHCNLKPSNVLLDD-------------------EMIGHVGDFGMARFLPAIDK--------------QNRFICI 320 (367)
Q Consensus 274 ~~~~~iiH~dlkp~Nil~~~-------------------~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~ 320 (367)
+++|+||||||+|||++. ++.+|++|||+++....... .......
T Consensus 98 --~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (793)
T PLN00181 98 --SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA 175 (793)
T ss_pred --hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence 899999999999999954 44556666666653211000 0001113
Q ss_pred cCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 321 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
.||+.|||||++.+..++.++|||||||+||||++|..|+..
T Consensus 176 ~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 176 MEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred CCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 478899999999999999999999999999999999998764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=186.66 Aligned_cols=176 Identities=11% Similarity=0.089 Sum_probs=132.6
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhH---------HHHHHHHHHhCCCCCcceeeeeeccc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKS---------FKSECKAAINIKHRNIVRVFTAFSGV 213 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (367)
..++|+..+++|.|+||.||.... ++..+|+|.+.......... +.+|+..+.++.||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 367899999999999999999754 57789999997443332222 67999999999999999999886543
Q ss_pred ccC---CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCcee
Q 017712 214 DYQ---GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (367)
Q Consensus 214 ~~~---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil 290 (367)
... .....+++|||++|.+|.++.. ++. ....+++.+|..+| ..|++|||+||+||+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nil 167 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFI 167 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEE
Confidence 211 1235789999999999988732 111 24558999999999 999999999999999
Q ss_pred ecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHH
Q 017712 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMF 354 (367)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~ 354 (367)
+++++ ++|+|||........... ..+.....+..++|+||||+++.-..
T Consensus 168 i~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99988 999999988644211110 01233334567899999999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-26 Score=216.67 Aligned_cols=197 Identities=23% Similarity=0.296 Sum_probs=150.0
Q ss_pred CCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcch----hHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 148 SSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGS----KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 148 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
....++|.|++|.|+... ....+..+.|.+... ..... ..+..|..+-..+.|||++.....+.... ..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~----~~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID----GI 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc----cc
Confidence 345789999999887776 333444444443210 11111 12556777777889999988777664322 22
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.-.||||++ +|..++.... .+...++-.++.|++.|++|+| ..|+.|||+||+|++++.++.+||+
T Consensus 397 -~~~mE~~~~-Dlf~~~~~~~---------~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~ 462 (601)
T KOG0590|consen 397 -LQSMEYCPY-DLFSLVMSNG---------KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKII 462 (601)
T ss_pred -hhhhhcccH-HHHHHHhccc---------ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEe
Confidence 233999999 9999998763 3556778889999999999999 9999999999999999999999999
Q ss_pred ccccccccCCCCCc--ceeeeccCCCcccCCccccCCCCCcc-hhHHHHHHHHHHHHhCCCCCCC
Q 017712 301 DFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGCEASTY-GDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 301 Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|||.+..+...... .......|+..|+|||++.+..|++. .||||.|+++..|++|+.||.-
T Consensus 463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~ 527 (601)
T KOG0590|consen 463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKV 527 (601)
T ss_pred ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccc
Confidence 99999766443332 33445678999999999999999776 5999999999999999999964
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=178.01 Aligned_cols=139 Identities=16% Similarity=0.142 Sum_probs=106.2
Q ss_pred CCcccccCceEEEEEEecCCCEEEEEEeecCCCcc---------hhHH-----------------HHHHHHHHhCCCCCc
Q 017712 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG---------SKSF-----------------KSECKAAINIKHRNI 203 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~-----------------~~E~~~l~~l~h~ni 203 (367)
...||+|+||.||+|...+|+.||+|+++...... ...| .+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999997689999999997542211 1122 349999999988776
Q ss_pred ceeeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHh-hhCCCCCeEec
Q 017712 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYL-HCDCQPPIAHC 282 (367)
Q Consensus 204 v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~l-H~~~~~~iiH~ 282 (367)
....... . ...++||||++++++...+.... .++...++.++.|++.+|.++ | +.+|+||
T Consensus 82 ~~p~~~~-----~--~~~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H---~~giiHr 142 (190)
T cd05147 82 PCPEPIL-----L--KSHVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQ---DCRLVHA 142 (190)
T ss_pred CCCcEEE-----e--cCCEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 4332221 1 11379999998877765432222 466788999999999999999 7 7899999
Q ss_pred CCCCCceeecCCCceEEecccccccc
Q 017712 283 NLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 283 dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
||||+|||++ ++.++|+|||+|...
T Consensus 143 DlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 143 DLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCCHHHEEEE-CCcEEEEEccccccC
Confidence 9999999998 478999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-23 Score=187.58 Aligned_cols=202 Identities=31% Similarity=0.484 Sum_probs=165.2
Q ss_pred CCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCc---chhHHHHHHHHHHhCCCC-CcceeeeeecccccCCceeee
Q 017712 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHR-NIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~~ 222 (367)
|.+...||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++++.+. .....+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEEE
Confidence 566788999999999999855 88899998743332 367789999999999988 7999999872 223369
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-ceEEec
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IGHVGD 301 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~-~~kl~D 301 (367)
++++++.++++.+++...... ..+.......++.|++.++.|+| ..+++|||+||+||+++..+ .++++|
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~d 145 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLID 145 (384)
T ss_pred EEEecCCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEec
Confidence 999999999999777654311 13667888999999999999999 88999999999999999988 799999
Q ss_pred cccccccCCCCCcc----eeeeccCCCcccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQN----RFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||.++.+....... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..||....
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 146 FGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred cCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998554433221 2345568999999999987 578889999999999999999999986553
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=171.67 Aligned_cols=139 Identities=17% Similarity=0.147 Sum_probs=107.9
Q ss_pred CCcccccCceEEEEEEecCCCEEEEEEeecCCCcc--------------------------hhHHHHHHHHHHhCCCCCc
Q 017712 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--------------------------SKSFKSECKAAINIKHRNI 203 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni 203 (367)
...||+|++|.||+|...+|+.||+|+++...... ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 56899999999999996689999999987542210 1124578999999999987
Q ss_pred ceeeeeecccccCCceeeeEEEEeccCCCHHHH-hhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEe
Q 017712 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEW-LRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAH 281 (367)
Q Consensus 204 v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH 281 (367)
.....+.. . ..++||||++++++... +.. . .++......++.|++.+|.++| . .||+|
T Consensus 82 ~~p~~~~~----~---~~~lVmE~~~g~~~~~~~l~~-~---------~~~~~~~~~i~~~l~~~l~~lH---~~~givH 141 (190)
T cd05145 82 PVPEPILL----K---KNVLVMEFIGDDGSPAPRLKD-V---------PLEEEEAEELYEQVVEQMRRLY---QEAGLVH 141 (190)
T ss_pred CCceEEEe----c---CCEEEEEEecCCCchhhhhhh-c---------cCCHHHHHHHHHHHHHHHHHHH---HhCCEec
Confidence 54333321 1 13899999988765433 322 1 3456788899999999999999 7 89999
Q ss_pred cCCCCCceeecCCCceEEeccccccccC
Q 017712 282 CNLKPSNVLLDDEMIGHVGDFGMARFLP 309 (367)
Q Consensus 282 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 309 (367)
|||||+||+++ ++.++|+|||++....
T Consensus 142 rDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 142 GDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999999 8899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=172.03 Aligned_cols=107 Identities=23% Similarity=0.269 Sum_probs=93.0
Q ss_pred CCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccCC
Q 017712 231 GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA 310 (367)
Q Consensus 231 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 310 (367)
|||.+++..... .+++..++.++.|++.||.||| +++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRGR--------PLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecc
Confidence 689999976432 4789999999999999999999 665 999999999999999 999886533
Q ss_pred CCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 311 IDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.. ..||+.|+|||++.+..++.++|||||||++|||+||..||...
T Consensus 62 ~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 62 EQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred cc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 21 14799999999999999999999999999999999999999754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=165.49 Aligned_cols=186 Identities=13% Similarity=-0.011 Sum_probs=136.6
Q ss_pred CCCcccccCceEEEEEEecCCCEEEEEEeecCCCc----chhHHHHHHHHHHhCC-CCCcceeeeeecccccCCceeeeE
Q 017712 149 SANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG----GSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 149 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|.+|. |+++++++++. ..++
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~l 75 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRHL 75 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEEE
Confidence 456899999999997764 7788887777633221 1225789999999995 58899998752 2489
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC-CCCceeecCCCceEEecc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL-KPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dl-kp~Nil~~~~~~~kl~Df 302 (367)
+|||+.|.+|...+.. ....++.|++.+|.++| .+||+|||| ||+|||++.++.++|+||
T Consensus 76 vmeyI~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDF 136 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR----------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDF 136 (218)
T ss_pred EEeeecCccHHhhhhh----------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEEC
Confidence 9999999998654311 11346779999999999 899999999 799999999999999999
Q ss_pred ccccccCCCCCc----ce-------eeeccCCCcccCCccccCC-CCC-cchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQ----NR-------FICIKGSTGYIPPEYDLGC-EAS-TYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|......... .. ......++.|++|+...-- ..+ ...+.++.|.-+|.++||..|+-+-
T Consensus 137 G~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 137 QLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 999855432210 00 0011247778888753321 233 5568889999999999999987554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.3e-22 Score=164.60 Aligned_cols=140 Identities=24% Similarity=0.301 Sum_probs=105.7
Q ss_pred CCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-----CCCCcceeeeeecccccCCcee-e
Q 017712 148 SSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KHRNIVRVFTAFSGVDYQGARF-K 221 (367)
Q Consensus 148 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~-~ 221 (367)
.-..+||+|+||.||. ...++.. +||++........+.+.+|+.+++.+ +||||+++++++.+.. +... .
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEE
Confidence 3457899999999996 3334444 68988765455667899999999999 6799999999985421 1233 3
Q ss_pred eEEEEe--ccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHH-HHhhhCCCCCeEecCCCCCceeecC----C
Q 017712 222 AVVYKF--MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL-RYLHCDCQPPIAHCNLKPSNVLLDD----E 294 (367)
Q Consensus 222 ~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L-~~lH~~~~~~iiH~dlkp~Nil~~~----~ 294 (367)
.+|+|| +++++|.+++.... +++. ..++.|++.++ +||| +++|+||||||+|||++. +
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~ 145 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESE 145 (210)
T ss_pred EEEecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCC
Confidence 478999 55799999996532 2233 35677888887 9999 899999999999999974 3
Q ss_pred CceEEecccccc
Q 017712 295 MIGHVGDFGMAR 306 (367)
Q Consensus 295 ~~~kl~Dfg~~~ 306 (367)
..++|+||+.+.
T Consensus 146 ~~~~LiDg~G~~ 157 (210)
T PRK10345 146 VIPVVCDNIGES 157 (210)
T ss_pred CcEEEEECCCCc
Confidence 479999954443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-23 Score=192.24 Aligned_cols=186 Identities=26% Similarity=0.272 Sum_probs=153.1
Q ss_pred cccccCceEEEEEE----ecCCCEEEEEEeecCCCc--chhHHHHHHHHHHhCC-CCCcceeeeeecccccCCceeeeEE
Q 017712 152 LIGAGNFGSVYNGT----LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 152 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
.+|+|+||.|+.++ ...++.+|+|..+..... .......|..++...+ ||.+++++..| +.....+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence 37999999999875 345778899988643322 2224556777888886 99999999886 566778999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
++|..+|.|...+.... .+...........++.|++++| +.+++|||+|++||+++.+|.+++.|||+
T Consensus 76 ld~~rgg~lft~l~~~~---------~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfgl 143 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEV---------MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGL 143 (612)
T ss_pred hhhcccchhhhccccCC---------chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchh
Confidence 99999999998887665 4556666667788999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
++..-..... +||..|||||++. .....+|.||||++++||+||..||.+
T Consensus 144 ske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 144 SKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 9865432222 6899999999988 567889999999999999999999986
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=168.13 Aligned_cols=197 Identities=22% Similarity=0.340 Sum_probs=152.3
Q ss_pred CCCCCcccccCceEEEEEEecCCCEEEEEEeec--CCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
..+..+|.+...|+.|+|++ .|..+++|+++. ........|..|.-.++...||||..+++.|. ....+.++
T Consensus 192 lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-----sppnlv~i 265 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-----SPPNLVII 265 (448)
T ss_pred hhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-----CCCCceEe
Confidence 34556788999999999985 456677787763 33345577999999999999999999999984 33456899
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe--cc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DF 302 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~--Df 302 (367)
..||+.|+|+..++..... ..+..++.+++.++++|++|||+. ..-|.---|.+..+++|++.+++|+ |-
T Consensus 266 sq~mp~gslynvlhe~t~v-------vvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSV-------VVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred eeeccchHHHHHHhcCccE-------EEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccc
Confidence 9999999999999876532 455678999999999999999965 4445556788999999999988874 32
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCC---cchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEAS---TYGDVYSFGILLLEMFTGIRPSDGIFTG 366 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~~l~el~tg~~Pf~~~~~~ 366 (367)
-++.. . .. ..=.|.||+||.++..+-+ ..+|+|||.+++|||.|+..||.++...
T Consensus 338 kfsfq--e---~g----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm 395 (448)
T KOG0195|consen 338 KFSFQ--E---VG----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM 395 (448)
T ss_pred eeeee--c---cc----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence 22211 0 00 1126889999999877643 4579999999999999999999987653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=192.13 Aligned_cols=197 Identities=21% Similarity=0.214 Sum_probs=152.3
Q ss_pred hhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC---CCCcceeeeeecccccCCc
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK---HRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~ 218 (367)
.....|.+.+.||+|+||.||+|...+++.||+|+-+.... =+|.--.+++.+|+ -+-|..+..++. -.
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~-----~~ 766 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHV-----FQ 766 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHc-----cC
Confidence 33456888899999999999999977799999998653222 12222234445555 123344433332 22
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec------
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD------ 292 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~------ 292 (367)
.-.+||+||.+.|+|.++++... .+++.....++.|++.-+++|| ..+|||+||||+|+||.
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~---------~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~ 834 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNK---------VMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICAD 834 (974)
T ss_pred CcceeeeeccccccHHHhhccCC---------CCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCC
Confidence 33489999999999999998554 4556777889999999999999 89999999999999993
Q ss_pred -CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 017712 293 -DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIR 358 (367)
Q Consensus 293 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~ 358 (367)
++..++|+|||.+-.+.--.....+....+|-.+-++|...|.+++.+.|.|.|..+++-|+.|++
T Consensus 835 ~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 835 SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 345689999999976544444456667778999999999999999999999999999999999964
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=162.13 Aligned_cols=141 Identities=16% Similarity=0.101 Sum_probs=108.9
Q ss_pred CCCCCCcccccCceEEEEEE--ecCCCEEEEEEeecCCCc------------------------chhHHHHHHHHHHhCC
Q 017712 146 GFSSANLIGAGNFGSVYNGT--LFDGTTIAVKVFNLIRPG------------------------GSKSFKSECKAAINIK 199 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 199 (367)
.|++.+.||+|+||.||+|. ..+|+.||+|+++..... ....+.+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788899999999999998 568999999998743211 0123568999999997
Q ss_pred CC--CcceeeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCC
Q 017712 200 HR--NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP 277 (367)
Q Consensus 200 h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ 277 (367)
+. .++++++. ...++||||+++.+|..+..... .+.......++.|++.+|.+|| ..
T Consensus 109 ~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~ 167 (237)
T smart00090 109 EAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLY---KE 167 (237)
T ss_pred hcCCCCCeeeEe---------cCceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHH---hc
Confidence 53 34444432 12379999999988876542222 2334556789999999999999 88
Q ss_pred C-eEecCCCCCceeecCCCceEEecccccccc
Q 017712 278 P-IAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 278 ~-iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
+ ++||||||+||+++ ++.++|+|||.+...
T Consensus 168 g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 168 GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9 99999999999999 889999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=151.41 Aligned_cols=139 Identities=19% Similarity=0.132 Sum_probs=108.2
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCc----------------------chhHHHHHHHHHHhCCC
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG----------------------GSKSFKSECKAAINIKH 200 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h 200 (367)
....|.+.+.||+|+||.||++...+++.+|||++...... ......+|..++..+.|
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 33347788999999999999999778999999987642211 01235778889998888
Q ss_pred CC--cceeeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC
Q 017712 201 RN--IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP 278 (367)
Q Consensus 201 ~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~ 278 (367)
++ +++.++. ...+++|||+++++|.++... .....++.+++.++.++| ..+
T Consensus 93 ~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh---~~g 145 (198)
T cd05144 93 EGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAY---KHG 145 (198)
T ss_pred cCCCCCceeec---------CCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHH---HCC
Confidence 74 4444432 224899999999998765421 123457889999999999 899
Q ss_pred eEecCCCCCceeecCCCceEEecccccccc
Q 017712 279 IAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 279 iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
++||||||+||++++++.++|+|||.+..+
T Consensus 146 i~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 146 IIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 999999999999999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-19 Score=152.78 Aligned_cols=134 Identities=19% Similarity=0.285 Sum_probs=108.5
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecCCCc--------chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+.||+|++|.||+|.. ++..+++|........ ....+.+|+.++..+.|++++....++.. ....+
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-----PENFI 75 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-----CCCCE
Confidence 5799999999999985 6778999986532221 12357789999999999988766555422 23458
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||++|++|.+++.... . ....++.+++.+|.++| +.+++|+|++|.||+++ ++.++|+||
T Consensus 76 lv~e~~~G~~L~~~~~~~~------------~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf 138 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSNG------------M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDF 138 (211)
T ss_pred EEEEEeCCcCHHHHHHhcc------------H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEEC
Confidence 9999999999999886432 1 67788999999999999 89999999999999999 788999999
Q ss_pred ccccc
Q 017712 303 GMARF 307 (367)
Q Consensus 303 g~~~~ 307 (367)
|.+..
T Consensus 139 ~~a~~ 143 (211)
T PRK14879 139 GLAEF 143 (211)
T ss_pred CcccC
Confidence 99875
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.1e-20 Score=159.17 Aligned_cols=203 Identities=22% Similarity=0.310 Sum_probs=127.3
Q ss_pred CCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCC----------CCcceeeeeeccc
Q 017712 148 SSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKH----------RNIVRVFTAFSGV 213 (367)
Q Consensus 148 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~~~ 213 (367)
.....||.|+++.||.++ -.+++.+|+|++..... ...+.+++|.-....+.+ -.++.-++.....
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 345789999999999999 45689999999864332 234566666644444322 1121111111100
Q ss_pred c-------cCCce-----eeeEEEEeccCCCHHHHhhC---CCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC
Q 017712 214 D-------YQGAR-----FKAVVYKFMPNGSLEEWLRG---KDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP 278 (367)
Q Consensus 214 ~-------~~~~~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~ 278 (367)
. ..... ..+++|+-+ .++|.+++.. .... +..+....++.+..|+++.+++|| ..|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-----~~~l~~~arl~lT~Q~I~lvA~Lh---~~G 165 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-----HSPLAFAARLSLTVQMIRLVANLH---SYG 165 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-----SHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-----cchhHHHHHHHHHHHHHHHHHHHh---hcc
Confidence 0 01111 125677777 5688877542 2211 224455566778899999999999 899
Q ss_pred eEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccC--------CCCCcchhHHHHHHHH
Q 017712 279 IAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG--------CEASTYGDVYSFGILL 350 (367)
Q Consensus 279 iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l 350 (367)
++|+||+|+|++++.+|.+.|+||+.....+. .......+..|.+||.... ..++.+.|.|+||+++
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 99999999999999999999999987764322 1111234677999997533 2468889999999999
Q ss_pred HHHHhCCCCCCCCC
Q 017712 351 LEMFTGIRPSDGIF 364 (367)
Q Consensus 351 ~el~tg~~Pf~~~~ 364 (367)
|.|++|..||....
T Consensus 241 y~lWC~~lPf~~~~ 254 (288)
T PF14531_consen 241 YSLWCGRLPFGLSS 254 (288)
T ss_dssp HHHHHSS-STCCCG
T ss_pred HHHHHccCCCCCCC
Confidence 99999999997654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-19 Score=149.37 Aligned_cols=131 Identities=17% Similarity=0.246 Sum_probs=102.4
Q ss_pred cccccCceEEEEEEecCCCEEEEEEeecCCCc--------chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 152 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.||+|+||.||+|. .++..+++|........ ....+.+|++++..+.|+++.....++.. ....++
T Consensus 1 ~ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKTI 74 (199)
T ss_pred CCCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCEE
Confidence 48999999999998 56788999986532211 12557789999999988765433333221 223489
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
+|||++|++|.+++.... . .++.+++.+|.+|| +.+++|+|++|.||+++ ++.++++|||
T Consensus 75 v~e~~~g~~l~~~~~~~~----------~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg 134 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN----------D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFG 134 (199)
T ss_pred EEEEECCccHHHHHhhcH----------H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECC
Confidence 999999999998875422 0 67889999999999 89999999999999999 8899999999
Q ss_pred ccccc
Q 017712 304 MARFL 308 (367)
Q Consensus 304 ~~~~~ 308 (367)
++...
T Consensus 135 ~a~~~ 139 (199)
T TIGR03724 135 LGKYS 139 (199)
T ss_pred CCcCC
Confidence 98754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.8e-20 Score=176.41 Aligned_cols=197 Identities=20% Similarity=0.229 Sum_probs=146.4
Q ss_pred CCCCCCcccccCceEEEEEEecCCCEEEEEEeecCC-CcchhHHHHHHHH--HHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR-PGGSKSFKSECKA--AINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
+|...+.||++.|=+|.+|+.+.|. |+||++-... .-....|.++++- ...++|||++.+.-.- ......|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~-----~t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVL-----VTDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHH-----HhhHHHH
Confidence 5667788999999999999977776 9999986444 3345555544433 4446899999876552 4455668
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+|-+|.. .+|+|.+..++ .+..-+..-|+.|++.||.-+| ..||+|||||.+|||++..+-+.|+||
T Consensus 98 lvRqyvk-hnLyDRlSTRP---------FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDF 164 (1431)
T KOG1240|consen 98 LVRQYVK-HNLYDRLSTRP---------FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDF 164 (1431)
T ss_pred HHHHHHh-hhhhhhhccch---------HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcc
Confidence 8888884 49999987665 5677788889999999999999 999999999999999999999999999
Q ss_pred cccccc--CCCCCcc-ee--eeccCCCcccCCccccCC----------C-CCcchhHHHHHHHHHHHHh-CCCCCC
Q 017712 303 GMARFL--PAIDKQN-RF--ICIKGSTGYIPPEYDLGC----------E-ASTYGDVYSFGILLLEMFT-GIRPSD 361 (367)
Q Consensus 303 g~~~~~--~~~~~~~-~~--~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~~l~el~t-g~~Pf~ 361 (367)
..-+.. +..+... .+ .....-.-|+|||.+... . .+++-||||+||++.||++ |.+||.
T Consensus 165 AsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 165 ASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred cccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 765432 2211111 11 111122349999975431 2 5677899999999999987 788884
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=167.25 Aligned_cols=138 Identities=17% Similarity=0.223 Sum_probs=106.8
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeec--CCC------cchhHHHHHHHHHHhCCCCCcceeeeeeccccc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRP------GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (367)
...|...+.||+|+||.||+|...+. .+++|+... ... ...+.+.+|++++..++|++++....++..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--- 407 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--- 407 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe---
Confidence 34456788999999999999985443 344443221 111 112568899999999999999877665432
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
....++||||+++++|.+++. ....++.+++.+|.+|| +.+++||||||+|||+ +++
T Consensus 408 --~~~~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~ 464 (535)
T PRK09605 408 --PEEKTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDD 464 (535)
T ss_pred --CCCCEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECC
Confidence 233589999999999998874 23558899999999999 8999999999999999 678
Q ss_pred ceEEecccccccc
Q 017712 296 IGHVGDFGMARFL 308 (367)
Q Consensus 296 ~~kl~Dfg~~~~~ 308 (367)
.++|+|||+++..
T Consensus 465 ~~~liDFGla~~~ 477 (535)
T PRK09605 465 RLYLIDFGLGKYS 477 (535)
T ss_pred cEEEEeCcccccC
Confidence 8999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-19 Score=169.97 Aligned_cols=169 Identities=27% Similarity=0.352 Sum_probs=121.1
Q ss_pred hhcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
...++|..+++|..|+||.||..+. .+.+.+|+|+ +..+ -+.+ ||..+.+.
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilR-----------nilt~a~n----------- 131 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILR-----------NILTFAGN----------- 131 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhh-----------ccccccCC-----------
Confidence 3456899999999999999999983 4577888854 2111 1111 22222211
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++| |+-...++..+ .++. +++.+++||| +.+|+|||+||+|.+++.-|.+|+.
T Consensus 132 pfvv------gDc~tllk~~g---------~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlT 185 (1205)
T KOG0606|consen 132 PFVV------GDCATLLKNIG---------PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLT 185 (1205)
T ss_pred ccee------chhhhhcccCC---------CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeeccccccc
Confidence 1222 34444444433 1111 3478999999 9999999999999999999999999
Q ss_pred ccccccccCCC----------C---CcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAI----------D---KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~----------~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+++...-. . .+-.-...+|||.|+|||++....|+...|+|++|+++||.+-|+.||.|-.
T Consensus 186 DfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt 262 (1205)
T KOG0606|consen 186 DFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 262 (1205)
T ss_pred chhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence 99998743110 0 0111124569999999999999999999999999999999999999999873
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-17 Score=138.01 Aligned_cols=135 Identities=19% Similarity=0.210 Sum_probs=96.3
Q ss_pred CCcccccCceEEEEEEecCCCEEEEEEeecCCCcc--hhH----------------------HHHHHHHHHhCCCC--Cc
Q 017712 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--SKS----------------------FKSECKAAINIKHR--NI 203 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~--ni 203 (367)
.+.||+|+||.||+|...+++.||+|+++...... ... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999997789999999987432211 111 13455566665443 24
Q ss_pred ceeeeeecccccCCceeeeEEEEeccCCCHHHH-hhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEe
Q 017712 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEW-LRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAH 281 (367)
Q Consensus 204 v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH 281 (367)
.+.+++. ..+++|||++++++... +.... . ..++..++.+++.++.++| . .+++|
T Consensus 82 ~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~----------~-~~~~~~~~~~~~~~l~~lh---~~~~ivH 138 (187)
T cd05119 82 PKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR----------L-LEDPEELYDQILELMRKLY---REAGLVH 138 (187)
T ss_pred CceEecC---------CCEEEEEEeCCCCccChhhhhhh----------h-cccHHHHHHHHHHHHHHHh---hccCcCc
Confidence 4444331 24899999998553211 11100 0 1456788999999999999 7 89999
Q ss_pred cCCCCCceeecCCCceEEecccccccc
Q 017712 282 CNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 282 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
+||||+||+++ ++.++|+|||.+...
T Consensus 139 ~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 139 GDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCCChhhEEEE-CCcEEEEECcccccc
Confidence 99999999999 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.9e-18 Score=146.48 Aligned_cols=150 Identities=27% Similarity=0.290 Sum_probs=111.7
Q ss_pred CCCCcceeeeeecccc----------------------cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHH
Q 017712 199 KHRNIVRVFTAFSGVD----------------------YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK 256 (367)
Q Consensus 199 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 256 (367)
+|||||++.++|.+.- .......|+||.-.+ .+|.+|+..+. .+...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----------~s~r~ 342 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----------RSYRT 342 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----------CchHH
Confidence 6999999998876531 113445689998884 59999998764 23455
Q ss_pred HHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee--cCCC--ceEEeccccccccCCCCCcc----eeeeccCCCcccC
Q 017712 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL--DDEM--IGHVGDFGMARFLPAIDKQN----RFICIKGSTGYIP 328 (367)
Q Consensus 257 ~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~--~~~~--~~kl~Dfg~~~~~~~~~~~~----~~~~~~gt~~y~a 328 (367)
..-++.|+++|+.||| ++||.|||+|++|||+ |+++ .+.++|||.+---.....+- .....-|....||
T Consensus 343 ~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 6668889999999999 9999999999999998 4444 46789999885332211111 1112236778999
Q ss_pred CccccCCCC------CcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 329 PEYDLGCEA------STYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 329 PE~~~~~~~------~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
||+....+- -.++|.|+.|.+.||+++...||.+
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 998765432 3578999999999999999999976
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.3e-18 Score=153.97 Aligned_cols=99 Identities=31% Similarity=0.469 Sum_probs=81.2
Q ss_pred CCccccccceeehhHHHHHHHhCCCCCCCCC-CCcccHHHHHHHhccc-chhhhhhhhhh-hhhHHHHHHhhhccccccc
Q 017712 1 MGYVSSYGDVYSFGILLLEMFTGLRPNDDMF-NDELNLHNFVKSALPE-RAEEILDVVFF-QEIEEEETMYKKASSTCTQ 77 (367)
Q Consensus 1 ~g~~s~ksDVySfGVvllEl~tg~~p~~~~~-~~~~~l~~~~~~~~~~-~~~~i~d~~~~-~~~~~~~~~~~~~~~~~~~ 77 (367)
+|.+|+||||||||||||||+|||+|.|... .++.+++.|++..+.+ .+.+++|+.+. ......
T Consensus 252 ~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~------------- 318 (361)
T KOG1187|consen 252 TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDE------------- 318 (361)
T ss_pred cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChH-------------
Confidence 4889999999999999999999999998543 4566799999888877 68899999875 332211
Q ss_pred hhhHHHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 78 SSIILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 78 ~~~~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
+++..++.+|..|++..+..||+|.+|++.|..+.
T Consensus 319 -----~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 319 -----KEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred -----HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 23667889999999999999999999988885443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-17 Score=153.84 Aligned_cols=154 Identities=27% Similarity=0.377 Sum_probs=119.4
Q ss_pred HHhCCCCCcceeeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhC
Q 017712 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD 274 (367)
Q Consensus 195 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~ 274 (367)
|+.+.|.|+.+++|.+... ...++|.+||..|+|.|.+..... .+++.-...+.++++.||.|||+
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~--------~~d~~F~~s~~rdi~~Gl~ylh~- 66 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDI--------KLDYFFILSFIRDISKGLAYLHN- 66 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhcccc--------CccHHHHHHHHHHHHHHHHHHhc-
Confidence 3567899999999998542 556899999999999999987432 34455566788999999999994
Q ss_pred CCCCe-EecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCC-------CCcchhHHHH
Q 017712 275 CQPPI-AHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-------ASTYGDVYSF 346 (367)
Q Consensus 275 ~~~~i-iH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dvwsl 346 (367)
.+| .|+.+++.|.++|....+||+|||+.................-..-|.|||.+.... .+.+.|||||
T Consensus 67 --s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 67 --SPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred --CcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 334 999999999999999999999999988664311111111111245699999987641 4677899999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 017712 347 GILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 347 G~~l~el~tg~~Pf~~~~ 364 (367)
|++++|+++...||+...
T Consensus 145 ~ii~~ei~~r~~~~~~~~ 162 (484)
T KOG1023|consen 145 GIIMYEILFRSGPFDLRN 162 (484)
T ss_pred HHHHHHHHhccCcccccc
Confidence 999999999999998643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=137.34 Aligned_cols=139 Identities=13% Similarity=0.093 Sum_probs=103.5
Q ss_pred Cccc-ccCceEEEEEEecCCCEEEEEEeecCC-------------CcchhHHHHHHHHHHhCCCCCc--ceeeeeecccc
Q 017712 151 NLIG-AGNFGSVYNGTLFDGTTIAVKVFNLIR-------------PGGSKSFKSECKAAINIKHRNI--VRVFTAFSGVD 214 (367)
Q Consensus 151 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~ 214 (367)
..|| .||.|+||.+.. ++..+++|.+.... ......+.+|+.++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4577 888889998875 47789999875211 1223567889999999998885 66666542211
Q ss_pred cCCceeeeEEEEeccC-CCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 215 YQGARFKAVVYKFMPN-GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
......++|||++++ .+|.+++.... ++.. .+.+++.+|.+|| ++||+||||||.|||++.
T Consensus 116 -~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~ 177 (239)
T PRK01723 116 -GLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDP 177 (239)
T ss_pred -CcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcC
Confidence 111223699999997 69999886432 2222 3568999999999 999999999999999999
Q ss_pred CCceEEecccccccc
Q 017712 294 EMIGHVGDFGMARFL 308 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~ 308 (367)
++.++|+|||.+...
T Consensus 178 ~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 178 DGKFWLIDFDRGELR 192 (239)
T ss_pred CCCEEEEECCCcccC
Confidence 899999999998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.5e-18 Score=155.35 Aligned_cols=125 Identities=26% Similarity=0.439 Sum_probs=104.3
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
.+.++.|++|...+|.+||....... .-++...+.++.|++.|++| ++.+|+|+||.||+...+..+|
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e------~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGE------ERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCccc------ccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhh
Confidence 46789999999999999998665433 23456678899999999999 4889999999999999999999
Q ss_pred EeccccccccCCCC----CcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh
Q 017712 299 VGDFGMARFLPAID----KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355 (367)
Q Consensus 299 l~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t 355 (367)
|.|||+........ .....+...||..||+||.+.+..|+.++||||||++|+||++
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99999987654433 1112234458999999999999999999999999999999987
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-16 Score=126.52 Aligned_cols=135 Identities=21% Similarity=0.218 Sum_probs=107.5
Q ss_pred CCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCC--CCcceeeeeecccccCCceeeeEEEE
Q 017712 149 SANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH--RNIVRVFTAFSGVDYQGARFKAVVYK 226 (367)
Q Consensus 149 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e 226 (367)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..+.| +++++++.++. .....+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEE
Confidence 35679999999999998544 7899998764322 5678999999999976 58889887753 2345799999
Q ss_pred eccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccc
Q 017712 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (367)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (367)
|++++++..+ +......++.+++.+|.++|.....+++|+|++|.||++++.+.++++|||.+.
T Consensus 74 ~~~g~~~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 74 WIEGETLDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ecCCeecccC----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 9988777554 124456678899999999994323579999999999999998999999999886
Q ss_pred c
Q 017712 307 F 307 (367)
Q Consensus 307 ~ 307 (367)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 4
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5e-18 Score=163.11 Aligned_cols=206 Identities=24% Similarity=0.268 Sum_probs=161.1
Q ss_pred cCCCCCCCcccccCceEEEEEEe--cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL--FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 218 (367)
...|.+.+.||+|+|+.|-.... .....+|.|.+.... .........|..+-..+. |+|++++++.. ...
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence 45678888899999999988774 334566777665332 223455566888888887 99999999885 455
Q ss_pred eeeeEEEEeccCCCHHHHhh-CCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-c
Q 017712 219 RFKAVVYKFMPNGSLEEWLR-GKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-I 296 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~-~ 296 (367)
...++.++|..++++.+-+. .... ..+...+-.++.|+..++.|+|. ..++.|+|+||+|.+++.++ .
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~--------~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~ 163 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDST--------GTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSA 163 (601)
T ss_pred cccccccCcccccccccccccCCcc--------CCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCc
Confidence 66789999999999988873 2221 12334556688899999999995 56899999999999999999 9
Q ss_pred eEEeccccccccCC-CCCcceeeeccC-CCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 297 GHVGDFGMARFLPA-IDKQNRFICIKG-STGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|++|||+|..+.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+...
T Consensus 164 l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 164 LKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred ccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 99999999988766 444444555668 9999999998884 45677899999999999999999997544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.3e-15 Score=141.99 Aligned_cols=142 Identities=18% Similarity=0.217 Sum_probs=97.8
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecCCCcc--------------------------h--------------hHHHH
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--------------------------S--------------KSFKS 190 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~--------------~~~~~ 190 (367)
+.||.|++|.||+|+..+|+.||||+.+...... . -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999899999999975321100 0 02445
Q ss_pred HHHHHHhC----CCCCcceeeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHH
Q 017712 191 ECKAAINI----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266 (367)
Q Consensus 191 E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 266 (367)
|+..+.++ +|.+-+.+-..+.+ .....+++|||++|++|.++...... .. ....++.+++.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~~~--------~~---~~~~ia~~~~~ 267 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALDEA--------GL---DRKALAENLAR 267 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHHhc--------CC---CHHHHHHHHHH
Confidence 66555554 23222333333311 12235899999999999887643211 01 12345555555
Q ss_pred -HHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccCC
Q 017712 267 -ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA 310 (367)
Q Consensus 267 -~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 310 (367)
.+..+| ..|++|+|++|.||++++++.++++|||++..+..
T Consensus 268 ~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 268 SFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 467889 88999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.8e-14 Score=133.17 Aligned_cols=146 Identities=16% Similarity=0.144 Sum_probs=93.3
Q ss_pred CCCCCCCcccccCceEEEEEEecC-CCEEEEEEeecCCCc----------------------------------chh---
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPG----------------------------------GSK--- 186 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~--- 186 (367)
..|+. +.||+|++|+||+|+..+ |+.||||+.++.-.. ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 789999999999999776 999999998643100 001
Q ss_pred ---HHHHHHHHHHhCC----CCCcceeeeeecccccCCceeeeEEEEeccCCCHHHHh--hCCCCCCCCCcchhhhHHHH
Q 017712 187 ---SFKSECKAAINIK----HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL--RGKDDTNWRPLNFNFLIKKK 257 (367)
Q Consensus 187 ---~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~~~~~~~ 257 (367)
.+.+|+..+.++. +.+.+.+-..+. +-....++||||++|+++.++- ...... ...+....+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~----d~st~~VLvmE~i~G~~l~d~~~l~~~g~d-----~~~la~~~v 269 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYW----DYCSETVMVMERMYGIPVSDVAALRAAGTD-----MKLLAERGV 269 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeec----ccCCCceEEEeeecCccHHhHHHHHhcCCC-----HHHHHHHHH
Confidence 2344554444442 333333333321 1123458999999999998752 221100 002333333
Q ss_pred HHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC----ceEEeccccccccCC
Q 017712 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM----IGHVGDFGMARFLPA 310 (367)
Q Consensus 258 ~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~ 310 (367)
..++.|+ + ..|++|+|++|.||+++.++ .++++|||++..+..
T Consensus 270 ~~~~~Qi-------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQV-------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3333443 3 46999999999999999888 999999999987644
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.6e-12 Score=105.79 Aligned_cols=136 Identities=15% Similarity=0.106 Sum_probs=97.0
Q ss_pred CCcccccCceEEEEEEecC-------CCEEEEEEeecCC----------------------CcchhHHH----HHHHHHH
Q 017712 150 ANLIGAGNFGSVYNGTLFD-------GTTIAVKVFNLIR----------------------PGGSKSFK----SECKAAI 196 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~ 196 (367)
...||.|-=+.||.|...+ +..+|+|+.+... ......+. +|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998442 4799999885211 01122333 8999999
Q ss_pred hCC--CCCcceeeeeecccccCCceeeeEEEEeccCCCHH-HHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHh-h
Q 017712 197 NIK--HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLE-EWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYL-H 272 (367)
Q Consensus 197 ~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~l-H 272 (367)
++. .-++++.+++. ..++||||+.+..+. ..++.. .++.++...+..+++.+|..| |
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H 142 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYK 142 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHH
Confidence 985 35677777542 238999999764332 122211 133345667788999999998 8
Q ss_pred hCCCCCeEecCCCCCceeecCCCceEEecccccccc
Q 017712 273 CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 273 ~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
+.++||+||++.||+++ ++.+.|+|||.+...
T Consensus 143 ---~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 143 ---ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred ---hCCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 88999999999999997 467999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.5e-13 Score=109.55 Aligned_cols=127 Identities=17% Similarity=0.128 Sum_probs=93.3
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCc-ceeeeeecccccCCceeeeEEEEecc
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNI-VRVFTAFSGVDYQGARFKAVVYKFMP 229 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~~~ 229 (367)
+.|+.|.++.||+++. .+..+++|....... ....+.+|+.++..+.+.++ ++++... . ...++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~--~~~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-----P--ETGVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-----C--CCCeEEEEecC
Confidence 4688999999999984 477899998753321 23456889999998865554 4555443 1 12379999999
Q ss_pred CCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC-----eEecCCCCCceeecCCCceEEecccc
Q 017712 230 NGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP-----IAHCNLKPSNVLLDDEMIGHVGDFGM 304 (367)
Q Consensus 230 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~-----iiH~dlkp~Nil~~~~~~~kl~Dfg~ 304 (367)
+.++.+.- . ....++.+++++|..|| ..+ ++|+|++|.||+++ ++.++++|||.
T Consensus 75 G~~l~~~~---~--------------~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 75 GSELLTED---F--------------SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred CCcccccc---c--------------cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 98875430 0 01224678999999999 666 59999999999999 66799999998
Q ss_pred ccc
Q 017712 305 ARF 307 (367)
Q Consensus 305 ~~~ 307 (367)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.1e-13 Score=125.88 Aligned_cols=197 Identities=24% Similarity=0.277 Sum_probs=149.3
Q ss_pred CCCCCCcccc--cCceEEEEEEe---cCCCEEEEEEee--cCCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCC
Q 017712 146 GFSSANLIGA--GNFGSVYNGTL---FDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 146 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 217 (367)
.|.+..-+|. |.+|.+|.+.. .++..+|+|.-+ ...+.....=.+|+...++++ |+|.++.+..+ .+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----EG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----cc
Confidence 4666778999 99999999874 457888988743 222223334456776666664 99999966664 56
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHH----HHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC----ALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~----~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
....++-.|++ +.+|..+...... .++......+..+... ||.++| ..+++|-|+||+||+...
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~--------~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~ 257 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCN--------FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTS 257 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcccc--------cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheeccc
Confidence 67778999988 5788888765432 2455666677777777 999999 899999999999999999
Q ss_pred C-CceEEeccccccccCCCCCccee---eeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 017712 294 E-MIGHVGDFGMARFLPAIDKQNRF---ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360 (367)
Q Consensus 294 ~-~~~kl~Dfg~~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf 360 (367)
+ ...+++|||+...+.+..-.... ....|...|++||...+ .++..+|+||+|.+..+..++..++
T Consensus 258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence 8 88999999999887665432222 22247788999998766 6788899999999999999887654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.4e-12 Score=118.56 Aligned_cols=166 Identities=17% Similarity=0.185 Sum_probs=123.6
Q ss_pred ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC
Q 017712 166 LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245 (367)
Q Consensus 166 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 245 (367)
..++.+|.|...+...........+-+..|+.++||||+++++.+ ......|||+|-+. .|..+++...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvTErV~--Pl~~~lk~l~---- 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVTERVR--PLETVLKELG---- 102 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEeeccc--cHHHHHHHhH----
Confidence 567889999888765554456677888999999999999999986 45557899999873 6777776433
Q ss_pred CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCc
Q 017712 246 RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325 (367)
Q Consensus 246 ~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 325 (367)
.....-.+.||+.||.|||. +.+++|++|.-..|+++..|..||++|-++.............. ---.
T Consensus 103 --------~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~--~~~s 170 (690)
T KOG1243|consen 103 --------KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLY--LIES 170 (690)
T ss_pred --------HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccch--hhhc
Confidence 34445567899999999985 57899999999999999999999999988764433221111111 1223
Q ss_pred ccCCccccCCCCCcchhHHHHHHHHHHHHhC
Q 017712 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356 (367)
Q Consensus 326 y~aPE~~~~~~~~~~~DvwslG~~l~el~tg 356 (367)
|..|+.+.... -..|.|-|||+++|++.|
T Consensus 171 ~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 171 FDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 55666543332 345999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.8e-13 Score=115.15 Aligned_cols=160 Identities=21% Similarity=0.359 Sum_probs=119.6
Q ss_pred HHHHhCCCCCcceeeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhh
Q 017712 193 KAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLH 272 (367)
Q Consensus 193 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH 272 (367)
.-+.++.|.|||+++.++.+..+.+.....++.|||..|+|..+|+.... ....+....-.+++.||+.||.|||
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-----~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-----NQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-----hhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 44566789999999999987777677778899999999999999986431 1224556667789999999999999
Q ss_pred hCCCCCeEecCCCCCceeecCCCceEEeccccccccCCC--CCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHH
Q 017712 273 CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI--DKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILL 350 (367)
Q Consensus 273 ~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l 350 (367)
+. +..|+|+++..+-|++..++.+|+.----...-... ..........+-++|.|||+-.....+..+|||+||...
T Consensus 194 s~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 194 SC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred cc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 54 899999999999999999999887421111000000 000111122367889999997777778889999999999
Q ss_pred HHHHhCCC
Q 017712 351 LEMFTGIR 358 (367)
Q Consensus 351 ~el~tg~~ 358 (367)
.+|..+..
T Consensus 273 lemailEi 280 (458)
T KOG1266|consen 273 LEMAILEI 280 (458)
T ss_pred HHHHHhee
Confidence 99987653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.3e-11 Score=101.71 Aligned_cols=144 Identities=15% Similarity=0.125 Sum_probs=103.7
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCC--CCcceeeeeecccccCCceeeeEEEEe
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKH--RNIVRVFTAFSGVDYQGARFKAVVYKF 227 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (367)
+.|+.|.++.+|++...+|..+++|....... .....+.+|++++..+.+ .++.+++.+..... .....+++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEEE
Confidence 46899999999999876668999998754322 135678999999999875 44677777653211 11245899999
Q ss_pred ccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhC---------------------------------
Q 017712 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD--------------------------------- 274 (367)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~--------------------------------- 274 (367)
++|.++.+.+.. . .++......++.+++.+|..||+.
T Consensus 82 i~G~~l~~~~~~-~---------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (223)
T cd05154 82 VDGRVLRDRLLR-P---------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT 151 (223)
T ss_pred eCCEecCCCCCC-C---------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence 999888765431 1 234455666777777777777731
Q ss_pred --------------------CCCCeEecCCCCCceeecC--CCceEEecccccc
Q 017712 275 --------------------CQPPIAHCNLKPSNVLLDD--EMIGHVGDFGMAR 306 (367)
Q Consensus 275 --------------------~~~~iiH~dlkp~Nil~~~--~~~~kl~Dfg~~~ 306 (367)
....++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 1256799999999999998 6678999998876
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.3e-12 Score=127.14 Aligned_cols=207 Identities=24% Similarity=0.335 Sum_probs=144.0
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEee---cCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
..+.+.+.+-+.+|.++.++.+. .-.+...+.|... .......+....+-.++..-.+|-++...-.+ ...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 45677788888999999999876 2334444444432 12222233344444444444556555443332 234
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+|+++|..+++|...++.... .+.+-+......+..++++|| ...+.|+|++|.|++...++..+
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~ 944 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRP 944 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcc
Confidence 556899999999999999887662 222333445567788999999 77799999999999999999999
Q ss_pred EeccccccccCCC----CC---------------------c----ceeeeccCCCcccCCccccCCCCCcchhHHHHHHH
Q 017712 299 VGDFGMARFLPAI----DK---------------------Q----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGIL 349 (367)
Q Consensus 299 l~Dfg~~~~~~~~----~~---------------------~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~ 349 (367)
++|||........ .. . .......||+.|.+||.+.+......+|+|++|++
T Consensus 945 l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~ 1024 (1205)
T KOG0606|consen 945 LTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVC 1024 (1205)
T ss_pred cCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhh
Confidence 9999843322110 00 0 01123458999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCC
Q 017712 350 LLEMFTGIRPSDGIFTG 366 (367)
Q Consensus 350 l~el~tg~~Pf~~~~~~ 366 (367)
++|.++|.+||..-+.+
T Consensus 1025 l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 1025 LFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred hhhhhcCCCCCCCcchh
Confidence 99999999999766544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.4e-10 Score=95.12 Aligned_cols=125 Identities=20% Similarity=0.229 Sum_probs=81.8
Q ss_pred EEEEEEecCCCEEEEEEeecCCCc----------------------c----hhHHHHHHHHHHhCCCC--Ccceeeeeec
Q 017712 160 SVYNGTLFDGTTIAVKVFNLIRPG----------------------G----SKSFKSECKAAINIKHR--NIVRVFTAFS 211 (367)
Q Consensus 160 ~Vy~~~~~~~~~vavK~~~~~~~~----------------------~----~~~~~~E~~~l~~l~h~--niv~~~~~~~ 211 (367)
.||.|...++..+|+|+.+..... . .....+|.+.|.++..- ++++.+++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999888999999988531100 0 13467899999999755 577777552
Q ss_pred ccccCCceeeeEEEEecc--CCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHH-hhhCCCCCeEecCCCCCc
Q 017712 212 GVDYQGARFKAVVYKFMP--NGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY-LHCDCQPPIAHCNLKPSN 288 (367)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~-lH~~~~~~iiH~dlkp~N 288 (367)
...|||||++ |..+..+.... ++......++.+++..+.. +| ..|++|+||.+.|
T Consensus 80 --------~~~ivME~I~~~G~~~~~l~~~~-----------~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~N 137 (188)
T PF01163_consen 80 --------RNVIVMEYIGEDGVPLPRLKDVD-----------LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYN 137 (188)
T ss_dssp --------TTEEEEE--EETTEEGGCHHHCG-----------GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTS
T ss_pred --------CCEEEEEecCCCccchhhHHhcc-----------ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhh
Confidence 1379999998 55554433221 1123345567777775555 58 8899999999999
Q ss_pred eeecCCCceEEecccccccc
Q 017712 289 VLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 289 il~~~~~~~kl~Dfg~~~~~ 308 (367)
|+++++ .+.++|||.+...
T Consensus 138 Ilv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 138 ILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EEEETT-CEEE--GTTEEET
T ss_pred EEeecc-eEEEEecCcceec
Confidence 999887 8999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-10 Score=92.50 Aligned_cols=130 Identities=21% Similarity=0.257 Sum_probs=92.5
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecC--CCcc------hhHHHHHHHHHHhCC--CCCcceeeeeecccccCCcee
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLI--RPGG------SKSFKSECKAAINIK--HRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~------~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~ 220 (367)
..+++|+=+.+|.+.+. +..+++|.-... +... ..+..+|++++.++. --+.+.++++.. ..
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~-------~~ 73 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP-------DN 73 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC-------CC
Confidence 35789999999998643 344666643221 1111 245678999999875 334455555521 12
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
..++|||++|..|.+++.... ..++..+-.-+.-|| ..||+|+||.++||++.... +.++
T Consensus 74 ~~I~me~I~G~~lkd~l~~~~----------------~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~I 133 (204)
T COG3642 74 GLIVMEYIEGELLKDALEEAR----------------PDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFI 133 (204)
T ss_pred CEEEEEEeCChhHHHHHHhcc----------------hHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEE
Confidence 369999999988988887542 235566666777899 99999999999999998665 8999
Q ss_pred cccccccc
Q 017712 301 DFGMARFL 308 (367)
Q Consensus 301 Dfg~~~~~ 308 (367)
|||++...
T Consensus 134 DfGLg~~s 141 (204)
T COG3642 134 DFGLGEFS 141 (204)
T ss_pred ECCccccc
Confidence 99999753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.1e-12 Score=116.37 Aligned_cols=194 Identities=21% Similarity=0.209 Sum_probs=139.1
Q ss_pred cCCCCCCCcccccCceEEEEEEe--cCCCEEEEEEeecCCCcchhH--HHHHHHHHHhC-CCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL--FDGTTIAVKVFNLIRPGGSKS--FKSECKAAINI-KHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 218 (367)
..+|.....||.|.|+.|+.... .++..+++|.+.........+ -..|+.+...+ .|.+++..+..+.. .
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-----~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-----L 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-----c
Confidence 44688889999999999998773 467889999876433332222 23455555554 48888887766533 2
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC-Cce
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-MIG 297 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~-~~~ 297 (367)
...++--|||+++++...+.... .+.+...+.+..|++.++.++| +..++|+|+||+||++..+ +..
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~---------~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~ 406 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQ---------MLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFS 406 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHH---------hcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhh
Confidence 33468889999998876653222 3556778889999999999999 8999999999999999876 788
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcc-cCCccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGY-IPPEYDLGCEASTYGDVYSFGILLLEMFTGIR 358 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~ 358 (367)
++.|||....+.-.. ......+..| .+|.......+..+.|++|||..+.+.+++..
T Consensus 407 ~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 407 KLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred hccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 999999886421100 0111123334 35555566678899999999999999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3e-10 Score=90.13 Aligned_cols=141 Identities=21% Similarity=0.272 Sum_probs=96.9
Q ss_pred CCCcccccCceEEEEEEecCCCEEEEEEeec--CCCc------chhHHHHHHHHHHhCCCCCc--ceeeeeecccccCCc
Q 017712 149 SANLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPG------GSKSFKSECKAAINIKHRNI--VRVFTAFSGVDYQGA 218 (367)
Q Consensus 149 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~------~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~ 218 (367)
....+-||+=+.|+++. ..|+.++||.-.. .+.. ...+..+|++.+.++.--.| ++++ |.+.
T Consensus 11 ~l~likQGAEArv~~~~-~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~--~~D~----- 82 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS-FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI--FIDT----- 82 (229)
T ss_pred cceeeeccceeeEeeec-cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE--EEec-----
Confidence 56788999999999997 5677777775321 1111 23567889999998753333 2333 2221
Q ss_pred eeeeEEEEeccC-CCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC--
Q 017712 219 RFKAVVYKFMPN-GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-- 295 (367)
Q Consensus 219 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~-- 295 (367)
..-.+.|||+++ .++.+++....... ........++.+|-+.+.-|| .++|||+||..+||++..++
T Consensus 83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 83 YGGQIYMEFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred CCCeEEEEeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCc
Confidence 123799999976 47888876543211 111222568888889999999 99999999999999996544
Q ss_pred -ceEEeccccccc
Q 017712 296 -IGHVGDFGMARF 307 (367)
Q Consensus 296 -~~kl~Dfg~~~~ 307 (367)
.+.++|||++..
T Consensus 153 ~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 153 ITPILIDFGLSSV 165 (229)
T ss_pred CceEEEeecchhc
Confidence 357999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.2e-11 Score=126.37 Aligned_cols=100 Identities=20% Similarity=0.384 Sum_probs=74.3
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhccc-chhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPE-RAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~-~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+.++.|+|||||||+++||+||+.|.+........+.+|++..... ....++|+.+......
T Consensus 853 ~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------- 915 (968)
T PLN00113 853 KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV----------------- 915 (968)
T ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc-----------------
Confidence 4578999999999999999999999876555566788888766544 2344555544221111
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
..+++.++..++..|+..+|.+||+|.++.+.|+.+.+
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 01335567788999999999999999999999987654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.1e-09 Score=95.70 Aligned_cols=199 Identities=15% Similarity=0.213 Sum_probs=127.8
Q ss_pred CCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcce--------eeeeecccccCCce
Q 017712 148 SSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVR--------VFTAFSGVDYQGAR 219 (367)
Q Consensus 148 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------~~~~~~~~~~~~~~ 219 (367)
.....||+|+-+.+|..- .-...+.|+...-......+...| ....-.||-+-. ++|- ....
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~a~--la~~p~~p~~~~rvaWPqa~L~G~------~~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKVAE--LAATPDAPLLNYRVAWPQATLHGG------RRGK 83 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHHHHH--hccCCCCcchhhhhcccHHHhhCC------Cccc
Confidence 345679999999999543 222345677653332222221111 112224554432 2221 2222
Q ss_pred eeeEEEEeccCCC-HHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 220 FKAVVYKFMPNGS-LEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 220 ~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++|..+++.. ...+.+.... +..-..+.|.-.++.++.++.+.+-|| ..|.+-+|+.++|+|+++++.+.
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tR---Rqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~ 157 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATR---RQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVV 157 (637)
T ss_pred eeEEecccCCCccchhhhcCchhh---cccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEE
Confidence 3567777776542 3333322211 111113556778889999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCcccc-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTG-IRPSDGIFT 365 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg-~~Pf~~~~~ 365 (367)
|.|-..-.. ........+..|.+.|.+||.-. +..-+...|-|.||+++++++.| +.||.|+..
T Consensus 158 LVdsDsfqi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~ 227 (637)
T COG4248 158 LVDSDSFQI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL 227 (637)
T ss_pred EEcccceee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc
Confidence 987432221 12344455677999999999643 44557788999999999999886 999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.1e-09 Score=96.93 Aligned_cols=177 Identities=20% Similarity=0.212 Sum_probs=129.8
Q ss_pred ceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEeccC-CCHHH
Q 017712 158 FGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPN-GSLEE 235 (367)
Q Consensus 158 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~ 235 (367)
..+.|++. ..+|..|++|+++..+.......-.-+++++++.|+|+|++.+.|.... -+...+++|++|.|+ ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHH
Confidence 35678998 7789999999996444443333445578899999999999999986332 345567899999985 57877
Q ss_pred HhhCCCCCC------CCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccC
Q 017712 236 WLRGKDDTN------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309 (367)
Q Consensus 236 ~l~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 309 (367)
+-....... ....+...++..++.++.|+..||.++| +.|..-+-|.|.+|+++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 654433222 1123345678889999999999999999 8899889999999999999999998877765442
Q ss_pred CCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCC
Q 017712 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGI 357 (367)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~ 357 (367)
... + |-+. --.+-|.-.||.+++.|.||.
T Consensus 445 ~d~---------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 445 EDP---------T-------EPLE---SQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CCC---------C-------cchh---HHhhhhHHHHHHHHHHHhhcc
Confidence 211 0 1111 123459999999999999994
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.5e-09 Score=91.51 Aligned_cols=144 Identities=14% Similarity=0.009 Sum_probs=94.6
Q ss_pred ccccCceEEEEEEecCCCEEEEEEeecCCC-----------cchhHHHHHHHHHHhCCCCCc--ceeeeeecccccCCce
Q 017712 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRP-----------GGSKSFKSECKAAINIKHRNI--VRVFTAFSGVDYQGAR 219 (367)
Q Consensus 153 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~ 219 (367)
+-+.....|++.. .+|+.+.||....... .....+.+|...+.++...+| ++...+..........
T Consensus 30 v~~~~~rrvvr~~-~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFE-LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEE-ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 3333334466654 4677899997642210 111247789988888743333 3333333211111123
Q ss_pred eeeEEEEeccCC-CHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-----
Q 017712 220 FKAVVYKFMPNG-SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD----- 293 (367)
Q Consensus 220 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~----- 293 (367)
..++|+|++++. +|.+++...... .........++.+++..+.-|| ..||+|+|+++.|||++.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~-------~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATN-------PPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCC
Confidence 468999999876 899988532110 2234566788999999999999 999999999999999975
Q ss_pred --CCceEEeccccccc
Q 017712 294 --EMIGHVGDFGMARF 307 (367)
Q Consensus 294 --~~~~kl~Dfg~~~~ 307 (367)
+..+.|+||+.+..
T Consensus 179 ~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 179 EEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCceEEEEECCcccc
Confidence 46789999998853
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-09 Score=90.57 Aligned_cols=136 Identities=20% Similarity=0.142 Sum_probs=96.7
Q ss_pred CCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCc----------------------chhHHHHHHHHHHhCCCC--
Q 017712 146 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG----------------------GSKSFKSECKAAINIKHR-- 201 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~-- 201 (367)
-..+...||-|-=|.||.|....|.++|+|.-+..... .....++|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 34567899999999999999888999999965321110 123467899999998654
Q ss_pred CcceeeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEe
Q 017712 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAH 281 (367)
Q Consensus 202 niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH 281 (367)
.+++-+++ +...+||||++|-.|...-- ..+..-.++..|++-+.-+- ..||||
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r~--------------~~en~~~il~~il~~~~~~~---~~GiVH 225 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRLRL--------------DVENPDEILDKILEEVRKAY---RRGIVH 225 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeecccC--------------cccCHHHHHHHHHHHHHHHH---HcCccc
Confidence 67766554 34589999998866654321 11222234444444444444 578999
Q ss_pred cCCCCCceeecCCCceEEeccccccc
Q 017712 282 CNLKPSNVLLDDEMIGHVGDFGMARF 307 (367)
Q Consensus 282 ~dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (367)
+|+.+-||+++++|.+.++||--+..
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCchheEEEecCCCEEEEeCccccc
Confidence 99999999999999999999966653
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.1e-10 Score=111.77 Aligned_cols=85 Identities=26% Similarity=0.495 Sum_probs=59.7
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
|..|++||||||||||+|++| |+-|.....+++ ..+.++. .++ +..
T Consensus 680 ~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--VIe~i~~---g~l---L~~------------------------- 726 (774)
T KOG1026|consen 680 GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--VIECIRA---GQL---LSC------------------------- 726 (774)
T ss_pred CcccchhhhhhhhhhhhhhhccccCcccccchHH--HHHHHHc---CCc---ccC-------------------------
Confidence 689999999999999999999 999976433222 1111111 001 100
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
...|=.++..+.+.|++..|.+||+.++|..+|+...+.
T Consensus 727 Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 727 PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 002345567778999999999999999999999887654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.5e-10 Score=104.01 Aligned_cols=84 Identities=26% Similarity=0.331 Sum_probs=55.4
Q ss_pred CCccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchh
Q 017712 1 MGYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSS 79 (367)
Q Consensus 1 ~g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (367)
.|..|.|||||||||+|+||+| |+-|...+. ..+-+...-..- .+--|.
T Consensus 378 ~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----n~ev~~~le~Gy--Rlp~P~----------------------- 427 (468)
T KOG0197|consen 378 YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----NEEVLELLERGY--RLPRPE----------------------- 427 (468)
T ss_pred hCCcccccceeehhhhHHHHhccCCCCCCCCC-----HHHHHHHHhccC--cCCCCC-----------------------
Confidence 3678999999999999999999 888866432 222221111110 000000
Q ss_pred hHHHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 80 IILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 80 ~~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
.|=..+..+...|++..|++||+.......+..+.
T Consensus 428 ---~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 428 ---GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred ---CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 12334556678899999999999998887777654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.5e-09 Score=98.34 Aligned_cols=88 Identities=26% Similarity=0.338 Sum_probs=56.7
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
.+|.|+|||||||||+||+||+.|+..... ......+... .....+-+.
T Consensus 222 ~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~--~~Rp~~p~~--------------------------- 270 (362)
T KOG0192|consen 222 PYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVG--GLRPPIPKE--------------------------- 270 (362)
T ss_pred cCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhc--CCCCCCCcc---------------------------
Confidence 489999999999999999999999875432 1111111110 000111110
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhhhcc
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLLK 122 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~~~ 122 (367)
|-..+..+...|+..+|..||++.++...|+.+......
T Consensus 271 -~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 271 -CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 111122333459999999999999999999988765443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.5e-08 Score=84.03 Aligned_cols=111 Identities=18% Similarity=0.206 Sum_probs=81.5
Q ss_pred hhHHHHHHHHHHhCCCC--CcceeeeeecccccCCceeeeEEEEeccCC-CHHHHhhCCCCCCCCCcchhhhHHHHHHHH
Q 017712 185 SKSFKSECKAAINIKHR--NIVRVFTAFSGVDYQGARFKAVVYKFMPNG-SLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261 (367)
Q Consensus 185 ~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~ 261 (367)
.....+|...+.+|..- ..++.+++..... ......++|+|++++. +|.+++..... .+......++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~~~---------~~~~~~~~ll 124 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQWEQ---------LDPSQRRELL 124 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhhcc---------cchhhHHHHH
Confidence 45678888888777432 3445555543221 1124458999999874 79999876331 2244567789
Q ss_pred HHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC---ceEEecccccccc
Q 017712 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM---IGHVGDFGMARFL 308 (367)
Q Consensus 262 ~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~ 308 (367)
.+++..+.-|| .+||+|+|++|.|||++.+. .+.++||+.++..
T Consensus 125 ~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 125 RALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999 99999999999999998877 8899999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.3e-09 Score=86.42 Aligned_cols=92 Identities=17% Similarity=0.216 Sum_probs=53.6
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
+..+.|+|||||||+++||+||+.|..........+..+.....+...... ......
T Consensus 79 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------------------- 135 (176)
T smart00750 79 QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR---SNLESV-------------------- 135 (176)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccc---ccHHHH--------------------
Confidence 346789999999999999999999975322111122222211111000000 000000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
.....+..+...|+..+|..||++.++...+....
T Consensus 136 -~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 136 -SAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred -HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 00012445667799999999999999988876654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.2e-07 Score=76.89 Aligned_cols=142 Identities=15% Similarity=0.168 Sum_probs=100.2
Q ss_pred ccccCceEEEEEEecCCCEEEEEEeec-----CC-CcchhHHHHHHHHHHhCCCC--CcceeeeeecccccCCceeeeEE
Q 017712 153 IGAGNFGSVYNGTLFDGTTIAVKVFNL-----IR-PGGSKSFKSECKAAINIKHR--NIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 153 lg~G~~g~Vy~~~~~~~~~vavK~~~~-----~~-~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv 224 (367)
-|+||.+-|++-.. +|+.+-+|.-.. .. +.....|.+|...+.++..- .+++.. ++...........+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 47789999998764 344677887541 11 44567899999999988532 244444 2211111223446799
Q ss_pred EEeccC-CCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc--eEEec
Q 017712 225 YKFMPN-GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI--GHVGD 301 (367)
Q Consensus 225 ~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~--~kl~D 301 (367)
+|-+++ .+|.+++...... +.+......+..+++..+.-|| +.|+.|+|+-+.||+++.++. ++++|
T Consensus 104 Te~L~g~~~L~~~l~~~~~~-------~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVS-------PYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred EEeCCCCccHHHHHhcCCcC-------CcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEE
Confidence 997743 5898888654321 2345666789999999999999 999999999999999986666 89999
Q ss_pred ccccc
Q 017712 302 FGMAR 306 (367)
Q Consensus 302 fg~~~ 306 (367)
|--++
T Consensus 174 lEk~r 178 (216)
T PRK09902 174 LEKSR 178 (216)
T ss_pred hhccc
Confidence 97665
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.1e-08 Score=92.67 Aligned_cols=142 Identities=18% Similarity=0.248 Sum_probs=90.0
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecCC----------------------Cc----ch--------------hHHHH
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR----------------------PG----GS--------------KSFKS 190 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~----~~--------------~~~~~ 190 (367)
..|+.++-|+||+|++.+|+.||||+.++.- +. .. -.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999999999999999875311 10 00 12455
Q ss_pred HHHHHHhCC-----CCCcceeeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHH
Q 017712 191 ECKAAINIK-----HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265 (367)
Q Consensus 191 E~~~l~~l~-----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 265 (367)
|+..+.++. .|++ ++=..+ .+-.....|+|||++|..+.+...-... .++.+.+.....++.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~----we~t~~~VLtmE~i~Gi~i~d~~~l~~~--------g~d~k~ia~~~~~~f 277 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVY----WEYTTRRVLTMEWIDGIKISDIAALKSA--------GIDRKELAELLVRAF 277 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-Eeceee----hhccCCcEEEEEeeCCEecccHHHHHhc--------CCCHHHHHHHHHHHH
Confidence 665555542 2332 222222 1223345899999999999887422221 122222222222211
Q ss_pred HHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccCC
Q 017712 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA 310 (367)
Q Consensus 266 ~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 310 (367)
+..+- ..|+.|.|..|.||+++.++.+-+.|||+...+.+
T Consensus 278 --~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 278 --LRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --HHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22222 35899999999999999999999999999887654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1e-08 Score=91.05 Aligned_cols=84 Identities=23% Similarity=0.390 Sum_probs=52.9
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
+..|.|+|||||||+++||+||+.|++... ...+...+. .... ...+...
T Consensus 197 ~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--~~~~~~~i~---~~~~----~~~~~~~--------------------- 246 (283)
T PHA02988 197 SEYTIKDDIYSLGVVLWEIFTGKIPFENLT--TKEIYDLII---NKNN----SLKLPLD--------------------- 246 (283)
T ss_pred ccccchhhhhHHHHHHHHHHHCCCCCCCCC--HHHHHHHHH---hcCC----CCCCCCc---------------------
Confidence 457889999999999999999999986431 111111111 0000 0000000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
+-..+..+...|+..+|+.||++.++...|+...
T Consensus 247 --~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 247 --CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0112334456799999999999999999988764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.74 E-value=9.7e-08 Score=79.28 Aligned_cols=143 Identities=13% Similarity=0.102 Sum_probs=88.9
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhH---------HHHHHHHHHhCCC---CCcceeeeee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKS---------FKSECKAAINIKH---RNIVRVFTAF 210 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~niv~~~~~~ 210 (367)
..++|...+++-......|.+-. -+++.+++|..+......... ..+.+..+.++.. -....++-+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe-i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE-IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE-ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 34567777777776666666655 456889999876432221111 2233333333322 2222323222
Q ss_pred cccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCcee
Q 017712 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (367)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil 290 (367)
......-....+++|||++|..|.++..- .. .++..+.+++.-|| +.|+.|+|..|.|++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~i-------------~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFl 167 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIEDI-------------DE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFL 167 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchhc-------------CH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEE
Confidence 22222223445789999999888765321 11 24456778899999 999999999999999
Q ss_pred ecCCCceEEeccccccc
Q 017712 291 LDDEMIGHVGDFGMARF 307 (367)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~ 307 (367)
+++++ ++++||+..+.
T Consensus 168 v~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 168 VSNNG-IRIIDTQGKRM 183 (229)
T ss_pred EECCc-EEEEECccccc
Confidence 98665 89999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.2e-09 Score=91.66 Aligned_cols=78 Identities=27% Similarity=0.414 Sum_probs=45.4
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..|.|||||||||+++||+| |+.|.... ...++.............+
T Consensus 181 ~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~~~~~~~~~~~~--------------------------- 228 (259)
T PF07714_consen 181 EYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEKLKQGQRLPIPD--------------------------- 228 (259)
T ss_dssp EESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHHHHTTEETTSBT---------------------------
T ss_pred ccccccccccccccccccccccccccccc-----ccccccccccccccceecc---------------------------
Confidence 35889999999999999999 67776533 1111111111111100000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHH
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRL 113 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L 113 (367)
.+-..+..+...|+..+|++||++.++.+.|
T Consensus 229 -~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 -NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0011233557789999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=9.6e-09 Score=102.24 Aligned_cols=88 Identities=26% Similarity=0.358 Sum_probs=59.6
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
|..|+|||||||||||+|++| |..|+-...+. ..+..|.. .+ .+++.-
T Consensus 879 ~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-~v~~~~~~----gg---RL~~P~----------------------- 927 (1025)
T KOG1095|consen 879 GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-EVLLDVLE----GG---RLDPPS----------------------- 927 (1025)
T ss_pred cccccccchhhhHHHHHHHHhCCCCCCCCcchH-HHHHHHHh----CC---ccCCCC-----------------------
Confidence 778999999999999999999 77887543221 11222211 11 112110
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhhhcc
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLLK 122 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~~~ 122 (367)
.|=..+.++...|+...|++||+...+.+++..+......
T Consensus 928 --~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 928 --YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred --CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 1223345677899999999999999999988877665443
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.1e-08 Score=90.75 Aligned_cols=96 Identities=18% Similarity=0.193 Sum_probs=53.8
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcc-cchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALP-ERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~-~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+++||+||+.|.......-..+..+...... ....+.++.... ..+.
T Consensus 185 ~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~---- 246 (283)
T cd05080 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR--------------LPCP---- 246 (283)
T ss_pred cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC--------------CCCC----
Confidence 356889999999999999999999865321110011111000000 001111111000 0000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
..+-..+..+...|+..+|+.||+++++...++.+
T Consensus 247 -~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 247 -KNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred -CCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 01122345667889999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.1e-09 Score=98.24 Aligned_cols=98 Identities=20% Similarity=0.373 Sum_probs=75.3
Q ss_pred HHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccCCCCCcc-------eeeeccCCCcccCCccccC
Q 017712 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN-------RFICIKGSTGYIPPEYDLG 334 (367)
Q Consensus 262 ~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 334 (367)
.+++.||.|+|. +.++||++|.|++|.++.++.+||+.|+++.......... ..........|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 355689999996 6799999999999999999999999999886543311110 0011123567999999999
Q ss_pred CCCCcchhHHHHHHHHHHHH-hCCCCCC
Q 017712 335 CEASTYGDVYSFGILLLEMF-TGIRPSD 361 (367)
Q Consensus 335 ~~~~~~~DvwslG~~l~el~-tg~~Pf~ 361 (367)
...+.++|+||+|+++|.+. .|+.-+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhh
Confidence 88899999999999999988 4554443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.8e-08 Score=94.27 Aligned_cols=182 Identities=14% Similarity=0.091 Sum_probs=127.1
Q ss_pred CCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCC-cceeeeeecccccCCceeeeEEEEec
Q 017712 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRN-IVRVFTAFSGVDYQGARFKAVVYKFM 228 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (367)
.+-+++|+++.+++.+--..+....+.+.. .....-+++.|.+++||| .+..++. ++.+.+.++.++++
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLWIPMRIC 316 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCccccccc-----CCcccccchhhhhh
Confidence 345789999999988732233333554432 245567889999999999 4444433 46677889999999
Q ss_pred cCC-CHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccc
Q 017712 229 PNG-SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (367)
Q Consensus 229 ~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (367)
.++ +-..-+. .....+-.-+...+.+.-.++|+++| +..=+|+| ||+..+ +..|..||+....
T Consensus 317 s~~rs~~~~~~--------~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 317 STGRSSALEMT--------VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQ 380 (829)
T ss_pred cCCccccccCC--------hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcc
Confidence 776 2211111 11123444445566777788999999 54458888 777765 5679999999887
Q ss_pred cCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 017712 308 LPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360 (367)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf 360 (367)
+.... ......+++.|+|||+...+.+....|.||+|+-..++.-|.+|-
T Consensus 381 L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 381 LTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 65433 233455899999999999999999999999998777777777664
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.3e-07 Score=86.34 Aligned_cols=138 Identities=16% Similarity=0.220 Sum_probs=89.8
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecCCCcc-------------------------------------hhHHHHHHH
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG-------------------------------------SKSFKSECK 193 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~~ 193 (367)
+.||.-+.|.||+|++.+|+.||||+-++.-... .-.|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999864211000 012455555
Q ss_pred HHHhC----CCCC------cceeeeeecccccCCceeeeEEEEeccCCCHHHH--hhCCCCCCCCCcchhhhHHHHHHHH
Q 017712 194 AAINI----KHRN------IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEW--LRGKDDTNWRPLNFNFLIKKKLDIA 261 (367)
Q Consensus 194 ~l~~l----~h~n------iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~~~~~~~~~i~ 261 (367)
-..+. .|-+ |+++|-.+ .....|+||||+|..+.+. |.... ++...+..-+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~-------st~RVLtME~~~G~~i~Dl~~i~~~g----------i~~~~i~~~l 309 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL-------STKRVLTMEYVDGIKINDLDAIDKRG----------ISPHDILNKL 309 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc-------CcceEEEEEecCCccCCCHHHHHHcC----------CCHHHHHHHH
Confidence 44433 4555 56665433 2345899999999887654 33332 2233333333
Q ss_pred HHHHHHHHHhhhCCCCCeEecCCCCCceeecC----CCceEEeccccccccCC
Q 017712 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDD----EMIGHVGDFGMARFLPA 310 (367)
Q Consensus 262 ~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~----~~~~kl~Dfg~~~~~~~ 310 (367)
.+...-+-+ ..|++|+|-.|.||+++. ++.+.+-|||+...+..
T Consensus 310 ~~~~~~qIf-----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 310 VEAYLEQIF-----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHHH-----hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 332222222 348999999999999984 67899999999886643
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.4e-08 Score=90.94 Aligned_cols=83 Identities=22% Similarity=0.230 Sum_probs=50.6
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
.+++|.|||||||||+||+||.-|+-+.. ...+.+-|- . +++...+-....+.
T Consensus 287 PcsEKVDIwSfGVVLWEmLT~EiPYkdVd--ssAIIwGVG----s---NsL~LpvPstcP~G------------------ 339 (904)
T KOG4721|consen 287 PCSEKVDIWSFGVVLWEMLTGEIPYKDVD--SSAIIWGVG----S---NSLHLPVPSTCPDG------------------ 339 (904)
T ss_pred CcccccceehhHHHHHHHHhcCCCccccc--hheeEEecc----C---CcccccCcccCchH------------------
Confidence 47899999999999999999999975431 111111111 0 11111111111111
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
+.-+.-.|+...|..||+.+++...|....
T Consensus 340 -----fklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 340 -----FKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred -----HHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 112234699999999999999988876543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.6e-08 Score=87.73 Aligned_cols=82 Identities=29% Similarity=0.422 Sum_probs=54.2
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..|..||||||||+|+||+| |+.|.-+....+ ...+ +.++ .. +.+..
T Consensus 474 ~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--m~~y----lkdG-yR-----laQP~-------------------- 521 (563)
T KOG1024|consen 474 HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--MEHY----LKDG-YR-----LAQPF-------------------- 521 (563)
T ss_pred hhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--HHHH----Hhcc-ce-----ecCCC--------------------
Confidence 36788999999999999999 999965432111 1111 1110 00 10100
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
+|-.++..+...|+...|++||+..+++.-|....
T Consensus 522 -NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 522 -NCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred -CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 23334556778899999999999999999887654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.6e-06 Score=74.08 Aligned_cols=144 Identities=14% Similarity=0.112 Sum_probs=79.7
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCC--cceeeeeecccccCCceeeeEEEEec
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRN--IVRVFTAFSGVDYQGARFKAVVYKFM 228 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (367)
..||+|..+.||+. .+..+++|..... .......+|.+++..+..-. +.+.+++.. ......++||++
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~-----~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVE-----DGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEe-----cCCeeeeeeeec
Confidence 46899999999984 2456788887532 23456789999998885433 355665542 223347899999
Q ss_pred cCCC-HHHHhhCCC----------------CCCCCCcchhhhHHHHHHHHH----------HHHH-HHHHhhh-CCCCCe
Q 017712 229 PNGS-LEEWLRGKD----------------DTNWRPLNFNFLIKKKLDIAI----------DVAC-ALRYLHC-DCQPPI 279 (367)
Q Consensus 229 ~~g~-L~~~l~~~~----------------~~~~~~~~~~~~~~~~~~i~~----------~i~~-~L~~lH~-~~~~~i 279 (367)
+|.+ +.+.+.... -.........+... ...+.. .+.. ...+|.. .....+
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 8863 221111000 00000000001000 000000 0111 1111211 113457
Q ss_pred EecCCCCCceeecCCCceEEecccccc
Q 017712 280 AHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (367)
Q Consensus 280 iH~dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (367)
+|+|+.|.||++++++ +.++||+.+.
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcC
Confidence 8999999999999888 8999999876
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.8e-08 Score=86.63 Aligned_cols=81 Identities=27% Similarity=0.560 Sum_probs=52.0
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+++||+| |+.|+..... ..+...+.... ...+. .
T Consensus 201 ~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--~~~~~~i~~~~---~~~~~-----~--------------------- 249 (283)
T cd05048 201 GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QEVIEMIRSRQ---LLPCP-----E--------------------- 249 (283)
T ss_pred CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCC---cCCCc-----c---------------------
Confidence 457889999999999999998 9999753221 11222211110 00000 0
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRL 115 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~ 115 (367)
.+-.++..+...|+..+|..||+++++...|+.
T Consensus 250 --~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 250 --DCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 011223455678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.3e-06 Score=73.50 Aligned_cols=136 Identities=17% Similarity=0.174 Sum_probs=91.7
Q ss_pred cccccCceEEEEEEecCCCEEEEEEeecCCCc-------------------chh-----HHHHHHHHHHhCC--CCCcce
Q 017712 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG-------------------GSK-----SFKSECKAAINIK--HRNIVR 205 (367)
Q Consensus 152 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~-----~~~~E~~~l~~l~--h~niv~ 205 (367)
.|+.|--+.||+|...++..+|+|+++..... +.. -..+|..-|.++. +-.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 45667778999998888999999998632211 111 1346777777773 444555
Q ss_pred eeeeecccccCCceeeeEEEEeccCCC-HHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC
Q 017712 206 VFTAFSGVDYQGARFKAVVYKFMPNGS-LEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (367)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dl 284 (367)
-+.+. ...|+|||+.... -.-.|+.. .+...+...+..++++.+.-|-. ..++||+||
T Consensus 135 Pi~~~---------~nVLvMEfIg~~g~pAP~LkDv----------~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDL 193 (268)
T COG1718 135 PIAFR---------NNVLVMEFIGDDGLPAPRLKDV----------PLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDL 193 (268)
T ss_pred ceeec---------CCeEEEEeccCCCCCCCCcccC----------CcCchhHHHHHHHHHHHHHHHHH--hcCcccccc
Confidence 55543 1379999995421 11111111 22233566677788888888872 389999999
Q ss_pred CCCceeecCCCceEEeccccccccC
Q 017712 285 KPSNVLLDDEMIGHVGDFGMARFLP 309 (367)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~ 309 (367)
..=|||+. ++.+.++|||-|....
T Consensus 194 SEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 194 SEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hhhheEEE-CCeEEEEECccccccC
Confidence 99999999 8889999999887543
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=98.50 E-value=1e-07 Score=84.97 Aligned_cols=84 Identities=25% Similarity=0.425 Sum_probs=53.5
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+++||+| |+.|+..... ....+.... .......+ .
T Consensus 200 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~---~~~~~~~~-----~-------------------- 249 (291)
T cd05094 200 RKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--TEVIECITQ---GRVLERPR-----V-------------------- 249 (291)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhC---CCCCCCCc-----c--------------------
Confidence 346789999999999999999 9888653211 111111111 00000000 0
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
+-..+..+...|+..+|.+||++.++.+.|..+.+
T Consensus 250 ---~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 250 ---CPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 01123456678999999999999999999988755
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.1e-07 Score=83.13 Aligned_cols=82 Identities=28% Similarity=0.436 Sum_probs=53.6
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+.++.++|||||||+++||+| |+.|++... ...+..++....+. ...+
T Consensus 173 ~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~~~~~~---~~~~-------------------------- 221 (257)
T cd05060 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLESGERL---PRPE-------------------------- 221 (257)
T ss_pred CCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcCCcC---CCCC--------------------------
Confidence 457789999999999999998 889876432 22233333221110 0000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
.+-..+..+...|+..+|.+||++.++...|+..
T Consensus 222 --~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 222 --ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0011233456789999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.6e-07 Score=83.20 Aligned_cols=84 Identities=19% Similarity=0.371 Sum_probs=53.0
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.++|||||||+++||+| |+.|+.... ...+.+++.... ....+..
T Consensus 186 ~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~~~-----~~~~~~~----------------------- 235 (279)
T cd05111 186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR--PHEVPDLLEKGE-----RLAQPQI----------------------- 235 (279)
T ss_pred CCcCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCC-----cCCCCCC-----------------------
Confidence 457889999999999999999 988875321 111222221100 0000000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
|-..+..+...|+..+|..||++.++.+.+..+..
T Consensus 236 ---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 236 ---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 01122344568999999999999999998877554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.8e-07 Score=82.07 Aligned_cols=81 Identities=21% Similarity=0.315 Sum_probs=50.0
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+.++.++|||||||+++||+| |..|.... ...++........ .......
T Consensus 180 ~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~~~~~~~~~-----~~~~~~~-------------------- 229 (263)
T cd05052 180 NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYELLEKGY-----RMERPEG-------------------- 229 (263)
T ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHHCCC-----CCCCCCC--------------------
Confidence 456789999999999999999 88886432 1111111110000 0000000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRL 115 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~ 115 (367)
+-..+..+...|+..+|++||++.++.+.|+.
T Consensus 230 ---~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 230 ---CPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred ---CCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 01223445678999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.9e-07 Score=85.09 Aligned_cols=84 Identities=25% Similarity=0.355 Sum_probs=51.9
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+|+||+| |+.|+......+ .+.. ...+.. .......
T Consensus 251 ~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~----~~~~~~----~~~~~~~-------------------- 301 (338)
T cd05102 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQ----RLKDGT----RMRAPEN-------------------- 301 (338)
T ss_pred CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHH----HHhcCC----CCCCCCC--------------------
Confidence 346889999999999999998 988865321111 1111 000000 0000000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
+-..+..+...|+..+|..||++.++.+.|+.+.
T Consensus 302 ---~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 302 ---ATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred ---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0112345667899999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.4e-07 Score=82.43 Aligned_cols=78 Identities=22% Similarity=0.397 Sum_probs=49.3
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++||+| |+.|..... .......+..... ...+..
T Consensus 177 ~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--~~~~~~~i~~~~~-----~~~~~~------------------------ 225 (256)
T cd05114 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--NYEVVEMISRGFR-----LYRPKL------------------------ 225 (256)
T ss_pred ccchhhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCCC-----CCCCCC------------------------
Confidence 45789999999999999999 888865321 1122222211100 000000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHH
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRL 113 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L 113 (367)
.-..+..+...|+..+|..||++.++...|
T Consensus 226 --~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 --ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 011245667789999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.3e-07 Score=83.87 Aligned_cols=80 Identities=28% Similarity=0.510 Sum_probs=50.1
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
|..+.++||||||++++||+| |..|..... ..++...........+.+
T Consensus 201 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~i~~~~~~~~~~-------------------------- 249 (283)
T cd05091 201 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQDVIEMIRNRQVLPCPD-------------------------- 249 (283)
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHcCCcCCCCC--------------------------
Confidence 567889999999999999999 766754211 111211111111000000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLR 114 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~ 114 (367)
.+-..+..+...|++.+|..||+++++..+|+
T Consensus 250 --~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 250 --DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred --CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 01122445677899999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.7e-07 Score=83.48 Aligned_cols=82 Identities=24% Similarity=0.423 Sum_probs=52.4
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|.+... ...+.+++...... + ...
T Consensus 205 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~~------~--~~~---------------------- 252 (290)
T cd05045 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--PERLFNLLKTGYRM------E--RPE---------------------- 252 (290)
T ss_pred CcchHhHHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCCCC------C--CCC----------------------
Confidence 46788999999999999999 888865321 11122221111000 0 000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
.+-..+..+...|+..+|.+||++.++...|+.+-
T Consensus 253 -~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 253 -NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 00122345677899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.3e-07 Score=81.70 Aligned_cols=81 Identities=20% Similarity=0.361 Sum_probs=50.7
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |..|..... ...+.+++..... ..+..
T Consensus 191 ~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--~~~~~~~~~~~~~---~~~~~--------------------------- 238 (273)
T cd05035 191 VYTSKSDVWAFGVTMWEIATRGQTPYPGVE--NHEIYDYLRHGNR---LKQPE--------------------------- 238 (273)
T ss_pred CCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC---CCCCc---------------------------
Confidence 46789999999999999999 777765321 1112222211000 00000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
.+...+..+...|+..+|.+||++.++.+.|..+
T Consensus 239 -~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 239 -DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112234455679999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=98.43 E-value=1e-07 Score=84.38 Aligned_cols=96 Identities=20% Similarity=0.237 Sum_probs=53.3
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccc-hhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPER-AEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~-~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+.++.++||||||++++||+||+.|........ ..++....... ...+.+ .+...... . .
T Consensus 187 ~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~----------~--~--- 247 (284)
T cd05038 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF---LRMIGIAQGQMIVTRLLE-LLKEGERL----------P--R--- 247 (284)
T ss_pred CCCCcccchHHHhhhhheeeccCCCcccccchh---ccccccccccccHHHHHH-HHHcCCcC----------C--C---
Confidence 356788999999999999999999865321111 00000000000 000000 00000000 0 0
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
...+-.++..+...|+..+|..||++.++...|..+
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 248 PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 001113355667899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.6e-07 Score=82.51 Aligned_cols=82 Identities=26% Similarity=0.393 Sum_probs=51.6
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.++|||||||+++||+| |+.|+..... ..+......... . +..
T Consensus 185 ~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~i~~~~~--~--~~~----------------------- 232 (268)
T cd05063 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAINDGFR--L--PAP----------------------- 232 (268)
T ss_pred CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHHhcCCC--C--CCC-----------------------
Confidence 346789999999999999998 9999753211 111111100000 0 000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
..+-..+..+...|+..+|..||++.++.+.|..+
T Consensus 233 -~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 233 -MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00112345667789999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.6e-07 Score=82.53 Aligned_cols=27 Identities=30% Similarity=0.361 Sum_probs=24.1
Q ss_pred CccccccceeehhHHHHHHHhCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
+..+.++|||||||+++||+||+.|..
T Consensus 188 ~~~~~~~Dv~slG~ll~~l~~g~~p~~ 214 (269)
T cd08528 188 EPYGEKADVWAFGCILYQMCTLQPPFY 214 (269)
T ss_pred CCCchHHHHHHHHHHHHHHHhCCCccc
Confidence 456889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=98.43 E-value=2e-07 Score=81.89 Aligned_cols=85 Identities=19% Similarity=0.149 Sum_probs=51.5
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++|||||||+++||+||+.|.... ......+........ .+.....
T Consensus 182 ~~~~~~Di~slG~~l~el~~g~~p~~~~---~~~~~~~~~~~~~~~-----~~~~~~~---------------------- 231 (267)
T cd08228 182 GYNFKSDIWSLGCLLYEMAALQSPFYGD---KMNLFSLCQKIEQCD-----YPPLPTE---------------------- 231 (267)
T ss_pred CCCchhhHHHHHHHHHHHhcCCCCCccc---cccHHHHHHHHhcCC-----CCCCChh----------------------
Confidence 4678899999999999999999996432 112222221111000 0000000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
..-..+..+...|+...|..||++.++.+.++.++
T Consensus 232 ~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 232 HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00011233455799999999999999999887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.7e-07 Score=80.96 Aligned_cols=84 Identities=19% Similarity=0.125 Sum_probs=51.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++|||||||+++||+||+.|.... ..++..+...........+...
T Consensus 182 ~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~--------------------------- 231 (267)
T cd08224 182 GYNFKSDIWSLGCLLYEMAALQSPFYGD---KMNLYSLCKKIEKCDYPPLPAD--------------------------- 231 (267)
T ss_pred CCCchhcHHHHHHHHHHHHHCCCCcccC---CccHHHHHhhhhcCCCCCCChh---------------------------
Confidence 3677899999999999999999996421 1222222211111000000000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
..-..+..+...|+..+|..||++.++...++.+
T Consensus 232 ~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 232 HYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred hcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0011233455679999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.6e-07 Score=85.46 Aligned_cols=83 Identities=22% Similarity=0.284 Sum_probs=50.9
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+++||+| |+.|+....... .+..-....... ..+. ..
T Consensus 289 ~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~-----~~~~---~~------------------- 340 (374)
T cd05106 289 CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQM-----SRPD---FA------------------- 340 (374)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCc-----cCCC---CC-------------------
Confidence 457889999999999999998 999875432111 111111100000 0000 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
-..+..+...|++.+|.+||++.++.+.|+.+
T Consensus 341 ----~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 341 ----PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01123445579999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.2e-07 Score=81.36 Aligned_cols=83 Identities=23% Similarity=0.373 Sum_probs=50.7
Q ss_pred CccccccceeehhHHHHHHHhCCCC-CCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRP-NDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p-~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+++||+||..| .... +...+..++..... .. .+ ..
T Consensus 177 ~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~~~~~~~---~~--~~---~~-------------------- 226 (262)
T cd05058 177 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDITVYLLQGRR---LL--QP---EY-------------------- 226 (262)
T ss_pred CccchHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhcCCC---CC--CC---Cc--------------------
Confidence 3467899999999999999997655 3321 11122222211000 00 00 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
+-..+..+...|+..+|+.||++.++...++.+.
T Consensus 227 ---~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 227 ---CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0112345677899999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.7e-07 Score=82.57 Aligned_cols=85 Identities=20% Similarity=0.262 Sum_probs=53.0
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.|+|||||||+++||+| |+.|+.... ..+....... .. .......
T Consensus 194 ~~~~~~DvwSlG~il~el~t~g~~pf~~~~-----~~~~~~~~~~-~~----~~~~~~~--------------------- 242 (297)
T cd05089 194 VYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-----CAELYEKLPQ-GY----RMEKPRN--------------------- 242 (297)
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHhc-CC----CCCCCCC---------------------
Confidence 46789999999999999998 988875321 1111111100 00 0000000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~ 120 (367)
+-..+..+...|+..+|.+||++.++...|..+....
T Consensus 243 --~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 243 --CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred --CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0112335567899999999999999999988766543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.6e-07 Score=81.74 Aligned_cols=83 Identities=27% Similarity=0.398 Sum_probs=54.1
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++|++| |+.|++.. +...+..++.....-. .. .
T Consensus 195 ~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~-----~~---~---------------------- 242 (280)
T cd05043 195 EYSSASDVWSFGVLLWELMTLGQTPYVEI--DPFEMAAYLKDGYRLA-----QP---I---------------------- 242 (280)
T ss_pred CCCchhhHHHhHHHHHHHhcCCCCCcCcC--CHHHHHHHHHcCCCCC-----CC---C----------------------
Confidence 35789999999999999999 99987642 2222333322211000 00 0
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
.+-..+.++...|+..+|+.||++.++...|..+.+
T Consensus 243 -~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 243 -NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 001123455677999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.3e-07 Score=81.54 Aligned_cols=85 Identities=24% Similarity=0.407 Sum_probs=53.6
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+++||+| |+.|...... ......+.. ....... ..
T Consensus 197 ~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--~~~~~~i~~---~~~~~~~-----~~-------------------- 246 (288)
T cd05093 197 RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIECITQ---GRVLQRP-----RT-------------------- 246 (288)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc---CCcCCCC-----CC--------------------
Confidence 346889999999999999999 8888653211 111111110 0000000 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
+-..+..+...|+..+|.+||++.++...|+.+.+.
T Consensus 247 ---~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 247 ---CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 011244567789999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.2e-07 Score=81.32 Aligned_cols=81 Identities=26% Similarity=0.363 Sum_probs=50.2
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.++|||||||+++||+| |+.|..... ...+...+..... . . ...
T Consensus 179 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~-----~-~--~~~--------------------- 227 (261)
T cd05068 179 NRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--NAEVLQQVDQGYR-----M-P--CPP--------------------- 227 (261)
T ss_pred CCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCC-----C-C--CCC---------------------
Confidence 346789999999999999999 887865321 1111111111000 0 0 000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRL 115 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~ 115 (367)
.+-..+..+...|+..+|..||++.++...|+.
T Consensus 228 --~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 228 --GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 001224456678999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.8e-07 Score=82.36 Aligned_cols=85 Identities=19% Similarity=0.344 Sum_probs=53.1
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+++||+| |+.|.+.... ..+........ . ...+.
T Consensus 186 ~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~~~~~~~~~~--~---~~~~~------------------------ 234 (316)
T cd05108 186 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGE--R---LPQPP------------------------ 234 (316)
T ss_pred CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhCCC--C---CCCCC------------------------
Confidence 346789999999999999998 9998764211 11111111000 0 00000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
.|-..+..+...|+..+|..||++.++...+..+...
T Consensus 235 --~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 235 --ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred --CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0011233456789999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.5e-07 Score=81.45 Aligned_cols=81 Identities=25% Similarity=0.323 Sum_probs=50.7
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++||+| |+.|+..... ..+...+.... .. +.. .
T Consensus 187 ~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~~~~~~~--~~-~~~-----~---------------------- 234 (270)
T cd05047 187 VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLPQGY--RL-EKP-----L---------------------- 234 (270)
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCccccCH--HHHHHHHhCCC--CC-CCC-----C----------------------
Confidence 46789999999999999997 9888753211 11111110000 00 000 0
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
.+-..+..+...|+..+|.+||++.++...|..+
T Consensus 235 -~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 235 -NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred -cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0012244567789999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.9e-08 Score=93.69 Aligned_cols=84 Identities=26% Similarity=0.411 Sum_probs=59.6
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
.+.|..|||||||||++|+++ |.||+.++.+.. |-+++.++ +. -+.
T Consensus 809 RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd------VIkaIe~g------------yR---------------LPp 855 (996)
T KOG0196|consen 809 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------VIKAIEQG------------YR---------------LPP 855 (996)
T ss_pred cccCchhhccccceEEEEecccCCCcccccchHH------HHHHHHhc------------cC---------------CCC
Confidence 457889999999999999999 999988765321 11111110 00 001
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
.++|-..+.++.+.|++.+...||...+++..|..+..
T Consensus 856 PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 856 PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 12445556778899999999999999999999987643
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.2e-07 Score=83.61 Aligned_cols=83 Identities=24% Similarity=0.350 Sum_probs=52.0
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..|.|+|||||||+|+||+| |+.|+.....++ .+. ..+......... .
T Consensus 251 ~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~~~~~----~---------------------- 299 (337)
T cd05054 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFC----RRLKEGTRMRAP----E---------------------- 299 (337)
T ss_pred CCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHH----HHHhccCCCCCC----c----------------------
Confidence 46789999999999999998 988865321111 111 111110000000 0
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
.+...+..+...|++..|+.||++.++.+.|+.+.
T Consensus 300 -~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 300 -YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred -cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01123445678899999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=98.37 E-value=4e-07 Score=81.70 Aligned_cols=84 Identities=19% Similarity=0.378 Sum_probs=53.1
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++||+| |+.|..... ...+.+++.... . ...+.
T Consensus 187 ~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~--~---~~~~~------------------------- 234 (303)
T cd05110 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLEKGE--R---LPQPP------------------------- 234 (303)
T ss_pred CCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHCCC--C---CCCCC-------------------------
Confidence 46789999999999999998 888875321 112222221100 0 00000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
.+-..+..+...|+..+|+.||++.++...++.+...
T Consensus 235 -~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 235 -ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011234556779999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=98.37 E-value=3e-07 Score=80.44 Aligned_cols=81 Identities=25% Similarity=0.308 Sum_probs=50.2
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.++|||||||+++||+| |+.|..... ...+..++..... .......
T Consensus 179 ~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~~--------~~~~~~~------------------- 229 (261)
T cd05072 179 GSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVMSALQRGYR--------MPRMENC------------------- 229 (261)
T ss_pred CCCChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHHHHHHcCCC--------CCCCCCC-------------------
Confidence 456789999999999999999 888864321 1112222111110 0000000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRL 115 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~ 115 (367)
-..+..+...|+..+|++||++.++.+.|+.
T Consensus 230 ----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 230 ----PDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1123345678999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.1e-07 Score=80.25 Aligned_cols=80 Identities=30% Similarity=0.330 Sum_probs=49.8
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++||+| |+.|+.... ...+.+.+.+.. ...+. ...
T Consensus 174 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~i~~~~---~~~~~-----~~~-------------------- 223 (257)
T cd05116 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--GNEVTQMIESGE---RMECP-----QRC-------------------- 223 (257)
T ss_pred CcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHCCC---CCCCC-----CCC--------------------
Confidence 45679999999999999998 988876421 112222221110 00000 000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHH
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRL 115 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~ 115 (367)
-..+..+-..|+..+|..||++.+|...|+.
T Consensus 224 ---~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 224 ---PPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1112344567899999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 367 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-32 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-31 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-22 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 7e-67
Identities = 80/233 (34%), Positives = 125/233 (53%), Gaps = 24/233 (10%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL-IRPGGSKSFKSECKA 194
S ++L A++ FS+ N++G G FG VY G L DGT +AVK GG F++E +
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 195 AINIKHRNIVRVFTAFSGVDY--QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNF 252
HRN++R+ + + +VY +M NGS+ LR + ++ PL++
Sbjct: 81 ISMAVHRNLLRL------RGFCMTPTE-RLLVYPYMANGSVASCLRERPESQ-PPLDWP- 131
Query: 253 LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID 312
K+ IA+ A L YLH C P I H ++K +N+LLD+E VGDFG+A+ +
Sbjct: 132 ---KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--Y 186
Query: 313 KQN----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
K ++G+ G+I PEY ++S DV+ +G++LLE+ TG R D
Sbjct: 187 KDTHVTTA---VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 7/84 (8%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMF---NDELNLHNFVKSALPE-RAEEILDVVF 57
G S DV+ +G++LLE+ TG R D +D++ L ++VK L E + E ++DV
Sbjct: 210 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL 269
Query: 58 FQEIEEEETMYK--KASSTCTQSS 79
++EE + + + + CTQSS
Sbjct: 270 QGNYKDEE-VEQLIQVALLCTQSS 292
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-56
Identities = 70/226 (30%), Positives = 112/226 (49%), Gaps = 13/226 (5%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
DL ATN F LIG G FG VY G L DG +A+K G + F++E +
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL 89
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
+H ++V + G + ++YK+M NG+L+ L G D +++ +
Sbjct: 90 SFCRHPHLVSLI----GFCDERNE-MILIYKYMENGNLKRHLYGSD-LPTMSMSW----E 139
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
++L+I I A L YLH I H ++K N+LLD+ + + DFG+++ +D+ +
Sbjct: 140 QRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
+KG+ GYI PEY + + DVYSFG++L E+
Sbjct: 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 23/103 (22%), Positives = 34/103 (33%), Gaps = 21/103 (20%)
Query: 9 DVYSFGILLLEMFTGLRPNDDMF-NDELNLHNFVKSALPER-AEEILDVVFFQEIEEEET 66
DVYSFG++L E+ + +NL + + E+I+D
Sbjct: 223 DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD------------ 270
Query: 67 MYKKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDV 109
I E L T V C A +R + DV
Sbjct: 271 -------PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-51
Identities = 77/239 (32%), Positives = 114/239 (47%), Gaps = 32/239 (13%)
Query: 136 SFKDLYNATNGFSS------ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG----GS 185
SF +L N TN F N +G G FG VY G + + TT+AVK +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 186 KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245
+ F E K +H N+V + FS +VY +MPNGSL + L D T
Sbjct: 75 QQFDQEIKVMAKCQHENLVELL-GFSSDGDD----LCLVYVYMPNGSLLDRLSCLDGT-- 127
Query: 246 RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305
PL+++ + IA A + +LH + H ++K +N+LLD+ + DFG+A
Sbjct: 128 PPLSWH----MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 306 RFLPAIDKQ---NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
R + +R I G+T Y+ PE G E + D+YSFG++LLE+ TG+ D
Sbjct: 181 RASEKFAQTVMTSR---IVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 6e-06
Identities = 17/55 (30%), Positives = 29/55 (52%), Gaps = 3/55 (5%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERA--EEILD 54
G ++ D+YSFG++LLE+ TGL D+ + L + + E E+ +D
Sbjct: 209 GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLDIKEEIEDEEKTIEDYID 262
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-50
Identities = 60/243 (24%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
++LY + + G FG V+ +AVK+F I+ S + E +
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFP-IQDKQSWQNEYEVYSL 72
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKA---VVYKFMPNGSLEEWLRGKDDTNWRPLNFNF 252
+KH NI++ F G + +G ++ F GSL ++L+ +++N
Sbjct: 73 PGMKHENILQ----FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA------NVVSWNE 122
Query: 253 LIKKKLDIAIDVACALRYLHCD-------CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305
L IA +A L YLH D +P I+H ++K NVLL + + + DFG+A
Sbjct: 123 LCH----IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 306 RFLPAIDKQNRFICIKGSTGYIPPEY-----DLGCEASTYGDVYSFGILLLEMFTGIRPS 360
A G+ Y+ PE + +A D+Y+ G++L E+ + +
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 361 DGI 363
DG
Sbjct: 239 DGP 241
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 9e-05
Identities = 16/115 (13%), Positives = 39/115 (33%), Gaps = 21/115 (18%)
Query: 9 DVYSFGILLLEMFTGLRPNDDMFND-ELNLHNFVKSALPERAEEILDVVFFQ----EIEE 63
D+Y+ G++L E+ + D ++ L + E++ +VV + + +
Sbjct: 220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL--EDMQEVVVHKKKRPVLRD 277
Query: 64 EETMYKKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118
+ + +C T C R+ V R+ +++
Sbjct: 278 Y----------WQKH----AGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-43
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
IGAG+FG+V+ + G+ +AVK+ F E ++H NIV F
Sbjct: 45 IGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL----F 99
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
G Q ++V +++ GSL L L+ +++L +A DVA + Y
Sbjct: 100 MGAVTQPPNL-SIVTEYLSRGSLYRLLHKSGAR--EQLDE----RRRLSMAYDVAKGMNY 152
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG---YI 327
LH PPI H NLK N+L+D + V DFG++R K + F+ K + G ++
Sbjct: 153 LHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-----KASTFLSSKSAAGTPEWM 206
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
PE ++ DVYSFG++L E+ T +P +
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 10/22 (45%), Positives = 16/22 (72%)
Query: 9 DVYSFGILLLEMFTGLRPNDDM 30
DVYSFG++L E+ T +P ++
Sbjct: 221 DVYSFGVILWELATLQQPWGNL 242
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-42
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 26/214 (12%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212
+G G FG V + +A+K K+F E + + H NIV+++
Sbjct: 16 VGRGAFGVVCKAK-WRAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLY----- 67
Query: 213 VDYQGARFKA--VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GA +V ++ GSL L G + + + + + + Y
Sbjct: 68 ----GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTA------AHAMSWCLQCSQGVAY 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEM-IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
LH + H +LKP N+LL + + DFG A D Q KGS ++ P
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP 172
Query: 330 EYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
E G S DV+S+GI+L E+ T +P D I
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 10/24 (41%), Positives = 17/24 (70%)
Query: 9 DVYSFGILLLEMFTGLRPNDDMFN 32
DV+S+GI+L E+ T +P D++
Sbjct: 185 DVFSWGIILWEVITRRKPFDEIGG 208
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 58/242 (23%), Positives = 95/242 (39%), Gaps = 35/242 (14%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
+ + + LIG G +G+VY G+L D +AVKVF ++F +E
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIY 59
Query: 196 I--NIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL 253
++H NI R V G +V ++ PNGSL ++L ++W
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-LHTSDW-------- 110
Query: 254 IKKKLDIAIDVACALRYLHCD------CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
+A V L YLH + +P I+H +L NVL+ ++ + DFG++
Sbjct: 111 -VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 308 L---PAIDKQNRFICIKGSTG---YIPPEY-------DLGCEASTYGDVYSFGILLLEMF 354
L + G Y+ PE A D+Y+ G++ E+F
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 355 TG 356
Sbjct: 230 MR 231
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 42/220 (19%), Positives = 83/220 (37%), Gaps = 32/220 (14%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--SKSFKSECKAAINIKHRNIVRVFTAF 210
+ + G ++ G + G I VKV + S+ F EC H N++
Sbjct: 18 LNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP----V 72
Query: 211 SGVDYQGARFK-AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
G ++ +MP GSL L + ++ + + A+D+A +
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQ----SQAVKFALDMARGMA 125
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
+LH +P I L +V++D++M + + + + + ++ P
Sbjct: 126 FLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAP 177
Query: 330 E------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
E D ++ D++SF +LL E+ T P +
Sbjct: 178 EALQKKPEDTNRRSA---DMWSFAVLLWELVTREVPFADL 214
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 7e-04
Identities = 9/22 (40%), Positives = 14/22 (63%)
Query: 9 DVYSFGILLLEMFTGLRPNDDM 30
D++SF +LL E+ T P D+
Sbjct: 193 DMWSFAVLLWELVTREVPFADL 214
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-39
Identities = 61/223 (27%), Positives = 92/223 (41%), Gaps = 32/223 (14%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNIVRVFT 208
IG G FG VY + G +AVK ++ + E K +KH NI+
Sbjct: 15 IGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA--- 70
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
GV + +V +F G L L GK ++ A+ +A +
Sbjct: 71 -LRGVCLKEPNL-CLVMEFARGGPLNRVLSGK----------RIPPDILVNWAVQIARGM 118
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGH--------VGDFGMARFLPAIDKQNRFICI 320
YLH + PI H +LK SN+L+ ++ + DFG+AR K +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA---- 174
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
G+ ++ PE S DV+S+G+LL E+ TG P GI
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 10/22 (45%), Positives = 15/22 (68%)
Query: 9 DVYSFGILLLEMFTGLRPNDDM 30
DV+S+G+LL E+ TG P +
Sbjct: 196 DVWSYGVLLWELLTGEVPFRGI 217
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-39
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 38/227 (16%)
Query: 153 IGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGS-------KSFKSECKAAINIKHRNIV 204
IG G FG V+ G L D + +A+K L G + F+ E N+ H NIV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ G+ + +V +F+P G L L K P+ + KL + +D+
Sbjct: 87 K----LYGLMHNP---PRMVMEFVPCGDLYHRLLDKA----HPIKW----SVKLRLMLDI 131
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLD-----DEMIGHVGDFGMARFLPAIDKQNRFIC 319
A + Y+ PPI H +L+ N+ L + V DFG+++ +
Sbjct: 132 ALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSG 185
Query: 320 IKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGI 363
+ G+ ++ PE +G E +Y D YSF ++L + TG P D
Sbjct: 186 LLGNFQWMAPET-IGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 9/22 (40%), Positives = 13/22 (59%)
Query: 9 DVYSFGILLLEMFTGLRPNDDM 30
D YSF ++L + TG P D+
Sbjct: 210 DTYSFAMILYTILTGEGPFDEY 231
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-38
Identities = 56/232 (24%), Positives = 93/232 (40%), Gaps = 38/232 (16%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAI--NIKHRNIVRVFT 208
IG G +G V+ G + G +AVKVF S+ E + ++H NI+
Sbjct: 43 KQIGKGRYGEVWMGK-WRGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILG--- 95
Query: 209 AFSGVDYQGARFKA---VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
F D +G ++ + NGSL ++L+ L+ ++K +A
Sbjct: 96 -FIAADIKGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLK----LAYSSV 144
Query: 266 CALRYLHCD-----CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
L +LH + +P IAH +LK N+L+ + D G+A + D I
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS-DTNEVDIPP 203
Query: 321 KGSTG---YIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
G Y+PPE ++ D+YSFG++L E+ +
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
IG+G+FG+VY G +AVK+ N+ P ++FK+E +H NI+ F
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL----F 85
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
G A+V ++ SL L + F +KK +DIA A + Y
Sbjct: 86 MGYSTAPQL--AIVTQWCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDY 135
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
LH I H +LK +N+ L ++ +GDFG+A ++F + GS ++ PE
Sbjct: 136 LH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 331 YDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGI 363
+++ Y DVY+FGI+L E+ TG P I
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 12/26 (46%), Positives = 18/26 (69%)
Query: 9 DVYSFGILLLEMFTGLRPNDDMFNDE 34
DVY+FGI+L E+ TG P ++ N +
Sbjct: 207 DVYAFGIVLYELMTGQLPYSNINNRD 232
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 47/229 (20%), Positives = 94/229 (41%), Gaps = 32/229 (13%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAI--NIKHRNIVRVFT 208
+G G +G V+ G+ + G +AVK+F KS+ E + ++H NI+
Sbjct: 14 ECVGKGRYGEVWRGS-WQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
+ + + ++ + GSL ++L+ L+ ++ I + +A L
Sbjct: 70 SDMTSRHSSTQL-WLITHYHEMGSLYDYLQLT------TLDTVSCLR----IVLSIASGL 118
Query: 269 RYLHCD-----CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+LH + +P IAH +LK N+L+ + D G+A Q +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD-VGNNPR 177
Query: 324 TG---YIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
G Y+ PE ++ D+++FG++L E+ + + +
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 51/227 (22%), Positives = 86/227 (37%), Gaps = 33/227 (14%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFT 208
LIG G FG VY+G +A+++ ++ R K+FK E A +H N+V
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL--- 93
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
F G A++ +L +R + K IA ++ +
Sbjct: 94 -FMGACMSPPHL-AIITSLCKGRTLYSVVRDAKIV--------LDVNKTRQIAQEIVKGM 143
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF---LPAIDKQNRFICIKGSTG 325
YLH I H +LK NV D+ + + DFG+ L A ++++ G
Sbjct: 144 GYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 326 YIPPE------YDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGI 363
++ PE D + + DV++ G + E+ P
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-36
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 32/229 (13%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAI--NIKHRNIVRVFT 208
IG G FG V+ G + G +AVK+F +S+ E + ++H NI+
Sbjct: 48 ESIGKGRFGEVWRGK-WRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
A + + + +V + +GSL ++L + +IK +A+ A L
Sbjct: 104 ADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR------YTVTVEGMIK----LALSTASGL 152
Query: 269 RYLHCD-----CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+LH + +P IAH +LK N+L+ + D G+A + I
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA-TDTIDIAPNHR 211
Query: 324 TG---YIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
G Y+ PE E+ D+Y+ G++ E+
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 50/225 (22%), Positives = 85/225 (37%), Gaps = 31/225 (13%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG T T + + LIR ++F E K ++H N+++ F
Sbjct: 18 LGKGCFGQAIKVTHR-ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK----F 72
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV Y+ R + +++ G+L ++ D + +++ A D+A + Y
Sbjct: 73 IGVLYKDKRLNFIT-EYIKGGTLRGIIKSMD----SQYPW----SQRVSFAKDIASGMAY 123
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
LH I H +L N L+ + V DFG+AR + Q +
Sbjct: 124 LH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 331 YDLGC------EASTYG------DVYSFGILLLEMFTGIRPSDGI 363
+G E DV+SFGI+L E+ +
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 9/22 (40%), Positives = 14/22 (63%)
Query: 9 DVYSFGILLLEMFTGLRPNDDM 30
DV+SFGI+L E+ + + D
Sbjct: 204 DVFSFGIVLCEIIGRVNADPDY 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 41/217 (18%), Positives = 80/217 (36%), Gaps = 31/217 (14%)
Query: 152 LIGAGNFGSVYNG--TLFDGTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNIVR 205
I G G +Y +G + +K + G +E + + H +IV+
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKG---LVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+F D G +V +++ SL+ L + + + +++
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLP----VAEAIAYLLEIL 192
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
AL YLH + + +LKP N++L +E + + D G I+ G+ G
Sbjct: 193 PALSYLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAVS---RINSFGYLY---GTPG 242
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ PE + D+Y+ G L + + +G
Sbjct: 243 FQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNG 278
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 50/213 (23%), Positives = 92/213 (43%), Gaps = 22/213 (10%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVFT 208
IG G+F +VY G +A + + FK E + ++H NIVR +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
++ +V + M +G+L+ +L+ ++ + +++ + L
Sbjct: 93 SWESTVKGKKCI-VLVTELMTSGTLKTYLK-----RFKVMKIK-VLRS---WCRQILKGL 142
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGY 326
++LH PPI H +LK N+ + G V GD G+A + + + + G+ +
Sbjct: 143 QFLH-TRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLA----TLKRASFAKAVIGTPEF 196
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ PE + DVY+FG+ +LEM T P
Sbjct: 197 MAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 34/252 (13%)
Query: 119 KLLKTPVYEGKQTINNPSFKDLY--NATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKV 176
+L+K V EG + ++ + N IG G FG V G + G +AVK
Sbjct: 166 RLIKPKVMEGTVAAQDEFYRSGWALNMKE-LKLLQTIGKGEFGDVMLGD-YRGNKVAVKC 223
Query: 177 FNLIRPGGS-KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEE 235
I+ + ++F +E ++H N+V++ GV + +V ++M GSL +
Sbjct: 224 ---IKNDATAQAFLAEASVMTQLRHSNLVQLL----GVIVEEKGGLYIVTEYMAKGSLVD 276
Query: 236 WLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLD 292
+LR + L + L+ ++DV A+ YL + + H +L NVL+
Sbjct: 277 YLRSRGR---SVLGGDCLL----KFSLDVCEAMEYLEGNNF-----V-HRDLAARNVLVS 323
Query: 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLE 352
++ + V DFG+ + + + +K + PE + ST DV+SFGILL E
Sbjct: 324 EDNVAKVSDFGLTKEASSTQDTGKLP-VK----WTAPEALREKKFSTKSDVWSFGILLWE 378
Query: 353 MFT-GIRPSDGI 363
+++ G P I
Sbjct: 379 IYSFGRVPYPRI 390
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKS--FKSECKAAINIKHRNIVRVFT 208
+G G FG V+ GT T +A+K ++PG F E + ++H +V+++
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLY- 328
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
V + + +V ++M GSL ++L+G+ + L L+ D+A +A +
Sbjct: 329 ---AVVSEEPIY--IVTEYMSKGSLLDFLKGETG---KYLRLPQLV----DMAAQIASGM 376
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID---KQNRFICIKGSTG 325
Y+ + H +L+ +N+L+ + ++ V DFG+AR + + +Q IK
Sbjct: 377 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK---- 429
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ PE L + DV+SFGILL E+ T G P G+
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 56/225 (24%), Positives = 104/225 (46%), Gaps = 41/225 (18%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFT 208
+GAG FG V+ T T +AVK ++PG ++F +E ++H +V++
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLH- 249
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
V + + ++ +FM GSL ++L+ + + K +D + +A +
Sbjct: 250 ---AVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPL-------PKLIDFSAQIAEGM 297
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID---KQNRFICIKGSTG 325
++ Q H +L+ +N+L+ ++ + DFG+AR + + ++ IK
Sbjct: 298 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK---- 350
Query: 326 YIPPEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
+ P EA +G DV+SFGILL+E+ T G P G+
Sbjct: 351 WTAP------EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKS--FKSECKAAINIKHRNIVRVFT 208
+G G FG V+ GT T +A+K ++PG F E + ++H +V+++
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLY- 245
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
V + + +V ++M GSL ++L+G+ + L L+ D+A +A +
Sbjct: 246 ---AVVSEEPIY--IVTEYMSKGSLLDFLKGETG---KYLRLPQLV----DMAAQIASGM 293
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID---KQNRFICIKGSTG 325
Y+ + H +L+ +N+L+ + ++ V DFG+AR + + +Q IK
Sbjct: 294 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK---- 346
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ PE L + DV+SFGILL E+ T G P G+
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 35/224 (15%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
LIG+G FG V+ DG T +K ++ + E KA + H NIV
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 210 FSGVDYQGARFKAVVYK-----------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
+ G DY + F G+LE+W+ + L+ L
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLA----L 125
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
++ + + Y+H + + +LKPSN+ L D +GDFG+ L K+ R
Sbjct: 126 ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE + YG D+Y+ G++L E+
Sbjct: 183 ---GTLRYMSPEQ---ISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 61/218 (27%), Positives = 86/218 (39%), Gaps = 35/218 (16%)
Query: 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNIVRVF 207
IG GNFG V++G L D T +AVK R F E + H NIVR+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKS---CRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
GV Q +V + + G +LR + +K L + D A
Sbjct: 179 ----GVCTQKQPI-YIVMELVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAG 225
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
+ YL H +L N L+ ++ + + DFGM+R + G +
Sbjct: 226 MEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE-----ADGVYAASGGLRQV 277
Query: 328 P-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
P PE S+ DV+SFGILL E F+ G P
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 52/235 (22%), Positives = 93/235 (39%), Gaps = 58/235 (24%)
Query: 153 IGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRPGGSKSFKSE--CKAAI--NIKHRNI 203
+G+G FG+VY G +A+K +R S E +A + ++ + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILDEAYVMASVDNPHV 79
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
R+ G+ ++ + MP G L +++R D N + L+ +
Sbjct: 80 CRLL----GICLTSTVQ--LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQ 125
Query: 264 VACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+A + YL H +L NVL+ + DFG+A+ L A +K
Sbjct: 126 IAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-----EY 174
Query: 321 KGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
G +P E+ + DV+S+G+ + E+ T G +P DGI
Sbjct: 175 HAEGGKVPIKWMAL------ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 57/231 (24%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
+GAG FG V+ G T +AVK ++ G +F +E ++H+ +VR++
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLAEANLMKQLQHQRLVRLY--- 74
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
V Q + ++ ++M NGSL ++L+ L N L+ D+A +A + +
Sbjct: 75 -AVVTQEPIY--IITEYMENGSLVDFLKTPSG---IKLTINKLL----DMAAQIAEGMAF 124
Query: 271 L------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
+ H D L+ +N+L+ D + + DFG+AR + + N + +G
Sbjct: 125 IEERNYIHRD---------LRAANILVSDTLSCKIADFGLARLI----EDNEYTAREG-- 169
Query: 325 GYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
P P EA YG DV+SFGILL E+ T G P G+
Sbjct: 170 AKFPIKWTAP------EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-25
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 49/227 (21%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS-KSFKSECKAAINIKHRNIVRVFTA 209
IG G FG V G G +AVK I+ + ++F +E ++H N+V++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQLL-- 80
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
GV + +V ++M GSL ++LR + L + L+ ++DV A+
Sbjct: 81 --GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLL----KFSLDVCEAME 131
Query: 270 YL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
YL H D L NVL+ ++ + V DFG+ + + + +K
Sbjct: 132 YLEGNNFVHRD---------LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VK-- 179
Query: 324 TGYIPPEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
+ PE A DV+SFGILL E+++ G P I
Sbjct: 180 --WTAPE------ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 57/234 (24%)
Query: 151 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+IG G+FG VY+GTL D AVK + F +E + H N
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---LNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 203 IVRVFTAFSGV--DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
++ + G+ +G+ VV +M +G L ++R + N +K +
Sbjct: 152 VLSLL----GICLRSEGSPL--VVLPYMKHGDLRNFIRNETH--------NPTVKDLIGF 197
Query: 261 AIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ VA +++L H +L N +LD++ V DFG+AR + +
Sbjct: 198 GLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARD---MYDKEFD 248
Query: 318 ICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+ +P E+ DV+SFG+LL E+ T G P
Sbjct: 249 SVHNKTGAKLPVKWMAL------ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 151 NLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVF 207
+ +G G +G VY G T+AVK ++ + F E IKH N+V++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
GV + F ++ +FM G+L ++LR + L +A ++ A
Sbjct: 283 ----GVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSA-------VVLLYMATQISSA 330
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA---IDKQNRFICIKGST 324
+ YL + H NL N L+ + + V DFG++R + IK
Sbjct: 331 MEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--- 384
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ PE + S DV++FG+LL E+ T G+ P GI
Sbjct: 385 -WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 52/226 (23%), Positives = 91/226 (40%), Gaps = 34/226 (15%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G FG V+ D A+K L + E KA ++H IVR F A
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 210 F----SGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+ + Q + K +Y M +L++W+ G+ R L I +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE------RSVCLHIFL 125
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
+A A+ +LH + H +LKPSN+ + + VGDFG+ + +++ +
Sbjct: 126 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 323 STG----------YIPPEYDLGCEASTYG---DVYSFGILLLEMFT 355
+ Y+ PE ++Y D++S G++L E+
Sbjct: 183 AYARHTGQVGTKLYMSPEQ---IHGNSYSHKVDIFSLGLILFELLY 225
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 53/229 (23%), Positives = 85/229 (37%), Gaps = 47/229 (20%)
Query: 151 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS-FKSECKAAINIKHRNIVR 205
+IG G+FG VY+G D A+K + I F E + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ G+ V+ +M +G L +++R N +K + + VA
Sbjct: 87 LI----GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVA 134
Query: 266 CALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
+ YL H +L N +LD+ V DFG+AR I + + +
Sbjct: 135 RGMEYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARD---ILDREYYSVQQH 185
Query: 323 STGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+P E+ DV+SFG+LL E+ T G P
Sbjct: 186 RHARLPVKWTAL------ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 30/235 (12%), Positives = 58/235 (24%), Gaps = 38/235 (16%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+ G+ V+ + A+KVF + AA + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 208 TAF------------------SGVDYQGARFKAVVYKFMP--NGSLEEWLRGKDDTNWRP 247
Q A MP + LE D
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV--YV 186
Query: 248 LNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
+ I + + L + H + P N+ + + +GD
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 308 LPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ R Y P E+ L +T+ + + G+ + ++ P
Sbjct: 244 VGT-----RGPASSVPVTYAPREF-LNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-24
Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 49/232 (21%)
Query: 153 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGS-----KSFKSECKAAINIKHRNI 203
+G G FGSV G L +AVK ++ S + F SE + H N+
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKT---MKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKLDIAI 262
+R+ + QG V+ FM G L +L + +T + + L+ +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL----KFMV 154
Query: 263 DVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
D+A + YL + H +L N +L D+M V DFG+++ + + D
Sbjct: 155 DIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD-----YY 203
Query: 320 IKGSTGYIP-----PE------YDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
+G +P E Y ++ DV++FG+ + E+ T G+ P
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVY------TSKSDVWAFGVTMWEIATRGMTP 249
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-24
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 47/222 (21%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
IG+G FG V+ G + +A+K IR G + F E + + + H +V+++
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQLY--- 69
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV + A +V +FM +G L ++LR + F + L + +DV + Y
Sbjct: 70 -GVCLEQAPI-CLVTEFMEHGCLSDYLRTQRGL--------FAAETLLGMCLDVCEGMAY 119
Query: 271 L---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA---IDKQNRFICIKGST 324
L H +L N L+ + + V DFGM RF+ +K
Sbjct: 120 LEEACV------IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--- 170
Query: 325 GYIPPEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+ P E ++ DV+SFG+L+ E+F+ G P
Sbjct: 171 -WASP------EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 7e-24
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 57/227 (25%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
+G+G FG V G +AVK+ I+ G F E + + + H +V+ +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKM---IKEGSMSEDEFFQEAQTMMKLSHPKLVKFY--- 69
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV + +V +++ NG L +LR + L + L+ ++ DV + +
Sbjct: 70 -GVCSKEYPI-YIVTEYISNGCLLNYLRSHG----KGLEPSQLL----EMCYDVCEGMAF 119
Query: 271 L------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
L H D L N L+D ++ V DFGM R++ ++++ G
Sbjct: 120 LESHQFIHRD---------LAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVG-- 164
Query: 325 GYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
P P E Y DV++FGIL+ E+F+ G P
Sbjct: 165 TKFPVKWSAP------EVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-24
Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 57/234 (24%)
Query: 151 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+IG G+FG VY+GTL D AVK + F +E + H N
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---LNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 203 IVRVFTAFSGV--DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
++ + G+ +G+ VV +M +G L ++R + N +K +
Sbjct: 88 VLSLL----GICLRSEGSPL--VVLPYMKHGDLRNFIRNETH--------NPTVKDLIGF 133
Query: 261 AIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ VA ++YL H +L N +LD++ V DFG+AR + + +
Sbjct: 134 GLQVAKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARD---MYDKEYY 184
Query: 318 ICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+ +P E+ DV+SFG+LL E+ T G P
Sbjct: 185 SVHNKTGAKLPVKWMAL------ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-24
Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 53/225 (23%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V G +A+K+ I+ G F E K +N+ H +V+++
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLY--- 85
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV + ++ ++M NG L +LR F ++ L++ DV A+ Y
Sbjct: 86 -GVCTKQRPI-FIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEY 135
Query: 271 L------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID---KQNRFICIK 321
L H D L N L++D+ + V DFG++R++ + ++
Sbjct: 136 LESKQFLHRD---------LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
Query: 322 GSTGYIPPEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+ PP E Y D+++FG+L+ E+++ G P
Sbjct: 187 ----WSPP------EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-23
Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 65/235 (27%)
Query: 153 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGS----KSFKSECKAAI--NIKHRN 202
IG+G+ G V G L +A+K ++ G + + F SE A+I H N
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKA---LKAGYTERQRRDFLSE--ASIMGQFDHPN 111
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
I+R+ GV +G +V ++M NGSL+ +LR D F I + + +
Sbjct: 112 IIRLE----GVVTRGRLA-MIVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGMLR 158
Query: 263 DVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
V +RYL H D L NVL+D ++ V DFG++R L + +
Sbjct: 159 GVGAGMRYLSDLGYVHRD---------LAARNVLVDSNLVCKVSDFGLSRVL----EDDP 205
Query: 317 FICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+ G IP P EA + DV+SFG+++ E+ G RP
Sbjct: 206 DAAYTTTGGKIPIRWTAP------EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-23
Identities = 51/235 (21%), Positives = 90/235 (38%), Gaps = 58/235 (24%)
Query: 153 IGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNI 203
+G+G FG+VY G +A+K +R S E ++ + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILDEAYVMASVDNPHV 79
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
R+ G+ ++ + MP G L +++R D N + L+ +
Sbjct: 80 CRLL----GICLTSTVQ--LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQ 125
Query: 264 VACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+A + YL H +L NVL+ + DFG+A+ L A +K
Sbjct: 126 IAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-----EY 174
Query: 321 KGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
G +P E+ + DV+S+G+ + E+ T G +P DGI
Sbjct: 175 HAEGGKVPIKWMAL------ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-23
Identities = 48/220 (21%), Positives = 89/220 (40%), Gaps = 32/220 (14%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS------FKSECKAAINIKHRNIV 204
+G G +VY +A+K I + F+ E + + H+NIV
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKA---IFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ + + +V +++ +L E++ PL+ + ++ +
Sbjct: 75 SMID--VDEE-DDCYY--LVMEYIEGPTLSEYIESH-----GPLS----VDTAINFTNQI 120
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA--IDKQNRFICIKG 322
+++ H I H ++KP N+L+D + DFG+A+ L + + N + G
Sbjct: 121 LDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL---G 174
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ Y PE G D+YS GI+L EM G P +G
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-23
Identities = 62/247 (25%), Positives = 86/247 (34%), Gaps = 80/247 (32%)
Query: 153 IGAGNFGSVYNGTL--FDGTTI--AVKVFNLIRPGGSKS------FKSECKAAINIKHRN 202
+G G+FG V G G T+ AVK ++P F E A ++ HRN
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKC---LKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 203 IVRVFTAFSGVDYQGARFKAVVYK--------FMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
++R++ VV P GSL + LR FL+
Sbjct: 83 LIRLY--------------GVVLTPPMKMVTELAPLGSLLDRLRKHQGH--------FLL 120
Query: 255 KKKLDIAIDVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308
A+ VA + YL H D L N+LL + +GDFG+ R L
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRD---------LAARNLLLATRDLVKIGDFGLMRAL 171
Query: 309 PAIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-G 356
P D +P P E+ D + FG+ L EMFT G
Sbjct: 172 PQNDDHYV----MQEHRKVPFAWCAP------ESLKTRTFSHASDTWMFGVTLWEMFTYG 221
Query: 357 IRPSDGI 363
P G+
Sbjct: 222 QEPWIGL 228
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-23
Identities = 67/237 (28%), Positives = 91/237 (38%), Gaps = 59/237 (24%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKS----FKSECKAAI--NIKH 200
+G G FG VY G + +AVK + S+ F E A I H
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFLME--ALIISKFNH 92
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
+NIVR GV Q ++ + M G L+ +LR +P + L +
Sbjct: 93 QNIVR----CIGVSLQSLPR-FILMELMAGGDLKSFLRETRPRPSQPSSLAM--LDLLHV 145
Query: 261 AIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHV---GDFGMARFLPAIDKQ 314
A D+AC +YL H H ++ N LL G V GDFGMAR +
Sbjct: 146 ARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-- 197
Query: 315 NRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
KG +P PE A G D +SFG+LL E+F+ G P
Sbjct: 198 ---YYRKGGCAMLPVKWMPPE------AFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-23
Identities = 52/232 (22%), Positives = 87/232 (37%), Gaps = 48/232 (20%)
Query: 153 IGAGNFGSVYNGTLFDG----TTIAVKVF--NLIRPGGSKSFKSECKAAINIKHRNIVR- 205
+G G FGSV L +AVK+ ++I + F E H ++ +
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 206 --VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKLDIAI 262
V V+ FM +G L +L + N L L+ +
Sbjct: 91 VGVSLRSRAKGRLPIPM--VILPFMKHGDLHAFLLASRIGENPFNLPLQTLV----RFMV 144
Query: 263 DVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
D+AC + YL + H +L N +L ++M V DFG++R + + D
Sbjct: 145 DIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-----YY 193
Query: 320 IKGSTGYIP-----PE------YDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
+G +P E Y + + DV++FG+ + E+ T G P
Sbjct: 194 RQGCASKLPVKWLALESLADNLY------TVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-23
Identities = 51/240 (21%), Positives = 82/240 (34%), Gaps = 77/240 (32%)
Query: 153 IGAGNFGSVYNGTLFDG---TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNIVR 205
+G GNFGSV G +A+KV ++ G K+ E + + + IVR
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 206 VFTAFSGVDYQGARFKAVVYK--------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
+ V G L ++L GK + +
Sbjct: 75 LI--------------GVCQAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNV 112
Query: 258 LDIAIDVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
++ V+ ++YL H D L NVLL + + DFG+++ L A
Sbjct: 113 AELLHQVSMGMKYLEEKNFVHRD---------LAARNVLLVNRHYAKISDFGLSKALGAD 163
Query: 312 DKQNRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
D S G P P E + DV+S+G+ + E + G +P
Sbjct: 164 DSYYT----ARSAGKWPLKWYAP------ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 55/235 (23%), Positives = 90/235 (38%), Gaps = 58/235 (24%)
Query: 153 IGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNI 203
+G+G FG+V+ G + +KV I ++ A ++ H +I
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKV---IEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
VR+ G+ + +V +++P GSL + +R + L+ +
Sbjct: 78 VRLL----GLCPGSSLQ--LVTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQ 123
Query: 264 VACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+A + YL H NL NVLL V DFG+A LP DKQ +
Sbjct: 124 IAKGMYYLEEHGM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-----L 172
Query: 321 KGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
S P E+ +G DV+S+G+ + E+ T G P G+
Sbjct: 173 LYSEAKTPIKWMAL------ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 66/236 (27%)
Query: 153 IGAGNFGSVYNGTLFDGT-----TIAVKVFNLIRPGGS----KSFKSECKAAI--NIKHR 201
IGAG FG VY G L + +A+K ++ G + F E A I H
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFLGE--AGIMGQFSHH 106
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
NI+R+ GV + ++ ++M NG+L+++LR KD F + + + +
Sbjct: 107 NIIRLE----GVISKYKPM-MIITEYMENGALDKFLREKDGE--------FSVLQLVGML 153
Query: 262 IDVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+A ++YL H D L N+L++ ++ V DFG++R L +
Sbjct: 154 RGIAAGMKYLANMNYVHRD---------LAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204
Query: 316 RFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
S G IP P EA +Y DV+SFGI++ E+ T G RP
Sbjct: 205 Y----TTSGGKIPIRWTAP------EAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 57/232 (24%)
Query: 153 IGAGNFGSVYNGTLFDGTT-IAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTA 209
+G G +G VY G + +AVK ++ + F E IKH N+V++
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLL-- 75
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
GV + F ++ +FM G+L ++LR + + ++ L+ +A ++ A+
Sbjct: 76 --GVCTREPPF-YIITEFMTYGNLLDYLRECNR---QEVSAVVLL----YMATQISSAME 125
Query: 270 YL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
YL H D L N L+ + + V DFG++R + +
Sbjct: 126 YLEKKNFIHRD---------LAARNCLVGENHLVKVADFGLSRLMT--GDTYT----AHA 170
Query: 324 TGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
P P E+ Y DV++FG+LL E+ T G+ P GI
Sbjct: 171 GAKFPIKWTAP------ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 51/233 (21%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+G G+FG VY G T +A+K + S F +E +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKT---VNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKLDIA 261
+VR+ GV QG V+ + M G L+ +LR + P+ + K + +A
Sbjct: 90 VVRLL----GVVSQGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 262 IDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
++A + YL H +L N ++ ++ +GDFGM R + D
Sbjct: 145 GEIADGMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-----Y 193
Query: 319 CIKGSTGYIP-----PE------YDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
KG G +P PE + +TY DV+SFG++L E+ T +P
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVF------TTYSDVWSFGVVLWEIATLAEQP 240
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 49/235 (20%), Positives = 86/235 (36%), Gaps = 68/235 (28%)
Query: 153 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGS----KSFKSECKAAI--NIKHRN 202
IG G FG V+ G +A+K + S + F E A H +
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKT---CKNCTSDSVREKFLQE--ALTMRQFDHPH 77
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
IV++ GV + + ++ + G L +L+ + + + + A
Sbjct: 78 IVKLI----GVITENPVW--IIMELCTLGELRSFLQVRKYS--------LDLASLILYAY 123
Query: 263 DVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
++ AL YL H D + NVL+ +GDFG++R++
Sbjct: 124 QLSTALAYLESKRFVHRD---------IAARNVLVSSNDCVKLGDFGLSRYMEDST---- 170
Query: 317 FICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
K S G +P P E+ + DV+ FG+ + E+ G++P
Sbjct: 171 --YYKASKGKLPIKWMAP------ESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 67/237 (28%), Positives = 91/237 (38%), Gaps = 59/237 (24%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKS----FKSECKAAI--NIKH 200
+G G FG VY G + +AVK + S+ F E A I H
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFLME--ALIISKFNH 133
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
+NIVR GV Q ++ + M G L+ +LR +P + L +
Sbjct: 134 QNIVR----CIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQPSSLAM--LDLLHV 186
Query: 261 AIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHV---GDFGMARFLPAIDKQ 314
A D+AC +YL H H ++ N LL G V GDFGMAR +
Sbjct: 187 ARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-- 238
Query: 315 NRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
KG +P PE A G D +SFG+LL E+F+ G P
Sbjct: 239 ---YYRKGGCAMLPVKWMPPE------AFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 53/231 (22%), Positives = 87/231 (37%), Gaps = 55/231 (23%)
Query: 153 IGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPGGSKS---FKSECKAAINIKHRNIV 204
+G GNFGSV G +AVK ++ G F+ E + + IV
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQ---LQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 205 RVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ GV Y R +V +++P+G L ++L+ + L +
Sbjct: 88 KYR----GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQ 135
Query: 264 VACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+ + YL C H +L N+L++ E + DFG+A+ LP
Sbjct: 136 ICKGMEYLGSRRC------VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV---- 185
Query: 321 KGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
G P P E+ + DV+SFG++L E+FT +
Sbjct: 186 VREPGQSPIFWYAP------ESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 52/241 (21%), Positives = 95/241 (39%), Gaps = 61/241 (25%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKS----FKSECKAAI--NIKH 200
+G FG VY G LF +A+K ++ F+ E A + ++H
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT---LKDKAEGPLREEFRHE--AMLRARLQH 71
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK--- 257
N+V + GV + ++++ + +G L E+L + + + K
Sbjct: 72 PNVVCLL----GVVTKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 258 ----LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA 310
+ + +A + YL H H +L NVL+ D++ + D G+ R + A
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 311 IDKQNRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIR 358
D +P PE A YG D++S+G++L E+F+ G++
Sbjct: 181 AD-----YYKLLGNSLLPIRWMAPE------AIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229
Query: 359 P 359
P
Sbjct: 230 P 230
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS------FKSECKAAINIKHRNIV 204
++G G V+ L D +AVKV +R ++ F+ E + A + H IV
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKV---LRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 205 RVFTAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
V+ +G A + Y M +L + + + P+ K+ +++
Sbjct: 76 AVYD--TGEAETPAG--PLPYIVMEYVDGVTLRDIVHTE-----GPMT----PKRAIEVI 122
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI--- 318
D AL + H Q I H ++KP+N+++ V DFG+AR AI +
Sbjct: 123 ADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR---AIADSGNSVTQT 176
Query: 319 -CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ G+ Y+ PE G DVYS G +L E+ TG P G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
++G G +G VY G L + IA+K S+ E ++KH+NIV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL--- 85
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFN-FLIKKKLDIAIDVACALR 269
G + K + + +P GSL LR K W PL N I + L+
Sbjct: 86 -GSFSENGFIK-IFMEQVPGGSLSALLRSK----WGPLKDNEQTIGF---YTKQILEGLK 136
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYI 327
YLH + I H ++K NVL++ G + DFG ++ L I+ G+ Y+
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTYS-GVLKISDFGTSKRLAGINPCTE--TFTGTLQYM 190
Query: 328 PPEYDLGCE--ASTYGDVYSFGILLLEMFTGIRP 359
PE D++S G ++EM TG P
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-22
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 42/220 (19%)
Query: 153 IGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPGGS---KSFKSECKAAINIKHRNIV 204
+G GNFGSV G +AVK ++ + F+ E + +++H NIV
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 205 RVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ GV Y R ++ +++P GSL ++L+ + K L
Sbjct: 106 KYK----GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQ 153
Query: 264 VACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+ + YL H +L N+L+++E +GDFG+ + LP Q++
Sbjct: 154 ICKGMEYLGTKRY------IHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEYYK 203
Query: 321 KGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
G P PE + S DV+SFG++L E+FT
Sbjct: 204 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-22
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 42/220 (19%)
Query: 153 IGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPGGS---KSFKSECKAAINIKHRNIV 204
+G GNFGSV G +AVK ++ + F+ E + +++H NIV
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 205 RVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ GV Y R ++ +++P GSL ++L+ + K L
Sbjct: 75 KYK----GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQ 122
Query: 264 VACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+ + YL H +L N+L+++E +GDFG+ + LP Q++
Sbjct: 123 ICKGMEYLGTKRY------IHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEFFK 172
Query: 321 KGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
G P PE + S DV+SFG++L E+FT
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 49/234 (20%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG V+ + +AVK + F+ E + ++H++IVR
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL------DI 260
F GV +G +V+++M +G L +LR + L +
Sbjct: 109 F----GVCTEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 261 AIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
A VA + YL H H +L N L+ ++ +GDFGM+R + + D
Sbjct: 164 ASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----- 212
Query: 318 ICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
G +P P E+ Y DV+SFG++L E+FT G +P
Sbjct: 213 YYRVGGRTMLPIRWMPP------ESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-22
Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 43/221 (19%)
Query: 153 IGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNI 203
+G G+FG V G +AVK ++P + K E + N+ H NI
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 204 VRVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
V+ G+ + ++ +F+P+GSL+E+L + +K++L A+
Sbjct: 86 VKYK----GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAV 133
Query: 263 DVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
+ + YL H +L NVL++ E +GDFG+ + + ++
Sbjct: 134 QICKGMDYLGSRQY------VHRDLAARNVLVESEHQVKIGDFGLTKAIE----TDKEYY 183
Query: 320 IKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
P PE + + DV+SFG+ L E+ T
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 49/238 (20%), Positives = 83/238 (34%), Gaps = 73/238 (30%)
Query: 153 IGAGNFGSVYNGTL---FDGTTIAVKVF--NLIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G+GNFG+V G T+AVK+ P +E + + IVR+
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 208 TAFSGVDYQGARFKAVVYK--------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
+ G L ++L+ + + ++
Sbjct: 85 --------------GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---------IE 121
Query: 260 IAIDVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
+ V+ ++YL H D L NVLL + + DFG+++ L A +
Sbjct: 122 LVHQVSMGMKYLEESNFVHRD---------LAARNVLLVTQHYAKISDFGLSKALRADEN 172
Query: 314 QNRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+ + G P P E Y DV+SFG+L+ E F+ G +P
Sbjct: 173 YYK----AQTHGKWPVKWYAP------ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 65/235 (27%)
Query: 153 IGAGNFGSVYNGTL----FDGTTIAVKVFNLIRPGGS----KSFKSECKAAI--NIKHRN 202
+GAG FG V +G L ++A+K ++ G + + F E A+I H N
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKT---LKVGYTEKQRRDFLGE--ASIMGQFDHPN 107
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
I+R+ GV + +V ++M NGSL+ +LR D F + + + +
Sbjct: 108 IIRLE----GVVTKSKPV-MIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGMLR 154
Query: 263 DVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
+A ++YL H D L N+L++ ++ V DFG+ R L +
Sbjct: 155 GIASGMKYLSDMGYVHRD---------LAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205
Query: 317 FICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
G IP P EA Y DV+S+GI+L E+ + G RP
Sbjct: 206 ----TTRGGKIPIRWTSP------EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 53/236 (22%), Positives = 88/236 (37%), Gaps = 61/236 (25%)
Query: 153 IGAGNFGSVYNGTLFDG---TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNIVR 205
+G GNFGSV G +A+KV ++ G K+ E + + + IVR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ GV A +V + G L ++L GK + + ++ V+
Sbjct: 401 LI----GVCQAEALM--LVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVS 446
Query: 266 CALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
++YL H + L NVLL + + DFG+++ L A D
Sbjct: 447 MGMKYLEEKNFVHRN---------LAARNVLLVNRHYAKISDFGLSKALGADDSYYT--- 494
Query: 320 IKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
S G P P E + DV+S+G+ + E + G +P +
Sbjct: 495 -ARSAGKWPLKWYAP------ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-21
Identities = 48/235 (20%), Positives = 90/235 (38%), Gaps = 68/235 (28%)
Query: 153 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS----FKSECKAAI--NIKHRN 202
+G G FG VY G + +AVK + + F SE A I N+ H +
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKT---CKKDCTLDNKEKFMSE--AVIMKNLDHPH 74
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
IV++ G+ + + ++ + P G L +L ++ + + ++
Sbjct: 75 IVKLI----GIIEEEPTW--IIMELYPYGELGHYLERNKNS--------LKVLTLVLYSL 120
Query: 263 DVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
+ A+ YL H D + N+L+ +GDFG++R++ D+
Sbjct: 121 QICKAMAYLESINCVHRD---------IAVRNILVASPECVKLGDFGLSRYI--EDEDY- 168
Query: 317 FICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
K S +P P E+ + DV+ F + + E+ + G +P
Sbjct: 169 ---YKASVTRLPIKWMSP------ESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 45/223 (20%), Positives = 74/223 (33%), Gaps = 47/223 (21%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KHRNIVR 205
+G G++G V+ DG AVK + P ++ A + +H VR
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKR--SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 206 VFTAFSGVDYQGARFKAVVYKFM--PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ A+ +Y SL++ + + D
Sbjct: 122 LEQAWEEGGI--------LYLQTELCGPSLQQHCEAW--------GASLPEAQVWGYLRD 165
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
AL +LH + H ++KP+N+ L G GDFG+ L
Sbjct: 166 TLLALAHLH---SQGLVHLDVKPANIFLGPR--GRCKLGDFGLLVELGTAGAGEVQE--- 217
Query: 322 GSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G Y+ PE Y DV+S G+ +LE+ +
Sbjct: 218 GDPRYMAPELLQGSYGTAA------DVFSLGLTILEVACNMEL 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-21
Identities = 50/236 (21%), Positives = 89/236 (37%), Gaps = 62/236 (26%)
Query: 153 IGAGNFGSVYNGTL--------FDGTTIAVKVFNLIRPGGSKSFKSECKAAI--NIKHRN 202
+G G F ++ G T + +KV + S+SF A++ + H++
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA--ASMMSKLSHKH 73
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+V + GV G +V +F+ GSL+ +L+ + I KL++A
Sbjct: 74 LVLNY----GVCVCGDEN-ILVQEFVKFGSLDTYLKKNKNC--------INILWKLEVAK 120
Query: 263 DVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGH--------VGDFGMARFLPAI 311
+A A+ +L H N+ N+LL E + D G++ + +
Sbjct: 121 QLAAAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--L 172
Query: 312 DKQNRFICIKGSTGYIPPEYDLGCEASTYG-------DVYSFGILLLEMFT-GIRP 359
K I ++PPE D +SFG L E+ + G +P
Sbjct: 173 PKDILQERIP----WVPPE------CIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 63/240 (26%), Positives = 96/240 (40%), Gaps = 44/240 (18%)
Query: 151 NLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKS----FKSECKAAINI-K 199
+GAG FG V T F +AVK +++ SE K ++ +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK-----DDTNWRPLNFNFLI 254
H NIV + G G V+ ++ G L +LR K D + N
Sbjct: 109 HENIVNLL----GACTHGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 255 KKKLDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
+ L + VA + +L +C I H ++ NVLL + + +GDFG+AR +
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNC-----I-HRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 312 DKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365
I +P PE C + DV+S+GILL E+F+ G+ P GI
Sbjct: 218 S-----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 54/244 (22%), Positives = 90/244 (36%), Gaps = 38/244 (15%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGSKSFKS 190
N F+ + +S IG+G V+ A+K NL S+++
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 191 ECKAAINIKHRN--IVRVFTAFSGVDYQGARFKAVVYKFM--PNGSLEEWLRGKDDTNWR 246
E ++ + I+R++ Y +Y M N L WL+ K +
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQY--------IYMVMECGNIDLNSWLKKK-----K 122
Query: 247 PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306
++ ++ A+ +H Q I H +LKP+N L+ D M+ + DFG+A
Sbjct: 123 SIDPWERKS----YWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIAN 174
Query: 307 FLPAIDKQNRFICIKGSTGYIPPE--------YDLGCEASTYG---DVYSFGILLLEMFT 355
+ G+ Y+PPE + G S DV+S G +L M
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
Query: 356 GIRP 359
G P
Sbjct: 235 GKTP 238
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 3e-21
Identities = 52/230 (22%), Positives = 84/230 (36%), Gaps = 38/230 (16%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKH--RNIVRV 206
IG+G V+ A+K NL S+++E ++ I+R+
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 207 FTAFSGVDYQGARFKAVVYKFM--PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ Y +Y M N L WL+ K + ++ ++
Sbjct: 122 YDYEITDQY--------IYMVMECGNIDLNSWLKKK-----KSIDPWERKS----YWKNM 164
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
A+ +H Q I H +LKP+N L+ D M+ + DFG+A + G+
Sbjct: 165 LEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 325 GYIPPE--------YDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGI 363
Y+PPE + G S DV+S G +L M G P I
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 4e-21
Identities = 33/250 (13%), Positives = 73/250 (29%), Gaps = 59/250 (23%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK----------- 199
++G + + T G + V V S + K + + ++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 200 -----------------HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDD 242
+ ++RV + + P G+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERD------MWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 243 TNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--G 300
+ + + + +L + + V L LH + H L+P +++LD G V
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR--GGVFLT 248
Query: 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-----------DVYSFGIL 349
F + + S G+ PPE + +Y D ++ G++
Sbjct: 249 GFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302
Query: 350 LLEMFTGIRP 359
+ ++ P
Sbjct: 303 IYWIWCADLP 312
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-21
Identities = 55/231 (23%), Positives = 92/231 (39%), Gaps = 47/231 (20%)
Query: 153 IGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGSKS----FKSECKAAINI-K 199
+G G FG V T+AVK+ ++ ++ SE + I K
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-- 257
H+NI+ + G Q V+ ++ G+L E+LR + + ++
Sbjct: 100 HKNIINLL----GACTQDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 258 -----LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
+ +A + YL C I H +L NVL+ + + + DFG+AR +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC-----I-HRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 310 AIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
ID K + G +P PE + DV+SFG+L+ E+FT
Sbjct: 209 NID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-21
Identities = 59/241 (24%), Positives = 99/241 (41%), Gaps = 62/241 (25%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKS----FKSECKAAI--NIKH 200
+G G FG V+ ++ +AVK + + F+ E A + N++H
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK----DPTLAARKDFQRE--AELLTNLQH 76
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK--- 257
+IV+ + GV G +V+++M +G L ++LR ++ K
Sbjct: 77 EHIVKFY----GVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 258 ----LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA 310
L IA +A + YL H H +L N L+ ++ +GDFGM+R + +
Sbjct: 132 LSQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 311 IDKQNRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIR 358
D G +P PE + Y DV+SFG++L E+FT G +
Sbjct: 186 TD-----YYRVGGHTMLPIRWMPPE------SIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 359 P 359
P
Sbjct: 235 P 235
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-21
Identities = 66/285 (23%), Positives = 109/285 (38%), Gaps = 65/285 (22%)
Query: 115 LIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDG----- 169
L+ +L P+Y+ + NP L N IG G FG V+
Sbjct: 17 LLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEP 76
Query: 170 -TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224
T +AVK+ ++ S F+ E + NIV++ GV G ++
Sbjct: 77 FTMVAVKM---LKEEASADMQADFQREAALMAEFDNPNIVKLL----GVCAVGKPM-CLL 128
Query: 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK---------------LDIAIDVACALR 269
+++M G L E+LR L+ + L + L IA VA +
Sbjct: 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 188
Query: 270 YL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
YL H +L N L+ + M+ + DFG++R + + D
Sbjct: 189 YLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-----YYKADGNDA 237
Query: 327 IP-----PE------YDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
IP PE Y +T DV+++G++L E+F+ G++P
Sbjct: 238 IPIRWMPPESIFYNRY------TTESDVWAYGVVLWEIFSYGLQP 276
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 56/233 (24%)
Query: 153 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS----FKSECKAAI--NIKHRN 202
IG G FG V+ G +A+K + S S F E A H +
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKT---CKNCTSDSVREKFLQE--ALTMRQFDHPH 452
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
IV++ GV + + ++ + G L +L+ + + + + A
Sbjct: 453 IVKLI----GVITENPVW--IIMELCTLGELRSFLQVRKFS--------LDLASLILYAY 498
Query: 263 DVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
++ AL YL H D + NVL+ +GDFG++R++
Sbjct: 499 QLSTALAYLESKRFVHRD---------IAARNVLVSSNDCVKLGDFGLSRYMEDST---- 545
Query: 317 FICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
K S G +P PE ++ DV+ FG+ + E+ G++P G+
Sbjct: 546 --YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-21
Identities = 56/231 (24%), Positives = 87/231 (37%), Gaps = 47/231 (20%)
Query: 153 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKS----FKSECKAAINI-KHR 201
+GAG FG V T + T+AVK +++P + SE K + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK---------DDTNWRPLNFNF 252
NIV + G G V+ ++ G L +LR K
Sbjct: 88 NIVNLL----GACTIGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 253 LIKKKLDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
++ L + VA + +L +C I H +L N+LL I + DFG+AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC-----I-HRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 310 AIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
+ +P PE C + DV+S+GI L E+F+
Sbjct: 197 NDS-----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-21
Identities = 47/226 (20%), Positives = 84/226 (37%), Gaps = 40/226 (17%)
Query: 152 LIGAGNFGSVYNGTLFD---GTTIAVKVFNLIRPGGSKS------FKSECKAAINIKHRN 202
L+G G G VY D +A+K+ + S + E + A ++ +
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKL---MSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+V + G G + V + + L LR + PL + + I
Sbjct: 96 VVPIHD--FGEI-DGQLY--VDMRLINGVDLAAMLRRQ-----GPLA----PPRAVAIVR 141
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL--PAIDKQNRFICI 320
+ AL H H ++KP N+L+ + ++ DFG+A + + +
Sbjct: 142 QIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-- 196
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366
G+ Y+ PE A+ D+Y+ +L E TG P + G
Sbjct: 197 -GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQG 237
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-21
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 48/240 (20%)
Query: 153 IGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGSKS----FKSECKAAINI-K 199
+G G FG V T +AVK +++ ++ SE + I K
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-- 257
H+NI+ + G Q V+ ++ G+L E+L+ + ++
Sbjct: 134 HKNIINLL----GACTQDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 258 -----LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
+ A VA + YL C H +L NVL+ ++ + + DFG+AR +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 310 AIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
ID K + G +P PE + DV+SFG+LL E+FT G P G+
Sbjct: 243 HID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 55/231 (23%), Positives = 92/231 (39%), Gaps = 47/231 (20%)
Query: 153 IGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGSKS----FKSECKAAINI-K 199
+G G FG V T+AVK+ ++ ++ SE + I K
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-- 257
H+NI+ + G Q V+ ++ G+L E+LR + + ++
Sbjct: 146 HKNIINLL----GACTQDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 258 -----LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
+ +A + YL C I H +L NVL+ + + + DFG+AR +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC-----I-HRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 310 AIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
ID K + G +P PE + DV+SFG+L+ E+FT
Sbjct: 255 NID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 51/226 (22%), Positives = 83/226 (36%), Gaps = 38/226 (16%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKH--RNIVRV 206
IG+G V+ A+K NL S+++E ++ I+R+
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 207 FTAFSGVDYQGARFKAVVYKFM--PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ Y +Y M N L WL+ K + ++ ++
Sbjct: 75 YDYEITDQY--------IYMVMECGNIDLNSWLKKK-----KSIDPWERKS----YWKNM 117
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
A+ +H Q I H +LKP+N L+ D M+ + DFG+A + G+
Sbjct: 118 LEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 325 GYIPPE--------YDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
Y+PPE + G S DV+S G +L M G P
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 45/238 (18%)
Query: 153 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKS----FKSECKAAINI-KHR 201
+G G FG V F T+AVK +++ G + S SE K I+I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK---- 257
N+V + G + V+ +F G+L +LR K + + K
Sbjct: 92 NVVNLL----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 258 ---LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
+ + VA + +L C H +L N+LL ++ + + DFG+AR +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 312 DKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
++ +P PE + DV+SFG+LL E+F+ G P G+
Sbjct: 202 P-----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 53/224 (23%), Positives = 83/224 (37%), Gaps = 25/224 (11%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFT 208
IG G++G DG + K + + SE +KH NIVR +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
+D +V ++ G L + + L + + AL
Sbjct: 73 RI--IDRTNTTLY-IVMEYCEGGDLASVIT-----KGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 269 RYLH--CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
+ H D + H +LKP+NV LD + +GDFG+AR L + G+ Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYY 182
Query: 327 IPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
+ PE +Y D++S G LL E+ + P FT
Sbjct: 183 MSPEQ---MNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF 219
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 29/243 (11%), Positives = 66/243 (27%), Gaps = 46/243 (18%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVR----- 205
++G + + T G + V V S + K + + ++ ++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 206 -----------------VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPL 248
+ + + P G+ +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 249 NFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR 306
+ + + +L + + V L LH + H L+P +++LD G V F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR--GGVFLTGFEHLV 259
Query: 307 FLPAIDKQNRFICIKGSTGYIPPEY-------DLGCEASTYG---DVYSFGILLLEMFTG 356
+ G+ PPE + D ++ G+ + ++
Sbjct: 260 ------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 357 IRP 359
P
Sbjct: 314 DLP 316
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-20
Identities = 53/236 (22%), Positives = 89/236 (37%), Gaps = 52/236 (22%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+G G FG V T F TT+AVK +++ S S SE + H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK----- 257
+++++ G Q ++ ++ GSL +LR L
Sbjct: 88 VIKLY----GACSQDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 258 ----------LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304
+ A ++ ++YL + H +L N+L+ + + DFG+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKL-----V-HRDLAARNILVAEGRKMKISDFGL 196
Query: 305 ARFLPAIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
+R + D +K S G IP E +T DV+SFG+LL E+ T
Sbjct: 197 SRDVYEED-----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-20
Identities = 50/221 (22%), Positives = 84/221 (38%), Gaps = 45/221 (20%)
Query: 153 IGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNI 203
+G G+FG V G +AVK ++ +K E + H +I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 204 VRVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
++ G +V +++P GSL ++L + + + L A
Sbjct: 96 IKYK----GCCEDAGAASLQLVMEYVPLGSLRDYLPRH----------SIGLAQLLLFAQ 141
Query: 263 DVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
+ + YL H H +L NVLLD++ + +GDFG+A+ +P +
Sbjct: 142 QICEGMAYLHAQHY------IHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYY 191
Query: 320 IKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
G P PE + DV+SFG+ L E+ T
Sbjct: 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 46/222 (20%), Positives = 75/222 (33%), Gaps = 26/222 (11%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G F V L DG A+K + + E H NI+R+
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
++ F G+L + D + L + + + L
Sbjct: 96 LRERGAKHEAW-LLLPFFKRGTLWNEIERLKDKGNF-----LTEDQILWLLLGICRGLEA 149
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR-------FICIKGS 323
+H AH +LKP+N+LL DE + D G + +R + + +
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 324 TGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y PE + + E + DV+S G +L M G P
Sbjct: 207 ISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGP 245
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 45/220 (20%), Positives = 89/220 (40%), Gaps = 35/220 (15%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHRNIVRV 206
IG G F VY L DG +A+K + +K+ +++C I++ H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKA-RADCIKEIDLLKQLNHPNVIKY 97
Query: 207 FTAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ +F + + + G L ++ +++ + +
Sbjct: 98 YASFIEDNE--------LNIVLELADAGDLSRMIK-----HFKKQKRLIPERTVWKYFVQ 144
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA-IDKQNRFICIKG 322
+ AL ++H + H ++KP+NV + + +GD G+ RF + + + G
Sbjct: 145 LCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---G 198
Query: 323 STGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ Y+ PE + Y D++S G LL EM P
Sbjct: 199 TPYYMSPER---IHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 44/229 (19%), Positives = 83/229 (36%), Gaps = 42/229 (18%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KHR 201
F +++G G G++ +FD +AVK S + + +H
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-------PECFSFADREVQLLRESDEHP 78
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMP--NGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
N++R F + Y + +L+E++ KD F L + +
Sbjct: 79 NVIRYFCTEKDRQF--------QYIAIELCAATLQEYVEQKD--------FAHLGLEPIT 122
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLL-----DDEMIGHVGDFGMARFL-PAIDK 313
+ L +LH I H +LKP N+L+ ++ + DFG+ + L
Sbjct: 123 LLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+R + G+ G+I PE D++S G + + +
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 48/216 (22%), Positives = 74/216 (34%), Gaps = 31/216 (14%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G+FG V+ G AVK L E A + IV ++
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPRIVPLY-- 116
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
G +G + + + GSL + ++ L + L
Sbjct: 117 --GAVREGPWVN-IFMELLEGGSLGQLIK-----QMGCLPED-RALY---YLGQALEGLE 164
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHV---GDFGMARFLPAIDKQNRFIC---IKGS 323
YLH I H ++K NVLL + G DFG A L + I G+
Sbjct: 165 YLHTRR---ILHGDVKADNVLLSSD--GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
++ PE +G D++S ++L M G P
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 54/236 (22%), Positives = 90/236 (38%), Gaps = 52/236 (22%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGS----KSFKSECKAAINI-KHR 201
+G+G FG V N T + +AVK +++ ++ SE K + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVK---MLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK-------------DDTNWRPL 248
NIV + G +++++ G L +LR K
Sbjct: 110 NIVNLL----GACTLSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 249 NFNFLIKKKL-DIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304
+ N L + L A VA + +L C + H +L NVL+ + + DFG+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSC-----V-HRDLAARNVLVTHGKVVKICDFGL 218
Query: 305 ARFLPAIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
AR I + ++ +P PE + DV+S+GILL E+F+
Sbjct: 219 ARD---IMSDSNYV--VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-19
Identities = 54/243 (22%), Positives = 90/243 (37%), Gaps = 58/243 (23%)
Query: 151 NLIGAGNFGSVYNGTLFDG---TTIAVKVFNLIRPGGSKS----FKSECKAAINI-KHRN 202
++IG GNFG V + A+K ++ SK F E + + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKR---MKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK----- 257
I+ + G + ++ P+G+L ++LR P
Sbjct: 88 IINLL----GACEHRGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 258 --LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID 312
L A DVA + YL H +L N+L+ + + + DFG++R
Sbjct: 143 QLLHFAADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSRGQEVY- 195
Query: 313 KQNRFICIKGSTGYIP-----PE------YDLGCEASTYGDVYSFGILLLEMFT-GIRPS 360
+K + G +P E Y +T DV+S+G+LL E+ + G P
Sbjct: 196 -------VKKTMGRLPVRWMAIESLNYSVY------TTNSDVWSYGVLLWEIVSLGGTPY 242
Query: 361 DGI 363
G+
Sbjct: 243 CGM 245
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 7e-19
Identities = 35/229 (15%), Positives = 72/229 (31%), Gaps = 35/229 (15%)
Query: 151 NLIGAGNFGSVY------NGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK---HR 201
+L+G G F VY + +KV +P F + +K
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV---QKPANPWEFYIGTQLMERLKPSMQH 127
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
++ ++A +Q +V + G+L + +T + + +I A
Sbjct: 128 MFMKFYSAH---LFQNGSV--LVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS----FA 178
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG-----------DFGMARFLPA 310
+ + + +H I H ++KP N +L + + D G + +
Sbjct: 179 MRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 311 IDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
K F ++G+ E + D + + M G
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 49/229 (21%), Positives = 82/229 (35%), Gaps = 38/229 (16%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
++G G FG V D A+K + SE ++ H+ +VR + A+
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 211 SGVDYQGARFKAVVYK--------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
AV K + NG+L + + + N N + +
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--------NLNQQRDEYWRLFR 123
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK- 321
+ AL Y+H I H +LKP N+ +D+ +GDFG+A+ + +
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 322 -----------GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTG 356
G+ Y+ E + Y D+YS GI+ EM
Sbjct: 181 PGSSDNLTSAIGTAMYVATE--VLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 43/230 (18%), Positives = 83/230 (36%), Gaps = 53/230 (23%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G F + + A K+ L++P + E ++ H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 208 TAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD----- 259
F V+ + SL E + + K L
Sbjct: 108 GFFE--------DNDFVFVVLELCRRRSLLELHKRR---------------KALTEPEAR 144
Query: 260 -IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
+ +YLH + + H +LK N+ L++++ +GDFG+A + ++ + +
Sbjct: 145 YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL 201
Query: 319 CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
C G+ YI PE + E DV+S G ++ + G P +
Sbjct: 202 C--GTPNYIAPEVLSKKGHS--FEV----DVWSIGCIMYTLLVGKPPFET 243
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 51/232 (21%), Positives = 80/232 (34%), Gaps = 50/232 (21%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V G +A+K P + + E + + H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 211 -SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK----------LD 259
+ ++ G L +L + +
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDL----------------RKYLNQFENCCGLKEGPIRT 125
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DEMIGHVGDFGMARFLPAIDKQNR 316
+ D++ ALRYLH + I H +LKP N++L +I + D G A+ L +
Sbjct: 126 LLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182
Query: 317 FICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
F G+ Y+ PE Y + D +SFG L E TG RP
Sbjct: 183 F-V--GTLQYLAPELLEQKKYTVTV------DYWSFGTLAFECITGFRPFLP 225
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 32/217 (14%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFT 208
IG G+FG DG +K N+ R + + E N+KH NIV+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 209 AFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+F + +Y M G L + + + F + LD + +
Sbjct: 91 SF--EE------NGSLYIVMDYCEGGDLFKRINAQK-------GVLFQEDQILDWFVQIC 135
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
AL+++H I H ++K N+ L + +GDFG+AR L + + R G+
Sbjct: 136 LALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI--GTPY 190
Query: 326 YIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
Y+ PE CE Y D+++ G +L E+ T
Sbjct: 191 YLSPEI---CENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 54/240 (22%), Positives = 91/240 (37%), Gaps = 49/240 (20%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTA 209
++G G +V+ G G A+KVFN I E + + H+NIV++F
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK----------LD 259
+ R K ++ +F P GSL + L + L
Sbjct: 76 E---EETTTRHKVLIMEFCPCGSL----------------YTVLEEPSNAYGLPESEFLI 116
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIGHVGDFGMARFLPAIDKQN 315
+ DV + +L + I H N+KP N++ D + + + DFG AR L +
Sbjct: 117 VLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDE 170
Query: 316 RFICIKGSTGYIPPE-----YDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
+F+ + G+ Y+ P+ YG D++S G+ TG P +
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 49/232 (21%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTA 209
++G G +V+ G G A+KVFN I E + + H+NIV++F
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK----------LD 259
+ R K ++ +F P GSL + L + L
Sbjct: 76 E---EETTTRHKVLIMEFCPCGSL----------------YTVLEEPSNAYGLPESEFLI 116
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIGHVGDFGMARFLPAIDKQN 315
+ DV + +L + I H N+KP N++ D + + + DFG AR L +
Sbjct: 117 VLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDE 170
Query: 316 RFICIKGSTGYIPPE-----YDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+F+ + G+ Y+ P+ YG D++S G+ TG P
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-18
Identities = 43/229 (18%), Positives = 83/229 (36%), Gaps = 53/229 (23%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G F + + A K+ L++P + E ++ H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 208 TAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD----- 259
F V+ + SL E + + K L
Sbjct: 82 GFFE--------DNDFVFVVLELCRRRSLLELHKRR---------------KALTEPEAR 118
Query: 260 -IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
+ +YLH + + H +LK N+ L++++ +GDFG+A + ++ + +
Sbjct: 119 YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL 175
Query: 319 CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
C G+ YI PE + E DV+S G ++ + G P +
Sbjct: 176 C--GTPNYIAPEVLSKKGHS--FEV----DVWSIGCIMYTLLVGKPPFE 216
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 6e-18
Identities = 44/228 (19%), Positives = 77/228 (33%), Gaps = 24/228 (10%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTA 209
++ G F VY + G A+K +++ E + H NIV+ +A
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 210 FSGVDYQGARFKAVVYKFM--PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
S + +A G L + L I A
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQL------VEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL---PAIDKQNRFICIK--- 321
++++H +PPI H +LK N+LL ++ + DFG A + P + +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 322 ----GSTGYIPPE-YDL--GCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ Y PE DL D+++ G +L + P +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 52/276 (18%), Positives = 90/276 (32%), Gaps = 79/276 (28%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGS-KSFKSECKAAINIKHRNIVRVFTA 209
+G G FG V+ D A+K L + + E KA ++H IVR F A
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 210 FSGVDYQGAR-------------------------------------------------F 220
+ + +
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 221 KAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP 277
K +Y M +L++W+ + R L I I +A A+ +LH
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDRE------HGVCLHIFIQIAEAVEFLH---SK 183
Query: 278 PIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK----------GSTGYI 327
+ H +LKPSN+ + + VGDFG+ + +++ + G+ Y+
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 328 PPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPS 360
PE + Y D++S G++L E+
Sbjct: 244 SPEQ---IHGNNYSHKVDIFSLGLILFELLYSFSTQ 276
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 46/221 (20%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
L+G G+F VY + G +A+K+ + + + G + ++E K +KH +I+ ++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 208 TAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD----- 259
F +Y VY + NG + +L+ + K
Sbjct: 78 NYFEDSNY--------VYLVLEMCHNGEMNRYLKNR--------------VKPFSENEAR 115
Query: 260 -IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
+ + YLH I H +L SN+LL M + DFG+A L +++ +
Sbjct: 116 HFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL 172
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTG 356
C G+ YI PE S +G DV+S G + + G
Sbjct: 173 C--GTPNYISPEI---ATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-17
Identities = 32/222 (14%), Positives = 52/222 (23%), Gaps = 66/222 (29%)
Query: 152 LIGAGNFGSVYNGTLFD---GTTIAVKVFNLIRPGGSKS------FKSECKAAINIKHRN 202
G + D +A+ + P G S I
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTF---VDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+ RV V + VV +++ GSL+E P +
Sbjct: 93 VARVLDV---VHTRAGGL--VVAEWIRGGSLQEVADT------SPS-----PVGAIRAMQ 136
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICI 320
+A A H + +A PS V + + G V
Sbjct: 137 SLAAAADAAH---RAGVALSIDHPSRVRVSID--GDVVLAYPA----------------- 174
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+P A+ D+ G L + P
Sbjct: 175 -----TMPD-------ANPQDDIRGIGASLYALLVNRWPLPE 204
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 43/244 (17%), Positives = 84/244 (34%), Gaps = 57/244 (23%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KH 200
F IG+G FGSV+ DG A+K P + + +H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK--PLAGSVDEQNALREVYAHAVLGQH 70
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
++VR F+A++ D+ + GSL + + ++ L
Sbjct: 71 SHVVRYFSAWAEDDH--------MLIQNEYCNGGSLADAIS-ENYRIMSYFKEAEL---- 117
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV------------------ 299
D+ + V LRY+H + H ++KPSN+ + I +
Sbjct: 118 KDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 300 -GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFT 355
GD G + + + +G + ++ E + E T+ D+++ + ++
Sbjct: 175 IGDLGHVTRISSPQVE------EGDSRFLANE--VLQENYTHLPKADIFALALTVVCAAG 226
Query: 356 GIRP 359
Sbjct: 227 AEPL 230
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 44/259 (16%), Positives = 90/259 (34%), Gaps = 51/259 (19%)
Query: 130 QTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFK 189
+ N P+F+ + N S ++G G+ G+V F G +AVK F
Sbjct: 2 RIANIPNFEQ--SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML-------IDFC 52
Query: 190 SECKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMP--NGSLEEWLRGKDD 242
I + H N++R + + + + +Y + N +L++ + K+
Sbjct: 53 DIALMEIKLLTESDDHPNVIRYYCSETTDRF--------LYIALELCNLNLQDLVESKNV 104
Query: 243 TNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG-- 300
++ + + +A + +LH I H +LKP N+L+
Sbjct: 105 SDENLKLQK--EYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQ 159
Query: 301 -----------DFGMARFLPAID--KQNRFICIKGSTGYIPPEYDLGCEAST----YG-- 341
DFG+ + L + + G++G+ PE
Sbjct: 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219
Query: 342 -DVYSFGILLLEMFTGIRP 359
D++S G + + + +
Sbjct: 220 IDIFSMGCVFYYILSKGKH 238
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 51/226 (22%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG+VY +A+KV L + G + E + +++H NI+R+
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 207 FTAFSGVDYQGARFKAVVY---KFMPNGSLEEWLRGKDDTNWRPLNFNFLIK-KKLD--- 259
+ F VY ++ P G++ + L K K D
Sbjct: 75 YGYFHDATR--------VYLILEYAPLGTV----------------YRELQKLSKFDEQR 110
Query: 260 ---IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
++A AL Y H + H ++KP N+LL + DFG + P +
Sbjct: 111 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRT 165
Query: 317 FICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+C G+ Y+PPE E + D++S G+L E G P
Sbjct: 166 DLC--GTLDYLPPEM---IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 32/216 (14%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR-----NIVRV 206
IG G +GSV G +AVK IR + + + +++ R IV+
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKR---IRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ A ++ + + M + S +++ + + L K I +
Sbjct: 87 YGAL----FREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGK----ITLATVK 136
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGST 324
AL +L + + I H ++KPSN+LLD G++ DFG++ L + R G
Sbjct: 137 ALNHLKENLK--IIHRDIKPSNILLDRS--GNIKLCDFGISGQLVDSIAKTRDA---GCR 189
Query: 325 GYIPPE-YDLGCEASTYG---DVYSFGILLLEMFTG 356
Y+ PE D Y DV+S GI L E+ TG
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 48/229 (20%), Positives = 90/229 (39%), Gaps = 38/229 (16%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAIN------------ 197
+ G F + D A+K + L + ++ + +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 198 --IKHRNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL 253
IK+ + + D Y ++Y++M N S+ ++ + F
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVY-------IIYEYMENDSILKFDEYFFVLDKNYTCF-IP 149
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
I+ I V + Y+H + I H ++KPSN+L+D + DFG + ++ DK
Sbjct: 150 IQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DK 205
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ + G+ ++PPE+ E+S G D++S GI L MF + P
Sbjct: 206 KIKGSR--GTYEFMPPEFFSN-ESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 33/216 (15%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR-----NIVRV 206
+G G +G V + G +AVK IR + + ++I R V
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKR---IRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ A ++ + + M + SL+++ + D + + + L K IA+ +
Sbjct: 72 YGAL----FREGDVW-ICMELM-DTSLDKFYKQVIDKG-QTIPEDILGK----IAVSIVK 120
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGST 324
AL +LH + H ++KPSNVL++ G V DFG++ +L ++ G
Sbjct: 121 ALEHLHSKLS--VIHRDVKPSNVLINAL--GQVKMCDFGISGYLVDDVAKDIDA---GCK 173
Query: 325 GYIPPE-YDLGCEASTYG---DVYSFGILLLEMFTG 356
Y+ PE + Y D++S GI ++E+
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHRNIVRVF 207
+GAGN G V+ + G +A K+ I + +++ + + IV
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKL---IHLEIKPAIRNQIIRELQVLHECNSPYIVG-- 95
Query: 208 TAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ GA + + + M GSL++ L+ + L K ++I
Sbjct: 96 -------FYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGK----VSIA 139
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
V L YL + I H ++KPSN+L++ G + DFG++ L N F+
Sbjct: 140 VIKGLTYLREKHK--IMHRDVKPSNILVNSR--GEIKLCDFGVSGQLID-SMANSFV--- 191
Query: 322 GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G+ Y+ PE G S D++S G+ L+EM G P
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 45/222 (20%)
Query: 152 LIGAGNFGSVYNG-TLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G FG+VY + +A+KV L + G + E + +++H NI+R++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK-KKLD------I 260
F + ++ +F P G L + L K + D
Sbjct: 81 NYF-----HDRKRIYLMLEFAPRGEL----------------YKELQKHGRFDEQRSATF 119
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
++A AL Y H + + H ++KP N+L+ + + DFG + P + R +C
Sbjct: 120 MEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP--SLRRRTMC- 173
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+PPE E T+ D++ G+L E G+ P
Sbjct: 174 -GTLDYLPPEM---IEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 32/101 (31%), Positives = 46/101 (45%), Gaps = 13/101 (12%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDKQNRFICIK 321
+ AL YL I H ++KP N+LLD+ GHV DF +A LP +
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEH--GHVHITDFNIAAMLPRETQITTM-A-- 175
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE + + Y D +S G+ E+ G RP
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 66/334 (19%), Positives = 111/334 (33%), Gaps = 48/334 (14%)
Query: 47 ERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI--ILECLISICRTGVACSAELPNERM 104
R LD V E+ ++ + + + + R V + +
Sbjct: 78 SRCVAFLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGP 137
Query: 105 KINDVESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNG------FSSANLIGAGNF 158
+ + RL + L P + +I F F ++G G F
Sbjct: 138 CKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGF 197
Query: 159 GSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
G V G ++ A K + + G +E + + R +V + A
Sbjct: 198 GEVCACQVRATGKMY-----ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA 252
Query: 210 FSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
+ D +V M G L+ + F + + A ++ C
Sbjct: 253 YETKDALC-------LVLTLMNGGDLKFHIY-------HMGQAGFPEARAVFYAAEICCG 298
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTG 325
L LH + I + +LKP N+LLDD GH+ D G+A +P G+ G
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGR-V--GTVG 350
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE + D ++ G LL EM G P
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 49/231 (21%), Positives = 84/231 (36%), Gaps = 49/231 (21%)
Query: 147 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAIN 197
F ++G G+F +V + A+K+ +I+ E
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREY-----AIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK-K 256
+ H V+++ F Q + NG L ++ K
Sbjct: 87 LDHPFFVKLYFTF-----QDDEKLYFGLSYAKNGEL----------------LKYIRKIG 125
Query: 257 KLDI------AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFL 308
D ++ AL YLH I H +LKP N+LL+++ H+ DFG A+ L
Sbjct: 126 SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED--MHIQITDFGTAKVL 180
Query: 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
KQ R G+ Y+ PE A D+++ G ++ ++ G+ P
Sbjct: 181 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 62/248 (25%), Positives = 105/248 (42%), Gaps = 41/248 (16%)
Query: 127 EGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGS 185
++++ L + F L+G G +G VY G + G A+KV ++ +
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----T 60
Query: 186 KSFKSECKAAINI-----KHRNIVRVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRG 239
+ E K IN+ HRNI + AF + G + +V +F GS+ + ++
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120
Query: 240 KDDTNWRPLNFNFLIKKKLDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296
T L K+ IA ++ L +LH + H ++K NVLL +
Sbjct: 121 ---TKGNTL-------KEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTEN-- 165
Query: 297 GHV--GDFGMARFL-PAIDKQNRFICIKGSTGYIPPE--YDLGCEASTYG---DVYSFGI 348
V DFG++ L + ++N FI G+ ++ PE +TY D++S GI
Sbjct: 166 AEVKLVDFGVSAQLDRTVGRRNTFI---GTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222
Query: 349 LLLEMFTG 356
+EM G
Sbjct: 223 TAIEMAEG 230
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 55/245 (22%), Positives = 87/245 (35%), Gaps = 62/245 (25%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINI--------KH 200
L+G G FG+V+ G L D +A+KV + S C + + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLD 259
++R+ F + + E L +D L F+++ +K L
Sbjct: 98 PGVIRLLDWFE--------TQEGFMLVL-----ERPLPAQD------L-FDYITEKGPLG 137
Query: 260 ------IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAI 311
V A+++ H + H ++K N+L+D G DFG L
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR-GCAKLIDFGSGALLH-- 191
Query: 312 DKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG--- 362
D+ G+ Y PPE Y A V+S GILL +M G P +
Sbjct: 192 DEPYTDFD--GTRVYSPPEWISRHQYH-ALPA----TVWSLGILLYDMVCGDIPFERDQE 244
Query: 363 IFTGK 367
I +
Sbjct: 245 ILEAE 249
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 53/238 (22%), Positives = 86/238 (36%), Gaps = 58/238 (24%)
Query: 147 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAIN 197
F +IG G FG V +F A+K+ N +++ + F+ E +N
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVF-----AMKILNKWEMLKRAETACFREERDVLVN 130
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
+ I + AF Q +V + G L L K +
Sbjct: 131 GDSKWITTLHYAF-----QDDNNLYLVMDYYVGGDL----------------LTLLSKFE 169
Query: 258 LDIAIDVA--------CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA-R 306
+ ++A A+ +H Q H ++KP N+L+D GH+ DFG +
Sbjct: 170 DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLK 224
Query: 307 FLPAIDKQNRFICIKGSTGYIPPE--YDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ Q+ G+ YI PE + YG D +S G+ + EM G P
Sbjct: 225 LMEDGTVQSSVAV--GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 49/271 (18%), Positives = 96/271 (35%), Gaps = 49/271 (18%)
Query: 100 PNERMKINDVESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFG 159
+ KIND + I KK + PV + S D Y+ +G+G FG
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPV-----EVKQGSVYDYYDI------LEELGSGAFG 65
Query: 160 SVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218
V+ G K N P + K+E + H ++ + A ++
Sbjct: 66 VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDK 120
Query: 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-----LDIAI---DVACALRY 270
++ +F+ G L F+ + + ++ L++
Sbjct: 121 YEMVLILEFLSGGEL----------------FDRIAAEDYKMSEAEVINYMRQACEGLKH 164
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIP 328
+H + I H ++KP N++ + + V DFG+A ++ + +
Sbjct: 165 MH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAA 218
Query: 329 PEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
PE Y D+++ G+L + +G+ P
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 47/231 (20%), Positives = 74/231 (32%), Gaps = 55/231 (23%)
Query: 154 GAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHRNIVRVFT 208
G + +V G + V+ NL S + + +++ H NIV
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVTFLQGELHVSKLFNHPNIVPYRA 93
Query: 209 AFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD---IA 261
F VV FM GS ++ + ++ IA
Sbjct: 94 TF---------IADNELWVVTSFMAYGSAKDLIC-------------THFMDGMNELAIA 131
Query: 262 I---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFG-MARFLPAIDKQN 315
V AL Y+H + H ++K S++L+ + G V + +Q
Sbjct: 132 YILQGVLKALDYIHHMGY--V-HRSVKASHILISVD--GKVYLSGLRSNLSMISHGQRQR 186
Query: 316 -RFICIKGSTGYIP---PEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
K S +P PE L Y D+YS GI E+ G P
Sbjct: 187 VVHDFPKYSVKVLPWLSPEV-LQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 49/233 (21%), Positives = 80/233 (34%), Gaps = 53/233 (22%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN--------LIRPGGSKSFKSECKAAINIKHRNI 203
+G+G FG V+ + VK I E ++H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLD--- 259
++V F + M E+ G D L F F+ + +LD
Sbjct: 92 IKVLDIFENQGF--------FQLVM-----EKHGSGLD------L-FAFIDRHPRLDEPL 131
Query: 260 ---IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
I + A+ YL I H ++K N+++ ++ + DFG A +L
Sbjct: 132 ASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 317 FICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
F C G+ Y PE Y G E +++S G+ L + P +
Sbjct: 189 F-C--GTIEYCAPEVLMGNPYR-GPEL----EMWSLGVTLYTLVFEENPFCEL 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 49/235 (20%), Positives = 87/235 (37%), Gaps = 55/235 (23%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN----LIRPGGSKSFKSECKAAINIKHRNIVRV 206
L+G G++G V AVK+ P G + K E + ++H+N++++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 207 FTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
V Y + K +V ++ G E + + + +K+ + A
Sbjct: 72 VD----VLYNEEKQKMYMVMEYCVCGMQE-------------M-LDSVPEKRFPV--CQA 111
Query: 266 C--------ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
L YLH I H ++KP N+LL + G+A +
Sbjct: 112 HGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE-ALHPFAADDT 167
Query: 318 I---CIKGSTGYIPPE-------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
GS + PPE + G + D++S G+ L + TG+ P +G
Sbjct: 168 CRTSQ--GSPAFQPPEIANGLDTFS-GFKV----DIWSAGVTLYNITTGLYPFEG 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 55/235 (23%), Positives = 84/235 (35%), Gaps = 55/235 (23%)
Query: 147 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAIN 197
+ +IG G FG V ++ A+K+ + +I+ S F E
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVY-----AMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
+V++F AF Q R+ +V ++MP G L N +
Sbjct: 126 ANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDL----------------VNLMSNYD 164
Query: 258 LDI------AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA-RFL 308
+ +V AL +H H ++KP N+LLD GH+ DFG +
Sbjct: 165 VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMN 219
Query: 309 PAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYG---DVYSFGILLLEMFTGIRP 359
+ G+ YI PE YG D +S G+ L EM G P
Sbjct: 220 KEGMVRCDTAV--GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 46/253 (18%), Positives = 97/253 (38%), Gaps = 56/253 (22%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS 187
Q++ + +D Y + +G+G G V +A+++ + + +
Sbjct: 125 DQSVYPKALRDEYIMSK------TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178
Query: 188 FKSECKAAI--------NIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG 239
+++ + + H I+++ F DY +V + M G L
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY------IVLELMEGGEL------ 226
Query: 240 KDDTNWRPLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL- 291
F+ ++ K + A++YLH + I H +LKP NVLL
Sbjct: 227 ----------FDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLS 273
Query: 292 --DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSF 346
+++ + + DFG ++ + + + + G+ Y+ PE + + Y D +S
Sbjct: 274 SQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 347 GILLLEMFTGIRP 359
G++L +G P
Sbjct: 331 GVILFICLSGYPP 343
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 59/230 (25%), Positives = 90/230 (39%), Gaps = 49/230 (21%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS-FKSECKAAINIKHRNIVRVFTAF 210
IG+G V +A+K NL + S E +A H NIV +T+F
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD---IAI---DV 264
+V K + GS+ + ++ LD IA +V
Sbjct: 83 ----VVKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHK-------SGVLDESTIATILREV 130
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFL------PAIDKQNR 316
L YLH + Q I H ++K N+LL ++ G V DFG++ FL +
Sbjct: 131 LEGLEYLHKNGQ--I-HRDVKAGNILLGED--GSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 317 FICIKGSTGYIPPE-------YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
F+ G+ ++ PE YD D++SFGI +E+ TG P
Sbjct: 186 FV---GTPCWMAPEVMEQVRGYDFKA------DIWSFGITAIELATGAAP 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 54/220 (24%), Positives = 86/220 (39%), Gaps = 37/220 (16%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KHRNIVRV 206
+G+G G V+ G IAVK +R G+K +++ IV+
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQ---MRRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
F F + + M + + R + P+ L K + + +
Sbjct: 90 FGTF----ITNTDVF-IAMELMGTCAEKLKKRMQ-----GPIPERILGK----MTVAIVK 135
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGST 324
AL YL + H ++KPSN+LLD+ G + DFG++ L ++R G
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKDRSA---GCA 188
Query: 325 GYIPPE--YDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
Y+ PE Y DV+S GI L+E+ TG P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 52/246 (21%), Positives = 84/246 (34%), Gaps = 43/246 (17%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN-----LIRPGGSKSFKSECKAAINIKHRNIVRV 206
IG G++G V A+K+ N I P + K+E + + H NI R+
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 207 FTAFSGVDY--------------------------QGARFKAVVYKFMPNGSLEEWLRGK 240
+ + Y + A EE + G
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 241 DDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV- 299
L+F K +I + AL YLH I H ++KP N L +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 300 -GDFGMARFLPAIDKQNRFICIK--GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEM 353
DFG+++ ++ + G+ ++ PE L +YG D +S G+LL +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV-LNTTNESYGPKCDAWSAGVLLHLL 269
Query: 354 FTGIRP 359
G P
Sbjct: 270 LMGAVP 275
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 51/240 (21%), Positives = 83/240 (34%), Gaps = 60/240 (25%)
Query: 147 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAIN 197
F +IG G F V G ++ A+K+ N +++ G F+ E +N
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVY-----AMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
R I ++ AF Q + +V ++ G L L K
Sbjct: 118 GDRRWITQLHFAF-----QDENYLYLVMEYYVGGDL----------------LTLLSKFG 156
Query: 258 LDIAIDVA--------CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA-R 306
I ++A A+ +H + H ++KP N+LLD GH+ DFG +
Sbjct: 157 ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLK 211
Query: 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVY-------SFGILLLEMFTGIRP 359
++ G+ Y+ PE Y + G+ EMF G P
Sbjct: 212 LRADGTVRSLVAV--GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 54/247 (21%), Positives = 94/247 (38%), Gaps = 48/247 (19%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSF 188
+ F D Y ++G G+FG V G AVKV + + + +S
Sbjct: 20 STAIFSDRYKG------QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 189 KSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPL 248
E + + H NI++++ ++ + +V + G L + + +
Sbjct: 74 LREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRK------- 121
Query: 249 NFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH---VGDFGMA 305
F I V + Y+H + I H +LKP N+LL+ + + DFG++
Sbjct: 122 --RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 306 RFLPAIDKQNRFICIKGSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGIRPS 360
+ + G+ YI PE YD C DV+S G++L + +G P
Sbjct: 177 TH---FEASKKMKDKIGTAYYIAPEVLHGTYDEKC------DVWSTGVILYILLSGCPP- 226
Query: 361 DGIFTGK 367
F G
Sbjct: 227 ---FNGA 230
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 51/246 (20%), Positives = 87/246 (35%), Gaps = 47/246 (19%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSK--SFK 189
++Y +G+G +G V A+K+ S
Sbjct: 31 KKGHLSEMY------QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL 84
Query: 190 SECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLN 249
E + H NI++++ ++ R +V + G L + + +
Sbjct: 85 EEVAVLKLLDHPNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHRM-------- 131
Query: 250 FNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH---VGDFGMAR 306
F I V + YLH + I H +LKP N+LL+ + + DFG++
Sbjct: 132 -KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 307 FLPAIDKQNRFICIKGSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
+ Q + G+ YI PE YD C DV+S G++L + G P
Sbjct: 188 V---FENQKKMKERLGTAYYIAPEVLRKKYDEKC------DVWSIGVILFILLAGYPP-- 236
Query: 362 GIFTGK 367
F G+
Sbjct: 237 --FGGQ 240
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 54/229 (23%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
IG GNF V + G +A+K+ + + P + E + + H NIV++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--- 79
Query: 210 FSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLD------ 259
++ + +Y M G + F++L+ ++
Sbjct: 80 -----FEVIETEKTLYLIMEYASGGEV----------------FDYLVAHGRMKEKEARS 118
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
+ A++Y H I H +LK N+LLD +M + DFG + K + F C
Sbjct: 119 KFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-C 174
Query: 320 IKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ Y PE YD G E DV+S G++L + +G P DG
Sbjct: 175 --GAPPYAAPELFQGKKYD-GPEV----DVWSLGVILYTLVSGSLPFDG 216
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 48/231 (20%), Positives = 83/231 (35%), Gaps = 51/231 (22%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN-----LIRPGGSKSFKSECKAAINI-----KHR 201
+G G V AVK+ + + + ++I H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL--- 258
NI+++ Y+ F +V+ M G L F++L +K
Sbjct: 85 NIIQLKDT-----YETNTFFFLVFDLMKKGEL----------------FDYLTEKVTLSE 123
Query: 259 ----DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
I + + LH I H +LKP N+LLDD+M + DFG + +D
Sbjct: 124 KETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPG 177
Query: 315 NRFICIKGSTGYIPPE---YDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ + G+ Y+ PE + YG D++S G+++ + G P
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 51/231 (22%), Positives = 86/231 (37%), Gaps = 61/231 (26%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHR 201
S IG G+ G V G +AVK+ +L + + + I +H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDL----RKQQRRELLFNEVVIMRDYQHF 102
Query: 202 NIVRVFTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
N+V + V+ +F+ G+L + + LN +
Sbjct: 103 NVVE---------MYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLN-------E 140
Query: 258 LDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGM-ARFLPAI 311
IA V AL YLH + H ++K ++LL + G V DFG A+ +
Sbjct: 141 EQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD--GRVKLSDFGFCAQISKDV 195
Query: 312 DKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTG 356
K+ + G+ ++ PE Y D++S GI+++EM G
Sbjct: 196 PKRKSLV---GTPYWMAPEVISRSLYATEV------DIWSLGIMVIEMVDG 237
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 55/247 (22%), Positives = 83/247 (33%), Gaps = 68/247 (27%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN------LIRPGGSKSFKSECKAAINIKHR--N 202
L+G+G FGSVY+G + D +A+K E +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFM----PNGSLEEWLRGKDDTNWRPLNFNFLIKK-K 257
++R+ F D + P L F+F+ ++
Sbjct: 110 VIRLLDWFERPDS--------FVLILERPEPVQDL----------------FDFITERGA 145
Query: 258 LD------IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLP 309
L V A+R+ H + H ++K N+L+D G + DFG L
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR-GELKLIDFGSGALLK 201
Query: 310 AIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG- 362
D G+ Y PPE Y G A V+S GILL +M G P +
Sbjct: 202 --DTVYTDFD--GTRVYSPPEWIRYHRYH-GRSA----AVWSLGILLYDMVCGDIPFEHD 252
Query: 363 --IFTGK 367
I G+
Sbjct: 253 EEIIRGQ 259
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 9e-12
Identities = 50/224 (22%), Positives = 90/224 (40%), Gaps = 46/224 (20%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS-FKSECKAAINIKHRNIV 204
F+ IG G+FG V+ G +A+K+ +L + E +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI-- 262
+ + ++ + + ++ +++ GS + L PL+ + IA
Sbjct: 84 KYYGSY----LKDTKL-WIIMEYLGGGSALDLLEPG------PLD-------ETQIATIL 125
Query: 263 -DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFL-PAIDKQNRFI 318
++ L YLH + H ++K +NVLL + G V DFG+A L K+N F+
Sbjct: 126 REILKGLDYLHSE---KKIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTFV 180
Query: 319 CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTG 356
G+ ++ PE YD D++S GI +E+ G
Sbjct: 181 ---GTPFWMAPEVIKQSAYDSKA------DIWSLGITAIELARG 215
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 9e-12
Identities = 67/351 (19%), Positives = 113/351 (32%), Gaps = 59/351 (16%)
Query: 40 FVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIILECLISICRTGVA----- 94
F L E V F++EI++ E + + I ++
Sbjct: 68 FRDFCLKHLEEAKPLVEFYEEIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKS 127
Query: 95 ----CSAELPNERMKINDVESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNAT------ 144
L +++ + + + I + L + ++ F N
Sbjct: 128 AIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLT 187
Query: 145 -NGFSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSE--- 191
N FS +IG G FG VY G ++ A+K + + G +E
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMY-----AMKCLDKKRIKMKQGETLALNERIM 242
Query: 192 CKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFN 251
IV + AF + + M G L L
Sbjct: 243 LSLVSTGDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQHG---------V 288
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLP 309
F A ++ L ++H + + +LKP+N+LLD+ GHV D G+A
Sbjct: 289 FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEH--GHVRISDLGLACDFS 343
Query: 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRP 359
K+ G+ GY+ PE A D +S G +L ++ G P
Sbjct: 344 --KKKPHASV--GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 9e-12
Identities = 51/245 (20%), Positives = 90/245 (36%), Gaps = 61/245 (24%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAA---INI--------- 198
+G G+F +V+ + + T +A+K+ + K +AA I +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV--------RGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 199 ------KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNG-SLEEWLRGKDDTNWRPLNFN 251
+I+++ F +++G VV F G +L ++ R +
Sbjct: 78 TKEDSMGANHILKLLDHF---NHKGPNGVHVVMVFEVLGENLLALIK---KYEHRGIPLI 131
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH------VGDFGMA 305
+K+ I+ + L Y+H C I H ++KP NVL++ + D G A
Sbjct: 132 -YVKQ---ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
Query: 306 RFLPAI---DKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ Q R Y PE LG D++S L+ E+ TG D
Sbjct: 186 CWYDEHYTNSIQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITG----DF 233
Query: 363 IFTGK 367
+F
Sbjct: 234 LFEPD 238
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 60/226 (26%), Positives = 89/226 (39%), Gaps = 37/226 (16%)
Query: 147 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAIN 197
F ++G G FG V+ G L+ A K N L + G + E K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLY-----ACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 198 IKHRNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
+ R IV + AF +V M G + + D+ N F
Sbjct: 242 VHSRFIVSLAYAFETKTDLC-------LVMTIMNGGDIRYHIYNVDEDNPG-----FQEP 289
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDK 313
+ + + L +LH Q I + +LKP NVLLDD+ G+V D G+A L A
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQT 344
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ + G+ G++ PE LG E D ++ G+ L EM P
Sbjct: 345 KTKGYA--GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 63/282 (22%), Positives = 102/282 (36%), Gaps = 60/282 (21%)
Query: 96 SAELPNERMKINDVESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGA 155
SA L E K+ND + + P E F Y+ ++IG
Sbjct: 51 SANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDP------KDVIGR 104
Query: 156 GNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAA----INI-----KHRNIVR 205
G V G AVK+ + S E + A +I H +I+
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL------- 258
+ + Y+ + F +V+ M G L F++L +K
Sbjct: 165 LIDS-----YESSSFMFLVFDLMRKGEL----------------FDYLTEKVALSEKETR 203
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
I + A+ +LH + I H +LKP N+LLDD M + DFG + ++ +
Sbjct: 204 SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKLR 257
Query: 319 CIKGSTGYIPPE---YDLGCEASTYG---DVYSFG----ILL 350
+ G+ GY+ PE + YG D+++ G LL
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 50/264 (18%), Positives = 99/264 (37%), Gaps = 28/264 (10%)
Query: 100 PNERMKINDVESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFG 159
ERM + + + P T + Y S ++G G FG
Sbjct: 48 LTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT----VSKTEILGGGRFG 103
Query: 160 SVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218
V+ G +A K+ + K+E + H N+++++ A ++
Sbjct: 104 QVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-----FESK 158
Query: 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP 278
+V +++ G L + + + +N + + +R++H Q
Sbjct: 159 NDIVLVMEYVDGGELFDRIIDES--------YNLTELDTILFMKQICEGIRHMH---QMY 207
Query: 279 IAHCNLKPSNVLL---DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC 335
I H +LKP N+L D + I + DFG+AR + + G+ ++ PE
Sbjct: 208 ILHLDLKPENILCVNRDAKQI-KIIDFGLARR---YKPREKLKVNFGTPEFLAPEVVNYD 263
Query: 336 EASTYGDVYSFGILLLEMFTGIRP 359
S D++S G++ + +G+ P
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 53/253 (20%), Positives = 86/253 (33%), Gaps = 70/253 (27%)
Query: 132 INNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKS 190
+ + F Y+ +G G+F AVK+ + K ++
Sbjct: 1 MKDSPFYQHYDL---DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-------KRMEA 50
Query: 191 ECKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245
+ I H NIV++ + +V + + G L
Sbjct: 51 NTQKEITALKLCEGHPNIVKLHEV-----FHDQLHTFLVMELLNGGEL------------ 93
Query: 246 RPLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE---- 294
F + KKK I + A+ ++H + H +LKP N+L DE
Sbjct: 94 ----FERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNL 146
Query: 295 --MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSF 346
I DFG AR P ++ + C + Y PE YD C D++S
Sbjct: 147 EIKI---IDFGFARLKPPDNQPLKTPC--FTLHYAAPELLNQNGYDESC------DLWSL 195
Query: 347 GILLLEMFTGIRP 359
G++L M +G P
Sbjct: 196 GVILYTMLSGQVP 208
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 56/236 (23%), Positives = 86/236 (36%), Gaps = 65/236 (27%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G FG V G G +AVK+ N + K E + +H +I+++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 208 TAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLDIAID 263
YQ + M G L F+++ K +++
Sbjct: 77 -------YQVISTPTDFFMVMEYVSGGEL----------------FDYICKHGRVEE--M 111
Query: 264 VAC--------ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
A A+ Y H + H +LKP NVLLD M + DFG++ +
Sbjct: 112 EARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDG 164
Query: 316 RFI---CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
F+ C GS Y PE Y G E D++S G++L + G P D
Sbjct: 165 EFLRTSC--GSPNYAAPEVISGRLYA-GPEV----DIWSCGVILYALLCGTLPFDD 213
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 53/233 (22%), Positives = 87/233 (37%), Gaps = 58/233 (24%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHR 201
+ +G G FG VY G A KV + + E I I H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVE----IEILATCDHP 76
Query: 202 NIVRVFTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
IV+ GA + ++ +F P G+++ + + +
Sbjct: 77 YIVK---------LLGAYYHDGKLWIMIEFCPGGAVDAIML--------------ELDRG 113
Query: 258 LD---IAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFL- 308
L I + + AL +LH I H +LK NVL+ E G + DFG++
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLE--GDIRLADFGVSAKNL 168
Query: 309 PAIDKQNRFICIKGSTGYIPPE--YDLGCEASTYG---DVYSFGILLLEMFTG 356
+ K++ FI G+ ++ PE + + Y D++S GI L+EM
Sbjct: 169 KTLQKRDSFI---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 59/230 (25%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVR 205
++ IG G G+VY + G +A++ NL + + +E K+ NIV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 206 VFTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD-- 259
Y + VV +++ GSL + + + +D
Sbjct: 82 ---------YLDSYLVGDELWVVMEYLAGGSLTDVVT----------------ETCMDEG 116
Query: 260 -IAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGM-ARFLPAID 312
IA + AL +LH + + H ++K N+LL + G V DFG A+ P
Sbjct: 117 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQS 171
Query: 313 KQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTG 356
K++ + G+ ++ PE Y D++S GI+ +EM G
Sbjct: 172 KRSTMV---GTPYWMAPEVVTRKAYGPKV------DIWSLGIMAIEMIEG 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 55/250 (22%), Positives = 94/250 (37%), Gaps = 47/250 (18%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGS 185
+ +F + YN ++G G+FG V AVKV N + +
Sbjct: 12 ENLYFQGTFAERYNIVC------MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 186 KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245
+ E + + H NI+++F + + +V + G L + + +
Sbjct: 66 STILREVELLKKLDHPNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEIIKRK---- 116
Query: 246 RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH---VGDF 302
F I V + Y+H + I H +LKP N+LL+ + + DF
Sbjct: 117 -----RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 303 GMARFLPAIDKQNRFICIKGSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGI 357
G++ + + G+ YI PE YD C DV+S G++L + +G
Sbjct: 169 GLSTC---FQQNTKMKDRIGTAYYIAPEVLRGTYDEKC------DVWSAGVILYILLSGT 219
Query: 358 RPSDGIFTGK 367
P F GK
Sbjct: 220 PP----FYGK 225
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 54/241 (22%), Positives = 86/241 (35%), Gaps = 69/241 (28%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSE 191
N+ F D Y IG G++ AVK+ + KS K +
Sbjct: 16 NSIQFTDGYEVKE------DIGVGSYSVCKRCIHKATNMEFAVKIID-------KS-KRD 61
Query: 192 CKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR 246
I I +H NI+ + Y ++ VV + M G L
Sbjct: 62 PTEEIEILLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGEL------------- 103
Query: 247 PLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH- 298
+ ++++K + + + YLH + H +LKPSN+L DE
Sbjct: 104 ---LDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPE 157
Query: 299 ---VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGIL 349
+ DFG A+ L A + C + ++ PE YD C D++S G+L
Sbjct: 158 SIRICDFGFAKQLRAENGLLMTPC--YTANFVAPEVLERQGYDAAC------DIWSLGVL 209
Query: 350 L 350
L
Sbjct: 210 L 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 3e-11
Identities = 48/242 (19%), Positives = 89/242 (36%), Gaps = 63/242 (26%)
Query: 131 TINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFK 189
++ + + + ++G+G F V+ G A+K S +
Sbjct: 1 SMQTTNIRKTFI------FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE 54
Query: 190 SECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLN 249
+E IKH NIV + + + Y M + + G + L
Sbjct: 55 NEIAVLKKIKHENIVTLEDIYESTTH--------YYLVM------QLVSGGE------L- 93
Query: 250 FNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIGH 298
F+ ++++ + + V A++YLH + I H +LKP N+L ++ I
Sbjct: 94 FDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKI-M 149
Query: 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFG----I 348
+ DFG+++ ++ G+ GY+ PE Y D +S G I
Sbjct: 150 ITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKPYSKAV------DCWSIGVITYI 199
Query: 349 LL 350
LL
Sbjct: 200 LL 201
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 57/256 (22%), Positives = 96/256 (37%), Gaps = 59/256 (23%)
Query: 124 PVYEGKQTINNPSFKDLYNATN---GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL 179
P ++ +P +L+ + FS IG G+FG+VY + + +A+K +
Sbjct: 30 PAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY 89
Query: 180 IRPGGSKSFKSECKAAINI----KHRNIVRVFTAFSGVDYQGARFKA----VVYKFMPNG 231
S + + +H N ++ Y+G + +V ++ G
Sbjct: 90 -SGKQSNEKWQDIIKEVRFLQKLRHPNTIQ---------YRGCYLREHTAWLVMEYCL-G 138
Query: 232 SLEEWLRGKDDTNWRPLNFNFLIKKKLD---IAI---DVACALRYLHCDCQPPIAHCNLK 285
S + L + KK L IA L YLH + H ++K
Sbjct: 139 SASDLLE--------------VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVK 181
Query: 286 PSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-- 341
N+LL + G V GDFG A + N F+ G+ ++ PE L + Y
Sbjct: 182 AGNILLSEP--GLVKLGDFGSASIM---APANSFV---GTPYWMAPEVILAMDEGQYDGK 233
Query: 342 -DVYSFGILLLEMFTG 356
DV+S GI +E+
Sbjct: 234 VDVWSLGITCIELAER 249
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 42/220 (19%), Positives = 86/220 (39%), Gaps = 50/220 (22%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAI--------NIKHRNI 203
+G+G G V +A+K+ + + + +++ + + H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL----- 258
+++ F DY +V + M G L F+ ++ K
Sbjct: 78 IKIKNFFDAEDYY------IVLELMEGGEL----------------FDKVVGNKRLKEAT 115
Query: 259 --DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHVGDFGMARFLPAIDK 313
+ A++YLH + I H +LKP NVLL +++ + + DFG ++ + +
Sbjct: 116 CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGE 169
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILL 350
+ + G+ Y+ PE + + Y D +S G++L
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 55/258 (21%), Positives = 98/258 (37%), Gaps = 48/258 (18%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVK-VFNLIRPGGSK 186
+ + + F + G G FG+V G G ++A+K V
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DP 60
Query: 187 SFK----SECKAAINIKHRNIVRVFTAF--SGVDYQGARFKAVVYKFMPNGSLEEWLRGK 240
F+ + + H NIV++ + F G + + VV +++P+ +L R
Sbjct: 61 RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCR-- 117
Query: 241 DDTNWRPLNFNFLIKKKLDIAID--------VACALRYLHCDCQPPIAHCNLKPSNVLLD 292
++++ + ++ LH + H ++KP NVL++
Sbjct: 118 -----------NYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVN 165
Query: 293 DEMIGH--VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGIL 349
+ G + DFG A+ L + +IC S Y PE G + +T D++S G +
Sbjct: 166 EAD-GTLKLCDFGSAKKLSPSEPNVAYIC---SRYYRAPELIFGNQHYTTAVDIWSVGCI 221
Query: 350 LLEMFTGIRPSDGIFTGK 367
EM G P IF G
Sbjct: 222 FAEMMLG-EP---IFRGD 235
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 55/236 (23%), Positives = 87/236 (36%), Gaps = 65/236 (27%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G FG V G G +AVK+ N + + E + +H +I+++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81
Query: 208 TAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLDIAID 263
YQ + ++ M G L F+++ K +LD
Sbjct: 82 -------YQVISTPSDIFMVMEYVSGGEL----------------FDYICKNGRLDE--K 116
Query: 264 VA--------CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+ + Y H + H +LKP NVLLD M + DFG++ +
Sbjct: 117 ESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDG 169
Query: 316 RFI---CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
F+ C GS Y PE Y G E D++S G++L + G P D
Sbjct: 170 EFLRTSC--GSPNYAAPEVISGRLYA-GPEV----DIWSSGVILYALLCGTLPFDD 218
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 46/247 (18%), Positives = 85/247 (34%), Gaps = 44/247 (17%)
Query: 124 PVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP 182
Y I + D Y+ +G G FG V+ T G A K
Sbjct: 142 QYYPQPVEIKHDHVLDHYDI------HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 195
Query: 183 GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDD 242
++ + E + ++H +V + A ++ ++Y+FM G L
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGEL--------- 241
Query: 243 TNWRPLNFNFLIKKK-----LDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294
F + + + V L ++H + H +LKP N++ +
Sbjct: 242 -------FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTK 291
Query: 295 MIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLE 352
+ DFG+ +D + G+ + PE G Y D++S G+L
Sbjct: 292 RSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348
Query: 353 MFTGIRP 359
+ +G+ P
Sbjct: 349 LLSGLSP 355
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 8e-11
Identities = 52/242 (21%), Positives = 91/242 (37%), Gaps = 43/242 (17%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGS 185
+ +F + YN ++G G+FG V AVKV N + +
Sbjct: 12 ENLYFQGTFAERYNIVC------MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 186 KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245
+ E + + H NI+++F + + +V + G L + + +
Sbjct: 66 STILREVELLKKLDHPNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEIIKRK---- 116
Query: 246 RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHVGDF 302
F I V + Y+H + I H +LKP N+LL + + + DF
Sbjct: 117 -----RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 303 GMARFLPAIDKQNRFICIKGSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGI 357
G++ + + G+ YI PE YD C DV+S G++L + +G
Sbjct: 169 GLSTC---FQQNTKMKDRIGTAYYIAPEVLRGTYDEKC------DVWSAGVILYILLSGT 219
Query: 358 RP 359
P
Sbjct: 220 PP 221
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 55/235 (23%), Positives = 87/235 (37%), Gaps = 64/235 (27%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G+FG V T +A+K + L + + E ++H +I+++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL- 74
Query: 208 TAFSGVDYQGARFKAVVYKFM--PNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLDIAIDV 264
Y + + G L F+++++K ++ D
Sbjct: 75 -------YDVITTPTDIVMVIEYAGGEL----------------FDYIVEKKRMTE--DE 109
Query: 265 AC--------ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
A+ Y H I H +LKP N+LLDD + + DFG++ I
Sbjct: 110 GRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLS----NIMTDGN 162
Query: 317 FI---CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
F+ C GS Y PE Y G E DV+S GI+L M G P D
Sbjct: 163 FLKTSC--GSPNYAAPEVINGKLYA-GPEV----DVWSCGIVLYVMLVGRLPFDD 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 53/256 (20%), Positives = 92/256 (35%), Gaps = 63/256 (24%)
Query: 128 GKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSK 186
G +T +D Y+ +G+G F V G A K + S+
Sbjct: 1 GMETFKQQKVEDFYDI------GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR 54
Query: 187 SF--KSECKAAINI----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK 240
+ E + ++I H NI+ + Y+ ++ + + G L
Sbjct: 55 RGVCREEIEREVSILRQVLHPNIITLHDV-----YENRTDVVLILELVSGGEL------- 102
Query: 241 DDTNWRPLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293
F+FL +K+ + + YLH IAH +LKP N++L D
Sbjct: 103 ---------FDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLD 150
Query: 294 EMIGH----VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDV 343
+ I + DFG+A I+ F I G+ ++ PE L D+
Sbjct: 151 KNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA------DM 201
Query: 344 YSFGILLLEMFTGIRP 359
+S G++ + +G P
Sbjct: 202 WSIGVITYILLSGASP 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 47/250 (18%), Positives = 80/250 (32%), Gaps = 78/250 (31%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN------------LIRPGGSKSFKSECKAAIN- 197
IG G++G V D T A+KV + P G++ C
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 198 -------------IKHRNIVRVF----TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK 240
+ H N+V++ Y +V++ + G +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY-------MVFELVNQGPV------- 125
Query: 241 DDTNWRPLNFNFLIKKKL--DIAI----DVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294
K L D A D+ + YLH I H ++KPSN+L+ ++
Sbjct: 126 ---------MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGED 173
Query: 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE--------YDLGCEASTYGDVYSF 346
+ DFG++ D G+ ++ PE + G DV++
Sbjct: 174 GHIKIADFGVSNEFKGSDALLSNTV--GTPAFMAPESLSETRKIFS-GKAL----DVWAM 226
Query: 347 GILLLEMFTG 356
G+ L G
Sbjct: 227 GVTLYCFVFG 236
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 51/257 (19%), Positives = 94/257 (36%), Gaps = 58/257 (22%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKV-------------FN 178
+ Y +G+G +G V + A+KV N
Sbjct: 30 KEGKIGESYFKVR------KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDN 83
Query: 179 LIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR 238
+ +E ++ H NI+++F ++ ++ +V +F G L E +
Sbjct: 84 KNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQII 138
Query: 239 GKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298
+ F +I + + YLH + I H ++KP N+LL+++
Sbjct: 139 NRH---------KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLL 186
Query: 299 ---VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE-----YDLGCEASTYGDVYSFGILL 350
+ DFG++ F K + G+ YI PE Y+ C DV+S G+++
Sbjct: 187 NIKIVDFGLSSF---FSKDYKLRDRLGTAYYIAPEVLKKKYNEKC------DVWSCGVIM 237
Query: 351 LEMFTGIRPSDGIFTGK 367
+ G P F G+
Sbjct: 238 YILLCGYPP----FGGQ 250
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 51/252 (20%), Positives = 87/252 (34%), Gaps = 65/252 (25%)
Query: 128 GKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSK 186
G + F+D+Y +++G G V L AVK+
Sbjct: 1 GSTDSFSGRFEDVYQLQE-----DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS 55
Query: 187 SFKSECKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD 241
E + + HRN++ + ++ +V++ M GS+
Sbjct: 56 RVFRE----VEMLYQCQGHRNVLELIEF-----FEEEDRFYLVFEKMRGGSI-------- 98
Query: 242 DTNWRPLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294
+ + K++ + DVA AL +LH IAH +LKP N+L +
Sbjct: 99 --------LSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHP 147
Query: 295 ------MIGHVGDFGMARFLPAIDKQNRFICIK-----GSTGYIPPE--YDLGCEASTYG 341
I DF + + + + GS Y+ PE EAS Y
Sbjct: 148 NQVSPVKI---CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 342 ---DVYSFGILL 350
D++S G++L
Sbjct: 205 KRCDLWSLGVIL 216
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 49/223 (21%), Positives = 77/223 (34%), Gaps = 49/223 (21%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
IG G++G V A K FK E + ++ H NI+R++ F
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-------LDIAIDV 264
+Y M E G + L F ++ K+ I DV
Sbjct: 77 DNTD--------IYLVM------ELCTGGE------L-FERVVHKRVFRESDAARIMKDV 115
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
A+ Y H + +AH +LKP N L + + DFG+A
Sbjct: 116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKV 169
Query: 322 GSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G+ Y+ P+ Y C D +S G+++ + G P
Sbjct: 170 GTPYYVSPQVLEGLYGPEC------DEWSAGVMMYVLLCGYPP 206
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 61/231 (26%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHR 201
F +G G++GSVY G +A+K + +S E I+I
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV------ESDLQEIIKEISIMQQCDSP 84
Query: 202 NIVRVFTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
++V+ Y G+ FK +V ++ GS+ + +R ++ + L +
Sbjct: 85 HVVK---------YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN----KTLT-------E 124
Query: 258 LDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFL-PAI 311
+IA L YLH H ++K N+LL+ E GH DFG+A L +
Sbjct: 125 DEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTE--GHAKLADFGVAGQLTDTM 179
Query: 312 DKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTG 356
K+N I G+ ++ PE Y+ D++S GI +EM G
Sbjct: 180 AKRNTVI---GTPFWMAPEVIQEIGYNCVA------DIWSLGITAIEMAEG 221
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 29/112 (25%), Positives = 49/112 (43%), Gaps = 14/112 (12%)
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ + VA + +L H +L N+LL ++ + + DFG+AR D
Sbjct: 196 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDP 247
Query: 318 ICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
++ +P PE + DV+SFG+LL E+F+ G P G+
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 46/248 (18%), Positives = 86/248 (34%), Gaps = 68/248 (27%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKA 194
+ D Y + ++G G G V G A+K+ S + E
Sbjct: 25 AVTDDYQLSK-----QVLGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKARQE--- 71
Query: 195 AINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLN 249
++ +IV + + + + ++ + M G L
Sbjct: 72 -VDHHWQASGGPHIVCILDVYENMHHGKRCL-LIIMECMEGGEL---------------- 113
Query: 250 FNFLIKKKL---------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH-- 298
F+ + ++ +I D+ A+++LH IAH ++KP N+L +
Sbjct: 114 FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVL 170
Query: 299 -VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLL 351
+ DFG A+ QN + Y+ PE YD C D++S G+++
Sbjct: 171 KLTDFGFAKET----TQNALQTPCYTPYYVAPEVLGPEKYDKSC------DMWSLGVIMY 220
Query: 352 EMFTGIRP 359
+ G P
Sbjct: 221 ILLCGFPP 228
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 52/245 (21%), Positives = 86/245 (35%), Gaps = 65/245 (26%)
Query: 131 TINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKS 187
TI F + Y +G G F V + G A + N + +
Sbjct: 3 TITCTRFTEEYQL------FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK 56
Query: 188 FKSECKAAI--NIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245
+ E A I +KH NIVR+ + S + Y + + G +
Sbjct: 57 LERE--ARICRLLKHPNIVRLHDSISEEGH--------HYLIF------DLVTGGE---- 96
Query: 246 RPLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298
L F ++ ++ + A+ + H Q + H NLKP N+LL ++ G
Sbjct: 97 --L-FEDIVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGA 150
Query: 299 ---VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFG-- 347
+ DFG+A + + G+ GY+ PE Y D+++ G
Sbjct: 151 AVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYGKPV------DLWACGVI 202
Query: 348 --ILL 350
ILL
Sbjct: 203 LYILL 207
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 55/264 (20%), Positives = 89/264 (33%), Gaps = 72/264 (27%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKV-----FNLIRPGGSK 186
++ F+D+Y +IG G F V G AVK+ F ++
Sbjct: 18 DDVLFEDVYEL------CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE 71
Query: 187 SFKSECKAAI--NIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN 244
K E A+I +KH +IV + Y +V++FM L
Sbjct: 72 DLKRE--ASICHMLKHPHIVELLET-----YSSDGMLYMVFEFMDGADL----------- 113
Query: 245 WRPLNFNFLIKKKL-----------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293
++K+ + ALRY H I H ++KP VLL
Sbjct: 114 -----CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLAS 165
Query: 294 EMIGH---VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVY 344
+ +G FG+A L G+ ++ PE Y DV+
Sbjct: 166 KENSAPVKLGGFGVAIQLGESGLVAGGRV--GTPHFMAPEVVKREPYGKPV------DVW 217
Query: 345 SFGILLLEMFTGIRP----SDGIF 364
G++L + +G P + +F
Sbjct: 218 GCGVILFILLSGCLPFYGTKERLF 241
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 51/256 (19%), Positives = 92/256 (35%), Gaps = 63/256 (24%)
Query: 128 GKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSK 186
G + +D Y+ +G+G F V G A K + S+
Sbjct: 1 GMEPFKQQKVEDFYDI------GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR 54
Query: 187 SF--KSECKAAINI----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK 240
+ E + ++I H N++ + Y+ ++ + + G L
Sbjct: 55 RGVSREEIEREVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGEL------- 102
Query: 241 DDTNWRPLNFNFLIKKK----LDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293
F+FL +K+ + + + YLH IAH +LKP N++L D
Sbjct: 103 ---------FDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLD 150
Query: 294 EMIGH----VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDV 343
+ I + DFG+A I+ F I G+ ++ PE L D+
Sbjct: 151 KNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA------DM 201
Query: 344 YSFGILLLEMFTGIRP 359
+S G++ + +G P
Sbjct: 202 WSIGVITYILLSGASP 217
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 47/221 (21%), Positives = 79/221 (35%), Gaps = 56/221 (25%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G F V G A K+ N + + + E + ++H NIVR+ +
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL-------DIAI 262
Q F +V+ + G L F ++ ++
Sbjct: 97 -----IQEESFHYLVFDLVTGGEL----------------FEDIVAREFYSEADASHCIQ 135
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH---VGDFGMARFLPAIDKQNRFIC 319
+ ++ Y H I H NLKP N+LL + G + DFG+A ++ +
Sbjct: 136 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHG 189
Query: 320 IKGSTGYIPPE------YDLGCEASTYGDVYSFG----ILL 350
G+ GY+ PE Y D+++ G ILL
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPV------DIWACGVILYILL 224
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 4e-10
Identities = 47/221 (21%), Positives = 79/221 (35%), Gaps = 56/221 (25%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G F V G A K+ N + + + E + ++H NIVR+ +
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL-------DIAI 262
Q F +V+ + G L F ++ ++
Sbjct: 74 -----IQEESFHYLVFDLVTGGEL----------------FEDIVAREFYSEADASHCIQ 112
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH---VGDFGMARFLPAIDKQNRFIC 319
+ ++ Y H I H NLKP N+LL + G + DFG+A ++ +
Sbjct: 113 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHG 166
Query: 320 IKGSTGYIPPE------YDLGCEASTYGDVYSFG----ILL 350
G+ GY+ PE Y D+++ G ILL
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPV------DIWACGVILYILL 201
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 49/223 (21%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR--------- 201
+IG G+FG V +A+K+ +R K F + I I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKM---VRN--EKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 202 -NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
N++ + F ++ + ++ + + +L E ++ ++ + L++K
Sbjct: 159 MNVIHMLENF---TFRN--HICMTFELL-SMNLYELIK---KNKFQGFSLP-LVRK---F 205
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH--VGDFGMARFL-----PAIDK 313
A + L LH + I HC+LKP N+LL + V DFG + + I
Sbjct: 206 AHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI-- 260
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
Q+RF Y PE LG D++S G +L E+ TG
Sbjct: 261 QSRF--------YRAPEVILGARYGMPIDMWSLGCILAELLTG 295
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 51/248 (20%), Positives = 90/248 (36%), Gaps = 50/248 (20%)
Query: 153 IGAGNFGSVYNGTLFD-GTTIAVK-VFNLIRPGGSKSFKS-ECKAAINIKHRNIVRVFTA 209
+G G+FG V + G A+K V +K+ E + H NI+++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 210 F-SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL--------------- 253
F + D + + G P +L
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 254 ---IKKKLDIAID--------VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--G 300
I+ I ++ + A+ ++H I H ++KP N+L++ + +
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD-NTLKLC 184
Query: 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRP 359
DFG A+ L + +IC S Y PE LG T D++S G + E+ G +P
Sbjct: 185 DFGSAKKLIPSEPSVAYIC---SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG-KP 240
Query: 360 SDGIFTGK 367
+F+G+
Sbjct: 241 ---LFSGE 245
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 36/107 (33%), Positives = 50/107 (46%), Gaps = 15/107 (14%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A ++A L +L I + +LK NV+LD E GH+ DFGM + +
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTF 502
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
C G+ YI PE YG D ++FG+LL EM G P +G
Sbjct: 503 C--GTPDYIAPEIIAYQP---YGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 8e-10
Identities = 59/232 (25%), Positives = 88/232 (37%), Gaps = 41/232 (17%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSK-SFKS----ECKAAINIKHRNIVRV 206
IG G FG V+ G +A+K + K F E K +KH N+V +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
R K +Y E L G + IK+ + +
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFD--FCEHDLAGLLSNVLVKFTLS-EIKR---VMQMLLN 135
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIKGST 324
L Y+H + I H ++K +NVL+ + + + DFG+AR L + NR+ T
Sbjct: 136 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY------T 186
Query: 325 G------YIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
Y PPE LG YG D++ G ++ EM+T P I G
Sbjct: 187 NRVVTLWYRPPELLLGER--DYGPPIDLWGAGCIMAEMWTR-SP---IMQGN 232
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 36/105 (34%), Positives = 49/105 (46%), Gaps = 17/105 (16%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFICI 320
+A L +L I + +LK NV+LD E GH+ DFGM + + F C
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTF-C- 182
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
G+ YI PE YG D ++FG+LL EM G P +G
Sbjct: 183 -GTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 36/105 (34%), Positives = 47/105 (44%), Gaps = 17/105 (16%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFICI 320
+ AL +LH I + +LK NVLLD E GH DFGM + + F C
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATF-C- 185
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
G+ YI PE YG D ++ G+LL EM G P +
Sbjct: 186 -GTPDYIAPEILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 28/101 (27%), Positives = 47/101 (46%), Gaps = 14/101 (13%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
+ AL YLH + + + +LK N++LD + GH+ DFG+ + + C
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFC-- 310
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE + YG D + G+++ EM G P
Sbjct: 311 GTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 38/102 (37%), Positives = 52/102 (50%), Gaps = 17/102 (16%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFICI 320
++ AL YLH + I + +LK NVLLD E GH+ D+GM + L D + F C
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTF-C- 214
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ YI PE G YG D ++ G+L+ EM G P
Sbjct: 215 -GTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 47/251 (18%), Positives = 89/251 (35%), Gaps = 47/251 (18%)
Query: 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVK--VFNLIRPGGSKSFKS---- 190
+L+ + ++ I +G++G+V G +G +A+K +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 191 -----ECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV--VYKFMPNGSLEEWLRGKDDT 243
E + + H NI+ + F + + V + M L + + +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPA--MHKLYLVTELMRT-DLAQVIHDQRIV 130
Query: 244 NWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303
P + + + L L LH + + H +L P N+LL D + DF
Sbjct: 131 -ISPQHIQYFMYHIL-------LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFN 179
Query: 304 MARFLPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTG 356
+AR D + T Y+ PE + + T D++S G ++ EMF
Sbjct: 180 LAR----EDTADANK-----THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 357 IRPSDGIFTGK 367
+ +F G
Sbjct: 231 -KA---LFRGS 237
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 55/253 (21%), Positives = 92/253 (36%), Gaps = 62/253 (24%)
Query: 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKS----E 191
+ + + IG+G G V +A+K L RP +++ E
Sbjct: 17 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRE 74
Query: 192 CKAAINIKHRNIVR---VFTAFSGVDYQGARFKAV--VYKFMPNGSLEEWLRGKDDTNWR 246
+ H+NI+ VFT ++ F+ V V + M D N
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLE----EFQDVYIVMELM-------------DAN-- 115
Query: 247 PLNFNFLIKKKLD------IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300
+I+ +LD + + C +++LH I H +LKPSN+++ + +
Sbjct: 116 ---LCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 169
Query: 301 DFGMARFLPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYGDVYSFGILLLEMF 354
DFG+AR T Y+ PE LG D++S G ++ EM
Sbjct: 170 DFGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220
Query: 355 TGIRPSDGIFTGK 367
G +F G
Sbjct: 221 KG-GV---LFPGT 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 38/102 (37%), Positives = 52/102 (50%), Gaps = 17/102 (16%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFICI 320
++ AL YLH + I + +LK NVLLD E GH+ D+GM + L D + F C
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTF-C- 171
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ YI PE G YG D ++ G+L+ EM G P
Sbjct: 172 -GTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 42/228 (18%)
Query: 153 IGAGNFGSVYNGTLFD-GTTIAVK-VFNLIRPGGSKSFKS-ECKAAINIKHRNIVRVFTA 209
IG G+FG VY L D G +A+K V K FK+ E + + H NIVR+
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 210 F-SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
F S + + + +V ++P ++ R + L +K + +L
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-QTLP-VIYVKL---YMYQLFRSL 169
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGY 326
Y+H I H ++KP N+LLD + + DFG A+ L + + Y
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQL----VRGEP-----NVSY 216
Query: 327 I------PPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
I PE G + ++ DV+S G +L E+ G +P IF G
Sbjct: 217 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QP---IFPGD 260
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-09
Identities = 52/233 (22%), Positives = 84/233 (36%), Gaps = 60/233 (25%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G +G V +AVK+ ++ R ++ K E + H N+V+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF--- 70
Query: 210 FSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLDIAIDVA 265
Y R + Y F+ G L F+ + + A
Sbjct: 71 -----YGHRREGNIQYLFLEYCSGGEL----------------FDRIEPDIGMPE--PDA 107
Query: 266 --------CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ YLH I H ++KP N+LLD+ + DFG+A + + + R
Sbjct: 108 QRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERL 163
Query: 318 I---CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
+ C G+ Y+ PE + DV+S GI+L M G P D
Sbjct: 164 LNKMC--GTLPYVAPELLKRREFH-AEPV----DVWSCGIVLTAMLAGELPWD 209
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 31/104 (29%), Positives = 51/104 (49%), Gaps = 18/104 (17%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA-RFLPAIDKQNRFICI 320
+ AL +LH + I + ++K N+LLD GHV DFG++ F+ ++ C
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFC- 221
Query: 321 KGSTGYIPPEYDLGCEASTYG-----DVYSFGILLLEMFTGIRP 359
G+ Y+ P+ G + G D +S G+L+ E+ TG P
Sbjct: 222 -GTIEYMAPDIVRGGD---SGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 11/102 (10%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFICI 320
+ L++LH I + +LK N+LLD + GH+ DFGM + + K N F C
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTF-C- 179
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ YI PE LG + + D +SFG+LL EM G P G
Sbjct: 180 -GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 38/109 (34%), Positives = 56/109 (51%), Gaps = 19/109 (17%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
+A AL +LH I + +LKP N+LLD+E GH+ DFG+++ +K+ C
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFC-- 187
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
G+ Y+ PE + D +SFG+L+ EM TG P F GK
Sbjct: 188 GTVEYMAPEVVNR---RGHTQSADWWSFGVLMFEMLTGTLP----FQGK 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 47/224 (20%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR-------- 201
+LIG G+FG V + +A+K+ I+ K+F ++ + + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKI---IK--NKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 202 --NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
IV + F ++ +V++ + + +L + LR +TN+R ++ N L +K
Sbjct: 115 KYYIVHLKRHF---MFRNHLC--LVFEML-SYNLYDLLR---NTNFRGVSLN-LTRK--- 161
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH--VGDFGMARFL-----PAID 312
A + AL +L + I HC+LKP N+LL + + DFG + L I
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI- 219
Query: 313 KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
Q+RF Y PE LG D++S G +L+EM TG
Sbjct: 220 -QSRF--------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 18/101 (17%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
+ YLH + + +LKP N+L+D + G++ DFG A+ + + C
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRVK--GRTWTL-C-- 199
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ + PE L Y D ++ G+L+ EM G P
Sbjct: 200 GTPEALAPEIILS---KGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 55/256 (21%), Positives = 94/256 (36%), Gaps = 68/256 (26%)
Query: 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
+ + + IG+G G V +A+K L RP +++ K A
Sbjct: 54 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTH---AKRA 108
Query: 196 I-------NIKHRNIVR---VFTAFSGVDYQGARFKAV--VYKFMPNGSLEEWLRGKDDT 243
+ H+NI+ VFT ++ F+ V V + M D
Sbjct: 109 YRELVLMKCVNHKNIISLLNVFTPQKTLE----EFQDVYLVMELM-------------DA 151
Query: 244 NWRPLNFNFLIKKKLD------IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297
N +I+ +LD + + C +++LH I H +LKPSN+++ +
Sbjct: 152 N-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 203
Query: 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYGDVYSFGILLL 351
+ DFG+AR T Y+ PE LG D++S G ++
Sbjct: 204 KILDFGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
Query: 352 EMFTGIRPSDGIFTGK 367
EM + +F G+
Sbjct: 255 EMVRH-KI---LFPGR 266
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 28/102 (27%), Positives = 47/102 (46%), Gaps = 17/102 (16%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFICI 320
+ AL YLH + + ++K N++LD + GH+ DFG+ + + F C
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTF-C- 166
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE + YG D + G+++ EM G P
Sbjct: 167 -GTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 34/109 (31%), Positives = 53/109 (48%), Gaps = 19/109 (17%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
++ AL +LH Q I + +LKP N++L+ + GHV DFG+ + C
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHTFC-- 182
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
G+ Y+ PE + S + D +S G L+ +M TG P FTG+
Sbjct: 183 GTIEYMAPEILMR---SGHNRAVDWWSLGALMYDMLTGAPP----FTGE 224
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 33/102 (32%), Positives = 47/102 (46%), Gaps = 17/102 (16%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA-RFLPAIDKQNRFICI 320
+A AL YLH I + +LKP N+LLD + GH+ DFG+ + + F C
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTSTF-C- 200
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE Y D + G +L EM G+ P
Sbjct: 201 -GTPEYLAPEVLHK---QPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 47/234 (20%), Positives = 79/234 (33%), Gaps = 54/234 (23%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G+G FG V+ G +K N R + ++E + ++ H NI+++F F
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 211 SGVDYQ---------GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
G + +V +L E ++
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSE-------------------GYVAELM 130
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHVGDFGMARFLPAIDKQNRFI 318
+ AL Y H + H +LKP N+L + DFG+A
Sbjct: 131 KQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHST 184
Query: 319 CIKGSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
G+ Y+ PE C D++S G+++ + TG P FTG
Sbjct: 185 NAAGTALYMAPEVFKRDVTFKC------DIWSAGVVMYFLLTGCLP----FTGT 228
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 5e-09
Identities = 39/101 (38%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
V AL YLH I + +LKP N+LLD GH+ DFG A+++P D C
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVP--DVTYTL-C-- 164
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ YI PE Y D +SFGIL+ EM G P
Sbjct: 165 GTPDYIAPEVVST---KPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 42/218 (19%), Positives = 78/218 (35%), Gaps = 39/218 (17%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
+G G FG V+ T K ++ K E +HRNI+ + +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES-- 69
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL-----DIAI---D 263
++ ++++F+ + F + +I
Sbjct: 70 ---FESMEELVMIFEFISGLDI----------------FERINTSAFELNEREIVSYVHQ 110
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
V AL++LH I H +++P N++ + +FG AR + + F +
Sbjct: 111 VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLF 164
Query: 322 GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ Y PE ST D++S G L+ + +GI P
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 52/255 (20%), Positives = 89/255 (34%), Gaps = 67/255 (26%)
Query: 131 TINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFK 189
+ D Y+ +G+G F V G A K R S+ +
Sbjct: 3 VFRQENVDDYYDT------GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--R 54
Query: 190 SECKAAI--------NIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD 241
+ I I+H N++ + Y+ ++ + + G L
Sbjct: 55 GVSREDIEREVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGEL-------- 101
Query: 242 DTNWRPLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294
F+FL +K+ + + + YLH IAH +LKP N++L D
Sbjct: 102 --------FDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDR 150
Query: 295 MIGH----VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVY 344
+ + DFG+A ID N F I G+ ++ PE L D++
Sbjct: 151 NVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA------DMW 201
Query: 345 SFGILLLEMFTGIRP 359
S G++ + +G P
Sbjct: 202 SIGVITYILLSGASP 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 5e-09
Identities = 55/235 (23%), Positives = 84/235 (35%), Gaps = 45/235 (19%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-IRPGGSKSFKS----------ECKAAINI 198
IG G +G+VY G +A+K + GG +A
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF--- 71
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
+H N+VR+ + +V++ + L +L D L IK
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL---DKAPPPGLPAE-TIKD-- 124
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
+ L +LH +C I H +LKP N+L+ + DFG+AR Q
Sbjct: 125 -LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMAL- 176
Query: 319 CIKGSTG------YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
T Y PE L +T D++S G + EMF +P +F G
Sbjct: 177 -----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KP---LFCGN 222
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 7e-09
Identities = 46/251 (18%), Positives = 81/251 (32%), Gaps = 64/251 (25%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSE 191
+ +F + Y T+ +G G F V G A K R G ++E
Sbjct: 22 SMENFNNFYILTS-----KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC--RAE 74
Query: 192 CKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR 246
I + ++ + Y+ ++ ++ G +
Sbjct: 75 ILHEIAVLELAKSCPRVINLHEV-----YENTSEIILILEYAAGGEI------------- 116
Query: 247 PLNFNFLIKKKLDI-----AIDVAC----ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297
F+ + + ++ I + + YLH Q I H +LKP N+LL
Sbjct: 117 ---FSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPL 170
Query: 298 H---VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGI 348
+ DFGM+R I I G+ Y+ PE D+++ GI
Sbjct: 171 GDIKIVDFGMSRK---IGHACELREIMGTPEYLAPEILNYDPITTAT------DMWNIGI 221
Query: 349 LLLEMFTGIRP 359
+ + T P
Sbjct: 222 IAYMLLTHTSP 232
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 7e-09
Identities = 52/233 (22%), Positives = 84/233 (36%), Gaps = 60/233 (25%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G +G V +AVK+ ++ R ++ K E + H N+V+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF--- 70
Query: 210 FSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLDIAIDVA 265
Y R + Y F+ G L F+ + + A
Sbjct: 71 -----YGHRREGNIQYLFLEYCSGGEL----------------FDRIEPDIGMPE--PDA 107
Query: 266 --------CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ YLH I H ++KP N+LLD+ + DFG+A + + + R
Sbjct: 108 QRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERL 163
Query: 318 I---CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
+ C G+ Y+ PE + DV+S GI+L M G P D
Sbjct: 164 LNKMC--GTLPYVAPELLKRREFH-AEPV----DVWSCGIVLTAMLAGELPWD 209
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 50/232 (21%), Positives = 75/232 (32%), Gaps = 59/232 (25%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
IG+GNFG +AVK ++ + E +++H NIVR
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLDIAIDVA---- 265
+ A++ ++ G L + + + D A
Sbjct: 86 LTPTHL-----AIIMEYASGGEL----------------YERICNAGRFSE--DEARFFF 122
Query: 266 ----CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH--VGDFGMARFLPAIDKQNRFI- 318
+ Y H I H +LK N LLD + DFG + +
Sbjct: 123 QQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSVLHSQPK 175
Query: 319 --CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ YI PE YD G A DV+S G+ L M G P +
Sbjct: 176 STV--GTPAYIAPEVLLRQEYD-GKIA----DVWSCGVTLYVMLVGAYPFED 220
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 41/227 (18%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVK-VFNLIRPGGSKSFKS-ECKAAINIKHRNIVRVFTAF 210
IG G+FG V+ L + +A+K V K FK+ E + +KH N+V + F
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 211 -SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
S D + F +V +++P ++ R + + LIK + +L
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLK-QTMP-MLLIKL---YMYQLLRSLA 155
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYI 327
Y+H I H ++KP N+LLD G + DFG A+ L A + + YI
Sbjct: 156 YIHSIG---ICHRDIKPQNLLLDPPS-GVLKLIDFGSAKILIAGEP---------NVSYI 202
Query: 328 ------PPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
PE G +T D++S G ++ E+ G +P +F G+
Sbjct: 203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QP---LFPGE 245
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 33/112 (29%), Positives = 51/112 (45%), Gaps = 18/112 (16%)
Query: 266 CALRYLH-CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS- 323
A++ LH + + H +LKPSN+L++ V DFG+AR + N + S
Sbjct: 123 RAVKVLHGSN----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 324 -TGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGK 367
++ PE L + DV+S G +L E+F RP IF G+
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RP---IFPGR 226
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 35/109 (32%), Positives = 50/109 (45%), Gaps = 19/109 (17%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
L+Y+H + H +LKPSN+LL+ + DFG+AR F+ T
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL-----TE 190
Query: 326 YI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGK 367
Y+ PE L + T D++S G +L EM + RP IF GK
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP---IFPGK 235
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 50/231 (21%), Positives = 88/231 (38%), Gaps = 57/231 (24%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSF--KSECKAAINI----KHRNIVR 205
+G+G F V G A K R S+ + E + +NI +H NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL------- 258
+ ++ ++ + + G L F+FL +K+
Sbjct: 73 LHDI-----FENKTDVVLILELVSGGEL----------------FDFLAEKESLTEDEAT 111
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH----VGDFGMARFLPAIDKQ 314
+ + YLH IAH +LKP N++L D+ + + + DFG+A I+
Sbjct: 112 QFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAG 165
Query: 315 NRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
N F I G+ ++ PE L D++S G++ + +G P
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEA------DMWSIGVITYILLSGASP 210
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 52/271 (19%), Positives = 92/271 (33%), Gaps = 82/271 (30%)
Query: 131 TINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFK 189
I + D Y T+ ++G G G V A+K+ ++ +
Sbjct: 53 QIKKNAIIDDYKVTS-----QVLGLGINGKVLQIFNKRTQEKFALKM---LQD--CPKAR 102
Query: 190 SECKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN 244
E + + + +IVR+ + + R + M E L G +
Sbjct: 103 RE----VELHWRASQCPHIVRIVDVYE--NLYAGRKC--LLIVM------ECLDGGE--- 145
Query: 245 WRPLNFNFLIKKKL---------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE- 294
L F+ + + +I + A++YLH IAH ++KP N+L +
Sbjct: 146 ---L-FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKR 198
Query: 295 -----MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDV 343
+ DFG A+ N + Y+ PE YD C D+
Sbjct: 199 PNAILKL---TDFGFAKE---TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC------DM 246
Query: 344 YSFGILLLEMFTGIRP---------SDGIFT 365
+S G+++ + G P S G+ T
Sbjct: 247 WSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 2e-08
Identities = 56/237 (23%), Positives = 89/237 (37%), Gaps = 64/237 (27%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINIKHR 201
+G G +G VY G +A+K L IR E + H
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR---------EISLLKELHHP 79
Query: 202 NIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
NIV + +V++FM L++ L D N L + IK
Sbjct: 80 NIVSLIDVIHSERCLT-------LVFEFMEK-DLKKVL----DENKTGLQDS-QIKI--- 123
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRF 317
+ + + H I H +LKP N+L++ + + DFG+AR +P
Sbjct: 124 YLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-------- 172
Query: 318 ICIKGSTG------YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
++ T Y P+ +G + ST D++S G + EM TG +P +F G
Sbjct: 173 --VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KP---LFPGV 223
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 3e-08
Identities = 30/108 (27%), Positives = 43/108 (39%), Gaps = 22/108 (20%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
L +LH + H +LKP N+L+ + DFG+AR Q T
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMAL------TS 178
Query: 326 ------YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
Y PE L +T D++S G + EMF +P +F G
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KP---LFRGS 222
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 45/223 (20%), Positives = 77/223 (34%), Gaps = 62/223 (27%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G VY A+KV + K ++E + + H NI+++ F
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 211 SGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKL-------DI 260
+ + G L F+ +++K D
Sbjct: 118 ETPTE--------ISLVLELVTGGEL----------------FDRIVEKGYYSERDAADA 153
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHVGDFGMARFLPAIDKQNRF 317
+ A+ YLH + I H +LKP N+L + + DFG+++ ++ Q
Sbjct: 154 VKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLM 207
Query: 318 ICIKGSTGYIPPE------YDLGCEASTYGDVYSFG----ILL 350
+ G+ GY PE Y D++S G ILL
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEV------DMWSVGIITYILL 244
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 26/110 (23%), Positives = 47/110 (42%), Gaps = 20/110 (18%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG-HVGDFGMARFLPAIDKQNRFICIKGST 324
L+Y+H + H +LKP+N+ ++ E + +GDFG+AR + + +
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL-----S 182
Query: 325 GYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGK 367
+ P L T D+++ G + EM TG + +F G
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KT---LFAGA 228
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 50/241 (20%), Positives = 87/241 (36%), Gaps = 41/241 (17%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKA 194
S + + + +G G + V+ + + + VK+ ++P K K E K
Sbjct: 27 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKI 83
Query: 195 AINIK-HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL 253
N++ NI+ + + + F E + D F L
Sbjct: 84 LENLRGGPNIITLADIV-----KDPVSRTPALVF-------EHVNNTD--------FKQL 123
Query: 254 IKKKLDIAI-----DVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-MIGHVGDFGMARF 307
+ D I ++ AL Y H I H ++KP NV++D E + D+G+A F
Sbjct: 124 YQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180
Query: 308 LPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTG 366
+ N + S + PE + + Y D++S G +L M P F G
Sbjct: 181 YHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHG 234
Query: 367 K 367
Sbjct: 235 H 235
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 57/254 (22%), Positives = 95/254 (37%), Gaps = 65/254 (25%)
Query: 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKS----E 191
K + + S +G+G +GSV + G +A+K L RP S+ F E
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRE 73
Query: 192 CKAAINIKHRNIVR---VFTAFSGVDYQGARFKAV--VYKFMPNGSLEEWLRGKDDTNWR 246
+++H N++ VFT S + F V FM T+
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLR----NFYDFYLVMPFM-------------QTD-- 114
Query: 247 PLNFNFLIKKKLD------IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300
++ K + + L+Y+H + H +LKP N+ ++++ +
Sbjct: 115 ---LQKIMGLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKIL 168
Query: 301 DFGMARFLPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYG-DVYSFGILLLEM 353
DFG+AR TGY+ PE L D++S G ++ EM
Sbjct: 169 DFGLAR-----------HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217
Query: 354 FTGIRPSDGIFTGK 367
TG + +F GK
Sbjct: 218 LTG-KT---LFKGK 227
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 9e-08
Identities = 49/238 (20%), Positives = 89/238 (37%), Gaps = 64/238 (26%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINIKH 200
IG G +G+V+ +A+K L +R E +KH
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---------EICLLKELKH 60
Query: 201 RNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
+NIVR+ +V++F L+++ D+ L+ ++K
Sbjct: 61 KNIVRLHDVLHSDKKLT-------LVFEFCDQ-DLKKYF----DSCNGDLDPE-IVKS-- 105
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNR 316
+ L + H + H +LKP N+L++ + +FG+AR +P
Sbjct: 106 -FLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP------- 154
Query: 317 FICIKGSTG------YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
++ + Y PP+ G + ST D++S G + E+ RP +F G
Sbjct: 155 ---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 32/143 (22%), Positives = 60/143 (41%), Gaps = 32/143 (22%)
Query: 232 SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291
+ E+L+ + N++P ++ +A + ALR+LH + Q + H +LKP N+L
Sbjct: 107 NTFEFLK---ENNFQPYPLP-HVRH---MAYQLCHALRFLH-ENQ--LTHTDLKPENILF 156
Query: 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIK----GS--------TGYI------PPEYDL 333
+ + + + ++ + I+ GS T + PPE L
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTS----IRVADFGSATFDHEHHTTIVATRHYRPPEVIL 212
Query: 334 GCEASTYGDVYSFGILLLEMFTG 356
+ DV+S G +L E + G
Sbjct: 213 ELGWAQPCDVWSIGCILFEYYRG 235
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 47/235 (20%), Positives = 87/235 (37%), Gaps = 44/235 (18%)
Query: 153 IGAGNFGSVYNGTLFDGTT---IAVKVFNLIRPGGSKSFKSECKAAI--NIKHRNIVRVF 207
+G G +G VY DG A+K G S + + A+ +KH N++ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACREIALLRELKHPNVISLQ 84
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNF---LIKKKLDIAIDV 264
F + + + +++ + + L ++ + ++K + +
Sbjct: 85 KVF--LSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKS---LLYQI 137
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH----VGDFGMARFL-----PAIDKQN 315
+ YLH + + H +LKP+N+L+ E + D G AR P D
Sbjct: 138 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
+ Y PE LG Y D+++ G + E+ T P IF +
Sbjct: 195 VVVTF----WYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTS-EP---IFHCR 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 58/243 (23%), Positives = 91/243 (37%), Gaps = 71/243 (29%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNL----------IRPGGSKSFKSECKAAINIKHR 201
+G G + +VY G G +A+K L IR E +KH
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---------EISLMKELKHE 63
Query: 202 NIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNF---LIKK 256
NIVR++ + +V++FM N L++++ D L+K
Sbjct: 64 NIVRLYDVIHTENKLT-------LVFEFMDN-DLKKYM---DSRTVGNTPRGLELNLVKY 112
Query: 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
+ L + H + I H +LKP N+L++ +GDFG+AR
Sbjct: 113 ---FQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA--------- 157
Query: 317 FICIKGSTG-----------YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIF 364
G Y P+ +G ST D++S G +L EM TG +P +F
Sbjct: 158 ----FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KP---LF 209
Query: 365 TGK 367
G
Sbjct: 210 PGT 212
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 54/238 (22%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL----------IRPGGSKSFKSECKAA 195
+ + +G G + +VY G +A+K L IR E
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---------EVSLL 54
Query: 196 INIKHRNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL 253
++KH NIV + +V++++ L+++L D +N +
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLT-------LVFEYLDK-DLKQYL----DDCGNIINMH-N 101
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAI 311
+K + L Y H + + H +LKP N+L+++ + DFG+AR +P
Sbjct: 102 VKL---FLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155
Query: 312 DKQNRFICIKGSTG-YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
N + T Y PP+ LG ST D++ G + EM TG RP +F G
Sbjct: 156 TYDNEVV-----TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RP---LFPGS 204
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 61/248 (24%), Positives = 100/248 (40%), Gaps = 52/248 (20%)
Query: 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKS----E 191
K ++ + + + +G+G +GSV G +AVK L RP S E
Sbjct: 21 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRE 78
Query: 192 CKAAINIKHRNIVR---VFTAFSGVDYQGARFKAV--VYKFMPNGSLEEWLRGKDDTNWR 246
+ ++KH N++ VFT ++ F V V M L ++ + T+
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLE----EFNDVYLVTHLMGA-DLNNIVKCQKLTDDH 133
Query: 247 PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306
FLI + L L+Y+H I H +LKPSN+ ++++ + DFG+AR
Sbjct: 134 ---VQFLIYQIL-------RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
Query: 307 FLPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRP 359
+ TGY+ PE L D++S G ++ E+ TG R
Sbjct: 181 ------HTADEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RT 228
Query: 360 SDGIFTGK 367
+F G
Sbjct: 229 ---LFPGT 233
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 36/122 (29%), Positives = 54/122 (44%), Gaps = 27/122 (22%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS-- 323
++YLH + H ++KPSN+LL+ E V DFG++R I + I + +
Sbjct: 120 KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 324 -----------TGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFT 365
T Y+ PE LG T G D++S G +L E+ G +P IF
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KP---IFP 232
Query: 366 GK 367
G
Sbjct: 233 GS 234
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 31/109 (28%), Positives = 50/109 (45%), Gaps = 25/109 (22%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
LRY+H I H +LKP N+ ++++ + DFG+AR + + + TG
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR------QADSEM-----TG 184
Query: 326 YI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGK 367
Y+ PE L T D++S G ++ EM TG + +F G
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KT---LFKGS 229
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 36/146 (24%), Positives = 50/146 (34%), Gaps = 30/146 (20%)
Query: 232 SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291
SL E + N+ + IK I++ AL YL + H +LKP N+LL
Sbjct: 121 SLYEIIT---RNNYNGFHIE-DIKL---YCIEILKALNYLR-KMS--LTHTDLKPENILL 170
Query: 292 DDEMIGHVGDFGMARFLPAIDKQNRFIC--IK----GS--------TGYI------PPEY 331
DD + R IK G I PE
Sbjct: 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEV 230
Query: 332 DLGCEASTYGDVYSFGILLLEMFTGI 357
L D++SFG +L E++TG
Sbjct: 231 ILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 49.4 bits (119), Expect = 6e-07
Identities = 55/237 (23%), Positives = 87/237 (36%), Gaps = 64/237 (27%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINIKHR 201
IG G +G VY G T A+K L IR E +KH
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---------EISILKELKHS 60
Query: 202 NIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
NIV+++ +V++ + L++ L D L K
Sbjct: 61 NIVKLYDVIHTKKRLV-------LVFEHLDQ-DLKKLL----DVCEGGLESV-TAKS--- 104
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRF 317
+ + + Y H + H +LKP N+L++ E + DFG+AR +P
Sbjct: 105 FLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-------- 153
Query: 318 ICIKGSTG------YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
++ T Y P+ +G + ST D++S G + EM G P +F G
Sbjct: 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TP---LFPGV 204
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 6e-07
Identities = 57/240 (23%), Positives = 83/240 (34%), Gaps = 66/240 (27%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKS--------ECKAAINIKHRNI 203
+G G F +VY +A+K I+ G K E K + H NI
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKK---IKLGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 204 VRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
+ + AF +V+ FM LE + N L + IK
Sbjct: 75 IGLLDAFGHKSNIS-------LVFDFMET-DLEVII----KDNSLVLTPS-HIKA---YM 118
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
+ L YLH I H +LKP+N+LLD+ + + DFG+A+
Sbjct: 119 LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS-------------F 162
Query: 322 GSTG-----------YIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
GS Y PE G YG D+++ G +L E+ P G
Sbjct: 163 GSPNRAYTHQVVTRWYRAPELLFGAR--MYGVGVDMWAVGCILAELLLR-VP---FLPGD 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 53/238 (22%), Positives = 87/238 (36%), Gaps = 61/238 (25%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINIKH 200
+G G +G VY T+A+K L IR E ++H
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---------EVSLLKELQH 92
Query: 201 RNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
RNI+ + + + +++++ N L++++ D N ++ +IK
Sbjct: 93 RNIIELKSVIHHNHRLH-------LIFEYAEN-DLKKYM----DKN-PDVSMR-VIKS-- 136
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG-----DFGMARF--LPAI 311
+ + + H H +LKP N+LL DFG+AR +P
Sbjct: 137 -FLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192
Query: 312 DKQNRFICIKGSTG-YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
+ I T Y PPE LG ST D++S + EM P +F G
Sbjct: 193 QFTHEII-----TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TP---LFPGD 241
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 30/144 (20%), Positives = 55/144 (38%), Gaps = 32/144 (22%)
Query: 232 SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291
S ++++ + + P + I+K +A + ++ +LH + + H +LKP N+L
Sbjct: 102 STYDFIK---ENGFLPFRLD-HIRK---MAYQICKSVNFLH-SNK--LTHTDLKPENILF 151
Query: 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIK----GSTGYI--------------PPEYDL 333
+ + R + + IK GS Y PE L
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPD----IKVVDFGSATYDDEHHSTLVSTRHYRAPEVIL 207
Query: 334 GCEASTYGDVYSFGILLLEMFTGI 357
S DV+S G +L+E + G
Sbjct: 208 ALGWSQPCDVWSIGCILIEYYLGF 231
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 50/240 (20%), Positives = 90/240 (37%), Gaps = 65/240 (27%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINI 198
L+G G++G V G +A+K F +R E K +
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR---------EIKLLKQL 81
Query: 199 KHRNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK 256
+H N+V + Y +V++F+ + ++ + L + L++ +++K
Sbjct: 82 RHENLVNLLEVCKKKKRWY-------LVFEFVDH-TILDDL----ELFPNGLDYQ-VVQK 128
Query: 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
+ + + H I H ++KP N+L+ + + DFG AR L
Sbjct: 129 ---YLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA--APGEV 180
Query: 317 FICIKGSTGYI------PPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
+ + PE +G YG DV++ G L+ EMF G P +F G
Sbjct: 181 Y------DDEVATRWYRAPELLVGDV--KYGKAVDVWAIGCLVTEMFMG-EP---LFPGD 228
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 49/238 (20%), Positives = 88/238 (36%), Gaps = 65/238 (27%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINIKH 200
IG G++G V+ G +A+K F +R E + +KH
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---------EIRMLKQLKH 61
Query: 201 RNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
N+V + F + +V+++ + ++ L D R + + L+K
Sbjct: 62 PNLVNLLEVFRRKRRLH-------LVFEYCDH-TVLHEL----DRYQRGVPEH-LVKS-- 106
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
I A+ + H + H ++KP N+L+ + + DFG AR L
Sbjct: 107 -ITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--- 159
Query: 319 CIKGSTGYI------PPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
+ PE +G YG DV++ G + E+ +G P ++ GK
Sbjct: 160 -----DDEVATRWYRSPELLVGDT--QYGPPVDVWAIGCVFAELLSG-VP---LWPGK 206
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 27/124 (21%), Positives = 48/124 (38%), Gaps = 26/124 (20%)
Query: 266 CALRYLH-CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS- 323
++H I H +LKP+N LL+ + V DFG+AR + + N ++ +
Sbjct: 140 LGENFIHESG----IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 324 -------------TGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGI 363
T ++ PE L E T D++S G + E+ ++
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 364 FTGK 367
T +
Sbjct: 256 PTNR 259
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 9e-06
Identities = 56/343 (16%), Positives = 112/343 (32%), Gaps = 81/343 (23%)
Query: 17 LLEMFTGLRPNDDMFNDELNLHN---FVKSALPERAEEILDVVFFQEIEEEETMYKKA-- 71
LLE LRP ++ + K+ + LDV +++ + M K
Sbjct: 144 LLE----LRPAKNVL-----IDGVLGSGKTWV------ALDVCLSYKVQCK--MDFKIFW 186
Query: 72 --SSTCTQSSIILECLISICRTGVACSAELP----NERMKINDVESRLRLIKKKLLKTPV 125
C +LE L + N +++I+ +++ LR +LLK+
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR----RLLKSKP 242
Query: 126 YEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS 185
YE + ++ N A A N L TT +V + + +
Sbjct: 243 YENCLLV----LLNVQN-------AKAWNAFNLSC---KILL--TTRFKQVTDFLSAATT 286
Query: 186 KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPN--GSLEEWLRGKDDT 243
+ ++ + + + + Q + + P + E +R T
Sbjct: 287 THISLD-HHSMTLTPDEVKSLLLKYLDCRPQDLPREVL--TTNPRRLSIIAESIRDGLAT 343
Query: 244 --NWRPLNFNFLIKKKLDIAIDV--ACALRYLHCDCQ--PPIAHCNLK-PSNVL------ 290
NW+ +N + L ++ +++V R + PP + P+ +L
Sbjct: 344 WDNWKHVNCDKL-TTIIESSLNVLEPAEYRKMFDRLSVFPP----SAHIPTILLSLIWFD 398
Query: 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL 333
+ + V + L ++KQ K ST I +
Sbjct: 399 VIKSDVMVVVNKLHKYSL--VEKQP-----KESTISI---PSI 431
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 32/135 (23%), Positives = 52/135 (38%), Gaps = 36/135 (26%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS-- 323
++Y+H I H +LKP+N L++ + V DFG+AR + + N + I
Sbjct: 167 VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 324 -----------------TGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRP 359
TG++ PE L E T DV+S G + E+ I+
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 360 SDG-------IFTGK 367
+ +F G
Sbjct: 284 NVAYHADRGPLFPGS 298
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 42/234 (17%), Positives = 83/234 (35%), Gaps = 41/234 (17%)
Query: 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTA 209
IG G FG +Y + ++ +++ P + +E K ++ +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 210 FSGVDYQG---------ARFKAVVYKFM------PNGSLEEWLRGKDDTNWRPLNFNFLI 254
+ Y G Y+FM L++ F
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQKIYEANAKR--------FSR 151
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD--DEMIGHVGDFGMA-RFLPAI 311
K L +++ + L Y+H H ++K SN+LL+ + ++ D+G+A R+ P
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP-- 206
Query: 312 DKQNRFI------CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ ++ C G+ + + G S GD+ G +++ TG P
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 36/162 (22%), Positives = 68/162 (41%), Gaps = 28/162 (17%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAA-INIKHRNIVRVFTAF 210
IG GNFG + G L+ +A+K+ + E + I +V+ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVY--Y 72
Query: 211 SGVDYQGARFKAVVYKFMPNG-SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
G ++ A+V + + G SLE+ + + F +K L IAI + +
Sbjct: 73 FGPC---GKYNAMVLELL--GPSLEDL--------FDLCDRTFSLKTVLMIAIQLISRME 119
Query: 270 YLHCDCQPPIAHCNLKPSNVLL-----DDEMIGHVGDFGMAR 306
Y+H + + ++KP N L+ + + H+ DF +A+
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 3e-04
Identities = 40/255 (15%), Positives = 67/255 (26%), Gaps = 49/255 (19%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP----GGSKSFKSE 191
F T IG G FG V+ D T +A+K+ + P G + E
Sbjct: 12 PFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 192 CKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK-------DDT 243
I I K +++ + G V P L+ W D
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 244 NWRPLNFNFLI--------------------KKKLDIAIDVACALRYLHCDCQPPIAHCN 283
++ + F++ I + +L + H +
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRD 187
Query: 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGD- 342
L NVLL + + + I G D
Sbjct: 188 LHWGNVLLKKTSLKKLHYTL----------NGKSSTIPSC-GLQVSIIDYTLSRLERDGI 236
Query: 343 -VYSFGILLLEMFTG 356
V+ + ++FTG
Sbjct: 237 VVFCDVSMDEDLFTG 251
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 28/146 (19%), Positives = 45/146 (30%), Gaps = 56/146 (38%)
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLL--DDEMIGH------------------- 298
I V L YLH C+ I H ++KP N+LL +++ I
Sbjct: 151 IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 299 ----------------------------VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
+ D G A ++ K + Y E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV---HKHFTEDI--QTRQYRSLE 263
Query: 331 YDLGCEASTYGDVYSFGILLLEMFTG 356
+G +T D++S + E+ TG
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATG 289
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 45/254 (17%), Positives = 81/254 (31%), Gaps = 76/254 (29%)
Query: 124 PVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP 182
P + I + D Y ++ ++G G G V A+K+
Sbjct: 2 PHVKSGLQIKKNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---- 52
Query: 183 GGSKSFKSECKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL 237
+ E + + + +IVR+ + + + M E L
Sbjct: 53 -DCPKARRE----VELHWRASQCPHIVRIVDVYE----NLYAGRKCLLIVM------ECL 97
Query: 238 RGKDDTNWRPLNFNFLIKKKL---------DIAIDVACALRYLHCDCQPPIAHCNLKPSN 288
G + L F+ + + +I + A++YLH IAH ++KP N
Sbjct: 98 DGGE------L-FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 147
Query: 289 VLL---DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYS 345
+L I + DFG A + YD C D++S
Sbjct: 148 LLYTSKRPNAILKLTDFGFA---KETTGEK---------------YDKSC------DMWS 183
Query: 346 FGILLLEMFTGIRP 359
G+++ + G P
Sbjct: 184 LGVIMYILLCGYPP 197
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 367 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.24 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.16 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.12 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.1 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.07 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 98.91 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 98.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.8 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 98.71 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 98.7 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 98.69 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 98.69 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 98.68 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.66 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 98.66 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 98.65 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 98.63 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 98.62 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.61 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 98.58 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 98.58 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 98.58 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 98.57 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 98.56 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 98.55 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 98.53 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 98.51 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 98.51 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 98.51 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.49 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 98.49 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 98.46 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 98.45 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 98.43 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 98.43 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 98.42 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 98.42 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 98.42 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 98.41 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 98.41 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 98.41 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 98.4 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 98.4 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 98.4 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 98.4 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 98.4 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 98.39 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 98.39 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 98.39 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 98.39 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 98.38 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 98.38 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 98.37 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 98.37 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 98.36 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 98.35 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 98.35 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 98.35 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 98.34 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 98.34 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 98.34 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 98.34 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 98.34 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 98.34 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 98.34 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 98.34 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 98.34 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 98.33 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 98.33 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 98.33 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 98.33 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 98.33 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 98.33 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 98.32 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 98.32 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 98.32 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 98.32 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 98.32 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 98.31 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 98.31 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.31 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 98.3 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 98.3 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 98.29 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 98.29 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 98.28 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 98.27 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 98.27 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 98.26 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 98.25 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 98.25 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 98.24 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 98.24 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 98.22 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 98.22 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 98.22 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 98.21 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 98.2 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 98.2 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 98.2 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 98.2 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.19 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 98.19 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 98.18 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 98.18 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 98.16 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 98.15 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 98.14 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 98.13 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 98.13 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 98.13 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 98.11 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 98.11 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 98.11 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 98.11 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 98.11 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 98.1 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 98.1 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 98.1 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 98.09 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 98.09 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 98.09 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 98.08 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 98.08 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.08 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 98.07 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 98.07 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 98.07 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 98.06 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 98.06 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 98.06 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 98.05 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 98.05 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 98.05 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 98.05 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 98.05 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 98.04 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 98.04 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 98.04 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 98.03 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 98.03 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 98.02 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 98.01 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 98.01 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 98.01 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 98.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 98.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 97.99 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 97.99 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 97.98 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 97.98 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 97.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 97.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 97.96 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 97.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 97.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 97.96 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 97.96 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 97.96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 97.96 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 97.95 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 97.95 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 97.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 97.94 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 97.94 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 97.93 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 97.93 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 97.92 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 97.92 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 97.92 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 97.91 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 97.91 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 97.9 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 97.9 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 97.88 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 97.88 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 97.88 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 97.88 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 97.88 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 97.87 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 97.87 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 97.86 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 97.86 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 97.85 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 97.85 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 97.85 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 97.85 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 97.84 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 97.84 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 97.84 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 97.84 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 97.83 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 97.83 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 97.83 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 97.82 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 97.82 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 97.81 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 97.81 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 97.8 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 97.8 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 97.8 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 97.79 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 97.79 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 97.78 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 97.78 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 97.76 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 97.76 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 97.76 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 97.76 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 97.76 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 97.75 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 97.75 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 97.74 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 97.74 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 97.74 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 97.73 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 97.73 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 97.7 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.69 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 97.69 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 97.68 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.66 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 97.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 97.65 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 97.65 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 97.64 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 97.64 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 97.64 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 97.61 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 97.6 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 97.57 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 97.55 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 97.5 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 97.5 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-56 Score=391.32 Aligned_cols=203 Identities=24% Similarity=0.396 Sum_probs=180.5
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||+||+|+ ..+++.||+|+++.. +....+.+.+|+++|++++|||||+++++| .+...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 469999999999999999999 567999999999732 334567899999999999999999999998 34567
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.|+|||||+||+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~---------~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~ 174 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQIT 174 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEE
Confidence 899999999999999998654 5789999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+|+.+............+||+.|||||++.+..++.++|||||||++|||+||+.||.+-.
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 175 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp CCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998755444444455679999999999999999999999999999999999999998643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=390.10 Aligned_cols=200 Identities=22% Similarity=0.297 Sum_probs=177.9
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
..|++.+.||+|+||.||+|+ ..+|+.||||+++..+....+.+.+|+.+|++++|||||+++++|. .....||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 468888999999999999999 4579999999998766667788999999999999999999999984 3456899
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
|||||++|+|.+++... .+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||
T Consensus 149 vmEy~~gg~L~~~l~~~----------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFG 215 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG 215 (346)
T ss_dssp EECCCTTEEHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEeCCCCCcHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCc
Confidence 99999999999999753 3778999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|+.+..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..
T Consensus 216 la~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 216 FCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp TCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 9987644322 2234569999999999999999999999999999999999999998743
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-55 Score=392.46 Aligned_cols=203 Identities=24% Similarity=0.336 Sum_probs=170.3
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|++++.||+|+||.||+|+ ..+++.||||+++.... ...+.+.+|+.+|++++|||||+++++|. +....
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEE
Confidence 689999999999999999999 56799999999975432 24567899999999999999999999984 34568
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
|+|||||+||+|.++|...... .+++.+++.++.||+.||.||| +++||||||||+|||++.++.+||+|
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~-------~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~D 168 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGV-------LFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGD 168 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECS
T ss_pred EEEEeCCCCCcHHHHHHHcCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcc
Confidence 9999999999999999754321 4678889999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|+.+.... .......||+.|||||++.+..++.++|||||||++|||+||+.||.+..
T Consensus 169 FGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 169 FGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp TTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 99998764321 12234569999999999999999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=383.10 Aligned_cols=206 Identities=28% Similarity=0.429 Sum_probs=169.5
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
|+...+++.+.+.||+|+||.||+|++. ..||||+++.... ...+.|.+|+.++++++|||||++++++..
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----- 103 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----- 103 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-----
Confidence 4455678888999999999999999853 3699999874332 245679999999999999999999998732
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
...++|||||++|+|.++|..... .+++.+++.|+.||+.||+||| +++||||||||+|||+++++.+
T Consensus 104 -~~~~iVmEy~~gGsL~~~l~~~~~--------~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~ 171 (307)
T 3omv_A 104 -DNLAIVTQWCEGSSLYKHLHVQET--------KFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTV 171 (307)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEE
T ss_pred -CeEEEEEEcCCCCCHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcE
Confidence 236899999999999999976542 4778999999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||+|+...............||+.|||||++.+ ..++.++|||||||++|||+||+.||.+..
T Consensus 172 Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 172 KIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp EECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred EEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999987654333333445679999999999864 458999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-55 Score=385.69 Aligned_cols=212 Identities=25% Similarity=0.401 Sum_probs=175.4
Q ss_pred CCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
++|.+.+.||+|+||.||+|+.. ++..||||+++.......+.|.+|+++|++++|||||+++++|. ..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eC
Confidence 46778899999999999999843 46789999998665556778999999999999999999999984 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCC----CCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDT----NWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
...++|||||++|+|.++|+..... ........+++.+++.|+.||+.||.||| +++||||||||+|||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCC
Confidence 5679999999999999999754210 00011125789999999999999999999 8899999999999999999
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999987654333222223458999999999999999999999999999999999 999998864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=392.09 Aligned_cols=200 Identities=22% Similarity=0.297 Sum_probs=178.5
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
+.|++.+.||+|+||.||+|+ ..+|+.||||++........+.+.+|+.+|++++|||||+++++|. .....||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCEEEE
Confidence 569999999999999999999 5579999999998777677788999999999999999999999984 3456899
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
|||||+||+|.+++... .+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||
T Consensus 226 VmEy~~gG~L~~~i~~~----------~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFG 292 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG 292 (423)
T ss_dssp EEECCTTEEHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCT
T ss_pred EEeCCCCCcHHHHHhcc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCc
Confidence 99999999999999754 3778999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|+.+..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..
T Consensus 293 la~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 293 FCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp TCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 9987644322 2234569999999999999999999999999999999999999997643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-54 Score=384.53 Aligned_cols=212 Identities=26% Similarity=0.386 Sum_probs=170.0
Q ss_pred CCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
++|.+.++||+|+||.||+|++. +++.||||+++.......+.|.+|+++|++++|||||+++++|. ..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----EG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 45677789999999999999853 47889999998665556788999999999999999999999984 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCC------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNW------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~ 292 (367)
...++|||||++|+|.++++....... ......+++.+++.|+.||+.||.||| +++||||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEEC
Confidence 567999999999999999986542110 111225789999999999999999999 88999999999999999
Q ss_pred CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 999999999999987654433333344568999999999999999999999999999999999 999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=372.39 Aligned_cols=199 Identities=25% Similarity=0.376 Sum_probs=169.0
Q ss_pred CCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 148 SSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 148 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
++.++||+|+||.||+|. ..++..||+|++.... ....+.|.+|+.++++++|||||+++++|.... ......++|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEE
Confidence 455679999999999999 4568999999997433 234567999999999999999999999985432 335667999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCCceeec-CCCceEEec
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLD-DEMIGHVGD 301 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~--iiH~dlkp~Nil~~-~~~~~kl~D 301 (367)
||||++|+|.+++.... .+++..+..++.||+.||+||| +++ ||||||||+|||++ .++.+||+|
T Consensus 108 mEy~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~D 175 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred EeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEe
Confidence 99999999999998654 5778999999999999999999 777 99999999999997 479999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|+.... .......||+.|||||++.+ .++.++|||||||++|||+||+.||.+..
T Consensus 176 FGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 176 LGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp TTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred CcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999985432 22334579999999999875 69999999999999999999999997643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=379.80 Aligned_cols=211 Identities=22% Similarity=0.365 Sum_probs=175.3
Q ss_pred CCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 146 GFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
++++.++||+|+||.||+|++. +++.||||+++... ....+.|.+|+.++++++|||||+++|+|. ..
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~~ 101 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-----KD 101 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----EC
Confidence 4566788999999999999852 46789999997433 334578999999999999999999999984 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCC-------CCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTN-------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~ 291 (367)
...++|||||++|+|.++|....... .......+++.+++.|+.||+.||.||| +++||||||||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEE
Confidence 45799999999999999997643211 0112235788999999999999999999 8899999999999999
Q ss_pred cCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++++.+||+|||+|+.....+.........||+.|||||++.+..++.++|||||||++|||+| |..||.+..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999987654433333334568999999999999999999999999999999998 899998865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=381.31 Aligned_cols=200 Identities=24% Similarity=0.287 Sum_probs=170.0
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.+.|.+.++||+|+||.||+|+ ..+|+.||||+++.... ..+|+.++++++|||||+++++|. +....|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVR-----EGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 3457778899999999999999 56799999999974322 257999999999999999999984 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-ceEEec
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IGHVGD 301 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~-~~kl~D 301 (367)
||||||+||+|.++|+... .+++.+++.++.||+.||+||| +++||||||||+|||++.++ .+||+|
T Consensus 127 ivmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~D 194 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMG---------CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCD 194 (336)
T ss_dssp EEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECC
T ss_pred EEEeccCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEee
Confidence 9999999999999998654 5789999999999999999999 89999999999999999887 699999
Q ss_pred cccccccCCCCCcc---eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQN---RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 302 fg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
||+|+.+....... .....+||+.|||||++.+..++.++|||||||++|||+||+.||.+...
T Consensus 195 FGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp CTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred CCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 99998765432221 12235699999999999999999999999999999999999999987654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=368.74 Aligned_cols=198 Identities=22% Similarity=0.361 Sum_probs=161.0
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|+ ..+++.||+|+++... ......+.+|+.++++++|||||++++++ .+...
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence 689999999999999999999 5679999999997432 33456799999999999999999999997 34566
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.|+||||+ +|+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~ 154 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRD---------KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIA 154 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSC---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEEC
T ss_pred EEEEEeCC-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEe
Confidence 89999999 689999998655 5789999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||+|+...... ......||+.|||||++.+..+ +.++||||+||++|+|+||+.||.+.
T Consensus 155 DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 155 DFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp CSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 999998654322 2234569999999999998876 57999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-54 Score=380.20 Aligned_cols=201 Identities=27% Similarity=0.343 Sum_probs=167.5
Q ss_pred CCCCCCCcccccCceEEEEEEe----cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++++++|||||+++++|. +.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----TE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----ET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----EC
Confidence 5799999999999999999984 247899999986422 223457889999999999999999999984 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...|+|||||+||+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+|
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vK 166 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIK 166 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEE
Confidence 56899999999999999998654 5788999999999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||+||+.||.+..
T Consensus 167 l~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 167 LTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp EESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 999999986543222 2234569999999999999999999999999999999999999998753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=376.87 Aligned_cols=222 Identities=24% Similarity=0.332 Sum_probs=182.9
Q ss_pred ChHHHHhhcCCCCCCCcccccCceEEEEEEecC------CCEEEEEEeecCCC-cchhHHHHHHHHHHhCCC-CCcceee
Q 017712 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKH-RNIVRVF 207 (367)
Q Consensus 136 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~~~ 207 (367)
...+|+...++|++.+.||+|+||.||+|.... ++.||||.++.... ...+.|.+|+.+|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 345677788899999999999999999998432 36799999875433 235679999999999975 9999999
Q ss_pred eeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCC-------CCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeE
Q 017712 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN-------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIA 280 (367)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~ii 280 (367)
++|. ......++|||||++|+|.++|+...... .......+++.+++.++.||+.||.||| +++||
T Consensus 135 g~~~----~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~ii 207 (353)
T 4ase_A 135 GACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCI 207 (353)
T ss_dssp EEEC----CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred EEEE----ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCee
Confidence 9984 33445799999999999999997543110 0011124788999999999999999999 88999
Q ss_pred ecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 017712 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359 (367)
Q Consensus 281 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~P 359 (367)
||||||+|||+++++.+||+|||+|+.+.............||+.|||||++.+..++.++|||||||++|||+| |+.|
T Consensus 208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence 999999999999999999999999997755443333344568999999999999999999999999999999998 9999
Q ss_pred CCCCC
Q 017712 360 SDGIF 364 (367)
Q Consensus 360 f~~~~ 364 (367)
|.+..
T Consensus 288 f~~~~ 292 (353)
T 4ase_A 288 YPGVK 292 (353)
T ss_dssp STTCC
T ss_pred CCCCC
Confidence 98864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=363.59 Aligned_cols=205 Identities=25% Similarity=0.436 Sum_probs=161.0
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeeccccc-------C
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-------Q 216 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------~ 216 (367)
+|++.+.||+|+||.||+|+ ..+++.||||+++.... ...+.+.+|+.+|++++|||||+++++|...+. .
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 58888999999999999999 55799999999975433 245678999999999999999999999865331 1
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
...+.|++||||++|+|.+++....... ......++.++.||+.||+||| +++|+||||||+|||++.++.
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~ 156 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIE------ERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDV 156 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGG------GSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCC------hhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCc
Confidence 2345799999999999999998754211 2334567889999999999999 889999999999999999999
Q ss_pred eEEeccccccccCCCCCcc----------eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQN----------RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+||+|||+|+.+....... ......||+.|||||++.+..++.++|||||||++|||++ ||.+
T Consensus 157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 9999999998765432211 1223469999999999999999999999999999999996 7754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=361.51 Aligned_cols=202 Identities=24% Similarity=0.353 Sum_probs=159.8
Q ss_pred CCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHH--HHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 146 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFK--SECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
+|.+.+.||+|+||.||+|+. +|+.||||+++.. ....+. .|+..+.+++|||||+++++|...+ ......+|
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l 78 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence 466778999999999999985 6899999998642 233344 4555567889999999999986432 22346799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCC-----CCCeEecCCCCCceeecCCCceE
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC-----QPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~-----~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
|||||++|+|.++++.. .++++.++.++.|++.||+|||+.+ ..+||||||||+|||++.++.+|
T Consensus 79 V~Ey~~~gsL~~~l~~~----------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K 148 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp EEECCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred EecCCCCCcHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence 99999999999999764 3678899999999999999999321 23999999999999999999999
Q ss_pred EeccccccccCCCCCc--ceeeeccCCCcccCCccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGC------EASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+|||+|+........ .......||+.|||||++.+. .++.++|||||||++|||+||..||..
T Consensus 149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 9999999876443222 122234699999999998764 367889999999999999999876643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=366.34 Aligned_cols=207 Identities=24% Similarity=0.325 Sum_probs=174.2
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccc-cCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVD-YQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 219 (367)
.++|++.+.||+|+||.||+|+ ..+|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.... +....
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4679999999999999999999 56799999999964332 23467889999999999999999999875432 23456
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..|+|||||+ |+|.+++.... .+++..+..++.||+.||.||| +++||||||||+|||++.++.+||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---------~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---------PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEE
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEE
Confidence 7899999995 68999998755 5788999999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCC--cceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDK--QNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+|+.+..... ........||+.|||||++.+. .++.++||||+||++|||++|++||.|-
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 99999987643221 2223445799999999998875 4689999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=374.58 Aligned_cols=198 Identities=25% Similarity=0.322 Sum_probs=169.0
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHH---HHHHHhCCCCCcceeeeeecccccCC
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSE---CKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
++|++.++||+|+||.||+|+ ..+|+.||+|+++... ........+| +.+++.++|||||+++++| .+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~~ 263 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HT 263 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----EC
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----EE
Confidence 579999999999999999999 5579999999996321 2223333444 5666778999999999998 44
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....|+||||++||+|.++|.... .|++..+..++.||+.||+||| +++||||||||+|||++.+|.+
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~---------~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~v 331 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHV 331 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCE
Confidence 567899999999999999998655 5789999999999999999999 9999999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|||+|+.+.... ....+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+-
T Consensus 332 KL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 332 RISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp EECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred EecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998764322 234569999999999974 57999999999999999999999999763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=352.38 Aligned_cols=199 Identities=23% Similarity=0.319 Sum_probs=166.4
Q ss_pred hcCCCCCCCcccccCceEEEEEEe----cCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCC
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 217 (367)
..++|++.+.||+|+||.||+|+. .+++.||+|.+... .....+.+|++++..+ +||||++++++|. .
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~ 91 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----K 91 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----E
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----E
Confidence 456899999999999999999973 24678999988643 3456788999999998 6999999999984 3
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC-Cc
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-MI 296 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~-~~ 296 (367)
....++||||+++|+|.++++ .+++.++..++.|++.||+||| ++||+||||||+|||++.+ +.
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~------------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~ 156 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN------------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKK 156 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT------------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTE
T ss_pred CCEEEEEEeCCCcccHHHHHc------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCe
Confidence 456899999999999999984 3668889999999999999999 8999999999999999876 79
Q ss_pred eEEeccccccccCCCCC--------------------------cceeeeccCCCcccCCccccCC-CCCcchhHHHHHHH
Q 017712 297 GHVGDFGMARFLPAIDK--------------------------QNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGIL 349 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~ 349 (367)
+||+|||+|+....... ........||+.|+|||++.+. .++.++||||+||+
T Consensus 157 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~i 236 (361)
T 4f9c_A 157 YALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVI 236 (361)
T ss_dssp EEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred EEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHH
Confidence 99999999986543211 0112234699999999999876 48999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 017712 350 LLEMFTGIRPSDGI 363 (367)
Q Consensus 350 l~el~tg~~Pf~~~ 363 (367)
+|||+||+.||.+-
T Consensus 237 l~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 237 FLSLLSGRYPFYKA 250 (361)
T ss_dssp HHHHHHTCSSSSCC
T ss_pred HHHHHHCCCCCCCC
Confidence 99999999999543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=369.81 Aligned_cols=201 Identities=22% Similarity=0.381 Sum_probs=177.6
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
++|++.+.||+|+||.||+|+ ..+|+.||+|++........+.+.+|+.+|+.++|||||+++++| ......++
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence 579999999999999999999 567999999999765555667889999999999999999999998 34567899
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC--CceEEec
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE--MIGHVGD 301 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~--~~~kl~D 301 (367)
|||||+||+|.++|..... .+++.++..++.||+.||.||| +++|+||||||+|||++.+ +.+||+|
T Consensus 232 v~E~~~gg~L~~~i~~~~~--------~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~D 300 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLID 300 (573)
T ss_dssp EEECCCCCBHHHHHTCTTS--------CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred EEeecCCCcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEee
Confidence 9999999999999965432 5889999999999999999999 8999999999999999754 8999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|+.+... .......||+.|||||++.+..++.++|||||||++|||++|..||.+..
T Consensus 301 FG~a~~~~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~ 360 (573)
T 3uto_A 301 FGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360 (573)
T ss_dssp CSSCEECCTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ccceeEccCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 9999977443 23344569999999999999999999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=318.41 Aligned_cols=200 Identities=22% Similarity=0.316 Sum_probs=176.4
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.++|++.+.||+|+||.||+|. ..+++.||+|++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEE
Confidence 3579999999999999999998 56799999999986666677889999999999999999999999743 34579
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||+++|+|.+++... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 94 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Df 160 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 160 (297)
T ss_dssp EEEECCTTCBHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEECCCCCCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeC
Confidence 999999999999999754 2667889999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++........ ......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.
T Consensus 161 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 161 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp TTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99986644322 223346899999999999999999999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=324.46 Aligned_cols=201 Identities=21% Similarity=0.278 Sum_probs=174.0
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|+++.. .......+.+|+.++..++||||+++++++. ...
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCC
Confidence 35788999999999999999994 56999999999742 2345677899999999999999999999973 445
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL 146 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKI 146 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEE
Confidence 6899999999999999997644 4678899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 147 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 147 TDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence 99999985432221 223345899999999999999999999999999999999999999764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=321.14 Aligned_cols=213 Identities=32% Similarity=0.543 Sum_probs=182.5
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
++...+++|++.+.||+|+||.||+|+..+++.||+|++........+.+.+|+.+++.++||||+++++++. ..
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 107 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----ER 107 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----CT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CC
Confidence 4455678999999999999999999997789999999987666666788999999999999999999999973 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++|+|.+++...... ...+++..++.++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~k 179 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLP-----TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPK 179 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCC-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCC-----ccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEE
Confidence 5679999999999999999765321 114778899999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||.+..
T Consensus 180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 999999986543332222333458999999999988889999999999999999999999997643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=335.16 Aligned_cols=210 Identities=23% Similarity=0.273 Sum_probs=176.9
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeeccc
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGV 213 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (367)
.++....++|++.++||+|+||.||+|+. .+++.||+|+++.. .......+.+|..++..++||||++++++|.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-- 144 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ-- 144 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE--
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--
Confidence 44455667899999999999999999995 45889999998632 2233455899999999999999999999983
Q ss_pred ccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
.....++||||+++|+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+|||++.
T Consensus 145 ---~~~~~~lV~Ey~~gg~L~~~l~~~~~--------~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~ 210 (437)
T 4aw2_A 145 ---DDNNLYLVMDYYVGGDLLTLLSKFED--------RLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDM 210 (437)
T ss_dssp ---CSSEEEEEECCCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECT
T ss_pred ---eCCEEEEEEecCCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcC
Confidence 45568999999999999999986432 4778999999999999999999 899999999999999999
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++.+||+|||+|+....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||.+..
T Consensus 211 ~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 211 NGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp TSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999986643222 1222346999999999987 4568999999999999999999999997643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=324.33 Aligned_cols=203 Identities=25% Similarity=0.405 Sum_probs=175.2
Q ss_pred hhcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
...++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. ..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~ 86 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TE 86 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence 3457899999999999999999994 679999999997432 234567889999999999999999999973 44
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~k 154 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHG---------RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIK 154 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred CEEEEEEECCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEE
Confidence 56799999999999999997654 4678899999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEAS-TYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+|||+++....... .....||+.|+|||++.+..++ .++|||||||++|+|++|..||++..
T Consensus 155 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 155 IADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp ECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 999999986543322 2334689999999999888765 78999999999999999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=332.81 Aligned_cols=206 Identities=26% Similarity=0.318 Sum_probs=175.1
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeec---CCCcchhHHHHHHHHHHhCCCCCcceeeeeecccc
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (367)
++....++|++.+.||+|+||.||+|+. .+++.||+|+++. ........+.+|+.++..++||||++++++|.
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--- 139 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ--- 139 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE---
Confidence 4445567899999999999999999994 4689999999863 12334556889999999999999999999983
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
.....++||||+++|+|.+++... .+++..+..++.||+.||.||| +++|+||||||+|||++.+
T Consensus 140 --~~~~~~lV~E~~~gg~L~~~l~~~----------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~ 204 (410)
T 3v8s_A 140 --DDRYLYMVMEYMPGGDLVNLMSNY----------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS 204 (410)
T ss_dssp --CSSEEEEEECCCTTEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred --ECCEEEEEEeCCCCCcHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCC
Confidence 456689999999999999999753 3668889999999999999999 8899999999999999999
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE----ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+.+||+|||+|+....... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.
T Consensus 205 g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 205 GHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp SCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 9999999999986643221 1223456999999999988765 788999999999999999999999764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=326.99 Aligned_cols=203 Identities=26% Similarity=0.306 Sum_probs=170.5
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCC
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 217 (367)
..++|++.+.||+|+||.||+|+ ..+++.||+|+++.. .......+.+|..++..+ +||||+++++++ ..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence 34689999999999999999999 456899999998742 223456788999999988 799999999997 34
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~i 163 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSR---------RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHC 163 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCE
Confidence 456899999999999999997654 4778999999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 164 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 164 KLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp EECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 999999998543222 22334569999999999998889999999999999999999999997643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=328.36 Aligned_cols=201 Identities=23% Similarity=0.285 Sum_probs=171.6
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|++.++||+|+||.||+|+ ..+++.||+|+++.. .......+.+|..++.++ +||||++++++| ...
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EEC
Confidence 3578899999999999999999 456889999999743 233456688999999887 899999999997 345
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ik 193 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIK 193 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEEcCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEE
Confidence 57899999999999999997654 4778999999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 194 L~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 194 LTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp ECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred EeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 99999998532222 2233456999999999999999999999999999999999999999653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=321.44 Aligned_cols=201 Identities=21% Similarity=0.320 Sum_probs=174.4
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc------chhHHHHHHHHHHhCCCCCcceeeeeeccccc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (367)
..+.|.+.+.||+|+||.||+|+ ..+++.||+|+++..... ..+.+.+|+.++.+++||||++++++|.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~---- 85 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE---- 85 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE----
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE----
Confidence 34578999999999999999999 456899999999753322 3467899999999999999999999973
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
.....++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++
T Consensus 86 -~~~~~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~ 152 (361)
T 2yab_A 86 -NRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKN 152 (361)
T ss_dssp -CSSEEEEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTT
T ss_pred -eCCEEEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCC
Confidence 4456799999999999999997654 5788999999999999999999 88999999999999998776
Q ss_pred ----ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 296 ----IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 296 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 153 ~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 153 IPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp SSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 79999999998764432 223345999999999999989999999999999999999999999764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=317.70 Aligned_cols=198 Identities=29% Similarity=0.403 Sum_probs=173.5
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|+++.. .....+.+.+|+.++..++||||+++++++. ...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence 35788899999999999999994 57999999998742 2334567889999999999999999999973 445
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL 147 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKI 147 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEE
Confidence 6899999999999999998654 4678889999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 148 ~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 148 TDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp CCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 999999865332 22346899999999999999999999999999999999999999764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=321.58 Aligned_cols=203 Identities=25% Similarity=0.353 Sum_probs=173.8
Q ss_pred hhcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccC
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 216 (367)
...++|.+.+.||+|+||.||+|+. .+++.||+|+++.. .......+.+|..++..+ +||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~----- 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ----- 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----
Confidence 3457899999999999999999994 56899999999742 233556788999999876 9999999999973
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
.....++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~ 156 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGH 156 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCC
Confidence 4456899999999999999997644 4678899999999999999999 889999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 157 vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 157 IKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp EEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 99999999985432221 223456999999999999999999999999999999999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=330.12 Aligned_cols=208 Identities=24% Similarity=0.323 Sum_probs=175.2
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccc
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (367)
+.....++|++.+.||+|+||.||+|+. .+++.||+|+++.. .......+.+|..++..++||||++++++|
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~---- 130 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF---- 130 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE----
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE----
Confidence 3444567899999999999999999994 57999999998642 122345688999999999999999999997
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
......++||||+++|+|.+++..... .+++..+..++.||+.||.||| +++|+||||||+|||++.+
T Consensus 131 -~~~~~~~lVmE~~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~ 198 (412)
T 2vd5_A 131 -QDENYLYLVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRC 198 (412)
T ss_dssp -ECSSEEEEEECCCCSCBHHHHHHHHSS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred -eeCCEEEEEEcCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCC
Confidence 345678999999999999999975321 4678889999999999999999 8899999999999999999
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCcccc-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-------GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+.+||+|||+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||.+.
T Consensus 199 g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 199 GHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp SCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 9999999999987643222 1222346999999999987 356899999999999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=322.31 Aligned_cols=200 Identities=25% Similarity=0.339 Sum_probs=173.1
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|. ..+++.||+|++... .......+.+|+.++..++||||++++++|. ...
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 3578899999999999999999 456899999998632 2345577889999999999999999999973 445
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL 156 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV---------HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHI 156 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEE
Confidence 6799999999999999998754 4778899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.
T Consensus 157 ~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 157 TDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred eccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 9999998764322 2234569999999999874 45899999999999999999999999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=312.49 Aligned_cols=203 Identities=22% Similarity=0.405 Sum_probs=170.1
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc---chhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|+ ..+++.||+|.+...... ..+.+.+|+.++.+++||||+++++++ ....
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence 4679999999999999999998 457899999998643322 346788999999999999999999997 3455
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++++|.+++.... .+++..++.++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl 152 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHG---------PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKI 152 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEEeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 6799999999999999997654 4678899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+..
T Consensus 153 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 153 FDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp CCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred EeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999986643221 12223458999999999999999999999999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=318.35 Aligned_cols=204 Identities=22% Similarity=0.339 Sum_probs=172.5
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++. .....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence 46899999999999999999984 4789999999874332 23467899999999999999999999973 44567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~D 148 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISD 148 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEEcCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEE
Confidence 99999999999999997654 4778899999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+++.+.............||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..
T Consensus 149 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp CTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred eeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 999986643333333334568999999999988765 778999999999999999999997654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=320.96 Aligned_cols=202 Identities=24% Similarity=0.269 Sum_probs=173.6
Q ss_pred hcCCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecC---CCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCC
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 217 (367)
..++|++.+.||+|+||.||+|+.. +++.||+|+++.. .......+.+|..++..+ +||||+++++++ ..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 3468999999999999999999954 5889999999742 234556788999999987 799999999997 34
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....++||||+++|+|.+++.... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~v 160 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHI 160 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcE
Confidence 457899999999999999997644 4778899999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 161 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 161 KIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp EECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 999999998543222 1223456999999999999999999999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=319.78 Aligned_cols=199 Identities=24% Similarity=0.286 Sum_probs=171.6
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC---cchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCce
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 219 (367)
++|++.+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|..++.++ +||||++++++|. ...
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~~ 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TES 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----eCC
Confidence 5688899999999999999994 5689999999974332 2345678999999987 8999999999973 445
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL 151 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKL 151 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEE
Confidence 6899999999999999997644 4778899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 152 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 152 TDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 9999998543222 122345699999999999999999999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=313.34 Aligned_cols=205 Identities=22% Similarity=0.389 Sum_probs=174.7
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++.+++||||+++++++. .....+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeE
Confidence 45788899999999999999994 568999999987655556778999999999999999999999984 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||+++++|.+++..... .+++.+++.++.|++.||.||| +++|+||||||+||+++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df 152 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADF 152 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCT--------TSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCC
T ss_pred EEEEecCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeec
Confidence 99999999999999986432 4778899999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcc------------eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQN------------RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+++......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp TTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred ccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 9998764332211 1113468999999999999999999999999999999999999997643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=320.10 Aligned_cols=209 Identities=16% Similarity=0.148 Sum_probs=174.2
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEE------ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC---CCCcceeeee
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGT------LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK---HRNIVRVFTA 209 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~ 209 (367)
++....++|.+.+.||+|+||.||+|. ..+++.||+|+++. .....+.+|+.++.+++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS---CCHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC---CChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 344456789999999999999999993 55689999999863 34567888999998887 9999999999
Q ss_pred ecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 017712 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNV 289 (367)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Ni 289 (367)
+. .....++||||+++|+|.+++....... ...+++..++.++.||+.||+||| +++|+||||||+||
T Consensus 136 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NI 203 (365)
T 3e7e_A 136 HL-----FQNGSVLVGELYSYGTLLNAINLYKNTP----EKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNF 203 (365)
T ss_dssp EE-----CSSCEEEEECCCCSCBHHHHHHHHHTST----TCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGE
T ss_pred ee-----cCCCcEEEEeccCCCcHHHHHHHhhccc----ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHE
Confidence 74 3345699999999999999997421100 014778999999999999999999 89999999999999
Q ss_pred eecC-----------CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 017712 290 LLDD-----------EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIR 358 (367)
Q Consensus 290 l~~~-----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~ 358 (367)
|++. ++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus 204 ll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 283 (365)
T 3e7e_A 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283 (365)
T ss_dssp EECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred EecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 9988 89999999999976543333444455679999999999999999999999999999999999999
Q ss_pred CCCC
Q 017712 359 PSDG 362 (367)
Q Consensus 359 Pf~~ 362 (367)
||..
T Consensus 284 pf~~ 287 (365)
T 3e7e_A 284 MKVK 287 (365)
T ss_dssp CCEE
T ss_pred cccc
Confidence 9854
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=314.02 Aligned_cols=201 Identities=22% Similarity=0.312 Sum_probs=173.7
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.++|++.+.||+|+||.||+|. ..+++.+|+|.+... ......+.+|+.++..++||||+++++++. .....+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEE
Confidence 4688999999999999999999 446889999998642 334567889999999999999999999984 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC--CCceEEe
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD--EMIGHVG 300 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~--~~~~kl~ 300 (367)
+||||+++|+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+|||++. ++.+||+
T Consensus 78 lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~ 146 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKII 146 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred EEEEeCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEE
Confidence 99999999999999976432 4778999999999999999999 889999999999999987 7899999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 147 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 147 EFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp CCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 999998764322 2334558999999999999888999999999999999999999997653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=311.82 Aligned_cols=197 Identities=22% Similarity=0.300 Sum_probs=172.1
Q ss_pred CCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 147 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
|...+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~ 121 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELWVLM 121 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEEEE
Confidence 455568999999999999954 799999999987666677889999999999999999999999743 34679999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 122 e~~~~~~L~~~l~~~----------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~ 188 (321)
T 2c30_A 122 EFLQGGALTDIVSQV----------RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188 (321)
T ss_dssp CCCCSCBHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ecCCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeee
Confidence 999999999998753 3678899999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 189 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 189 AQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp EECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred eecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 866443221 22346899999999999999999999999999999999999999764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=314.69 Aligned_cols=219 Identities=36% Similarity=0.611 Sum_probs=183.3
Q ss_pred CCCCChHHHHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeee
Q 017712 132 INNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAF 210 (367)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 210 (367)
....++.++....++|++.+.||+|+||.||+|+..+++.||+|++..... .....+.+|+.++..++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 344577899999999999999999999999999977899999999874432 2344789999999999999999999998
Q ss_pred cccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCcee
Q 017712 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (367)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil 290 (367)
. .....++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+.+..+|+||||||+|||
T Consensus 97 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil 166 (326)
T 3uim_A 97 M-----TPTERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166 (326)
T ss_dssp C-----CSSCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEE
T ss_pred e-----cCCceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEE
Confidence 4 344568999999999999999875421 114778899999999999999999322229999999999999
Q ss_pred ecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 167 LDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 99999999999999987643322 22333458999999999988889999999999999999999999995
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=319.10 Aligned_cols=197 Identities=22% Similarity=0.297 Sum_probs=173.0
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|+.++..++||||+++++++. ....
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 115 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCCE
Confidence 5788999999999999999994 57899999998632 2335577889999999999999999999973 4456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~ 183 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVT 183 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEc
Confidence 899999999999999997644 4678899999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 184 DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 184 DFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 99999865432 12345899999999999999999999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=311.18 Aligned_cols=200 Identities=22% Similarity=0.349 Sum_probs=173.0
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCc------chhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
++|.+.+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|+.++++++||||+++++++. .
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~ 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 4588889999999999999994 56899999999743322 3567999999999999999999999973 3
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC--
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-- 295 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~-- 295 (367)
....++||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~ 153 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVP 153 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSS---------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSS
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCC
Confidence 456799999999999999997654 4778999999999999999999 88999999999999998877
Q ss_pred --ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 296 --IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 296 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 154 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 154 KPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp SCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 799999999987643222 223458999999999998899999999999999999999999997643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=311.16 Aligned_cols=206 Identities=28% Similarity=0.390 Sum_probs=166.3
Q ss_pred hhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCc--chhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
...++|++.+.||+|+||.||+|+. +++.||+|++...... ....+.+|+.++++++||||+++++++. ...
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 107 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----QPP 107 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----STT
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence 4456788999999999999999975 6889999998744322 3457889999999999999999999984 334
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCCceeecCCCce
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~--iiH~dlkp~Nil~~~~~~~ 297 (367)
..++||||+++|+|.+++..... ...+++..++.++.|++.||.||| +++ |+||||||+||+++.++.+
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~ 178 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGA------REQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTV 178 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTH------HHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCE
T ss_pred ceEEEEecCCCCcHHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcE
Confidence 57999999999999999986541 113778899999999999999999 888 9999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+..
T Consensus 179 kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 179 KVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp EECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred EECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999997543321 11233458999999999999999999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=309.86 Aligned_cols=204 Identities=24% Similarity=0.333 Sum_probs=171.1
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
..++|++.+.||+|+||.||+|+..+++.||+|++..... .....+.+|+.++++++||||+++++++. ....
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 93 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERC 93 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSC
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCE
Confidence 4568999999999999999999987899999999874322 23467889999999999999999999973 4456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||++ ++|.+++..... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 94 ~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~ 161 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDENKT--------GLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLA 161 (311)
T ss_dssp EEEEEECCS-EEHHHHHHTCTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEcCCC-CCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEc
Confidence 799999997 488888876542 4678899999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 162 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 162 DFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp CCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred cCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999987643222 2223458999999999876 4689999999999999999999999987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=321.45 Aligned_cols=214 Identities=26% Similarity=0.387 Sum_probs=174.8
Q ss_pred hcCCCCCCCcccccCceEEEEEEec--------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhC-CCCCcceeeeeecc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAFSG 212 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 212 (367)
..++|.+.+.||+|+||.||+|+.. ++..||+|+++.... .....+.+|+.+++++ +||||++++++|.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC-
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc-
Confidence 3467889999999999999999842 345799999874322 2346789999999999 8999999999983
Q ss_pred cccCCceeeeEEEEeccCCCHHHHhhCCCCCCC-------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 017712 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (367)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlk 285 (367)
.....++||||+++|+|.+++........ ......+++..++.++.||+.||.||| +++|+|||||
T Consensus 158 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlk 230 (370)
T 2psq_A 158 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 230 (370)
T ss_dssp ----SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred ----cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccc
Confidence 34557999999999999999986542100 001114678889999999999999999 8899999999
Q ss_pred CCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 286 PSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 286 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||.+..
T Consensus 231 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999987654333223333457889999999999999999999999999999999 999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=318.83 Aligned_cols=212 Identities=26% Similarity=0.358 Sum_probs=174.9
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
.++....++|++.+.||+|+||.||+|+. .++.||+|++.... .......+|+.++.+++||||+++++++.... ..
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 93 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SV 93 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SS
T ss_pred cccccchhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CC
Confidence 34455667899999999999999999985 47899999986432 23345667888999999999999999985432 22
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCC----------CeEecCCCCC
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP----------PIAHCNLKPS 287 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~----------~iiH~dlkp~ 287 (367)
....++||||+++|+|.+++... .+++..+..++.|++.||.||| +. +|+||||||+
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~ 160 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN----------VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSK 160 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGG
T ss_pred CceEEEEEecCCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChH
Confidence 44579999999999999999764 3678899999999999999999 88 9999999999
Q ss_pred ceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 288 NVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-----EASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 288 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|||++.++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||+||+.||.+
T Consensus 161 Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp GEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred hEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999876544333333335689999999998873 456678999999999999999999987
Q ss_pred CCC
Q 017712 363 IFT 365 (367)
Q Consensus 363 ~~~ 365 (367)
..+
T Consensus 241 ~~~ 243 (322)
T 3soc_A 241 PVD 243 (322)
T ss_dssp CCC
T ss_pred Ccc
Confidence 543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=318.04 Aligned_cols=200 Identities=23% Similarity=0.370 Sum_probs=172.1
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.++|++.+.||+|+||.||+|. ..+++.||+|++..... ...+.+.+|+.++++++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 3568889999999999999998 45689999999975433 23467889999999999999999999973 4456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC---Cce
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE---MIG 297 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~---~~~ 297 (367)
.++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.+ +.+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAV 170 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCE
T ss_pred EEEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCE
Confidence 799999999999999997654 4778899999999999999999 8899999999999999765 459
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 171 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 171 KLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp EECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999986643222 22346899999999999989999999999999999999999999764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=314.88 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=171.9
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|.+.+.||+|+||.||+|. ..+++.||+|++... .......+.+|+.+++.++||||+++++++. ...
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 4689999999999999999999 467899999998632 2234567899999999999999999999974 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+ +|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl 149 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKK---------RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKI 149 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEE
T ss_pred EEEEEEECC-CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEE
Confidence 679999999 789999887654 4778899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||++........ .....||+.|+|||.+.+..+ ++++|||||||++|+|++|..||++..
T Consensus 150 ~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 150 ADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp CCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred EEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 99999986644322 223458999999999988776 789999999999999999999998653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=314.55 Aligned_cols=201 Identities=24% Similarity=0.334 Sum_probs=163.7
Q ss_pred cCCCCCCCcccccCceEEEEEEe----cCCCEEEEEEeecCC----CcchhHHHHHHHHHHhCCCCCcceeeeeeccccc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 91 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ---- 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE----
Confidence 45789999999999999999985 478999999987432 223456789999999999999999999973
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
.....++||||+++++|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++
T Consensus 92 -~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~ 158 (327)
T 3a62_A 92 -TGGKLYLILEYLSGGELFMQLEREG---------IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQG 158 (327)
T ss_dssp -CSSCEEEEEECCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTS
T ss_pred -cCCEEEEEEeCCCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCC
Confidence 3456799999999999999997644 4668889999999999999999 88999999999999999999
Q ss_pred ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.
T Consensus 159 ~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 159 HVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp CEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 99999999997543221 1222346899999999999989999999999999999999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=318.40 Aligned_cols=202 Identities=19% Similarity=0.321 Sum_probs=174.3
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.++|++.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++..++||||+++++++. .....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence 35789999999999999999984 568999999987554445567899999999999999999999973 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC--CCceEEe
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD--EMIGHVG 300 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~--~~~~kl~ 300 (367)
+||||+++|+|.+++..... .+++..+..++.||+.||.||| +++|+||||||+|||++. ++.+||+
T Consensus 125 lv~E~~~gg~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~ 193 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 193 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred EEEEcCCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEE
Confidence 99999999999999975432 4778999999999999999999 889999999999999974 5789999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 194 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 194 DFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp CCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ecccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 999998764322 2233468999999999999999999999999999999999999998643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=319.90 Aligned_cols=201 Identities=27% Similarity=0.331 Sum_probs=163.6
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC---CcchhHHHHHHHH-HHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKA-AINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|..+ ++.++||||++++++|. ..
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----CS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----eC
Confidence 45799999999999999999994 468899999997432 2234456677776 46789999999999973 44
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ik 179 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIV 179 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEE
Confidence 57899999999999999997644 4678889999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 180 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 180 LTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp ECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred EeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 99999998543222 1223456999999999999999999999999999999999999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=324.18 Aligned_cols=201 Identities=21% Similarity=0.332 Sum_probs=171.7
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.++|++.+.||+|+||.||+|. ..+++.+|+|++..... ...+.+.+|+.++++++||||+++++++ .....
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence 4568889999999999999998 56789999999875432 2346788999999999999999999997 34566
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec---CCCce
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DEMIG 297 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~---~~~~~ 297 (367)
.++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++ +++.+
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~---------~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~v 152 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAV 152 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCE
T ss_pred EEEEEEeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcE
Confidence 799999999999999997654 4778999999999999999999 88999999999999998 56889
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 153 kL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 153 KLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp EECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 9999999986644322 223356999999999999999999999999999999999999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=320.26 Aligned_cols=224 Identities=24% Similarity=0.310 Sum_probs=182.5
Q ss_pred CCChHHHHhhcCCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhC-CCCCcce
Q 017712 134 NPSFKDLYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVR 205 (367)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~ 205 (367)
......+....++|++.+.||+|+||.||+|+. .+++.||+|+++.... ...+.+.+|+.++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 344567777888999999999999999999972 2457899999975332 2346789999999999 7999999
Q ss_pred eeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC----------------------------------------
Q 017712 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------------------------------------- 245 (367)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------------------------------- 245 (367)
+++++.. .....+++|||+++|+|.+++........
T Consensus 91 ~~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 91 LLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp EEEEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred eeeeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 9999843 33457999999999999999987542100
Q ss_pred -----------------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecccccccc
Q 017712 246 -----------------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 246 -----------------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
......+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 000112788899999999999999999 889999999999999999999999999999876
Q ss_pred CCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
.............||+.|+|||++.+..++.++|||||||++|||+| |..||.+..
T Consensus 244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp TSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 54433333344557899999999999899999999999999999998 999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=313.34 Aligned_cols=208 Identities=25% Similarity=0.396 Sum_probs=168.6
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc---chhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|+ ..+++.||+|+++..... ....+.+|+.++.+++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 4689999999999999999999 467899999999754332 2356889999999999999999999975432 2234
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++++|.+++.... .+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEE
T ss_pred ccEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEE
Confidence 5699999999999999997544 4678899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999866433221 22223458999999999999999999999999999999999999998653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=306.37 Aligned_cols=203 Identities=22% Similarity=0.297 Sum_probs=167.2
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--------------------------cchhHHHHHHHHH
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--------------------------GGSKSFKSECKAA 195 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l 195 (367)
..++|++.+.||+|+||.||+|+ ..+++.||+|++..... ...+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 34689999999999999999998 45689999999864321 1235789999999
Q ss_pred HhCCCCCcceeeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCC
Q 017712 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC 275 (367)
Q Consensus 196 ~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~ 275 (367)
++++||||+++++++.. ......++||||+++++|.+++... .+++..+..++.|++.||.|||
T Consensus 91 ~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH--- 154 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPTLK----------PLSEDQARFYFQDLIKGIEYLH--- 154 (298)
T ss_dssp HTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSCSS----------CCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHH---
Confidence 99999999999999853 2345679999999999998765432 4678899999999999999999
Q ss_pred CCCeEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCC---CCcchhHHHHHHHHHH
Q 017712 276 QPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE---ASTYGDVYSFGILLLE 352 (367)
Q Consensus 276 ~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~e 352 (367)
+++|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++|||||||++|+
T Consensus 155 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 155 YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp HTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred HCCeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence 88999999999999999999999999999987643322 223346899999999988765 3788999999999999
Q ss_pred HHhCCCCCCCC
Q 017712 353 MFTGIRPSDGI 363 (367)
Q Consensus 353 l~tg~~Pf~~~ 363 (367)
|++|..||.+.
T Consensus 233 l~~g~~pf~~~ 243 (298)
T 2zv2_A 233 FVFGQCPFMDE 243 (298)
T ss_dssp HHHSSCSSCCS
T ss_pred HHHCCCCCCCc
Confidence 99999999764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=306.35 Aligned_cols=207 Identities=26% Similarity=0.379 Sum_probs=158.3
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|++.+.||+|+||.||+|. ..+++.||+|+++... ......+.+|+.++++++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeE
Confidence 4679999999999999999998 4568999999997443 334577899999999999999999999973 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||++ ++|.+++....... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSS---CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred EEEEEecC-CCHHHHHHhccccc---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECc
Confidence 99999997 69999986532110 0113678889999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..
T Consensus 152 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 152 FGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp CSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999986643221 12234589999999998764 68999999999999999999999997653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=328.86 Aligned_cols=203 Identities=25% Similarity=0.366 Sum_probs=175.7
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
..++|++.+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++..++||||+++++++. ..
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TK 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----eC
Confidence 346789999999999999999994 57999999998632 2334567889999999999999999999973 44
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++|+|.+++...... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~-------~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQA-------GFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSC-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeE
Confidence 5789999999999999999765421 3778899999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 327 L~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 327 ISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp ECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred EEecccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 99999998764322 223346999999999999988999999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=324.30 Aligned_cols=207 Identities=20% Similarity=0.279 Sum_probs=161.3
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.++|++.+.||+|+||.||+|+ ..+++.||+|++..... ...+.+.+|+.++.+++||||+++++++..........
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999998 55789999999864322 24467889999999999999999999986655455567
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+ +++|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~ 198 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---------YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVC 198 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEecc-ccchhhhcccCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeec
Confidence 89999998 679999998654 4778999999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCc-------------------------ceeeeccCCCcccCCccc-cCCCCCcchhHHHHHHHHHHHH
Q 017712 301 DFGMARFLPAIDKQ-------------------------NRFICIKGSTGYIPPEYD-LGCEASTYGDVYSFGILLLEMF 354 (367)
Q Consensus 301 Dfg~~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~ 354 (367)
|||+|+........ .......||+.|+|||++ .+..++.++|||||||++|||+
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell 278 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence 99999876432111 122344689999999976 4567999999999999999999
Q ss_pred h-----------CCCCCCCC
Q 017712 355 T-----------GIRPSDGI 363 (367)
Q Consensus 355 t-----------g~~Pf~~~ 363 (367)
+ |++||.|.
T Consensus 279 tg~~~~~~~~~~~~p~f~g~ 298 (458)
T 3rp9_A 279 NMIKENVAYHADRGPLFPGS 298 (458)
T ss_dssp TTSTTTCSSGGGCCCSCC--
T ss_pred HhccccccccccccccCCCC
Confidence 9 66777653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=313.24 Aligned_cols=204 Identities=24% Similarity=0.326 Sum_probs=170.4
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC-----CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI-----RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
++|++.+.||+|+||.||+|. ..+++.||+|++... .....+.+.+|+.+++.++||||+++++++. ..
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~ 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----SD 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence 468888999999999999998 457899999998632 1224678999999999999999999999974 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc--
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI-- 296 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~-- 296 (367)
...++||||+++++|.+++...... ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCC
Confidence 5679999999999998887543210 113678899999999999999999 889999999999999976554
Q ss_pred -eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 297 -GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 297 -~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 171 ~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 99999999987654322 122345899999999999999999999999999999999999999763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=326.96 Aligned_cols=205 Identities=27% Similarity=0.362 Sum_probs=175.2
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|.+.+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++.+++||||++++++|. ...
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eCC
Confidence 35788899999999999999995 56999999999632 2234567889999999999999999999973 445
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++|+|.+++...... ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL 330 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRI 330 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEE
Confidence 689999999999999999764311 114778899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 331 ~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 331 SDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp CCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred eecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 999999876443221 22346999999999999999999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=311.27 Aligned_cols=202 Identities=23% Similarity=0.377 Sum_probs=172.6
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|++.+.||+|+||.||+|+ ..+++.||+|++.... ....+.+|+.+++++ +||||+++++++. .....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCcc
Confidence 4679999999999999999999 4678999999987432 345689999999999 9999999999874 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc-----
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI----- 296 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~----- 296 (367)
++||||+ +++|.+++..... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~ 148 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDR--------TFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQV 148 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTS
T ss_pred EEEEEeC-CCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCce
Confidence 9999999 9999999985421 4778999999999999999999 889999999999999998887
Q ss_pred eEEeccccccccCCCCCcc-----eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred EEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 9999999998764432211 1234569999999999999999999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=309.18 Aligned_cols=206 Identities=25% Similarity=0.393 Sum_probs=172.7
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|.+.+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|+.++++++||||+++++++.. ......
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceE
Confidence 35688999999999999999994 458999999987433 2345778899999999999999999998753 233467
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee----cCCCce
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIG 297 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~----~~~~~~ 297 (367)
++||||+++++|.+++...... ..+++..++.++.|++.||.||| +++|+||||||+|||+ +.++.+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEE
T ss_pred EEEEeCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceE
Confidence 9999999999999999865321 13778899999999999999999 8899999999999999 788889
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCcccc--------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL--------GCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||+++....... .....||+.|+|||++. +..++.++|||||||++|||++|..||.+..
T Consensus 156 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred EEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999987644322 22345899999999876 5678999999999999999999999997543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=304.84 Aligned_cols=201 Identities=23% Similarity=0.369 Sum_probs=167.6
Q ss_pred CCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|++.+.||+|+||.||+|+..+++.||+|++..... .....+.+|+.++++++||||+++++++. .....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRLV 76 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeEE
Confidence 47888999999999999999987799999999864332 23467889999999999999999999974 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||+++ +|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+||
T Consensus 77 lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df 144 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADF 144 (288)
T ss_dssp EEEECCSE-EHHHHHHTSTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCT
T ss_pred EEEEecCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeEC
Confidence 99999975 99999876432 4677889999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus 145 g~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 145 GLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp THHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99986543211 22234589999999998764 58999999999999999999999998643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=304.72 Aligned_cols=208 Identities=24% Similarity=0.308 Sum_probs=173.1
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-----CcchhHHHHHHHHHHhCC---CCCcceeeeeeccc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-----PGGSKSFKSECKAAINIK---HRNIVRVFTAFSGV 213 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 213 (367)
..++|++.+.||+|+||.||+|+ ..+++.||+|++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 45789999999999999999999 4678999999987432 122456778888887775 99999999998655
Q ss_pred ccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
........+++|||+. ++|.+++...... .+++..+..++.|++.||.||| +++|+||||||+|||++.
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP-------GLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTS 155 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT-------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECT
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcC
Confidence 4444456799999996 6999999876522 3778999999999999999999 889999999999999999
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 156 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 156 GGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp TSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred CCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999986543222 233458999999999999999999999999999999999999997643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=321.24 Aligned_cols=210 Identities=27% Similarity=0.349 Sum_probs=173.4
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccC
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
.+....++|.+.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++++++||||+++++++.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----- 182 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT----- 182 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----
Confidence 34455678889999999999999999954 789999999874322 23456889999999999999999999983
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
.....++||||+++|+|.+++..... .+++..++.++.|++.||+||| +++|+||||||+|||++.++.
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~ 251 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNV 251 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCC
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCc
Confidence 34457999999999999999975331 4678899999999999999999 889999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||+| |..||.+..
T Consensus 252 ~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 252 LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp EEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred EEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999986432211111111124678999999998889999999999999999998 999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=310.08 Aligned_cols=205 Identities=28% Similarity=0.423 Sum_probs=170.0
Q ss_pred cCCCCCCCcccccCceEEEEEEec----CCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|++.+.||+|+||.||+|... .+..||+|+++... ....+.+.+|+.++.+++||||+++++++. ..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----RG 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----GG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence 457888999999999999999953 34569999987432 234567899999999999999999999973 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++++|.+++..... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~k 191 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCK 191 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred CccEEEeeCCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEE
Confidence 567999999999999999975432 4778899999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcc-eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999998765432221 2223346778999999998889999999999999999999 999997653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=301.24 Aligned_cols=217 Identities=34% Similarity=0.515 Sum_probs=181.2
Q ss_pred CCCCChHHHHhhcCCCCCC------CcccccCceEEEEEEecCCCEEEEEEeecCC----CcchhHHHHHHHHHHhCCCC
Q 017712 132 INNPSFKDLYNATNGFSSA------NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR----PGGSKSFKSECKAAINIKHR 201 (367)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~ 201 (367)
.....+.++...+++|... +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3456788888888888776 8999999999999984 68899999986422 23356789999999999999
Q ss_pred CcceeeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEe
Q 017712 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAH 281 (367)
Q Consensus 202 niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH 281 (367)
||+++++++. .....+++|||+++++|.+++...... ..+++..+..++.|++.||.||| +++++|
T Consensus 91 ~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H 156 (307)
T 2nru_A 91 NLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLSWHMRCKIAQGAANGINFLH---ENHHIH 156 (307)
T ss_dssp TBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTGGGC------CCCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred CeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHh---cCCeec
Confidence 9999999973 344579999999999999999753211 14678889999999999999999 889999
Q ss_pred cCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 282 CNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 282 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
|||||+||+++.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|+|++|..||+
T Consensus 157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcc
Confidence 99999999999999999999999986654333222333468999999998865 57899999999999999999999998
Q ss_pred CCC
Q 017712 362 GIF 364 (367)
Q Consensus 362 ~~~ 364 (367)
+..
T Consensus 236 ~~~ 238 (307)
T 2nru_A 236 EHR 238 (307)
T ss_dssp TTB
T ss_pred cCc
Confidence 754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.54 Aligned_cols=202 Identities=21% Similarity=0.266 Sum_probs=163.9
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
..++|++.+.||+|+||.||+|+ ..+++.||+|++... .......+.+|+.++..++||||++++++|. ..
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~ 220 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----TH 220 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ET
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eC
Confidence 34679999999999999999999 567899999999742 3334567789999999999999999999984 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEecCCCCCceeecCCCce
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH~dlkp~Nil~~~~~~~ 297 (367)
...++||||+++|+|.+++.... .+++..+..++.|++.||.||| + ++|+||||||+|||++.++.+
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCE
T ss_pred CEEEEEEeeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCE
Confidence 46799999999999999997654 4778899999999999999999 6 899999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 289 kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 289 KITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 999999998543222 2223456999999999999999999999999999999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=321.34 Aligned_cols=200 Identities=24% Similarity=0.395 Sum_probs=173.4
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|.+.+.||+|+||.||+|+. .+++.||+|+++.. .......+.+|+.+++.++||||+++++++. ...
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECC
Confidence 46789999999999999999994 47999999999642 2234567899999999999999999999973 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL 157 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKI 157 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSS---------SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEE
Confidence 6799999999999999997654 4778999999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||++.
T Consensus 158 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 158 ADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp CCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Eeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 9999998764322 2223468999999999988765 68999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=308.71 Aligned_cols=208 Identities=24% Similarity=0.398 Sum_probs=169.2
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-------
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY------- 215 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 215 (367)
++|++.+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|+.++++++||||++++++|.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 4688889999999999999995 479999999997433 3355789999999999999999999998854321
Q ss_pred ---------------------------------------------CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcch
Q 017712 216 ---------------------------------------------QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNF 250 (367)
Q Consensus 216 ---------------------------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 250 (367)
....+.+++|||+++++|.+++.......
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~------ 159 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE------ 159 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG------
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc------
Confidence 11234799999999999999998754211
Q ss_pred hhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccccCCCCCc----------ceeeec
Q 017712 251 NFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ----------NRFICI 320 (367)
Q Consensus 251 ~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~ 320 (367)
...+..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++........ ......
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred chhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence 2345668899999999999999 889999999999999999999999999999876543211 111234
Q ss_pred cCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 321 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
.||+.|+|||.+.+..++.++|||||||++|||++|..|+.
T Consensus 237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 58999999999999999999999999999999999988763
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=312.50 Aligned_cols=201 Identities=24% Similarity=0.290 Sum_probs=163.0
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
..++|++.+.||+|+||.||+++. .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++. .....
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEE
Confidence 346899999999999999999994 478999999987433 34577899999999999999999999984 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc--eEE
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI--GHV 299 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~--~kl 299 (367)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++. +||
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAG---------RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred EEEEEeCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEE
Confidence 99999999999999997544 4778899999999999999999 899999999999999987765 999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTY-GDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..
T Consensus 160 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 160 CDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp CCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred eecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 9999997432221 2223458999999999988877665 899999999999999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=321.72 Aligned_cols=203 Identities=21% Similarity=0.249 Sum_probs=166.8
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (367)
..++|++.+.||+|+||.||+|. ..+++.||+|++... .....+.+.+|+.+++.++||||+++++++..... ...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 35789999999999999999998 556899999998743 22345678899999999999999999999854322 233
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-----------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEeCCCC-CHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEE
Confidence 567999999965 57777653 2557888999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998654322 223346899999999999999999999999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=310.62 Aligned_cols=200 Identities=23% Similarity=0.366 Sum_probs=157.9
Q ss_pred hcCCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
..++|++.+.||+|+||.||+|+.. +++.||+|+++... ..+.+.+|+.++.+++||||+++++++. .....
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeE
Confidence 3467899999999999999999954 58899999987432 4567889999999999999999999983 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC---CCceE
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EMIGH 298 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~---~~~~k 298 (367)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+|
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~k 191 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLK 191 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEE
T ss_pred EEEEEeCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEE
Confidence 99999999999999997654 4678899999999999999999 889999999999999975 88999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 192 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 192 IADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp ECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred EccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 99999998653321 1223458999999999999899999999999999999999999997543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=313.68 Aligned_cols=205 Identities=26% Similarity=0.422 Sum_probs=161.1
Q ss_pred cCCCCCCCcccccCceEEEEEEec----CCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|++.+.||+|+||.||+|+.. ++..||+|.++... ....+.+.+|+.++.+++||||+++++++. ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eC
Confidence 357999999999999999999843 57789999987532 234567899999999999999999999983 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++|+|.+++..... .+++.+++.++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~k 187 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 187 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEE
T ss_pred CceEEEEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEE
Confidence 567999999999999999986532 4678889999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||.+..
T Consensus 188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp ECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred ECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999876433211 11122235778999999998899999999999999999998 999997653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.25 Aligned_cols=205 Identities=24% Similarity=0.341 Sum_probs=162.1
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 218 (367)
..++|++.+.||+|+||.||+|. ..+++.||+|++... .......+.+|+.++..+. ||||+++++++.. .+.
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DND 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCC
Confidence 35689999999999999999998 567999999998632 2234566789999999997 9999999999853 234
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||++ ++|.+++... .++...+..++.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~k 149 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRAN----------ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVK 149 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHT----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred CEEEEEecccC-cCHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEE
Confidence 46799999996 6999998753 3667888899999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCC-------------------CcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCC
Q 017712 299 VGDFGMARFLPAID-------------------KQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIR 358 (367)
Q Consensus 299 l~Dfg~~~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~ 358 (367)
|+|||+|+.+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 229 (388)
T 3oz6_A 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229 (388)
T ss_dssp ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence 99999998653311 1112233468999999999887 578999999999999999999999
Q ss_pred CCCCCC
Q 017712 359 PSDGIF 364 (367)
Q Consensus 359 Pf~~~~ 364 (367)
||.+..
T Consensus 230 pf~~~~ 235 (388)
T 3oz6_A 230 IFPGSS 235 (388)
T ss_dssp SCCCSS
T ss_pred CCCCCC
Confidence 998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=311.25 Aligned_cols=205 Identities=25% Similarity=0.427 Sum_probs=165.8
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCE----EEEEEeecC-CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTT----IAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
.++|++.+.||+|+||.||+|+. .+++. ||+|.+... .....+.+.+|+.++++++||||++++++|..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence 35688899999999999999984 34443 588877532 23456789999999999999999999999843
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
...++++||+++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+|||++.++.+
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~ 156 (327)
T 3poz_A 89 -STVQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV 156 (327)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEE
T ss_pred -CCeEEEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCE
Confidence 125799999999999999976432 4678889999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~~ 365 (367)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||++...
T Consensus 157 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp EECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred EEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 9999999987655444333344557889999999999999999999999999999999 9999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=301.35 Aligned_cols=204 Identities=25% Similarity=0.412 Sum_probs=174.2
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++||||+++++++. .....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceE
Confidence 346788899999999999999998788899999987432 34577999999999999999999999973 345579
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||+++++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+||
T Consensus 82 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Df 150 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDF 150 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCT
T ss_pred EEEEeCCCCcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccc
Confidence 99999999999999976442 4678889999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|+++....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 151 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 151 GMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp TGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 99986543211 11223346778999999998899999999999999999999 999997653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=314.57 Aligned_cols=208 Identities=19% Similarity=0.163 Sum_probs=173.8
Q ss_pred hcCCCCCCCccccc--CceEEEEEEe-cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 143 ATNGFSSANLIGAG--NFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 143 ~~~~~~~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
..++|++.+.||+| +||.||+|+. .+++.||+|+++... ......+.+|+.++++++||||+++++++. .
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~ 97 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----A 97 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----E
Confidence 45679999999999 9999999994 479999999997433 223467888999999999999999999984 3
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....++||||+++|+|.+++...... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~ 167 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMD-------GMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKV 167 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTT-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhccc-------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence 45679999999999999999765321 4678899999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCc-----ceeeeccCCCcccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
||+|||.+......... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+...
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp EECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred EEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999998654322111 11122358999999999987 5789999999999999999999999987543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=309.09 Aligned_cols=204 Identities=25% Similarity=0.387 Sum_probs=169.6
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCE----EEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTT----IAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
.++|++.+.||+|+||.||+|+. .+++. ||+|.+.... ......+.+|+.++.+++||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------ 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------
Confidence 35788899999999999999984 44554 7788775332 234567889999999999999999999873
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....++||||+++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+|||++.++.+
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~ 154 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQV 154 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCE
T ss_pred CCccEEEEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeE
Confidence 2346899999999999999976431 4677889999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
||+|||+++...............||+.|+|||.+.+..++.++||||||+++|+|+| |..||.+..
T Consensus 155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred EECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 9999999987755444433444567889999999998899999999999999999999 999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=304.45 Aligned_cols=200 Identities=21% Similarity=0.326 Sum_probs=173.2
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCc------chhHHHHHHHHHHhCCCCCcceeeeeecccccC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|.+...... ..+.+.+|+.++.+++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----- 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 34688899999999999999994 56899999999743322 3567999999999999999999999973
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM- 295 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~- 295 (367)
.....++||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~ 153 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNI 153 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTS
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCC
Confidence 3456799999999999999998654 4778999999999999999999 88999999999999999887
Q ss_pred ---ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 296 ---IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 296 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 154 PIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp SSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 799999999987644322 22345899999999999989999999999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=312.23 Aligned_cols=196 Identities=23% Similarity=0.346 Sum_probs=164.2
Q ss_pred CCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEec
Q 017712 150 ANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (367)
.+.||+|+||.||+|. ..+++.||+|+++.......+.+.+|+.++.+++||||+++++++. .....++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEeCC
Confidence 5679999999999998 4578999999998655456678999999999999999999999984 345679999999
Q ss_pred cCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee--cCCCceEEecccccc
Q 017712 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL--DDEMIGHVGDFGMAR 306 (367)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~--~~~~~~kl~Dfg~~~ 306 (367)
++++|.+++..... .+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 169 ~~~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~ 237 (373)
T 2x4f_A 169 DGGELFDRIIDESY--------NLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237 (373)
T ss_dssp TTCEEHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred CCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence 99999998865321 4778889999999999999999 8899999999999999 667899999999998
Q ss_pred ccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 238 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 238 RYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp ECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 7644322 223458999999999998889999999999999999999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=301.22 Aligned_cols=197 Identities=22% Similarity=0.344 Sum_probs=164.9
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++. .....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 5788899999999999999994 5689999999974433 23467889999999999999999999974 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||+++ +|.+++..... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~D 144 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLAN 144 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEee
Confidence 999999975 66665544221 4778899999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPS 360 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~Pf 360 (367)
||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus 145 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 145 FGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred cccceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 999986643222 222345899999999988765 799999999999999999988885
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=333.39 Aligned_cols=203 Identities=24% Similarity=0.261 Sum_probs=174.8
Q ss_pred hhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccC
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 216 (367)
...++|++.+.||+|+||.||+|+ ..+++.||+|+++.. .......+..|..++..+ +||||+++++++ .
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~ 412 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----Q 412 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----B
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----E
Confidence 345689999999999999999999 456889999998732 234567788999999987 799999999997 4
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
.....++||||+++|+|.+++.... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ 480 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGH 480 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSC
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCc
Confidence 4567899999999999999998654 4778899999999999999999 889999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 481 ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 481 IKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp EEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 9999999998543222 2233456999999999999999999999999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=303.40 Aligned_cols=192 Identities=24% Similarity=0.324 Sum_probs=148.5
Q ss_pred CCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCceeeeEEEEe
Q 017712 150 ANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (367)
.+.||+|+||.||+|.. .+++.||+|++.. .....+.+|+.++..+. ||||+++++++. .....++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEEEEEc
Confidence 47899999999999994 5689999999864 24567889999999997 999999999973 44567999999
Q ss_pred ccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC---ceEEecccc
Q 017712 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM---IGHVGDFGM 304 (367)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~---~~kl~Dfg~ 304 (367)
+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++ .+||+|||+
T Consensus 88 ~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 88 LNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGF 155 (325)
T ss_dssp CCSCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEecccc
Confidence 99999999998654 4778999999999999999999 88999999999999997665 899999999
Q ss_pred ccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 156 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 156 ARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp CEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred ceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 986543222 223345899999999999999999999999999999999999999764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=308.24 Aligned_cols=218 Identities=23% Similarity=0.339 Sum_probs=174.2
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC-----CCcchhHHHHHHHHHHhCCCCCcceeeeeecc
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI-----RPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 212 (367)
.+....++|++.+.||+|+||.||+|. ..+++.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~- 98 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE- 98 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-
Confidence 345566789999999999999999998 456889999998632 3345678999999999999999999999983
Q ss_pred cccCCceeeeEEEEeccCCCHHHHhhCCCCC-------------------------------CCCCcchhhhHHHHHHHH
Q 017712 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDT-------------------------------NWRPLNFNFLIKKKLDIA 261 (367)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------~~~~~~~~~~~~~~~~i~ 261 (367)
.....++||||+++|+|.+++...... ........+++..+..++
T Consensus 99 ----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 99 ----DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp ----CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred ----cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 345689999999999999998521100 001123456788899999
Q ss_pred HHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC--ceEEeccccccccCCCCCc--ceeeeccCCCcccCCccccC--C
Q 017712 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM--IGHVGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLG--C 335 (367)
Q Consensus 262 ~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~ 335 (367)
.|++.||.||| +++|+||||||+||+++.++ .+||+|||+++.+...... .......||+.|+|||.+.+ .
T Consensus 175 ~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 175 RQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 99999999999 88999999999999998776 8999999999865432221 12234568999999999875 6
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 336 EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 336 ~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.++.++|||||||++|+|++|+.||.+..
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 78899999999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=311.76 Aligned_cols=201 Identities=21% Similarity=0.338 Sum_probs=162.9
Q ss_pred CCCCCC-CcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHh-CCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSA-NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN-IKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~-~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|.+. +.||+|+||.||+|. ..+++.||+|+++. ...+.+|+.++.+ .+||||++++++|... ..+....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcEE
Confidence 456655 689999999999998 45689999999862 3567889988754 5899999999987432 2345678
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC---CCceE
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EMIGH 298 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~---~~~~k 298 (367)
++||||+++|+|.+++...... .+++..+..++.||+.||.||| +++|+||||||+|||++. ++.+|
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~k 204 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILK 204 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEE
T ss_pred EEEEEeCCCCcHHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEE
Confidence 9999999999999999865421 4778999999999999999999 889999999999999987 78999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 205 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp ECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred EEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999998654322 2234458999999999999999999999999999999999999997643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=298.32 Aligned_cols=200 Identities=24% Similarity=0.302 Sum_probs=173.5
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.++|++.+.||+|+||.||+|.. .++..+|+|.+........+.+.+|+.++++++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence 45688899999999999999994 457899999998666667788999999999999999999999983 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee---cCCCceEE
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHV 299 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~---~~~~~~kl 299 (367)
+||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||++ +.++.+||
T Consensus 83 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l 150 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKL 150 (277)
T ss_dssp EEEECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred EEEeccCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEE
Confidence 9999999999999987654 4678899999999999999999 8899999999999999 78899999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||++........ .....||+.|+|||.+.+. ++.++||||||+++|+|++|..||.+..
T Consensus 151 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 151 IDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp CCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EecccceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 99999986643322 2234589999999998764 8999999999999999999999997643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.57 Aligned_cols=217 Identities=25% Similarity=0.354 Sum_probs=177.6
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEec--------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhC-CCCCcceeeee
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTA 209 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 209 (367)
+....++|.+.+.||+|+||.||+|+.. .+..||+|+++.... .....+.+|+++++++ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3445678999999999999999999842 235799999875432 2346788999999999 99999999999
Q ss_pred ecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC-------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEec
Q 017712 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHC 282 (367)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~ 282 (367)
+. .....++||||+++|+|.+++........ ......+++..++.++.|++.||.||| +++|+||
T Consensus 144 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 215 (382)
T 3tt0_A 144 CT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHR 215 (382)
T ss_dssp EC-----SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred ec-----cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecC
Confidence 84 34557999999999999999976542110 001124788999999999999999999 8899999
Q ss_pred CCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 017712 283 NLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSD 361 (367)
Q Consensus 283 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~ 361 (367)
||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 216 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp CCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654433333334457889999999999999999999999999999999 999998
Q ss_pred CCC
Q 017712 362 GIF 364 (367)
Q Consensus 362 ~~~ 364 (367)
+..
T Consensus 296 ~~~ 298 (382)
T 3tt0_A 296 GVP 298 (382)
T ss_dssp TCC
T ss_pred CCC
Confidence 753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=317.06 Aligned_cols=206 Identities=20% Similarity=0.271 Sum_probs=168.6
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
..++|.+.+.||+|+||.||+|+ ..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.........
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 35689999999999999999998 45688999999974322 2346788999999999999999999998654434446
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||++ ++|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI---------FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecCC-cCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEE
Confidence 7899999985 69999998654 4778999999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCc--------------------ceeeeccCCCcccCCccc-cCCCCCcchhHHHHHHHHHHHHhCCC
Q 017712 300 GDFGMARFLPAIDKQ--------------------NRFICIKGSTGYIPPEYD-LGCEASTYGDVYSFGILLLEMFTGIR 358 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~tg~~ 358 (367)
+|||+++........ .......||+.|+|||++ ....++.++|||||||++|||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999876433211 122455689999999986 55679999999999999999998655
Q ss_pred CCC
Q 017712 359 PSD 361 (367)
Q Consensus 359 Pf~ 361 (367)
||.
T Consensus 251 p~~ 253 (432)
T 3n9x_A 251 SHI 253 (432)
T ss_dssp TTC
T ss_pred ccc
Confidence 554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=306.51 Aligned_cols=205 Identities=26% Similarity=0.382 Sum_probs=169.3
Q ss_pred cCCCCCCCcccccCceEEEEEEe-----cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++.+++||||+++++++... ..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence 45788999999999999999973 36889999998765555567899999999999999999999987432 23
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~k 154 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVK 154 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEE
T ss_pred CceEEEEEeCCCCCHHHHHHhccc--------ccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEE
Confidence 346899999999999999976532 4778899999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|+|+||..||..
T Consensus 155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp ECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred EccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 9999999876443221 112233467789999999998999999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=312.53 Aligned_cols=208 Identities=18% Similarity=0.267 Sum_probs=168.1
Q ss_pred hcCCCCCCCcccccCceEEEEEEecC------CCEEEEEEeecCCCc-----------chhHHHHHHHHHHhCCCCCcce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPG-----------GSKSFKSECKAAINIKHRNIVR 205 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~ 205 (367)
..++|++.+.||+|+||.||+|.... ++.||+|++...... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998543 478999998643211 1122345556667788999999
Q ss_pred eeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 017712 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (367)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlk 285 (367)
+++++.... ....+.++||||+ +++|.+++..... .+++..++.++.||+.||.||| +++|+|||||
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlk 179 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEANAK--------RFSRKTVLQLSLRILDILEYIH---EHEYVHGDIK 179 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCC
Confidence 999985432 3346689999999 9999999976432 4778999999999999999999 8899999999
Q ss_pred CCceeec--CCCceEEeccccccccCCCCCcc-----eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 017712 286 PSNVLLD--DEMIGHVGDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIR 358 (367)
Q Consensus 286 p~Nil~~--~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~ 358 (367)
|+|||++ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus 180 p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 259 (364)
T 3op5_A 180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL 259 (364)
T ss_dssp GGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999998 88999999999998764432211 1123458999999999999999999999999999999999999
Q ss_pred CCCCC
Q 017712 359 PSDGI 363 (367)
Q Consensus 359 Pf~~~ 363 (367)
||.+.
T Consensus 260 Pf~~~ 264 (364)
T 3op5_A 260 PWEDN 264 (364)
T ss_dssp TTGGG
T ss_pred Ccccc
Confidence 99864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.82 Aligned_cols=202 Identities=24% Similarity=0.307 Sum_probs=165.3
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCc--chhHHHHHHHHHHhCCC--CCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKH--RNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|...+++.||+|++...... ..+.+.+|+.++.+++| |||+++++++. ...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~ 82 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 82 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eCC
Confidence 4579999999999999999999888999999998754332 34678999999999987 99999999973 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++|||+ .+++|.+++.... .+++.++..++.|++.||.||| +++|+||||||+|||++ ++.+||
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl 148 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKL 148 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred EEEEEEeC-CCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEE
Confidence 78999995 5889999998754 4678889999999999999999 88999999999999997 678999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----------CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||+++...............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 99999987654333323334569999999999864 568899999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=312.72 Aligned_cols=219 Identities=25% Similarity=0.380 Sum_probs=176.7
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeee
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAF 210 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 210 (367)
..+....++|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.++.+++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344455678999999999999999999853 348899999875432 2356789999999999999999999998
Q ss_pred cccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC---------------CCcchhhhHHHHHHHHHHHHHHHHHhhhCC
Q 017712 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------------RPLNFNFLIKKKLDIAIDVACALRYLHCDC 275 (367)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~ 275 (367)
. .....++||||+++|+|.+++........ ......+++.+++.++.||+.||.|||
T Consensus 120 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--- 191 (343)
T 1luf_A 120 A-----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--- 191 (343)
T ss_dssp C-----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred c-----cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 3 34567999999999999999976431110 000125778999999999999999999
Q ss_pred CCCeEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh
Q 017712 276 QPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355 (367)
Q Consensus 276 ~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t 355 (367)
+++|+||||||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|+|+|
T Consensus 192 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 271 (343)
T 1luf_A 192 ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271 (343)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHh
Confidence 88999999999999999999999999999986644332222334457899999999998899999999999999999999
Q ss_pred -CCCCCCCCC
Q 017712 356 -GIRPSDGIF 364 (367)
Q Consensus 356 -g~~Pf~~~~ 364 (367)
|..||.+..
T Consensus 272 ~g~~p~~~~~ 281 (343)
T 1luf_A 272 YGLQPYYGMA 281 (343)
T ss_dssp TTCCTTTTSC
T ss_pred cCCCcCCCCC
Confidence 999997653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.39 Aligned_cols=204 Identities=24% Similarity=0.370 Sum_probs=174.5
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..++|++.+.||+|+||.||+|...++..||+|+++... ...+.+.+|+.++.+++||||+++++++ ......+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 346788999999999999999998888899999987533 3457799999999999999999999997 3445679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||+++++|.+++..... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Df 148 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGK--------GLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDF 148 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCT
T ss_pred EEEEccCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccC
Confidence 99999999999999975431 4778899999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||++..
T Consensus 149 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 149 GMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp TCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 99986644322 12223346778999999998889999999999999999999 999997643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.99 Aligned_cols=218 Identities=24% Similarity=0.319 Sum_probs=175.5
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecC-CCcchhHHHHHHHHHHhC-CCCCcceeeeee
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLI-RPGGSKSFKSECKAAINI-KHRNIVRVFTAF 210 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 210 (367)
++....++|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++.++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3445567899999999999999999984 24568999998743 233567899999999999 899999999998
Q ss_pred cccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCC--------------CcchhhhHHHHHHHHHHHHHHHHHhhhCCC
Q 017712 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR--------------PLNFNFLIKKKLDIAIDVACALRYLHCDCQ 276 (367)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~--------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~ 276 (367)
. .....++||||+++|+|.+++......... .....+++..++.++.|++.||.||| +
T Consensus 119 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 190 (344)
T 1rjb_A 119 T-----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---F 190 (344)
T ss_dssp C-----SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---H
T ss_pred e-----eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---h
Confidence 4 344579999999999999999865421000 00113678899999999999999999 8
Q ss_pred CCeEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-
Q 017712 277 PPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT- 355 (367)
Q Consensus 277 ~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t- 355 (367)
++|+||||||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|+|+|
T Consensus 191 ~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 191 KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred CCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 8999999999999999999999999999987654333222333446889999999988899999999999999999998
Q ss_pred CCCCCCCCC
Q 017712 356 GIRPSDGIF 364 (367)
Q Consensus 356 g~~Pf~~~~ 364 (367)
|..||.+..
T Consensus 271 g~~p~~~~~ 279 (344)
T 1rjb_A 271 GVNPYPGIP 279 (344)
T ss_dssp SCCSSTTCC
T ss_pred CCCCcccCC
Confidence 999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=316.36 Aligned_cols=211 Identities=26% Similarity=0.392 Sum_probs=171.9
Q ss_pred cCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
.++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++.+++||||+++++++.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----- 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 457888999999999999999832 46689999986432 234457889999999999999999999974
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM- 295 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~- 295 (367)
.....++||||+++|+|.+++........ ....+++..++.++.|++.||.||| +++|+||||||+|||++.++
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPS--QPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSS--SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSST
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccC--ccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCC
Confidence 34456999999999999999976442211 1114778899999999999999999 88999999999999998544
Q ss_pred --ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 296 --IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 296 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 599999999976533322223334457999999999998899999999999999999998 999997653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=307.97 Aligned_cols=216 Identities=23% Similarity=0.325 Sum_probs=175.9
Q ss_pred hhcCCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccc
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (367)
...++|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--- 96 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS--- 96 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe---
Confidence 3456788999999999999999984 2357899999874332 34467889999999999999999999973
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCC---------------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPI 279 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~i 279 (367)
.....++||||+++++|.+++........ ......+++..++.++.|++.||.||| +++|
T Consensus 97 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i 171 (314)
T 2ivs_A 97 --QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKL 171 (314)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred --cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCC
Confidence 34457999999999999999986542100 001124778899999999999999999 8899
Q ss_pred EecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCC
Q 017712 280 AHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIR 358 (367)
Q Consensus 280 iH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~ 358 (367)
+||||||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987654333222333457889999999998889999999999999999999 999
Q ss_pred CCCCCCC
Q 017712 359 PSDGIFT 365 (367)
Q Consensus 359 Pf~~~~~ 365 (367)
||.+...
T Consensus 252 p~~~~~~ 258 (314)
T 2ivs_A 252 PYPGIPP 258 (314)
T ss_dssp SSTTCCG
T ss_pred CCCCCCH
Confidence 9987643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=319.22 Aligned_cols=203 Identities=27% Similarity=0.397 Sum_probs=172.0
Q ss_pred HhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
....++|++.+.||+|+||.||+|.. .++.||||+++... ..+.+.+|+.++++++||||+++++++.. ....
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCc
Confidence 34556788899999999999999985 47899999987433 56789999999999999999999999743 3345
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++...... .++...++.++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~ 331 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVS 331 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTT-------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEe
Confidence 79999999999999999864321 3567889999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~~ 365 (367)
|||+++...... ....+++.|+|||.+.+..++.++|||||||++|||+| |..||.+...
T Consensus 332 DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 392 (450)
T 1k9a_A 332 DFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392 (450)
T ss_dssp CCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT
T ss_pred eCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999998543211 12246889999999999999999999999999999998 9999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=309.05 Aligned_cols=221 Identities=24% Similarity=0.384 Sum_probs=163.0
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEecC-C---CEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeec
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLFD-G---TTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 211 (367)
+++....++|++.+.||+|+||.||+|+... + ..||+|+++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 3444556789999999999999999998433 3 27999998743 3345678999999999999999999999985
Q ss_pred ccccCC-ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCcee
Q 017712 212 GVDYQG-ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (367)
Q Consensus 212 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil 290 (367)
.....+ ....+++|||+++|+|.+++...... .....+++..++.++.|++.||.||| +++|+||||||+|||
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIl 169 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG---ENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCM 169 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhcc---ccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEE
Confidence 432111 12348999999999999998643211 01114678899999999999999999 889999999999999
Q ss_pred ecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+..
T Consensus 170 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp ECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 99999999999999987644333333334456889999999999899999999999999999999 999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=307.15 Aligned_cols=213 Identities=21% Similarity=0.244 Sum_probs=172.1
Q ss_pred hHHHHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcc-----------hhHHHHHHHHHHhCCCCCcce
Q 017712 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG-----------SKSFKSECKAAINIKHRNIVR 205 (367)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 205 (367)
+.++....++|.+.+.||+|+||.||+|...+++.||+|++....... .+.+.+|+.++.+++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 345566778999999999999999999997779999999986432221 267899999999999999999
Q ss_pred eeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 017712 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (367)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlk 285 (367)
+++++...........++||||++ |+|.+++..... .+++..+..++.|++.||.||| +++|+|||||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk 161 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--------VISPQHIQYFMYHILLGLHVLH---EAGVVHRDLH 161 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCC
Confidence 999986654455567899999996 689888875432 4678899999999999999999 8899999999
Q ss_pred CCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 286 PSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 286 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+||+++.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999997543322 2223458999999999877 678999999999999999999999998743
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=302.91 Aligned_cols=204 Identities=23% Similarity=0.323 Sum_probs=166.8
Q ss_pred cCCCCCC-CcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSA-NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~-~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.+.|.+. +.||+|+||.||+|. ..+++.||+|++..........+.+|+.++.++ +||||+++++++. ....
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCE
Confidence 3567774 789999999999999 557999999999866556678899999999985 7999999999984 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc---e
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI---G 297 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~---~ 297 (367)
.++||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++. +
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~ 153 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPV 153 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSE
T ss_pred EEEEEEcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCce
Confidence 799999999999999997644 4678889999999999999999 889999999999999988765 9
Q ss_pred EEeccccccccCCCCC-----cceeeeccCCCcccCCccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDK-----QNRFICIKGSTGYIPPEYDLG-----CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp EECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred EEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 9999999976532211 111223458999999999875 457899999999999999999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=307.63 Aligned_cols=200 Identities=21% Similarity=0.313 Sum_probs=172.1
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--------cchhHHHHHHHHHHhCCCCCcceeeeeecccc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--------GGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (367)
.++|++.+.||+|+||.||+|+ ..+++.||+|+++.... .....+.+|+.++++++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---- 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 4578899999999999999998 56789999999975432 1334678899999999999999999997
Q ss_pred cCCceeeeEEEEeccCC-CHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 215 YQGARFKAVVYKFMPNG-SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
......++||||+.+| +|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~ 165 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFIDRHP---------RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAE 165 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHHTCC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcC
Confidence 3455679999999776 9999998765 4778899999999999999999 889999999999999999
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++.+||+|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.
T Consensus 166 ~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 166 DFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp TSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred CCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 99999999999987644322 223458999999999988876 78999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=307.37 Aligned_cols=219 Identities=25% Similarity=0.358 Sum_probs=176.6
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEe--------cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhC-CCCCcceee
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTL--------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVF 207 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~ 207 (367)
..+....++|.+.+.||+|+||.||+|.. .++..||+|+++.... .....+.+|+.++.++ +||||++++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 33445567899999999999999999984 3467899999874332 2356788999999999 899999999
Q ss_pred eeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCC-------CcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeE
Q 017712 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIA 280 (367)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~ii 280 (367)
+++. .....++||||+++|+|.+++......... .....+++..++.++.|++.||.||| +++|+
T Consensus 108 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~iv 179 (334)
T 2pvf_A 108 GACT-----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCI 179 (334)
T ss_dssp EEEC-----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred EEEc-----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 9973 345679999999999999999865421100 01113678899999999999999999 88999
Q ss_pred ecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 017712 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359 (367)
Q Consensus 281 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~P 359 (367)
||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 180 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 259 (334)
T 2pvf_A 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259 (334)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654333223333457889999999988889999999999999999999 9999
Q ss_pred CCCCC
Q 017712 360 SDGIF 364 (367)
Q Consensus 360 f~~~~ 364 (367)
|.+..
T Consensus 260 ~~~~~ 264 (334)
T 2pvf_A 260 YPGIP 264 (334)
T ss_dssp STTCC
T ss_pred cCcCC
Confidence 98753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=312.12 Aligned_cols=201 Identities=24% Similarity=0.306 Sum_probs=164.7
Q ss_pred CCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCC--CCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIK--HRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|...+++.||+|++..... ...+.+.+|+.++.+++ ||||+++++++. ....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~~ 130 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQY 130 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCCE
Confidence 45899999999999999999977799999999875432 24467899999999996 599999999874 3445
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||| +.+++|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++ ++.+||+
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~ 196 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLI 196 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEEC
T ss_pred EEEEEe-cCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEE
Confidence 899999 56889999998654 4667788999999999999999 89999999999999996 5889999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----------CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|..||.+..
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 9999987644332222334569999999999865 368899999999999999999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=299.91 Aligned_cols=206 Identities=23% Similarity=0.363 Sum_probs=168.1
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHh--CCCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN--IKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|++.+.||+|+||.||+|+. +++.||+|++.. .....+.+|.+++.. ++||||+++++++.... ......
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCcee
Confidence 46799999999999999999985 789999999863 244566777777776 79999999999875432 345667
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCC-----CCCeEecCCCCCceeecCCCc
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC-----QPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~-----~~~iiH~dlkp~Nil~~~~~~ 296 (367)
++||||+++|+|.++++.. .+++..++.++.|++.||.|||+.. +++|+||||||+|||++.++.
T Consensus 82 ~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT----------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred EEehhhccCCCHHHHHhhc----------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC
Confidence 9999999999999999643 3678889999999999999999321 469999999999999999999
Q ss_pred eEEeccccccccCCCCCcc--eeeeccCCCcccCCccccCC------CCCcchhHHHHHHHHHHHHhC----------CC
Q 017712 297 GHVGDFGMARFLPAIDKQN--RFICIKGSTGYIPPEYDLGC------EASTYGDVYSFGILLLEMFTG----------IR 358 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~tg----------~~ 358 (367)
+||+|||+++......... ......||+.|+|||.+.+. .++.++|||||||++|||+|| ..
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 9999999997654332221 11223589999999998876 445789999999999999999 88
Q ss_pred CCCCCC
Q 017712 359 PSDGIF 364 (367)
Q Consensus 359 Pf~~~~ 364 (367)
||.+..
T Consensus 232 pf~~~~ 237 (301)
T 3q4u_A 232 PFYDVV 237 (301)
T ss_dssp TTTTTS
T ss_pred cccccC
Confidence 987653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.45 Aligned_cols=203 Identities=22% Similarity=0.330 Sum_probs=172.9
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (367)
..++|++.+.||+|+||.||+|. ..+++.||+|++... .....+.+|+.++.++ +|+|++++++++ .....
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~ 80 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLH 80 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCce
Confidence 34679999999999999999999 467999999998643 3456788999999999 799999999987 33456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc----
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI---- 296 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~---- 296 (367)
.+++|||+ +++|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~ 148 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNAN 148 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTT
T ss_pred eEEEEEec-CCCHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCC
Confidence 79999999 9999999986432 3778899999999999999999 899999999999999987765
Q ss_pred -eEEeccccccccCCCCCc-----ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 297 -GHVGDFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 297 -~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+..
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 999999999876543221 11234568999999999999999999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=321.64 Aligned_cols=209 Identities=24% Similarity=0.383 Sum_probs=177.0
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
..+....++|.+.+.||+|+||.||+|...++..||||.++... ...+.+.+|+.++++++||||+++++++.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------ 253 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------ 253 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------
Confidence 45566777899999999999999999998888899999987533 45788999999999999999999999873
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....++||||+++|+|.+++..... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~ 323 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEG-------SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVC 323 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHH-------HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCE
T ss_pred CCccEEEEeecCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcE
Confidence 2346899999999999999975421 13567888999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
||+|||+++....... .......+|+.|+|||++....++.++|||||||++|||+| |+.||.+..
T Consensus 324 kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 324 KIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp EECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEeeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 9999999986543211 11122336788999999998899999999999999999999 999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=308.69 Aligned_cols=210 Identities=29% Similarity=0.334 Sum_probs=177.0
Q ss_pred CCCCChHHHHhhcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-----CCCcce
Q 017712 132 INNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-----HRNIVR 205 (367)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 205 (367)
....++++.....++|.+.+.||+|+||.||+|+. .+++.||+|+++.. ......+..|+.++..+. ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 33445566666778999999999999999999994 57899999998632 234466788999999986 999999
Q ss_pred eeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 017712 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (367)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlk 285 (367)
+++++.. ....++||||+ +++|.+++...... .+++..+..++.||+.||.||| +++|+|||||
T Consensus 101 ~~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlk 164 (360)
T 3llt_A 101 YHGKFMY-----YDHMCLIFEPL-GPSLYEIITRNNYN-------GFHIEDIKLYCIEILKALNYLR---KMSLTHTDLK 164 (360)
T ss_dssp EEEEEEE-----TTEEEEEECCC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred ccceeeE-----CCeeEEEEcCC-CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCC
Confidence 9999843 34679999999 99999999765421 3678889999999999999999 8999999999
Q ss_pred CCceeecC-------------------------CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcc
Q 017712 286 PSNVLLDD-------------------------EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTY 340 (367)
Q Consensus 286 p~Nil~~~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 340 (367)
|+|||++. ++.+||+|||+++...... ....||+.|+|||++.+..++.+
T Consensus 165 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~ 239 (360)
T 3llt_A 165 PENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVS 239 (360)
T ss_dssp GGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTT
T ss_pred cccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCc
Confidence 99999975 7899999999998643321 23458999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCC
Q 017712 341 GDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 341 ~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||||||++|+|++|+.||.+.
T Consensus 240 ~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 240 SDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cchHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=296.87 Aligned_cols=203 Identities=22% Similarity=0.337 Sum_probs=172.9
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. .....+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEEE
Confidence 5688889999999999999994 478999999987433 334578899999999999999999999973 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||+++++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+||
T Consensus 82 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df 149 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149 (276)
T ss_dssp EEEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEecCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeC
Confidence 9999999999999987644 4778899999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|.+................||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.+..
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred CCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 99986543322222334568999999999987765 778999999999999999999997654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=300.93 Aligned_cols=208 Identities=24% Similarity=0.425 Sum_probs=173.5
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.+....++|++.+.||+|+||.||+|...++..||+|++.... ...+.+.+|+.++.+++||||+++++++. ..
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~ 91 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQ 91 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cC
Confidence 3444566889999999999999999998888899999987433 34577999999999999999999999973 44
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++++|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~k 160 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVK 160 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGG--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEE
T ss_pred CCeEEEEeccCCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEE
Confidence 567999999999999999976321 4778899999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.+..
T Consensus 161 l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 161 VSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp ECSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred Ecccccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 999999986543211 11223346788999999998889999999999999999998 999998643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=294.54 Aligned_cols=198 Identities=27% Similarity=0.424 Sum_probs=167.0
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcc-------hhHHHHHHHHHHhCCCCCcceeeeeeccccc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGG-------SKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++....... .+.+.+|+.++.+++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 46789999999999999999994 578999999986433322 26789999999999999999999997432
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCCceeecC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLDD 293 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~--iiH~dlkp~Nil~~~ 293 (367)
.+++|||+++|+|.+++..... .+++..++.++.|++.||.||| +++ |+||||||+||+++.
T Consensus 96 -----~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~ 159 (287)
T 4f0f_A 96 -----PRMVMEFVPCGDLYHRLLDKAH--------PIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQS 159 (287)
T ss_dssp -----TEEEEECCTTCBHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESC
T ss_pred -----CeEEEEecCCCCHHHHHhcccC--------CccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEec
Confidence 2699999999999998876442 4678899999999999999999 888 999999999999987
Q ss_pred CCc-----eEEeccccccccCCCCCcceeeeccCCCcccCCcccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 294 EMI-----GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL--GCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 294 ~~~-----~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++. +||+|||+++.... ......||+.|+|||.+. ...++.++|||||||++|+|++|..||.+..
T Consensus 160 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 160 LDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 776 99999999975422 223356899999999984 4557899999999999999999999998654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=300.77 Aligned_cols=201 Identities=22% Similarity=0.325 Sum_probs=166.3
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCc--chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|++.+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|+.++.+++||||+++++++. .....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence 5788999999999999999994 46899999998643332 2466789999999999999999999984 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 145 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQR---------GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCD 145 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSS---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCchHHHHHhhhc---------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEee
Confidence 99999999999999887654 4678889999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||++........ ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+..
T Consensus 146 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 146 FGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp CTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999986643222 1223458999999999876 567999999999999999999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=312.73 Aligned_cols=202 Identities=20% Similarity=0.326 Sum_probs=162.6
Q ss_pred hhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--------CcchhHHHHHHHHHHhCCCCCcceeeeeecc
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--------PGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 212 (367)
...++|.+.+.||+|+||.||+|. ..+++.||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 346789999999999999999998 4568999999987422 1123458899999999999999999998732
Q ss_pred cccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec
Q 017712 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (367)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~ 292 (367)
...++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++
T Consensus 212 ------~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~ 273 (419)
T 3i6u_A 212 ------EDYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLS 273 (419)
T ss_dssp ------SEEEEEEECCTTCBGGGGTSSSC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEES
T ss_pred ------CceEEEEEcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEe
Confidence 23589999999999999987654 4778899999999999999999 88999999999999996
Q ss_pred CC---CceEEeccccccccCCCCCcceeeeccCCCcccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 293 DE---MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 293 ~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.+ ..+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 274 ~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 274 SQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp SSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 54 459999999998764322 2233458999999999864 567889999999999999999999997653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=300.82 Aligned_cols=206 Identities=31% Similarity=0.468 Sum_probs=161.5
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCc--chhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
.....++|++.+.||+|+||.||+|+. ...+|+|+++..... ..+.+.+|+.++++++||||+++++++.
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------ 90 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------ 90 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEES--SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------
T ss_pred CccCccceeeeeEecCCCCeEEEEEEE--cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------
Confidence 344567899999999999999999974 346999998744332 3467899999999999999999999752
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....++||||+++++|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~ 159 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTV 159 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred CCccEEEEEecCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCE
Confidence 2346899999999999999965432 4778899999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||++................||+.|+|||.+. +..++.++||||||+++|+|++|..||.+..
T Consensus 160 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp EECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred EEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 999999998654433333334456899999999986 5678889999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=296.21 Aligned_cols=201 Identities=22% Similarity=0.362 Sum_probs=172.0
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
..++|++.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.++++++||||+++++++. ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCC
Confidence 35689999999999999999998 45689999999874332 23467889999999999999999999973 445
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc---
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI--- 296 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~--- 296 (367)
..+++|||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~ 146 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAA 146 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCC
T ss_pred EEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCc
Confidence 6799999999999999887554 4678899999999999999999 889999999999999976655
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 147 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 147 VKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp EEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 99999999976643322 22345899999999999999999999999999999999999999764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=295.00 Aligned_cols=202 Identities=25% Similarity=0.462 Sum_probs=153.5
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++.+++||||+++++++. ...
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence 35788899999999999999984 67999999998632 2233577899999999999999999999973 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl 153 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVK--------PFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKI 153 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEE
T ss_pred eEEEEEecCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEE
Confidence 67999999999999999986532 4678899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.
T Consensus 154 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 154 ADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp CCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred EeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 99999986543221 122345899999999999888999999999999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=302.71 Aligned_cols=219 Identities=26% Similarity=0.345 Sum_probs=178.2
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhC-CCCCcceeeee
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTA 209 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 209 (367)
..+....++|++.+.||+|+||.||+|+. .+++.||+|+++.... ...+.+.+|+.++.++ +||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 34445567899999999999999999983 3467899999874433 2457789999999999 99999999999
Q ss_pred ecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC---------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeE
Q 017712 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIA 280 (367)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~ii 280 (367)
+. .....++||||+++|+|.+++........ ......+++..++.++.|++.||.||| +++|+
T Consensus 96 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~ 167 (313)
T 1t46_A 96 CT-----IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCI 167 (313)
T ss_dssp EC-----SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred Ee-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence 84 34456999999999999999976542100 001123778999999999999999999 88999
Q ss_pred ecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 017712 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359 (367)
Q Consensus 281 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~P 359 (367)
||||||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|+|+| |..|
T Consensus 168 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 247 (313)
T 1t46_A 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (313)
T ss_dssp CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654433222233446789999999998899999999999999999999 9999
Q ss_pred CCCCC
Q 017712 360 SDGIF 364 (367)
Q Consensus 360 f~~~~ 364 (367)
|.+..
T Consensus 248 ~~~~~ 252 (313)
T 1t46_A 248 YPGMP 252 (313)
T ss_dssp STTCC
T ss_pred CCccc
Confidence 98754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=302.33 Aligned_cols=222 Identities=25% Similarity=0.366 Sum_probs=167.0
Q ss_pred hHHHHhhcCCCCCCCcccccCceEEEEEEec----CCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeee
Q 017712 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAF 210 (367)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~ 210 (367)
+.++....++|.+.+.||+|+||.||+|... ++..||+|.++.... ...+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3444556678999999999999999999843 345899999874432 2346789999999999999999999998
Q ss_pred cccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCcee
Q 017712 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (367)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil 290 (367)
...........+++|||+++++|.+++....... ....+++..++.++.|++.||.||| +++|+||||||+||+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIl 179 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET---GPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCM 179 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTT---SCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEE
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhc---CCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEE
Confidence 6544333345699999999999999985322110 0114778999999999999999999 899999999999999
Q ss_pred ecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 99999999999999987644332222233457889999999999999999999999999999999 999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.77 Aligned_cols=211 Identities=26% Similarity=0.382 Sum_probs=177.3
Q ss_pred hHHHHhhcCCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc
Q 017712 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (367)
+..+....++|++.+.||+|+||.||+|... ++..||+|.++... ...+.|.+|+.++++++||||++++++|.
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~---- 286 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT---- 286 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe----
Confidence 4455566678888999999999999999954 48899999987533 35678999999999999999999999984
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
.....++||||+++|+|.+++...... .+++..++.++.||+.||.||| +++|+||||||+|||++.++
T Consensus 287 -~~~~~~lv~E~~~~g~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~ 355 (495)
T 1opk_A 287 -REPPFYIITEFMTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENH 355 (495)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred -cCCcEEEEEEccCCCCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCC
Confidence 334579999999999999999754321 4678889999999999999999 88999999999999999999
Q ss_pred ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
.+||+|||+++...... ........+++.|+|||++.+..++.++|||||||++|||+| |..||.+..
T Consensus 356 ~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 356 LVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp CEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 99999999998664321 111122335778999999998889999999999999999999 999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=307.13 Aligned_cols=197 Identities=24% Similarity=0.372 Sum_probs=166.8
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+|++++.++ +||||+++++++ ......
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVY-----DDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEE
Confidence 45688899999999999999994 5689999999975432 345788888887 799999999997 345678
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC----Cce
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE----MIG 297 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~----~~~ 297 (367)
++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||+.++ +.+
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~ 159 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQK---------FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESI 159 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCT---------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGE
T ss_pred EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeE
Confidence 99999999999999998654 5778999999999999999999 8899999999999998433 359
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 160 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 160 RICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp EECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred EEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 9999999986643322 223346899999999998878899999999999999999999999763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=300.43 Aligned_cols=213 Identities=25% Similarity=0.389 Sum_probs=180.1
Q ss_pred CChHHHHhhcCCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeeccc
Q 017712 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGV 213 (367)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (367)
+.++++....++|++.+.||+|+||.||+|... ++..||+|.+... ....+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 79 (288)
T 3kfa_A 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-- 79 (288)
T ss_dssp TTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred CchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--
Confidence 445566667788999999999999999999944 5889999998743 335678999999999999999999999973
Q ss_pred ccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
.....++||||+++++|.+++...... .+++..++.++.|++.||.||| +++|+||||||+||+++.
T Consensus 80 ---~~~~~~~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~ 146 (288)
T 3kfa_A 80 ---REPPFYIITEFMTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGE 146 (288)
T ss_dssp ---SSSSEEEEEECCTTEEHHHHHHHCCTT-------TSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECG
T ss_pred ---cCCCEEEEEEcCCCCcHHHHHHhcccC-------CccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcC
Confidence 345579999999999999999764321 4778889999999999999999 889999999999999999
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 147 ~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 147 NHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp GGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999986643322 22223346888999999998899999999999999999999 999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=305.81 Aligned_cols=208 Identities=21% Similarity=0.288 Sum_probs=173.9
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
..++|++.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.++.+++||||+++++++..........
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 35689999999999999999998 45688999999874332 23467889999999999999999999986554445567
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||++ ++|.+++... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEcccC-cCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEE
Confidence 899999996 5999998754 3678899999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCcc-eeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 999998664332211 1233468999999998654 458999999999999999999999998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=302.76 Aligned_cols=221 Identities=24% Similarity=0.316 Sum_probs=179.6
Q ss_pred hHHHHhhcCCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecCCCc-chhHHHHHHHHHHhC-CCCCcceeee
Q 017712 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRPG-GSKSFKSECKAAINI-KHRNIVRVFT 208 (367)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~ 208 (367)
...+....++|++.+.||+|+||.||+|.. .+++.||+|+++..... ....+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 445556678899999999999999999973 34688999998753322 345788999999999 7999999999
Q ss_pred eecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCC-------CcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEe
Q 017712 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAH 281 (367)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH 281 (367)
++.. .....+++|||+++++|.+++......... .....+++..+..++.|++.||.||| +++|+|
T Consensus 99 ~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H 171 (316)
T 2xir_A 99 ACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIH 171 (316)
T ss_dssp EECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred EEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence 9742 334579999999999999999875421000 00112778999999999999999999 889999
Q ss_pred cCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 017712 282 CNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPS 360 (367)
Q Consensus 282 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf 360 (367)
|||||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|+|+| |..||
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654333333333457889999999999899999999999999999998 99999
Q ss_pred CCCC
Q 017712 361 DGIF 364 (367)
Q Consensus 361 ~~~~ 364 (367)
.+..
T Consensus 252 ~~~~ 255 (316)
T 2xir_A 252 PGVK 255 (316)
T ss_dssp TTCC
T ss_pred cccc
Confidence 8754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=304.09 Aligned_cols=205 Identities=25% Similarity=0.433 Sum_probs=164.2
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCE----EEEEEeec-CCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTT----IAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~----vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
.++|++.+.||+|+||.||+|. ..+++. ||+|.+.. ........+.+|+.++.+++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 4579999999999999999998 344554 57777653 233456789999999999999999999999843
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
...+++++|+++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+|||++.++.+
T Consensus 89 -~~~~~v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~ 156 (327)
T 3lzb_A 89 -STVQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV 156 (327)
T ss_dssp -SSEEEEECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEE
T ss_pred -CCceEEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCE
Confidence 125899999999999999976432 4678889999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~~ 365 (367)
||+|||+++...............||+.|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus 157 kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp EECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred EEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 9999999987654433333344457889999999999999999999999999999999 9999987643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=306.85 Aligned_cols=202 Identities=21% Similarity=0.294 Sum_probs=164.8
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (367)
..++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++..... ...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 356899999999999999999994 5799999999864322 234678899999999999999999999854321 122
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+ +++|.+++... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE----------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred ceEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEE
Confidence 4569999999 88999999753 3668889999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 169 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 169 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999865332 223458999999999887 67899999999999999999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=304.53 Aligned_cols=201 Identities=23% Similarity=0.365 Sum_probs=162.2
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|.+.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.++++++||||+++++++. .....+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 5788899999999999999994 4789999999864332 22234568999999999999999999973 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||++ |+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 77 lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Df 144 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGN--------IINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADF 144 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSS
T ss_pred EEecccc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccC
Confidence 9999996 599998876442 3678889999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 145 g~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 145 GLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp SEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998653322 12223457999999999876 568999999999999999999999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=295.60 Aligned_cols=199 Identities=26% Similarity=0.425 Sum_probs=169.0
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|. ..++..||+|++.... ......+.+|+.++++++||||+++++++. ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cCC
Confidence 4578899999999999999998 4567899999986321 223567889999999999999999999973 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l 150 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKI 150 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEE
T ss_pred EEEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEE
Confidence 6799999999999999987644 4678899999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 151 ~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 151 ADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp CSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred EeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 999998654322 122345899999999999989999999999999999999999999764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=294.08 Aligned_cols=200 Identities=23% Similarity=0.363 Sum_probs=169.5
Q ss_pred CCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCCc------chhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
++|++.+.||+|+||.||+|+.. +++.||+|.++..... ..+.+.+|+.++++++||||+++++++. .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence 46888899999999999999954 6899999998743221 3577999999999999999999999974 3
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC--
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-- 295 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~-- 295 (367)
....+++|||+++++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 147 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKE---------SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVP 147 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSS
T ss_pred CCeEEEEEeecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCC
Confidence 456799999999999999997543 4678899999999999999999 88999999999999998877
Q ss_pred --ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 296 --IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 296 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+..
T Consensus 148 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 148 NPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp SCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 89999999998654322 2223458999999999998899999999999999999999999997643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.49 Aligned_cols=199 Identities=23% Similarity=0.344 Sum_probs=169.0
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.++|.+.+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.++++++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence 34688889999999999999994 578999999998655445677899999999999999999999973 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee---cCCCceEE
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHV 299 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~---~~~~~~kl 299 (367)
++|||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||
T Consensus 83 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl 150 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERG---------VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMI 150 (304)
T ss_dssp EEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEB
T ss_pred EEEEcCCCccHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEE
Confidence 9999999999999987544 4678889999999999999999 8899999999999999 78899999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 151 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 151 TDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp CSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 9999997543221 12335899999999999999999999999999999999999999764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=305.88 Aligned_cols=207 Identities=21% Similarity=0.299 Sum_probs=165.3
Q ss_pred hhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-----
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY----- 215 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 215 (367)
...++|++.+.||+|+||.||+|+ ..+++.||+|++.... ....+|+.+++.++||||++++++|.....
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 456789999999999999999998 4679999999986432 223479999999999999999999854321
Q ss_pred ----------------------------CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHH
Q 017712 216 ----------------------------QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267 (367)
Q Consensus 216 ----------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~ 267 (367)
....+.++||||++ ++|.+.+...... ...+++..+..++.||+.|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-----GRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHH
Confidence 23455789999997 5887776531100 0147788999999999999
Q ss_pred HHHhhhCCCCCeEecCCCCCceeec-CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHH
Q 017712 268 LRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYS 345 (367)
Q Consensus 268 L~~lH~~~~~~iiH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws 345 (367)
|.||| +++|+||||||+|||++ .++.+||+|||+++........ ....||+.|+|||.+.+. .++.++||||
T Consensus 154 L~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 154 VGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 99999 89999999999999997 6889999999999876443322 234579999999998875 4899999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 017712 346 FGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 346 lG~~l~el~tg~~Pf~~~~ 364 (367)
|||++|||++|+.||.+..
T Consensus 228 lG~il~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGET 246 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHhCCCCCCCCC
Confidence 9999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=295.70 Aligned_cols=201 Identities=20% Similarity=0.304 Sum_probs=172.7
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|.+.+.||+|+||.||+|.. .+++.+|+|++.... ....+.+.+|+.+++.++||||+++++++. ...
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence 35788899999999999999994 458899999987432 224567889999999999999999999973 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 156 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKI 156 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEE
Confidence 6799999999999999987644 4678899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||++......... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 157 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 157 GDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp CCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred EeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999866432221 22345899999999999988999999999999999999999999764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=292.34 Aligned_cols=200 Identities=25% Similarity=0.369 Sum_probs=169.3
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.|.+.+.||+|+||.||+|. ..++..||+|.+.... ....+.+.+|+.++++++||||+++++++.... ......+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEE
Confidence 46777889999999999998 4568899999987432 234567899999999999999999999875432 3456789
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCCceeec-CCCceEE
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLD-DEMIGHV 299 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~--iiH~dlkp~Nil~~-~~~~~kl 299 (367)
+||||+++++|.+++.... .+++..+..++.|++.||.||| +.+ |+||||||+||+++ .++.+||
T Consensus 106 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl 173 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred EEEEecCCCCHHHHHHHcc---------CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEE
Confidence 9999999999999997643 4668889999999999999999 778 99999999999997 7899999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||++...... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+.
T Consensus 174 ~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 174 GDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eeCCCccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 999999754332 2233458999999998875 5899999999999999999999999764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=307.77 Aligned_cols=201 Identities=22% Similarity=0.320 Sum_probs=168.7
Q ss_pred CCCCCCCcccccCceEEEEEEe----cCCCEEEEEEeecCC----CcchhHHHHHHHHHHhC-CCCCcceeeeeeccccc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 215 (367)
++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++.++ +||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---- 129 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---- 129 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe----
Confidence 5789999999999999999985 478999999986322 23456678899999999 6999999999873
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
.....++||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++
T Consensus 130 -~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~ 196 (355)
T 1vzo_A 130 -TETKLHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNG 196 (355)
T ss_dssp -ETTEEEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTS
T ss_pred -eCceEEEEeecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCC
Confidence 3456799999999999999997644 4678899999999999999999 88999999999999999999
Q ss_pred ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC--EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 197 ~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 197 HVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp CEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred cEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 9999999999865432221 22234689999999998863 4789999999999999999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=301.98 Aligned_cols=204 Identities=24% Similarity=0.356 Sum_probs=164.2
Q ss_pred hhcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC-----cchhHHHHHHHHHHhCCCCCcceeeeeeccccc
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-----GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (367)
...++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.++.+++||||+++++++.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 82 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG---- 82 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe----
Confidence 3456899999999999999999994 5689999999874322 12357889999999999999999999973
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
.....++||||+++ +|.+++..... .+++..+..++.|++.||.||| +++|+||||||+|||++.++
T Consensus 83 -~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~ 149 (346)
T 1ua2_A 83 -HKSNISLVFDFMET-DLEVIIKDNSL--------VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENG 149 (346)
T ss_dssp -CTTCCEEEEECCSE-EHHHHHTTCCS--------SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred -eCCceEEEEEcCCC-CHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCC
Confidence 34557999999975 89998876432 3667788999999999999999 88999999999999999999
Q ss_pred ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.+||+|||+++....... ......||+.|+|||.+.+. .++.++|||||||++|+|++|.+||.+..
T Consensus 150 ~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 150 VLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp CEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 999999999987643222 22234589999999998764 47899999999999999999999997643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=301.90 Aligned_cols=201 Identities=20% Similarity=0.304 Sum_probs=173.2
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|.+.+.||+|+||.||++.. .+++.+|+|++.... ....+.+.+|+.+++.++||||+++++++. ...
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence 45788999999999999999994 458899999987432 234567889999999999999999999974 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++++|.+++.... .+++.+++.++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl 182 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKI 182 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecCCCCCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEE
Confidence 6799999999999999987644 4678899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||++......... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 183 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 183 GDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp CCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eeccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 999999866432221 22345899999999999988999999999999999999999999764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=318.37 Aligned_cols=209 Identities=25% Similarity=0.427 Sum_probs=171.6
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
..+....++|++.+.||+|+||.||+|...++..||+|+++... ...+.+.+|+.++++++||||+++++++..
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----- 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----
Confidence 34555667889999999999999999998777889999987533 345789999999999999999999998732
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
...++||||+++|+|.+++..... ..+++..++.++.|++.||.||| +++|+||||||+|||++.++.+
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~ 319 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVC 319 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred -CceEEEehhhcCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCE
Confidence 346899999999999999974321 13678889999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||+| |..||.+..
T Consensus 320 kl~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 320 KVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp EECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EECCCccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 9999999986643221 11223346789999999998899999999999999999999 999998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=313.15 Aligned_cols=206 Identities=25% Similarity=0.393 Sum_probs=171.5
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|.+.+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCee
Confidence 35688999999999999999994 458999999987433 2345778899999999999999999998753 233467
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee----cCCCce
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIG 297 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~----~~~~~~ 297 (367)
++||||+++|+|.+++...... ..+++..++.++.|++.||.||| +++|+||||||+|||+ +.++.+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEE
T ss_pred EEEEecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeE
Confidence 9999999999999999764311 12778999999999999999999 8899999999999999 778889
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG--------CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 156 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp EECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred EEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999998764432 2223458999999998765 456788999999999999999999997543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=318.39 Aligned_cols=199 Identities=26% Similarity=0.404 Sum_probs=172.1
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC---CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++++. ....
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 100 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKGY 100 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCCE
Confidence 4688889999999999999994 578999999986432 335678999999999999999999999973 4556
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee---cCCCce
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIG 297 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~---~~~~~~ 297 (367)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||+ +.++.+
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 168 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRK---------RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANI 168 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---------CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCE
T ss_pred EEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcE
Confidence 799999999999999997655 4778999999999999999999 8899999999999999 567899
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..
T Consensus 169 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 169 RIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp EECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999986644322 223458999999999876 68999999999999999999999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.34 Aligned_cols=200 Identities=24% Similarity=0.377 Sum_probs=169.9
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++++++||||+++++++. ....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCE
Confidence 35688899999999999999994 57899999998632 2345678899999999999999999999973 4556
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec---CCCce
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DEMIG 297 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~---~~~~~ 297 (367)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++ .++.+
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 163 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDI 163 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCE
T ss_pred EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCE
Confidence 799999999999999887554 4778899999999999999999 88999999999999994 45679
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..
T Consensus 164 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 164 KIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp EECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999998654322 2233458999999999876 58999999999999999999999997643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.92 Aligned_cols=203 Identities=22% Similarity=0.315 Sum_probs=166.0
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|.+.+.||+|+||.||+|. ..++..+|+|.+.... ....+.+.+|++++++++||||+++++++. .....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeEE
Confidence 468888999999999999998 4568999999987543 335678999999999999999999999973 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee---cCCCceEE
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHV 299 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~---~~~~~~kl 299 (367)
+||||+++|+|.+++..... ....+++..+..++.|++.||.||| +++|+||||||+||++ +.++.+||
T Consensus 97 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQA-----RGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHH-----HTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred EEEEeCCCCcHHHHHHhhhh-----cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEE
Confidence 99999999999998854210 0014678899999999999999999 8899999999999999 45688999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||++........ .....||+.|+|||.+. ..++.++||||||+++|+|++|+.||.+..
T Consensus 169 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 169 IDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp CCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 99999986543222 23345899999999976 468899999999999999999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=293.74 Aligned_cols=199 Identities=25% Similarity=0.439 Sum_probs=171.9
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++++++||||+++++++. ...
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCC
Confidence 35788899999999999999994 46789999998632 2234567899999999999999999999973 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 155 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHG---------RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKI 155 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEE
T ss_pred EEEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEE
Confidence 6799999999999999997644 4678899999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 156 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 156 ADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp CCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 9999987654322 12345899999999999989999999999999999999999999764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=298.54 Aligned_cols=205 Identities=20% Similarity=0.340 Sum_probs=161.0
Q ss_pred hhcCCCCCCCcccccCceEEEEEEecC----CCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccC
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
...++|++.+.||+|+||.||+|.... +..||+|.+..... ...+.+.+|+.++++++||||+++++++.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 86 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-----
Confidence 345678899999999999999998432 45699999864332 23567899999999999999999999873
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
....++||||+++++|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 154 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDC 154 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTE
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCC
Confidence 2346899999999999999975432 4678889999999999999999 889999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 155 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 155 VKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp EEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 999999999866432221 1223346789999999998899999999999999999997 999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=304.04 Aligned_cols=201 Identities=22% Similarity=0.366 Sum_probs=161.5
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
..++|++.+.||+|+||.||+|+ ..+++.||+|+++.... .....+.+|+.++++++||||+++++++. ...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HNH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ETT
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cCC
Confidence 34679999999999999999998 55789999999864332 23456789999999999999999999974 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee-----cCC
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL-----DDE 294 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~-----~~~ 294 (367)
..++||||++ |+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||+ +.+
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~~---------~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 173 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKNP---------DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASET 173 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----C
T ss_pred EEEEEEecCC-CCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCcc
Confidence 6799999997 59999998665 4678899999999999999999 8899999999999999 455
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 174 PVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp CEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 5699999999986543221 22234579999999998875 4899999999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=313.71 Aligned_cols=209 Identities=17% Similarity=0.205 Sum_probs=162.8
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHH---HHHHhCCCCCcceeeeeec-----
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSEC---KAAINIKHRNIVRVFTAFS----- 211 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~~~~~~~----- 211 (367)
.++|.+.+.||+|+||.||+|+ ..+++.||||++... .....+.+.+|+ +++++++||||+++++.+.
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4678889999999999999999 467999999999732 334557889999 4555668999999984432
Q ss_pred --cccc-------CCc-----eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCC
Q 017712 212 --GVDY-------QGA-----RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP 277 (367)
Q Consensus 212 --~~~~-------~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~ 277 (367)
.... .+. ...+++|||+ +|+|.+++....... .....+++..++.++.||+.||+||| ++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH---~~ 225 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLH---HY 225 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT--TTTHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc--cccccccHHHHHHHHHHHHHHHHHHH---hC
Confidence 1100 000 1368999999 689999997543111 11124667888899999999999999 88
Q ss_pred CeEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC-----------CCCcchhHHHH
Q 017712 278 PIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-----------EASTYGDVYSF 346 (367)
Q Consensus 278 ~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dvwsl 346 (367)
+|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 999999999999999999999999999985322 2334457 999999999887 79999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 017712 347 GILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 347 G~~l~el~tg~~Pf~~~~ 364 (367)
||++|||++|+.||.+..
T Consensus 300 G~il~elltg~~Pf~~~~ 317 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDA 317 (377)
T ss_dssp HHHHHHHHHSSCCC----
T ss_pred HHHHHHHHHCCCCCcccc
Confidence 999999999999997643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=306.87 Aligned_cols=204 Identities=28% Similarity=0.440 Sum_probs=159.4
Q ss_pred CCCCCCcccccCceEEEEEEec--CC--CEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 146 GFSSANLIGAGNFGSVYNGTLF--DG--TTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.|.+.+.||+|+||.||+|+.. ++ ..||+|.++... ....+.+.+|+.++++++||||+++++++. .....
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----CCSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----cCCCC
Confidence 3566789999999999999843 22 468999886432 334578999999999999999999999873 33445
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~ 234 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVA 234 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred eEEEEECCCCCCHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEe
Confidence 6899999999999999976542 3567889999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCc--ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|||+++........ .......+|+.|+|||.+.+..++.++|||||||++|||+| |.+||.+..
T Consensus 235 DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp CC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred eccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 99999865432211 11223346889999999999899999999999999999999 788887654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=295.86 Aligned_cols=198 Identities=27% Similarity=0.410 Sum_probs=161.9
Q ss_pred CCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
++|++.+.||+|+||.||+|+. .++.||+|.+.. ....+.+.+|+.++++++||||+++++++.+ ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcEEE
Confidence 4688889999999999999985 478899999863 3456789999999999999999999998742 25899
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc-eEEeccc
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI-GHVGDFG 303 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~-~kl~Dfg 303 (367)
|||+++++|.+++...... ..++...++.++.|++.||.|||+...++|+||||||+||+++.++. +||+|||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg 151 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151 (307)
T ss_dssp EECCTTCBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred EEcCCCCCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence 9999999999999865421 13567888999999999999999321189999999999999988886 7999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||++.
T Consensus 152 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 152 TACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp C-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred cccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 99754321 12234899999999999989999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=315.58 Aligned_cols=201 Identities=23% Similarity=0.364 Sum_probs=169.2
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-------------cchhHHHHHHHHHHhCCCCCcceeee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-------------GGSKSFKSECKAAINIKHRNIVRVFT 208 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~ 208 (367)
..++|.+.+.||+|+||.||+|+ ..+++.+|+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45679999999999999999999 45689999999874321 23567899999999999999999999
Q ss_pred eecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCc
Q 017712 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSN 288 (367)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~N 288 (367)
++. .....++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|
T Consensus 114 ~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~N 176 (504)
T 3q5i_A 114 VFE-----DKKYFYLVTEFYEGGELFEQIINRH---------KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPEN 176 (504)
T ss_dssp EEE-----CSSEEEEEEECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred EEE-----cCCEEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHH
Confidence 983 4566799999999999999987654 4778999999999999999999 8899999999999
Q ss_pred eeecCCC---ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 289 VLLDDEM---IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 289 il~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||++.++ .+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..
T Consensus 177 il~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 177 ILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp EEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998775 69999999998764432 2223458999999999875 68999999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=291.72 Aligned_cols=198 Identities=30% Similarity=0.422 Sum_probs=160.0
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCC----cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP----GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|.. .++.+|+|+++.... ...+.+.+|+.+++.++||||+++++++. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 79 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KEP 79 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC-
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCC
Confidence 45788899999999999999985 588999999864322 23467899999999999999999999974 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC---eEecCCCCCceeecC---
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP---IAHCNLKPSNVLLDD--- 293 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~---iiH~dlkp~Nil~~~--- 293 (367)
..++||||+++++|.+++... .+++..+..++.|++.||.||| +++ |+||||||+||+++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~ 146 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSGK----------RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVE 146 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTSS----------CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCS
T ss_pred ceEEEEEcCCCCCHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccc
Confidence 579999999999999998643 3678889999999999999999 667 999999999999986
Q ss_pred -----CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 294 -----EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 294 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++.+||+|||++........ ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+..
T Consensus 147 ~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 147 NGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp SSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 77899999999986543221 23458999999999998889999999999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.41 Aligned_cols=196 Identities=22% Similarity=0.324 Sum_probs=166.0
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc---chhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
+.|++.+.||+|+||.||+|+ ..+++.||+|++...... ....+.+|+.++.+++||||+++++++.. ...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence 347788899999999999999 467899999998743322 23568899999999999999999999843 456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||++ |+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~ 196 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLG 196 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEEC
T ss_pred EEEEEecCC-CCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEe
Confidence 799999996 688888754321 4678889999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||+++..... ....||+.|+|||++. ...++.++|||||||++|||++|..||.+.
T Consensus 197 DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 197 DFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp CCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred eccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999865332 1245899999999984 567899999999999999999999999764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=300.86 Aligned_cols=209 Identities=23% Similarity=0.321 Sum_probs=171.2
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeeccccc---CC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY---QG 217 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 217 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.++..++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46799999999999999999994 6789999999864332 335678899999999999999999999854321 11
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....++||||+++ +|.+.+..... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred CceEEEEEeccCC-CHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCE
Confidence 4467999999965 88887765432 4778899999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCC--cceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDK--QNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999987643221 222234468999999999876 457999999999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=297.95 Aligned_cols=197 Identities=23% Similarity=0.305 Sum_probs=160.5
Q ss_pred CCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCCc--chhHHHHHHHHHHhC-CCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG--GSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.++||+|+||.||+|+.. +++.||||++...... ....+..|+..+.++ +||||++++++|. ....
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 47889999999999999999954 7999999997643322 233455566655555 8999999999983 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+ +++|.+++..... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~ 199 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGA--------SLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLG 199 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEEC
T ss_pred EEEEEecc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEc
Confidence 79999999 7799998875432 4778999999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|||++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+
T Consensus 200 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 200 DFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp CCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred cceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999998664322 2223458999999999876 789999999999999999999776643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.64 Aligned_cols=205 Identities=19% Similarity=0.229 Sum_probs=165.2
Q ss_pred cCCCCCCCcccccCceEEEEEEec----CCCEEEEEEeecCCCc-----------chhHHHHHHHHHHhCCCCCcceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPG-----------GSKSFKSECKAAINIKHRNIVRVFT 208 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~ 208 (367)
.++|.+.+.||+|+||.||+|... ++..+|+|++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999954 6788999998754321 1234678888999999999999999
Q ss_pred eecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCc
Q 017712 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSN 288 (367)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~N 288 (367)
++... .......++||||+ +++|.+++.... .+++..++.++.|++.||.||| +++|+||||||+|
T Consensus 116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N 181 (345)
T 2v62_A 116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAAN 181 (345)
T ss_dssp EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHH
Confidence 98542 23467789999999 999999997654 4778999999999999999999 8899999999999
Q ss_pred eeecCCC--ceEEeccccccccCCCCCc-----ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 289 VLLDDEM--IGHVGDFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 289 il~~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
||++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp EEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred EEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9998877 9999999999876432211 11133468999999999999999999999999999999999999996
Q ss_pred C
Q 017712 362 G 362 (367)
Q Consensus 362 ~ 362 (367)
+
T Consensus 262 ~ 262 (345)
T 2v62_A 262 Q 262 (345)
T ss_dssp G
T ss_pred c
Confidence 5
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=303.31 Aligned_cols=219 Identities=27% Similarity=0.406 Sum_probs=175.8
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEec-CC-----CEEEEEEeecCCC-cchhHHHHHHHHHHhC-CCCCcceeeee
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLF-DG-----TTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTA 209 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 209 (367)
..+....++|++.+.||+|+||.||+|... ++ ..||+|.+..... ...+.+.+|+.++.++ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 345556788999999999999999999843 22 4799999874432 2456789999999999 89999999999
Q ss_pred ecccccCCceeeeEEEEeccCCCHHHHhhCCCCC-----CCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC
Q 017712 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDT-----NWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (367)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dl 284 (367)
+. .....++||||+++|+|.+++...... ........+++..++.++.|++.||.||| +++|+||||
T Consensus 119 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dl 190 (333)
T 2i1m_A 119 CT-----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDV 190 (333)
T ss_dssp EC-----SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred Ee-----cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCc
Confidence 73 344579999999999999998753210 00001114678899999999999999999 889999999
Q ss_pred CCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 285 KPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|+|+| |..||.+.
T Consensus 191 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 191 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp SGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999999999986644332222223346789999999998899999999999999999998 99999875
Q ss_pred C
Q 017712 364 F 364 (367)
Q Consensus 364 ~ 364 (367)
.
T Consensus 271 ~ 271 (333)
T 2i1m_A 271 L 271 (333)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=297.66 Aligned_cols=202 Identities=20% Similarity=0.283 Sum_probs=162.4
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCc---chhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|+.++.+++||||+++++++.. ..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----DG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----CC
Confidence 46899999999999999999994 46899999998743222 24678899999999999999999999743 45
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++++|.+++.... .+++..++.++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl 175 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQG---------PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYL 175 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred eEEEEEEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEE
Confidence 6799999999999999997644 4678899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||++........ .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 176 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 176 VDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp CSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred ecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 99999976543221 1222345899999999999989999999999999999999999999764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=314.65 Aligned_cols=199 Identities=23% Similarity=0.354 Sum_probs=165.9
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|++.+.||+|+||.||+|+. .++..+|+|++.... ......+.+|+.+++.++||||++++++|. .....
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCEE
Confidence 4688899999999999999994 578999999987433 334678899999999999999999999983 44567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC---CCceE
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EMIGH 298 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~---~~~~k 298 (367)
++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++. ++.+|
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k 179 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIK 179 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred EEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEE
Confidence 99999999999999887544 4678889999999999999999 889999999999999976 45599
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..
T Consensus 180 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 180 IVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp ECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCeECCCCc---cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998764332 2233458999999999864 68999999999999999999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=299.94 Aligned_cols=202 Identities=22% Similarity=0.304 Sum_probs=166.6
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCc--chhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... ..+.+.+|+.++++++||||+++++++. ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCE
Confidence 45788899999999999999994 45899999998643332 2455789999999999999999999974 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~ 166 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN---------GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLC 166 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCCcchHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEE
Confidence 799999999999988876554 4678899999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+++....... ......||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+..
T Consensus 167 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 167 DFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp CCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999986543221 22234589999999998875 68999999999999999999999997653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=293.12 Aligned_cols=200 Identities=21% Similarity=0.327 Sum_probs=173.0
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.+.|++.+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+.++.+++||||+++++++.. ....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence 3468889999999999999998 4568999999997543 3356789999999999999999999999743 3467
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||+++++|.+++... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|
T Consensus 96 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~D 162 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPG----------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLAD 162 (303)
T ss_dssp EEEEECCTTEEHHHHHTTS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEee
Confidence 9999999999999999753 3678899999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 163 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 163 FGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp CTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 999986643221 122345899999999999989999999999999999999999999764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=303.44 Aligned_cols=202 Identities=21% Similarity=0.261 Sum_probs=162.2
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 219 (367)
.++|++.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.+++.++||||+++++++..... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4689999999999999999998 45689999999874322 234678899999999999999999999854321 2234
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||++ ++|.+++.. .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl 168 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 168 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEEcCC-CCHHHHHhh-----------ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEE
Confidence 6799999996 588888863 2557888999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 169 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 169 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp CCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998653321 222345899999999999999999999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=294.56 Aligned_cols=205 Identities=28% Similarity=0.426 Sum_probs=167.0
Q ss_pred CCCCCCCcccccCceEEEEEEecC----CCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.+|++.+.||+|+||.||+|+..+ ...+|+|.+..... ...+.+.+|+.++++++||||+++++++. ....
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cCCC
Confidence 357888999999999999998432 23589998874332 24567899999999999999999999863 3345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl 169 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKV 169 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTC--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEE
T ss_pred ceEEEEeCCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEE
Confidence 67899999999999999976432 3667889999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCC--cceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 300 GDFGMARFLPAIDK--QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+|||+++....... ........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||.+..
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp CSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred CcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 99999986644321 112233457889999999999899999999999999999999 667776543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=293.63 Aligned_cols=203 Identities=25% Similarity=0.408 Sum_probs=172.8
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++||||+++++++. .....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 79 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCE
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeE
Confidence 345788899999999999999998788899999987533 24578999999999999999999999974 334579
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+||
T Consensus 80 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~df 148 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDF 148 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCT
T ss_pred EEEeCCCCCcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccc
Confidence 99999999999999976432 3668889999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
|++....... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus 149 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 149 GMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp TGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 9998653321 111122346788999999998889999999999999999999 99999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=302.93 Aligned_cols=219 Identities=24% Similarity=0.362 Sum_probs=175.5
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeee
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAF 210 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 210 (367)
.++....++|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 455666778999999999999999999743 468899999874332 2345688999999999999999999997
Q ss_pred cccccCCceeeeEEEEeccCCCHHHHhhCCCCCC-CCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 017712 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN-WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNV 289 (367)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Ni 289 (367)
. .....++||||+++|+|.+++....... .......+++..++.++.|++.||.||| +++|+||||||+||
T Consensus 98 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NI 169 (322)
T 1p4o_A 98 S-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNC 169 (322)
T ss_dssp C-----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGE
T ss_pred c-----cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceE
Confidence 3 3445799999999999999987532000 0000013567889999999999999999 88999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 290 LLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 290 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 999999999999999986543322222222346889999999998889999999999999999999 899998753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=300.97 Aligned_cols=201 Identities=29% Similarity=0.441 Sum_probs=163.3
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHH--HhCCCCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA--INIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l--~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
..++|++.+.||+|+||.||+|+. +++.||+|++... ....+..|.+++ ..++||||+++++.+..........
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 456899999999999999999974 7899999998642 334455555554 4589999999998765554556667
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCC---------CeEecCCCCCceee
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP---------PIAHCNLKPSNVLL 291 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~---------~iiH~dlkp~Nil~ 291 (367)
.++||||+++|+|.+++.... .++..+..++.|++.||.||| +. +|+||||||+|||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill 153 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLV 153 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred EEEEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEE
Confidence 899999999999999997654 357788899999999999999 77 99999999999999
Q ss_pred cCCCceEEeccccccccCCCCC------cceeeeccCCCcccCCccccC-------CCCCcchhHHHHHHHHHHHHhCCC
Q 017712 292 DDEMIGHVGDFGMARFLPAIDK------QNRFICIKGSTGYIPPEYDLG-------CEASTYGDVYSFGILLLEMFTGIR 358 (367)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~tg~~ 358 (367)
+.++.+||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..
T Consensus 154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 233 (336)
T 3g2f_A 154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233 (336)
T ss_dssp CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence 9999999999999987643221 112223458999999999887 345678999999999999999977
Q ss_pred CC
Q 017712 359 PS 360 (367)
Q Consensus 359 Pf 360 (367)
||
T Consensus 234 p~ 235 (336)
T 3g2f_A 234 DL 235 (336)
T ss_dssp GG
T ss_pred cC
Confidence 65
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=292.24 Aligned_cols=206 Identities=23% Similarity=0.386 Sum_probs=170.2
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC----CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|.+.+.||+|+||.||+|.. .+++.+|+|+++... ......+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 46899999999999999999994 568999999986422 3345778999999999999999999998743 334
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||++++ |.+++...... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+|
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~k 149 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEK-------RFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLK 149 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTC-------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred CeEEEEehhccCC-HHHHHHhCccc-------ccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEE
Confidence 5679999999776 77777653321 4678899999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE--ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||++................||+.|+|||.+.+.. .+.++||||||+++|+|++|..||.+.
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 99999998765433333344456899999999987644 377999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=294.85 Aligned_cols=207 Identities=26% Similarity=0.417 Sum_probs=174.2
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
+....++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++||||+++++++.. .
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~ 80 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------E 80 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------C
Confidence 344556889999999999999999998788899999987433 346789999999999999999999998732 2
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||+++++|.+++.... ...+++..+..++.|++.||.||| +++++||||||+||+++.++.+||
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl 150 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPS-------GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKI 150 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHH-------HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred CcEEEEecCCCCCHHHHHhcCC-------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEE
Confidence 3689999999999999997532 113678899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 151 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 151 ADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp CCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 99999987643221 11122346788999999988889999999999999999999 999998753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=302.71 Aligned_cols=205 Identities=24% Similarity=0.340 Sum_probs=174.4
Q ss_pred cCCCCCCCcccccCceEEEEEEe-----cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++.. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence 35788899999999999999983 4688999999976555556779999999999999999999998753 345
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++++|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~k 167 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVK 167 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred ceEEEEEeecCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEE
Confidence 667999999999999999975321 4778999999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcc-eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+|||++.......... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999998764432211 11233478889999999988899999999999999999999999854
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=298.23 Aligned_cols=212 Identities=21% Similarity=0.251 Sum_probs=174.0
Q ss_pred CCChHHHHhhcCCCCCC-CcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCC-CCCcceeee
Q 017712 134 NPSFKDLYNATNGFSSA-NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIK-HRNIVRVFT 208 (367)
Q Consensus 134 ~~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~ 208 (367)
+..|+......+.|.+. +.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.++..+. ||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 33455555666677777 889999999999998 45689999999874332 34578899999999995 699999999
Q ss_pred eecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCc
Q 017712 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSN 288 (367)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~N 288 (367)
++. .....++||||+++|+|.+++...... .+++..++.++.|++.||.||| +++|+||||||+|
T Consensus 97 ~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~N 161 (327)
T 3lm5_A 97 VYE-----NTSEIILILEYAAGGEIFSLCLPELAE-------MVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQN 161 (327)
T ss_dssp EEE-----CSSEEEEEEECCTTEEGGGGGSSCC-C-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGG
T ss_pred EEE-----eCCeEEEEEEecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHH
Confidence 973 445679999999999999998654321 4778899999999999999999 8899999999999
Q ss_pred eeecC---CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 289 VLLDD---EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 289 il~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 162 Il~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 162 ILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp EEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99987 78999999999987643222 22345899999999999999999999999999999999999999764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=296.43 Aligned_cols=197 Identities=23% Similarity=0.344 Sum_probs=166.2
Q ss_pred cCCCCCCCcccccCceEEEEEEec-CC-------CEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF-DG-------TTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (367)
.++|.+.+.||+|+||.||+|... ++ ..||+|.+........+.+.+|+.++++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC--- 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC---
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe---
Confidence 357888999999999999999833 33 4799999976665667889999999999999999999999843
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
....++||||+++++|.+++..... .+++..++.++.|++.||.||| +++|+||||||+|||++.++
T Consensus 84 --~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~ 150 (289)
T 4fvq_A 84 --GDENILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREE 150 (289)
T ss_dssp --TTCCEEEEECCTTCBHHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECC
T ss_pred --CCCCEEEEECCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCC
Confidence 3456899999999999999976431 3778889999999999999999 88999999999999998887
Q ss_pred c--------eEEeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 017712 296 I--------GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTG-IRPSDG 362 (367)
Q Consensus 296 ~--------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg-~~Pf~~ 362 (367)
. +||+|||++...... ....||+.|+|||.+.+ ..++.++||||||+++|+|++| .+||.+
T Consensus 151 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 151 DRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp BGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 7 999999999754321 12347899999999987 6789999999999999999995 455544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=302.15 Aligned_cols=206 Identities=24% Similarity=0.373 Sum_probs=173.2
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCc--------chhHHHHHHHHHHhC-CCCCcceee
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--------GSKSFKSECKAAINI-KHRNIVRVF 207 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~~~ 207 (367)
.......++|.+.+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 33444556799999999999999999995 47999999998754321 135678999999999 799999999
Q ss_pred eeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCC
Q 017712 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPS 287 (367)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~ 287 (367)
+++. .....++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++||||||+
T Consensus 167 ~~~~-----~~~~~~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~ 229 (365)
T 2y7j_A 167 DSYE-----SSSFMFLVFDLMRKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPE 229 (365)
T ss_dssp EEEE-----BSSEEEEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred EEEe-----eCCEEEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence 9973 3456799999999999999997543 4678899999999999999999 889999999999
Q ss_pred ceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccC------CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 288 NVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG------CEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 288 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
||+++.++.+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 230 NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 230 NILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred HEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999987644322 233468999999998763 357889999999999999999999997
Q ss_pred CC
Q 017712 362 GI 363 (367)
Q Consensus 362 ~~ 363 (367)
+.
T Consensus 307 ~~ 308 (365)
T 2y7j_A 307 HR 308 (365)
T ss_dssp CS
T ss_pred CC
Confidence 64
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=290.20 Aligned_cols=200 Identities=22% Similarity=0.318 Sum_probs=168.3
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|++.+.||+|+||.||+|+. +++.+|+|+++.... ...+.+.+|+.++++++||||+++++++... .....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 84 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPHP 84 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSSC
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCCe
Confidence 35788899999999999999985 488999999875432 2346789999999999999999999998532 23567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCCceeecCCCceEE
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~--iiH~dlkp~Nil~~~~~~~kl 299 (367)
+++|||+++|+|.+++...... .+++..++.++.|++.||.||| +++ ++||||||+||+++.++.++|
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l 154 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNF-------VVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARI 154 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSC-------CCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEE
T ss_pred EeeecccCCCcHHHHHhhcccC-------CCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeE
Confidence 9999999999999999875421 3678899999999999999999 778 999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCc---chhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEAST---YGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||++...... ...||+.|+|||.+.+...+. ++||||||+++|||++|..||.+..
T Consensus 155 ~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 155 SMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp EGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred Eeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 999887643221 134799999999988765544 7999999999999999999998653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=293.01 Aligned_cols=204 Identities=23% Similarity=0.347 Sum_probs=168.6
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
..++|++.+.||+|+||.||+|+ ..+++.||+|++.... ....+.+|+.++..++|++++..+..+. ......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeec----CCCCce
Confidence 45789999999999999999999 4678999999876432 3456889999999999998888777763 344567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee---cCCCceE
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGH 298 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~---~~~~~~k 298 (367)
+++|||+ +++|.+++..... .+++..++.++.|++.||.||| +++|+||||||+|||+ +.++.+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~k 148 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEE
T ss_pred EEEEEcc-CCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEE
Confidence 9999999 9999999974332 4678899999999999999999 8899999999999999 7889999
Q ss_pred EeccccccccCCCCCcc-----eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+..
T Consensus 149 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred EecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 99999998765432211 1224468999999999999999999999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=304.97 Aligned_cols=203 Identities=22% Similarity=0.313 Sum_probs=154.8
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccc-cCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVD-YQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 218 (367)
..++|++.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.+++.++||||+++++++.... ....
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 45789999999999999999998 56789999999864322 24567889999999999999999999985421 1223
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++++|++ +++|.+++... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp CCCEEEEECC-CEECC-----C----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred CeEEEEeccc-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEE
Confidence 5579999999 78999988653 3678899999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999864321 223458999999999887 678999999999999999999999998753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=305.45 Aligned_cols=204 Identities=25% Similarity=0.337 Sum_probs=163.7
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~ 222 (367)
.+|++.+.||+|+||.||+|+. .+++.||||++.... ....+|++++++++||||++++++|..... ....+.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4688899999999999999995 468999999986432 223479999999999999999998854322 2345678
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC-CceEEec
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-MIGHVGD 301 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~-~~~kl~D 301 (367)
+||||+++ +|.+++..... ....+++..+..++.||+.||.||| +++|+||||||+|||++.+ +.+||+|
T Consensus 130 lv~e~~~~-~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSR-----AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eehhcccc-cHHHHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEecc
Confidence 99999975 67666542110 0014678889999999999999999 8999999999999999955 6789999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+++.+...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..
T Consensus 201 FG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 201 FGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp CTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred chhhhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9999876433222 234589999999998765 68999999999999999999999998753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=296.88 Aligned_cols=203 Identities=24% Similarity=0.347 Sum_probs=168.7
Q ss_pred CCCCCCCcccccCceEEEEEE-----ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-----LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
+.|++.+.||+|+||.||+|+ ..+++.||+|++.... ......+.+|+.++.+++||||+++++++.. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 457888999999999999998 3468899999987433 3345789999999999999999999999853 223
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++++|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~k 166 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVK 166 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEE
Confidence 557899999999999999954332 4678899999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
|+|||++......... .......||+.|+|||.+.+..++.++||||||+++|+|++|..|+.
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 9999999876543321 12223457888999999998889999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=306.08 Aligned_cols=199 Identities=26% Similarity=0.348 Sum_probs=170.1
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++.+++||||+++++++. .....
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCEE
Confidence 34788899999999999999994 468999999987542 234567899999999999999999999974 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCC-CeEecCCCCCceeecCCCceEEe
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~-~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~ 174 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLC 174 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEECCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEE
Confidence 99999999999999997654 4668889999999999999999 64 89999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 175 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 175 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp CCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999754221 122345899999999999999999999999999999999999999764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=291.32 Aligned_cols=204 Identities=23% Similarity=0.347 Sum_probs=171.8
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
..++|++.+.||+|+||.||+|+ ..+++.||+|++.... ....+.+|+.++..++|++++..+..+. ......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~ 80 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN 80 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCcccccc----CCCCce
Confidence 35689999999999999999999 4679999999986433 3457899999999999998877776653 334567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee---cCCCceE
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGH 298 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~---~~~~~~k 298 (367)
+++|||+ +++|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||++ +.++.+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~k 148 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEE
Confidence 9999999 9999999974332 4778899999999999999999 8899999999999999 4889999
Q ss_pred EeccccccccCCCCCcc-----eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+..
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 99999998765433211 1234468999999999999999999999999999999999999998753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=306.49 Aligned_cols=208 Identities=20% Similarity=0.259 Sum_probs=154.1
Q ss_pred CCC-CCcccccCceEEEEEEec---CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 147 FSS-ANLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 147 ~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
|.+ .++||+|+||.||+|+.. +++.||+|++... .....+.+|+.++++++||||++++++|.. ......+
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~~ 96 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRKVW 96 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeEE
Confidence 444 457999999999999854 5789999998632 345678899999999999999999999853 3345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee----cCCCceE
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIGH 298 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~----~~~~~~k 298 (367)
+||||++ ++|.+++..............+++..+..++.||+.||.||| +++|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999995 588888753221100011124778899999999999999999 8899999999999999 6788999
Q ss_pred EeccccccccCCCCC-cceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDK-QNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999999987643221 1222345689999999998874 4899999999999999999999999754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=294.52 Aligned_cols=195 Identities=21% Similarity=0.296 Sum_probs=167.7
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|++.+.||+|+||.||+|+ ..+++.||+|+++. ...+.+.+|+.++.+++ ||||+++++++.. ......
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCce
Confidence 3578999999999999999998 56789999999863 34678999999999997 9999999999853 224567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-ceEEe
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IGHVG 300 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~-~~kl~ 300 (367)
+++|||+++++|.+++. .++...+..++.|++.||.||| +++|+||||||+|||++.++ .+||+
T Consensus 109 ~lv~e~~~~~~l~~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~ 173 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLI 173 (330)
T ss_dssp EEEEECCCCCCHHHHGG------------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEEeccCchhHHHHHH------------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEE
Confidence 99999999999999885 3557889999999999999999 88999999999999999776 89999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|||+++....... .....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||..
T Consensus 174 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 174 DWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred eCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999986644322 223458999999999877 6689999999999999999999999943
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=289.14 Aligned_cols=201 Identities=24% Similarity=0.389 Sum_probs=164.9
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
..++|.+.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++. ..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TP 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cC
Confidence 346899999999999999999995 47899999998642 2334567899999999999999999999973 34
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++++|.+++.... .+++..+..++.|++.||.||| +++++|+||||+||+++.++.+|
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHG---------RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEE
Confidence 56799999999999999997654 4668889999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||++........ .....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.+.
T Consensus 152 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 152 IADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp ECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999986543221 223458999999999988765 68999999999999999999999764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=299.61 Aligned_cols=207 Identities=24% Similarity=0.303 Sum_probs=171.1
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
..++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.++++++||||+++++++..........
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 356899999999999999999994 4689999999864322 23456789999999999999999999876544444567
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||+. ++|.+++... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----------MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeccC-ccHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEE
Confidence 899999996 6999998753 3678899999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCcc--------eeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQN--------RFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999998764322111 1223458999999998764 67899999999999999999999999764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=297.35 Aligned_cols=213 Identities=24% Similarity=0.335 Sum_probs=169.9
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeeccccc
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 215 (367)
.++....++|++.+.||+|+||.||+|+. .+++.||+|++... ......+.+|+.++.++ +||||+++++++.....
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 33445677899999999999999999994 57899999998743 33567889999999998 79999999999854321
Q ss_pred C-CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 216 Q-GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 216 ~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
. .....++||||+++++|.+++..... ..+++..+..++.|++.||.||| +++|+||||||+||+++.+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTEN 165 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCC
Confidence 1 14567999999999999999975421 14678889999999999999999 8899999999999999999
Q ss_pred CceEEeccccccccCCCCCcceeeeccCCCcccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+.+||+|||++........ ......||+.|+|||.+. +..++.++|||||||++|+|++|..||.+.
T Consensus 166 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp CCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999986543221 122345899999999987 556889999999999999999999999764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=293.92 Aligned_cols=207 Identities=23% Similarity=0.327 Sum_probs=172.8
Q ss_pred hcCCCCCCCcccccCceEEEEEEe--cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhC---CCCCcceeeeeeccccc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL--FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINI---KHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~ 215 (367)
..++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456899999999999999999995 468899999987432 22345677888887776 89999999999853333
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
......+++|||++ |+|.+++...... .+++..+..++.|++.||.||| +++|+||||||+||+++.++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSG 157 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT-------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCC
Confidence 35677899999997 6999999765421 3678899999999999999999 88999999999999999999
Q ss_pred ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 158 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 158 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999998654322 223345899999999999989999999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.19 Aligned_cols=201 Identities=22% Similarity=0.326 Sum_probs=167.5
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
..++|++.+.||+|+||.||+|.. .+++.||+|.+... .....+.+|+.++.+++||||+++++++.. ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence 456789999999999999999984 45899999998753 346789999999999999999999999743 3467
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+++|||+++++|.+++..... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d 168 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNK--------TLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLAD 168 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEee
Confidence 999999999999999863221 4678899999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 169 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 169 FGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp CTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 999976543221 122345899999999999989999999999999999999999999764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=296.23 Aligned_cols=211 Identities=21% Similarity=0.208 Sum_probs=171.6
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
..++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.... ......
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCcee
Confidence 346799999999999999999994 679999999987655556678999999999999999999999985321 245577
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||+++|+|.+++...... ...+++..++.++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEe
Confidence 9999999999999998752110 014778999999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCc-------ceeeeccCCCcccCCccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 302 FGMARFLPAIDKQ-------NRFICIKGSTGYIPPEYDLGCE---ASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 302 fg~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
||++......... .......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 9998754321111 0112234799999999987654 68899999999999999999999964
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=301.92 Aligned_cols=205 Identities=24% Similarity=0.325 Sum_probs=163.6
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~ 222 (367)
..+|++.+.||+|+||.||+|+...+..+|+|++..... ...+|+.+++.++||||++++++|..... ....+.+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346899999999999999999976767799998864322 22479999999999999999999855432 3445678
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec-CCCceEEec
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGD 301 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~-~~~~~kl~D 301 (367)
+||||++++ +.+.+..... ....+++..+..++.|++.||.||| +++|+||||||+|||++ .++.+||+|
T Consensus 115 lv~e~~~~~-l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAK-----LKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHH-----TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEeeccCcc-HHHHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 999999764 4443321100 0014678889999999999999999 88999999999999998 799999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..
T Consensus 186 FG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 186 FGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp CTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999876433222 234589999999998765 58999999999999999999999998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=289.93 Aligned_cols=203 Identities=27% Similarity=0.385 Sum_probs=166.8
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
++|.....||+|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||+++++++. .....++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEE
Confidence 345556689999999999999 4568999999998666666788999999999999999999999984 3346799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-CCceEEecc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVGDF 302 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-~~~~kl~Df 302 (367)
+|||+++++|.+++...... ..+++..+..++.|++.||.||| +++++||||||+||+++. ++.+||+||
T Consensus 97 v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCT
T ss_pred EEEeCCCCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeec
Confidence 99999999999999764311 13557788889999999999999 889999999999999987 899999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE--ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|++........ ......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.
T Consensus 168 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 168 GTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp TTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred ccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 99986643221 122345899999999987643 789999999999999999999999653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.65 Aligned_cols=208 Identities=23% Similarity=0.321 Sum_probs=170.5
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 45788999999999999999994 5789999999975332 245678899999999999999999998743 23456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC-----eEecCCCCCceeecCCC
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP-----IAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~-----iiH~dlkp~Nil~~~~~ 295 (367)
.++||||+++++|.+++...... ...+++..++.++.|++.||.||| +.+ ++||||||+||+++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~ 153 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQ 153 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSS
T ss_pred EEEEEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCC
Confidence 79999999999999999753210 013678899999999999999999 667 99999999999999999
Q ss_pred ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+..
T Consensus 154 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 154 NVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp CEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 999999999986543221 1123358999999999999889999999999999999999999998653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=295.74 Aligned_cols=204 Identities=22% Similarity=0.281 Sum_probs=168.2
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
..++|++.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++.+++||||+++++++. .....
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCCeE
Confidence 456799999999999999999995 458999999998666667788999999999999999999999974 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||+++++|.+++..... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~D 160 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDR--------GLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLAD 160 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEE
Confidence 999999999999998865321 4678899999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccc-----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYD-----LGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||++....... .......||+.|+|||.+ .+..++.++||||||+++|+|++|..||.+..
T Consensus 161 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 161 FGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp CHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 99875432111 111234589999999987 46678999999999999999999999998653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=291.45 Aligned_cols=200 Identities=27% Similarity=0.447 Sum_probs=169.8
Q ss_pred CCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc--------
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-------- 215 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------- 215 (367)
++|++.+.||+|+||.||+|... +++.||+|.+... ...+.+|+.++.+++||||+++++++....+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 46888899999999999999954 7999999998743 2467899999999999999999998754222
Q ss_pred ---CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec
Q 017712 216 ---QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (367)
Q Consensus 216 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~ 292 (367)
......+++|||+++++|.+++...... .+++..+..++.|++.||.||| +++|+||||||+||+++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-------KLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLV 156 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEc
Confidence 1245579999999999999999753211 4678889999999999999999 88999999999999999
Q ss_pred CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
.++.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 999999999999987644322 223458999999999999899999999999999999999998874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=320.87 Aligned_cols=209 Identities=25% Similarity=0.432 Sum_probs=175.9
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
..+....++|++.+.||+|+||.||+|...++..||||+++... ...+.|.+|+.+|++++||||+++++++..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----- 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-----
Confidence 44556667888999999999999999998777889999997543 345789999999999999999999998732
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
...++||||+++|+|.+++...... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~ 402 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVC 402 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred -ccceEeeehhcCCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcE
Confidence 3468999999999999999743210 3668889999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 403 kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 403 KVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp EECCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred EEcccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999986543211 11122346788999999998899999999999999999999 999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=296.45 Aligned_cols=205 Identities=27% Similarity=0.423 Sum_probs=163.8
Q ss_pred cCCCCCCCcccccCceEEEEEEecC-----CCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFD-----GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
.++|.+.+.||+|+||.||+|.... +..||+|.++.... .....+.+|+.++.+++||||+++++++. .
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----K 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----c
Confidence 3567778999999999999998432 23599999874332 23457889999999999999999999973 3
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....++||||+++++|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~ 186 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVC 186 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcE
Confidence 4567999999999999999975432 4678899999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999876433211 11122346788999999998899999999999999999999 999997653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=295.38 Aligned_cols=200 Identities=25% Similarity=0.349 Sum_probs=168.3
Q ss_pred CCCCCcccccCceEEEEEEe-----cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 147 FSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
|++.+.||+|+||.||++.. .+++.||+|+++.... .....+.+|+.++++++||||+++++++.. .....
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CCCce
Confidence 38889999999999988863 3678999999975432 235678999999999999999999999854 23456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++++|.+++.... +++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~ 176 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIG 176 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEEC
Confidence 799999999999999997643 667889999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 301 DFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 301 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|||++......... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 99999876543321 112234478889999999988899999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=289.78 Aligned_cols=202 Identities=25% Similarity=0.371 Sum_probs=165.1
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCC---EEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGT---TIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.|.+.+.||+|+||.||+|.. .++. .+|+|.+..... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CCCC
Confidence 355568899999999999983 3333 799999874333 245678999999999999999999999843 3344
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.+++|||+.+++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~ 166 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVA 166 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEEC
T ss_pred cEEEEecccCCCHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeC
Confidence 5899999999999999986432 4678889999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCC--cceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCC-CCC
Q 017712 301 DFGMARFLPAIDK--QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP-SDG 362 (367)
Q Consensus 301 Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~P-f~~ 362 (367)
|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..| |.+
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~ 231 (298)
T 3pls_A 167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231 (298)
T ss_dssp CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred cCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc
Confidence 9999986543221 1222334578899999999999999999999999999999995554 543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=292.46 Aligned_cols=204 Identities=24% Similarity=0.371 Sum_probs=169.6
Q ss_pred cCCCCCCC-cccccCceEEEEEEe---cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSAN-LIGAGNFGSVYNGTL---FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|.+.+ .||+|+||.||+|.. .++..||+|+++.... ...+.+.+|+.++.+++||||+++++++..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------ 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------
Confidence 34566666 899999999999974 3578899999975432 345678999999999999999999999721
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++++|.+++..... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~k 150 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAK 150 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCc--------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEE
Confidence 236999999999999999975432 4778899999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|+|||++......... .......||+.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999876433221 11222346889999999988889999999999999999998 999997654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=318.56 Aligned_cols=196 Identities=24% Similarity=0.380 Sum_probs=162.4
Q ss_pred cccccCceEEEEEEec---CCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEEEe
Q 017712 152 LIGAGNFGSVYNGTLF---DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (367)
Q Consensus 152 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (367)
.||+|+||.||+|... ++..||||+++... ....+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~ 416 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEM 416 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEEC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEe
Confidence 7999999999999843 45679999997543 3356789999999999999999999999842 237999999
Q ss_pred ccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccccc
Q 017712 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (367)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (367)
+++|+|.+++..... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 417 ~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 417 AGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp CTTCBHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred CCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 999999999975432 4778899999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 308 LPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 308 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 6433221 11122335689999999998899999999999999999998 999998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=290.99 Aligned_cols=204 Identities=21% Similarity=0.346 Sum_probs=167.2
Q ss_pred hcCCCCCCCcccccCceEEEEEEecC----CCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
..++|.+.+.||+|+||.||+|+..+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 34678889999999999999998432 3459999987542 2345778999999999999999999998732
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
...+++|||+++++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 152 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKN--------SLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECV 152 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEE
T ss_pred -CCCEEEEecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcE
Confidence 235899999999999999975432 3678889999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.+..
T Consensus 153 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~ 219 (281)
T 3cc6_A 153 KLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219 (281)
T ss_dssp EECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred EeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC
Confidence 99999999866432211 1223346889999999988889999999999999999998 999997543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=302.30 Aligned_cols=205 Identities=17% Similarity=0.207 Sum_probs=166.5
Q ss_pred cCCCCCCCcccccCceEEEEEEec---------CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeeccc-
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF---------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGV- 213 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 213 (367)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+... ..+.+|+.++.+++||||+++++.+...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 368999999999999999999854 3789999998743 5688999999999999999843322110
Q ss_pred ----------ccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecC
Q 017712 214 ----------DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283 (367)
Q Consensus 214 ----------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~d 283 (367)
........++||||+ +++|.+++..... ..+++..++.++.|++.||.||| +++|+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~D 184 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-------HVLSERSVLQVACRLLDALEFLH---ENEYVHGN 184 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSC
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCC
Confidence 012346779999999 9999999986421 15778999999999999999999 88999999
Q ss_pred CCCCceeecCCC--ceEEeccccccccCCCCCcc-----eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhC
Q 017712 284 LKPSNVLLDDEM--IGHVGDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356 (367)
Q Consensus 284 lkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg 356 (367)
|||+|||++.++ .+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 264 (352)
T 2jii_A 185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG 264 (352)
T ss_dssp CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999998 89999999998764432211 11234689999999999998999999999999999999999
Q ss_pred CCCCCCCC
Q 017712 357 IRPSDGIF 364 (367)
Q Consensus 357 ~~Pf~~~~ 364 (367)
+.||.+..
T Consensus 265 ~~pf~~~~ 272 (352)
T 2jii_A 265 FLPWTNCL 272 (352)
T ss_dssp CCTTGGGT
T ss_pred CCCcccCC
Confidence 99997653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=292.73 Aligned_cols=206 Identities=22% Similarity=0.368 Sum_probs=160.5
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
..++|++.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.++++++||||+++++++.. .
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 104 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----D 104 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence 34579999999999999999998 46789999999874322 234678899999999999999999999843 3
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...+++|||+++++|.+++...... ...+++..++.++.|++.||.||| +.+++||||||+||+++.++.+|
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~k 176 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVK 176 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred CcEEEEEecCCCCCHHHHHHHhccc-----ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEE
Confidence 4679999999999999998642100 014678889999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 177 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 177 LGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred EEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 999999986543221 122345899999999999989999999999999999999999999753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=294.65 Aligned_cols=212 Identities=20% Similarity=0.221 Sum_probs=158.7
Q ss_pred hhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccc---cC
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVD---YQ 216 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~---~~ 216 (367)
....+|++.+.||+|+||.||+|+ ..+++.||+|++..........+.+|+.++.++. ||||+++++++.... ..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 334578999999999999999999 4578999999987655556678899999999996 999999999984221 13
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCCceeecCC
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLDDE 294 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~--iiH~dlkp~Nil~~~~ 294 (367)
.....+++|||+. |+|.+++...... ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.+
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESR------GPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTT------CSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCC
Confidence 4566799999995 7999988642110 04778899999999999999999 778 9999999999999999
Q ss_pred CceEEeccccccccCCCCCcc----------eeeeccCCCcccCCccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 295 MIGHVGDFGMARFLPAIDKQN----------RFICIKGSTGYIPPEYD---LGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
+.+||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 999999999998764432211 11134589999999998 56678899999999999999999999997
Q ss_pred CC
Q 017712 362 GI 363 (367)
Q Consensus 362 ~~ 363 (367)
+.
T Consensus 255 ~~ 256 (337)
T 3ll6_A 255 DG 256 (337)
T ss_dssp --
T ss_pred ch
Confidence 54
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=295.47 Aligned_cols=200 Identities=21% Similarity=0.318 Sum_probs=164.5
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC--------CcchhHHHHHHHHHHhCCCCCcceeeeeecccc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--------PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (367)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 35688899999999999999984 568999999986422 1223468899999999999999999999732
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
. ..++||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.+
T Consensus 87 ---~-~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~ 150 (322)
T 2ycf_A 87 ---E-DYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQ 150 (322)
T ss_dssp ---S-SEEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSS
T ss_pred ---C-ceEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecC
Confidence 1 2699999999999999997654 4678889999999999999999 8899999999999999876
Q ss_pred Cc---eEEeccccccccCCCCCcceeeeccCCCcccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 295 MI---GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 295 ~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+. +||+|||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|..||.+..
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 151 EEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp SSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred CCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 54 9999999998654321 122345899999999964 4578899999999999999999999997643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=289.57 Aligned_cols=201 Identities=23% Similarity=0.314 Sum_probs=170.6
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC---------cchhHHHHHHHHHHhCC-CCCcceeeeeec
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---------GGSKSFKSECKAAINIK-HRNIVRVFTAFS 211 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 211 (367)
..++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 346899999999999999999994 4689999999975431 12356789999999995 999999999973
Q ss_pred ccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee
Q 017712 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (367)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~ 291 (367)
.....++||||+++++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||++
T Consensus 95 -----~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~ 157 (298)
T 1phk_A 95 -----TNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILL 157 (298)
T ss_dssp -----CSSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred -----cCCeEEEEEeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEE
Confidence 4466799999999999999997643 4678899999999999999999 8899999999999999
Q ss_pred cCCCceEEeccccccccCCCCCcceeeeccCCCcccCCcccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL------GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+.++.+||+|||++........ .....||+.|+|||.+. ...++.++||||||+++|+|++|..||.+.
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 158 DDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp CTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 9999999999999986643222 22345899999999875 456789999999999999999999999764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=304.57 Aligned_cols=204 Identities=23% Similarity=0.342 Sum_probs=169.2
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.++|++.++||+|+||.||+|+ ..+++.||||++.... ....+.+|+.++..++|++.+..+..+. ......+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEE
Confidence 4689999999999999999999 4679999999876433 3456889999999998755554444432 3345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee---cCCCceEE
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHV 299 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~---~~~~~~kl 299 (367)
+||||+ +++|.+++..... .+++..++.|+.||+.||.||| +++|+||||||+|||+ +.++.+||
T Consensus 80 lvme~~-g~sL~~ll~~~~~--------~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL 147 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSR--------KLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYI 147 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEE
T ss_pred EEEECC-CCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEE
Confidence 999999 9999999974332 4778999999999999999999 8899999999999999 68899999
Q ss_pred eccccccccCCCCCcc-----eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
+|||+++.+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+...
T Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred EeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 9999998765433221 11245689999999999999999999999999999999999999988653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=292.95 Aligned_cols=207 Identities=22% Similarity=0.337 Sum_probs=164.7
Q ss_pred cCCCCCCCcccccCceEEEEEEec-CCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccc--------
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD-------- 214 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 214 (367)
.++|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467899999999999999999954 58999999988655556678899999999999999999999874321
Q ss_pred -cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec-
Q 017712 215 -YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD- 292 (367)
Q Consensus 215 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~- 292 (367)
.......++||||++ |+|.+++... .+++..+..++.|++.||.||| +++|+||||||+||+++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----------PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINT 155 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEET
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----------CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcC
Confidence 123456799999997 6999999653 3667889999999999999999 88999999999999997
Q ss_pred CCCceEEeccccccccCCCCC-cceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 293 DEMIGHVGDFGMARFLPAIDK-QNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+++.+||+|||+++....... ........||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+..
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 567999999999986543211 112223457899999998765 678999999999999999999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=291.41 Aligned_cols=205 Identities=25% Similarity=0.355 Sum_probs=163.9
Q ss_pred hhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC--CCCCcceeeeeecccccCCce
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI--KHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~ 219 (367)
...++|++.+.||+|+||.||+|+. +++.||+|++... ....+.+|.+++..+ +||||+++++++.... ....
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~ 108 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWT 108 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGC
T ss_pred ccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCC
Confidence 3456899999999999999999985 4899999998632 334555666666554 8999999999985432 2225
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCC--------CeEecCCCCCceee
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP--------PIAHCNLKPSNVLL 291 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~--------~iiH~dlkp~Nil~ 291 (367)
..++||||+++|+|.++++.. .+++..++.++.|++.||.||| +. +|+||||||+|||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST----------TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEE
T ss_pred ceEEEEeccCCCcHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEE
Confidence 679999999999999999754 3678889999999999999999 77 99999999999999
Q ss_pred cCCCceEEeccccccccCCCCCcce--eeeccCCCcccCCccccCCCCCcc------hhHHHHHHHHHHHHhC-------
Q 017712 292 DDEMIGHVGDFGMARFLPAIDKQNR--FICIKGSTGYIPPEYDLGCEASTY------GDVYSFGILLLEMFTG------- 356 (367)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~~l~el~tg------- 356 (367)
+.++.+||+|||+++.......... .....||+.|+|||++.+...+.. +|||||||++|||+||
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 9999999999999976644322211 123458999999999988766655 9999999999999999
Q ss_pred ---CCCCCCCC
Q 017712 357 ---IRPSDGIF 364 (367)
Q Consensus 357 ---~~Pf~~~~ 364 (367)
..||.+..
T Consensus 256 ~~~~~p~~~~~ 266 (337)
T 3mdy_A 256 EEYQLPYHDLV 266 (337)
T ss_dssp CCCCCTTTTTS
T ss_pred ccccccHhhhc
Confidence 77776543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=296.69 Aligned_cols=205 Identities=26% Similarity=0.387 Sum_probs=171.7
Q ss_pred cCCCCCCCcccccCceEEEEEEe-----cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++.. ...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCC
Confidence 34688899999999999999983 4688999999986655566789999999999999999999998743 223
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++++|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k 185 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVK 185 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEE
T ss_pred CceEEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEE
Confidence 457899999999999999976532 3678889999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcce-eeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNR-FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+|||++........... .....++..|+|||.+.+..++.++||||||+++|+|+||..||..
T Consensus 186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred EecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 999999987654322111 1223467789999999888899999999999999999999998853
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=296.84 Aligned_cols=211 Identities=26% Similarity=0.398 Sum_probs=167.7
Q ss_pred hcCCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeeccccc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (367)
..++|.+.+.||+|+||.||+|+. .++..||+|.+.... ......+.+|+.++.+++||||+++++++.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 103 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL---- 103 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc----
Confidence 346899999999999999999983 346789999986432 234567889999999999999999999974
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC--
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-- 293 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-- 293 (367)
.....++||||+++++|.+++........ ....+++..++.++.|++.||.||| +++|+||||||+||+++.
T Consensus 104 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 104 -QSLPRFILMELMAGGDLKSFLRETRPRPS--QPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHTSCCSS--STTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSS
T ss_pred -CCCCcEEEEecCCCCcHHHHHHhhccccc--ccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCC
Confidence 33456999999999999999986542211 1124778889999999999999999 889999999999999984
Q ss_pred -CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 294 -EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 294 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
+..+||+|||++................||+.|+|||.+.+..++.++||||||+++|+|+| |..||.+.
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 45699999999975533222222233457899999999988899999999999999999998 99999764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=297.59 Aligned_cols=201 Identities=22% Similarity=0.327 Sum_probs=171.0
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCc---ch--------------hHHHHHHHHHHhCCCCCccee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG---GS--------------KSFKSECKAAINIKHRNIVRV 206 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~--------------~~~~~E~~~l~~l~h~niv~~ 206 (367)
.++|.+.+.||+|+||.||+|.. +++.||+|.+...... .. +.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999997 9999999998732211 11 789999999999999999999
Q ss_pred eeeecccccCCceeeeEEEEeccCCCHHHH------hhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCe
Q 017712 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEW------LRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPI 279 (367)
Q Consensus 207 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~i 279 (367)
++++. .....++||||+++++|.++ +..... ..+++..+..++.|++.||.||| + +++
T Consensus 109 ~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~~i 173 (348)
T 2pml_X 109 EGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNYT-------CFIPIQVIKCIIKSVLNSFSYIH---NEKNI 173 (348)
T ss_dssp SEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSSC-------CCCCHHHHHHHHHHHHHHHHHHH---HTSCE
T ss_pred EEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhccc-------cCCCHHHHHHHHHHHHHHHHHHh---ccCCE
Confidence 99974 34567999999999999998 543211 15778999999999999999999 7 899
Q ss_pred EecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCc-chhHHHHHHHHHHHHhCC
Q 017712 280 AHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EAST-YGDVYSFGILLLEMFTGI 357 (367)
Q Consensus 280 iH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~~l~el~tg~ 357 (367)
+||||||+||+++.++.+||+|||.+...... ......||+.|+|||.+.+. .++. ++||||||+++|+|++|.
T Consensus 174 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 249 (348)
T 2pml_X 174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249 (348)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred eecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999865332 23345589999999999887 5666 899999999999999999
Q ss_pred CCCCCCC
Q 017712 358 RPSDGIF 364 (367)
Q Consensus 358 ~Pf~~~~ 364 (367)
.||.+..
T Consensus 250 ~pf~~~~ 256 (348)
T 2pml_X 250 VPFSLKI 256 (348)
T ss_dssp CSSCCSS
T ss_pred CCCCCCC
Confidence 9998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=295.20 Aligned_cols=216 Identities=22% Similarity=0.267 Sum_probs=154.3
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
+....++|++.+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.++.+++||||+++++++..
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 84 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV----- 84 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----
Confidence 34456789999999999999999998 4578999999986432 2345678899999999999999999999843
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....++||||+++++|.+++........ .....+++..+..++.|++.||.||| +++++||||||+||+++.++.+
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTT-TTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCE
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccc-cccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCE
Confidence 3457999999999999999864110000 00114778899999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCC---cceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDK---QNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||++........ ........||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+..
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 9999999976543221 111223458999999999875 468899999999999999999999997643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=305.58 Aligned_cols=200 Identities=23% Similarity=0.297 Sum_probs=168.1
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC------CCCCcceeeeeeccccc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI------KHRNIVRVFTAFSGVDY 215 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~ 215 (367)
...+|++.+.||+|+||.||+|. ..+++.||+|+++.. ......+.+|+.++..+ +|+||+++++++.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~---- 169 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT---- 169 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE----
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc----
Confidence 34579999999999999999998 456899999998642 22345678899888887 6789999999974
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
.....+++|||+. ++|.+++...... .+++..+..++.||+.||.||| +++|+||||||+|||++.++
T Consensus 170 -~~~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~ 237 (429)
T 3kvw_A 170 -FRNHICMTFELLS-MNLYELIKKNKFQ-------GFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQG 237 (429)
T ss_dssp -ETTEEEEEECCCC-CBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTT
T ss_pred -cCCeEEEEEeccC-CCHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCC
Confidence 3456799999995 6999998765421 3678889999999999999999 88999999999999999988
Q ss_pred c--eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 296 I--GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 296 ~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
. +||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 238 ~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 7 999999999754321 223458999999999999999999999999999999999999998753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=294.58 Aligned_cols=216 Identities=22% Similarity=0.269 Sum_probs=161.2
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY- 215 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 215 (367)
.......++|++.+.||+|+||.||+|+. .+++.||+|++... ......+.+|+..+..++||||++++++|.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34556678999999999999999999994 56899999998643 3345567888889999999999999999855332
Q ss_pred -CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-
Q 017712 216 -QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD- 293 (367)
Q Consensus 216 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~- 293 (367)
....+.++||||+++ +|.+.+...... ...+++..+..++.|++.||.|||.+ +++|+||||||+|||++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRR-----QVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETT
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCC
Confidence 234457899999975 555544321000 00466788899999999999999954 679999999999999996
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+..
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 89999999999987644322 22345899999999987654 8999999999999999999999998753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=295.21 Aligned_cols=209 Identities=24% Similarity=0.385 Sum_probs=166.8
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEE--EEEEeecC-CCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCce
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTI--AVKVFNLI-RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 219 (367)
++|++.+.||+|+||.||+|+ ..++..+ |+|.+... .......+.+|+.++.++ +||||+++++++. ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eCC
Confidence 578899999999999999998 4456644 99988742 233557789999999999 8999999999974 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCC-------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~ 292 (367)
..++||||+++++|.+++........ ......+++..++.++.|++.||.||| +++|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEc
Confidence 67999999999999999986531000 000114678899999999999999999 88999999999999999
Q ss_pred CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
.++.+||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp GGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999997432211 1122346889999999988889999999999999999998 999997653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=289.65 Aligned_cols=200 Identities=28% Similarity=0.412 Sum_probs=163.5
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..++|++.+.||+|+||.||+|.. +++.||+|.++.. ...+.+.+|+.++.+++||||+++++++. ......+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~ 91 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY 91 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCE
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCceE
Confidence 346788999999999999999985 5889999998643 35678999999999999999999999863 3334579
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+++++|.+++..... ..+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+||
T Consensus 92 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Df 161 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDF 161 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHH-------HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeec
Confidence 99999999999999975321 12677889999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|++....... ....+++.|+|||.+.+..++.++||||||+++|+|+| |..||.+..
T Consensus 162 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 162 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred cccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9997543321 12347889999999998899999999999999999998 999997653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=304.48 Aligned_cols=203 Identities=12% Similarity=0.088 Sum_probs=150.2
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhC--CCCCcceeeeeec------
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINI--KHRNIVRVFTAFS------ 211 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~~~~~------ 211 (367)
..+|.+.+.||+|+||.||+|+ ..+++.||+|++..... ...+.+.+|+.++..+ +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3458889999999999999999 45789999999986443 2345677885554444 6999888664332
Q ss_pred -cccc------------CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHH------HHHHHHHHHHHHHhh
Q 017712 212 -GVDY------------QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK------LDIAIDVACALRYLH 272 (367)
Q Consensus 212 -~~~~------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~------~~i~~~i~~~L~~lH 272 (367)
.... ......++||||++ |+|.+++..... .+....+ ..++.||+.||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--------VYVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--------SCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--------ccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 1100 01145799999998 899999975421 1122233 667799999999999
Q ss_pred hCCCCCeEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccC--CCCCcchhHHHHHHHH
Q 017712 273 CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILL 350 (367)
Q Consensus 273 ~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l 350 (367)
+++|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++
T Consensus 212 ---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 212 ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp ---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred ---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 88999999999999999999999999999986532 1113457799999999987 6789999999999999
Q ss_pred HHHHhCCCCCCCC
Q 017712 351 LEMFTGIRPSDGI 363 (367)
Q Consensus 351 ~el~tg~~Pf~~~ 363 (367)
|||++|+.||.+.
T Consensus 284 ~elltg~~Pf~~~ 296 (371)
T 3q60_A 284 YRVWCLFLPFGLV 296 (371)
T ss_dssp HHHHHSSCSTTBC
T ss_pred HHHHhCCCCCCCc
Confidence 9999999999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=291.76 Aligned_cols=204 Identities=25% Similarity=0.364 Sum_probs=168.0
Q ss_pred hcCCCCCCC-cccccCceEEEEEEe---cCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccC
Q 017712 143 ATNGFSSAN-LIGAGNFGSVYNGTL---FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 143 ~~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
..++|.+.+ .||+|+||.||+|.. .+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 88 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE----- 88 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----
Confidence 345677777 999999999999952 3468899999874332 23567899999999999999999999972
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
....++||||+++++|.+++.... .+++..++.++.|++.||.||| +++++||||||+||+++.++.
T Consensus 89 -~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~ 155 (291)
T 1xbb_A 89 -AESWMLVMEMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHY 155 (291)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred -CCCcEEEEEeCCCCCHHHHHHhCc---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCc
Confidence 234689999999999999998654 4678899999999999999999 889999999999999999999
Q ss_pred eEEeccccccccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+||+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 156 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 156 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999876443222 11222346788999999988888999999999999999999 999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=287.73 Aligned_cols=199 Identities=21% Similarity=0.343 Sum_probs=165.0
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+..+..+ +||||+++++++. ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----EDD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ETT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCC
Confidence 35688899999999999999995 479999999987532 23456788999999999 9999999999974 344
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC------
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD------ 293 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~------ 293 (367)
..++||||+++++|.+++..... ....+++..+..++.|++.||.||| +++|+||||||+||+++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~ 156 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYR-----IMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNA 156 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHH-----HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-------
T ss_pred eEEEEEEecCCCcHHHHHHhhcc-----cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcc
Confidence 67999999999999999975321 0014678899999999999999999 889999999999999984
Q ss_pred -------------CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCC
Q 017712 294 -------------EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRP 359 (367)
Q Consensus 294 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~P 359 (367)
...+||+|||.+....... ...||+.|+|||.+.+. .++.++||||||+++|+|++|.+|
T Consensus 157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp -------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 4479999999998664322 12489999999998876 566899999999999999999987
Q ss_pred CC
Q 017712 360 SD 361 (367)
Q Consensus 360 f~ 361 (367)
+.
T Consensus 231 ~~ 232 (289)
T 1x8b_A 231 PR 232 (289)
T ss_dssp CS
T ss_pred Cc
Confidence 64
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=301.03 Aligned_cols=203 Identities=19% Similarity=0.264 Sum_probs=168.3
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC--------CCCcceeeeeecccc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK--------HRNIVRVFTAFSGVD 214 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~ 214 (367)
.++|++.+.||+|+||.||+|+ ..+++.||+|+++.. ....+.+.+|+.+++.++ ||||++++++|....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 4689999999999999999998 456899999998632 234567889999999985 788999999984321
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCC-CeEecCCCCCceeecC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDD 293 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~-~iiH~dlkp~Nil~~~ 293 (367)
......++||||+ +++|.+++...... .+++..++.++.||+.||.||| ++ +|+||||||+|||++.
T Consensus 115 -~~~~~~~lv~e~~-~~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 115 -VNGTHICMVFEVL-GHHLLKWIIKSNYQ-------GLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSV 182 (397)
T ss_dssp -TTEEEEEEEECCC-CCBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECC
T ss_pred -CCCceEEEEEecc-CccHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEec
Confidence 2456789999999 66776666543211 4678899999999999999999 77 9999999999999987
Q ss_pred CC-------------------------------------------------ceEEeccccccccCCCCCcceeeeccCCC
Q 017712 294 EM-------------------------------------------------IGHVGDFGMARFLPAIDKQNRFICIKGST 324 (367)
Q Consensus 294 ~~-------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 324 (367)
++ .+||+|||++...... .....||+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~ 257 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTR 257 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCG
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCC
Confidence 75 7999999999865432 22335899
Q ss_pred cccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 325 ~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999999999999999999999999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=296.02 Aligned_cols=201 Identities=23% Similarity=0.315 Sum_probs=165.4
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc--chhHHHHHHHHHHhCCCCCcceeeeeecccccC-Cc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ-GA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~ 218 (367)
..++|.+.+.||+|+||.||+|. ..+++.||+|++...... ....+.+|+.+++.++||||+++++++...... ..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 45789999999999999999998 456899999998743222 346788999999999999999999998543221 11
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+. ++|.+++.. .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----------EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEE
T ss_pred eeEEEEEcccc-ccHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEE
Confidence 23489999996 689888743 3668899999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999854321 223458999999999887 67899999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.63 Aligned_cols=209 Identities=24% Similarity=0.308 Sum_probs=167.4
Q ss_pred hHHHHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCC--CCCcceeeeeecc
Q 017712 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIK--HRNIVRVFTAFSG 212 (367)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~ 212 (367)
++.+....++|++.+.||+|+||.||+|...+++.||+|++..... .....+.+|+.++.+++ ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~- 98 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI- 98 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-
Confidence 3444455667999999999999999999977899999999974332 24567899999999997 599999999974
Q ss_pred cccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec
Q 017712 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (367)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~ 292 (367)
.....+++|| +.+++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++
T Consensus 99 ----~~~~~~lv~e-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~ 161 (313)
T 3cek_A 99 ----TDQYIYMVME-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV 161 (313)
T ss_dssp ----CSSEEEEEEC-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE
T ss_pred ----cCCEEEEEEe-cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE
Confidence 3456799999 55889999998654 4667889999999999999999 88999999999999996
Q ss_pred CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----------CEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
+ +.+||+|||+++...............||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 162 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (313)
T 3cek_A 162 D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240 (313)
T ss_dssp T-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred C-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence 4 8899999999987644332222234458999999999875 467889999999999999999999998
Q ss_pred CCC
Q 017712 362 GIF 364 (367)
Q Consensus 362 ~~~ 364 (367)
+..
T Consensus 241 ~~~ 243 (313)
T 3cek_A 241 QII 243 (313)
T ss_dssp TCC
T ss_pred hHH
Confidence 653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=317.30 Aligned_cols=196 Identities=26% Similarity=0.393 Sum_probs=162.2
Q ss_pred CcccccCceEEEEEEe---cCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGTL---FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.+++||||+++++++.. ...++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 3699999999999963 346789999997432 2335789999999999999999999998732 2368999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|.+++.... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 449 E~~~~g~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla 516 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 516 (635)
T ss_dssp ECCTTEEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred EccCCCCHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence 9999999999997654 4678899999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 306 RFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 306 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+.+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 876443221 12223346788999999999999999999999999999998 999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=287.19 Aligned_cols=203 Identities=21% Similarity=0.229 Sum_probs=152.4
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc-c-hhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG-G-SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
..++|++.+.||+|+||.||+|+ ..+++.||+|+++..... . ...+.++...++.++||||+++++++. ...
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccC
Confidence 34678899999999999999999 457899999998743222 2 223444555577889999999999984 344
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCC-CeEecCCCCCceeecCCCceE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~-~iiH~dlkp~Nil~~~~~~~k 298 (367)
..++||||++ |+|.+++...... ...+++..+..++.|++.||.||| ++ +|+||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~k 150 (290)
T 3fme_A 80 DVWICMELMD-TSLDKFYKQVIDK-----GQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVK 150 (290)
T ss_dssp SEEEEEECCS-EEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEE
T ss_pred CEEEEEehhc-cchHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEE
Confidence 5799999996 5888877531100 014778899999999999999999 76 999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYD----LGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+|||++........ .....||+.|+|||.+ .+..++.++||||||+++|+|++|..||++
T Consensus 151 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 151 MCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp BCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred EeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 999999986543222 2223589999999996 556789999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=284.65 Aligned_cols=199 Identities=25% Similarity=0.378 Sum_probs=168.6
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++++++||||+++++++. ....
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence 45788999999999999999994 47899999998643 2345678999999999999999999999973 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC---Cce
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE---MIG 297 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~---~~~ 297 (367)
.+++|||+++++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||+++.+ +.+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~ 163 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDI 163 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred EEEEEEccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccE
Confidence 799999999999999886543 4678899999999999999999 8899999999999999654 479
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|||++......... ....||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+.
T Consensus 164 kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 164 KIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp EECSTTGGGTBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeccCcceeecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 99999999865432221 22347899999999876 4889999999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=291.90 Aligned_cols=200 Identities=23% Similarity=0.308 Sum_probs=164.2
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccC-Cce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ-GAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 219 (367)
.++|.+.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.+++.++||||+++++++...... ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 4678999999999999999998 45689999999864322 2346788999999999999999999998543211 112
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++|||++ ++|.+++.. .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----------KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEE
T ss_pred eEEEEecccc-CCHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEE
Confidence 3589999996 688887743 3668889999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++..... .....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 168 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 168 LDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp CSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred eecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999864321 223458999999999877 67899999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=293.17 Aligned_cols=204 Identities=25% Similarity=0.297 Sum_probs=167.6
Q ss_pred HhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CC-----Ccceeeeeeccc
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HR-----NIVRVFTAFSGV 213 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~ 213 (367)
....++|++.+.||+|+||.||+|. ..+++.||+|+++.. ......+.+|+.++..++ |+ +|+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~-- 126 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM-- 126 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE--
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec--
Confidence 3446789999999999999999998 446889999998632 223466778898888875 44 4899998874
Q ss_pred ccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec-
Q 017712 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD- 292 (367)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~- 292 (367)
.....++||||++ ++|.+++...... .+++..+..++.|++.||.|||+. ..+|+||||||+|||++
T Consensus 127 ---~~~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~ 194 (382)
T 2vx3_A 127 ---FRNHLCLVFEMLS-YNLYDLLRNTNFR-------GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCN 194 (382)
T ss_dssp ---ETTEEEEEEECCC-CBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESS
T ss_pred ---cCCceEEEEecCC-CCHHHHHhhcCcC-------CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEec
Confidence 3356799999995 5999999765421 367888999999999999999943 46899999999999994
Q ss_pred -CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 293 -DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 293 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+..
T Consensus 195 ~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 195 PKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 5788999999999866432 223458999999999999999999999999999999999999998753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=290.24 Aligned_cols=211 Identities=23% Similarity=0.325 Sum_probs=169.1
Q ss_pred CChHHHHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecc
Q 017712 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212 (367)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 212 (367)
....++....++|++.+.||+|+||.||+|...+ .+|+|+++... ....+.+.+|+.++.+++||||+++++++..
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 3456666677899999999999999999998543 59999987432 2345678899999999999999999999843
Q ss_pred cccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec
Q 017712 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (367)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~ 292 (367)
....+++|||+++++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++
T Consensus 101 -----~~~~~iv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~ 164 (319)
T 2y4i_B 101 -----PPHLAIITSLCKGRTLYSVVRDAKI--------VLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD 164 (319)
T ss_dssp -----SSCEEEECBCCCSEEHHHHTTSSCC--------CCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC
T ss_pred -----CCceEEEeecccCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe
Confidence 3457999999999999999976432 3667889999999999999999 88999999999999998
Q ss_pred CCCceEEeccccccccCCCC---CcceeeeccCCCcccCCccccC---------CCCCcchhHHHHHHHHHHHHhCCCCC
Q 017712 293 DEMIGHVGDFGMARFLPAID---KQNRFICIKGSTGYIPPEYDLG---------CEASTYGDVYSFGILLLEMFTGIRPS 360 (367)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~~l~el~tg~~Pf 360 (367)
++.+||+|||+++...... .........||+.|+|||.+.+ ..++.++||||||+++|+|++|..||
T Consensus 165 -~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 243 (319)
T 2y4i_B 165 -NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243 (319)
T ss_dssp ---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred -CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 6799999999987543211 1122233458999999999864 35788999999999999999999999
Q ss_pred CCCC
Q 017712 361 DGIF 364 (367)
Q Consensus 361 ~~~~ 364 (367)
.+..
T Consensus 244 ~~~~ 247 (319)
T 2y4i_B 244 KTQP 247 (319)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 7643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=287.54 Aligned_cols=210 Identities=23% Similarity=0.339 Sum_probs=169.9
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHh--CCCCCcceeeeeecccccCC
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN--IKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~ 217 (367)
.....++|.+.+.||+|+||.||+|+. +++.||+|++.. .....+.+|++++.. ++||||+++++++.... ..
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~ 111 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDN-GT 111 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SS
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cc
Confidence 344556899999999999999999985 689999999863 245677889999887 78999999999985432 11
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCC-----CCCeEecCCCCCceeec
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC-----QPPIAHCNLKPSNVLLD 292 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~-----~~~iiH~dlkp~Nil~~ 292 (367)
....++||||+++|+|.+++... .+++..++.++.|++.||.|||+.. +.+|+||||||+||+++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred cceeEEEEeecCCCcHHHHHhcc----------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence 23679999999999999999753 3678899999999999999999321 36899999999999999
Q ss_pred CCCceEEeccccccccCCCCCcc--eeeeccCCCcccCCccccCCC------CCcchhHHHHHHHHHHHHhC--------
Q 017712 293 DEMIGHVGDFGMARFLPAIDKQN--RFICIKGSTGYIPPEYDLGCE------ASTYGDVYSFGILLLEMFTG-------- 356 (367)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~el~tg-------- 356 (367)
.++.+||+|||++.......... ......||+.|+|||.+.+.. ++.++||||||+++|||+||
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 99999999999997664432211 122345899999999987753 33689999999999999999
Q ss_pred --CCCCCCCC
Q 017712 357 --IRPSDGIF 364 (367)
Q Consensus 357 --~~Pf~~~~ 364 (367)
..||.+..
T Consensus 262 ~~~~p~~~~~ 271 (342)
T 1b6c_B 262 DYQLPYYDLV 271 (342)
T ss_dssp CCCCTTTTTS
T ss_pred ccccCccccC
Confidence 78987653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=289.16 Aligned_cols=204 Identities=25% Similarity=0.349 Sum_probs=162.5
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC------cchhHHHHHHHHHHhC----CCCCccee
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP------GGSKSFKSECKAAINI----KHRNIVRV 206 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~~ 206 (367)
.+.....++|++.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.++.++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 3445566789999999999999999998 45789999999864332 1234566899999998 89999999
Q ss_pred eeeecccccCCceeeeEEEEe-ccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 017712 207 FTAFSGVDYQGARFKAVVYKF-MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (367)
Q Consensus 207 ~~~~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlk 285 (367)
++++. .....+++||+ +++++|.+++.... .+++..++.++.|++.||.||| +++|+|||||
T Consensus 104 ~~~~~-----~~~~~~~v~e~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk 166 (312)
T 2iwi_A 104 LDWFE-----TQEGFMLVLERPLPAQDLFDYITEKG---------PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIK 166 (312)
T ss_dssp EEEC----------CEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCS
T ss_pred EEEEe-----cCCeEEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCC
Confidence 99973 34556899999 78999999997644 4678899999999999999999 8899999999
Q ss_pred CCceeec-CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCC
Q 017712 286 PSNVLLD-DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEAS-TYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 286 p~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+||+++ .++.+||+|||++....... .....||+.|+|||++.+..+. .++||||||+++|+|++|+.||.+
T Consensus 167 p~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 167 DENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp GGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred hhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 9999999 88999999999998764322 2234589999999998876664 589999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=286.36 Aligned_cols=204 Identities=29% Similarity=0.430 Sum_probs=161.3
Q ss_pred cCCCCCCCcccccCceEEEEEEec--CCC--EEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF--DGT--TIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
.++|++.+.||+|+||.||+|+.. +++ .||+|+++.. .....+.+.+|+.++.+++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 457899999999999999999842 333 6899988643 233457789999999999999999999997431
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
..+++|||+++++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.
T Consensus 94 ---~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~ 159 (291)
T 1u46_A 94 ---PMKMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDL 159 (291)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTE
T ss_pred ---CceeeEecccCCCHHHHHHhccC--------CcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCC
Confidence 26899999999999999975321 4778899999999999999999 889999999999999999999
Q ss_pred eEEeccccccccCCCCCcc-eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+||+|||++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 160 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 9999999998765433221 1223346888999999988888999999999999999999 999997653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=289.40 Aligned_cols=198 Identities=21% Similarity=0.331 Sum_probs=167.4
Q ss_pred cCCCCCCCcccccCceEEEEEEe--cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCC------cceeeeeeccccc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL--FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRN------IVRVFTAFSGVDY 215 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 215 (367)
.++|++.+.||+|+||.||+|.. .+++.||+|+++.. ....+.+.+|+.++..++|+| ++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~---- 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE---- 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc----
Confidence 46899999999999999999984 46889999998632 234567889999999987665 899999873
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC--
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-- 293 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-- 293 (367)
.....++||||+ +++|.+++...... .+++..+..++.|++.||.||| +++|+||||||+|||++.
T Consensus 88 -~~~~~~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 88 -HHGHICIVFELL-GLSTYDFIKENGFL-------PFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSD 155 (339)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCC
T ss_pred -cCCcEEEEEcCC-CCCHHHHHHhcCCC-------CCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccc
Confidence 345679999999 88999999765421 4668889999999999999999 889999999999999987
Q ss_pred -----------------CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhC
Q 017712 294 -----------------EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356 (367)
Q Consensus 294 -----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg 356 (367)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 230 (339)
T 1z57_A 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230 (339)
T ss_dssp EEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred cccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence 668999999999864322 1234589999999999998999999999999999999999
Q ss_pred CCCCCCC
Q 017712 357 IRPSDGI 363 (367)
Q Consensus 357 ~~Pf~~~ 363 (367)
..||.+.
T Consensus 231 ~~pf~~~ 237 (339)
T 1z57_A 231 FTVFPTH 237 (339)
T ss_dssp SCSCCCS
T ss_pred CCCCCCC
Confidence 9999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=283.74 Aligned_cols=200 Identities=23% Similarity=0.370 Sum_probs=160.6
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccc--------
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD-------- 214 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 214 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++... ......+.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 34688889999999999999994 57899999998642 234567889999999999999999999875421
Q ss_pred cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC
Q 017712 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~ 294 (367)
.......++||||+++++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~ 152 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENL--------NQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDES 152 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCG--------GGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred cccCCceEEEEecCCCCCHHHhhhcccc--------ccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCC
Confidence 1235678999999999999999975431 4667889999999999999999 8899999999999999999
Q ss_pred CceEEeccccccccCCCCC------------cceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHh
Q 017712 295 MIGHVGDFGMARFLPAIDK------------QNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFT 355 (367)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t 355 (367)
+.+||+|||++........ ........||+.|+|||.+.+. .++.++|||||||++|+|++
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999999999986542210 1122334589999999998865 68999999999999999998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=287.71 Aligned_cols=202 Identities=21% Similarity=0.326 Sum_probs=146.7
Q ss_pred hcCCCCCCC-cccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHH-HHHHhCCCCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSAN-LIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSEC-KAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
..++|.+.+ .||+|+||.||+|.. .+++.||+|++... ....+|+ ..+..++||||+++++++.... ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMH-HGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCc
Confidence 456788854 699999999999994 46999999998631 2233344 3466779999999999985432 3356
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC---CCc
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EMI 296 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~---~~~ 296 (367)
..++||||+++|+|.+++...... .+++..++.++.|++.||.||| +++|+||||||+||+++. ++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQ-------AFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CC-------CCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCC
T ss_pred eEEEEEeccCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCce
Confidence 679999999999999999865421 4778999999999999999999 889999999999999976 456
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+||+|||+++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 170 ~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 170 LKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp EEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 999999999865322 1223457999999999988889999999999999999999999996543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=306.48 Aligned_cols=206 Identities=24% Similarity=0.342 Sum_probs=170.7
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC-CCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~ 221 (367)
++|++.+.||+|+||.||+|. ..+++.||+|+++.. .....+.+.+|+.++.+++||||+++++++..... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 689999999999999999998 456899999998643 22345678999999999999999999998754221 225667
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc---eE
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI---GH 298 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~---~k 298 (367)
++||||+++|+|.+++...... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +|
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEE
T ss_pred EEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEE
Confidence 9999999999999999865421 13567788999999999999999 889999999999999987664 89
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+
T Consensus 165 L~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 165 IIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp ECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Ecccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 999999987644322 2234589999999999999999999999999999999999999965
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.29 Aligned_cols=212 Identities=21% Similarity=0.344 Sum_probs=171.9
Q ss_pred CChHHHHhhcCCCCCCCcccccCceEEEEEEec----CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeee
Q 017712 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTA 209 (367)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~ 209 (367)
+...+.....++|++.+.||+|+||.||+|... .+..||+|.++.... ...+.+.+|+.++++++||||++++++
T Consensus 380 ~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 380 PSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp SCGGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 344455556677888999999999999999843 245799999864332 234678999999999999999999998
Q ss_pred ecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 017712 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNV 289 (367)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Ni 289 (367)
+.+ ...++||||+++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||
T Consensus 460 ~~~------~~~~lv~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NI 522 (656)
T 2j0j_A 460 ITE------NPVWIIMELCTLGELRSFLQVRKF--------SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNV 522 (656)
T ss_dssp ECS------SSCEEEEECCTTCBHHHHHHHTTT--------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred Eec------CceEEEEEcCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhE
Confidence 732 246899999999999999975431 4678889999999999999999 88999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 290 LLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 290 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
|++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 523 Ll~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 523 LVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp EEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999876433221 1223346789999999998899999999999999999997 999998753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=286.07 Aligned_cols=205 Identities=23% Similarity=0.234 Sum_probs=147.0
Q ss_pred hcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC-cchhHHHHHHH-HHHhCCCCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECK-AAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
..++|.+.+.||+|+||.||+|.. .+++.||+|++..... .....+..|+. +++.++||||+++++++. ...
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~ 94 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REG 94 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCC
Confidence 456899999999999999999995 5789999999975432 23345566665 667789999999999984 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCC-CeEecCCCCCceeecCCCceE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~-~iiH~dlkp~Nil~~~~~~~k 298 (367)
..++||||+++ +|.+++...... ....+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+|
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSV----LDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHT----TCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEE
T ss_pred ceEEEEeecCC-ChHHHHHHHHhh----hcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEE
Confidence 67999999975 888877531000 0014678889999999999999999 77 999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYD----LGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||+++....... .....||+.|+|||.+ .+..++.++||||||+++|+|++|..||.+.
T Consensus 167 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 167 LCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp ECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred EccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 999999986543221 1223589999999998 4566899999999999999999999999764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=288.97 Aligned_cols=202 Identities=22% Similarity=0.311 Sum_probs=168.6
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc------chhHHHHHHHHHHhCC--CCCcceeeeee
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIK--HRNIVRVFTAF 210 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~ 210 (367)
.....++|++.+.||+|+||.||+|+ ..+++.||+|++...... ....+.+|+.++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34456789999999999999999998 457899999999743322 2356778999999996 59999999998
Q ss_pred cccccCCceeeeEEEEeccC-CCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 017712 211 SGVDYQGARFKAVVYKFMPN-GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNV 289 (367)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Ni 289 (367)
. .....+++||++.+ ++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||
T Consensus 118 ~-----~~~~~~lv~e~~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NI 180 (320)
T 3a99_A 118 E-----RPDSFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENI 180 (320)
T ss_dssp E-----CSSEEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred e-----cCCcEEEEEEcCCCCccHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHE
Confidence 4 34567999999976 89999997644 4678889999999999999999 88999999999999
Q ss_pred eec-CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 290 LLD-DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 290 l~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|++ +++.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|..||.+
T Consensus 181 ll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 181 LIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp EEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 999 78999999999998764322 223458999999999887665 6788999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.39 Aligned_cols=203 Identities=19% Similarity=0.292 Sum_probs=167.1
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-----------CCCcceeeeeec
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-----------HRNIVRVFTAFS 211 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 211 (367)
.++|.+.+.||+|+||.||+|+ ..+++.||+|++... ......+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 4689999999999999999999 467899999998632 224567889999999886 899999999985
Q ss_pred ccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCC-CeEecCCCCCcee
Q 017712 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVL 290 (367)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~-~iiH~dlkp~Nil 290 (367)
... ......+++|||+ +++|.+++...... .+++..+..++.||+.||.||| ++ +|+||||||+|||
T Consensus 97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIl 164 (373)
T 1q8y_A 97 HKG-PNGVHVVMVFEVL-GENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVL 164 (373)
T ss_dssp EEE-TTEEEEEEEECCC-CEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEE
T ss_pred ccC-CCCceEEEEEecC-CCCHHHHHHHhhcc-------CCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeE
Confidence 432 2344779999999 88999999764321 3678889999999999999999 77 9999999999999
Q ss_pred ec------CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 291 LD------DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 291 ~~------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++ ..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 94 4458999999999865432 122358999999999999999999999999999999999999998643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=295.55 Aligned_cols=204 Identities=21% Similarity=0.279 Sum_probs=154.7
Q ss_pred CCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceeeeEE
Q 017712 146 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
.|.+.+.||+|+||+||.+...+++.||||++... ..+.+.+|+.++.++ +||||+++++++ ......++|
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv 87 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIA 87 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEE
Confidence 34556789999999998776778999999998642 345678999999876 899999999987 345668999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCC----------
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE---------- 294 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~---------- 294 (367)
|||++ |+|.+++.......... ....+..++.++.||+.||.||| +++|+||||||+|||++.+
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENL--KLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp ECCCS-EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred EecCC-CCHHHHHhccCCCchhh--hhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccC
Confidence 99995 69999998754221100 01123345779999999999999 8899999999999999654
Q ss_pred ---CceEEeccccccccCCCCCc--ceeeeccCCCcccCCccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 017712 295 ---MIGHVGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLG-------CEASTYGDVYSFGILLLEMFT-GIRPSD 361 (367)
Q Consensus 295 ---~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~t-g~~Pf~ 361 (367)
+.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+| |..||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 48999999999876543221 11223468999999999875 568999999999999999999 999997
Q ss_pred CC
Q 017712 362 GI 363 (367)
Q Consensus 362 ~~ 363 (367)
+.
T Consensus 242 ~~ 243 (434)
T 2rio_A 242 DK 243 (434)
T ss_dssp ST
T ss_pred Cc
Confidence 64
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=286.91 Aligned_cols=198 Identities=23% Similarity=0.361 Sum_probs=164.7
Q ss_pred cCCCCCCCcccccCceEEEEEEec-CC-CEEEEEEeecCCCcchhHHHHHHHHHHhCCCCC------cceeeeeeccccc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLF-DG-TTIAVKVFNLIRPGGSKSFKSECKAAINIKHRN------IVRVFTAFSGVDY 215 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 215 (367)
.++|++.+.||+|+||.||+|... ++ +.||+|+++.. ......+.+|+.++++++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~---- 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN---- 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee----
Confidence 468999999999999999999843 44 68999998632 234567889999999997766 888888863
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee----
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---- 291 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~---- 291 (367)
.....++||||+ +++|.+++...... .+++..+..++.||+.||.||| +++|+||||||+|||+
T Consensus 93 -~~~~~~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~ 160 (355)
T 2eu9_A 93 -FHGHMCIAFELL-GKNTFEFLKENNFQ-------PYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSE 160 (355)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCC
T ss_pred -eCCeEEEEEecc-CCChHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccc
Confidence 345679999999 66777777654321 4678899999999999999999 8999999999999999
Q ss_pred ---------------cCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhC
Q 017712 292 ---------------DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356 (367)
Q Consensus 292 ---------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg 356 (367)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 235 (355)
T 2eu9_A 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235 (355)
T ss_dssp EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence 567899999999998643221 234589999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 017712 357 IRPSDGI 363 (367)
Q Consensus 357 ~~Pf~~~ 363 (367)
..||.+.
T Consensus 236 ~~pf~~~ 242 (355)
T 2eu9_A 236 FTLFQTH 242 (355)
T ss_dssp SCSCCCS
T ss_pred CCCCCCC
Confidence 9999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=313.11 Aligned_cols=200 Identities=19% Similarity=0.309 Sum_probs=165.8
Q ss_pred hcCCCCCCCcccccCceEEEEEEec--CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLF--DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++.+++||||+++++++...+.....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3478999999999999999999854 689999999864322 2345788999999999999999999998654433334
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++++|.+++.. .+++.+++.++.||+.||.||| +++|+||||||+|||++.+ .+||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EEEEEEECCCCEECC----C-----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEE
T ss_pred eeEEEEEeCCCCcHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEE
Confidence 46999999999999887654 3668899999999999999999 8899999999999999875 8999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||+++..... ....||+.|+|||++.+. .+.++|||||||++|+|++|..||.+..
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~ 280 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRY 280 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEE
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccc
Confidence 999999865432 234589999999998765 4889999999999999999999987643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=294.14 Aligned_cols=200 Identities=23% Similarity=0.358 Sum_probs=155.2
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..+|.+.+.||+|+||.||.....+++.||||++... ....+.+|+.+++.+ +||||+++++++. .....+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~~ 94 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQY 94 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEEE
Confidence 3468888999999999976555678999999998642 234467899999999 7999999999873 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-----CCce
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-----EMIG 297 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-----~~~~ 297 (367)
+||||++ |+|.+++...... +....+..++.||+.||.||| +++|+||||||+|||++. ...+
T Consensus 95 lv~E~~~-g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~ 162 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKDFA--------HLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKA 162 (432)
T ss_dssp EEEECCS-EEHHHHHHSSSCC--------CCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCE
T ss_pred EEEECCC-CCHHHHHHhcCCC--------ccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeE
Confidence 9999995 6999999865421 223345679999999999999 889999999999999943 3367
Q ss_pred EEeccccccccCCCCCc-ceeeeccCCCcccCCcccc---CCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
||+|||+++........ .......||+.|+|||++. ...++.++|||||||++|||++ |..||.+.
T Consensus 163 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp EECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred EEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 89999999876433211 2223456999999999987 4567889999999999999999 99999654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=291.40 Aligned_cols=198 Identities=16% Similarity=0.162 Sum_probs=157.8
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCC--------CcchhHHHHHHHHHHhCC---------CCCccee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--------PGGSKSFKSECKAAINIK---------HRNIVRV 206 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~~ 206 (367)
.++|++.+.||+|+||.||+|+. +++.||+|++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45788899999999999999986 78999999997543 223378899999999886 5555555
Q ss_pred ee-----------------eecccc--------cCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHH
Q 017712 207 FT-----------------AFSGVD--------YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261 (367)
Q Consensus 207 ~~-----------------~~~~~~--------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~ 261 (367)
.+ +|.... .......++||||+++|++.+.+... .+++..+..++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----------~~~~~~~~~i~ 167 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----------LSSLATAKSIL 167 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----------CCCHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----------CCCHHHHHHHH
Confidence 54 432200 11256789999999999777766432 36788999999
Q ss_pred HHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC--------------------ceEEeccccccccCCCCCcceeeecc
Q 017712 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM--------------------IGHVGDFGMARFLPAIDKQNRFICIK 321 (367)
Q Consensus 262 ~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~ 321 (367)
.||+.||.|||+ +++|+||||||+|||++.++ .+||+|||+|+..... ...
T Consensus 168 ~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~ 238 (336)
T 2vuw_A 168 HQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVV 238 (336)
T ss_dssp HHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEE
T ss_pred HHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEE
Confidence 999999999993 36899999999999999887 8999999999865321 235
Q ss_pred CCCcccCCccccCCCCCcchhHHHHHHH-HHHHHhCCCCCCC
Q 017712 322 GSTGYIPPEYDLGCEASTYGDVYSFGIL-LLEMFTGIRPSDG 362 (367)
Q Consensus 322 gt~~y~aPE~~~~~~~~~~~DvwslG~~-l~el~tg~~Pf~~ 362 (367)
||+.|+|||++.+.. +.++||||||++ .+++++|..||.+
T Consensus 239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 899999999998766 889999998777 7788899999854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=278.19 Aligned_cols=200 Identities=23% Similarity=0.273 Sum_probs=146.8
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCc-c-hhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG-G-SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... . ...+.++..++..++||||+++++++. ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCCc
Confidence 45788889999999999999995 47899999999754322 1 223444555678889999999999974 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCC-CeEecCCCCCceeecCCCceEE
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~-~iiH~dlkp~Nil~~~~~~~kl 299 (367)
.++||||+ ++.+..+...... .+++..+..++.|++.||.||| ++ +++||||||+||+++.++.+||
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl 166 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQG--------PIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKL 166 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEecc-CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEE
Confidence 79999999 5566665543211 4678889999999999999999 74 9999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||++........ .....||+.|+|||.+. ...++.++||||||+++|+|++|..||.+.
T Consensus 167 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 167 CDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp CCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 99999976543221 22345899999999984 456789999999999999999999999763
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=285.70 Aligned_cols=208 Identities=15% Similarity=0.145 Sum_probs=154.8
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC---cchhHHHHHHHHHHhCCC-CCcceeeee----------
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKH-RNIVRVFTA---------- 209 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~~~~~---------- 209 (367)
.+|...+.||+|+||.||+|+ ..+++.||||+++.... ...+.+.+|+.++..++| +|...+..+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 457777899999999999999 56799999999873332 236789999999999987 322211111
Q ss_pred -----------ecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC
Q 017712 210 -----------FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP 278 (367)
Q Consensus 210 -----------~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~ 278 (367)
+...........+++|+++ +++|.+++...... ......+++..++.++.|++.||.||| +++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 231 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH--SSTHKSLVHHARLQLTLQVIRLLASLH---HYG 231 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHH--TTTSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc--cccCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 1000000122346677765 78999988521000 001125788899999999999999999 889
Q ss_pred eEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccc----------cCCCCCcchhHHHHHH
Q 017712 279 IAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYD----------LGCEASTYGDVYSFGI 348 (367)
Q Consensus 279 iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~ 348 (367)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999864322 333457 999999998 5556888999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 017712 349 LLLEMFTGIRPSDGIF 364 (367)
Q Consensus 349 ~l~el~tg~~Pf~~~~ 364 (367)
++|||++|+.||.+..
T Consensus 306 il~elltg~~Pf~~~~ 321 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDA 321 (413)
T ss_dssp HHHHHHHSSCCCCTTG
T ss_pred HHHHHHHCCCCCCCcc
Confidence 9999999999998753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=267.76 Aligned_cols=173 Identities=14% Similarity=0.054 Sum_probs=147.2
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCc---chhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... ....+.+|+.++.+++||||+++++++.. ..
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CC
Confidence 46799999999999999999995 45899999999754332 23678999999999999999999999743 35
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++++|.++++... ...++..++.|++.||.||| +++|+||||||+|||++.++.+||
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~~~-----------~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl 170 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADTSP-----------SPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVL 170 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTTCC-----------CHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEE
T ss_pred cEEEEEEecCCCCHHHHHhcCC-----------ChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEE
Confidence 6799999999999999996421 23467889999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+++| |++ .++.++|||||||++|||+||+.||.+..
T Consensus 171 ~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 171 AYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp CSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred Eecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 8543 333 36889999999999999999999998754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=264.16 Aligned_cols=179 Identities=22% Similarity=0.387 Sum_probs=150.4
Q ss_pred CCCCCC-CcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHH-HhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSA-NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAA-INIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~-~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|.+. +.||+|+||.||+|. ..+++.||+|+++. ...+.+|+.++ +.++||||+++++++... .......
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCceE
Confidence 456666 779999999999998 46789999999863 45678899888 556999999999997432 1335678
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC---CCceE
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EMIGH 298 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~---~~~~k 298 (367)
++||||+++|+|.+++...... .+++..+..++.|++.||.||| +++|+||||||+||+++. ++.+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTC-------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEE
T ss_pred EEEEeecCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEE
Confidence 9999999999999999865421 4778999999999999999999 889999999999999988 78999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|+|||++.... +..++.++|||||||++|+|++|..||.+.
T Consensus 161 l~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 161 LTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp ECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred Eeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 99999986431 134677899999999999999999999754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=282.97 Aligned_cols=184 Identities=17% Similarity=0.059 Sum_probs=126.7
Q ss_pred ccccCceEEEEEE-ecCCCEEEEEEeecCCC----------cchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCcee
Q 017712 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP----------GGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 153 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.+.|++|.+..++ ...|+.+|+|.+..... ...+.|.+|+++|+++ .|+||+++++++ ++...
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQS 316 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSSE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECCE
Confidence 4566777666665 56789999999964321 1235699999999999 799999999997 45667
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.||||||++|++|.++|.... .++.. +|+.||+.||+|+| ++|||||||||+|||+++++.+||+
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~~---------~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~ 381 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAGE---------EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLI 381 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTTC---------CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHHhCC---------CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEe
Confidence 899999999999999998765 23332 48899999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~P 359 (367)
|||+|+....... ......||+.|||||++.+ .+...+|+||+|++++++.++..|
T Consensus 382 DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 382 DFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ecccCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9999987644322 2233569999999999876 466789999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=249.36 Aligned_cols=186 Identities=14% Similarity=0.087 Sum_probs=141.0
Q ss_pred CCCCcccccCceEEEEEEecCCCEEEEEEeecCCCc--------chhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 148 SSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 148 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
...+.||+|+||.||+|. ..++.+++|........ ..+.+.+|++++++++||||+++..++.. ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-----~~ 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-----LD 412 (540)
T ss_dssp ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-----TT
T ss_pred CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-----CC
Confidence 345689999999999995 56788999986532221 12457999999999999999944444321 22
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++++|.+++.. ++.++.|++.||.||| +++|+||||||+|||++. .+||
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL 470 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYI 470 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEE
T ss_pred ccEEEEECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEE
Confidence 34899999999999999875 2358999999999999 889999999999999998 9999
Q ss_pred eccccccccCCCCCcc-----eeeeccCCCcccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 300 GDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
+|||+++......... ......||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9999999765432211 1124568999999999876 567788899999999999998888774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=208.63 Aligned_cols=163 Identities=18% Similarity=0.078 Sum_probs=124.9
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCc------------------chhHHHHHHHHHHhCCCC
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG------------------GSKSFKSECKAAINIKHR 201 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~ 201 (367)
+......|.+.+.||+|+||.||+|...+++.||+|.++..... ....+.+|+.++++++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 34445567777999999999999999877999999998643221 24568899999999994
Q ss_pred CcceeeeeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEe
Q 017712 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAH 281 (367)
Q Consensus 202 niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH 281 (367)
+++++++. ....++||||+++++|.+ +... ....++.|++.||.||| +++|+|
T Consensus 164 --~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~~---------------~~~~i~~qi~~~l~~lH---~~giiH 216 (282)
T 1zar_A 164 --LAVPKVYA------WEGNAVLMELIDAKELYR-VRVE---------------NPDEVLDMILEEVAKFY---HRGIVH 216 (282)
T ss_dssp --SSSCCEEE------EETTEEEEECCCCEEGGG-CCCS---------------CHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred --CCcCeEEe------ccceEEEEEecCCCcHHH-cchh---------------hHHHHHHHHHHHHHHHH---HCCCEe
Confidence 55555441 134599999999999988 4221 13358999999999999 899999
Q ss_pred cCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccC----------CCCCcchhHHHH
Q 017712 282 CNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG----------CEASTYGDVYSF 346 (367)
Q Consensus 282 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvwsl 346 (367)
|||||+|||++ ++.+||+|||+|+. +..++|||++.+ ..+...+|+|++
T Consensus 217 rDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 217 GDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp SCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred CCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 99999999999 99999999999973 445789998654 234555666653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7e-22 Score=171.81 Aligned_cols=137 Identities=20% Similarity=0.213 Sum_probs=104.7
Q ss_pred CCCCCcccccCceEEEEEEe-cCCCE--EEEEEeecCCCcc------------------------hhHHHHHHHHHHhCC
Q 017712 147 FSSANLIGAGNFGSVYNGTL-FDGTT--IAVKVFNLIRPGG------------------------SKSFKSECKAAINIK 199 (367)
Q Consensus 147 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~ 199 (367)
|.+.+.||+|+||.||+|.. .+|+. ||||+++...... ...+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678899999999999995 68888 9999875321110 126789999999998
Q ss_pred CCCc--ceeeeeecccccCCceeeeEEEEeccC-C----CHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhh
Q 017712 200 HRNI--VRVFTAFSGVDYQGARFKAVVYKFMPN-G----SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLH 272 (367)
Q Consensus 200 h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH 272 (367)
|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.|++.||.|||
T Consensus 129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHH
Confidence 8864 344432 234899999942 3 67766432 223456789999999999999
Q ss_pred hCCCCCeEecCCCCCceeecCCCceEEecccccccc
Q 017712 273 CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (367)
Q Consensus 273 ~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (367)
. +.+|+||||||+|||+++ .++|+|||+|...
T Consensus 188 ~--~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 Q--EAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp H--TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred H--HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 4 469999999999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-19 Score=163.78 Aligned_cols=150 Identities=13% Similarity=0.087 Sum_probs=99.3
Q ss_pred HhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCC--------------cchhHHHHHHHHHHhCCCCCccee
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--------------GGSKSFKSECKAAINIKHRNIVRV 206 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~ 206 (367)
.....-|++.+.||+|++|.||+|...+|+.||||+++.... ........+.++.....|+|+.++
T Consensus 91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 91 AARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 333345889999999999999999988899999998753210 011122222222222234444333
Q ss_pred eeeeccccc-CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 017712 207 FTAFSGVDY-QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (367)
Q Consensus 207 ~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlk 285 (367)
+........ -.....+|||||++|++|.++... .....++.|++.+|.+|| +.||||||||
T Consensus 171 ~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~---------------~~~~~l~~qll~~l~~lH---~~gIVHrDLK 232 (397)
T 4gyi_A 171 YEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV---------------PDPASLYADLIALILRLA---KHGLIHGDFN 232 (397)
T ss_dssp HHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC---------------SCHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred HhcCCCCCeeeeccCceEEEEecCCccHhhhccc---------------HHHHHHHHHHHHHHHHHH---HCCCcCCCCC
Confidence 322111000 001123799999999888665321 123457889999999999 8899999999
Q ss_pred CCceeecCCC----------ceEEecccccccc
Q 017712 286 PSNVLLDDEM----------IGHVGDFGMARFL 308 (367)
Q Consensus 286 p~Nil~~~~~----------~~kl~Dfg~~~~~ 308 (367)
|.|||+++++ .+.|+||+-+...
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999998776 3889999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=3.1e-13 Score=117.44 Aligned_cols=144 Identities=13% Similarity=0.094 Sum_probs=108.7
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCceee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 221 (367)
...+|.+...++.|+.+.||++.. ++..+++|............+.+|+.++..+. +.+++++++++. .....
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~ 85 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWS 85 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCce
Confidence 335677777788888899999974 46899999986432233456899999999884 677888988763 23457
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhC---------------------------
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD--------------------------- 274 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~--------------------------- 274 (367)
++||||++|.+|.+.+... .....++.+++++|..||+.
T Consensus 86 ~lv~e~i~G~~l~~~~~~~--------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYEDE--------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp EEEEECCSSEEHHHHCCTT--------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred EEEEEecCCeehhhccCCc--------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence 8999999999998764211 11235778899999999951
Q ss_pred -----------------------------CCCCeEecCCCCCceeecCCCceEEecccccc
Q 017712 275 -----------------------------CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (367)
Q Consensus 275 -----------------------------~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (367)
....++|+|++|.||+++++..+.|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876667899999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.33 E-value=3.3e-12 Score=110.62 Aligned_cols=137 Identities=14% Similarity=0.057 Sum_probs=95.5
Q ss_pred CCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCC--cceeeeeecccccCCceeeeE
Q 017712 146 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRN--IVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~l 223 (367)
++.+....+.|..+.||++...+|..+++|..... ....+.+|+.++..+.+.+ +++++++.. .....++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~~ 92 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWL 92 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCEE
Confidence 34433333456669999998767788999996532 3356889999999886544 556777652 2244699
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCC----------------------------
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC---------------------------- 275 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~---------------------------- 275 (367)
||||++|.+|. ..... ...++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~--~~~~~---------------~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSHLA---------------PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ 155 (264)
T ss_dssp EEECCSSEETT--TSCCC---------------HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred EEEecCCcccC--cCcCC---------------HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence 99999998884 21100 1245667777888888321
Q ss_pred ---------------------------CCCeEecCCCCCceeecCCCceEEeccccccc
Q 017712 276 ---------------------------QPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (367)
Q Consensus 276 ---------------------------~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (367)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998877778999998763
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-12 Score=114.90 Aligned_cols=89 Identities=24% Similarity=0.385 Sum_probs=55.7
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhccc-chhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPE-RAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~-~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
|.+|.|||||||||+|+||+||+.|++.... ...+...+...... ....+. ..
T Consensus 212 ~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-~~~~~~~~~~~~~~p~~~~~~-----~~-------------------- 265 (307)
T 3omv_A 212 NPFSFQSDVYSYGIVLYELMTGELPYSHINN-RDQIIFMVGRGYASPDLSKLY-----KN-------------------- 265 (307)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHTTCCCCCSTTSC-----TT--------------------
T ss_pred CCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcCCCCCCccccc-----cc--------------------
Confidence 4578999999999999999999999864321 11111111111100 000000 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
|-..+..+...|+..+|.+||++.++...|+.++..
T Consensus 266 ---~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 266 ---CPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp ---SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ---chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 011233456789999999999999999999877643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=2e-11 Score=108.17 Aligned_cols=94 Identities=13% Similarity=0.116 Sum_probs=57.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcc----------cHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhcc
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDEL----------NLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKAS 72 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~----------~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~ 72 (367)
..|.|+|||||||+|+||+||+.|.......+. ............ .+++.+....
T Consensus 194 ~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~~rp~~p~~~----------- 258 (303)
T 3hmm_A 194 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ----KLRPNIPNRW----------- 258 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS----CCCCCCCGGG-----------
T ss_pred ccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcc----cCCCCCCccc-----------
Confidence 467899999999999999999887542211111 111111111110 0111110000
Q ss_pred ccccchhhHHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 73 STCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
...++...+..+...|+..+|..||++.++.+.|+.+.+
T Consensus 259 -------~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 259 -------QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp -------GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 001334556678889999999999999999999988764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.16 E-value=7.6e-12 Score=110.82 Aligned_cols=81 Identities=27% Similarity=0.543 Sum_probs=53.4
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|||||||||+|+||+| |+.|+.... ...+...+... ......+
T Consensus 222 ~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--~~~~~~~i~~~---~~~~~p~-------------------------- 270 (308)
T 4gt4_A 222 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--NQDVVEMIRNR---QVLPCPD-------------------------- 270 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--HHHHHHHHHTT---CCCCCCT--------------------------
T ss_pred CCCCccchhhhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcC---CCCCCcc--------------------------
Confidence 567999999999999999999 889976432 11222222211 0000000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRL 115 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~ 115 (367)
.|-..+..+...|+..+|.+||++.+|.+.|+.
T Consensus 271 --~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 271 --DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred --cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 011223455678999999999999999998874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=9.2e-11 Score=106.62 Aligned_cols=144 Identities=9% Similarity=0.093 Sum_probs=101.5
Q ss_pred CCcccccCceEEEEEEecCCCEEEEEEee--cCCC-cchhHHHHHHHHHHhCC--CCCcceeeeeecccccCCceeeeEE
Q 017712 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFN--LIRP-GGSKSFKSECKAAINIK--HRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
.+.|+.|.++.||+.... +..+++|+.. .... .....+.+|+.++..+. +..+++++.++.+.. .....++|
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~~v 119 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAFYI 119 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeEEE
Confidence 356899999999998754 4678888765 2221 22457889999999987 456788888764321 12346899
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCC-----------------------------
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC----------------------------- 275 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~----------------------------- 275 (367)
|||++|.++.+... . .++..+...++.+++..|..||...
T Consensus 120 me~v~G~~l~~~~~--~---------~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL--P---------GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp EECCCCBCCCCTTC--T---------TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred EEecCCeecCCCcc--c---------cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 99999877743111 0 2446677788999999999999520
Q ss_pred --------------------------CCCeEecCCCCCceeecCCCc--eEEeccccccc
Q 017712 276 --------------------------QPPIAHCNLKPSNVLLDDEMI--GHVGDFGMARF 307 (367)
Q Consensus 276 --------------------------~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~~~ 307 (367)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999987653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.12 E-value=1.6e-11 Score=109.00 Aligned_cols=189 Identities=18% Similarity=0.120 Sum_probs=115.9
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCC--cceeeeeecccccCCceeeeEEEEe
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRN--IVRVFTAFSGVDYQGARFKAVVYKF 227 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~~~~~~~~~lv~e~ 227 (367)
+.++.|.+..||+.. ..+++|+... ......+.+|+.++..+. +.. +.+++..... .......|+||++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGFTK 97 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEEEC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEEcc
Confidence 468999999999763 5688898542 123567889999998873 332 4455544311 1112245889999
Q ss_pred ccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhC---------------------------------
Q 017712 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD--------------------------------- 274 (367)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~--------------------------------- 274 (367)
++|.+|.+.... .++..+...++.+++..|..||+.
T Consensus 98 i~G~~l~~~~~~-----------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (304)
T 3sg8_A 98 IKGVPLTPLLLN-----------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK 166 (304)
T ss_dssp CCCEECCHHHHH-----------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred cCCeECCccccc-----------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence 999888653221 234555666777777777777741
Q ss_pred ----------------------CCCCeEecCCCCCceeecC--CCceEEeccccccccCCCCCcceeeec---cC-----
Q 017712 275 ----------------------CQPPIAHCNLKPSNVLLDD--EMIGHVGDFGMARFLPAIDKQNRFICI---KG----- 322 (367)
Q Consensus 275 ----------------------~~~~iiH~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~---~g----- 322 (367)
....++|+|++|.||++++ ...+.|+||+.+..-............ .+
T Consensus 167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHH
T ss_pred cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHH
Confidence 0135899999999999988 566789999988643211000000000 00
Q ss_pred ----CCcccC-CccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 017712 323 ----STGYIP-PEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360 (367)
Q Consensus 323 ----t~~y~a-PE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf 360 (367)
..+... |+.... .....+.|++|.++|.+.+|..||
T Consensus 247 ~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000011 111111 112258999999999999998876
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=2.3e-11 Score=107.20 Aligned_cols=85 Identities=20% Similarity=0.350 Sum_probs=55.2
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|||||||||+|+||+| |+.|+.... ...+...+.... .... + ..
T Consensus 205 ~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--~~~~~~~i~~~~---~~~~--p---~~-------------------- 254 (299)
T 4asz_A 205 RKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--NNEVIECITQGR---VLQR--P---RT-------------------- 254 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHHHTC---CCCC--C---TT--------------------
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHcCC---CCCC--C---cc--------------------
Confidence 467899999999999999999 899976432 111222221110 0000 0 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
|-..+..+...|+..+|..||++.++...|+.+.+.
T Consensus 255 ---~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 255 ---CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 011233456789999999999999999999877653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.07 E-value=3.6e-11 Score=107.49 Aligned_cols=84 Identities=26% Similarity=0.429 Sum_probs=54.9
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|||||||||+|+||+| |+.|+..... ..+...+..... ... + ..
T Consensus 235 ~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i~~g~~---~~~--p---~~-------------------- 284 (329)
T 4aoj_A 235 RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAIDCITQGRE---LER--P---RA-------------------- 284 (329)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHHHHHHHTCC---CCC--C---TT--------------------
T ss_pred CCCCccccccchHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCCC---CCC--c---cc--------------------
Confidence 457899999999999999999 8999764321 112222211100 000 0 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
|-..+..+...|+..+|.+||++.+|...|+.+.+
T Consensus 285 ---~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 285 ---CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp ---CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 01123345678999999999999999999988764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=2e-10 Score=103.58 Aligned_cols=85 Identities=24% Similarity=0.338 Sum_probs=54.0
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|||||||||+|+||+| |+.|+......+ .+...+..... ..+.+ ..
T Consensus 262 ~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-~~~~~i~~g~~---~~~p~-----~~------------------- 313 (353)
T 4ase_A 262 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTR---MRAPD-----YT------------------- 313 (353)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTCC---CCCCT-----TC-------------------
T ss_pred CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-HHHHHHHcCCC---CCCCc-----cC-------------------
Confidence 457899999999999999999 899976432111 12121111100 00000 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-.++..+...|+..+|.+||++.++.+.|..+.+
T Consensus 314 ----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 314 ----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 1112344567999999999999999999887654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=5e-10 Score=100.19 Aligned_cols=94 Identities=30% Similarity=0.468 Sum_probs=67.6
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC---CCCCcccHHHHHHHhccc-chhhhhhhhhhhhhHHHHHHhhhccccccch
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD---MFNDELNLHNFVKSALPE-RAEEILDVVFFQEIEEEETMYKKASSTCTQS 78 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~---~~~~~~~l~~~~~~~~~~-~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~ 78 (367)
..+.++|||||||+++||+||+.|++. .......+..|+...... ....+.+..+......
T Consensus 211 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 275 (326)
T 3uim_A 211 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKD--------------- 275 (326)
T ss_dssp EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCH---------------
T ss_pred CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCH---------------
Confidence 467899999999999999999999862 123445677887776654 3444555443322211
Q ss_pred hhHHHHHHHHhhhcccccccccccccchhHHHHHHHH
Q 017712 79 SIILECLISICRTGVACSAELPNERMKINDVESRLRL 115 (367)
Q Consensus 79 ~~~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~ 115 (367)
++...+..+...|+..+|.+||++.++.+.|+.
T Consensus 276 ----~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 276 ----EEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp ----HHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ----HHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 224456667788999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=8.4e-10 Score=98.56 Aligned_cols=98 Identities=26% Similarity=0.393 Sum_probs=66.1
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCC-CCcccHHHHHHHhccc-chhhhhhhhhhhhhHHHHHHhhhccccccchh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMF-NDELNLHNFVKSALPE-RAEEILDVVFFQEIEEEETMYKKASSTCTQSS 79 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~-~~~~~l~~~~~~~~~~-~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (367)
+..+.++|||||||+++||+||+.|+.... .+...+..|....... ....++++.+......
T Consensus 216 ~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 279 (321)
T 2qkw_B 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP---------------- 279 (321)
T ss_dssp CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCH----------------
T ss_pred CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCH----------------
Confidence 356889999999999999999999976432 2334566665443322 2334444332221111
Q ss_pred hHHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 80 IILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 80 ~~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
++...+..+...|+..+|..||++.++...|+.+.+
T Consensus 280 ---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 280 ---ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp ---HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 223445566778999999999999999999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.71 E-value=6.2e-09 Score=91.12 Aligned_cols=28 Identities=36% Similarity=0.515 Sum_probs=25.0
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
|..+.|+|||||||+|+||+||+.|+..
T Consensus 204 ~~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 204 EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 4578999999999999999999999753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=7.9e-09 Score=91.46 Aligned_cols=95 Identities=24% Similarity=0.366 Sum_probs=59.5
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcc--cchhhhhhhhhhhhhHHHHHHhhhccccccchh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALP--ERAEEILDVVFFQEIEEEETMYKKASSTCTQSS 79 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~--~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (367)
|..+.++||||||++++||+||+.|++.... ...+..+...... ..+.+.++..+....
T Consensus 209 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------ 269 (307)
T 2nru_A 209 GEITPKSDIYSFGVVLLEIITGLPAVDEHRE-PQLLLDIKEEIEDEEKTIEDYIDKKMNDAD------------------ 269 (307)
T ss_dssp TEECTHHHHHHHHHHHHHHHHCCCSBCTTBS-SSBTTHHHHHHHTTSCCHHHHSCSSCSCCC------------------
T ss_pred CCCCccchhHHHHHHHHHHHHCCCCcccCcc-hHHHHHHHHHhhhhhhhhhhhccccccccc------------------
Confidence 4568899999999999999999999864322 2222233222111 112222232211100
Q ss_pred hHHHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 80 IILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 80 ~~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
..+...+..+...|+..+|..||++.++...|+.+.
T Consensus 270 --~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 270 --STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp --HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred --hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 012334556678899999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=1.3e-08 Score=90.87 Aligned_cols=104 Identities=16% Similarity=0.239 Sum_probs=56.8
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCc-ccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhcccccc-chhh
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDE-LNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCT-QSSI 80 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~-~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~-~~~~ 80 (367)
..+.|+|||||||+++||+||+.|++...... ..+...... .+ ...++.+...... ..... ....
T Consensus 214 ~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~-----------~~~~~~~~~~ 280 (322)
T 3soc_A 214 DAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ-HP-SLEDMQEVVVHKK-----------KRPVLRDYWQ 280 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS-SC-CHHHHHHHHTTSC-----------CCCCCCGGGG
T ss_pred CCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc-CC-chhhhhhhhhccc-----------CCCCcccccc
Confidence 35678899999999999999999976432211 111111000 00 0001110000000 00000 0000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
...+...+..+...|+..+|.+||++.++.+.|+.+.+.
T Consensus 281 ~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 281 KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 002233455667889999999999999999999987653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=1.4e-08 Score=89.50 Aligned_cols=90 Identities=19% Similarity=0.277 Sum_probs=53.7
Q ss_pred cccccceeehhHHHHHHHhC----------CCCCCCCCCCcccHHHHHHHhcccc-hhhhhhhhhhhhhHHHHHHhhhcc
Q 017712 4 VSSYGDVYSFGILLLEMFTG----------LRPNDDMFNDELNLHNFVKSALPER-AEEILDVVFFQEIEEEETMYKKAS 72 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg----------~~p~~~~~~~~~~l~~~~~~~~~~~-~~~i~d~~~~~~~~~~~~~~~~~~ 72 (367)
.+.|+|||||||+++||+|| +.|+..................... ...+....+
T Consensus 200 ~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 264 (301)
T 3q4u_A 200 SYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWF--------------- 264 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG---------------
T ss_pred CCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhc---------------
Confidence 45799999999999999999 6665433222222222221111110 000000000
Q ss_pred ccccchhhHHHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 73 STCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
...+...+..+...|+..+|.+||++.++.+.|+.+
T Consensus 265 --------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 265 --------SDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp --------GSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred --------cCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 001233455667889999999999999999998865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=98.68 E-value=5.8e-09 Score=94.83 Aligned_cols=94 Identities=18% Similarity=0.106 Sum_probs=59.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++|||||||+|+||+||+.|++....+ ..+..+..........++++..+....
T Consensus 237 ~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------- 294 (364)
T 3op5_A 237 APSRRGDLEILGYCMIQWLTGHLPWEDNLKD-PKYVRDSKIRYRENIASLMDKCFPAAN--------------------- 294 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-HHHHHHHHHHHHHCHHHHHHHHSCTTC---------------------
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCccccccC-HHHHHHHHHHhhhhHHHHHHHhccccc---------------------
Confidence 3678999999999999999999998642222 122233332222233333333221000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
+-..+..+...|+..+|.+||++.++...|+.+...
T Consensus 295 -~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 295 -APGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp -CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 011233445679999999999999999999877654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=2.5e-08 Score=89.65 Aligned_cols=94 Identities=13% Similarity=0.195 Sum_probs=56.6
Q ss_pred cccccceeehhHHHHHHHhC----------CCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccc
Q 017712 4 VSSYGDVYSFGILLLEMFTG----------LRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASS 73 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg----------~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~ 73 (367)
.+.|+|||||||+++||+|| +.|.............+......... .+.+.....
T Consensus 234 ~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~----------- 298 (342)
T 1b6c_B 234 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIPNRWQ----------- 298 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCGGGG-----------
T ss_pred cCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHh----CCCCccccc-----------
Confidence 34789999999999999999 45544322222233333222211110 010000000
Q ss_pred cccchhhHHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 74 TCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
..++...+..+...|+..+|..||++.++.+.|+.+.+.
T Consensus 299 -------~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 299 -------SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp -------TSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------chhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 002234455677889999999999999999999987653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.63 E-value=3e-08 Score=88.86 Aligned_cols=35 Identities=20% Similarity=0.277 Sum_probs=29.0
Q ss_pred HHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 85 LISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 85 ~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
...+..+...|+..+|.+||++.++.+.|+.+...
T Consensus 298 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 298 LRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 44455677889999999999999999999887653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.62 E-value=2.5e-08 Score=88.34 Aligned_cols=87 Identities=17% Similarity=0.308 Sum_probs=54.5
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++|||||||+++||+||+.|++........+ .|... ...... +.....
T Consensus 179 ~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~--~~~~~~-----~~~~~~-------------------- 230 (307)
T 2eva_A 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI-MWAVH--NGTRPP-----LIKNLP-------------------- 230 (307)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH-HHHHH--TTCCCC-----CBTTCC--------------------
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH-HHHHh--cCCCCC-----cccccC--------------------
Confidence 56889999999999999999999986432211111 11110 000000 000000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~ 120 (367)
..+..+...|+..+|..||++.++.+.|..+....
T Consensus 231 ---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 231 ---KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred ---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 11223456799999999999999999999876644
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=1.7e-07 Score=82.87 Aligned_cols=136 Identities=17% Similarity=0.099 Sum_probs=87.8
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCC---CcceeeeeecccccCCceeeeEEEEe
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR---NIVRVFTAFSGVDYQGARFKAVVYKF 227 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (367)
..++.|....||+. +..+++|+.. .......+.+|+.++..+.+. .+.+++.+.. ......+++||+
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEec
Confidence 45788888899987 5678888842 222356789999999998652 3556665542 123446899999
Q ss_pred ccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhC---------------------------------
Q 017712 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD--------------------------------- 274 (367)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~--------------------------------- 274 (367)
++|.+|.+..... ++..+...++.+++..|..||+.
T Consensus 95 i~G~~l~~~~~~~-----------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~ 163 (306)
T 3tdw_A 95 VQGQILGEDGMAV-----------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL 163 (306)
T ss_dssp CCSEECHHHHHTT-----------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred cCCeECchhhhhh-----------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence 9998886532110 11222333333333333333311
Q ss_pred ------------------------CCCCeEecCCCCCceeecC---CCc-eEEeccccccc
Q 017712 275 ------------------------CQPPIAHCNLKPSNVLLDD---EMI-GHVGDFGMARF 307 (367)
Q Consensus 275 ------------------------~~~~iiH~dlkp~Nil~~~---~~~-~kl~Dfg~~~~ 307 (367)
....++|+|++|.||+++. ++. ..|+||+.+..
T Consensus 164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1446799999999999987 355 48999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=98.58 E-value=3.7e-08 Score=88.07 Aligned_cols=83 Identities=18% Similarity=0.323 Sum_probs=54.0
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.|+|||||||+++||+| |+.|++... ...+...+....... .+ ..
T Consensus 195 ~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~~~~-----~~---~~--------------------- 243 (327)
T 3poz_A 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGERLP-----QP---PI--------------------- 243 (327)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTCCCC-----CC---TT---------------------
T ss_pred CCCchhhhhhhHHHHHHHHhcCCCCccCCC--HHHHHHHHHcCCCCC-----CC---cc---------------------
Confidence 46889999999999999999 999976432 122222222111000 00 00
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
+-..+..+...|+..+|..||++.++...|+.+..
T Consensus 244 --~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 244 --CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred --CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01123345678999999999999999999887654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=98.58 E-value=3.1e-08 Score=87.01 Aligned_cols=90 Identities=11% Similarity=0.072 Sum_probs=54.7
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCC-CcccHH-HHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFN-DELNLH-NFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~-~~~~l~-~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
..+.++|||||||+++||+||+.|+..... +..... ............. +....
T Consensus 191 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~------------------- 246 (296)
T 3uzp_A 191 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-----LCKGY------------------- 246 (296)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH-----HTTTS-------------------
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH-----HHhhC-------------------
Confidence 467899999999999999999999864321 111111 1111100000000 00000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~ 120 (367)
-..+..+...|+..+|.+||++.++.+.|+.+....
T Consensus 247 ----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 247 ----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 012334566799999999999999999998876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=98.57 E-value=1.3e-08 Score=89.23 Aligned_cols=86 Identities=22% Similarity=0.345 Sum_probs=52.9
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhc-ccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSAL-PERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~-~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+||+.|++.... ...+...+.... ......+. ..
T Consensus 201 ~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~-----~~--------------------- 253 (289)
T 3og7_A 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIEMVGRGSLSPDLSKVR-----SN--------------------- 253 (289)
T ss_dssp CSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-HHHHHHHHHHTSCCCCTTSSC-----TT---------------------
T ss_pred CCCcccchHHHHHHHHHHHHCCCCccccch-HHHHHHHhcccccCcchhhcc-----cc---------------------
Confidence 457799999999999999999999764321 111222221110 00000000 00
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
+-..+..+...|+..+|.+||++.++.+.|+.+.
T Consensus 254 --~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 254 --CPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0112334456799999999999999999998764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=4.1e-08 Score=87.53 Aligned_cols=85 Identities=16% Similarity=0.167 Sum_probs=51.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.|+|||||||+|+||+||+.|+......+ +..-+...-+ ...++ ...++.
T Consensus 232 ~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i~~~~~-~~~~~-----~~~~s~------------------- 284 (336)
T 4g3f_A 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LCLKIASEPP-PIREI-----PPSCAP------------------- 284 (336)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CHHHHHHSCC-GGGGS-----CTTSCH-------------------
T ss_pred CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHHcCCC-Cchhc-----CccCCH-------------------
Confidence 46789999999999999999999986432221 1111111100 00000 000000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
.+..+-..|+..+|.+||+..++.+.+.....
T Consensus 285 ----~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 285 ----LTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp ----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 11223456899999999999999888776543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.55 E-value=1.7e-08 Score=91.00 Aligned_cols=92 Identities=15% Similarity=0.125 Sum_probs=52.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++|||||||+++||+||+.|++....+...+... ...........+.... .. .
T Consensus 236 ~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~----~~------------~------ 292 (345)
T 2v62_A 236 ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA-KTNLLDELPQSVLKWA----PS------------G------ 292 (345)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH-HHHHHHTTTHHHHHHS----CT------------T------
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH-HHhhcccccHHHHhhc----cc------------c------
Confidence 46889999999999999999999975322221111111 1110000000000000 00 0
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
.+-..+..+...|+..+|..||++.++.+.|+...
T Consensus 293 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 293 SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 00112334456899999999999999999887643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=98.53 E-value=3.9e-08 Score=86.35 Aligned_cols=90 Identities=11% Similarity=0.076 Sum_probs=54.5
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCc-ccH-HHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDE-LNL-HNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~-~~l-~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
..+.++|||||||+++||+||+.|+....... ... ........+..... +....
T Consensus 191 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~------------------- 246 (296)
T 4hgt_A 191 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-----LCKGY------------------- 246 (296)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH-----HTTTS-------------------
T ss_pred CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh-----hhccC-------------------
Confidence 46789999999999999999999986432211 111 11111000000000 00000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~ 120 (367)
-..+..+...|+..+|.+||++.++.+.|+.+....
T Consensus 247 ----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 247 ----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 012334456799999999999999999998876643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=5.4e-08 Score=85.58 Aligned_cols=92 Identities=10% Similarity=0.051 Sum_probs=54.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++|||||||+++||+||+.|+....... ....... +............ +.
T Consensus 194 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~--------~~~~~~~~~~~~~----------~~------ 247 (298)
T 1csn_A 194 EQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT--NKQKYER--------IGEKKQSTPLREL----------CA------ 247 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC--HHHHHHH--------HHHHHHHSCHHHH----------TT------
T ss_pred CCChHHHHHHHHHHHHHHHcCCCCcchhhccc--cHHHHHH--------HHhhccCccHHHH----------Hh------
Confidence 46889999999999999999999976432111 1111000 0000000000000 00
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~ 120 (367)
.+-..+..+...|+..+|..||++.++.+.|+.+....
T Consensus 248 ~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 248 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 00112334566799999999999999999999876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=4.2e-08 Score=89.62 Aligned_cols=85 Identities=32% Similarity=0.443 Sum_probs=54.0
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+++||+| |+.|+..... .....++.....- . .+ ..
T Consensus 290 ~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~---~--~~---~~-------------------- 339 (377)
T 3cbl_A 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEKGGRL---P--CP---EL-------------------- 339 (377)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHHHHTTCCC---C--CC---TT--------------------
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCC---C--CC---CC--------------------
Confidence 456789999999999999999 8888754321 1122222111000 0 00 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
+-..+..+...|+..+|.+||++.++...|+.+.+.
T Consensus 340 ---~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 340 ---CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 001123445679999999999999999999987653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.51 E-value=3.2e-08 Score=89.42 Aligned_cols=95 Identities=12% Similarity=0.083 Sum_probs=55.3
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++|||||||+|+||+||+.|+.........+....... ......+.+..... ...
T Consensus 244 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~----------------~~~---- 302 (352)
T 2jii_A 244 GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKF-VDKPGPFVGPCGHW----------------IRP---- 302 (352)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHH-HHSCCCEECTTSCE----------------ECC----
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhc-cCChhhhhhhcccc----------------CCC----
Confidence 467899999999999999999999764321221122211110 00000111100000 000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~ 120 (367)
-..+..+...|+..+|.+||++.++.+.|+.+....
T Consensus 303 --~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 303 --SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp --CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 011234456788999999999999999998876654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=9.8e-07 Score=76.45 Aligned_cols=134 Identities=13% Similarity=0.082 Sum_probs=89.6
Q ss_pred ccccCce-EEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCceeeeEEEEecc
Q 017712 153 IGAGNFG-SVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAVVYKFMP 229 (367)
Q Consensus 153 lg~G~~g-~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 229 (367)
+..|..+ .||+... .++..+++|+-. ......+.+|...|..+. +--+.+++.++.+ ....++|||+++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~---~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l~ 103 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGK---GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAIP 103 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEE---THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECC---CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEeeC
Confidence 3445444 6898773 456788999854 234567889999998874 3336677777532 245699999999
Q ss_pred CCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCC----------------------------------
Q 017712 230 NGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC---------------------------------- 275 (367)
Q Consensus 230 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~---------------------------------- 275 (367)
|.++.+...... .....+..+++..|.-||...
T Consensus 104 G~~~~~~~~~~~-------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (272)
T 4gkh_A 104 GKTAFQVLEEYP-------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE 170 (272)
T ss_dssp SEEHHHHHHHCG-------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred CccccccccCCH-------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence 988876543211 122234555555566665310
Q ss_pred ---------------------CCCeEecCCCCCceeecCCCceEEeccccccc
Q 017712 276 ---------------------QPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (367)
Q Consensus 276 ---------------------~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (367)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887778999998763
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.49 E-value=3.5e-08 Score=87.45 Aligned_cols=83 Identities=25% Similarity=0.383 Sum_probs=53.9
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCc----ccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccch
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDE----LNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQS 78 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~----~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~ 78 (367)
..+.++|||||||+++||+||+.|........ .....+.....+.. .
T Consensus 198 ~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~----------------- 248 (310)
T 3s95_A 198 SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN------------C----------------- 248 (310)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTT------------C-----------------
T ss_pred CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCC------------C-----------------
Confidence 46789999999999999999998865322111 11111111111100 0
Q ss_pred hhHHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhhh
Q 017712 79 SIILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (367)
Q Consensus 79 ~~~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~ 120 (367)
-..+..+...|+..+|.+||++.++.+.|+.+....
T Consensus 249 ------~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 249 ------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ------CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 001223456799999999999999999999887654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=6.1e-08 Score=84.83 Aligned_cols=82 Identities=17% Similarity=0.256 Sum_probs=50.3
Q ss_pred cccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHHH
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIILE 83 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (367)
.+.++||||||++++||+||+.|++........+......... .+.+....
T Consensus 205 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------~~~~~~~~---------------------- 255 (287)
T 4f0f_A 205 YTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL-------RPTIPEDC---------------------- 255 (287)
T ss_dssp ECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC-------CCCCCTTS----------------------
T ss_pred cCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC-------CCCCCccc----------------------
Confidence 5789999999999999999999986432222111111111100 00000000
Q ss_pred HHHHHhhhcccccccccccccchhHHHHHHHH
Q 017712 84 CLISICRTGVACSAELPNERMKINDVESRLRL 115 (367)
Q Consensus 84 ~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~ 115 (367)
-..+..+...|+..+|.+||++.++.+.|+.
T Consensus 256 -~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 256 -PPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 0112334567899999999999999998864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=4.8e-08 Score=84.57 Aligned_cols=81 Identities=22% Similarity=0.247 Sum_probs=49.1
Q ss_pred ccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHHHH
Q 017712 5 SSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIILEC 84 (367)
Q Consensus 5 s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (367)
+.++||||||++++||+||+.|++.... ............ .+.+....
T Consensus 189 ~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~----~~~~~~~~----------------------- 236 (271)
T 3kmu_A 189 RRSADMWSFAVLLWELVTREVPFADLSN-----MEIGMKVALEGL----RPTIPPGI----------------------- 236 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHCSCTTTTSCH-----HHHHHHHHHSCC----CCCCCTTC-----------------------
T ss_pred CchhhHHHHHHHHHHHHhCCCCccccCh-----HHHHHHHHhcCC----CCCCCCCC-----------------------
Confidence 3479999999999999999999764221 111111100000 00000000
Q ss_pred HHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 85 LISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 85 ~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
-..+..+...|+..+|..||++.++.+.|+.+.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 237 SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 011223455699999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.3e-07 Score=83.77 Aligned_cols=85 Identities=22% Similarity=0.259 Sum_probs=52.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++|||||||+++||+||+.|+.... .......+...... ..+. ...+
T Consensus 215 ~~~~~~DiwslG~il~elltg~~Pf~~~~--~~~~~~~~~~~~~~--~~~~-----~~~~-------------------- 265 (309)
T 3p86_A 215 PSNEKSDVYSFGVILWELATLQQPWGNLN--PAQVVAAVGFKCKR--LEIP-----RNLN-------------------- 265 (309)
T ss_dssp CCCTTHHHHHHHHHHHHHHHCCCTTTTSC--HHHHHHHHHHSCCC--CCCC-----TTSC--------------------
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCC--CCCC-----ccCC--------------------
Confidence 36789999999999999999999976421 11111111100000 0000 0000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
..+..+...|+..+|.+||++.++.+.|+.+.+.
T Consensus 266 ---~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 266 ---PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1122345579999999999999999999877654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.43 E-value=1.3e-07 Score=84.47 Aligned_cols=84 Identities=15% Similarity=0.245 Sum_probs=53.7
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++||+| |+.|++... ...+...+........ + ...
T Consensus 195 ~~~~~~Di~slG~il~ell~~g~~p~~~~~--~~~~~~~~~~~~~~~~-----~---~~~-------------------- 244 (327)
T 3lzb_A 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGERLPQ-----P---PIC-------------------- 244 (327)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTCCCCC-----C---TTB--------------------
T ss_pred CCChHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCCCC-----C---ccC--------------------
Confidence 46789999999999999999 999976432 1222222221110000 0 000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|.+||++.++...|..+...
T Consensus 245 ---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 245 ---TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 01123445679999999999999999999887643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=98.42 E-value=1.7e-07 Score=87.70 Aligned_cols=85 Identities=20% Similarity=0.236 Sum_probs=54.3
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|+|||||||+|+||+| |+.|+..... ..+...+.....- ... ...
T Consensus 361 ~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~~---~~p-----~~~------------------- 411 (450)
T 1k9a_A 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKM---DAP-----DGC------------------- 411 (450)
T ss_dssp SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--TTHHHHHHTTCCC---CCC-----TTC-------------------
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCC---CCC-----CcC-------------------
Confidence 457889999999999999999 9999764321 1122222111100 000 000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|..||++.++...|+.+...
T Consensus 412 ----~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 412 ----PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 01123345679999999999999999999887653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.3e-07 Score=83.69 Aligned_cols=89 Identities=17% Similarity=0.101 Sum_probs=53.7
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++||||||++++||+||+.|..... .....+.............. ...
T Consensus 212 ~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~----~~~--------------------- 263 (310)
T 2wqm_A 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEQCDYPPLPS----DHY--------------------- 263 (310)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTC------CCHHHHHHHHHTTCSCCCCT----TTS---------------------
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcccc---hhHHHHHHHhhcccCCCCcc----ccc---------------------
Confidence 46789999999999999999999975321 11212211110000000000 000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhhhc
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLL 121 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~~ 121 (367)
-..+..+...|+..+|..||++.++...++.+.....
T Consensus 264 --~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 264 --SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0112344567999999999999999999988876543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.42 E-value=4.5e-08 Score=88.15 Aligned_cols=28 Identities=32% Similarity=0.466 Sum_probs=24.0
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|++.
T Consensus 195 ~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 195 SKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp --CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 4578899999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=98.41 E-value=8e-08 Score=84.44 Aligned_cols=100 Identities=19% Similarity=0.312 Sum_probs=54.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++|||||||+++||+||+.|..... ..+................+........ .... ..
T Consensus 193 ~~~~~~Di~slG~~l~~l~~g~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~-~~------ 255 (295)
T 3ugc_A 193 KFSVASDVWSFGVVLYELFTYIEKSKSPP------AEFMRMIGNDKQGQMIVFHLIELLKNNG----RLPR-PD------ 255 (295)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTTCTTCSHH------HHHHHHHCTTCCTHHHHHHHHHHHHTTC----CCCC-CT------
T ss_pred CCChHHHHHHHHHHHHHHHhcccccCCCh------HHHHhhhcCccccchhHHHHHHHHhccC----cCCC-Cc------
Confidence 46789999999999999999998864211 1111111100000000000000000000 0000 00
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
.+-..+..+...|+..+|.+||++.++...|+.+.+.
T Consensus 256 ~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 256 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0112234456789999999999999999999987653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2.1e-07 Score=81.18 Aligned_cols=83 Identities=13% Similarity=0.164 Sum_probs=52.3
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|+..... ..+...+......... ...
T Consensus 190 ~~~~~~Di~slG~il~~llt~g~~p~~~~~~--~~~~~~~~~~~~~~~~--------~~~-------------------- 239 (281)
T 3cc6_A 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGVLEKGDRLPKP--------DLC-------------------- 239 (281)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--GGHHHHHHHTCCCCCC--------TTC--------------------
T ss_pred CCCchhccHHHHHHHHHHHhCCCCCcccCCh--HHHHHHHhcCCCCCCC--------CCC--------------------
Confidence 46788999999999999999 9999753221 1222211111000000 000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|..||++.++...|+.+..
T Consensus 240 ---~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 240 ---PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 0112234567999999999999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.41 E-value=2.7e-07 Score=81.10 Aligned_cols=88 Identities=23% Similarity=0.283 Sum_probs=54.8
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++||||||++++||+||+.|..... +...+...+......... ...
T Consensus 204 ~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~--------~~~--------------------- 253 (298)
T 3pls_A 204 RFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQGRRLPQP--------EYC--------------------- 253 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHHHTTCCCCCC--------TTC---------------------
T ss_pred CCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHhhcCCCCCCC--------ccc---------------------
Confidence 45789999999999999999777743221 122222222211110000 000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhhhcc
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLLK 122 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~~~ 122 (367)
-..+..+...|+..+|..||++.++...|+.+......
T Consensus 254 --~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 254 --PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred --hHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 01123445678999999999999999999988765443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.4e-07 Score=84.13 Aligned_cols=84 Identities=18% Similarity=0.301 Sum_probs=53.4
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.++|||||||+++||+| |+.|+.... ...+...+............
T Consensus 192 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~--------------------------- 242 (325)
T 3kex_A 192 GKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--LAEVPDLLEKGERLAQPQIC--------------------------- 242 (325)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--TTHHHHHHHTTCBCCCCTTB---------------------------
T ss_pred CCCChhhHhHHhHHHHHHHHhCCCCCccccC--HHHHHHHHHcCCCCCCCCcC---------------------------
Confidence 456889999999999999999 999976422 11222222211100000000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|..||++.++...|+.+..
T Consensus 243 ----~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 243 ----TIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ----CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0012234567999999999999999999987754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=98.40 E-value=1.1e-07 Score=89.48 Aligned_cols=90 Identities=13% Similarity=0.062 Sum_probs=54.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++|||||||+|+||+||+.|+....... ..+.... +.+..+........ .
T Consensus 189 ~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~--------i~~~~~~~~~~~l~----------~------ 242 (483)
T 3sv0_A 189 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--KKQKYEK--------ISEKKVATSIEALC----------R------ 242 (483)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS--HHHHHHH--------HHHHHHHSCHHHHH----------T------
T ss_pred CCChHHHHHHHHHHHHHHHhCCCCCccccchh--HHHHHHH--------HhhccccccHHHHh----------c------
Confidence 46789999999999999999999986432211 1111110 11110000000000 0
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
.+-.++..+...|+..+|.+||++.++...|+.+..
T Consensus 243 ~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 243 GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 001223455677999999999999999999887654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=98.40 E-value=1.1e-07 Score=86.57 Aligned_cols=85 Identities=24% Similarity=0.333 Sum_probs=53.1
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.++|||||||+|+||+| |+.|+.... ...+...+..... . ....
T Consensus 225 ~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--~~~~~~~i~~~~~--~------~~~~--------------------- 273 (373)
T 2qol_A 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMS--NQDVIKAVDEGYR--L------PPPM--------------------- 273 (373)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--HHHHHHHHHTTEE--C------CCCT---------------------
T ss_pred CCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC--C------CCCc---------------------
Confidence 346889999999999999998 999975421 1111111111000 0 0000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
.+-..+..+...|+..+|..||++.++...|+.+...
T Consensus 274 --~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 274 --DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp --TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0012234556789999999999999999999887553
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.7e-07 Score=84.70 Aligned_cols=85 Identities=25% Similarity=0.362 Sum_probs=52.9
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++||+| |+.|+....... .+...+......... ...
T Consensus 271 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~--------~~~-------------------- 321 (359)
T 3vhe_A 271 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMRAP--------DYT-------------------- 321 (359)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTCCCCCC--------TTC--------------------
T ss_pred CCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCCCCCCC--------CCC--------------------
Confidence 46789999999999999999 999975322111 111111111000000 000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|.+||++.++...|+.+...
T Consensus 322 ---~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 322 ---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 01123345679999999999999999999877643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.5e-07 Score=81.52 Aligned_cols=84 Identities=21% Similarity=0.302 Sum_probs=52.3
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.++||||||++++||+| |+.|.+... ...+...+...... ..+. ..
T Consensus 182 ~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--~~~~~~~~~~~~~~-----~~~~---~~------------------- 232 (269)
T 4hcu_A 182 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFRL-----YKPR---LA------------------- 232 (269)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTTCCC-----CCCT---TS-------------------
T ss_pred CCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--HHHHHHHHhcCccC-----CCCC---cC-------------------
Confidence 346789999999999999999 888875321 11111111111000 0000 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|.+||++.++.+.|+.+.+
T Consensus 233 ----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 233 ----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 0112234567999999999999999999988765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.39 E-value=4.3e-08 Score=87.09 Aligned_cols=84 Identities=21% Similarity=0.249 Sum_probs=51.3
Q ss_pred cccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHHH
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIILE 83 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (367)
.+.++|||||||+++||+||+.|++........+......... .... ...
T Consensus 223 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~---~~~---------------------- 272 (317)
T 2buj_A 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS-----IPQS---PRH---------------------- 272 (317)
T ss_dssp ECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-------CCCC---TTS----------------------
T ss_pred CCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC-----CCcc---ccC----------------------
Confidence 5789999999999999999999975321111112111111000 0000 000
Q ss_pred HHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 84 CLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 84 ~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|..||++.++...|+.+..
T Consensus 273 -~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 273 -SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0112344567899999999999999999987643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.9e-07 Score=83.59 Aligned_cols=84 Identities=26% Similarity=0.340 Sum_probs=52.6
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++||+| |+.|...... ...+...+....... .+. ..
T Consensus 242 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~-----~~~---~~-------------------- 292 (333)
T 2i1m_A 242 VYTVQSDVWSYGILLWEIFSLGLNPYPGILV-NSKFYKLVKDGYQMA-----QPA---FA-------------------- 292 (333)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS-SHHHHHHHHHTCCCC-----CCT---TC--------------------
T ss_pred CCChHHHHHHHHHHHHHHHcCCCCCCcccch-hHHHHHHHhcCCCCC-----CCC---CC--------------------
Confidence 46789999999999999999 8888754321 111222222111100 000 00
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|..||++.++...|+.+..
T Consensus 293 ---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 293 ---PKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 0112334567999999999999999999987654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=98.39 E-value=1.1e-07 Score=89.05 Aligned_cols=83 Identities=27% Similarity=0.388 Sum_probs=52.8
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|+|||||||+|+||+| |+.|+..... ..+...+..... ...+ .
T Consensus 360 ~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~-----~~~~---~--------------------- 408 (454)
T 1qcf_A 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYR-----MPRP---E--------------------- 408 (454)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHHTCC-----CCCC---T---------------------
T ss_pred CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC-----CCCC---C---------------------
Confidence 457889999999999999999 9998764211 111111111100 0000 0
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
.|-..+..+...|+..+|..||++.++...|+.+.
T Consensus 409 --~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 409 --NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred --CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 00112334567899999999999999999988654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.39 E-value=3.8e-07 Score=83.06 Aligned_cols=87 Identities=20% Similarity=0.306 Sum_probs=53.5
Q ss_pred CccccccceeehhHHHHHHHhC-CCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTG-LRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg-~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.++|||||||+++||+|| +.|..... ...+...+..... ...+. ..
T Consensus 271 ~~~~~~~DvwSlG~il~ellt~~~~p~~~~~--~~~~~~~~~~~~~-----~~~p~---~~------------------- 321 (373)
T 3c1x_A 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRR-----LLQPE---YC------------------- 321 (373)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--SSCHHHHHHTTCC-----CCCCT---TC-------------------
T ss_pred CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC--HHHHHHHHHcCCC-----CCCCC---CC-------------------
Confidence 3468899999999999999995 45554321 1222222221100 00000 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhhhc
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLL 121 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~~ 121 (367)
-..+..+...|+..+|..||++.++.+.|+.+.....
T Consensus 322 ----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 322 ----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0112344567999999999999999999998876544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=6.1e-08 Score=88.93 Aligned_cols=27 Identities=33% Similarity=0.479 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.|+|||||||+|+||+||+.|+..
T Consensus 243 ~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 243 KISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp -CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 578899999999999999999999764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1.7e-07 Score=80.88 Aligned_cols=83 Identities=22% Similarity=0.297 Sum_probs=51.9
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|..... ...+...+....... .+. ..
T Consensus 181 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~i~~~~~~~-----~~~---~~-------------------- 230 (267)
T 3t9t_A 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFRLY-----KPR---LA-------------------- 230 (267)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTTCCCC-----CCT---TS--------------------
T ss_pred CccchhchhhhHHHHHHHhccCCCCCCCCC--HHHHHHHHhcCCcCC-----CCc---cC--------------------
Confidence 46789999999999999999 888865321 111111111110000 000 00
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|..||++.++...|+.+.+
T Consensus 231 ---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 231 ---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0112344567999999999999999999988765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.37 E-value=4.4e-08 Score=87.82 Aligned_cols=35 Identities=17% Similarity=0.151 Sum_probs=29.0
Q ss_pred HHhhhcccccccccccccchhHHHHHHHHHhhhhc
Q 017712 87 SICRTGVACSAELPNERMKINDVESRLRLIKKKLL 121 (367)
Q Consensus 87 ~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~~ 121 (367)
.+..+...|+..+|..||++.++.+.|+.+.....
T Consensus 287 ~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 287 SLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 34556778999999999999999999998876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.37 E-value=1.6e-07 Score=83.83 Aligned_cols=84 Identities=23% Similarity=0.315 Sum_probs=53.2
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++||+| |+.|+..... ..+...+...... .....
T Consensus 230 ~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~~~~~--------~~~~~--------------------- 278 (325)
T 3kul_A 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVISSVEEGYRL--------PAPMG--------------------- 278 (325)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHHTTCCC--------CCCTT---------------------
T ss_pred CCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCCC--------CCCCC---------------------
Confidence 46789999999999999999 9999753211 1111111111000 00000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
+-..+..+...|+..+|..||++.++...|+.+...
T Consensus 279 --~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 279 --CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 011233456779999999999999999999887653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.36 E-value=1.9e-07 Score=84.86 Aligned_cols=84 Identities=24% Similarity=0.393 Sum_probs=53.3
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++||+| |+.|+.... ...+...+...... ... ..
T Consensus 262 ~~~~~~DvwslG~il~ellt~g~~pf~~~~--~~~~~~~i~~~~~~---~~~-----~~--------------------- 310 (367)
T 3l9p_A 262 IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEVLEFVTSGGRM---DPP-----KN--------------------- 310 (367)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHTTCCC---CCC-----TT---------------------
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCC---CCC-----cc---------------------
Confidence 46789999999999999999 888875321 11122221111000 000 00
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
+-..+..+...|+..+|.+||++.++.+.|+.+...
T Consensus 311 --~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 311 --CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 001133456679999999999999999999887653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=98.36 E-value=2.8e-07 Score=83.84 Aligned_cols=83 Identities=23% Similarity=0.342 Sum_probs=52.7
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++||+| |+.|+.... ...+...+....... . ...
T Consensus 281 ~~~~~~DvwslG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~~~~---~-----~~~--------------------- 329 (370)
T 2psq_A 281 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VEELFKLLKEGHRMD---K-----PAN--------------------- 329 (370)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHHTTCCCC---C-----CTT---------------------
T ss_pred CCCcHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCCCCC---C-----CCC---------------------
Confidence 46789999999999999999 888875422 112222211110000 0 000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
+-..+..+...|+..+|..||++.++...|+.+..
T Consensus 330 --~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 330 --CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01112344567999999999999999999988754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.35 E-value=3.3e-07 Score=89.02 Aligned_cols=85 Identities=24% Similarity=0.313 Sum_probs=55.2
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+|+||+| |+.|+..... ..+...+..... .... ..
T Consensus 514 ~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~~---~~~p-----~~-------------------- 563 (613)
T 2ozo_A 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKR---MECP-----PE-------------------- 563 (613)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHHHHHHTTCC---CCCC-----TT--------------------
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCC---CCCC-----Cc--------------------
Confidence 457889999999999999999 9999764321 122222221100 0000 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
|-..+..+...|+..+|.+||++.++...|+.+...
T Consensus 564 ---~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 564 ---CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp ---CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 011233456789999999999999999999876544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.35 E-value=3.5e-07 Score=79.96 Aligned_cols=84 Identities=21% Similarity=0.240 Sum_probs=53.4
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|+.... ...+...+..... . .+....
T Consensus 189 ~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~i~~~~~---~-----~~~~~~-------------------- 238 (287)
T 1u59_A 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKR---M-----ECPPEC-------------------- 238 (287)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTTCC---C-----CCCTTC--------------------
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHhcCCc---C-----CCCCCc--------------------
Confidence 46789999999999999999 999976422 1122222211100 0 000000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|..||++.++...|+.+...
T Consensus 239 ---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 239 ---PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp ---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 01123445679999999999999999999887554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.5e-07 Score=81.37 Aligned_cols=83 Identities=27% Similarity=0.361 Sum_probs=51.3
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|.+.... .....-+..... ...+.. .
T Consensus 181 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~-----~~~~~~---~-------------------- 230 (268)
T 3sxs_A 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEVVLKVSQGHR-----LYRPHL---A-------------------- 230 (268)
T ss_dssp EEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHTTCC-----CCCCTT---S--------------------
T ss_pred CCchhhhhHHHHHHHHHHHcCCCCCccccCh--HHHHHHHHcCCC-----CCCCCc---C--------------------
Confidence 46789999999999999999 9888763211 111111110000 000000 0
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|..||++.++.+.|+.+..
T Consensus 231 ---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 231 ---SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ---hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 0012334567999999999999999999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.3e-07 Score=79.86 Aligned_cols=83 Identities=18% Similarity=0.296 Sum_probs=52.1
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|++.... ..+...+...... . +....
T Consensus 193 ~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--~~~~~~i~~~~~~---~-----~~~~~-------------------- 242 (281)
T 1mp8_A 193 RFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGERL---P-----MPPNC-------------------- 242 (281)
T ss_dssp CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCCC---C-----CCTTC--------------------
T ss_pred CCCCccCchHHHHHHHHHHhcCCCCCCcCCH--HHHHHHHHcCCCC---C-----CCCCC--------------------
Confidence 46788999999999999997 8888764321 1222222111000 0 00000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|..||++.++...|+.+..
T Consensus 243 ---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 243 ---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0112234567899999999999999999987654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.34 E-value=1.3e-07 Score=84.09 Aligned_cols=85 Identities=15% Similarity=0.165 Sum_probs=50.6
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++||||||++++||+||+.|++.... .................. .. +
T Consensus 219 ~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~----~~-----------------~--- 269 (319)
T 2y4i_B 219 PFSKHSDVFALGTIWYELHAREWPFKTQPA-----EAIIWQMGTGMKPNLSQI----GM-----------------G--- 269 (319)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-----HHHHHHHHTTCCCCCCCS----SC-----------------C---
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHhccCCCCCCCcC----CC-----------------C---
Confidence 468899999999999999999999764221 111111100000000000 00 0
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
..+..+...|+..+|..||++.++...|+.+.+.
T Consensus 270 ---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 270 ---KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ---TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 0122345678999999999999999999876554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=98.34 E-value=1.8e-07 Score=88.52 Aligned_cols=82 Identities=20% Similarity=0.327 Sum_probs=51.5
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+|+||+| |+.|+.... ...+...+........ + ..
T Consensus 394 ~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~~~~-----~---~~-------------------- 443 (495)
T 1opk_A 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMER-----P---EG-------------------- 443 (495)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHHTTCCCCC-----C---TT--------------------
T ss_pred CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCCCC-----C---CC--------------------
Confidence 346789999999999999999 888875432 1122222211110000 0 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
+-..+..+...|+..+|.+||++.++.+.|+.+
T Consensus 444 ---~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 444 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 011123445679999999999999999988754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.1e-07 Score=79.89 Aligned_cols=84 Identities=21% Similarity=0.222 Sum_probs=52.6
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|..... ...+...+..... .......
T Consensus 190 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~~~~~~~--------~~~~~~~-------------------- 239 (278)
T 1byg_A 190 KFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGYK--------MDAPDGC-------------------- 239 (278)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHHTTTCC--------CCCCTTC--------------------
T ss_pred CCCchhcHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCCC--------CCCcccC--------------------
Confidence 46789999999999999999 988875321 1112111111000 0000000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|..||++.++...|+.+...
T Consensus 240 ---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 240 ---PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 01122344579999999999999999999887653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.7e-07 Score=80.86 Aligned_cols=84 Identities=17% Similarity=0.278 Sum_probs=52.8
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|..... ...+...+....... .....
T Consensus 225 ~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~~~~~--------~~~~~-------------------- 274 (313)
T 3brb_A 225 VYTSKSDVWAFGVTMWEIATRGMTPYPGVQ--NHEMYDYLLHGHRLK--------QPEDC-------------------- 274 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHHTTCCCC--------CBTTC--------------------
T ss_pred CccchhhhHHHHHHHHHHHhcCCCCCccCC--HHHHHHHHHcCCCCC--------CCccc--------------------
Confidence 46789999999999999999 777765322 112222211110000 00000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|..||++.++...|+.+...
T Consensus 275 ---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 275 ---LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp ---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11233445679999999999999999999887653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.5e-07 Score=80.96 Aligned_cols=85 Identities=19% Similarity=0.276 Sum_probs=52.9
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|....... ..+...+........ . ...
T Consensus 223 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~----~----~~~-------------------- 273 (313)
T 1t46_A 223 VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFYKMIKEGFRMLS----P----EHA-------------------- 273 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHHHHHHHHTCCCCC----C----TTS--------------------
T ss_pred CCChHHHHHHHHHHHHHHHhCCCCCCCcccch-hHHHHHhccCCCCCC----c----ccC--------------------
Confidence 46789999999999999999 88887543211 111111111110000 0 000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|..||++.++.+.|+.+...
T Consensus 274 ---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 274 ---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 01123345679999999999999999999876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3e-07 Score=81.44 Aligned_cols=83 Identities=24% Similarity=0.338 Sum_probs=52.8
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|...... ..+...+....... .....
T Consensus 228 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~--------~~~~~-------------------- 277 (314)
T 2ivs_A 228 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP--ERLFNLLKTGHRME--------RPDNC-------------------- 277 (314)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCCCC--------CCTTC--------------------
T ss_pred CcCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHhhcCCcCC--------CCccC--------------------
Confidence 36789999999999999999 9888754321 12222221111000 00000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|..||++.++...|+.+..
T Consensus 278 ---~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 278 ---SEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0112344567999999999999999999987654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.34 E-value=2.7e-07 Score=82.49 Aligned_cols=81 Identities=19% Similarity=0.202 Sum_probs=49.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++|||||||+++||+||+.|++.... . ............ ....
T Consensus 229 ~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~---~~~~~~~~~~~~--------~~~~-------------------- 275 (337)
T 3ll6_A 229 PIGEKQDIWALGCILYLLCFRQHPFEDGAK--L---RIVNGKYSIPPH--------DTQY-------------------- 275 (337)
T ss_dssp CSSHHHHHHHHHHHHHHHHHSSCCC-----------------CCCCTT--------CCSS--------------------
T ss_pred CCChHHhHHHHHHHHHHHHhCCCCCcchhH--H---HhhcCcccCCcc--------cccc--------------------
Confidence 467899999999999999999999753211 0 011100000000 0000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
..+..+...|+..+|.+||++.++...|+.+...
T Consensus 276 ---~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 276 ---TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ---GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0012334568899999999999999999887654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=3.4e-07 Score=81.89 Aligned_cols=91 Identities=11% Similarity=0.025 Sum_probs=54.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++|||||||+++||+||+.|+..... ..+.+..... .+...... ... . +..
T Consensus 193 ~~~~~~Di~slG~il~ell~g~~Pf~~~~~--~~~~~~~~~i--------~~~~~~~~--~~~-~-------~~~----- 247 (330)
T 2izr_A 193 EQSRRDDLEALGHMFMYFLRGSLPWQGLKA--DTLKERYQKI--------GDTKRATP--IEV-L-------CEN----- 247 (330)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--SSHHHHHHHH--------HHHHHHSC--HHH-H-------TTT-----
T ss_pred CCCchhHHHHHHHHHHHHhcCCCCcccccc--ccHHHHHHHH--------HhhhccCC--HHH-H-------hcc-----
Confidence 367899999999999999999999764321 1221111110 00000000 000 0 000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~ 120 (367)
.-.+..+...|+..+|..||++.++.+.|+.+....
T Consensus 248 --~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 248 --FPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp --CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --ChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 002344556799999999999999999998776543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=98.33 E-value=3.4e-07 Score=81.11 Aligned_cols=85 Identities=25% Similarity=0.362 Sum_probs=52.6
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|........ .+...+......... ...
T Consensus 226 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~--------~~~-------------------- 276 (316)
T 2xir_A 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMRAP--------DYT-------------------- 276 (316)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HHHHHHHHTCCCCCC--------TTC--------------------
T ss_pred cccchhHHHHHHHHHHHHHhCCCCCCcccchhH-HHHHHhccCccCCCC--------CCC--------------------
Confidence 46789999999999999999 988875432111 111111111000000 000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|..||++.++...|+.+.+.
T Consensus 277 ---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 277 ---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 01122345679999999999999999999887653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.33 E-value=2.6e-07 Score=83.07 Aligned_cols=85 Identities=24% Similarity=0.285 Sum_probs=53.0
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.++|||||||+++||+| |+.|+...... ..+...+........ + ...
T Consensus 249 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~-----~---~~~------------------- 300 (344)
T 1rjb_A 249 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD-ANFYKLIQNGFKMDQ-----P---FYA------------------- 300 (344)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHTTCCCCC-----C---TTC-------------------
T ss_pred CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH-HHHHHHHhcCCCCCC-----C---CCC-------------------
Confidence 346889999999999999999 99887643211 112222221110000 0 000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|..||++.++...|+.+..
T Consensus 301 ----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 301 ----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 0112334567999999999999999999987644
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2e-07 Score=81.71 Aligned_cols=83 Identities=24% Similarity=0.235 Sum_probs=52.1
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|+.... ...+...+....... .....
T Consensus 196 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~~--------~~~~~-------------------- 245 (291)
T 1xbb_A 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKGERMG--------CPAGC-------------------- 245 (291)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTCCCC--------CCTTC--------------------
T ss_pred CCChhhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCC--------CCCCC--------------------
Confidence 35778999999999999999 999976421 111222111110000 00000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|..||++.++...|+.+-.
T Consensus 246 ---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 246 ---PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0113344567999999999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.33 E-value=2.8e-07 Score=84.26 Aligned_cols=84 Identities=23% Similarity=0.301 Sum_probs=53.3
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++||+| |+.|..... ...+...+...... ... ...
T Consensus 269 ~~~~~~DiwslG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~~~---~~~-----~~~-------------------- 318 (382)
T 3tt0_A 269 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEELFKLLKEGHRM---DKP-----SNC-------------------- 318 (382)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHTTCCC---CCC-----SSC--------------------
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCC---CCC-----ccC--------------------
Confidence 46789999999999999999 988875321 11111111111000 000 000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|.+||++.++.+.|+.+...
T Consensus 319 ---~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 319 ---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11123445679999999999999999999887654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.4e-08 Score=90.55 Aligned_cols=34 Identities=12% Similarity=0.144 Sum_probs=27.7
Q ss_pred HhhhcccccccccccccchhHHHHHHHHHhhhhc
Q 017712 88 ICRTGVACSAELPNERMKINDVESRLRLIKKKLL 121 (367)
Q Consensus 88 ~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~~ 121 (367)
+..+...|+..+|.+||++.++.+.|+.+.....
T Consensus 280 l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 280 VYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 3345668999999999999999999988766543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.1e-07 Score=84.40 Aligned_cols=27 Identities=33% Similarity=0.479 Sum_probs=24.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 215 ~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 215 KISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 577899999999999999999999764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.6e-07 Score=84.20 Aligned_cols=26 Identities=19% Similarity=0.313 Sum_probs=23.9
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.|+|||||||+|+||+||+.|+.
T Consensus 201 ~y~~~~DiwSlGvilyemltG~~PF~ 226 (350)
T 4b9d_A 201 PYNNKSDIWALGCVLYELCTLKHAFE 226 (350)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 36789999999999999999999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=98.32 E-value=2.1e-07 Score=80.59 Aligned_cols=81 Identities=21% Similarity=0.262 Sum_probs=49.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++||||||++++||+||+.|...... ......+. .... ........
T Consensus 190 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~---~~~~----~~~~~~~~--------------------- 239 (271)
T 3dtc_A 190 MFSKGSDVWSYGVLLWELLTGEVPFRGIDG--LAVAYGVA---MNKL----ALPIPSTC--------------------- 239 (271)
T ss_dssp CCSHHHHHHHHHHHHHHHHHCCCTTTTSCH--HHHHHHHH---TSCC----CCCCCTTC---------------------
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHhhh---cCCC----CCCCCccc---------------------
Confidence 467899999999999999999999763211 11111000 0000 00000000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHH
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRL 115 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~ 115 (367)
-..+..+...|+..+|.+||++.++.+.|+.
T Consensus 240 --~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 240 --PEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --CHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0112344567999999999999999988864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=98.32 E-value=1.5e-07 Score=82.40 Aligned_cols=27 Identities=30% Similarity=0.378 Sum_probs=23.8
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|.+.
T Consensus 189 ~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 189 GYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp -CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 467899999999999999999999764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=98.32 E-value=3.3e-07 Score=79.93 Aligned_cols=83 Identities=19% Similarity=0.296 Sum_probs=51.7
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|.+.... ......+............
T Consensus 197 ~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~---------------------------- 246 (283)
T 3gen_A 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIAQGLRLYRPHLA---------------------------- 246 (283)
T ss_dssp CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHTTCCCCCCTTC----------------------------
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccccCh--hHHHHHHhcccCCCCCCcC----------------------------
Confidence 46789999999999999999 9888764211 1111111111000000000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|.+||++.++.+.|..+..
T Consensus 247 ---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 247 ---SEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp ---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 0112344567999999999999999999987654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=98.31 E-value=4e-07 Score=79.99 Aligned_cols=86 Identities=19% Similarity=0.228 Sum_probs=51.8
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++||||||++++||+||..|...... ...+........... .+. ..
T Consensus 208 ~~~~~~Di~slG~il~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~-----~~~---~~--------------------- 257 (298)
T 3f66_A 208 KFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRRLL-----QPE---YC--------------------- 257 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-TTTHHHHHHTTCCCC-----CCT---TC---------------------
T ss_pred CCChHHHHHHHHHHHHHHHhCCCCCCccCC-HHHHHHHHhcCCCCC-----CCc---cC---------------------
Confidence 467899999999999999996665322111 112222211111000 000 00
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~ 120 (367)
-..+..+...|+..+|..||++.++.+.|+.+....
T Consensus 258 --~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 258 --PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred --CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 011223456799999999999999999998876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.31 E-value=1.7e-07 Score=84.13 Aligned_cols=85 Identities=19% Similarity=0.377 Sum_probs=52.6
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.++|||||||+++||+| |+.|+.... ...+...+.. ....... ...
T Consensus 251 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~---~~~~~~~-----~~~------------------- 301 (343)
T 1luf_A 251 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA--HEEVIYYVRD---GNILACP-----ENC------------------- 301 (343)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHHT---TCCCCCC-----TTC-------------------
T ss_pred CCcCcccccHHHHHHHHHHHhcCCCcCCCCC--hHHHHHHHhC---CCcCCCC-----CCC-------------------
Confidence 346789999999999999999 988875321 1111111111 0000000 000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|..||++.++.+.|+.+...
T Consensus 302 ----~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 302 ----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred ----CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 01123445679999999999999999999886543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=98.31 E-value=1.5e-07 Score=82.47 Aligned_cols=28 Identities=36% Similarity=0.515 Sum_probs=24.7
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++||||||++++||+||+.|+..
T Consensus 204 ~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 204 EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 3568899999999999999999999754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=1.2e-06 Score=79.21 Aligned_cols=82 Identities=7% Similarity=-0.121 Sum_probs=54.3
Q ss_pred Ccc-cccCceEEEEEEec-------CCCEEEEEEeecCC---CcchhHHHHHHHHHHhCC-C--CCcceeeeeecccccC
Q 017712 151 NLI-GAGNFGSVYNGTLF-------DGTTIAVKVFNLIR---PGGSKSFKSECKAAINIK-H--RNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 151 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~ 216 (367)
+.| +.|....+|+.... ++..+++|+..... ......+.+|+.++..+. + -.+.+++.++.+..
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~-- 103 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD-- 103 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST--
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC--
Confidence 456 78888999988743 26688899864322 112356788999988874 2 35777887753221
Q ss_pred CceeeeEEEEeccCCCHH
Q 017712 217 GARFKAVVYKFMPNGSLE 234 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~ 234 (367)
.....++||||++|.++.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 113457999999887654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=98.30 E-value=3.1e-07 Score=79.94 Aligned_cols=85 Identities=24% Similarity=0.283 Sum_probs=52.5
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.++||||||++++||+| |+.|..... ...+...+...... ..+ ...
T Consensus 185 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~~~~-----~~~---~~~------------------- 235 (279)
T 1qpc_A 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLERGYRM-----VRP---DNC------------------- 235 (279)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTCCC-----CCC---TTC-------------------
T ss_pred CCCCchhhhHHHHHHHHHHHhCCCCCCcccC--HHHHHHHHhcccCC-----CCc---ccc-------------------
Confidence 346789999999999999999 888865321 11111111111000 000 000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|..||++.++...|+.+...
T Consensus 236 ----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 236 ----PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 01123445679999999999999999999876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.30 E-value=5.1e-07 Score=80.36 Aligned_cols=84 Identities=19% Similarity=0.340 Sum_probs=53.2
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|++... ...+...+........ . ..
T Consensus 215 ~~~~~~Di~slG~il~ell~~g~~p~~~~~--~~~~~~~~~~~~~~~~----~----~~--------------------- 263 (323)
T 3qup_A 215 LYTVHSDVWAFGVTMWEIMTRGQTPYAGIE--NAEIYNYLIGGNRLKQ----P----PE--------------------- 263 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTCCCCC----C----TT---------------------
T ss_pred CCCCccchhhHHHHHHHHHhCCCCCccccC--hHHHHHHHhcCCCCCC----C----Cc---------------------
Confidence 36789999999999999999 888876422 1112111111000000 0 00
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
+-..+..+...|+..+|.+||++.++.+.++.+...
T Consensus 264 --~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 264 --CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp --CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 011233456689999999999999999999887553
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=98.29 E-value=3.5e-07 Score=81.88 Aligned_cols=84 Identities=21% Similarity=0.275 Sum_probs=52.7
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++||+| |+.|..... ...+...+....... .....
T Consensus 235 ~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~~~~--------~~~~~-------------------- 284 (334)
T 2pvf_A 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VEELFKLLKEGHRMD--------KPANC-------------------- 284 (334)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHHTCCCC--------CCTTC--------------------
T ss_pred CcChHHHHHHHHHHHHHHHhCCCCCcCcCC--HHHHHHHHhcCCCCC--------CCccC--------------------
Confidence 46789999999999999999 988875321 111111111110000 00000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|..||++.++...|+.+...
T Consensus 285 ---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 285 ---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 01123445679999999999999999999887654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.29 E-value=5.1e-07 Score=80.86 Aligned_cols=85 Identities=25% Similarity=0.364 Sum_probs=53.1
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.++|||||||+++||+| |+.|+..... ..+...+..... ......
T Consensus 225 ~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~~~~~~~~--------~~~~~~-------------------- 274 (333)
T 1mqb_A 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAINDGFR--------LPTPMD-------------------- 274 (333)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCC--------CCCCTT--------------------
T ss_pred CCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHCCCc--------CCCccc--------------------
Confidence 346789999999999999999 9999753211 111111111000 000000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
+-..+..+...|+..+|..||++.++...|+.+...
T Consensus 275 ---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 275 ---CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011123456689999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=98.28 E-value=2e-07 Score=87.29 Aligned_cols=83 Identities=29% Similarity=0.353 Sum_probs=51.8
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+|+||+| |+.|+..... ..+...+..... ......
T Consensus 356 ~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~--------~~~~~~-------------------- 405 (452)
T 1fmk_A 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYR--------MPCPPE-------------------- 405 (452)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCC--------CCCCTT--------------------
T ss_pred CCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC--------CCCCCC--------------------
Confidence 457889999999999999999 8888753211 111111111000 000000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
+-..+..+...|+..+|..||++.++...|+.+.
T Consensus 406 ---~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 406 ---CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0112334556899999999999999999887654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=4.1e-07 Score=81.17 Aligned_cols=84 Identities=24% Similarity=0.361 Sum_probs=52.6
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.++||||||++++||+| |+.|..... ...+..++........ ....
T Consensus 220 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~~~~~--------~~~~------------------- 270 (327)
T 2yfx_A 220 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEVLEFVTSGGRMDP--------PKNC------------------- 270 (327)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHTTCCCCC--------CTTC-------------------
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--HHHHHHHHhcCCCCCC--------CCCC-------------------
Confidence 346789999999999999999 888865321 1112222211100000 0000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|..||++.++...+..+..
T Consensus 271 ----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 271 ----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 0112344567999999999999999999987755
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=98.27 E-value=3.7e-07 Score=79.11 Aligned_cols=26 Identities=35% Similarity=0.480 Sum_probs=23.4
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++||||+||+|+||+||+.|++.
T Consensus 189 ~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 189 AGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 46789999999999999999999763
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.26 E-value=2.5e-07 Score=82.55 Aligned_cols=100 Identities=19% Similarity=0.319 Sum_probs=53.7
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++||||||++++||+||+.|.... ...+................+........ ... ...
T Consensus 224 ~~~~~~Di~slG~il~el~tg~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-~~~------ 286 (326)
T 2w1i_A 224 KFSVASDVWSFGVVLYELFTYIEKSKSP------PAEFMRMIGNDKQGQMIVFHLIELLKNNG----RLP-RPD------ 286 (326)
T ss_dssp EEEHHHHHHHHHHHHHHHHHTTCGGGSH------HHHHHHHHCTTCCTHHHHHHHHHHHHTTC----CCC-CCT------
T ss_pred CCCchhhHHHHHHHHHHHHhcCCCCCCC------HHHHHHhhccccchhhhHHHHHHHhhcCC----CCC-CCC------
Confidence 3578899999999999999998885421 11111111000000000000000000000 000 000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
.+-..+..+...|+..+|..||++.++...|+.+...
T Consensus 287 ~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 287 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0112234456789999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=98.25 E-value=7.2e-07 Score=77.93 Aligned_cols=84 Identities=18% Similarity=0.271 Sum_probs=52.4
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|..... ...+...+......... ...
T Consensus 188 ~~~~~~Di~slG~il~~ll~~g~~p~~~~~--~~~~~~~~~~~~~~~~~--------~~~-------------------- 237 (288)
T 3kfa_A 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERP--------EGC-------------------- 237 (288)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHHTTCCCCCC--------TTC--------------------
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhccCCCCCC--------CCC--------------------
Confidence 46789999999999999999 888865321 11222222111100000 000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|.+||++.++.+.|+.+...
T Consensus 238 ---~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 238 ---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 01123445678999999999999999998876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=98.25 E-value=4e-07 Score=78.98 Aligned_cols=26 Identities=38% Similarity=0.505 Sum_probs=23.4
Q ss_pred ccccceeehhHHHHHHHhCCCCCCCC
Q 017712 5 SSYGDVYSFGILLLEMFTGLRPNDDM 30 (367)
Q Consensus 5 s~ksDVySfGVvllEl~tg~~p~~~~ 30 (367)
+.++||||||++++||+||+.|.+..
T Consensus 186 ~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 186 AEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred CCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 67899999999999999999998643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=4.4e-07 Score=88.44 Aligned_cols=82 Identities=26% Similarity=0.308 Sum_probs=52.2
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.|+|||||||+|+||+| |+.|+..... ..+...+...... ... ..
T Consensus 548 ~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~~~---~~p-----~~--------------------- 596 (635)
T 4fl3_A 548 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERM---GCP-----AG--------------------- 596 (635)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCC---CCC-----TT---------------------
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCC---CCC-----CC---------------------
Confidence 56889999999999999999 9999764321 1111111111000 000 00
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
+-..+..+...|+..+|.+||++.++...|+.+-
T Consensus 597 --~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 597 --CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp --CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 0112334456799999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=5.3e-07 Score=80.64 Aligned_cols=27 Identities=30% Similarity=0.488 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.|+|||||||+|+||+||+.|+..
T Consensus 246 ~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 246 PYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 368899999999999999999999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.22 E-value=2.7e-07 Score=81.84 Aligned_cols=26 Identities=27% Similarity=0.499 Sum_probs=23.0
Q ss_pred CccccccceeehhHHHHHHHhCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPN 27 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~ 27 (367)
|..+.++|||||||+++||+||+.|.
T Consensus 230 ~~~~~~~DiwslG~il~el~~g~~~~ 255 (311)
T 3p1a_A 230 GSYGTAADVFSLGLTILEVACNMELP 255 (311)
T ss_dssp TCCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 45788999999999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=98.22 E-value=4.6e-07 Score=79.27 Aligned_cols=83 Identities=23% Similarity=0.270 Sum_probs=50.5
Q ss_pred cccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 4 VSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
.+.++||||||++++||+| |+.|..... ...+...+. .... ........
T Consensus 201 ~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~---~~~~----~~~~~~~~--------------------- 250 (291)
T 1u46_A 201 FSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHKID---KEGE----RLPRPEDC--------------------- 250 (291)
T ss_dssp EEHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHH---TSCC----CCCCCTTC---------------------
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCcccCC--HHHHHHHHH---ccCC----CCCCCcCc---------------------
Confidence 5778999999999999999 998875321 111111111 0000 00000000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|.+||++.++.+.|..+..
T Consensus 251 --~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 251 --PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0112344567999999999999999999887654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=5.2e-07 Score=80.38 Aligned_cols=28 Identities=29% Similarity=0.514 Sum_probs=24.7
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 216 ~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 216 SLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3468899999999999999999999753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=98.21 E-value=4.4e-07 Score=80.69 Aligned_cols=84 Identities=20% Similarity=0.273 Sum_probs=50.8
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.++||||||++++||+| |+.|..... ...+...+.. ....... ...
T Consensus 215 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~---~~~~~~~-----~~~------------------- 265 (322)
T 1p4o_A 215 GVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQVLRFVME---GGLLDKP-----DNC------------------- 265 (322)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--HHHHHHHHHT---TCCCCCC-----TTC-------------------
T ss_pred CCCCchhhHHHHHHHHHHHHhcCCCccccCC--HHHHHHHHHc---CCcCCCC-----CCC-------------------
Confidence 346789999999999999999 777765321 1111111111 0000000 000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|..||++.++...|+....
T Consensus 266 ----~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 266 ----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 0112234567899999999999999999876543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=98.20 E-value=5.6e-07 Score=78.36 Aligned_cols=79 Identities=16% Similarity=0.193 Sum_probs=49.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++||||||++++||+||+.|... ...+............++
T Consensus 197 ~~~~~~Di~slG~il~~l~~~~~~~~~-------~~~~~~~~~~~~~~~~~~---------------------------- 241 (284)
T 2a19_B 197 DYGKEVDLYALGLILAELLHVCDTAFE-------TSKFFTDLRDGIISDIFD---------------------------- 241 (284)
T ss_dssp CCCTHHHHHHHHHHHHHHHSCCSSHHH-------HHHHHHHHHTTCCCTTSC----------------------------
T ss_pred CCcchhhhHHHHHHHHHHHhcCCcchh-------HHHHHHHhhcccccccCC----------------------------
Confidence 467899999999999999999887421 011111000000000000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
..+..+...|+..+|.+||++.++...+..+.+.
T Consensus 242 ---~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 242 ---KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0112334578899999999999999999877653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=4.6e-07 Score=81.67 Aligned_cols=28 Identities=29% Similarity=0.342 Sum_probs=24.8
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|...
T Consensus 228 ~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 228 GQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4578899999999999999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=5.6e-07 Score=80.23 Aligned_cols=26 Identities=38% Similarity=0.510 Sum_probs=23.4
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++|||||||+++||+||+.|++.
T Consensus 185 ~~~~~DiwslG~il~~ll~g~~pf~~ 210 (323)
T 3tki_A 185 HAEPVDVWSCGIVLTAMLAGELPWDQ 210 (323)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 36789999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=9.7e-07 Score=78.72 Aligned_cols=84 Identities=21% Similarity=0.269 Sum_probs=52.2
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++||||||++++||+| |+.|..... ....... +.... ........
T Consensus 217 ~~~~~~Di~slG~il~ellt~g~~pf~~~~-----~~~~~~~-~~~~~----~~~~~~~~-------------------- 266 (327)
T 1fvr_A 217 VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEK-LPQGY----RLEKPLNC-------------------- 266 (327)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHH-GGGTC----CCCCCTTB--------------------
T ss_pred cCCchhcchHHHHHHHHHHcCCCCCCCCCc-----HHHHHHH-hhcCC----CCCCCCCC--------------------
Confidence 35789999999999999999 999975321 1111111 11100 00000000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
-..+..+...|+..+|.+||++.++...|..+...
T Consensus 267 ---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 267 ---DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 01123445678999999999999999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1.1e-05 Score=73.93 Aligned_cols=74 Identities=19% Similarity=0.132 Sum_probs=48.4
Q ss_pred CcccccCceEEEEEEe-cCCCEEEEEEeecCC-------CcchhHHHHHHHHHHhCCC--C-CcceeeeeecccccCCce
Q 017712 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-------PGGSKSFKSECKAAINIKH--R-NIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~~~ 219 (367)
+.||.|..+.||++.. .+++.+++|...... ......+..|.+++..+.. | .+++++.+. . .
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-----~--~ 108 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-----T--E 108 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-----T--T
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-----C--C
Confidence 4689999999999974 356889999864321 1234567889999887742 3 455666542 1 1
Q ss_pred eeeEEEEeccCC
Q 017712 220 FKAVVYKFMPNG 231 (367)
Q Consensus 220 ~~~lv~e~~~~g 231 (367)
..++|||++++.
T Consensus 109 ~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 MAVTVMEDLSHL 120 (397)
T ss_dssp TTEEEECCCTTS
T ss_pred ccEEEEEeCCCc
Confidence 237999999764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=98.19 E-value=3.4e-07 Score=87.57 Aligned_cols=82 Identities=29% Similarity=0.361 Sum_probs=51.1
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+|+||+| |+.|+..... ..+...+..... .. ....
T Consensus 439 ~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~---~~-----~~~~-------------------- 488 (535)
T 2h8h_A 439 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYR---MP-----CPPE-------------------- 488 (535)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHHHHHHHTTCC---CC-----CCTT--------------------
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC---CC-----CCCC--------------------
Confidence 457889999999999999999 8888753221 111111111000 00 0000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
|-..+..+...|+..+|..||++.++...|+.+
T Consensus 489 ---~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 489 ---CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011223445679999999999999999988764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=9.3e-07 Score=78.66 Aligned_cols=80 Identities=15% Similarity=0.171 Sum_probs=48.0
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++|||||||+++||+||+.|++.... ...+...+.........+.. ...
T Consensus 195 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~-----~~~--------------------- 247 (322)
T 2ycf_A 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQITSGKYNFIPEVW-----AEV--------------------- 247 (322)
T ss_dssp TCTTHHHHHHHHHHHHHHHHSSCSSCSTTC-SSCHHHHHHHTCCCCCHHHH-----TTS---------------------
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcccch-HHHHHHHHHhCccccCchhh-----hhc---------------------
Confidence 467899999999999999999999764321 22233322221110000000 000
Q ss_pred HHHHHHhhhcccccccccccccchhHHHH
Q 017712 83 ECLISICRTGVACSAELPNERMKINDVES 111 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~ 111 (367)
-..+..+...|+..+|.+||++.++..
T Consensus 248 --~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 248 --SEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 011234456789999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=4.4e-07 Score=79.83 Aligned_cols=27 Identities=33% Similarity=0.513 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|.+.
T Consensus 203 ~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 203 GYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 367899999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=7.2e-07 Score=77.52 Aligned_cols=27 Identities=26% Similarity=0.420 Sum_probs=23.6
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|...
T Consensus 192 ~~~~~~Di~slG~il~~l~~g~~p~~~ 218 (279)
T 2w5a_A 192 SYNEKSDIWSLGCLLYELCALMPPFTA 218 (279)
T ss_dssp -CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 467899999999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=98.15 E-value=5e-07 Score=80.66 Aligned_cols=28 Identities=21% Similarity=0.201 Sum_probs=24.7
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|...
T Consensus 206 ~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 206 QMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 3468899999999999999999999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.14 E-value=4.9e-07 Score=79.27 Aligned_cols=25 Identities=32% Similarity=0.494 Sum_probs=23.1
Q ss_pred cccccceeehhHHHHHHHhCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
.+.++||||||++++||+||+.|+.
T Consensus 202 ~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 202 YGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp CSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 5789999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=7.4e-07 Score=78.43 Aligned_cols=27 Identities=30% Similarity=0.486 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 192 ~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 192 AYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 467899999999999999999999753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=98.13 E-value=1.2e-06 Score=81.15 Aligned_cols=27 Identities=22% Similarity=0.432 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+|+||+||+.|+..
T Consensus 320 ~~~~~~DiwslG~il~~lltg~~pf~~ 346 (419)
T 3i6u_A 320 GYNRAVDCWSLGVILFICLSGYPPFSE 346 (419)
T ss_dssp TTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 457799999999999999999999764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.3e-06 Score=79.87 Aligned_cols=28 Identities=18% Similarity=0.148 Sum_probs=24.8
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDM 30 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~ 30 (367)
..+.++|||||||+|+||+||+.|++..
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 4688999999999999999999998643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=7e-07 Score=78.55 Aligned_cols=30 Identities=10% Similarity=0.194 Sum_probs=24.9
Q ss_pred HhhhcccccccccccccchhHHHHHHHHHh
Q 017712 88 ICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 88 ~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
+..+...|+..+|.+||++.++.+.|+.+.
T Consensus 272 l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 272 VYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 335567899999999999999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.11 E-value=1e-06 Score=79.39 Aligned_cols=27 Identities=26% Similarity=0.412 Sum_probs=24.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 226 ~~~~~~DiwslG~il~ell~g~~pf~~ 252 (349)
T 2w4o_A 226 AYGPEVDMWSVGIITYILLCGFEPFYD 252 (349)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=1.2e-06 Score=81.45 Aligned_cols=28 Identities=21% Similarity=0.449 Sum_probs=24.6
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~ 29 (367)
+..+.++|||||||+++||+| |+.|.+.
T Consensus 214 ~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 214 RRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred cCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 457889999999999999999 8888764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=98.11 E-value=2e-06 Score=75.51 Aligned_cols=27 Identities=37% Similarity=0.639 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|++.
T Consensus 188 ~~~~~~Di~slG~~l~~ll~g~~pf~~ 214 (294)
T 4eqm_A 188 ATDECTDIYSIGIVLYEMLVGEPPFNG 214 (294)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 457889999999999999999999763
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=98.11 E-value=1.5e-06 Score=75.65 Aligned_cols=28 Identities=18% Similarity=0.337 Sum_probs=24.6
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++||||||++++||+||+.|...
T Consensus 186 ~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 186 EPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 3467899999999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.10 E-value=1.4e-06 Score=77.63 Aligned_cols=27 Identities=30% Similarity=0.536 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 179 ~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 179 VVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 357899999999999999999999763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.10 E-value=1.7e-06 Score=76.83 Aligned_cols=28 Identities=21% Similarity=0.262 Sum_probs=24.9
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 198 ~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 198 KKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4578899999999999999999999764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=9.8e-08 Score=85.24 Aligned_cols=32 Identities=16% Similarity=0.264 Sum_probs=24.6
Q ss_pred HhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 88 ICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 88 ~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
+..+...|+..+|.+||++.++.+.|+.+...
T Consensus 273 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 273 VHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 33456679999999999999999999876543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.09 E-value=8.5e-07 Score=78.61 Aligned_cols=27 Identities=37% Similarity=0.513 Sum_probs=23.7
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|++.
T Consensus 205 ~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 205 DYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp -CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCccccchhhHHHHHHHHHhCCCCCCC
Confidence 467799999999999999999999764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=4.7e-07 Score=79.14 Aligned_cols=83 Identities=14% Similarity=0.160 Sum_probs=48.9
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
+..+.++|||||||+++||+||..|...... ............ ... ... +
T Consensus 193 ~~~~~~~DiwslG~il~el~~g~~~~~~~~~-~~~~~~~~~~~~--~~~--------~~~-----------------~-- 242 (289)
T 4fvq_A 193 KNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQRKLQFYEDRH--QLP--------APK-----------------A-- 242 (289)
T ss_dssp GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHHHTTC--CCC--------CCS-----------------S--
T ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCccccc-hHHHHHHhhccC--CCC--------CCC-----------------C--
Confidence 3468899999999999999997665332111 111111111000 000 000 0
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
..+..+...|+..+|.+||++.++.+.|+.+..
T Consensus 243 ----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 243 ----AELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp ----CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 012234557899999999999999999987644
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=98.09 E-value=4.1e-07 Score=79.62 Aligned_cols=89 Identities=9% Similarity=0.029 Sum_probs=51.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhh-hhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDV-VFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+|+||+||+.|++....... +.. ........ ...+ .+....
T Consensus 178 ~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~~-~~~~~~~~---~~~~~~~~~~~-------------------- 232 (286)
T 3uqc_A 178 DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LAP-AERDTAGQ---PIEPADIDRDI-------------------- 232 (286)
T ss_dssp TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SEE-CCBCTTSC---BCCHHHHCTTS--------------------
T ss_pred CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hHH-HHHHhccC---CCChhhcccCC--------------------
Confidence 468899999999999999999999764221110 000 00000000 0000 000000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~ 120 (367)
-..+..+...|+..+|..| ++.++.+.|+......
T Consensus 233 ---~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 233 ---PFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp ---CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ---CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0112334567899999999 9999999998876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.08 E-value=5.6e-07 Score=78.63 Aligned_cols=28 Identities=25% Similarity=0.373 Sum_probs=24.6
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++||||||++++||+||+.|+..
T Consensus 200 ~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 200 RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 3567899999999999999999999763
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=98.08 E-value=2.3e-06 Score=77.35 Aligned_cols=27 Identities=30% Similarity=0.393 Sum_probs=24.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 235 ~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 235 GWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 468899999999999999999999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.08 E-value=3.3e-05 Score=67.48 Aligned_cols=74 Identities=16% Similarity=0.113 Sum_probs=55.2
Q ss_pred CCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCC---CCcceeeeeecccccCCceeeeEEEE
Q 017712 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH---RNIVRVFTAFSGVDYQGARFKAVVYK 226 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~lv~e 226 (367)
...+|.|..+.||+.+..+|+.+.+|+...........|..|+..|+.|.- --+++++... ..+++||
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~lv~e 90 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRTLAME 90 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTEEEEE
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------CceEEEE
Confidence 356899999999999999999999998764444445678899999988742 2355665542 1378999
Q ss_pred eccCCC
Q 017712 227 FMPNGS 232 (367)
Q Consensus 227 ~~~~g~ 232 (367)
|++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.07 E-value=1.8e-06 Score=76.99 Aligned_cols=27 Identities=19% Similarity=0.348 Sum_probs=24.1
Q ss_pred CccccccceeehhHHHHHHHhCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
+..+.++|||||||+++||+||+.|+.
T Consensus 192 ~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 192 EPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 346789999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=98.07 E-value=4.7e-07 Score=82.54 Aligned_cols=26 Identities=12% Similarity=0.253 Sum_probs=23.5
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.++|||||||+|+||+||+.|+.
T Consensus 289 ~~~~~~DvwSlG~il~elltg~~Pf~ 314 (377)
T 3byv_A 289 LMTFSFDAWALGLVIYWIWCADLPIT 314 (377)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred cCChhhhHHHHHHHHHHHHHCCCCCc
Confidence 57889999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=1.4e-06 Score=76.65 Aligned_cols=27 Identities=30% Similarity=0.539 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|.+.
T Consensus 195 ~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 195 AYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 467899999999999999999999753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=1.4e-06 Score=76.57 Aligned_cols=27 Identities=19% Similarity=0.407 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 174 ~~~~~~DiwslG~il~el~tg~~pf~~ 200 (299)
T 3m2w_A 174 KYDKSCDMWSLGVIMYILLCGYPPFYS 200 (299)
T ss_dssp GGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 467899999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.06 E-value=1.7e-06 Score=79.39 Aligned_cols=27 Identities=30% Similarity=0.488 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.|+|||||||+|+||+||+.|+..
T Consensus 323 ~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 323 PYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 367899999999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=2.2e-06 Score=83.89 Aligned_cols=83 Identities=17% Similarity=0.284 Sum_probs=51.9
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..+.++|||||||+++||+| |+.|+.... ...+...+...... . +....
T Consensus 568 ~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--~~~~~~~i~~~~~~---~-----~~~~~-------------------- 617 (656)
T 2j0j_A 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGERL---P-----MPPNC-------------------- 617 (656)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHHTCCC---C-----CCTTC--------------------
T ss_pred CCCchhhHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCCCC---C-----CCccc--------------------
Confidence 46789999999999999998 888875321 11111111111000 0 00000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|..||++.++...|+.+..
T Consensus 618 ---~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 618 ---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0112344567999999999999999999987643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=3.7e-07 Score=81.44 Aligned_cols=27 Identities=37% Similarity=0.452 Sum_probs=23.7
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|++.
T Consensus 205 ~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 205 GYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp -CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 367899999999999999999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=98.05 E-value=2e-06 Score=78.00 Aligned_cols=27 Identities=19% Similarity=0.340 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 281 ~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 281 GYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 367899999999999999999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=1.7e-06 Score=76.10 Aligned_cols=27 Identities=37% Similarity=0.608 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||+||+|+||+||+.|+..
T Consensus 202 ~y~~~~DiwSlGvilyemltG~~PF~~ 228 (304)
T 3ubd_A 202 GHTQSADWWSFGVLMFEMLTGTLPFQG 228 (304)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCCCcccchHHHHHHHHhCCCCCCC
Confidence 467899999999999999999999763
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=98.05 E-value=1.8e-06 Score=76.30 Aligned_cols=84 Identities=17% Similarity=0.231 Sum_probs=48.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhHH
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (367)
..+.++||||||++++||+||+.|+.... ...+...+....+. ... .. ...+
T Consensus 211 ~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~-~~~-~~----~~~~-------------------- 262 (309)
T 2h34_A 211 HATYRADIYALTCVLYECLTGSPPYQGDQ--LSVMGAHINQAIPR-PST-VR----PGIP-------------------- 262 (309)
T ss_dssp ---CCCHHHHHHHHHHHHHHSSCSSCSCH--HHHHHHHHHSCCCC-GGG-TS----TTCC--------------------
T ss_pred CCCchHhHHHHHHHHHHHHHCCCCCCCch--HHHHHHHhccCCCC-ccc-cC----CCCC--------------------
Confidence 45789999999999999999999975321 00111111110000 000 00 0000
Q ss_pred HHHHHHhhhccccccccccccc-chhHHHHHHHHHh
Q 017712 83 ECLISICRTGVACSAELPNERM-KINDVESRLRLIK 117 (367)
Q Consensus 83 ~~~~~~~~~~~~c~~~~~~~Rp-~m~~v~~~L~~~~ 117 (367)
..+..+...|+..+|..|| ++.++...|+...
T Consensus 263 ---~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 263 ---VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp ---THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred ---HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 0122345678999999999 8999999887653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=98.05 E-value=2.3e-06 Score=76.78 Aligned_cols=28 Identities=25% Similarity=0.313 Sum_probs=24.8
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~ 278 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPG 278 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 4567899999999999999999999753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=98.04 E-value=2.4e-06 Score=75.96 Aligned_cols=28 Identities=18% Similarity=0.337 Sum_probs=24.6
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++||||||++++||+||+.|+..
T Consensus 193 ~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 193 EPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 3467899999999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=98.04 E-value=1.9e-06 Score=76.28 Aligned_cols=27 Identities=22% Similarity=0.461 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 202 ~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 202 IYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp HHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 357899999999999999999999764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=98.04 E-value=1.5e-06 Score=78.93 Aligned_cols=27 Identities=22% Similarity=0.215 Sum_probs=23.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|++.
T Consensus 211 ~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 211 PWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.3e-06 Score=76.72 Aligned_cols=27 Identities=30% Similarity=0.424 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|...
T Consensus 198 ~~~~~~Di~slG~il~~l~~g~~p~~~ 224 (302)
T 2j7t_A 198 PYDYKADIWSLGITLIEMAQIEPPHHE 224 (302)
T ss_dssp TTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 467899999999999999999999763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=98.03 E-value=3.9e-06 Score=77.10 Aligned_cols=28 Identities=18% Similarity=0.383 Sum_probs=24.7
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+|+||+||+.|+..
T Consensus 238 ~~~~~~~DiwslG~il~ell~g~~pf~~ 265 (400)
T 1nxk_A 238 EKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_dssp CCSSSHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 3467899999999999999999999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=98.02 E-value=8.4e-07 Score=80.19 Aligned_cols=26 Identities=23% Similarity=0.321 Sum_probs=23.9
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++|||||||+++||+||+.|+..
T Consensus 209 ~~~~~Di~slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 209 YTTAVDIWSVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence 68899999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=2.4e-06 Score=74.33 Aligned_cols=27 Identities=26% Similarity=0.399 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|+..
T Consensus 183 ~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 183 PYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 468899999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=2.4e-06 Score=76.24 Aligned_cols=28 Identities=18% Similarity=0.339 Sum_probs=24.6
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 208 ~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 208 DPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3467899999999999999999999753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.01 E-value=3e-06 Score=77.11 Aligned_cols=28 Identities=29% Similarity=0.514 Sum_probs=24.5
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 263 ~~~~~~~DiwslG~il~elltg~~pf~~ 290 (373)
T 2x4f_A 263 DFVSFPTDMWSVGVIAYMLLSGLSPFLG 290 (373)
T ss_dssp CBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 3467899999999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=6e-07 Score=81.68 Aligned_cols=28 Identities=7% Similarity=0.172 Sum_probs=25.0
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDM 30 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~ 30 (367)
..+.++|||||||+|+||+||+.|+...
T Consensus 269 ~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 269 TFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 4688999999999999999999997643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=2.8e-06 Score=73.69 Aligned_cols=28 Identities=21% Similarity=0.436 Sum_probs=24.9
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
|..+.++||||||++++||+||+.|+..
T Consensus 182 ~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 182 GLYGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp TCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCchhhehhHHHHHHHHHHCCCCCCC
Confidence 4568899999999999999999999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=3e-06 Score=73.93 Aligned_cols=28 Identities=29% Similarity=0.461 Sum_probs=24.7
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
|..+.++||||||++++||+||+.|...
T Consensus 197 ~~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 197 GTYDEKCDVWSAGVILYILLSGTPPFYG 224 (287)
T ss_dssp TCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence 4568899999999999999999999753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=2.8e-06 Score=75.43 Aligned_cols=27 Identities=33% Similarity=0.343 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 185 ~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 185 TYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=2.5e-06 Score=75.49 Aligned_cols=27 Identities=30% Similarity=0.353 Sum_probs=24.3
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 196 ~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (311)
T 3niz_A 196 KYSTSVDIWSIGCIFAEMITGKPLFPG 222 (311)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCchHHhHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=5.5e-05 Score=67.58 Aligned_cols=32 Identities=25% Similarity=0.352 Sum_probs=28.7
Q ss_pred CCCeEecCCCCCceeecCCCceEEeccccccc
Q 017712 276 QPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (367)
Q Consensus 276 ~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (367)
...++|+|+++.||+++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 57899999999999998888899999998753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.98 E-value=1.8e-06 Score=76.85 Aligned_cols=27 Identities=33% Similarity=0.431 Sum_probs=23.7
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 210 ~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 210 TYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp -CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 467899999999999999999999753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=97.97 E-value=1.1e-06 Score=81.11 Aligned_cols=26 Identities=19% Similarity=0.359 Sum_probs=23.7
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.|.|+|||||||+|+||+||+.|++.
T Consensus 294 ~~~~~DvwSlGvil~elltg~~Pf~~ 319 (413)
T 3dzo_A 294 MTFAFDTWTLGLAIYWIWCADLPNTD 319 (413)
T ss_dssp ECHHHHHHHHHHHHHHHHHSSCCCCT
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 67799999999999999999999763
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.96 E-value=1.9e-06 Score=79.09 Aligned_cols=27 Identities=22% Similarity=0.286 Sum_probs=23.8
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 199 ~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 199 KYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 356789999999999999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.96 E-value=2.9e-06 Score=77.58 Aligned_cols=27 Identities=30% Similarity=0.562 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 226 ~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 226 PVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 467899999999999999999999763
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=3.7e-06 Score=75.06 Aligned_cols=27 Identities=19% Similarity=0.133 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 214 ~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 214 HYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 368899999999999999999999753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=1.7e-06 Score=77.60 Aligned_cols=27 Identities=19% Similarity=0.432 Sum_probs=22.9
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|+..
T Consensus 205 ~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (336)
T 3fhr_A 205 KYDKSCDMWSLGVIMYILLCGFPPFYS 231 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 357789999999999999999999753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=97.96 E-value=1.6e-06 Score=76.36 Aligned_cols=25 Identities=20% Similarity=0.570 Sum_probs=23.2
Q ss_pred cccccceeehhHHHHHHHhCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
.+.++||||+||+|.||+||+.|+.
T Consensus 211 y~~~~DiWSlGvilyeml~G~~PF~ 235 (311)
T 4aw0_A 211 ACKSSDLWALGCIIYQLVAGLPPFR 235 (311)
T ss_dssp BCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 5788999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=7.3e-06 Score=73.65 Aligned_cols=27 Identities=26% Similarity=0.390 Sum_probs=24.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 215 ~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 215 GWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.95 E-value=2.2e-06 Score=75.33 Aligned_cols=26 Identities=27% Similarity=0.331 Sum_probs=23.0
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++|||||||+++||+||+.|+..
T Consensus 217 ~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 217 SGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp ESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 36789999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=97.95 E-value=4.8e-06 Score=72.31 Aligned_cols=27 Identities=26% Similarity=0.468 Sum_probs=23.9
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|++.
T Consensus 183 ~~~~~~Di~slG~il~~l~~g~~p~~~ 209 (279)
T 3fdn_A 183 MHDEKVDLWSLGVLCYEFLVGKPPFEA 209 (279)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCccchhHhHHHHHHHHHHCCCCCCC
Confidence 457899999999999999999999763
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=7.9e-06 Score=72.85 Aligned_cols=27 Identities=30% Similarity=0.386 Sum_probs=24.3
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 210 ~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 210 GWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999763
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=97.94 E-value=4.2e-06 Score=75.83 Aligned_cols=27 Identities=26% Similarity=0.399 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 206 ~~~~~~DiwslG~il~~ll~g~~Pf~~ 232 (362)
T 2bdw_A 206 PYSKPVDIWACGVILYILLVGYPPFWD 232 (362)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 467899999999999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.94 E-value=4.2e-06 Score=74.09 Aligned_cols=28 Identities=21% Similarity=0.266 Sum_probs=24.7
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 200 ~~~~~~~Di~slG~il~el~~g~~pf~~ 227 (320)
T 2i6l_A 200 NNYTKAIDMWAAGCIFAEMLTGKTLFAG 227 (320)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence 3567899999999999999999999763
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=4.5e-06 Score=73.16 Aligned_cols=27 Identities=19% Similarity=0.294 Sum_probs=24.0
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|...
T Consensus 205 ~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 205 GYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 467899999999999999999999753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=97.93 E-value=3.1e-06 Score=74.53 Aligned_cols=27 Identities=22% Similarity=0.341 Sum_probs=24.0
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|+..
T Consensus 183 ~~~~~~Di~slG~il~~l~~g~~pf~~ 209 (304)
T 2jam_A 183 PYSKAVDCWSIGVITYILLCGYPPFYE 209 (304)
T ss_dssp SCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 467899999999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=4.2e-06 Score=76.33 Aligned_cols=27 Identities=30% Similarity=0.305 Sum_probs=24.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+|+||+||+.|+..
T Consensus 234 ~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 234 PYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=2.6e-06 Score=76.68 Aligned_cols=27 Identities=19% Similarity=0.176 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|.+.
T Consensus 205 ~~~~~~DiwslG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 205 DYGPPIDLWGAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence 368899999999999999999999763
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=97.92 E-value=2.1e-06 Score=76.57 Aligned_cols=27 Identities=26% Similarity=0.490 Sum_probs=23.7
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 185 ~~~~~~DiwslG~il~~ll~g~~pf~~ 211 (325)
T 3kn6_A 185 GYDESCDLWSLGVILYTMLSGQVPFQS 211 (325)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 357889999999999999999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=4.9e-06 Score=73.58 Aligned_cols=27 Identities=41% Similarity=0.621 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 195 ~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 195 SVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 467899999999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=97.91 E-value=3.1e-06 Score=77.42 Aligned_cols=27 Identities=33% Similarity=0.449 Sum_probs=24.6
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 213 ~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 213 GYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 478899999999999999999999764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.90 E-value=3.8e-06 Score=74.76 Aligned_cols=27 Identities=26% Similarity=0.254 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 177 ~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 177 DYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.90 E-value=3.4e-06 Score=74.63 Aligned_cols=27 Identities=33% Similarity=0.519 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|+..
T Consensus 201 ~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 201 GYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 467899999999999999999999753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.88 E-value=6.1e-06 Score=76.81 Aligned_cols=27 Identities=22% Similarity=0.361 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||+||+++||+||+.|+..
T Consensus 189 ~~~~~~DIwSlGvilyell~G~~Pf~~ 215 (444)
T 3soa_A 189 PYGKPVDLWACGVILYILLVGYPPFWD 215 (444)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=5.7e-06 Score=76.77 Aligned_cols=27 Identities=26% Similarity=0.309 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+|+||+||+.|+..
T Consensus 275 ~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 275 RYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999988753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=97.88 E-value=5.1e-06 Score=74.88 Aligned_cols=27 Identities=22% Similarity=0.353 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+|+||+||+.|+..
T Consensus 209 ~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 209 PYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 467899999999999999999999753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=6.9e-06 Score=71.88 Aligned_cols=27 Identities=26% Similarity=0.364 Sum_probs=24.0
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|++.
T Consensus 191 ~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 191 GHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 367899999999999999999999763
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=97.88 E-value=3.7e-06 Score=75.99 Aligned_cols=27 Identities=33% Similarity=0.458 Sum_probs=24.3
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 206 ~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 206 HYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp CCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=4.7e-06 Score=72.20 Aligned_cols=25 Identities=32% Similarity=0.612 Sum_probs=22.8
Q ss_pred ccccceeehhHHHHHHHhCCCCCCC
Q 017712 5 SSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 5 s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+.++||||||++++||+||+.|++.
T Consensus 189 ~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 189 GPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccchHHHHHHHHHHHHhCCCCCCC
Confidence 6789999999999999999999763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=4.3e-06 Score=75.23 Aligned_cols=28 Identities=29% Similarity=0.240 Sum_probs=24.7
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 198 ~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 198 AKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4567899999999999999999999763
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.86 E-value=5.3e-06 Score=72.97 Aligned_cols=26 Identities=31% Similarity=0.452 Sum_probs=23.1
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++||||||++++||+||+.|.+.
T Consensus 190 ~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 190 SGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp ESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 36789999999999999999999763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=5.9e-06 Score=77.87 Aligned_cols=28 Identities=29% Similarity=0.519 Sum_probs=24.9
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
|..+.++||||+||+++||+||+.|+..
T Consensus 202 ~~~~~~~DiwslG~il~~ll~g~~pf~~ 229 (484)
T 3nyv_A 202 GTYDEKCDVWSTGVILYILLSGCPPFNG 229 (484)
T ss_dssp TCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence 4568899999999999999999999763
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.85 E-value=4.6e-06 Score=72.34 Aligned_cols=27 Identities=26% Similarity=0.437 Sum_probs=21.5
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|.+.
T Consensus 188 ~~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 188 AHGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp ----CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 357799999999999999999999763
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.85 E-value=2.8e-06 Score=75.04 Aligned_cols=27 Identities=19% Similarity=0.309 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|...
T Consensus 179 ~~~~~~Di~slG~il~~l~~g~~p~~~ 205 (311)
T 4agu_A 179 QYGPPVDVWAIGCVFAELLSGVPLWPG 205 (311)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=2.1e-06 Score=76.68 Aligned_cols=27 Identities=30% Similarity=0.338 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 201 ~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (331)
T 4aaa_A 201 KYGKAVDVWAIGCLVTEMFMGEPLFPG 227 (331)
T ss_dssp TCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence 467899999999999999999999753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=97.85 E-value=7.1e-06 Score=71.43 Aligned_cols=27 Identities=26% Similarity=0.463 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||||++++||+||+.|++.
T Consensus 188 ~~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 188 THDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCcccchhhHHHHHHHHHHCCCCCCC
Confidence 467899999999999999999999763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=4.9e-06 Score=73.11 Aligned_cols=20 Identities=30% Similarity=0.590 Sum_probs=18.4
Q ss_pred ccccccceeehhHHHHHHHh
Q 017712 3 YVSSYGDVYSFGILLLEMFT 22 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t 22 (367)
..+.|+|||||||+|+||++
T Consensus 206 ~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 206 SYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp CCCTHHHHHHHHHHHHHHHS
T ss_pred CCCCHHHHHHHHHHHHHHcc
Confidence 46889999999999999997
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=6.5e-06 Score=74.48 Aligned_cols=27 Identities=19% Similarity=0.359 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 194 ~~~~~~DiwslGvil~~ll~g~~Pf~~ 220 (361)
T 2yab_A 194 PLGLEADMWSIGVITYILLSGASPFLG 220 (361)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 467899999999999999999999753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=97.84 E-value=5.7e-06 Score=73.82 Aligned_cols=25 Identities=32% Similarity=0.582 Sum_probs=22.7
Q ss_pred ccccceeehhHHHHHHHhCCCCCCC
Q 017712 5 SSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 5 s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+.++|||||||+|+||+||+.|++.
T Consensus 192 ~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 192 GPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CchhhhhhhHHHHHHHHhCCCCCCC
Confidence 4789999999999999999999763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=97.84 E-value=3.7e-06 Score=75.29 Aligned_cols=25 Identities=44% Similarity=0.604 Sum_probs=23.0
Q ss_pred ccccceeehhHHHHHHHhCCCCCCC
Q 017712 5 SSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 5 s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+.++|||||||+++||+||+.|++.
T Consensus 186 ~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 186 GPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred CCccchhHHHHHHHHHHhCCCCCCC
Confidence 6789999999999999999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.83 E-value=6.1e-06 Score=72.81 Aligned_cols=28 Identities=21% Similarity=0.211 Sum_probs=24.7
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 194 ~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 194 STYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp SCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred CCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 3568899999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.83 E-value=6.3e-06 Score=74.38 Aligned_cols=26 Identities=31% Similarity=0.484 Sum_probs=23.0
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++|||||||+|+||+||+.|+..
T Consensus 239 ~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 239 HDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp -CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 57889999999999999999999763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=97.83 E-value=6.9e-06 Score=71.82 Aligned_cols=25 Identities=28% Similarity=0.283 Sum_probs=22.9
Q ss_pred cccccceeehhHHHHHHHhCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
.+.++|||||||+++||+||+.|..
T Consensus 179 ~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 179 YSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred cCchHHHHHHHHHHHHHHHcCCCCc
Confidence 6889999999999999999999854
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=4.3e-06 Score=72.76 Aligned_cols=24 Identities=4% Similarity=0.041 Sum_probs=21.2
Q ss_pred cccccceeehhHHHHHHHhCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPN 27 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~ 27 (367)
.+.++|||||||+++||+||+.+.
T Consensus 208 ~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 208 HLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp THHHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCchhhHHHHHHHHHHHhcCCCCC
Confidence 457999999999999999998764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=5.2e-06 Score=75.05 Aligned_cols=28 Identities=21% Similarity=0.223 Sum_probs=24.7
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 209 ~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 209 KGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp TTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 3578899999999999999999999763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=97.81 E-value=8.2e-06 Score=71.21 Aligned_cols=27 Identities=26% Similarity=0.302 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 177 ~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 177 KYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.81 E-value=1e-05 Score=74.38 Aligned_cols=26 Identities=15% Similarity=0.220 Sum_probs=23.9
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.++|||||||+|+||+||+.|+.
T Consensus 212 ~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 212 HYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp SCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccchhhhHHHHHHHHHHHhCCCCCC
Confidence 47889999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=97.80 E-value=7.6e-06 Score=75.69 Aligned_cols=27 Identities=30% Similarity=0.255 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+|+||+||+.|+..
T Consensus 233 ~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 233 DYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=97.80 E-value=7.3e-06 Score=74.17 Aligned_cols=24 Identities=38% Similarity=0.636 Sum_probs=21.0
Q ss_pred cccceeehhHHHHHHHhCCCCCCC
Q 017712 6 SYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 6 ~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.++|||||||+++||+||+.|+..
T Consensus 197 ~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 197 KIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred CeeeeehhHHHHHHHHhCCCCCCC
Confidence 348999999999999999999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=97.80 E-value=6.7e-06 Score=73.85 Aligned_cols=26 Identities=35% Similarity=0.662 Sum_probs=23.3
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++|||||||+++||+||+.|+..
T Consensus 197 ~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 197 YDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 46789999999999999999999763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.79 E-value=1.2e-05 Score=73.25 Aligned_cols=26 Identities=31% Similarity=0.392 Sum_probs=23.8
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++|||||||+++||+||+.|+..
T Consensus 194 ~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 194 YSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCccceeechHHHHHHHHhCCCCCCC
Confidence 67899999999999999999999763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.79 E-value=7.5e-06 Score=72.83 Aligned_cols=24 Identities=25% Similarity=0.531 Sum_probs=21.4
Q ss_pred ccccccceeehhHHHHHHHhCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRP 26 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p 26 (367)
..+.++|||||||+++||+||..|
T Consensus 252 ~~~~~~Di~slG~il~el~~~~~~ 275 (332)
T 3qd2_B 252 NYSHKVDIFSLGLILFELLYSFST 275 (332)
T ss_dssp CCCTHHHHHHHHHHHHHHHSCCCC
T ss_pred CCcchhhHHHHHHHHHHHHHcCCC
Confidence 468899999999999999998665
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.78 E-value=4.1e-06 Score=75.00 Aligned_cols=25 Identities=16% Similarity=0.268 Sum_probs=22.8
Q ss_pred ccccceeehhHHHHHHHhCCCCCCC
Q 017712 5 SSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 5 s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+.++|||||||+++||+||+.|+..
T Consensus 208 ~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 208 GPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCcccchhHHHHHHHHHhCCCchhh
Confidence 6789999999999999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=8.7e-06 Score=72.82 Aligned_cols=27 Identities=26% Similarity=0.364 Sum_probs=23.9
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|++.
T Consensus 217 ~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 217 GHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 357799999999999999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=97.76 E-value=6.4e-06 Score=75.52 Aligned_cols=27 Identities=19% Similarity=0.267 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+|+||+||+.|+..
T Consensus 218 ~~~~~~DiwSlG~il~ell~g~~pf~~ 244 (394)
T 4e7w_A 218 NYTTNIDIWSTGCVMAELMQGQPLFPG 244 (394)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=97.76 E-value=1e-05 Score=73.40 Aligned_cols=28 Identities=25% Similarity=0.300 Sum_probs=24.8
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
...+.++|||||||+++||+||+.|++.
T Consensus 217 ~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 217 MHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp SCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 3578899999999999999999999763
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=97.76 E-value=1.1e-05 Score=71.56 Aligned_cols=28 Identities=21% Similarity=0.248 Sum_probs=24.6
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 194 ~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (326)
T 1blx_A 194 SSYATPVDLWSVGCIFAEMFRRKPLFRG 221 (326)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 3468899999999999999999999763
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=97.76 E-value=1.2e-05 Score=72.74 Aligned_cols=26 Identities=23% Similarity=0.281 Sum_probs=23.7
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++|||||||+++||+||+.|+..
T Consensus 209 ~~~~~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 209 YTKSIDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp CSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcchhHHHHHHHHHHHHHCCCCCCC
Confidence 68899999999999999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=1.3e-05 Score=75.66 Aligned_cols=28 Identities=29% Similarity=0.461 Sum_probs=24.6
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
|..+.++|||||||+++||+||+.|+..
T Consensus 197 ~~~~~~~DiwslG~il~~ll~g~~pf~~ 224 (486)
T 3mwu_A 197 GTYDEKCDVWSAGVILYILLSGTPPFYG 224 (486)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4567899999999999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=1.1e-05 Score=76.26 Aligned_cols=28 Identities=25% Similarity=0.469 Sum_probs=24.8
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 212 ~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 212 KKYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 3568899999999999999999999753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.75 E-value=1.2e-05 Score=74.73 Aligned_cols=26 Identities=19% Similarity=0.314 Sum_probs=22.5
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~ 28 (367)
..|.++|||||||+++||+| |+.|..
T Consensus 205 ~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 205 NPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred CCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 35678999999999999999 888864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=97.74 E-value=2.5e-05 Score=70.89 Aligned_cols=27 Identities=22% Similarity=0.182 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 202 ~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 202 GYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 467899999999999999999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=97.74 E-value=1.1e-05 Score=76.46 Aligned_cols=28 Identities=21% Similarity=0.401 Sum_probs=24.8
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 222 ~~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 222 KKYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 4568899999999999999999999763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=97.74 E-value=5e-06 Score=73.89 Aligned_cols=24 Identities=38% Similarity=0.595 Sum_probs=22.1
Q ss_pred ccccceeehhHHHHHHHhCCCCCC
Q 017712 5 SSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 5 s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
+.++||||||++++||+||+.|++
T Consensus 227 ~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 227 GRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccchHHhHHHHHHHHHHCCCCCC
Confidence 678899999999999999999975
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=97.73 E-value=6e-06 Score=72.42 Aligned_cols=26 Identities=27% Similarity=0.296 Sum_probs=23.8
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++|||||||+++||+||+.|+..
T Consensus 181 ~~~~~Di~slG~~l~~l~~g~~pf~~ 206 (299)
T 2r3i_A 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206 (299)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 68899999999999999999999763
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.73 E-value=1.9e-05 Score=72.20 Aligned_cols=26 Identities=19% Similarity=0.165 Sum_probs=23.7
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
+.+.++||||+||+++||+||+.|+.
T Consensus 239 ~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 239 EYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred CCCChhheehhHHHHHHHHHCCCCCC
Confidence 46789999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=97.70 E-value=2e-05 Score=71.39 Aligned_cols=26 Identities=23% Similarity=0.331 Sum_probs=23.9
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.++|||||||+++||+||+.|+.
T Consensus 206 ~~~~~~DiwslG~il~ell~g~~pf~ 231 (367)
T 2fst_X 206 HYNQTVDIWSVGCIMAELLTGRTLFP 231 (367)
T ss_dssp SCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 56889999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=97.70 E-value=1.1e-05 Score=73.56 Aligned_cols=27 Identities=19% Similarity=0.191 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 218 ~~~~~~DiwslG~il~ell~g~~pf~~ 244 (383)
T 3eb0_A 218 EYTPSIDLWSIGCVFGELILGKPLFSG 244 (383)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence 368899999999999999999999763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00022 Score=65.78 Aligned_cols=31 Identities=16% Similarity=0.303 Sum_probs=28.0
Q ss_pred CCCeEecCCCCCceeecCCCceEEeccccccc
Q 017712 276 QPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (367)
Q Consensus 276 ~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (367)
...++|+|++|.|||++.++ ++++||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 67899999999999998776 99999998864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=7e-06 Score=74.18 Aligned_cols=26 Identities=23% Similarity=0.448 Sum_probs=23.5
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++||||+||++.||+||+.|+..
T Consensus 224 y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 224 QTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCCccchhhhHHHHHHHHHCCCCCCC
Confidence 57889999999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=97.68 E-value=8e-06 Score=73.30 Aligned_cols=23 Identities=35% Similarity=0.472 Sum_probs=21.5
Q ss_pred ccceeehhHHHHHHHhCCCCCCC
Q 017712 7 YGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 7 ksDVySfGVvllEl~tg~~p~~~ 29 (367)
++||||||++++||+||+.|...
T Consensus 232 ~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 232 KVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hhhHHHHHHHHHHHHhCCCCCCC
Confidence 89999999999999999999764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00015 Score=63.72 Aligned_cols=71 Identities=10% Similarity=0.047 Sum_probs=43.9
Q ss_pred CCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCc-ceeeeeecccccCCceeeeEEEEec
Q 017712 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNI-VRVFTAFSGVDYQGARFKAVVYKFM 228 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~~ 228 (367)
.+.|+.|....+|+. ..+++|+...... ......+|+.++..+...++ .+++..+. . .-++++||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~-----~--~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDP-----A--TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT-----T--TCCEEEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEEC-----C--CCEEEEeec
Confidence 567889999999988 5688888753221 12234568887777642222 46665531 1 126899999
Q ss_pred -cCCCH
Q 017712 229 -PNGSL 233 (367)
Q Consensus 229 -~~g~L 233 (367)
++.+|
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 65444
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=97.66 E-value=2.3e-05 Score=75.28 Aligned_cols=26 Identities=35% Similarity=0.662 Sum_probs=23.5
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++||||+||+|+||+||+.|+..
T Consensus 333 y~~~~DiWSlGvilyeml~G~~Pf~~ 358 (573)
T 3uto_A 333 VGYYTDMWSVGVLSYILLSGLSPFGG 358 (573)
T ss_dssp BCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 57789999999999999999999753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00038 Score=61.32 Aligned_cols=74 Identities=11% Similarity=0.103 Sum_probs=55.5
Q ss_pred CcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC---CCCcceeeeeecccccCCceeeeEEEEe
Q 017712 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK---HRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (367)
+.|+.|....+|+... ++..+++|+... .....+..|+..|..|. ...+++++.+.. .....++||||
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~ 112 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEA 112 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEEC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEe
Confidence 4689999999999874 567888998653 23567889999888873 356778887652 22457999999
Q ss_pred ccCCCH
Q 017712 228 MPNGSL 233 (367)
Q Consensus 228 ~~~g~L 233 (367)
+++.++
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=97.65 E-value=2e-05 Score=71.94 Aligned_cols=26 Identities=23% Similarity=0.222 Sum_probs=23.8
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.++|||||||+++||+||+.|+.
T Consensus 207 ~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 207 KYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 46889999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=1.9e-05 Score=73.51 Aligned_cols=28 Identities=21% Similarity=0.349 Sum_probs=24.7
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+|+||+||+.|+..
T Consensus 324 ~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 3468899999999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.64 E-value=1.9e-05 Score=71.06 Aligned_cols=28 Identities=25% Similarity=0.300 Sum_probs=24.6
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 199 ~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp SCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3568899999999999999999999753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.64 E-value=1.3e-05 Score=70.73 Aligned_cols=24 Identities=38% Similarity=0.566 Sum_probs=21.8
Q ss_pred ccccceeehhHHHHHHHhCCCCCC
Q 017712 5 SSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 5 s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
+.++||||||++++||+||+.|++
T Consensus 217 ~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 217 ALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccchHHHHHHHHHHHHHCCCCCC
Confidence 458999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=97.64 E-value=1.9e-05 Score=74.04 Aligned_cols=26 Identities=31% Similarity=0.565 Sum_probs=23.4
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++|||||||+++||+||+.|++.
T Consensus 193 ~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 193 AGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp CSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcceehhhHHHHHHHhhCCCCCCC
Confidence 36789999999999999999999764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.61 E-value=1.8e-05 Score=70.99 Aligned_cols=25 Identities=16% Similarity=0.178 Sum_probs=22.7
Q ss_pred cccccceeehhHHHHHHHhCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
.+.++|||||||+++||+||+.|..
T Consensus 190 ~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 190 YGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCchhhhHhHHHHHHHHHHCCCCCC
Confidence 5788999999999999999988865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=3e-05 Score=72.67 Aligned_cols=26 Identities=19% Similarity=0.095 Sum_probs=23.6
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.++|||||||+|+||+||+.|+.
T Consensus 239 ~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 239 GYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 46789999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.57 E-value=5.7e-05 Score=68.40 Aligned_cols=27 Identities=26% Similarity=0.310 Sum_probs=24.3
Q ss_pred CccccccceeehhHHHHHHHhCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
+..+.++|||||||+++||+||+.|+.
T Consensus 201 ~~~~~~~DiwslG~il~ell~g~~pf~ 227 (367)
T 1cm8_A 201 MRYTQTVDIWSVGCIMAEMITGKTLFK 227 (367)
T ss_dssp TCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 357889999999999999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=97.55 E-value=3.6e-05 Score=68.90 Aligned_cols=26 Identities=23% Similarity=0.342 Sum_probs=23.7
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.++|||||||+++||+||+.|+.
T Consensus 181 ~~~~~~DiwslG~il~ell~g~~Pf~ 206 (337)
T 1o6l_A 181 DYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCchhhcccchhHHHHHhcCCCCCC
Confidence 46789999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=5.4e-05 Score=67.39 Aligned_cols=27 Identities=30% Similarity=0.406 Sum_probs=24.0
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 197 ~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 197 GHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 457899999999999999999999763
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=3e-05 Score=71.91 Aligned_cols=26 Identities=19% Similarity=0.289 Sum_probs=22.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.++|||||||+|+||+||..|..
T Consensus 228 ~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 228 NYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CCCcccccchHHHHHHHHHhcccccc
Confidence 46789999999999999998766643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 367 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-49 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-06 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-42 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 0.001 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-42 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 0.001 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 0.003 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 0.002 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-39 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 0.002 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-05 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-04 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-04 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 0.003 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 0.002 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-29 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 0.002 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 0.004 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 5e-49
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVFT 208
IG+G+FG+VY G +AVK+ N+ P ++FK+E +H NI+
Sbjct: 14 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM- 70
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
Y A A+V ++ SL L + F + K +DIA A +
Sbjct: 71 -----GYSTAPQLAIVTQWCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGM 117
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328
YLH I H +LK +N+ L +++ +GDFG+A ++F + GS ++
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 329 PEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGI 363
PE + + Y DVY+FGI+L E+ TG P I
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (112), Expect = 1e-06
Identities = 22/119 (18%), Positives = 43/119 (36%), Gaps = 28/119 (23%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEI 61
S DVY+FGI+L E+ TG P ++ N + + + L ++
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS------- 236
Query: 62 EEEETMYKKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120
+ M + ++ ECL + +ER + + + L+ + L
Sbjct: 237 NCPKAMKR----------LMAECL-----------KKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-42
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+GAG FG V+ G T +AVK +F +E ++H+ +VR++
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY--- 74
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
V Q + ++ ++M NGSL ++L+ I K LD+A +A + +
Sbjct: 75 -AVVTQEPIY--IITEYMENGSLVDFLKTPS-------GIKLTINKLLDMAAQIAEGMAF 124
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
+ + H +L+ +N+L+ D + + DFG+AR + ++ K + PE
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPE 180
Query: 331 YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ DV+SFGILL E+ T R
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.7 bits (87), Expect = 0.001
Identities = 14/53 (26%), Positives = 22/53 (41%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILD 54
G + DV+SFGILL E+ T R + + N + R + +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-42
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 22/222 (9%)
Query: 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKH 200
+ F + +GAGN G V+ + G +A K+ +L I+P E +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
IV + AF ++ + M GSL++ L+ + L +
Sbjct: 64 PYIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---------GKV 109
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+I V L YL I H ++KPSN+L++ + DFG++ L +
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSF 163
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ Y+ PE G S D++S G+ L+EM G P
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.7 bits (87), Expect = 0.001
Identities = 12/36 (33%), Positives = 17/36 (47%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNL 37
+ S D++S G+ L+EM G P EL L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 8e-41
Identities = 48/228 (21%), Positives = 87/228 (38%), Gaps = 23/228 (10%)
Query: 138 KDLYNATNGFSSANL-IGAGNFGSVYNGTLF---DGTTIAVKVFNL-IRPGGSKSFKSEC 192
K L+ + A++ +G GNFGSV G +A+KV ++ E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 193 KAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNF 252
+ + + IVR+ +V + G L ++L GK +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKRE--------EI 106
Query: 253 LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID 312
+ ++ V+ ++YL H +L NVLL + + DFG+++ L A D
Sbjct: 107 PVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163
Query: 313 KQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
K + PE + S+ DV+S+G+ + E + +
Sbjct: 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-40
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V+ GT T +A+K ++F E + ++H +V+++
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
S +V ++M GSL ++L+G+ R + +D+A +A + Y
Sbjct: 82 SEEPI------YIVTEYMSKGSLLDFLKGETGKYLRL-------PQLVDMAAQIASGMAY 128
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
+ H +L+ +N+L+ + ++ V DFG+AR + ++ K + PE
Sbjct: 129 VERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPE 184
Query: 331 YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
L + DV+SFGILL E+ T R
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRV 213
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.6 bits (84), Expect = 0.003
Identities = 14/53 (26%), Positives = 20/53 (37%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILD 54
G + DV+SFGILL E+ T R + L + E +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 2e-40
Identities = 54/248 (21%), Positives = 93/248 (37%), Gaps = 30/248 (12%)
Query: 134 NPSFKDLYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNL-IRPGGSK 186
NP L N IG G FG V+ T +AVK+
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 187 SFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR 246
F+ E + NIV++ + +++++M G L E+LR
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 247 PLNFNFL---------------IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291
L+ + L ++L IA VA + YL + H +L N L+
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLV 173
Query: 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLL 351
+ M+ + DFG++R + + D ++PPE +T DV+++G++L
Sbjct: 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 352 EMFTGIRP 359
E+F+
Sbjct: 234 EIFSYGLQ 241
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-39
Identities = 49/217 (22%), Positives = 80/217 (36%), Gaps = 15/217 (6%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVF 207
IG G++G DG + K + + + SE +KH NIVR +
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
+ +V ++ G L + + L + + A
Sbjct: 70 DRIID---RTNTTLYIVMEYCEGGDLASVITKG-----TKERQYLDEEFVLRVMTQLTLA 121
Query: 268 LRYLH--CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
L+ H D + H +LKP+NV LD + +GDFG+AR L + G+
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPY 179
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
Y+ PE + D++S G LL E+ + P
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.3 bits (86), Expect = 0.002
Identities = 9/44 (20%), Positives = 14/44 (31%), Gaps = 1/44 (2%)
Query: 9 DVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEI 52
D++S G LL E+ + P EL +
Sbjct: 196 DIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFRRIPYRY 238
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-39
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
IG G FG V G G +AVK +++F +E ++H N+V++
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLL--- 66
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV + +V ++M GSL ++LR + L + L+K ++DV A+ Y
Sbjct: 67 -GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLK----FSLDVCEAMEY 118
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
L H +L NVL+ ++ + V DFG+ + + K + PE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPE 170
Query: 331 YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ ST DV+SFGILL E+++ R
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRV 199
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.9 bits (85), Expect = 0.002
Identities = 18/117 (15%), Positives = 32/117 (27%), Gaps = 32/117 (27%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEI 61
S+ DV+SFGILL E+++ R + + K + + V+
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY---- 230
Query: 62 EEEETMYKKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118
++ C R + +L IK
Sbjct: 231 -----------------EVMKNCW-----------HLDAAMRPSFLQLREQLEHIKT 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (348), Expect = 7e-39
Identities = 51/241 (21%), Positives = 96/241 (39%), Gaps = 33/241 (13%)
Query: 136 SFKDLYNATNGFSSA---------NLIGAGNFGSVYNGTLF----DGTTIAVKVFNL-IR 181
+F+D A F+ +IGAG FG V +G L +A+K
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 182 PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD 241
+ F SE H N++ + + ++ +FM NGSL+ +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSF----- 117
Query: 242 DTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301
R + F + + + + +A ++YL H +L N+L++ ++ V D
Sbjct: 118 ---LRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSD 171
Query: 302 FGMARFLP---AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIR 358
FG++RFL + + K + PE + ++ DV+S+GI++ E+ +
Sbjct: 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 359 P 359
Sbjct: 232 R 232
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 3e-38
Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 18/209 (8%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
IG+G FG V+ G + +A+K + F E + + + H +V+++
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+V++FM +G L ++ R F + L + +DV + Y
Sbjct: 70 LEQAP-----ICLVFEFMEHGCLSDY--------LRTQRGLFAAETLLGMCLDVCEGMAY 116
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
L + + H +L N L+ + + V DFGM RF+ D+ K + PE
Sbjct: 117 L---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPE 172
Query: 331 YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
S+ DV+SFG+L+ E+F+ +
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 6e-38
Identities = 48/223 (21%), Positives = 89/223 (39%), Gaps = 26/223 (11%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212
IG G FG V+ G G +AVK+F+ R S ++E + ++H NI+ A +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLH 272
+ + +V + +GSL ++L + ++ + +A+ A L +LH
Sbjct: 69 DNGTWTQL-WLVSDYHEHGSLFDYLN----------RYTVTVEGMIKLALSTASGLAHLH 117
Query: 273 CDC-----QPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC--IKGSTG 325
+ +P IAH +LK N+L+ + D G+A + G+
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 326 YIPPEYDLGCEASTYG------DVYSFGILLLEMFTGIRPSDG 362
Y+ PE + D+Y+ G++ E+
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 3e-05
Identities = 17/117 (14%), Positives = 36/117 (30%), Gaps = 12/117 (10%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEI 61
D+Y+ G++ E+ + +L ++ V S EE+ VV Q++
Sbjct: 193 FESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP--SVEEMRKVVCEQKL 250
Query: 62 EEEETMYKKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118
E L + + C R+ ++ L + +
Sbjct: 251 RPN----------IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 9e-38
Identities = 48/209 (22%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V G +A+K+ F E K +N+ H +V+++
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ ++ ++M NG L +LR F ++ L++ DV A+ Y
Sbjct: 69 TKQRPI-----FIITEYMANGCLLNYLREM--------RHRFQTQQLLEMCKDVCEAMEY 115
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
L H +L N L++D+ + V DFG++R++ D+ + K + PPE
Sbjct: 116 LES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPE 171
Query: 331 YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ + S+ D+++FG+L+ E+++ +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKM 200
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (339), Expect = 2e-37
Identities = 46/238 (19%), Positives = 86/238 (36%), Gaps = 33/238 (13%)
Query: 135 PSFKDLY---NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL---IRPGGSKS 187
P +L+ + FS IG G+FG+VY + + +A+K + +
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 188 FKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP 247
E + ++H N ++ + +V ++ + + K
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQE-- 114
Query: 248 LNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
+ + L YLH + H ++K N+LL + + +GDFG A
Sbjct: 115 -------VEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 308 LPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
+ N F+ G+ ++ PE L + Y DV+S GI +E+ P
Sbjct: 165 ---MAPANSFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-37
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 25/216 (11%)
Query: 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG+VY +A+KV L + G + E + +++H NI+R+
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ F A ++ ++ P G++ L+ + ++ ++A
Sbjct: 72 YGYF-----HDATRVYLILEYAPLGTVYRELQ-----KLSKFD----EQRTATYITELAN 117
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
AL Y H + H ++KP N+LL + DFG + P +R + G+ Y
Sbjct: 118 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDY 170
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+PPE G D++S G+L E G P +
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-37
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 22/215 (10%)
Query: 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
IG G+F +VY G +A + + FK E + ++H NIVR + +
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
+ +G + +V + M +G+L+ +L+ + L + L+
Sbjct: 77 WESTV-KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL---------RSWCRQILKGLQ 126
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYI 327
+LH PPI H +LK N+ + G V GD G+A + + G+ ++
Sbjct: 127 FLHTRT-PPIIHRDLKCDNIFITGPT-GSVKIGDLGLATLKR--ASFAKAVI--GTPEFM 180
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
PE + DVY+FG+ +LEM T P
Sbjct: 181 APEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSE 214
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (89), Expect = 7e-04
Identities = 12/46 (26%), Positives = 19/46 (41%)
Query: 9 DVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILD 54
DVY+FG+ +LEM T P + N P +++
Sbjct: 194 DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-36
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 24/218 (11%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G FG VY A KV + + + E + H NIV++ A
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
F + ++ +F G+++ + + RPL + + + AL
Sbjct: 78 FYYENN-----LWILIEFCAGGAVDAVMLELE----RPLTESQIQV----VCKQTLDALN 124
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
YLH I H +LK N+L + + DFG++ ++ G+ ++ P
Sbjct: 125 YLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAP 179
Query: 330 EYDLGCEASTYG-----DVYSFGILLLEMFTGIRPSDG 362
E + + DV+S GI L+EM P
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-36
Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 22/216 (10%)
Query: 151 NLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVR 205
+IG G+FG VY+GTL D AVK N I G F +E + H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ G+ + VV +M +G L + R N +K + + VA
Sbjct: 93 LL----GICLRSEGSPLVVLPYMKHGDLRNF--------IRNETHNPTVKDLIGFGLQVA 140
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC--IKGS 323
+ H +L N +LD++ V DFG+AR + + + K
Sbjct: 141 KGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
++ E + +T DV+SFG+LL E+ T P
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (94), Expect = 2e-04
Identities = 19/121 (15%), Positives = 37/121 (30%), Gaps = 32/121 (26%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEI 61
++ DV+SFG+LL E+ T P N ++ + E D ++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY---- 264
Query: 62 EEEETMYKKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLL 121
++L+C R +++ SR+ I +
Sbjct: 265 -----------------EVMLKCW-----------HPKAEMRPSFSELVSRISAIFSTFI 296
Query: 122 K 122
Sbjct: 297 G 297
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 133 bits (335), Expect = 2e-36
Identities = 50/260 (19%), Positives = 97/260 (37%), Gaps = 33/260 (12%)
Query: 106 INDVESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT 165
IND + I KK + PV + S D Y+ +G+G FG V+
Sbjct: 1 INDYDKFYEDIWKKYVPQPV-----EVKQGSVYDYYDILE------ELGSGAFGVVHRCV 49
Query: 166 -LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224
G K N P + K+E + H ++ + AF + ++
Sbjct: 50 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMVLI 104
Query: 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284
+F+ G L + + + ++ + ++ L+++H + I H ++
Sbjct: 105 LEFLSGGELFDRIAAE--------DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 153
Query: 285 KPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGD 342
KP N++ + + V DFG+A L + + + PE Y D
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYTD 210
Query: 343 VYSFGILLLEMFTGIRPSDG 362
+++ G+L + +G+ P G
Sbjct: 211 MWAIGVLGYVLLSGLSPFAG 230
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-36
Identities = 45/216 (20%), Positives = 80/216 (37%), Gaps = 21/216 (9%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRV 206
++G G+F +V L A+K+ +I+ E + H V++
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ F Q + NG L +++R + A
Sbjct: 74 YFTF-----QDDEKLYFGLSYAKNGELLKYIR-----KIGSFDET-------CTRFYTAE 116
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
+ L I H +LKP N+LL+++M + DFG A+ L KQ R G+ Y
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ PE A D+++ G ++ ++ G+ P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-36
Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 25/219 (11%)
Query: 151 NLIGAGNFGSVYNGTLFD---GTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVR 205
+G+GNFG+V G T+AVK+ P +E + + IVR
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ + +V + G L ++L+ + + +++ V+
Sbjct: 73 MIGICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNI---------IELVHQVS 117
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA-IDKQNRFICIKGST 324
++YL H +L NVLL + + DFG+++ L A + K
Sbjct: 118 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDG 362
+ PE + S+ DV+SFG+L+ E F+ G +P G
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 5e-36
Identities = 52/228 (22%), Positives = 85/228 (37%), Gaps = 25/228 (10%)
Query: 151 NLIGAGNFGSVYNGTLF------DGTTIAVKVFNL-IRPGGSKSFKSECKAAINIK-HRN 202
+GAG FG V T + T+AVK+ ++ SE K + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI-------- 254
IV + A + V+ ++ G L +LR K D+ ++
Sbjct: 89 IVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 255 -KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
+ L + VA + +L H +L N+LL I + DFG+AR +
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
+ ++ PE C + DV+S+GI L E+F+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-36
Identities = 49/230 (21%), Positives = 85/230 (36%), Gaps = 30/230 (13%)
Query: 152 LIGAGNFGSVYNGTLFD------GTTIAVKVFNL-IRPGGSKSFKSECKAAINI-KHRNI 203
++G+G FG V N T + +AVK+ ++ SE K + H NI
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDT--------------NWRPLN 249
V + A + +++++ G L +LR K +
Sbjct: 104 VNLLGACTLSGPI-----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 250 FNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
+ L A VA + +L H +L NVL+ + + DFG+AR +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ + ++ PE + DV+S+GILL E+F+
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 131 bits (331), Expect = 6e-36
Identities = 45/214 (21%), Positives = 83/214 (38%), Gaps = 22/214 (10%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V+ T G A K ++ + E + ++H +V + AF
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ ++Y+FM G L E + + + + ++ V L +
Sbjct: 93 -----EDDNEMVMIYEFMSGGELFEKVADE--------HNKMSEDEAVEYMRQVCKGLCH 139
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIP 328
+H + H +LKP N++ + + DFG+ L D + G+ +
Sbjct: 140 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAA 193
Query: 329 PEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
PE G Y D++S G+L + +G+ P G
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 2e-35
Identities = 45/213 (21%), Positives = 83/213 (38%), Gaps = 21/213 (9%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
IG G G+VY + G +A++ NL + + +E K+ NIV +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
+ D VV +++ GSL + + + + + AL
Sbjct: 86 YLVGDE-----LWVVMEYLAGGSLTDVVTETCMDE----------GQIAAVCRECLQALE 130
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
+LH + H ++K N+LL + + DFG + +Q++ + G+ ++ P
Sbjct: 131 FLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAP 185
Query: 330 EYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
E D++S GI+ +EM G P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.9 bits (85), Expect = 0.003
Identities = 11/46 (23%), Positives = 18/46 (39%), Gaps = 1/46 (2%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPE 47
D++S GI+ +EM G P + L+ + PE
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPE 235
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-35
Identities = 45/215 (20%), Positives = 80/215 (37%), Gaps = 20/215 (9%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFT 208
+G G +G V +AVK+ ++ R ++ K E + H N+V+ +
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
+ + + ++ G L + + + +
Sbjct: 71 HR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA---------QRFFHQLMAGV 116
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328
YLH I H ++KP N+LLD+ + DFG+A +++ + G+ Y+
Sbjct: 117 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 329 PEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDG 362
PE E DV+S GI+L M G P D
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-35
Identities = 49/227 (21%), Positives = 84/227 (37%), Gaps = 23/227 (10%)
Query: 145 NGFSSANLIGAGNFGSVYNGTLFDG---TTIAVKVFNLI-RPGGSKSFKSECKAAINI-K 199
N ++IG GNFG V + A+K + F E + +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-- 257
H NI+ + A Y + ++ P+G+L ++LR P
Sbjct: 70 HPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 258 -----LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID 312
L A DVA + YL Q H +L N+L+ + + + DFG++R
Sbjct: 125 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 313 KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
K+ + ++ E +T DV+S+G+LL E+ +
Sbjct: 182 KKT---MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (320), Expect = 6e-35
Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 18/226 (7%)
Query: 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECK 193
P++ + + +G G +G VY G T+AVK + F E
Sbjct: 7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAA 65
Query: 194 AAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL 253
IKH N+V++ ++ +FM G+L ++L
Sbjct: 66 VMKEIKHPNLVQLLGVC-----TREPPFYIITEFMTYGNLLDYL-------RECNRQEVS 113
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
L +A ++ A+ YL + H +L N L+ + + V DFG++R + D
Sbjct: 114 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DT 169
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
K + PE + S DV++FG+LL E+ T
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 215
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-34
Identities = 47/220 (21%), Positives = 88/220 (40%), Gaps = 25/220 (11%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKV-----FNLIRPGGSKSFKSECKAAINIKH 200
F ++G+G FG+VY G + +G + + V P +K E ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSL-EEWLRGKDDTNWRPLNFNFLIKKKLD 259
++ R+ Q ++ + MP G L + KD+ + L L+
Sbjct: 71 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL---------LN 115
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
+ +A + YL + H +L NVL+ + DFG+A+ L A +K+
Sbjct: 116 WCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 320 IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
K ++ E L + DV+S+G+ + E+ T
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 123 bits (309), Expect = 2e-33
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 18/216 (8%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
++G G V+ L +AVKV P F+ E + A + H IV V+
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
G +V +++ +L + + P+ K+ +++ D A
Sbjct: 74 DTGEAETPAGPLP-YIVMEYVDGVTLRDIVH-----TEGPMT----PKRAIEVIADACQA 123
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL-PAIDKQNRFICIKGSTGY 326
L + Q I H ++KP+N+++ V DFG+AR + + + + + G+ Y
Sbjct: 124 LNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ PE G DVYS G +L E+ TG P G
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 3e-33
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 23/220 (10%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGT-----TIAVKVFNL-IRPGGSKSFKSECKAAINIKH 200
+ +IGAG FG VY G L + +A+K F E H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
NI+R+ S ++ ++M NG+L+++LR KD F + + + +
Sbjct: 69 HNIIRLEGVISKYKP-----MMIITEYMENGALDKFLREKDG--------EFSVLQLVGM 115
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA-IDKQNRFIC 319
+A ++YL H +L N+L++ ++ V DFG++R L +
Sbjct: 116 LRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172
Query: 320 IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
K + PE + ++ DV+SFGI++ E+ T
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 212
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.002
Identities = 17/116 (14%), Positives = 35/116 (30%), Gaps = 36/116 (31%)
Query: 9 DVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMY 68
DV+SFGI++ E+ T ++ + + ++
Sbjct: 195 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY----------- 243
Query: 69 KKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLLKTP 124
++++C + R K D+ S L KL++ P
Sbjct: 244 ----------QLMMQCW-----------QQERARRPKFADIVSIL----DKLIRAP 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-33
Identities = 57/215 (26%), Positives = 85/215 (39%), Gaps = 25/215 (11%)
Query: 153 IGAGNFGSVYNGTLF----DGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVR 205
+G G+FG V G ++AVK L +P F E A ++ HRN++R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
++ + +V + P GSL + LR +FL+ A+ VA
Sbjct: 76 LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVA 121
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF-ICIKGST 324
+ YL H +L N+LL + +GDFG+ R LP D K
Sbjct: 122 EGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ PE S D + FG+ L EMFT +
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 5e-33
Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 16/217 (7%)
Query: 151 NLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNI 203
+G G+FG VY G T +A+K N F +E ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKLDIAI 262
VR+ S V+ + M G L+ +LR + P+ + K + +A
Sbjct: 86 VRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
++A + YL H +L N ++ ++ +GDFGM R + D +
Sbjct: 141 EIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
++ PE +TY DV+SFG++L E+ T
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-31
Identities = 44/214 (20%), Positives = 81/214 (37%), Gaps = 23/214 (10%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V+ T K ++ K E +HRNI+ + +F
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
++ ++++F+ + E + F ++ + V AL++
Sbjct: 71 ESMEE-----LVMIFEFISGLDIFERINTS--------AFELNEREIVSYVHQVCEALQF 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIP 328
LH I H +++P N++ + +FG AR L + F + + Y
Sbjct: 118 LH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYA 171
Query: 329 PEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
PE ST D++S G L+ + +GI P
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 3e-31
Identities = 51/223 (22%), Positives = 84/223 (37%), Gaps = 20/223 (8%)
Query: 151 NLIGAGNFGSVYNGTLF------DGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNI 203
+G G FG V F T+AVK+ ++ SE K I+I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK------ 257
V G + V+ +F G+L +LR K + + K
Sbjct: 79 VVNLL---GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 258 -LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
+ + VA + +L H +L N+LL ++ + + DFG+AR + R
Sbjct: 136 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 317 FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ ++ PE + DV+SFG+LL E+F+
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-31
Identities = 42/217 (19%), Positives = 78/217 (35%), Gaps = 24/217 (11%)
Query: 152 LIGAGNFGSVYNGTLFD----GTTIAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRV 206
IG G FG V+ G +A+K + F E H +IV++
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ ++ + G L + L+ + + A ++
Sbjct: 74 IGVITE------NPVWIIMELCTLGELRSF----LQVRKYSLD----LASLILYAYQLST 119
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
AL YL H ++ NVL+ +GDFG++R++ + K +
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKW 175
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDG 362
+ PE ++ DV+ FG+ + E+ G++P G
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 7e-31
Identities = 52/226 (23%), Positives = 84/226 (37%), Gaps = 25/226 (11%)
Query: 151 NLIGAGNFGSVYNGTL--------FDGTTIAVKVFNL-IRPGGSKSFKSECKAAINI-KH 200
+G G FG V T +AVK+ SE + I KH
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK-------DDTNWRPLNFNFL 253
+NI+ + A V+ ++ G+L E+L+ +
Sbjct: 79 KNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
K + A VA + YL H +L NVL+ ++ + + DFG+AR + ID
Sbjct: 134 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ + ++ PE + DV+SFG+LL E+FT
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 1e-29
Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 26/216 (12%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G+FG V+ +G A+KV ++R + E + H I+R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ F + +++ G + + + F A +V
Sbjct: 70 WGTFQDAQQ--------------IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 115
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
AL YLH I + +LKP N+LLD + DFG A+++P + + G+ Y
Sbjct: 116 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDY 167
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
I PE + D +SFGIL+ EM G P
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (284), Expect = 1e-29
Identities = 42/228 (18%), Positives = 78/228 (34%), Gaps = 19/228 (8%)
Query: 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-IRPGGSKSFKSECKA 194
+K + + + +++G G F V +A+K G S ++E
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
IKH NIV + + + ++ + + G L + + K R
Sbjct: 61 LHKIKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTER-------- 107
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
+ V A++YLH LD++ + DFG+++ D
Sbjct: 108 -DASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPG 163
Query: 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ G+ GY+ PE S D +S G++ + G P
Sbjct: 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 4e-29
Identities = 43/216 (19%), Positives = 82/216 (37%), Gaps = 24/216 (11%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTA 209
++G G G V A+K+ + E + + +IVR+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
+ + Y G + +V + + G L ++ + D F ++ +I + A++
Sbjct: 74 YENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQA-------FTEREASEIMKSIGEAIQ 125
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEM---IGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
YLH IAH ++KP N+L + I + DFG A+ N + Y
Sbjct: 126 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCYTPYY 179
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ PE + D++S G+++ + G P
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-29
Identities = 49/217 (22%), Positives = 86/217 (39%), Gaps = 24/217 (11%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKA-AINIKHRNIVR 205
++G G+FG V+ A+K ++ + E + ++ +H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+F F Q V +++ G L ++ + + A ++
Sbjct: 68 MFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---------RATFYAAEII 113
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
L++L I + +LK N+LLD + + DFGM + D + C G+
Sbjct: 114 LGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPD 168
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
YI PE LG + + D +SFG+LL EM G P G
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 112 bits (281), Expect = 9e-29
Identities = 51/226 (22%), Positives = 81/226 (35%), Gaps = 29/226 (12%)
Query: 145 NGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFN---LIRPGGSKSFKSECKAA---IN 197
N FS +IG G FG VY D G A+K + + G +E
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
IV + AF D + + M G L L + + F
Sbjct: 64 GDCPFIVCMSYAFHTPDKL-----SFILDLMNGGDLHYHLSQHGVFSEADMRF------- 111
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
A ++ L ++H + + +LKP+N+LLD+ + D G+A + +
Sbjct: 112 --YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKP 162
Query: 318 ICIKGSTGYIPPEYDLGCEASTY-GDVYSFGILLLEMFTGIRPSDG 362
G+ GY+ PE A D +S G +L ++ G P
Sbjct: 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-28
Identities = 45/219 (20%), Positives = 81/219 (36%), Gaps = 26/219 (11%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-----IRPGGSKSFKSECKAAINIKHRNIV 204
+ +G G F +VY +A+K L + G +++ E K + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ A + ++V+ FM I +
Sbjct: 64 GLLDA-----FGHKSNISLVFDFMETDLEVIIKDNSLVLTPS------------HIKAYM 106
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
L+ L Q I H +LKP+N+LLD+ + + DFG+A+ + ++ +
Sbjct: 107 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTR 164
Query: 325 GYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDG 362
Y PE G G D+++ G +L E+ + G
Sbjct: 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-28
Identities = 54/220 (24%), Positives = 85/220 (38%), Gaps = 20/220 (9%)
Query: 147 FSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVR 205
++ +IG G+FG VY L D G +A+K + E + + H NIVR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVR 77
Query: 206 VFTAF-SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ F S + + + +V ++P + +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA------KQTLPVIYVKLYMYQL 131
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+L Y+H I H ++KP N+LLD D + + DFG A+ L + +IC
Sbjct: 132 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS--- 185
Query: 324 TGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDG 362
Y PE G T DV+S G +L E+ G G
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 7e-28
Identities = 45/224 (20%), Positives = 85/224 (37%), Gaps = 18/224 (8%)
Query: 140 LYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAIN 197
+++ +++ + IG G +G V + + +A+K + + E K +
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
+H NI+ + + + +V M L + L+ + +
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQ----------HLSNDHI 111
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL-PAIDKQNR 316
+ L+Y+H + H +LKPSN+LL+ + DFG+AR P D
Sbjct: 112 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
Query: 317 FICIKGSTGYIPPEYDLGCEASTY-GDVYSFGILLLEMFTGIRP 359
+ Y PE L + T D++S G +L EM +
Sbjct: 169 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 9e-28
Identities = 44/219 (20%), Positives = 75/219 (34%), Gaps = 21/219 (9%)
Query: 151 NLIGAGNFGSVYNGT--LFDGTTIAVKVFNL--IRPGGSKSFKSE---CKAAINIKHRNI 203
IG G +G V+ G +A+K + G S E + +H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
VR+F + +V++ + + + D+
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--------EPGVPTETIKDMMFQ 124
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+ L +LH + H +LKP N+L+ + DFG+AR + +
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VT 178
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
Y PE L +T D++S G + EMF G
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 217
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-27
Identities = 45/222 (20%), Positives = 80/222 (36%), Gaps = 31/222 (13%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGS------KSFKSECKAAINIKHRNIV 204
+G+G F V G A K R S + + E I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ + + ++ + + G L ++L K+ +
Sbjct: 77 TLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEE------------ATEFL 119
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG----HVGDFGMARFLPAIDKQNRFICI 320
L ++ IAH +LKP N++L D + + DFG+A ID N F I
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNI 176
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ ++ PE D++S G++ + +G P G
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (86), Expect = 0.002
Identities = 11/99 (11%), Positives = 31/99 (31%), Gaps = 27/99 (27%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDEL---------------------NLHNF 40
+ D++S G++ + +G P E +F
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250
Query: 41 VKSAL---PER---AEEILDVVFFQEIEEEETMYKKASS 73
++ L P++ ++ L + + + ++ + S
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSH 289
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 106 bits (266), Expect = 3e-27
Identities = 47/229 (20%), Positives = 85/229 (37%), Gaps = 37/229 (16%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGS---------KSFKSECKAAINIK- 199
++G G V AVK+ ++ G ++ E +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
H NI+++ + + F +V+ M G L ++L K + K+
Sbjct: 69 HPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSE---------KETRK 114
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
I + + LH + I H +LKP N+LLDD+M + DFG + L D +
Sbjct: 115 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLRE 168
Query: 320 IKGSTGYIPPEYDLGCEASTYG------DVYSFGILLLEMFTGIRPSDG 362
+ G+ Y+ PE + D++S G+++ + G P
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 7e-27
Identities = 48/221 (21%), Positives = 79/221 (35%), Gaps = 21/221 (9%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVF 207
IG G FG V+ G +A+K + + G + E K +KH N+V +
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 208 TAFSGVDYQGARFKAVVY---KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
R K +Y F + +I +
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS------------EIKRVM 123
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI--DKQNRFICIKG 322
L L+ + I H ++K +NVL+ + + + DFG+AR + NR+
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 323 STGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDG 362
+ Y PPE LG D++ G ++ EM+T G
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 105 bits (262), Expect = 1e-26
Identities = 44/215 (20%), Positives = 77/215 (35%), Gaps = 22/215 (10%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFT 208
IG G +G VY G T A+K L + G + E +KH NIV+++
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
+ +V++ + + + + L
Sbjct: 68 VI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESV------------TAKSFLLQLL 110
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328
+ + H +LKP N+L++ E + DFG+AR ++ + Y
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--LWYRA 168
Query: 329 PEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDG 362
P+ +G + ST D++S G + EM G G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 103 bits (257), Expect = 1e-25
Identities = 50/245 (20%), Positives = 94/245 (38%), Gaps = 34/245 (13%)
Query: 125 VYEGKQTINNPSFKDLYNATNGFSSAN------LIGAGNFGSVYNGT-LFDGTTIAVKVF 177
VY T + D + + + + +G G + V+ + + + VK+
Sbjct: 9 VYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI- 67
Query: 178 NLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEW 236
++P K K E K N++ NI+ + +R A+V++ + N ++
Sbjct: 68 --LKPVKKKKIKREIKILENLRGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFKQL 122
Query: 237 LRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-M 295
+ D + R ++ AL Y H I H ++KP NV++D E
Sbjct: 123 YQTLTDYDIR------------FYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHR 167
Query: 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMF 354
+ D+G+A F + N + S + PE + + Y D++S G +L M
Sbjct: 168 KLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224
Query: 355 TGIRP 359
P
Sbjct: 225 FRKEP 229
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-25
Identities = 47/220 (21%), Positives = 76/220 (34%), Gaps = 22/220 (10%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNI 203
F IG G +G VY G +A+K L G + E + H NI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
V++ D K + + L++++ T
Sbjct: 64 VKLL------DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL-------PLIKSYLFQ 110
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+ L + + H +LKP N+L++ E + DFG+AR + +
Sbjct: 111 LLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VT 165
Query: 324 TGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDG 362
Y PE LGC+ + D++S G + EM T G
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 6e-25
Identities = 41/222 (18%), Positives = 74/222 (33%), Gaps = 23/222 (10%)
Query: 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKH 200
N F L+G G FG V G A+K+ +I +E + N +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
+ + A +Q V ++ G L L +
Sbjct: 65 PFLTALKYA-----FQTHDRLCFVMEYANGGELFFHLSRERVFTEE------------RA 107
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
A + L + + ++K N++LD + + DFG+ + + + C
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC- 166
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ Y+ PE + D + G+++ EM G P
Sbjct: 167 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 99 bits (248), Expect = 1e-24
Identities = 39/214 (18%), Positives = 74/214 (34%), Gaps = 27/214 (12%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
IG+G+FG +Y GT + G +A+K+ E K ++ +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ +V + + + + + + + L +A + + Y
Sbjct: 72 ----GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTV---------LLLADQMISRIEY 118
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHV---GDFGMARFLP-----AIDKQNRFICIKG 322
+H H ++KP N L+ G++ DFG+A+ + G
Sbjct: 119 IH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
+ Y LG E S D+ S G +L+ G
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 209
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.1 bits (243), Expect = 5e-24
Identities = 41/212 (19%), Positives = 71/212 (33%), Gaps = 21/212 (9%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVF 207
IG G +G+V+ +A+K L G S E +KH+NIVR+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
+ + E+ + N + + +
Sbjct: 68 DVL--------------HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
L + H + H +LKP N+L++ + +FG+AR I + +
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRP 169
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
P ST D++S G + E+ RP
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 8e-24
Identities = 45/222 (20%), Positives = 80/222 (36%), Gaps = 31/222 (13%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR------PGGSKSFKSECK--AAINIKHRN 202
L+G+G FGSVY+G + D +A+K R E ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
++R+ + F ++ + P L +++ + +
Sbjct: 71 VIRLL----DWFERPDSFVLILERPEPVQDLFDFITERGALQE---------ELARSFFW 117
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLPAIDKQNRFICIK 321
V A+R+ + H ++K N+L+D + + DFG L K +
Sbjct: 118 QVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 170
Query: 322 GSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDG 362
G+ Y PPE+ V+S GILL +M G P +
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.2 bits (83), Expect = 0.004
Identities = 16/77 (20%), Positives = 31/77 (40%), Gaps = 17/77 (22%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRP---NDDMFNDEL--------NLHNFVKSAL---PE 47
Y V+S GILL +M G P ++++ ++ + ++ L P
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPS 244
Query: 48 R---AEEILDVVFFQEI 61
EEI + + Q++
Sbjct: 245 DRPTFEEIQNHPWMQDV 261
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 96.4 bits (239), Expect = 2e-23
Identities = 37/223 (16%), Positives = 75/223 (33%), Gaps = 29/223 (13%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
IG G+FG ++ GT L + +A+K R + + E + + + F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
Q +V + + + + + A + ++
Sbjct: 70 ----GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTV---------AMAAKQMLARVQS 116
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVG-----DFGMARFLPAIDKQNRFIC-----I 320
+H + + + ++KP N L+ + DFGM +F + +
Sbjct: 117 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
G+ Y+ LG E S D+ + G + + G P G+
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 97.2 bits (241), Expect = 3e-23
Identities = 42/214 (19%), Positives = 81/214 (37%), Gaps = 26/214 (12%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVFT 208
+G G+FG V G A+K+ + +++ + +E + + +V++
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
++ +V +++ G + LR F A +
Sbjct: 109 -----SFKDNSNLYMVMEYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTF 154
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328
YLH + + +LKP N+L+D + V DFG A+ + R + G+ +
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALA 206
Query: 329 PEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
PE L + D ++ G+L+ EM G P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.0 bits (240), Expect = 4e-23
Identities = 38/218 (17%), Positives = 78/218 (35%), Gaps = 13/218 (5%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G+F +V+ + + T +A+K+ +++ + E K + + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 211 SGVDYQGARFKAVVYKFMPNGSL-----EEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ + PNG E + + + I+ +
Sbjct: 79 A---NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
L Y+H C I H ++KP NVL++ + ++ +A A + +
Sbjct: 136 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
Y PE LG D++S L+ E+ TG +
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.0 bits (235), Expect = 2e-22
Identities = 45/238 (18%), Positives = 90/238 (37%), Gaps = 26/238 (10%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGS 185
+Q +N K ++ + + + +G+G +GSV G +AVK + +
Sbjct: 6 RQELN----KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 186 KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245
K E + ++KH N++ + F+ + + L ++ + T+
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 246 RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305
+ + L+Y+H H +LKPSN+ ++++ + DFG+A
Sbjct: 122 HVQFLIY----------QILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLA 168
Query: 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDG 362
R + + Y PE L D++S G ++ E+ TG G
Sbjct: 169 RHT-----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 3e-22
Identities = 43/213 (20%), Positives = 80/213 (37%), Gaps = 24/213 (11%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFT 208
+G+G +G+V + G +A+K +K E + +++H N++ +
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 209 AFSGVDYQGARFK-AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
F+ + +V FM + K + + +
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI-----------QFLVYQMLKG 133
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
LRY+H I H +LKP N+ ++++ + DFG+AR + + Y
Sbjct: 134 LRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWYR 185
Query: 328 PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRP 359
PE L T D++S G ++ EM TG
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.5 bits (231), Expect = 6e-22
Identities = 40/212 (18%), Positives = 74/212 (34%), Gaps = 22/212 (10%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFT 208
IG+G G V +A+K + +K E + H+NI+ +
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 209 AFSGVD-YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
F+ + + +V + M + D ++ + + C
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH------------ERMSYLLYQMLCG 131
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
+++LH H +LKPSN+++ + + DFG+AR + Y
Sbjct: 132 IKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYR 185
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
PE LG D++S G ++ EM
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 2e-21
Identities = 39/219 (17%), Positives = 84/219 (38%), Gaps = 27/219 (12%)
Query: 151 NLIGAGNFGSVYNGTLF----DGTTIAVKVFNLI----RPGGSKSFKSECKAAINIKHRN 202
++G G +G V+ G A+KV + ++ ++E + +I+
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+ +Q ++ ++ G L L ++ ++ I
Sbjct: 90 FLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTEH------------EVQI 133
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
V + L + I + ++K N+LLD + DFG+++ A + + + G
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-G 192
Query: 323 STGYIPPEYDLGCEA--STYGDVYSFGILLLEMFTGIRP 359
+ Y+ P+ G ++ D +S G+L+ E+ TG P
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.0 bits (173), Expect = 3e-15
Identities = 25/168 (14%), Positives = 49/168 (29%), Gaps = 31/168 (18%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNL----------IRPGGSKSFKSECKAAINIKH 200
L+G G +V+N VK + R G F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
R + ++ Y + N L E + ++ ++
Sbjct: 66 RALQKLQGLAVPKVYA----------WEGNAVLMEL-------IDAKELYRVRVENPDEV 108
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308
+ + + I H +L NVL+ +E I + DF + +
Sbjct: 109 LDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 367 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.17 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.05 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.03 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 98.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 98.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 98.96 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 98.93 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 98.92 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 98.92 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 98.9 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 98.89 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 98.88 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 98.85 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 98.84 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 98.84 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 98.83 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 98.82 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 98.81 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 98.8 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 98.79 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 98.76 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 98.75 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 98.74 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 98.64 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.62 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 98.58 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 98.53 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 98.52 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 98.47 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 98.44 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 98.43 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 98.42 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 98.4 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 98.38 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 98.31 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 98.26 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 98.22 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 98.22 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 98.22 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 98.2 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 98.17 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 98.15 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 98.15 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 98.13 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 98.13 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 98.11 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 98.11 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.08 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 98.07 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 98.07 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 98.06 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 98.04 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 98.01 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 97.94 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 97.93 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 97.86 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 97.82 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 97.81 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.79 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 97.73 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 97.73 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 97.7 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 97.57 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.43 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 97.32 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 97.27 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.06 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.75 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=371.67 Aligned_cols=204 Identities=22% Similarity=0.340 Sum_probs=174.3
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|++.+.||+|+||.||+|+ ..+++.||+|+++.... ...+.+.+|+.++++++||||+++++++. .....
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCcee
Confidence 3579999999999999999999 45799999999975432 34567899999999999999999999984 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||+++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||+++++.+||+|
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~D 146 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISD 146 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECC
T ss_pred EEEEeccCCCcHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEcc
Confidence 99999999999999997654 5788999999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|+...............||+.|||||++.+..+ +.++|||||||++|||+||+.||.+..
T Consensus 147 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp CTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred chhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 999987654433333445679999999999988776 577999999999999999999997654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=369.50 Aligned_cols=200 Identities=22% Similarity=0.311 Sum_probs=177.4
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
++|++.+.||+|+||.||+|+ ..+|+.||+|+++.......+.+.+|+.++++++||||++++++|.. ....++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence 479999999999999999999 56799999999986666667889999999999999999999999843 456799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
||||+++|+|.+++... .+++.++..++.||+.||.||| ++||+||||||+|||++.++.+||+|||
T Consensus 95 vmEy~~gg~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG 161 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (293)
T ss_dssp EEECCTTCBHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEecCCCcHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccch
Confidence 99999999999988653 3678899999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|+.+..... ......||+.|+|||++.+..++.++|||||||++|+|+||..||.+..
T Consensus 162 ~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 162 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp TCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred hheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 9987644322 2234469999999999999999999999999999999999999997643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=367.19 Aligned_cols=206 Identities=30% Similarity=0.456 Sum_probs=169.8
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
|+...++|++.+.||+|+||.||+|+.. ..||||+++.. .....+.|.+|+.++.+++|||||++++++..
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----- 75 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----- 75 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-----
Confidence 4455678999999999999999999743 46999998743 33456789999999999999999999998632
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
...++||||+++|+|.+++..... .+++..++.++.||+.||+||| +++||||||||+|||++.++.+
T Consensus 76 -~~~~lv~Ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~ 143 (276)
T d1uwha_ 76 -PQLAIVTQWCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTV 143 (276)
T ss_dssp -SSCEEEEECCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSE
T ss_pred -cEEEEEEecCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCE
Confidence 346899999999999999976542 4778899999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||+|+...............||+.|||||++.+ ..++.++|||||||++|||+||+.||.+..
T Consensus 144 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp EECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred EEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 9999999987654443334445679999999999864 357899999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=362.93 Aligned_cols=199 Identities=26% Similarity=0.426 Sum_probs=175.2
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeec---CCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|+. .+++.||+|++.. .+......+.+|+.++++++||||+++++++. ....
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence 4688899999999999999994 5789999999863 23345678899999999999999999999984 4456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~ 148 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 148 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeecCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeec
Confidence 799999999999999997654 5778999999999999999999 8899999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+|+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 149 DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 149 DFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp CCCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 99999865432 2234569999999999999999999999999999999999999998753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=368.30 Aligned_cols=202 Identities=24% Similarity=0.398 Sum_probs=174.0
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeec---CCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|+. .+++.||||+++. .+....+.+.+|+.++++++||||++++++|. ....
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCE
Confidence 4699999999999999999994 5799999999863 23345678999999999999999999999973 4466
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||+++++.+||+
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~---------~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~ 150 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQIT 150 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEEEccCCCCHHHhhhccC---------CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEec
Confidence 799999999999999988655 5778999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||+||..||.+.
T Consensus 151 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 151 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp CCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 999998775544443444556999999999999999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=366.69 Aligned_cols=204 Identities=22% Similarity=0.278 Sum_probs=175.3
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.+.|++.+.||+|+||.||+|+ ..+++.||+|+++.......+.+.+|++++++++|||||++++++. .....+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~ 85 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLW 85 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEE
Confidence 3568889999999999999999 4578999999998766677788999999999999999999999984 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||+++|+|.+++..... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 86 lvmEy~~~g~L~~~~~~~~~--------~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DF 154 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELER--------PLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADF 154 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEec
Confidence 99999999999999764331 4778999999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
|+|+...... .......||+.|+|||++. +..++.++|||||||++|||+||+.||.+...
T Consensus 155 G~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 155 GVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp TTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred hhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence 9997653221 1122346999999999974 44678999999999999999999999987643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=362.38 Aligned_cols=210 Identities=23% Similarity=0.306 Sum_probs=163.0
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|++.+.||+|+||.||+|+ ..+|+.||+|.+..... ...+.+.+|++++++++||||+++++++.+ ......
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEE
Confidence 578999999999999999998 46789999999875432 234678899999999999999999998853 234557
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCC--CCCeEecCCCCCceeecCCCceEE
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC--QPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~--~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~-----~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl 155 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTK-----ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 155 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHH-----HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred EEEEecCCCCcHHHHHHhccc-----cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence 999999999999999864210 0014778999999999999999999421 134999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||+|+.+..... ......||+.|||||++.+..++.++|||||||++|||+||+.||.+..
T Consensus 156 ~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 156 GDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp CCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 99999987644222 2234568999999999999999999999999999999999999998753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=370.84 Aligned_cols=200 Identities=26% Similarity=0.342 Sum_probs=173.8
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
..++|++.+.||+|+||.||+|+ ..+++.||+|+++... ......+.+|+.+|++++|||||+++++|. ....
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 35689999999999999999999 4578999999997533 334567899999999999999999999984 3456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCC-CCeEecCCCCCceeecCCCceEE
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| + ++|+||||||+|||+++++.+||
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~---------~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl 146 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKL 146 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEcCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEE
Confidence 799999999999999997654 4778999999999999999999 5 48999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+|+...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+-
T Consensus 147 ~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 147 CDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred eeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999998653321 22346999999999999999999999999999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=352.05 Aligned_cols=199 Identities=25% Similarity=0.372 Sum_probs=168.6
Q ss_pred CCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEE
Q 017712 148 SSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (367)
Q Consensus 148 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (367)
+..++||+|+||.||+|+ ..+++.||+|.+.... ....+.+.+|++++++++|||||+++++|.... .+....++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEEE
Confidence 455689999999999999 4568899999987433 234567899999999999999999999985432 345667999
Q ss_pred EEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCCceeec-CCCceEEec
Q 017712 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLD-DEMIGHVGD 301 (367)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~--iiH~dlkp~Nil~~-~~~~~kl~D 301 (367)
|||+++|+|.+++.... .+++..+..++.||+.||+||| +++ |+||||||+|||++ +++.+||+|
T Consensus 91 mE~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~D 158 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGD 158 (270)
T ss_dssp EECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EeCCCCCcHHHHHhccc---------cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEee
Confidence 99999999999997654 4778899999999999999999 777 99999999999996 578999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|+..... ......||+.|||||++.+ .++.++|||||||++|||++|+.||.+..
T Consensus 159 FGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 159 LGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp TTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred cCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 9999854322 2234569999999999876 59999999999999999999999997653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-51 Score=361.11 Aligned_cols=211 Identities=24% Similarity=0.344 Sum_probs=179.2
Q ss_pred CCChHHHHhhcCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecc
Q 017712 134 NPSFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212 (367)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 212 (367)
.|.+++|+...++|++.+.||+|+||.||+|+. .+++.||||+++.. ....+.|.+|+.++++++|||||+++++|.
T Consensus 6 ~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~- 83 (287)
T d1opja_ 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT- 83 (287)
T ss_dssp STTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEe-
Confidence 455666777778899999999999999999995 46889999998743 345678999999999999999999999984
Q ss_pred cccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec
Q 017712 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (367)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~ 292 (367)
.....+++|||+++|+|.+++...... .+++..++.++.||+.||.||| +++|+||||||+|||++
T Consensus 84 ----~~~~~~iv~E~~~~g~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~ 149 (287)
T d1opja_ 84 ----REPPFYIITEFMTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVG 149 (287)
T ss_dssp ----SSSSCEEEEECCTTCBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred ----eCCeeEEEeecccCcchHHHhhhcccc-------chHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEEC
Confidence 345579999999999999999754322 5778899999999999999999 88999999999999999
Q ss_pred CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
.++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 150 ~~~~~Kl~DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 150 ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp GGGCEEECCCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCcEEEccccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 999999999999987644322 22233457899999999999999999999999999999999766653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=363.65 Aligned_cols=202 Identities=22% Similarity=0.274 Sum_probs=177.3
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
-++|++.+.||+|+||.||+|+ ..+++.||+|+++.. .....+.+.+|+.+|++++||||++++++| .+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 3578999999999999999999 567999999999732 234567889999999999999999999998 4456
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~---------~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl 146 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKI 146 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred ccccceeccCCCchhhhhhccc---------CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEE
Confidence 7899999999999999998755 5778899999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+-.
T Consensus 147 ~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 147 TDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 99999986543222 2233569999999999999999999999999999999999999998743
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-51 Score=362.69 Aligned_cols=202 Identities=22% Similarity=0.322 Sum_probs=159.9
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC-CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
..+.|++.+.||+|+||.||+|+ ..+++.||+|++.... ......+.+|+.++++++||||+++++++. ....
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-----SGGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 34569999999999999999999 4578999999997433 233466889999999999999999999983 4456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec---CCCce
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DEMIG 297 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~---~~~~~ 297 (367)
.++||||+++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||+. +++.+
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~v 149 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKG---------FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKI 149 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCE
T ss_pred EEEEEeccCCCcHHHhhhccc---------CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceE
Confidence 899999999999999998655 5788999999999999999999 89999999999999994 57899
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||+|+...... ......||+.|||||++.+..++.++|||||||++|||++|..||.+..
T Consensus 150 kl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 150 MISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp EECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 999999998654322 2233569999999999999999999999999999999999999998653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=350.82 Aligned_cols=202 Identities=25% Similarity=0.422 Sum_probs=164.3
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.++|++.+.||+|+||.||+|+..+++.||||+++.. ....+.|.+|++++++++||||++++++|.. ....++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~l 77 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL 77 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEE
Confidence 3578889999999999999999888889999998753 3356789999999999999999999999843 345799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
||||+++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+|||+++++.+||+|||
T Consensus 78 v~E~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFG 146 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFG 146 (263)
T ss_dssp EEECCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC
T ss_pred EEEecCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccc
Confidence 9999999999999876542 4678889999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~ 363 (367)
+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.
T Consensus 147 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 147 MTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp -------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred hheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 99876443222 2223458999999999999999999999999999999999 56666543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3e-50 Score=363.14 Aligned_cols=201 Identities=19% Similarity=0.327 Sum_probs=176.4
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
++|++.+.||+|+||.||+|+ ..+|+.||+|+++.........+.+|+.++++++||||++++++|. .....++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 469999999999999999999 4679999999997655445677889999999999999999999983 4566799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec--CCCceEEec
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD--DEMIGHVGD 301 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~--~~~~~kl~D 301 (367)
|||||++|+|.+++..... .+++.+++.++.||+.||.||| ++||+||||||+|||++ .++.+||+|
T Consensus 104 vmE~~~gg~L~~~~~~~~~--------~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~D 172 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIID 172 (352)
T ss_dssp EEECCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred EEEcCCCChHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEee
Confidence 9999999999998765432 4789999999999999999999 89999999999999997 678999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|+.+.... ......||+.|+|||++.+..++.++|||||||++|||+||..||.+..
T Consensus 173 FGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 173 FGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp CTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred cccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 99998765432 2334568999999999999999999999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-50 Score=358.56 Aligned_cols=198 Identities=29% Similarity=0.413 Sum_probs=174.7
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeec---CCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|+ ..+|+.||||+++. .+....+.+.+|+.++++++||||+++++++. ....
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence 468899999999999999999 46799999999863 23345678999999999999999999999983 4567
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+++|+|..++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~ 146 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKIT 146 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEEC
T ss_pred eeeEeeecCCccccccccccc---------cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEe
Confidence 899999999999999988765 4567888889999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+|+...... ....||+.|||||++.+..++.++|||||||++|||+||+.||.+..
T Consensus 147 DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 147 DFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp CCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 999998764322 23569999999999999999999999999999999999999998643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-50 Score=363.82 Aligned_cols=201 Identities=22% Similarity=0.377 Sum_probs=175.9
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
++|++.+.||+|+||.||+|+ ..+|+.||||++........+.+.+|+.++++++|||||+++++|. .....++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 479999999999999999999 4579999999997655556678899999999999999999999984 3456899
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec--CCCceEEec
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD--DEMIGHVGD 301 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~--~~~~~kl~D 301 (367)
|||||++|+|.+++..... .+++..+..++.||+.||.||| +++||||||||+|||++ .++.+||+|
T Consensus 101 vmE~~~gg~L~~~l~~~~~--------~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~D 169 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLID 169 (350)
T ss_dssp EECCCCSCBHHHHHTCTTS--------CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECC
T ss_pred EEEcCCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEee
Confidence 9999999999999965432 4789999999999999999999 89999999999999995 468899999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|+.+.... ......||+.|||||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 170 FG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 170 FGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp CTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence 99998764432 2334569999999999999999999999999999999999999998643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=353.98 Aligned_cols=205 Identities=26% Similarity=0.398 Sum_probs=173.1
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
|+...++|++.+.||+|+||.||+|+..+++.||||+++... ...+.|.+|+.++.+++|||||++++++.. .
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~ 80 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------E 80 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------C
Confidence 344557889999999999999999998888899999987433 356789999999999999999999998732 2
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++|+|.+++..... ..+++..++.|+.||+.||.||| +++|+||||||+|||+++++.+||
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~-------~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl 150 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSG-------IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKI 150 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHH-------HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred CeEEEEEeCCCCcHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceee
Confidence 35899999999999998765331 14778999999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCC-CCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP-SDG 362 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~P-f~~ 362 (367)
+|||+|+.+..... .......||+.|+|||++.+..++.++|||||||++|||+||..| |.+
T Consensus 151 ~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~ 213 (272)
T d1qpca_ 151 ADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (272)
T ss_dssp CCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccccceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 99999987654322 122234589999999999988999999999999999999996554 443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=351.00 Aligned_cols=201 Identities=21% Similarity=0.344 Sum_probs=174.5
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCC------cchhHHHHHHHHHHhCCCCCcceeeeeecccccC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP------GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++|||||+++++|.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~----- 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----- 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 45799999999999999999994 6799999999864321 23567999999999999999999999983
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM- 295 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~- 295 (367)
+....++|||||++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~~---------~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~ 151 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 151 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSS
T ss_pred ECCEEEEEEEcCCCccccchhcccc---------ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCC
Confidence 4566899999999999999997654 5778999999999999999999 89999999999999998776
Q ss_pred ---ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 296 ---IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 296 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
.+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 152 ~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 152 PKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp SSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 499999999987644322 223458999999999999999999999999999999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=341.78 Aligned_cols=203 Identities=25% Similarity=0.444 Sum_probs=177.3
Q ss_pred cCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
.++|++.++||+|+||.||+|+..+++.||||+++... ...+.|.+|+.++.+++||||++++++|. .....++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~i 76 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEE
Confidence 46899999999999999999998888899999998543 35678999999999999999999999984 3455799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
||||+++|+|.+++..... .+++..+..++.|+++||.||| +++|+||||||+|||++.++.+||+|||
T Consensus 77 v~Ey~~~g~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG 145 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFG 145 (258)
T ss_dssp EEECCTTEEHHHHHHSGGG--------CCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEccCCCcHHHhhhcccc--------CCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcch
Confidence 9999999999999766542 4667889999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+..
T Consensus 146 ~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 146 LSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp SCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred hheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 99876543322 2333458999999999999999999999999999999998 899998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=358.75 Aligned_cols=217 Identities=24% Similarity=0.335 Sum_probs=174.9
Q ss_pred HhhcCCCCCCCcccccCceEEEEEEec-CC-----CEEEEEEeecC-CCcchhHHHHHHHHHHhC-CCCCcceeeeeecc
Q 017712 141 YNATNGFSSANLIGAGNFGSVYNGTLF-DG-----TTIAVKVFNLI-RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSG 212 (367)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 212 (367)
+...++|++.++||+|+||+||+|+.. .+ ..||+|.+... .......+.+|+.++.++ +|||||+++++|.
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~- 111 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT- 111 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe-
Confidence 345568899999999999999999843 22 36899988633 334567899999999998 8999999999984
Q ss_pred cccCCceeeeEEEEeccCCCHHHHhhCCCCCCC--------------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCC
Q 017712 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW--------------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP 278 (367)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~ 278 (367)
.....++||||+++|+|.++|+....... ......+++..++.++.||+.||.||| +++
T Consensus 112 ----~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~ 184 (325)
T d1rjba_ 112 ----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKS 184 (325)
T ss_dssp ----SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred ----eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 34557999999999999999986542100 011124778999999999999999999 889
Q ss_pred eEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CC
Q 017712 279 IAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GI 357 (367)
Q Consensus 279 iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~ 357 (367)
||||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |.
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 99999999999999999999999999987655443333334457999999999999999999999999999999998 89
Q ss_pred CCCCCCCC
Q 017712 358 RPSDGIFT 365 (367)
Q Consensus 358 ~Pf~~~~~ 365 (367)
.||.+...
T Consensus 265 ~Pf~~~~~ 272 (325)
T d1rjba_ 265 NPYPGIPV 272 (325)
T ss_dssp CSSTTCCC
T ss_pred CCCCCCCH
Confidence 99988654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-50 Score=354.29 Aligned_cols=196 Identities=21% Similarity=0.293 Sum_probs=169.1
Q ss_pred CCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc---chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
.|+.++.||+|+||.||+|+ ..+++.||||+++..... ..+.+.+|+.++++++|||||+++++|. .....
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCEE
Confidence 48888999999999999998 567899999998754332 3356889999999999999999999984 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++|||||++|+|..++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 91 ~iv~E~~~~g~l~~~~~~~~---------~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~D 158 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGD 158 (309)
T ss_dssp EEEEECCSEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECC
T ss_pred EEEEEecCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEee
Confidence 99999999999987766544 5778999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|+..... ....||+.|||||++.+ ..++.++|||||||++|||++|..||.+..
T Consensus 159 FG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 159 FGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp CTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 9999865332 23459999999999864 458999999999999999999999997653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=352.52 Aligned_cols=205 Identities=23% Similarity=0.367 Sum_probs=171.3
Q ss_pred cCCCCCCC-cccccCceEEEEEEec---CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 144 TNGFSSAN-LIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 144 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
.++|.+.+ +||+|+||.||+|... ++..||||+++.... ...+.|.+|+++|++++|||||++++++..
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 80 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 80 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------
Confidence 34566666 4999999999999742 355799999874432 345789999999999999999999998732
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+++|+|.+++..... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~K 149 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAK 149 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEE
T ss_pred CeEEEEEEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCcee
Confidence 236899999999999999865432 4778999999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~~ 365 (367)
|+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||+| |..||.+...
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~ 218 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 218 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence 9999999877543322 22223458999999999998899999999999999999998 9999987643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-50 Score=353.56 Aligned_cols=204 Identities=26% Similarity=0.431 Sum_probs=160.4
Q ss_pred CCCCCCCcccccCceEEEEEEec-CC---CEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF-DG---TTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
++|++.++||+|+||.||+|+.. ++ ..||||.+..... ...+.|.+|+.+|++++|||||+++++|. ...
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KST 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eCC
Confidence 45777889999999999999843 33 2588888764332 34567999999999999999999999983 334
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..++||||+++|+|.+++..... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.+||
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~--------~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl 169 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKV 169 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEE
T ss_pred EEEEEEEecCCCcceeeeccccC--------CCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEE
Confidence 57999999999999999886542 4778899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcc---eeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQN---RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+|||+|+.+....... ......||+.|||||.+.+..++.++|||||||++|||+| |..||.+..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp CCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 9999998765432221 1223357899999999999999999999999999999998 899998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-49 Score=357.76 Aligned_cols=197 Identities=22% Similarity=0.309 Sum_probs=174.4
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeec---CCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
++|++.+.||+|+||.||+|+ ..+|+.||||++.. ......+.+.+|+.+|+.++||||+++++++. ....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----cccc
Confidence 479999999999999999999 45799999999863 22345677899999999999999999999973 4456
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++||||+.+|+|.+++.... .+++..+..++.||+.||.||| +++||||||||+|||++.++.+||+
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~---------~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~ 183 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVT 183 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred cccccccccccchhhhHhhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEee
Confidence 799999999999999997655 4778999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||+|+.+.... ....||+.|||||++.+..++.++|||||||++|||+||..||.+.
T Consensus 184 DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 184 DFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 999998764322 2345899999999999999999999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=346.68 Aligned_cols=196 Identities=26% Similarity=0.394 Sum_probs=164.7
Q ss_pred CcccccCceEEEEEEec---CCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
++||+|+||.||+|... .++.||||+++... ....+.|.+|+.++++++|||||+++++|.. ...++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 46999999999999843 34689999986432 2345679999999999999999999999732 2358999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
||+++|+|.+++.... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|
T Consensus 87 E~~~~g~L~~~l~~~~---------~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla 154 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 154 (277)
T ss_dssp ECCTTEEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EcCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhh
Confidence 9999999999998655 5778999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 306 RFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 306 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
+.+...... .......||+.|+|||.+.+..++.++|||||||++|||+| |..||.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 155 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred hhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 876543322 22234468999999999999999999999999999999998 899998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-49 Score=350.05 Aligned_cols=201 Identities=25% Similarity=0.350 Sum_probs=173.4
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC---CCcchhHHHHHHHHHH-hCCCCCcceeeeeecccccCCce
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAI-NIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
++|.+.+.||+|+||+||+|+ ..+++.||||+++.. .....+.+.+|..++. .++||||+++++++. ...
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-----~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-----cCC
Confidence 578899999999999999999 457999999999632 2344566777877765 689999999999983 455
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..|+||||+++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||+++++.+||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~---------~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl 144 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKI 144 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred ceeEEEeecCCCcHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceec
Confidence 6899999999999999998655 4678899999999999999999 889999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+-.
T Consensus 145 ~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 145 ADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp CCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccchhhhccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 999999865443222 233469999999999999999999999999999999999999998743
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.8e-49 Score=344.39 Aligned_cols=208 Identities=24% Similarity=0.379 Sum_probs=170.9
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc---chhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
.++|++.+.||+|+||.||+|+ ..+++.||+|+++..... ....+.+|+.++++++||||+++++++...+ ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 4679999999999999999999 467999999999753332 3457899999999999999999999986532 3345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..|+||||+++++|.+++.... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++..++
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~---------~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l 152 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKV 152 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEE
T ss_pred eEEEEEECCCCCEehhhhcccC---------CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCcccccee
Confidence 6799999999999999987655 5778999999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCC-cceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 300 GDFGMARFLPAIDK-QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+|||.+........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||.+..
T Consensus 153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 99999876543222 223334569999999999999999999999999999999999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=349.65 Aligned_cols=202 Identities=20% Similarity=0.321 Sum_probs=171.2
Q ss_pred cCCCCCCC-cccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCcee
Q 017712 144 TNGFSSAN-LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 144 ~~~~~~~~-~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.++|.+.. .||+|+||.||+|+ ..+++.||||+++. ...+.+|+.++.++ +||||++++++|.+.. .....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCE
Confidence 35788765 59999999999999 46799999999863 46788999987655 8999999999985422 34567
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC---CCce
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EMIG 297 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~---~~~~ 297 (367)
.|+|||||+||+|.+++...... .+++.++..++.||+.||+||| +++|+||||||+|||++. ++.+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~-------~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~ 153 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL 153 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCC-------CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCE
T ss_pred EEEEEECCCCCcHHHHHHhcCCC-------CcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccc
Confidence 89999999999999999865321 5889999999999999999999 899999999999999975 5679
Q ss_pred EEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+..
T Consensus 154 Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 154 KLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp EECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred cccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 9999999987654322 234569999999999999999999999999999999999999997643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-48 Score=353.59 Aligned_cols=200 Identities=24% Similarity=0.300 Sum_probs=168.0
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC---CcchhHHHH---HHHHHHhCCCCCcceeeeeecccccC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKS---ECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
-++|++.++||+|+||.||+|+ ..+|+.||+|++.... ......+.+ |+.+++.++|||||+++++|.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~----- 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH----- 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----
Confidence 3679999999999999999999 4579999999986321 112233444 466777788999999999983
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
.....|+||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~ 145 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGH 145 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSC
T ss_pred ECCEEEEEEEecCCCcHHHHHHhcc---------cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCc
Confidence 3456799999999999999997654 4678899999999999999999 899999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+||+|||+|+.+.... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.+..
T Consensus 146 iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 146 VRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp EEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred EEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 9999999998764432 223469999999999875 568999999999999999999999998643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=348.10 Aligned_cols=204 Identities=25% Similarity=0.430 Sum_probs=168.0
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCC----EEEEEEeec-CCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGT----TIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (367)
++|++.++||+|+||.||+|.. .+|+ +||+|.++. ......+.|.+|+.++++++|||||+++++|..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 4699999999999999999984 3444 588898863 333456789999999999999999999999843
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++++||+.+|+|.+++..... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~k 151 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVK 151 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEE
T ss_pred CCeeEEEEeccCCccccccccccc--------CCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeE
Confidence 235788999999999998876542 4778899999999999999999 88999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~~ 365 (367)
|+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |.+||++...
T Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~ 219 (317)
T d1xkka_ 152 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219 (317)
T ss_dssp ECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred eeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH
Confidence 999999998765444444444568999999999999999999999999999999998 8999987643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=341.81 Aligned_cols=203 Identities=26% Similarity=0.388 Sum_probs=161.3
Q ss_pred cCCCCCCCcccccCceEEEEEEecC-C----CEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTLFD-G----TTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
.+.|+..++||+|+||.||+|...+ + ..||||+++.... .....|.+|+.++++++|||||++++++. .
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~ 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----K 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----c
Confidence 3567888999999999999998543 2 4799999864333 23457899999999999999999999983 3
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....+++|||+.+++|.+++..... .+++.+++.++.|++.||.||| +++|+||||||+|||++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~ 149 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVC 149 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred CCceEEEEEecccCcchhhhhcccc--------cccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeE
Confidence 4557999999999999998865432 4778899999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCc-ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCC-CCC
Q 017712 298 HVGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP-SDG 362 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~P-f~~ 362 (367)
||+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||++|..| |.+
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~ 216 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc
Confidence 99999999876543222 222334589999999999999999999999999999999996555 444
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.6e-48 Score=336.73 Aligned_cols=200 Identities=24% Similarity=0.336 Sum_probs=172.5
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcc---------hhHHHHHHHHHHhCC-CCCcceeeeeeccc
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG---------SKSFKSECKAAINIK-HRNIVRVFTAFSGV 213 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 213 (367)
++|++.+.||+|+||+||+|+ ..+++.||||+++...... .+.+.+|+.++++++ ||||+++++++.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 80 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-- 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence 578999999999999999999 4578999999997543221 235889999999997 999999999983
Q ss_pred ccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
+....|+||||+++|+|.+++.... .+++.+++.++.||+.||+||| +++|+||||||+|||++.
T Consensus 81 ---~~~~~~ivmE~~~~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~ 145 (277)
T d1phka_ 81 ---TNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDD 145 (277)
T ss_dssp ---CSSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred ---cCcceEEEEEcCCCchHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcC
Confidence 4567899999999999999997654 5789999999999999999999 889999999999999999
Q ss_pred CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG------CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
++.+||+|||+++.+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|..||.+..
T Consensus 146 ~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 146 DMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp TCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 99999999999987654322 233468999999998753 356889999999999999999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=344.47 Aligned_cols=201 Identities=22% Similarity=0.311 Sum_probs=173.2
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
.++|++.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+.+|++++||||++++++|. .....|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence 35799999999999999999994 578999999987532 34456889999999999999999999984 345689
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC--CCceEEe
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD--EMIGHVG 300 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~--~~~~kl~ 300 (367)
+|||||++|+|.+++..... .+++.++..++.||+.||.||| +++|+||||||+|||++. ...+||+
T Consensus 78 lvmE~~~gg~L~~~i~~~~~--------~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~ 146 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKII 146 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred EEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEc
Confidence 99999999999999976542 4788999999999999999999 899999999999999974 4589999
Q ss_pred ccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
|||+++...... ......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+-.
T Consensus 147 DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 147 EFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp CCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence 999998764322 2334458999999999999999999999999999999999999997643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-48 Score=347.13 Aligned_cols=222 Identities=24% Similarity=0.361 Sum_probs=180.0
Q ss_pred CChHHHHhhcCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceee
Q 017712 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVF 207 (367)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~ 207 (367)
|.+.+++...++|++.+.||+|+||.||+|+.. +++.||||+++..... ..+.|.+|+.++++++||||++++
T Consensus 3 p~~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 3 PKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp HHHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cchhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccce
Confidence 445666667789999999999999999999843 3578999998743332 356799999999999999999999
Q ss_pred eeecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCC---------------CcchhhhHHHHHHHHHHHHHHHHHhh
Q 017712 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR---------------PLNFNFLIKKKLDIAIDVACALRYLH 272 (367)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~---------------~~~~~~~~~~~~~i~~~i~~~L~~lH 272 (367)
++|. .....+++|||+++|+|.+++......... .....+++..++.|+.|++.||+|||
T Consensus 83 ~~~~-----~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH 157 (301)
T d1lufa_ 83 GVCA-----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 157 (301)
T ss_dssp EEEC-----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eeec-----cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc
Confidence 9984 345579999999999999999754321100 01123678899999999999999999
Q ss_pred hCCCCCeEecCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHH
Q 017712 273 CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLE 352 (367)
Q Consensus 273 ~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~e 352 (367)
+++||||||||+|||++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++||
T Consensus 158 ---~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 158 ---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234 (301)
T ss_dssp ---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ---cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence 88999999999999999999999999999987655444444445568999999999999999999999999999999
Q ss_pred HHhCC-CCCCCCC
Q 017712 353 MFTGI-RPSDGIF 364 (367)
Q Consensus 353 l~tg~-~Pf~~~~ 364 (367)
|++|. +||.+..
T Consensus 235 ll~~~~~p~~~~~ 247 (301)
T d1lufa_ 235 IFSYGLQPYYGMA 247 (301)
T ss_dssp HHTTTCCTTTTSC
T ss_pred HHccCCCCCCCCC
Confidence 99985 6787654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=342.49 Aligned_cols=201 Identities=25% Similarity=0.423 Sum_probs=165.9
Q ss_pred hhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
...++|++.+.||+|+||.||+|+..+++.||||+++.. ....+.|.+|+.++++++|||||++++++.+ ...
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~ 86 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI 86 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCe
Confidence 345689999999999999999999888888999998743 3456789999999999999999999999732 235
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||+++|+|.+++...... .+++.+++.++.||+.||.||| +++|+||||||+|||+++++.+||+|
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~-------~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~D 156 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 156 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEEecCCCchhhhhhhcccc-------cchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcc
Confidence 8999999999999988653211 4778999999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf 360 (367)
||+|+........ ......||+.|+|||++....++.++|||||||++|||+||..||
T Consensus 157 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~ 214 (285)
T d1fmka3 157 FGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 214 (285)
T ss_dssp CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCC
Confidence 9999876433222 223345899999999999999999999999999999999965554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=339.42 Aligned_cols=206 Identities=20% Similarity=0.338 Sum_probs=162.4
Q ss_pred hhcCCCCCCCcccccCceEEEEEEecC----CCEEEEEEeecCCCc-chhHHHHHHHHHHhCCCCCcceeeeeecccccC
Q 017712 142 NATNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (367)
...++|++.+.||+|+||.||+|+... +..||+|.++..... ..+.+.+|+.++++++||||+++++++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---- 79 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---- 79 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec----
Confidence 345689999999999999999998432 346888887643332 35679999999999999999999999732
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
...++||||+++|+|.+++..... .+++..++.++.||+.||.||| +++|+||||||+||+++.++.
T Consensus 80 --~~~~iv~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~ 146 (273)
T d1mp8a_ 80 --NPVWIIMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDC 146 (273)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTE
T ss_pred --CeEEEEEEeccCCcHHhhhhccCC--------CCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCc
Confidence 346899999999999998765432 4778999999999999999999 899999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~~ 365 (367)
+||+|||+|+.+...... ......||+.|+|||.+.+..++.++|||||||++|||+| |.+||.+...
T Consensus 147 ~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~ 215 (273)
T d1mp8a_ 147 VKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215 (273)
T ss_dssp EEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred EEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH
Confidence 999999999876443222 2234458999999999999999999999999999999998 8999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=338.83 Aligned_cols=195 Identities=23% Similarity=0.318 Sum_probs=161.8
Q ss_pred CCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc-----chhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 150 ANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG-----GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 150 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
+++||+|+||+||+|+ ..+|+.||||+++..... ..+.+.+|+.++++++|||||+++++|. .....++
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~i 77 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----HKSNISL 77 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-----cCCceee
Confidence 4689999999999999 567999999998643221 2457899999999999999999999984 3456799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccc
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 303 (367)
||||++++++..+..... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 78 vmE~~~~~~~~~~~~~~~---------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG 145 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFG 145 (299)
T ss_dssp EEECCSEEHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred hhhhhcchHHhhhhhccc---------CCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCc
Confidence 999998887776665443 4667889999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|+........ .....||+.|+|||++.+. .++.++|||||||++|||+||.+||.+.
T Consensus 146 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 146 LAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp GGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 99866443222 2234589999999998754 5799999999999999999999999764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=335.85 Aligned_cols=201 Identities=27% Similarity=0.408 Sum_probs=164.6
Q ss_pred hcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
..++|++.+.||+|+||.||+|+. .|+.||||+++. ....+.+.+|+.++++++||||++++++|. +.....+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcEE
Confidence 345678889999999999999986 578899999864 345678999999999999999999999874 3334569
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
+||||+++|+|.+++..... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 78 lv~ey~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~df 147 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDF 147 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHH-------HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EEEeccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeeccc
Confidence 99999999999999975321 14678999999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~~ 365 (367)
|+++..... .....+|+.|+|||++.+..+++++|||||||++|||+| |++||.+...
T Consensus 148 g~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~ 206 (262)
T d1byga_ 148 GLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206 (262)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred ccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH
Confidence 999865332 122347899999999999999999999999999999998 7889887643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-48 Score=340.87 Aligned_cols=220 Identities=24% Similarity=0.324 Sum_probs=168.7
Q ss_pred HHHHhhcCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhC-CCCCcceeeee
Q 017712 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTA 209 (367)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 209 (367)
..|....++|++.+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|..++.++ +||||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 455556678999999999999999999832 246899999874332 3456678888888777 68999999998
Q ss_pred ecccccCCceeeeEEEEeccCCCHHHHhhCCCCCC-------CCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEec
Q 017712 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN-------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHC 282 (367)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~ 282 (367)
+. ......+++||||++|+|.++++...... .......+++.+++.++.||+.||.||| +++|+||
T Consensus 86 ~~----~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHr 158 (299)
T d1ywna1 86 CT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR 158 (299)
T ss_dssp EC----STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred ec----cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCC
Confidence 73 33456799999999999999997543110 0011224788999999999999999999 8899999
Q ss_pred CCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhC-CCCCC
Q 017712 283 NLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG-IRPSD 361 (367)
Q Consensus 283 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg-~~Pf~ 361 (367)
||||+|||+++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+|| .+||.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876554443333445689999999999999999999999999999999986 56887
Q ss_pred CCC
Q 017712 362 GIF 364 (367)
Q Consensus 362 ~~~ 364 (367)
+..
T Consensus 239 ~~~ 241 (299)
T d1ywna1 239 GVK 241 (299)
T ss_dssp TCC
T ss_pred CCC
Confidence 654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-47 Score=335.53 Aligned_cols=207 Identities=21% Similarity=0.291 Sum_probs=171.9
Q ss_pred cCCCCCCCcccccCceEEEEEEe-cC-CCEEEEEEeecC--CCcchhHHHHHHHHHHhC---CCCCcceeeeeecccccC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGTL-FD-GTTIAVKVFNLI--RPGGSKSFKSECKAAINI---KHRNIVRVFTAFSGVDYQ 216 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~ 216 (367)
.++|++++.||+|+||.||+|+. .+ ++.||||+++.. .......+.+|+.+++.+ +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999984 44 567999998642 233445677888887766 799999999998665555
Q ss_pred CceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCc
Q 017712 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (367)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~ 296 (367)
.....+++|||++++++......... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT--------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCC
Confidence 66788999999988777555443332 4678889999999999999999 899999999999999999999
Q ss_pred eEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~ 364 (367)
+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 155 ~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 155 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 9999999998653322 2234569999999999999999999999999999999999999998653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=335.57 Aligned_cols=201 Identities=25% Similarity=0.387 Sum_probs=166.0
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|++.+.||+|+||.||+|+ ..+++.||+|+++... ....+.+.+|++++++++||||++++++|. .....
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 578999999999999999999 4679999999996433 234678999999999999999999999984 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
++||||+.+ ++.+++...... .+++..+..++.|++.||+||| +++||||||||+|||++.++.+||+|
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~~~-------~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~D 145 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLAD 145 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECS
T ss_pred eEEEeecCC-chhhhhhhhccc-------CCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceecc
Confidence 999999965 555554332211 4788999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|+....... ......||+.|+|||.+.... .+.++|||||||++|+|++|+.||.+.
T Consensus 146 FG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 146 FGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp TTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCcceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 999986643222 222345899999999877765 478999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=332.24 Aligned_cols=198 Identities=22% Similarity=0.320 Sum_probs=166.3
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc------chhHHHHHHHHHHhCC--CCCcceeeeeecccc
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIK--HRNIVRVFTAFSGVD 214 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 214 (367)
.++|++.+.||+|+||.||+|+ ..+++.||||+++..... ....+.+|+.++++++ ||||+++++++.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--- 79 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--- 79 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe---
Confidence 4679999999999999999999 457999999998743221 2345679999999986 899999999983
Q ss_pred cCCceeeeEEEEeccC-CCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC
Q 017712 215 YQGARFKAVVYKFMPN-GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (367)
Q Consensus 215 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~ 293 (367)
.....++||||+.+ +++.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.
T Consensus 80 --~~~~~~lv~e~~~~~~~l~~~~~~~~---------~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~ 145 (273)
T d1xwsa_ 80 --RPDSFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDL 145 (273)
T ss_dssp --CSSEEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEET
T ss_pred --eCCeEEEEEEeccCcchHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEec
Confidence 44567999999975 68888887654 5778999999999999999999 899999999999999985
Q ss_pred -CCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 294 -EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 294 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
++.+||+|||+|+..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.+
T Consensus 146 ~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 146 NRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp TTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 479999999999865332 2223569999999999987765 5678999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=331.32 Aligned_cols=203 Identities=30% Similarity=0.433 Sum_probs=161.8
Q ss_pred CCCCCCCcccccCceEEEEEEec--CC--CEEEEEEeecC---CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCC
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLF--DG--TTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (367)
++|++.+.||+|+||.||+|+.. ++ ..||||+++.. .....+.|.+|+.++++++||||++++++|..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 46888999999999999999842 22 36899988643 23345689999999999999999999999843
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
...++||||+++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~v 150 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 150 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEE
T ss_pred -cchheeeeeecCcchhhhhhcccC--------CCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccce
Confidence 235899999999999998765432 5788999999999999999999 8899999999999999999999
Q ss_pred EEeccccccccCCCCCcce-eeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQNR-FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~~~~ 364 (367)
||+|||+++.......... .....|+..|+|||.+.+..++.++|||||||++|||+| |..||.+..
T Consensus 151 kl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 9999999997754433222 223347889999999999999999999999999999998 899998754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-46 Score=330.19 Aligned_cols=200 Identities=23% Similarity=0.343 Sum_probs=168.2
Q ss_pred CCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCC--CcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|++.+.||+|+||.||+|+..+++.||||+++... ....+.+.+|+.+|++++||||++++++|. .....+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ 76 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRLV 76 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCcee
Confidence 5788999999999999999998889999999996432 234578999999999999999999999984 345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEecc
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Df 302 (367)
++|||+.++.+..+..... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 77 i~~e~~~~~~~~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~Df 144 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADF 144 (286)
T ss_dssp EEEECCSEEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCT
T ss_pred EEEEeehhhhHHHHHhhcC---------CcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEeccc
Confidence 9999998777766665444 5789999999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|.|........ ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.
T Consensus 145 G~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 145 GLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp THHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 99987643322 22334589999999998765 4689999999999999999999999765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=331.35 Aligned_cols=202 Identities=23% Similarity=0.340 Sum_probs=161.7
Q ss_pred CCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHH--HHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 146 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKS--ECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
+|.+.+.||+|+||.||+|+. +|+.||||+++.. ....+.+ |+..+.+++||||+++++++...+ ......++
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~l 78 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEE
Confidence 466778899999999999984 6889999998632 2334444 444556789999999999986543 33456799
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCC-----CCCeEecCCCCCceeecCCCceE
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC-----QPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~-----~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
||||+++|+|.++++.. .+++..++.++.|++.||.|||+.. +++|+||||||+|||++.++.+|
T Consensus 79 v~Ey~~~g~L~~~l~~~----------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K 148 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp EEECCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred EEecccCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence 99999999999999864 3668889999999999999999321 36999999999999999999999
Q ss_pred EeccccccccCCCCCcc--eeeeccCCCcccCCccccCCC------CCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQN--RFICIKGSTGYIPPEYDLGCE------ASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
|+|||+++......... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||..
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 99999998765433221 223456999999999987643 56789999999999999999988754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=331.75 Aligned_cols=217 Identities=25% Similarity=0.348 Sum_probs=173.3
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEec-C-------CCEEEEEEeecCCC-cchhHHHHHHHHHHhC-CCCCcceeeee
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTLF-D-------GTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTA 209 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 209 (367)
|....++|.+.+.||+|+||.||+|+.. . +..||||+++.... .....+.+|...+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 4455678999999999999999999832 2 24799999875433 2446788899999888 79999999999
Q ss_pred ecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC-------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEec
Q 017712 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHC 282 (367)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~ 282 (367)
|.+ ....++||||+++|+|.+++........ ......+++..++.++.||+.||.||| +++||||
T Consensus 88 ~~~-----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHr 159 (299)
T d1fgka_ 88 CTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHR 159 (299)
T ss_dssp ECS-----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred ccc-----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEee
Confidence 843 3557999999999999999976542110 011124788999999999999999999 8999999
Q ss_pred CCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 017712 283 NLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSD 361 (367)
Q Consensus 283 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf~ 361 (367)
||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |.+||.
T Consensus 160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp CCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 9999999999999999999999997765444444445568999999999999999999999999999999998 799997
Q ss_pred CCC
Q 017712 362 GIF 364 (367)
Q Consensus 362 ~~~ 364 (367)
+..
T Consensus 240 ~~~ 242 (299)
T d1fgka_ 240 GVP 242 (299)
T ss_dssp TCC
T ss_pred CCC
Confidence 654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=327.55 Aligned_cols=197 Identities=28% Similarity=0.433 Sum_probs=164.6
Q ss_pred CcccccCceEEEEEEecCC----CEEEEEEeecC-CCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeEEE
Q 017712 151 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (367)
++||+|+||+||+|+..++ ..||||+++.. .....+.|.+|++++++++||||+++++++.. .....++||
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv~ 108 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVVL 108 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEEE
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEEE
Confidence 6799999999999985332 35899998743 33355789999999999999999999999743 334579999
Q ss_pred EeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEeccccc
Q 017712 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (367)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 305 (367)
|||++|+|.+++..... .+++..++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 109 E~~~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA 177 (311)
T ss_dssp ECCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGG
T ss_pred EEeecCchhhhhccccc--------cchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccch
Confidence 99999999999886543 3556788999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCCc--ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 017712 306 RFLPAIDKQ--NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (367)
Q Consensus 306 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~ 362 (367)
+........ .......||+.|+|||.+.+..++.++||||||+++|||+||..||..
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred hhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 876443222 122234589999999999999999999999999999999998777754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=331.61 Aligned_cols=218 Identities=26% Similarity=0.346 Sum_probs=178.8
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEEe------cCCCEEEEEEeecCCC-cchhHHHHHHHHHHhC-CCCCcceeeeee
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAF 210 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 210 (367)
.|....++|++.++||+|+||.||+|+. .+++.||||+++.... .....+.+|+.+++++ +|||||+++++|
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 4555667899999999999999999974 3457899999975433 3455789999999999 699999999998
Q ss_pred cccccCCceeeeEEEEeccCCCHHHHhhCCCCCCC---------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEe
Q 017712 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAH 281 (367)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH 281 (367)
. .....+++|||+++|+|.++++....... ......+++..++.++.||+.||.||| +++++|
T Consensus 97 ~-----~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivH 168 (311)
T d1t46a_ 97 T-----IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIH 168 (311)
T ss_dssp C-----SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred e-----eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 4 34557999999999999999976542111 011224778999999999999999999 889999
Q ss_pred cCCCCCceeecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 017712 282 CNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPS 360 (367)
Q Consensus 282 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~Pf 360 (367)
|||||+||+++.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||
T Consensus 169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence 99999999999999999999999997765544444445568999999999999999999999999999999999 66666
Q ss_pred CCCC
Q 017712 361 DGIF 364 (367)
Q Consensus 361 ~~~~ 364 (367)
.+..
T Consensus 249 ~~~~ 252 (311)
T d1t46a_ 249 PGMP 252 (311)
T ss_dssp TTCC
T ss_pred CCCC
Confidence 6543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=331.44 Aligned_cols=207 Identities=20% Similarity=0.273 Sum_probs=168.6
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCcee
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (367)
.+++|++.+.||+|+||+||+|+ ..+++.||||+++.... ...+.+.+|+.+|++++||||+++++++..........
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 45679999999999999999998 56899999999874332 23567889999999999999999999986544433444
Q ss_pred eeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEe
Q 017712 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (367)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~ 300 (367)
.++ ++|+.+|+|.+++... .+++..+..++.|++.||+||| +++||||||||+|||++.++.+||+
T Consensus 86 ~~l-~~~~~~g~L~~~l~~~----------~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~ 151 (345)
T d1pmea_ 86 VYL-VTHLMGADLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKIC 151 (345)
T ss_dssp EEE-EEECCCEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEE-EEeecCCchhhhhhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEc
Confidence 445 4566799999999754 3778999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCc-ceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 301 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
|||+|+........ .......||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 99999866443222 12234458999999999854 46789999999999999999999999764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=328.39 Aligned_cols=209 Identities=24% Similarity=0.379 Sum_probs=166.3
Q ss_pred CCCCCCCcccccCceEEEEEEe-cCCC--EEEEEEeecC-CCcchhHHHHHHHHHHhC-CCCCcceeeeeecccccCCce
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL-FDGT--TIAVKVFNLI-RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 219 (367)
++|++.++||+|+||.||+|+. .++. .||||.++.. .....+.+.+|++++.++ +||||++++++|. ...
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----cCC
Confidence 5788889999999999999984 3444 4778887533 334567899999999998 7999999999984 345
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCC-------CCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~ 292 (367)
..++||||+++|+|.++++....... ......+++..++.++.||+.||.||| +++|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEc
Confidence 67999999999999999976521000 001115778999999999999999999 88999999999999999
Q ss_pred CCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCC
Q 017712 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGI-RPSDGIF 364 (367)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~-~Pf~~~~ 364 (367)
.++.+||+|||+|+........ ....||+.|+|||.+.+..++.++|||||||++|||++|. +||.+..
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999865432222 2345899999999999999999999999999999999965 5787643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=331.15 Aligned_cols=218 Identities=24% Similarity=0.355 Sum_probs=176.1
Q ss_pred HHHhhcCCCCCCCcccccCceEEEEEEec------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhCCCCCcceeeeeec
Q 017712 139 DLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFS 211 (367)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 211 (367)
+|+...++|++.+.||+|+||.||+|... +++.||||+++.... .....|.+|+.++++++||||++++++|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 45556678999999999999999999842 357899999874322 23456899999999999999999999983
Q ss_pred ccccCCceeeeEEEEeccCCCHHHHhhCCCCCC-CCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCcee
Q 017712 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN-WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (367)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil 290 (367)
.....++||||+++|+|.+++....... .......+++..+..++.|++.||.||| +++|+||||||+|||
T Consensus 94 -----~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiL 165 (308)
T d1p4oa_ 94 -----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCM 165 (308)
T ss_dssp -----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEE
T ss_pred -----cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCcee
Confidence 3445799999999999999986432100 0000113567889999999999999999 889999999999999
Q ss_pred ecCCCceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCC
Q 017712 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG-IRPSDGIF 364 (367)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg-~~Pf~~~~ 364 (367)
++.++++||+|||+|+.+.............||+.|+|||.+.+..++.++||||||+++|||+|| ..||.+..
T Consensus 166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999876554433333344589999999999999999999999999999999998 57887654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-44 Score=319.88 Aligned_cols=203 Identities=21% Similarity=0.335 Sum_probs=170.7
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCC-CCcceeeeeecccccCCceee
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH-RNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 221 (367)
.++|++.+.||+|+||.||+|+ ..+++.||||+++.. .....+.+|++++..++| +|++.+++++. .....
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCcc
Confidence 4689999999999999999999 457899999988643 234568899999999976 89999998863 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecC-----CCc
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-----EMI 296 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~-----~~~ 296 (367)
++||||+ +++|.+++..... .++...+..++.|++.||.||| ++||+||||||+|||++. ++.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~--------~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~ 144 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANM 144 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTC
T ss_pred EEEEEec-CCCHHHHHHhhcc--------chhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCc
Confidence 9999999 7899999876442 4678889999999999999999 999999999999999964 578
Q ss_pred eEEeccccccccCCCCCc-----ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 297 GHVGDFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
+||+|||+|+.+...... .......||+.|||||.+.+..++.++|||||||++|||+||..||.+...
T Consensus 145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred eEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 999999999876543221 122345699999999999999999999999999999999999999987543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-45 Score=324.43 Aligned_cols=208 Identities=23% Similarity=0.303 Sum_probs=167.3
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecC--CCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc---CC
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY---QG 217 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 217 (367)
.++|++.+.||+|+||+||+|+ ..+|+.||||++... .......+.+|+.+|++++||||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4689999999999999999999 467999999998633 33456788999999999999999999999854321 12
Q ss_pred ceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCce
Q 017712 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (367)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~ 297 (367)
....+++|||+.++.+..+..... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCE
T ss_pred CceEEEEEeccCCCccchhhhccc---------ccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcE
Confidence 345799999998776665544333 4677888999999999999999 8999999999999999999999
Q ss_pred EEeccccccccCCCCCc--ceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 298 HVGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 298 kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|||+++........ .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||++.
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 99999999876543221 122234589999999998765 6899999999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=325.87 Aligned_cols=199 Identities=26% Similarity=0.353 Sum_probs=162.3
Q ss_pred CCCCCCcccccCceEEEEEEe-cCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCceeeeE
Q 017712 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGARFKAV 223 (367)
Q Consensus 146 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~l 223 (367)
+|+..++||+|+||+||+|+. .+++.||||++..... ...+|+.+|++++||||++++++|..... .+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 577888999999999999994 5799999999875332 23479999999999999999999854322 34556799
Q ss_pred EEEeccCCCHHHHh---hCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-ceEE
Q 017712 224 VYKFMPNGSLEEWL---RGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IGHV 299 (367)
Q Consensus 224 v~e~~~~g~L~~~l---~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~-~~kl 299 (367)
||||++++.+..+. .... .+++.++..++.||+.||+||| ++||+||||||+|||++.++ .+||
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~---------~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQ---------TLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEE
T ss_pred EEeccCCccHHHHHhhhhccC---------CCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeE
Confidence 99999765433332 2222 5788999999999999999999 89999999999999999775 8999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++........ ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 165 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 165 CDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp CCCTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred ecccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 999999876443322 23458999999998765 46899999999999999999999999764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=327.00 Aligned_cols=202 Identities=21% Similarity=0.293 Sum_probs=165.1
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCc
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (367)
..++|++.+.||+|+||.||+|+ ..+++.||||+++.... ...+.+.+|+.+|++++|||||+++++|...+. ...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 45789999999999999999999 45799999999974322 234678899999999999999999999865432 233
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceE
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~k 298 (367)
...++||||+ +.+|..+++.. .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE----------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred ceEEEEEecc-cccHHHHHHhc----------cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccc
Confidence 4569999999 66888877643 3778999999999999999999 89999999999999999999999
Q ss_pred EeccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
++|||+|+..... .....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.
T Consensus 162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 9999999865332 2334589999999998764 5689999999999999999999999764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-44 Score=317.83 Aligned_cols=203 Identities=23% Similarity=0.350 Sum_probs=165.8
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceeeeE
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (367)
++|++.+.||+|+||.||+|+ ..+++.||||++.... ....+.+|+++++.++|+|++..+..+. ......++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEE
Confidence 579999999999999999998 4678999999987432 3456889999999998887766665542 34456789
Q ss_pred EEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeec---CCCceEEe
Q 017712 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DEMIGHVG 300 (367)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~---~~~~~kl~ 300 (367)
||||+ +++|.+.+..... .+++..++.++.|++.||+||| +++|+||||||+|||++ .+..+||+
T Consensus 81 vme~~-~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp EEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred EEEEc-CCchhhhhhhccC--------CCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeee
Confidence 99999 5677776654332 4778999999999999999999 89999999999999875 45679999
Q ss_pred ccccccccCCCCCc-----ceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 301 DFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 301 Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
|||+|+.+...... .......||+.|||||.+.+..++.++|||||||++|||+||..||.+...
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence 99999877543221 122345699999999999999999999999999999999999999987543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-45 Score=324.30 Aligned_cols=203 Identities=22% Similarity=0.313 Sum_probs=170.0
Q ss_pred CCCCCCCcccccCceEEEEEEe----cCCCEEEEEEeecCC----CcchhHHHHHHHHHHhCCC-CCcceeeeeeccccc
Q 017712 145 NGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINIKH-RNIVRVFTAFSGVDY 215 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 215 (367)
++|++.+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+.++++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---- 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---- 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec----
Confidence 5699999999999999999983 247899999986322 2345678899999999977 89999999974
Q ss_pred CCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC
Q 017712 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (367)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~ 295 (367)
.....+++|||+.+|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++
T Consensus 100 -~~~~~~~v~e~~~~~~L~~~i~~~~---------~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~ 166 (322)
T d1vzoa_ 100 -TETKLHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNG 166 (322)
T ss_dssp -ETTEEEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTS
T ss_pred -cCCceeeeeecccccHHHHHHHhcc---------cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCC
Confidence 3456799999999999999997665 3567888899999999999999 88999999999999999999
Q ss_pred ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 017712 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC--EASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (367)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~Pf~~~~~ 365 (367)
.+||+|||+|+.+...... ......|++.|+|||.+.+. .++.++|||||||+||||+||+.||.+...
T Consensus 167 ~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~ 237 (322)
T d1vzoa_ 167 HVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237 (322)
T ss_dssp CEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred CEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999876443322 22345689999999998765 468899999999999999999999987643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-43 Score=318.41 Aligned_cols=195 Identities=21% Similarity=0.291 Sum_probs=166.3
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCceeee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKA 222 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 222 (367)
++|++.++||+|+||+||+|+ ..+++.||+|+++. ...+.+.+|+.+|..++ ||||++++++|.. ......+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence 579999999999999999999 46799999999863 34678899999999995 9999999999853 3345679
Q ss_pred EEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCC-ceEEec
Q 017712 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IGHVGD 301 (367)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~-~~kl~D 301 (367)
+||||+++++|..+.+ .+++..+..++.||+.||.||| +++|+||||||+|||++.++ .+||+|
T Consensus 109 ~v~e~~~~~~L~~~~~------------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~D 173 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLID 173 (328)
T ss_dssp EEEECCCSCBGGGTTT------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEeecCCCcHHHHhc------------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecc
Confidence 9999999999977643 4678899999999999999999 89999999999999998654 689999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
||+|+....... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 174 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 174 WGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp GGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 999987644322 2334589999999998765 4799999999999999999999999654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=313.07 Aligned_cols=198 Identities=22% Similarity=0.291 Sum_probs=169.2
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeecccccCCceee
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (367)
++|++++.||+|+||+||+|+ ..+++.||||+++.... .....+.+|+.+++.++||||++++++|. .....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence 478999999999999999999 56789999999974332 34578899999999999999999999984 34567
Q ss_pred eEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEEec
Q 017712 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (367)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl~D 301 (367)
+++++++.+++|..++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~---------~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~D 144 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG---------DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLAN 144 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred eEEeeecccccccccccccc---------ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeee
Confidence 89999999999988887655 4668889999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeccCCCcccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCC
Q 017712 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSD 361 (367)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~Pf~ 361 (367)
||.|+......... ....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||.
T Consensus 145 FG~a~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 145 FGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CTTCEECCSCCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred cchhhcccCCCccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 99998765433222 2234688899999987665 6899999999999999999999973
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-44 Score=322.47 Aligned_cols=203 Identities=21% Similarity=0.314 Sum_probs=167.3
Q ss_pred hcCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCc--chhHHHHHHHHHHhCCCCCcceeeeeecccccCCce
Q 017712 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (367)
..++|++.++||+|+||+||+|+ ..+++.||||+++..... ..+.+.+|+.++++++||||+++++++.........
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 36789999999999999999999 567999999998743322 345788999999999999999999998554333334
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..+++++|+.+|+|.+++... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+|+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~----------~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred ceEEEEEeecCCchhhhcccc----------cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccc
Confidence 456777888899999999653 3778999999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||++..... ......||+.|+|||...+. .++.++|||||||++|+|++|+.||.+.
T Consensus 163 ~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 163 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp CCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 99999975432 22234589999999987765 4688999999999999999999999764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=319.07 Aligned_cols=202 Identities=21% Similarity=0.243 Sum_probs=160.9
Q ss_pred cCCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCC--cchhHHHHHHHHHHhCCCCCcceeeeeeccccc-CCce
Q 017712 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGAR 219 (367)
Q Consensus 144 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 219 (367)
.++|++.++||+|+||+||+|+ ..+|+.||||+++.... .....+.+|+.++++++||||++++++|..... +...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 3679999999999999999999 45799999999974332 234568899999999999999999999854322 3457
Q ss_pred eeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceeecCCCceEE
Q 017712 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (367)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~~~~~~~kl 299 (367)
..|+||||+.++ +.+.+.. .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+|+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~~-----------~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEE
T ss_pred eeEEEEeccchH-HHHhhhc-----------CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceee
Confidence 789999999664 5455532 3668899999999999999999 899999999999999999999999
Q ss_pred eccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+|||+++...... ......||+.|+|||++.+..+++++||||+||++|+|++|+.||.+.
T Consensus 161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred echhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 9999988654322 223445899999999999999999999999999999999999999764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-37 Score=282.19 Aligned_cols=201 Identities=20% Similarity=0.257 Sum_probs=154.9
Q ss_pred CCCCCCCcccccCceEEEEEE-ecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-----------CCCcceeeeeecc
Q 017712 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-----------HRNIVRVFTAFSG 212 (367)
Q Consensus 145 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 212 (367)
++|++.++||+|+||+||+|+ ..+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 359999999999999999999 4679999999987422 23467788999988875 5789999988743
Q ss_pred cccCCceeeeEEEEeccCCCH-HHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceee
Q 017712 213 VDYQGARFKAVVYKFMPNGSL-EEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (367)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Nil~ 291 (367)
......+++++++..+.. ......... ..+++..+..++.||+.||+|||+ ..||+||||||+|||+
T Consensus 92 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll 159 (362)
T d1q8ya_ 92 ---KGPNGVHVVMVFEVLGENLLALIKKYEH-------RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLM 159 (362)
T ss_dssp ---EETTEEEEEEEECCCCEEHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEE
T ss_pred ---ccccceeeeeeecccccccccccccccc-------cCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeee
Confidence 223344566666544432 222222211 146678899999999999999993 3799999999999999
Q ss_pred cCCC------ceEEeccccccccCCCCCcceeeeccCCCcccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 017712 292 DDEM------IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (367)
Q Consensus 292 ~~~~------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~Pf~~~ 363 (367)
+.++ .+|++|||.+....... ....||+.|+|||++.+..++.++||||+||++++|++|+.||.+.
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 7654 38999999998653322 2345899999999999999999999999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=4.4e-27 Score=193.34 Aligned_cols=163 Identities=17% Similarity=0.122 Sum_probs=117.7
Q ss_pred CCCCcccccCceEEEEEEecCCCEEEEEEeecCCCc------------------chhHHHHHHHHHHhCCCCCcceeeee
Q 017712 148 SSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG------------------GSKSFKSECKAAINIKHRNIVRVFTA 209 (367)
Q Consensus 148 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~~~~~ 209 (367)
.+.++||+|+||.||+|+..+|+.||||+++..... ......+|...+.++.|+++++.+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356789999999999999888999999987531110 01234578889999999999998866
Q ss_pred ecccccCCceeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 017712 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNV 289 (367)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~~~iiH~dlkp~Ni 289 (367)
.. .+++|||+++..+.++ +...+..++.|++.||.||| +++|+||||||+||
T Consensus 83 ~~---------~~lvme~~~~~~~~~l----------------~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NI 134 (191)
T d1zara2 83 EG---------NAVLMELIDAKELYRV----------------RVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNV 134 (191)
T ss_dssp ET---------TEEEEECCCCEEGGGC----------------CCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSE
T ss_pred cC---------CEEEEEeeccccccch----------------hhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhhe
Confidence 31 2799999987655332 22334568999999999999 89999999999999
Q ss_pred eecCCCceEEeccccccccCCCCCcceeeeccCCCcccCC------ccccCCCCCcchhHHHHHHHH
Q 017712 290 LLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP------EYDLGCEASTYGDVYSFGILL 350 (367)
Q Consensus 290 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwslG~~l 350 (367)
|+++++ ++|+|||.|......... .|... +.+ ...++.++|+||..--+
T Consensus 135 Lv~~~~-~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 135 LVSEEG-IWIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EEETTE-EEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred eeeCCC-EEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999655 899999999765322111 11110 111 24567889999975443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=3.9e-12 Score=109.05 Aligned_cols=89 Identities=22% Similarity=0.355 Sum_probs=55.6
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhccc-chhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPE-RAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~-~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|||||||||+|+||+||+.|++.... ...+...+...... ....+. ..
T Consensus 184 ~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-~~~~~~~~~~~~~~p~~~~~~-----~~-------------------- 237 (276)
T d1uwha_ 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIFMVGRGYLSPDLSKVR-----SN-------------------- 237 (276)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHHTSCCCCGGGSC-----TT--------------------
T ss_pred CCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcCCCCCcchhcc-----cc--------------------
Confidence 3468899999999999999999999764321 11111111111100 000000 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
+-..+..+...|+..+|.+||++.++.+.|+.+.+.
T Consensus 238 ---~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 238 ---CPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 011233456789999999999999999999887653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.05 E-value=2.7e-11 Score=105.51 Aligned_cols=88 Identities=19% Similarity=0.275 Sum_probs=56.0
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
+..|.||||||||++|+||+||++|...... ...+..++..... ...+. ..
T Consensus 209 ~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~~~~~i~~g~~-----~~~p~---~~-------------------- 259 (311)
T d1r0pa_ 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRR-----LLQPE---YC-------------------- 259 (311)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC-----CCCCT---TC--------------------
T ss_pred CCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHHHHHHHHcCCC-----CCCcc---cC--------------------
Confidence 5678999999999999999998888653221 1222233221110 00110 00
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhhhhc
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLL 121 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~~~ 121 (367)
-..+..+...|+..+|++||+|.+|.+.|+.+.+...
T Consensus 260 ---~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 260 ---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 1123345678999999999999999999998876543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.03 E-value=6.3e-11 Score=100.69 Aligned_cols=85 Identities=19% Similarity=0.268 Sum_probs=52.9
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
+..|.|+|||||||+|+||+||.+|..... ....+.+.+..... ...+..
T Consensus 177 ~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~~~~-----~~~p~~------------------------ 226 (263)
T d1sm2a_ 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGFR-----LYKPRL------------------------ 226 (263)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CHHHHHHHHHHTCC-----CCCCTT------------------------
T ss_pred CCCCchhhhcchHHHHHHHHHCCCCCCCCC-CHHHHHHHHHhcCC-----CCCccc------------------------
Confidence 457899999999999999999766643211 11112222221111 000000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
+-.++..+...|+..+|++||++.++.+.|+.+.+
T Consensus 227 --~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 227 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 00123345678999999999999999999987754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.97 E-value=1.4e-10 Score=98.31 Aligned_cols=84 Identities=21% Similarity=0.222 Sum_probs=54.3
Q ss_pred CccccccceeehhHHHHHHHhC-CCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTG-LRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg-~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+.+|.|||||||||+++||+|+ +.|.+.. ....+..++..... .++.+ ...
T Consensus 175 ~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~~---~~~~~-----~~~------------------ 226 (262)
T d1byga_ 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYK---MDAPD-----GCP------------------ 226 (262)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTCC---CCCCT-----TCC------------------
T ss_pred CCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCC---CCCCc-----cCC------------------
Confidence 5689999999999999999994 5554422 22334444432111 01100 000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
.++.++...|+..+|.+||++.++.+.|+.++.
T Consensus 227 -----~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 227 -----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 112244567999999999999999999987754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.97 E-value=1.9e-10 Score=99.73 Aligned_cols=94 Identities=13% Similarity=0.126 Sum_probs=56.6
Q ss_pred cccccceeehhHHHHHHHhCCCCCCCCCCCcc----------cHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccc
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDDMFNDEL----------NLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASS 73 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~----------~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~ 73 (367)
.|.|+|||||||+|+||+||+.|.......+. ........... ...++.+...
T Consensus 195 ~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~p~~~~~------------- 257 (303)
T d1vjya_ 195 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE----QKLRPNIPNR------------- 257 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT----SCCCCCCCGG-------------
T ss_pred cCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhc----cccCCCCCcc-------------
Confidence 67899999999999999999887542211111 11111000000 0001110000
Q ss_pred cccchhhHHHHHHHHhhhcccccccccccccchhHHHHHHHHHhhh
Q 017712 74 TCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (367)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~~ 119 (367)
....++...+..+...|+..+|.+||++.++.+.|+.+...
T Consensus 258 -----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 258 -----WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp -----GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 00112345566788999999999999999999999887653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.96 E-value=8.3e-11 Score=102.03 Aligned_cols=83 Identities=18% Similarity=0.339 Sum_probs=52.6
Q ss_pred CccccccceeehhHHHHHHHhCCC-CCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLR-PNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~-p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|+|||||||+|+||+||.. |..... ...+...+... ...++.+ .
T Consensus 217 ~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~--~~e~~~~v~~~---~~~~~p~-----~-------------------- 266 (301)
T d1lufa_ 217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA--HEEVIYYVRDG---NILACPE-----N-------------------- 266 (301)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHHTT---CCCCCCT-----T--------------------
T ss_pred CCCChhhhhccchhhHHHHHccCCCCCCCCC--HHHHHHHHHcC---CCCCCCc-----c--------------------
Confidence 357899999999999999999975 443221 11222222211 1100000 0
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
+-.++..+...|+..+|.+||++.+|.+.|+.+.
T Consensus 267 ---~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 267 ---CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 0112345678899999999999999999988753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.93 E-value=1.7e-10 Score=98.40 Aligned_cols=83 Identities=22% Similarity=0.245 Sum_probs=51.4
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
+..|.|||||||||+|+||+||.+|...... ...+...+..... ...+ ...
T Consensus 185 ~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~i~~~~~-----~~~p---~~~-------------------- 235 (272)
T d1qpca_ 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYR-----MVRP---DNC-------------------- 235 (272)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCC-----CCCC---TTC--------------------
T ss_pred CCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCC-----CCCc---ccC--------------------
Confidence 4578999999999999999998777543211 1112222211100 0000 000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
-..+..+...|+..+|++||+|.++.+.|+..
T Consensus 236 ---~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 236 ---PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 11233456789999999999999999988753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.92 E-value=1.6e-10 Score=99.97 Aligned_cols=84 Identities=23% Similarity=0.361 Sum_probs=54.0
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+|+||+| |+.|+.... ...+...+..... . ... ..
T Consensus 208 ~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--~~~~~~~i~~~~~--~----~~~--~~-------------------- 257 (299)
T d1jpaa_ 208 RKFTSASDVWSYGIVMWEVMSYGERPYWDMT--NQDVINAIEQDYR--L----PPP--MD-------------------- 257 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTTCC--C----CCC--TT--------------------
T ss_pred CCCCcccccccchHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC--C----CCC--cc--------------------
Confidence 567889999999999999999 888875432 1122222221100 0 000 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
+-..+..+...|+..+|.+||++.++.+.|+.+.+
T Consensus 258 ---~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 258 ---CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 01123345678999999999999999999976543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=1.7e-10 Score=99.15 Aligned_cols=85 Identities=20% Similarity=0.241 Sum_probs=53.3
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
+..+.|||||||||+|+||+||+.|...... ...+...+..... +....
T Consensus 188 ~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~~~~--------~~~~~---------------------- 236 (283)
T d1mqba_ 188 RKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFR--------LPTPM---------------------- 236 (283)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTTCC--------CCCCT----------------------
T ss_pred CCCCCcccccccHHHHHHHHhCCCCccccCC-HHHHHHHHhccCC--------CCCch----------------------
Confidence 4678899999999999999998776442211 1112222111100 00000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
.+-..+..+...|+..+|++||++.++.+.|+.+.+
T Consensus 237 -~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 237 -DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 001223456778999999999999999999887654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.90 E-value=5e-10 Score=97.36 Aligned_cols=84 Identities=19% Similarity=0.150 Sum_probs=52.3
Q ss_pred CccccccceeehhHHHHHHHhCCCC-CCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRP-NDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p-~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|||||||||+++||+||..| .... +...+.+.+.... ..+ .....
T Consensus 201 ~~~~~~sDvwSfGvil~ell~~~~~p~~~~--~~~~~~~~i~~~~---~~~-----~~~~~------------------- 251 (309)
T d1fvra_ 201 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEKLPQGY---RLE-----KPLNC------------------- 251 (309)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHGGGTC---CCC-----CCTTB-------------------
T ss_pred CCCCccceeehhHHHHHHHHhcCCCCCCCC--CHHHHHHHHHhcC---CCC-----CCccC-------------------
Confidence 4578999999999999999998765 4321 1111222211100 000 00000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-.++..+...|+..+|++||+|.++.+.|+.+.+
T Consensus 252 ----~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 252 ----DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1123344567999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.89 E-value=2.8e-10 Score=97.68 Aligned_cols=84 Identities=23% Similarity=0.268 Sum_probs=53.9
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|||||||||+|+||+| |+.|+..... ..+...+.... ..++. ...
T Consensus 187 ~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~~~---~~~~p-----~~~------------------- 237 (285)
T d1u59a_ 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGK---RMECP-----PEC------------------- 237 (285)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTC---CCCCC-----TTC-------------------
T ss_pred CCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC---CCCCC-----CcC-------------------
Confidence 457889999999999999999 8999764321 12222221110 00000 000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-.++..+...|+..+|++||++.++.+.|+....
T Consensus 238 ----~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 238 ----PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0112345678999999999999999999876543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.88 E-value=5.5e-10 Score=97.15 Aligned_cols=85 Identities=14% Similarity=0.151 Sum_probs=53.1
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
+..|.|+|||||||+|+||+|++.|..........+...+......... ...
T Consensus 222 ~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~--------~~~-------------------- 273 (311)
T d1t46a_ 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--------EHA-------------------- 273 (311)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC--------TTS--------------------
T ss_pred CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc--------ccc--------------------
Confidence 5678999999999999999996666442222212223333222111000 000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHHh
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~ 117 (367)
-..+..+...|+..+|.+||++.++.+.|+...
T Consensus 274 ---~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 274 ---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 011334567899999999999999999987653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.85 E-value=4.6e-10 Score=95.89 Aligned_cols=82 Identities=24% Similarity=0.246 Sum_probs=51.6
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|||||||||+++||+| |+.|+.... ...+...+.... ...+. ...
T Consensus 185 ~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--~~~~~~~i~~~~---~~~~p-----~~~------------------- 235 (277)
T d1xbba_ 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKGE---RMGCP-----AGC------------------- 235 (277)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTC---CCCCC-----TTC-------------------
T ss_pred CCCCchhhhccchhhhhHHhhCCCCCCCCCC--HHHHHHHHHcCC---CCCCC-----ccc-------------------
Confidence 456889999999999999998 899975421 111222221110 00000 000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
-..+..+...|+..+|.+||++.++...|+..
T Consensus 236 ----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 236 ----PREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 01123456689999999999999999888654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.84 E-value=8.3e-10 Score=95.48 Aligned_cols=85 Identities=20% Similarity=0.248 Sum_probs=51.9
Q ss_pred CccccccceeehhHHHHHHHhCCC-CCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLR-PNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~-p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|+|||||||+++||+||.+ |...... ...+...+..... ..+.+ ..
T Consensus 211 ~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~~~~~~~~~~~~~---~~~~~-----~~------------------- 262 (299)
T d1ywna1 211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRLKEGTR---MRAPD-----YT------------------- 262 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-SHHHHHHHHHTCC---CCCCT-----TC-------------------
T ss_pred CCCCcccceeehHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCC---CCCCc-----cC-------------------
Confidence 457899999999999999999865 4432211 1112221111110 00000 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+..+...|+..+|.+||++.++.+.|+.+.+
T Consensus 263 ----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 263 ----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0112345668999999999999999999987643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.84 E-value=1.1e-09 Score=95.54 Aligned_cols=84 Identities=18% Similarity=0.314 Sum_probs=53.2
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|||||||||+|+||+| |+.|++.... ..+...+.....-. .+ ..
T Consensus 188 ~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~~~~~~-----~p---~~-------------------- 237 (317)
T d1xkka_ 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLP-----QP---PI-------------------- 237 (317)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHHTCCCC-----CC---TT--------------------
T ss_pred CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCCC-----CC---cc--------------------
Confidence 457899999999999999999 6777654321 12222222111000 00 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
+-..+..+...|+..+|..||++.++...+..+.+
T Consensus 238 ---~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 238 ---CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 01123345668999999999999999998877644
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.83 E-value=3.5e-10 Score=98.31 Aligned_cols=82 Identities=21% Similarity=0.294 Sum_probs=51.3
Q ss_pred CccccccceeehhHHHHHHHhCCCC-CCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRP-NDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p-~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+||||||++|+||+||++| ... .+..++..........++.+ .
T Consensus 210 ~~~~~~~Dv~S~G~il~El~t~~~~p~~~-----~~~~~~~~~i~~~~~~~~p~-----~-------------------- 259 (308)
T d1p4oa_ 210 GVFTTYSDVWSFGVVLWEIATLAEQPYQG-----LSNEQVLRFVMEGGLLDKPD-----N-------------------- 259 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTSCCTTTT-----SCHHHHHHHHHTTCCCCCCT-----T--------------------
T ss_pred CCCCcccccccHHHHHHHHHhCCCCCCCC-----CCHHHHHHHHHhCCCCCCcc-----c--------------------
Confidence 4578899999999999999999754 332 12222222111111111100 0
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
+-..+..+...|+..+|+.||++.++.+.|+..
T Consensus 260 ---~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 260 ---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ---chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 011244567789999999999999999888654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=5e-10 Score=95.98 Aligned_cols=82 Identities=24% Similarity=0.214 Sum_probs=51.6
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
+..|.|+|||||||+|+||+||.+|...... ...+..++...... . .....+
T Consensus 189 ~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~i~~~~~~---~-----~~~~~~------------------- 240 (285)
T d1fmka3 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRM---P-----CPPECP------------------- 240 (285)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCCC---C-----CCTTSC-------------------
T ss_pred CCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCCC---C-----CCcccC-------------------
Confidence 5678999999999999999998877543221 11122222211110 0 000100
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHH
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRL 115 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~ 115 (367)
.++..+...|+..+|++||++.+|...|+.
T Consensus 241 ----~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 241 ----ESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ----HHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 112345678999999999999999887765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.81 E-value=1.4e-09 Score=92.79 Aligned_cols=84 Identities=17% Similarity=0.288 Sum_probs=53.6
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..+.|+|||||||+|+||+| |+.|.+... ...+...+..... ..+ ....+
T Consensus 184 ~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~--~~~~~~~i~~~~~---~~~-----~~~~~------------------ 235 (273)
T d1mp8a_ 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGER---LPM-----PPNCP------------------ 235 (273)
T ss_dssp CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTCC---CCC-----CTTCC------------------
T ss_pred CCCCCccccccchHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCC---CCC-----CCCCC------------------
Confidence 457889999999999999998 788876432 2223222222110 000 00000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
..+..+...|+..+|.+||++.++.+.|+.+.+
T Consensus 236 -----~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 236 -----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112334568999999999999999999887643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.80 E-value=9.1e-10 Score=96.36 Aligned_cols=81 Identities=25% Similarity=0.318 Sum_probs=51.3
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|+|||||||+|+||+| |+.|+..... ...+...+.....- + .....
T Consensus 241 ~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~-~~~~~~~~~~~~~~------~--~p~~~------------------- 292 (325)
T d1rjba_ 241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV-DANFYKLIQNGFKM------D--QPFYA------------------- 292 (325)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHHHHHHHTTCCC------C--CCTTC-------------------
T ss_pred CCCCcceeccchhHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCCC------C--CCCcC-------------------
Confidence 457899999999999999998 8888764322 11222222211100 0 00000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLR 114 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~ 114 (367)
-..+..+...|+..+|++||++.++.+.|.
T Consensus 293 ----~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 293 ----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 011234566899999999999999998874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.79 E-value=9.1e-10 Score=93.83 Aligned_cols=82 Identities=23% Similarity=0.255 Sum_probs=50.9
Q ss_pred ccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
..|.|+|||||||+++||+| |+.|+.... ...+..++...-. . .+..+ ..
T Consensus 190 ~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~--~~~~~~~i~~~~~-~-~~~~~-----~~-------------------- 240 (273)
T d1u46a_ 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHKIDKEGE-R-LPRPE-----DC-------------------- 240 (273)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTSCC-C-CCCCT-----TC--------------------
T ss_pred CCCcchhhhhhHHHHHHHHhCCCCCCCCcC--HHHHHHHHHhCCC-C-CCCcc-----cc--------------------
Confidence 46789999999999999999 888865321 1122222221100 0 00000 00
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
-..+.++...|+..+|++||++.++.+.|...
T Consensus 241 ---~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 241 ---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 01133456789999999999999998877653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.76 E-value=1.5e-09 Score=93.70 Aligned_cols=84 Identities=23% Similarity=0.287 Sum_probs=53.1
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|+||||||||++||+| |+.|..... ...+..++..... +......
T Consensus 212 ~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~--~~~~~~~i~~~~~--------~~~p~~~------------------- 262 (299)
T d1fgka_ 212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEELFKLLKEGHR--------MDKPSNC------------------- 262 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHTTCC--------CCCCSSC-------------------
T ss_pred CCCCchhhhHHhHHHHHHhccCCCCCCCCCC--HHHHHHHHHcCCC--------CCCCccc-------------------
Confidence 467899999999999999999 566654321 1112222211100 0000000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-..+.++...|++.+|.+||++.++.+.|+.+..
T Consensus 263 ----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 263 ----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1123456778999999999999999999987643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.75 E-value=1.6e-09 Score=92.91 Aligned_cols=83 Identities=18% Similarity=0.178 Sum_probs=51.2
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhhH
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (367)
+..|.|+|||||||+|+||+||..|..... +...+.+.+..... .... ...
T Consensus 191 ~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-~~~~~~~~i~~~~~---~~~~-----~~~-------------------- 241 (287)
T d1opja_ 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYR---MERP-----EGC-------------------- 241 (287)
T ss_dssp CCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHHTTCC---CCCC-----TTC--------------------
T ss_pred CCCCchhhhhhHHHHHHHHHhCCCCCCCcc-hHHHHHHHHhcCCC---CCCC-----ccc--------------------
Confidence 457899999999999999999877754211 11112122111110 0000 000
Q ss_pred HHHHHHHhhhcccccccccccccchhHHHHHHHHH
Q 017712 82 LECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (367)
Q Consensus 82 ~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~ 116 (367)
-..+..+...|+..+|.+||++.++.+.|+.+
T Consensus 242 ---~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 242 ---PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 01233456789999999999999998888764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.74 E-value=2e-09 Score=90.76 Aligned_cols=80 Identities=20% Similarity=0.317 Sum_probs=49.7
Q ss_pred CccccccceeehhHHHHHHHh-CCCCCCCCCCCcccHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
+..|.|||||||||+++||+| |+.|++.... ..+..-+.... ....+. ..
T Consensus 176 ~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~~~~~~i~~~~-----~~~~p~---~~------------------- 226 (258)
T d1k2pa_ 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIAQGL-----RLYRPH---LA------------------- 226 (258)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHHTTC-----CCCCCT---TC-------------------
T ss_pred CCCCcceeecccchhhHhHHhcCCCCCCCCCH--HHHHHHHHhCC-----CCCCcc---cc-------------------
Confidence 356889999999999999999 7878754321 11111111110 000000 00
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHH
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLR 114 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~ 114 (367)
-..+..+...|+..+|++||++.++.+.|.
T Consensus 227 ----~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 227 ----SEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp ----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ----cHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 012334566799999999999999988774
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.64 E-value=6.2e-09 Score=88.33 Aligned_cols=28 Identities=36% Similarity=0.515 Sum_probs=25.0
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
|..+.|+|||||||+|+||+||+.|+..
T Consensus 187 ~~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 187 EKYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 4578999999999999999999999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.62 E-value=1.2e-07 Score=79.71 Aligned_cols=148 Identities=13% Similarity=0.087 Sum_probs=92.6
Q ss_pred HHhhcCCCCCCCcccccCceEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCc
Q 017712 140 LYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGA 218 (367)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 218 (367)
+...-..|+..+..+-++.+.||+.. .+++.+++|+...........+.+|...+..+. +--+.+++.+.. ..
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-----~~ 82 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HD 82 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ET
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe-----cC
Confidence 33333455544443334456899886 456677888876544445556788988887764 333566666542 23
Q ss_pred eeeeEEEEeccCCCHHHHhhCCCCCCCCCcchhhhHHHHHHHHHHHHHHHHHhhhCC-----------------------
Q 017712 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC----------------------- 275 (367)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~----------------------- 275 (367)
...++||++++|.++.+...... ....++.+++..|..||+..
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~~--------------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDEQ--------------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTCS--------------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred CceEEEEEecccccccccccccc--------------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence 45689999999988865442211 01113334444444444210
Q ss_pred ---------------------------------CCCeEecCCCCCceeecCCCceEEeccccccc
Q 017712 276 ---------------------------------QPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (367)
Q Consensus 276 ---------------------------------~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (367)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877778999988763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=8.2e-09 Score=87.54 Aligned_cols=28 Identities=25% Similarity=0.363 Sum_probs=24.9
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.|+|||||||+|+||+||+.|++.
T Consensus 189 ~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 189 MSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 3578999999999999999999999763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=1.5e-08 Score=85.90 Aligned_cols=26 Identities=38% Similarity=0.510 Sum_probs=23.2
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++|||||||+|+||+||+.|.+.
T Consensus 183 ~~~~~DiwSlGvilyeml~G~~pf~~ 208 (271)
T d1nvra_ 183 HAEPVDVWSCGIVLTAMLAGELPWDQ 208 (271)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCCceeeeHhHHHHHHHHhCCCCCCC
Confidence 36789999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=98.52 E-value=2.5e-08 Score=84.87 Aligned_cols=27 Identities=41% Similarity=0.621 Sum_probs=24.5
Q ss_pred CccccccceeehhHHHHHHHhCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
+..+.++|||||||+|+||+||+.|++
T Consensus 189 ~~~~~~~DiwSlGvilyelltG~~Pf~ 215 (277)
T d1o6ya_ 189 DSVDARSDVYSLGCVLYEVLTGEPPFT 215 (277)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCCcceecccchHHHHHHHhCCCCCC
Confidence 357889999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.47 E-value=3.3e-08 Score=85.12 Aligned_cols=88 Identities=11% Similarity=0.085 Sum_probs=50.6
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCCCCCCcc--cHHHHHHHhcccchhhhhhhhhhhhhHHHHHHhhhccccccchhh
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDEL--NLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~~~~~~~--~l~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (367)
..+.|+|||||||+++||+||+.|......... ....+...........+ ....
T Consensus 189 ~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~------------------- 244 (299)
T d1ckia_ 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL-----CKGY------------------- 244 (299)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH-----TTTS-------------------
T ss_pred CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh-----ccCC-------------------
Confidence 368899999999999999999999764322111 11111110000000000 0000
Q ss_pred HHHHHHHHhhhcccccccccccccchhHHHHHHHHHhh
Q 017712 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (367)
Q Consensus 81 ~~~~~~~~~~~~~~c~~~~~~~Rp~m~~v~~~L~~~~~ 118 (367)
-.++..+...|+..+|++||+..++.+.|+.+..
T Consensus 245 ----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 245 ----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0112334557888999999999999888776543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.44 E-value=2.9e-08 Score=85.80 Aligned_cols=27 Identities=30% Similarity=0.327 Sum_probs=24.4
Q ss_pred CccccccceeehhHHHHHHHhCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
+..|.|+|||||||+++||+||+.|+.
T Consensus 189 ~~y~~~~DiwSlGvilyel~~g~~Pf~ 215 (309)
T d1u5ra_ 189 GQYDGKVDVWSLGITCIELAERKPPLF 215 (309)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence 357889999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=4.8e-08 Score=82.35 Aligned_cols=27 Identities=26% Similarity=0.468 Sum_probs=24.3
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.|+|||||||+|+||+||+.|++.
T Consensus 180 ~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 180 MHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence 468899999999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.42 E-value=5.3e-08 Score=83.57 Aligned_cols=28 Identities=18% Similarity=0.337 Sum_probs=24.9
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.|+|||||||+|+||+||+.|+..
T Consensus 191 ~~~~~~~DiwSlGvilyell~g~~Pf~~ 218 (293)
T d1jksa_ 191 EPLGLEADMWSIGVITYILLSGASPFLG 218 (293)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCCcccchhhhHHHHHHHcCCCCCCC
Confidence 3578999999999999999999999753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=2.6e-08 Score=85.26 Aligned_cols=26 Identities=35% Similarity=0.483 Sum_probs=23.7
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.|+|||||||+|+||+||+.|+..
T Consensus 192 y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 192 YDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp TTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CChhhhHHHHHHHHHHHhhCCCCCCC
Confidence 57899999999999999999999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.38 E-value=6.5e-08 Score=83.47 Aligned_cols=27 Identities=26% Similarity=0.367 Sum_probs=24.5
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.|+|||||||+|+||+||+.|+..
T Consensus 185 ~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 185 PYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence 468999999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=8.5e-08 Score=82.07 Aligned_cols=27 Identities=30% Similarity=0.446 Sum_probs=24.3
Q ss_pred CccccccceeehhHHHHHHHhCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
+..+.++|||||||+++||+||+.|+.
T Consensus 191 ~~~~~~~DiwSlGvilyemltG~~Pf~ 217 (293)
T d1yhwa1 191 KAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (293)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCCchhceehHhHHHHHHhhCCCCCC
Confidence 346889999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.26 E-value=9.8e-08 Score=83.39 Aligned_cols=26 Identities=19% Similarity=0.416 Sum_probs=23.7
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.|+|||||||+|+||+||+.|+.
T Consensus 189 ~y~~~~DiwSlGvily~lltg~~Pf~ 214 (335)
T d2ozaa1 189 KYDKSCDMWSLGVIMYILLCGYPPFY 214 (335)
T ss_dssp GGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred CCCHHHHHHhhchhHHHHhhCCCCCC
Confidence 36789999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=98.22 E-value=2.4e-07 Score=78.54 Aligned_cols=26 Identities=19% Similarity=0.357 Sum_probs=23.6
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.|.|+||||+||+|+||+||+.|+..
T Consensus 192 ~~~~~DiwslGvilyeml~g~~Pf~~ 217 (277)
T d1phka_ 192 YGKEVDMWSTGVIMYTLLAGSPPFWH 217 (277)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCchheEcccchhhhhhccCCCCCCC
Confidence 57899999999999999999999763
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=2.8e-07 Score=78.57 Aligned_cols=27 Identities=19% Similarity=0.501 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.|+|||||||+|+||+||+.|+..
T Consensus 186 ~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (288)
T d1uu3a_ 186 SACKSSDLWALGCIIYQLVAGLPPFRA 212 (288)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcccceehhhHHHHHHhhCCCCCCC
Confidence 467899999999999999999999763
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=4.3e-07 Score=78.78 Aligned_cols=28 Identities=32% Similarity=0.428 Sum_probs=25.2
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.++|||||||+++||+||+.|+..
T Consensus 178 ~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 178 THYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp SCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 4578999999999999999999999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.20 E-value=2.2e-07 Score=80.08 Aligned_cols=28 Identities=21% Similarity=0.248 Sum_probs=24.9
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
+..+.|+||||+||+++||+||+.|++.
T Consensus 190 ~~y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 190 SSYATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCChhehhhchHHHHHHHHHCCCCCCC
Confidence 3468999999999999999999999763
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=98.17 E-value=3.2e-07 Score=80.53 Aligned_cols=26 Identities=31% Similarity=0.583 Sum_probs=23.9
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.|+||||+||+|+||+||+.|+.
T Consensus 204 ~~~~~~DiwSlGvilyelltG~~Pf~ 229 (352)
T d1koba_ 204 PVGFYTDMWAIGVLGYVLLSGLSPFA 229 (352)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCC
Confidence 46889999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=98.15 E-value=4.5e-07 Score=79.49 Aligned_cols=26 Identities=35% Similarity=0.621 Sum_probs=23.6
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.++|||||||+++||+||+.|+.
T Consensus 201 ~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 201 PVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 35789999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=98.15 E-value=2.1e-07 Score=79.42 Aligned_cols=27 Identities=26% Similarity=0.302 Sum_probs=24.5
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++|||||||+++||+||+.|+..
T Consensus 177 ~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 177 KYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 468999999999999999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=5.3e-07 Score=78.12 Aligned_cols=27 Identities=30% Similarity=0.536 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.|+||||+||+++||+||+.|+..
T Consensus 179 ~~~~~~DiWSlGvily~ll~G~~Pf~~ 205 (321)
T d1tkia_ 179 VVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCchhhcccHHHHHHHHHhCCCCCCC
Confidence 467899999999999999999999753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.13 E-value=3.5e-07 Score=80.72 Aligned_cols=26 Identities=27% Similarity=0.530 Sum_probs=24.0
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.|+|||||||+|+||+||+.|+..
T Consensus 183 ~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 183 YDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCcccchhHHHHHHHHHHhCCCCCCC
Confidence 68899999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.11 E-value=2.8e-07 Score=78.80 Aligned_cols=26 Identities=27% Similarity=0.272 Sum_probs=23.6
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.|+|||||||+++||+||+.|..
T Consensus 178 ~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 178 LYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred CCCchhhccccchHHHHHhhCCCCCC
Confidence 36889999999999999999999964
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.11 E-value=4.1e-07 Score=78.78 Aligned_cols=27 Identities=19% Similarity=0.176 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.|+|||||||+++||+||+.|++.
T Consensus 198 ~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 198 DYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 357899999999999999999999763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.08 E-value=9.6e-06 Score=67.32 Aligned_cols=73 Identities=12% Similarity=0.024 Sum_probs=48.9
Q ss_pred ccccCc-eEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCC--CCcceeeeeecccccCCceeeeEEEEecc
Q 017712 153 IGAGNF-GSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH--RNIVRVFTAFSGVDYQGARFKAVVYKFMP 229 (367)
Q Consensus 153 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 229 (367)
+..|.. +.||+....++..+++|..... ....+..|+..+..+.. -.+.+++.+.. .....+++|++++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEVP 89 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECCS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEeee
Confidence 344443 6789998777888899985432 34457788888877643 33566676542 2345689999998
Q ss_pred CCCH
Q 017712 230 NGSL 233 (367)
Q Consensus 230 ~g~L 233 (367)
|.++
T Consensus 90 G~~~ 93 (255)
T d1nd4a_ 90 GQDL 93 (255)
T ss_dssp SEET
T ss_pred cccc
Confidence 7665
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.07 E-value=7.6e-07 Score=76.10 Aligned_cols=27 Identities=19% Similarity=0.273 Sum_probs=24.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..|.|+|||||||+++||+||+.|...
T Consensus 189 ~~~~~~DiwSlG~~l~elltg~~Pf~~ 215 (293)
T d1csna_ 189 EQSRRDDLEALGHVFMYFLRGSLPWQG 215 (293)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred CCChHHHHHHhhHHHHHHHhCCCcCCC
Confidence 378899999999999999999999863
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.07 E-value=3.1e-07 Score=78.79 Aligned_cols=28 Identities=29% Similarity=0.355 Sum_probs=24.7
Q ss_pred CccccccceeehhHHHHHHHhCCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
++.+.|+|||||||+++||+||+.|++.
T Consensus 178 ~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 178 KYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp SSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCccccccccchhhhHHhhCCCCCCC
Confidence 3468899999999999999999999763
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.06 E-value=3e-07 Score=77.83 Aligned_cols=25 Identities=36% Similarity=0.545 Sum_probs=22.3
Q ss_pred cccccceeehhHHHHHHHhCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
.+.++|||||||+|+||+||+.|+.
T Consensus 187 ~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 187 HGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCcccccccceeeehhHhhCCCCCC
Confidence 3567899999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.04 E-value=8.8e-07 Score=76.72 Aligned_cols=27 Identities=30% Similarity=0.417 Sum_probs=23.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.|+|||||||+|+||+||+.|+..
T Consensus 208 ~~~~ksDIWSlG~iLyelltG~~PF~~ 234 (322)
T d1vzoa_ 208 GHDKAVDWWSLGVLMYELLTGASPFTV 234 (322)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred CCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 357899999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.01 E-value=8.2e-07 Score=76.12 Aligned_cols=25 Identities=16% Similarity=0.178 Sum_probs=22.9
Q ss_pred cccccceeehhHHHHHHHhCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
.+.|+|||||||+++||+||+.|+.
T Consensus 178 ~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 178 YGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChhhhhhhcchHHHHHHhCcCCCC
Confidence 5789999999999999999998865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.94 E-value=1.5e-06 Score=75.20 Aligned_cols=27 Identities=37% Similarity=0.536 Sum_probs=24.6
Q ss_pred CccccccceeehhHHHHHHHhCCCCCC
Q 017712 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 2 g~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
+..+.|+|||||||++.||+||+.|+.
T Consensus 178 ~~~~~~~DiwSlGvilyemltG~~PF~ 204 (320)
T d1xjda_ 178 QKYNHSVDWWSFGVLLYEMLIGQSPFH 204 (320)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCchhhhhhhhHHHHHHHhCCCCCC
Confidence 457889999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.93 E-value=1.3e-06 Score=76.58 Aligned_cols=27 Identities=26% Similarity=0.354 Sum_probs=24.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||+||+|+||+||+.|...
T Consensus 195 ~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 195 RYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCccchhhcchHHHHHHHHCcCCCCC
Confidence 468899999999999999999999753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.86 E-value=1.6e-06 Score=76.08 Aligned_cols=26 Identities=31% Similarity=0.263 Sum_probs=23.7
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.|+||||+||+++||+||+.|+.
T Consensus 199 ~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 199 DYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp SCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred CCCcceeecccceEEEehhhCCCCCC
Confidence 46789999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.82 E-value=4e-06 Score=72.22 Aligned_cols=27 Identities=41% Similarity=0.575 Sum_probs=24.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||+||+|+||+||+.|+..
T Consensus 177 ~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 177 PYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCchhhccccchhHHHHHhCCCCCCC
Confidence 468899999999999999999999763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.81 E-value=3.6e-06 Score=73.58 Aligned_cols=26 Identities=27% Similarity=0.362 Sum_probs=23.8
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.++|||||||+|+||+||+.|+.
T Consensus 214 ~~~~~~DiwSlGvilyemltG~~Pf~ 239 (350)
T d1rdqe_ 214 GYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCccccccchhHHHHHHHhCCCCCC
Confidence 36789999999999999999999975
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.79 E-value=5.5e-05 Score=66.95 Aligned_cols=75 Identities=19% Similarity=0.155 Sum_probs=47.8
Q ss_pred CcccccCceEEEEEEec-CCCEEEEEEeec----C---CCcchhHHHHHHHHHHhCC---CCCcceeeeeecccccCCce
Q 017712 151 NLIGAGNFGSVYNGTLF-DGTTIAVKVFNL----I---RPGGSKSFKSECKAAINIK---HRNIVRVFTAFSGVDYQGAR 219 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~---~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~ 219 (367)
+.||.|....||+.... +++.+++|.-.. . -+....+...|...+..+. ...+++++.+.. .
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-------~ 104 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-------E 104 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------T
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------C
Confidence 35899999999999843 467899997532 1 1123455677888887652 245677776531 1
Q ss_pred eeeEEEEeccCCC
Q 017712 220 FKAVVYKFMPNGS 232 (367)
Q Consensus 220 ~~~lv~e~~~~g~ 232 (367)
..+++||++++..
T Consensus 105 ~~~lvmE~L~~~~ 117 (392)
T d2pula1 105 MAVTVMEDLSHLK 117 (392)
T ss_dssp TTEEEECCCTTSE
T ss_pred CCEEEEeccCCcc
Confidence 2378999997654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.73 E-value=5.6e-06 Score=72.27 Aligned_cols=26 Identities=23% Similarity=0.281 Sum_probs=23.4
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.|+||||+||+++||+||+.|++.
T Consensus 190 ~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 190 YTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp CSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCchhhhhccCceehHHhhCCCCCCC
Confidence 46789999999999999999999764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.73 E-value=8.1e-06 Score=71.66 Aligned_cols=27 Identities=22% Similarity=0.215 Sum_probs=23.2
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.|+||||+||+++||+||+.|+..
T Consensus 205 ~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 205 PWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCccccccchHHHHHHHHHCCCCCCC
Confidence 468899999999999999999999763
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.70 E-value=5.6e-06 Score=72.34 Aligned_cols=26 Identities=23% Similarity=0.331 Sum_probs=23.7
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.++|||||||+++||+||+.|+.
T Consensus 195 ~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 195 HYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCcccchhhhhHHHHHHHhCCCCCC
Confidence 46789999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.57 E-value=2.4e-05 Score=68.42 Aligned_cols=26 Identities=19% Similarity=0.095 Sum_probs=23.4
Q ss_pred ccccccceeehhHHHHHHHhCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~ 28 (367)
..+.++||||+||+++||+||+.|+.
T Consensus 194 ~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 194 GYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCCcccccccchHHHHhhCCCCCC
Confidence 46889999999999999999998864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.43 E-value=0.00013 Score=62.62 Aligned_cols=146 Identities=15% Similarity=0.083 Sum_probs=77.7
Q ss_pred eEEEEEEecCCCEEEEEEeecCCCcchhHHHHHHHHHHhCCCCCcc--eeeeeecccccCCceeeeEEEEeccCCCH---
Q 017712 159 GSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIV--RVFTAFSGVDYQGARFKAVVYKFMPNGSL--- 233 (367)
Q Consensus 159 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~~~~~~~~~~~~~~~~~~lv~e~~~~g~L--- 233 (367)
-.||+++..+|..+++|+.+.... ..+++..|...+..|...++. .....--..........+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 479999988999999999764322 456788898888877432221 11111101111234456788998875322
Q ss_pred ---------------HHHhhCCCCCCCCCcch-hhh-----------------HHHHHHHHHHHHHHHHHh-hhCCCCCe
Q 017712 234 ---------------EEWLRGKDDTNWRPLNF-NFL-----------------IKKKLDIAIDVACALRYL-HCDCQPPI 279 (367)
Q Consensus 234 ---------------~~~l~~~~~~~~~~~~~-~~~-----------------~~~~~~i~~~i~~~L~~l-H~~~~~~i 279 (367)
+..............+. .+. .......+.++...+.-. ......++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11111111110001110 000 011122223333333222 12224678
Q ss_pred EecCCCCCceeecCCCceEEeccccccc
Q 017712 280 AHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (367)
Q Consensus 280 iH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (367)
||+|+.|.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998763
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=97.32 E-value=2e-05 Score=68.15 Aligned_cols=26 Identities=23% Similarity=0.231 Sum_probs=23.5
Q ss_pred cccccceeehhHHHHHHHhCCCCCCC
Q 017712 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 4 ~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
.+.++||||+||+++||++|+.|+..
T Consensus 207 ~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 207 YDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp CCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCcccchhhhhhhhHHhccCCCCCCC
Confidence 57899999999999999999999753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.27 E-value=3.1e-05 Score=67.06 Aligned_cols=27 Identities=22% Similarity=0.357 Sum_probs=24.1
Q ss_pred ccccccceeehhHHHHHHHhCCCCCCC
Q 017712 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (367)
Q Consensus 3 ~~s~ksDVySfGVvllEl~tg~~p~~~ 29 (367)
..+.++||||+||+|.||+||+.|+..
T Consensus 181 ~y~~~~DiwSlGvilyeml~G~~pf~~ 207 (337)
T d1o6la_ 181 DYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCChhhcccchhhHHHHHHHCCCCCCC
Confidence 468899999999999999999999753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.06 E-value=0.0013 Score=57.91 Aligned_cols=72 Identities=15% Similarity=0.258 Sum_probs=48.3
Q ss_pred CcccccCceEEEEEEecC--------CCEEEEEEeecCCCcchhHHHHHHHHHHhCC-CCCcceeeeeecccccCCceee
Q 017712 151 NLIGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFK 221 (367)
Q Consensus 151 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 221 (367)
+.|+-|-.-.+|++...+ .+.|.+++.- . ........+|..+++.+. +.-.++++++|.+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--------- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG--------- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---------
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---------
Confidence 457788888999987543 3567777754 2 223345678998888874 4334588887631
Q ss_pred eEEEEeccCCCH
Q 017712 222 AVVYKFMPNGSL 233 (367)
Q Consensus 222 ~lv~e~~~~g~L 233 (367)
.+|+||++|.+|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 689999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.75 E-value=0.004 Score=52.69 Aligned_cols=31 Identities=23% Similarity=0.293 Sum_probs=28.2
Q ss_pred CCCeEecCCCCCceeecCCCceEEecccccc
Q 017712 276 QPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (367)
Q Consensus 276 ~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (367)
..++||+|+.+.||+++++...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5789999999999999988877899999875
|